




Analysis Type:	PANTHER Overrepresentation Test (Released 20200728)
Annotation Version and Release Date:	GO Ontology database DOI:  10.5281/zenodo.4437524 Released 2021-01-01
Analyzed List:	upload_1 (Mus musculus)
Reference List:	mouse_bg.txt (Mus musculus)	There are duplicate IDs in the file. The unique set of IDs will be used.
Test Type:	BINOMIAL
Correction:	NONE
GO biological process complete	mouse_bg.txt - REFLIST (18060)	upload_1 (421)	upload_1 (expected)	upload_1 (over/under)	upload_1 (fold Enrichment)	upload_1 (raw P-value)
negative regulation of citrulline biosynthetic process (GO:1903249)	1	1	.02	+	42.90	2.30E-02
regulation of citrulline biosynthetic process (GO:1903248)	1	1	.02	+	42.90	2.30E-02
positive regulation of cytosolic calcium ion concentration involved in egg activation (GO:0060470)	1	1	.02	+	42.90	2.30E-02
positive regulation of cellular defense response (GO:0010186)	1	1	.02	+	42.90	2.30E-02
regulation of cellular defense response (GO:0010185)	1	1	.02	+	42.90	2.30E-02
response to chlorate (GO:0010157)	1	1	.02	+	42.90	2.30E-02
coronal suture morphogenesis (GO:0060365)	1	1	.02	+	42.90	2.30E-02
asparagine transport (GO:0006867)	1	1	.02	+	42.90	2.30E-02
neural fold bending (GO:0021503)	1	1	.02	+	42.90	2.30E-02
transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185)	1	1	.02	+	42.90	2.30E-02
negative regulation of cellular amine catabolic process (GO:0033242)	1	1	.02	+	42.90	2.30E-02
regulation of cellular amine catabolic process (GO:0033241)	1	1	.02	+	42.90	2.30E-02
mRNA cleavage involved in gene silencing by siRNA (GO:0090625)	1	1	.02	+	42.90	2.30E-02
positive regulation of glutamine transport (GO:2000487)	1	1	.02	+	42.90	2.30E-02
benzoyl-CoA metabolic process (GO:1901787)	1	1	.02	+	42.90	2.30E-02
cellular response to oleic acid (GO:0071400)	1	1	.02	+	42.90	2.30E-02
vasoconstriction of artery involved in ischemic response to lowering of systemic arterial blood pressure (GO:0002014)	1	1	.02	+	42.90	2.30E-02
aminophospholipid translocation (GO:0140331)	1	1	.02	+	42.90	2.30E-02
lysophospholipid translocation (GO:0140329)	1	1	.02	+	42.90	2.30E-02
fibroblast growth factor receptor apoptotic signaling pathway (GO:1902178)	1	1	.02	+	42.90	2.30E-02
behavioral response to nutrient (GO:0051780)	1	1	.02	+	42.90	2.30E-02
endosome fission (GO:0140285)	2	2	.05	+	42.90	1.05E-03
cellular response to tumor cell (GO:0071228)	1	1	.02	+	42.90	2.30E-02
negative regulation of elastin biosynthetic process (GO:0051545)	1	1	.02	+	42.90	2.30E-02
regulation of elastin biosynthetic process (GO:0051543)	1	1	.02	+	42.90	2.30E-02
regulation of prostaglandin catabolic process (GO:1905828)	1	1	.02	+	42.90	2.30E-02
negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis (GO:2000057)	1	1	.02	+	42.90	2.30E-02
regulation of Wnt signaling pathway involved in digestive tract morphogenesis (GO:2000056)	1	1	.02	+	42.90	2.30E-02
negative regulation of axon extension involved in regeneration (GO:0048692)	1	1	.02	+	42.90	2.30E-02
proline import across plasma membrane (GO:1905647)	1	1	.02	+	42.90	2.30E-02
negative regulation of the force of heart contraction (GO:0098736)	1	1	.02	+	42.90	2.30E-02
negative regulation of heat generation (GO:0031651)	1	1	.02	+	42.90	2.30E-02
negative regulation of myeloid progenitor cell differentiation (GO:1905454)	1	1	.02	+	42.90	2.30E-02
negative regulation of macrophage proliferation (GO:0120042)	1	1	.02	+	42.90	2.30E-02
protein localization to M-band (GO:0036309)	1	1	.02	+	42.90	2.30E-02
positive regulation of calcium-independent cell-cell adhesion (GO:0051041)	1	1	.02	+	42.90	2.30E-02
glycine betaine transport (GO:0031460)	1	1	.02	+	42.90	2.30E-02
negative regulation of glutamate receptor signaling pathway (GO:1900450)	1	1	.02	+	42.90	2.30E-02
fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow (GO:0035604)	1	1	.02	+	42.90	2.30E-02
fibroblast growth factor receptor signaling pathway involved in hemopoiesis (GO:0035603)	1	1	.02	+	42.90	2.30E-02
fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell (GO:0035602)	1	1	.02	+	42.90	2.30E-02
G protein-coupled purinergic nucleotide receptor signaling pathway (GO:0035589)	1	1	.02	+	42.90	2.30E-02
L-proline transmembrane transport (GO:1904555)	1	1	.02	+	42.90	2.30E-02
endosome membrane tubulation (GO:0097750)	2	2	.05	+	42.90	1.05E-03
negative regulation of lung blood pressure (GO:0061767)	1	1	.02	+	42.90	2.30E-02
endothelin maturation (GO:0034959)	1	1	.02	+	42.90	2.30E-02
negative regulation of arginine catabolic process (GO:1900082)	1	1	.02	+	42.90	2.30E-02
regulation of arginine catabolic process (GO:1900081)	1	1	.02	+	42.90	2.30E-02
regulation of phosphatidylserine metabolic process (GO:0150178)	1	1	.02	+	42.90	2.30E-02
regulation of phosphatidylethanolamine metabolic process (GO:0150175)	1	1	.02	+	42.90	2.30E-02
positive regulation of CD80 production (GO:0150145)	1	1	.02	+	42.90	2.30E-02
regulation of CD80 production (GO:0150143)	1	1	.02	+	42.90	2.30E-02
positive regulation of CD86 production (GO:0150142)	1	1	.02	+	42.90	2.30E-02
regulation of CD86 production (GO:0150140)	1	1	.02	+	42.90	2.30E-02
calcitonin catabolic process (GO:0010816)	1	1	.02	+	42.90	2.30E-02
substance P catabolic process (GO:0010814)	1	1	.02	+	42.90	2.30E-02
cellular response to arsenite(3-) (GO:1903841)	1	1	.02	+	42.90	2.30E-02
response to arsenite(3-) (GO:1903840)	1	1	.02	+	42.90	2.30E-02
multiple spine synapse organization, single dendrite (GO:0150090)	1	1	.02	+	42.90	2.30E-02
multiple spine synapse organization (GO:0150089)	1	1	.02	+	42.90	2.30E-02
L-proline import across plasma membrane (GO:1904271)	1	1	.02	+	42.90	2.30E-02
negative regulation of nitric oxide mediated signal transduction (GO:0010751)	2	2	.05	+	42.90	1.05E-03
positive regulation of transcription from RNA polymerase II promoter in response to heat stress (GO:0061408)	1	1	.02	+	42.90	2.30E-02
regulation of phosphatidate phosphatase activity (GO:1903730)	1	1	.02	+	42.90	2.30E-02
negative regulation of membrane tubulation (GO:1903526)	1	1	.02	+	42.90	2.30E-02
cellular response to methyl methanesulfonate (GO:0072703)	1	1	.02	+	42.90	2.30E-02
response to methyl methanesulfonate (GO:0072702)	1	1	.02	+	42.90	2.30E-02
negative regulation of chronic inflammatory response to non-antigenic stimulus (GO:0002881)	1	1	.02	+	42.90	2.30E-02
positive regulation of translation, ncRNA-mediated (GO:0045975)	1	1	.02	+	42.90	2.30E-02
adult somatic muscle development (GO:0007527)	1	1	.02	+	42.90	2.30E-02
regulation of retina development in camera-type eye (GO:1902866)	1	1	.02	+	42.90	2.30E-02
regulation of vasoconstriction by circulating norepinephrine (GO:0003117)	1	1	.02	+	42.90	2.30E-02
regulation of vasoconstriction by norepinephrine (GO:0003116)	1	1	.02	+	42.90	2.30E-02
negative regulation of hippocampal neuron apoptotic process (GO:0110091)	3	2	.07	+	28.60	2.33E-03
response to oleic acid (GO:0034201)	2	1	.05	+	21.45	4.56E-02
negative regulation of cellular amino acid metabolic process (GO:0045763)	2	1	.05	+	21.45	4.56E-02
orbitofrontal cortex development (GO:0021769)	2	1	.05	+	21.45	4.56E-02
mammillary body development (GO:0021767)	2	1	.05	+	21.45	4.56E-02
substantia nigra development (GO:0021762)	2	1	.05	+	21.45	4.56E-02
regulation of systemic arterial blood pressure by atrial natriuretic peptide (GO:0003050)	2	1	.05	+	21.45	4.56E-02
isoprenoid biosynthetic process via mevalonate (GO:1902767)	2	1	.05	+	21.45	4.56E-02
positive regulation of lens fiber cell differentiation (GO:1902748)	2	1	.05	+	21.45	4.56E-02
negative regulation of toll-like receptor 9 signaling pathway (GO:0034164)	2	1	.05	+	21.45	4.56E-02
pro-T cell differentiation (GO:0002572)	2	1	.05	+	21.45	4.56E-02
farnesyl diphosphate biosynthetic process, mevalonate pathway (GO:0010142)	2	1	.05	+	21.45	4.56E-02
peptide antigen assembly with MHC class I protein complex (GO:0002502)	2	1	.05	+	21.45	4.56E-02
negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071878)	4	2	.09	+	21.45	4.08E-03
negative regulation of B cell differentiation (GO:0045578)	4	2	.09	+	21.45	4.08E-03
regulation of melanosome organization (GO:1903056)	2	1	.05	+	21.45	4.56E-02
regulation of systemic arterial blood pressure by ischemic conditions (GO:0001980)	2	1	.05	+	21.45	4.56E-02
positive regulation of microtubule plus-end binding (GO:1903033)	2	1	.05	+	21.45	4.56E-02
regulation of microtubule plus-end binding (GO:1903031)	2	1	.05	+	21.45	4.56E-02
MHC class I protein complex assembly (GO:0002397)	2	1	.05	+	21.45	4.56E-02
progesterone biosynthetic process (GO:0006701)	2	1	.05	+	21.45	4.56E-02
positive regulation of transforming growth factor beta3 production (GO:0032916)	2	1	.05	+	21.45	4.56E-02
positive regulation of MHC class I biosynthetic process (GO:0045345)	4	2	.09	+	21.45	4.08E-03
interleukin-33-mediated signaling pathway (GO:0038172)	2	1	.05	+	21.45	4.56E-02
lysophospholipid transport (GO:0051977)	2	1	.05	+	21.45	4.56E-02
regulation of glutamate uptake involved in transmission of nerve impulse (GO:0051946)	2	1	.05	+	21.45	4.56E-02
regulation of amino acid uptake involved in synaptic transmission (GO:0051941)	2	1	.05	+	21.45	4.56E-02
regulation of glutamine transport (GO:2000485)	2	1	.05	+	21.45	4.56E-02
ovarian follicle atresia (GO:0001552)	2	1	.05	+	21.45	4.56E-02
negative regulation of lamellipodium morphogenesis (GO:2000393)	2	1	.05	+	21.45	4.56E-02
transepithelial L-ascorbic acid transport (GO:0070904)	2	1	.05	+	21.45	4.56E-02
interleukin-18 production (GO:0032621)	2	1	.05	+	21.45	4.56E-02
positive regulation of presynaptic membrane organization (GO:1901631)	2	1	.05	+	21.45	4.56E-02
Golgi calcium ion transport (GO:0032472)	2	1	.05	+	21.45	4.56E-02
Golgi calcium ion homeostasis (GO:0032468)	2	1	.05	+	21.45	4.56E-02
bombesin receptor signaling pathway (GO:0031989)	2	1	.05	+	21.45	4.56E-02
negative regulation of somatostatin secretion (GO:0090275)	2	1	.05	+	21.45	4.56E-02
NMDA selective glutamate receptor signaling pathway (GO:0098989)	4	2	.09	+	21.45	4.08E-03
negative regulation of transforming growth factor beta activation (GO:1901389)	2	1	.05	+	21.45	4.56E-02
negative regulation of sprouting of injured axon (GO:0048688)	2	1	.05	+	21.45	4.56E-02
vitamin D receptor signaling pathway (GO:0070561)	2	1	.05	+	21.45	4.56E-02
collateral sprouting in absence of injury (GO:0048669)	2	1	.05	+	21.45	4.56E-02
leukocyte adhesive activation (GO:0050902)	2	1	.05	+	21.45	4.56E-02
mRNA cleavage involved in gene silencing (GO:0098795)	2	1	.05	+	21.45	4.56E-02
intrinsic apoptotic signaling pathway in response to hydrogen peroxide (GO:0036481)	2	1	.05	+	21.45	4.56E-02
cell death in response to hydrogen peroxide (GO:0036474)	4	2	.09	+	21.45	4.08E-03
regulation of myeloid progenitor cell differentiation (GO:1905453)	2	1	.05	+	21.45	4.56E-02
pore formation in membrane of other organism (GO:0035915)	2	1	.05	+	21.45	4.56E-02
regulation of myosin II filament organization (GO:0043519)	2	1	.05	+	21.45	4.56E-02
protein localization to T-tubule (GO:0036371)	2	1	.05	+	21.45	4.56E-02
vesicle tethering to endoplasmic reticulum (GO:0099044)	2	1	.05	+	21.45	4.56E-02
aortic smooth muscle cell differentiation (GO:0035887)	2	1	.05	+	21.45	4.56E-02
regulation of calcium-independent cell-cell adhesion (GO:0051040)	2	1	.05	+	21.45	4.56E-02
negative regulation of beta-catenin-TCF complex assembly (GO:1904864)	2	1	.05	+	21.45	4.56E-02
regulation of beta-catenin-TCF complex assembly (GO:1904863)	2	1	.05	+	21.45	4.56E-02
negative regulation of core promoter binding (GO:1904797)	2	1	.05	+	21.45	4.56E-02
dendritic cell homeostasis (GO:0036145)	2	1	.05	+	21.45	4.56E-02
very long-chain fatty-acyl-CoA metabolic process (GO:0036111)	2	1	.05	+	21.45	4.56E-02
fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development (GO:0035607)	2	1	.05	+	21.45	4.56E-02
progesterone secretion (GO:0042701)	2	1	.05	+	21.45	4.56E-02
negative regulation of astrocyte activation (GO:0061889)	2	1	.05	+	21.45	4.56E-02
regulation of astrocyte activation (GO:0061888)	2	1	.05	+	21.45	4.56E-02
positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry (GO:1900224)	2	1	.05	+	21.45	4.56E-02
membrane tubulation (GO:0097749)	4	2	.09	+	21.45	4.08E-03
L-ascorbic acid transmembrane transport (GO:0015882)	2	1	.05	+	21.45	4.56E-02
positive regulation of cardiac muscle tissue development (GO:0055025)	2	1	.05	+	21.45	4.56E-02
histidine transport (GO:0015817)	2	1	.05	+	21.45	4.56E-02
myo-inositol transport (GO:0015798)	2	1	.05	+	21.45	4.56E-02
neuropeptide catabolic process (GO:0010813)	2	1	.05	+	21.45	4.56E-02
mRNA cleavage involved in gene silencing by miRNA (GO:0035279)	2	1	.05	+	21.45	4.56E-02
positive regulation of transcription from RNA polymerase II promoter in response to acidic pH (GO:0061402)	2	1	.05	+	21.45	4.56E-02
response to luteinizing hormone (GO:0034699)	2	1	.05	+	21.45	4.56E-02
epicardium-derived cardiac fibroblast cell development (GO:0060939)	2	1	.05	+	21.45	4.56E-02
epicardium-derived cardiac fibroblast cell differentiation (GO:0060938)	2	1	.05	+	21.45	4.56E-02
cardiac fibroblast cell development (GO:0060936)	2	1	.05	+	21.45	4.56E-02
cardiac fibroblast cell differentiation (GO:0060935)	2	1	.05	+	21.45	4.56E-02
mesenchymal cell differentiation involved in lung development (GO:0060915)	2	1	.05	+	21.45	4.56E-02
melanocyte migration (GO:0097324)	2	1	.05	+	21.45	4.56E-02
closure of optic fissure (GO:0061386)	2	1	.05	+	21.45	4.56E-02
mammillary axonal complex development (GO:0061373)	2	1	.05	+	21.45	4.56E-02
positive regulation of extracellular exosome assembly (GO:1903553)	4	2	.09	+	21.45	4.08E-03
cellular response to diamide (GO:0072738)	2	1	.05	+	21.45	4.56E-02
response to diamide (GO:0072737)	2	1	.05	+	21.45	4.56E-02
transition between slow and fast fiber (GO:0014886)	2	1	.05	+	21.45	4.56E-02
regulation of chronic inflammatory response to non-antigenic stimulus (GO:0002880)	2	1	.05	+	21.45	4.56E-02
hydrogen peroxide-mediated programmed cell death (GO:0010421)	2	1	.05	+	21.45	4.56E-02
neural plate axis specification (GO:0021997)	2	1	.05	+	21.45	4.56E-02
positive regulation of sodium:potassium-exchanging ATPase activity (GO:1903408)	2	1	.05	+	21.45	4.56E-02
branch elongation involved in salivary gland morphogenesis (GO:0060667)	2	1	.05	+	21.45	4.56E-02
mammary gland bud formation (GO:0060615)	2	1	.05	+	21.45	4.56E-02
endodermal digestive tract morphogenesis (GO:0061031)	4	2	.09	+	21.45	4.08E-03
oxygen metabolic process (GO:0072592)	2	1	.05	+	21.45	4.56E-02
fibroblast growth factor receptor signaling pathway involved in mammary gland specification (GO:0060595)	2	1	.05	+	21.45	4.56E-02
squamous basal epithelial stem cell differentiation involved in prostate gland acinus development (GO:0060529)	2	1	.05	+	21.45	4.56E-02
miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280)	7	3	.16	+	18.38	6.37E-04
fat pad development (GO:0060613)	7	3	.16	+	18.38	6.37E-04
negative regulation of lamellipodium organization (GO:1902744)	5	2	.12	+	17.16	6.27E-03
definitive erythrocyte differentiation (GO:0060318)	5	2	.12	+	17.16	6.27E-03
anterior/posterior axon guidance (GO:0033564)	5	2	.12	+	17.16	6.27E-03
regulation of hippocampal neuron apoptotic process (GO:0110089)	5	2	.12	+	17.16	6.27E-03
maternal process involved in parturition (GO:0060137)	5	2	.12	+	17.16	6.27E-03
microglial cell activation involved in immune response (GO:0002282)	5	2	.12	+	17.16	6.27E-03
regulation of MHC class I biosynthetic process (GO:0045343)	5	2	.12	+	17.16	6.27E-03
dichotomous subdivision of terminal units involved in salivary gland branching (GO:0060666)	5	2	.12	+	17.16	6.27E-03
muscular septum morphogenesis (GO:0003150)	5	2	.12	+	17.16	6.27E-03
RNA secondary structure unwinding (GO:0010501)	8	3	.19	+	16.09	9.35E-04
small RNA loading onto RISC (GO:0070922)	9	3	.21	+	14.30	1.31E-03
nonassociative learning (GO:0046958)	9	3	.21	+	14.30	1.31E-03
negative regulation of dendritic cell antigen processing and presentation (GO:0002605)	3	1	.07	+	14.30	6.75E-02
negative regulation of cardiac muscle hypertrophy in response to stress (GO:1903243)	6	2	.14	+	14.30	8.90E-03
negative regulation of leukocyte tethering or rolling (GO:1903237)	3	1	.07	+	14.30	6.75E-02
glial cell fate determination (GO:0007403)	3	1	.07	+	14.30	6.75E-02
negative regulation of lens fiber cell differentiation (GO:1902747)	6	2	.14	+	14.30	8.90E-03
negative regulation of satellite cell differentiation (GO:1902725)	3	1	.07	+	14.30	6.75E-02
negative regulation of skeletal muscle satellite cell proliferation (GO:1902723)	3	1	.07	+	14.30	6.75E-02
negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:0002581)	3	1	.07	+	14.30	6.75E-02
wax metabolic process (GO:0010166)	3	1	.07	+	14.30	6.75E-02
neurofilament bundle assembly (GO:0033693)	3	1	.07	+	14.30	6.75E-02
peptide antigen assembly with MHC protein complex (GO:0002501)	3	1	.07	+	14.30	6.75E-02
positive regulation of dopamine biosynthetic process (GO:1903181)	3	1	.07	+	14.30	6.75E-02
regulation of dopamine biosynthetic process (GO:1903179)	3	1	.07	+	14.30	6.75E-02
positive regulation of glucose mediated signaling pathway (GO:1902661)	3	1	.07	+	14.30	6.75E-02
regulation of glucose mediated signaling pathway (GO:1902659)	3	1	.07	+	14.30	6.75E-02
glutamine transport (GO:0006868)	6	2	.14	+	14.30	8.90E-03
wax biosynthetic process (GO:0010025)	3	1	.07	+	14.30	6.75E-02
isopentenyl diphosphate biosynthetic process, mevalonate pathway (GO:0019287)	3	1	.07	+	14.30	6.75E-02
thigmotaxis (GO:0001966)	3	1	.07	+	14.30	6.75E-02
phospholipase C-activating serotonin receptor signaling pathway (GO:0007208)	3	1	.07	+	14.30	6.75E-02
formin-nucleated actin cable organization (GO:0110009)	3	1	.07	+	14.30	6.75E-02
B-1a B cell differentiation (GO:0002337)	3	1	.07	+	14.30	6.75E-02
transforming growth factor beta receptor complex assembly (GO:0007181)	3	1	.07	+	14.30	6.75E-02
negative regulation of integrin-mediated signaling pathway (GO:2001045)	3	1	.07	+	14.30	6.75E-02
farnesyl diphosphate biosynthetic process (GO:0045337)	3	1	.07	+	14.30	6.75E-02
negative regulation of endothelial cell chemotaxis (GO:2001027)	3	1	.07	+	14.30	6.75E-02
positive regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000588)	3	1	.07	+	14.30	6.75E-02
circadian temperature homeostasis (GO:0060086)	3	1	.07	+	14.30	6.75E-02
synaptic transmission involved in micturition (GO:0060084)	3	1	.07	+	14.30	6.75E-02
bile acid signaling pathway (GO:0038183)	3	1	.07	+	14.30	6.75E-02
zonula adherens maintenance (GO:0045218)	3	1	.07	+	14.30	6.75E-02
peripheral nervous system axon regeneration (GO:0014012)	3	1	.07	+	14.30	6.75E-02
succinate transmembrane transport (GO:0071422)	6	2	.14	+	14.30	8.90E-03
negative regulation of interleukin-1 alpha production (GO:0032690)	3	1	.07	+	14.30	6.75E-02
regulation of presynaptic membrane organization (GO:1901629)	3	1	.07	+	14.30	6.75E-02
negative regulation of peptidyl-cysteine S-nitrosylation (GO:1902083)	6	2	.14	+	14.30	8.90E-03
negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process (GO:0140199)	3	1	.07	+	14.30	6.75E-02
stem cell fate specification (GO:0048866)	3	1	.07	+	14.30	6.75E-02
negative regulation of locomotion involved in locomotory behavior (GO:0090327)	3	1	.07	+	14.30	6.75E-02
regulation of arginine metabolic process (GO:0000821)	3	1	.07	+	14.30	6.75E-02
formin-nucleated actin cable assembly (GO:0070649)	3	1	.07	+	14.30	6.75E-02
negative regulation of planar cell polarity pathway involved in axis elongation (GO:2000041)	3	1	.07	+	14.30	6.75E-02
regulation of planar cell polarity pathway involved in axis elongation (GO:2000040)	3	1	.07	+	14.30	6.75E-02
N-terminal peptidyl-lysine acetylation (GO:0018076)	3	1	.07	+	14.30	6.75E-02
epidermal cell fate specification (GO:0009957)	3	1	.07	+	14.30	6.75E-02
regulation of SA node cell action potential (GO:0098907)	3	1	.07	+	14.30	6.75E-02
L-alanine metabolic process (GO:0042851)	3	1	.07	+	14.30	6.75E-02
fibroblast proliferation (GO:0048144)	3	1	.07	+	14.30	6.75E-02
positive regulation of protein localization to phagocytic vesicle (GO:1905171)	3	1	.07	+	14.30	6.75E-02
regulation of protein localization to phagocytic vesicle (GO:1905169)	3	1	.07	+	14.30	6.75E-02
negative regulation of vascular associated smooth muscle contraction (GO:1904694)	3	1	.07	+	14.30	6.75E-02
positive regulation of microtubule binding (GO:1904528)	6	2	.14	+	14.30	8.90E-03
creatine transmembrane transport (GO:0015881)	3	1	.07	+	14.30	6.75E-02
sensitization (GO:0046960)	3	1	.07	+	14.30	6.75E-02
habituation (GO:0046959)	6	2	.14	+	14.30	8.90E-03
positive regulation of vitamin D 24-hydroxylase activity (GO:0010980)	3	1	.07	+	14.30	6.75E-02
regulation of vitamin D 24-hydroxylase activity (GO:0010979)	3	1	.07	+	14.30	6.75E-02
positive regulation of TRAIL-activated apoptotic signaling pathway (GO:1903984)	3	1	.07	+	14.30	6.75E-02
response to sodium arsenite (GO:1903935)	6	2	.14	+	14.30	8.90E-03
negative regulation of protein ADP-ribosylation (GO:0010836)	3	1	.07	+	14.30	6.75E-02
programmed cell death in response to reactive oxygen species (GO:0097468)	3	1	.07	+	14.30	6.75E-02
positive regulation of serine C-palmitoyltransferase activity (GO:1904222)	3	1	.07	+	14.30	6.75E-02
positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity (GO:1904219)	3	1	.07	+	14.30	6.75E-02
regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity (GO:1904217)	3	1	.07	+	14.30	6.75E-02
positive regulation of I-kappaB phosphorylation (GO:1903721)	6	2	.14	+	14.30	8.90E-03
mesenchymal cell proliferation involved in lung development (GO:0060916)	3	1	.07	+	14.30	6.75E-02
positive regulation of mitotic centrosome separation (GO:0046604)	3	1	.07	+	14.30	6.75E-02
positive regulation of microglial cell migration (GO:1904141)	6	2	.14	+	14.30	8.90E-03
behavioral response to formalin induced pain (GO:0061368)	3	1	.07	+	14.30	6.75E-02
behavioral response to chemical pain (GO:0061366)	3	1	.07	+	14.30	6.75E-02
branching involved in lymph vessel morphogenesis (GO:0060854)	3	1	.07	+	14.30	6.75E-02
activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:0097296)	3	1	.07	+	14.30	6.75E-02
negative regulation of lamellipodium assembly (GO:0010593)	3	1	.07	+	14.30	6.75E-02
positive regulation of phosphatidylinositol biosynthetic process (GO:0010513)	3	1	.07	+	14.30	6.75E-02
regulation of extracellular exosome assembly (GO:1903551)	6	2	.14	+	14.30	8.90E-03
establishment of cell polarity involved in ameboidal cell migration (GO:0003365)	3	1	.07	+	14.30	6.75E-02
epicardial cell to mesenchymal cell transition (GO:0003347)	3	1	.07	+	14.30	6.75E-02
negative regulation of skeletal muscle cell proliferation (GO:0014859)	3	1	.07	+	14.30	6.75E-02
DNA methylation on cytosine within a CG sequence (GO:0010424)	3	1	.07	+	14.30	6.75E-02
alveolar secondary septum development (GO:0061144)	3	1	.07	+	14.30	6.75E-02
regulation of sodium:potassium-exchanging ATPase activity (GO:1903406)	3	1	.07	+	14.30	6.75E-02
ventricular zone neuroblast division (GO:0021847)	3	1	.07	+	14.30	6.75E-02
somatic muscle development (GO:0007525)	3	1	.07	+	14.30	6.75E-02
negative regulation of DNA-templated transcription, termination (GO:0060567)	3	1	.07	+	14.30	6.75E-02
negative regulation of non-motile cilium assembly (GO:1902856)	3	1	.07	+	14.30	6.75E-02
prostate epithelial cord elongation (GO:0060523)	3	1	.07	+	14.30	6.75E-02
regulation of systemic arterial blood pressure by endothelin (GO:0003100)	6	2	.14	+	14.30	8.90E-03
regulation of lens fiber cell differentiation (GO:1902746)	10	3	.23	+	12.87	1.76E-03
parturition (GO:0007567)	10	3	.23	+	12.87	1.76E-03
membranous septum morphogenesis (GO:0003149)	10	3	.23	+	12.87	1.76E-03
toll-like receptor 9 signaling pathway (GO:0034162)	7	2	.16	+	12.26	1.19E-02
protein retention in ER lumen (GO:0006621)	7	2	.16	+	12.26	1.19E-02
virion attachment to host cell (GO:0019062)	7	2	.16	+	12.26	1.19E-02
adhesion of symbiont to host cell (GO:0044650)	7	2	.16	+	12.26	1.19E-02
negative regulation of skeletal muscle tissue development (GO:0048642)	7	2	.16	+	12.26	1.19E-02
succinate transport (GO:0015744)	7	2	.16	+	12.26	1.19E-02
regulation of I-kappaB phosphorylation (GO:1903719)	7	2	.16	+	12.26	1.19E-02
regulation of microglial cell migration (GO:1904139)	7	2	.16	+	12.26	1.19E-02
negative regulation of cardiac muscle adaptation (GO:0010616)	7	2	.16	+	12.26	1.19E-02
mammary gland branching involved in pregnancy (GO:0060745)	7	2	.16	+	12.26	1.19E-02
positive regulation of dopamine metabolic process (GO:0045964)	7	2	.16	+	12.26	1.19E-02
positive regulation of catecholamine metabolic process (GO:0045915)	7	2	.16	+	12.26	1.19E-02
negative regulation of synaptic transmission, glutamatergic (GO:0051967)	11	3	.26	+	11.70	2.31E-03
negative regulation of translation, ncRNA-mediated (GO:0040033)	11	3	.26	+	11.70	2.31E-03
miRNA mediated inhibition of translation (GO:0035278)	11	3	.26	+	11.70	2.31E-03
regulation of translation, ncRNA-mediated (GO:0045974)	11	3	.26	+	11.70	2.31E-03
lens fiber cell development (GO:0070307)	15	4	.35	+	11.44	4.66E-04
striatal medium spiny neuron differentiation (GO:0021773)	4	1	.09	+	10.72	8.90E-02
toll-like receptor 2 signaling pathway (GO:0034134)	4	1	.09	+	10.72	8.90E-02
integrin activation (GO:0033622)	8	2	.19	+	10.72	1.53E-02
regulation of TRAIL-activated apoptotic signaling pathway (GO:1903121)	4	1	.09	+	10.72	8.90E-02
positive regulation of axon guidance (GO:1902669)	4	1	.09	+	10.72	8.90E-02
Wnt signaling pathway, calcium modulating pathway (GO:0007223)	4	1	.09	+	10.72	8.90E-02
positive regulation of ovulation (GO:0060279)	4	1	.09	+	10.72	8.90E-02
endocardium formation (GO:0060214)	4	1	.09	+	10.72	8.90E-02
MHC protein complex assembly (GO:0002396)	4	1	.09	+	10.72	8.90E-02
activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171)	4	1	.09	+	10.72	8.90E-02
negative regulation of dendritic cell apoptotic process (GO:2000669)	4	1	.09	+	10.72	8.90E-02
regulation of protein autoubiquitination (GO:1902498)	4	1	.09	+	10.72	8.90E-02
negative regulation of growth hormone secretion (GO:0060125)	4	1	.09	+	10.72	8.90E-02
regulation of transforming growth factor beta3 production (GO:0032910)	4	1	.09	+	10.72	8.90E-02
diacylglycerol biosynthetic process (GO:0006651)	8	2	.19	+	10.72	1.53E-02
farnesyl diphosphate metabolic process (GO:0045338)	4	1	.09	+	10.72	8.90E-02
negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033)	4	1	.09	+	10.72	8.90E-02
somite specification (GO:0001757)	4	1	.09	+	10.72	8.90E-02
chemokine (C-X-C motif) ligand 12 signaling pathway (GO:0038146)	4	1	.09	+	10.72	8.90E-02
positive regulation of natural killer cell chemotaxis (GO:2000503)	4	1	.09	+	10.72	8.90E-02
negative regulation of natural killer cell differentiation involved in immune response (GO:0032827)	4	1	.09	+	10.72	8.90E-02
regulation of natural killer cell differentiation involved in immune response (GO:0032826)	4	1	.09	+	10.72	8.90E-02
negative regulation of natural killer cell differentiation (GO:0032824)	4	1	.09	+	10.72	8.90E-02
negative regulation of appetite by leptin-mediated signaling pathway (GO:0038108)	4	1	.09	+	10.72	8.90E-02
alanine metabolic process (GO:0006522)	4	1	.09	+	10.72	8.90E-02
cellular response to temperature stimulus (GO:0071502)	4	1	.09	+	10.72	8.90E-02
malate transmembrane transport (GO:0071423)	4	1	.09	+	10.72	8.90E-02
conditioned place preference (GO:1990708)	4	1	.09	+	10.72	8.90E-02
cellular response to vitamin D (GO:0071305)	4	1	.09	+	10.72	8.90E-02
positive regulation of bile acid biosynthetic process (GO:0070859)	4	1	.09	+	10.72	8.90E-02
oxidative stress-induced premature senescence (GO:0090403)	4	1	.09	+	10.72	8.90E-02
negative regulation of long-chain fatty acid import into cell (GO:0140213)	4	1	.09	+	10.72	8.90E-02
atrial cardiac muscle cell membrane repolarization (GO:0099624)	4	1	.09	+	10.72	8.90E-02
regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process (GO:0140192)	4	1	.09	+	10.72	8.90E-02
stem cell fate commitment (GO:0048865)	4	1	.09	+	10.72	8.90E-02
response to hydrostatic pressure (GO:0051599)	4	1	.09	+	10.72	8.90E-02
response to folic acid (GO:0051593)	4	1	.09	+	10.72	8.90E-02
locomotion involved in locomotory behavior (GO:0031987)	8	2	.19	+	10.72	1.53E-02
membrane repolarization during ventricular cardiac muscle cell action potential (GO:0098915)	4	1	.09	+	10.72	8.90E-02
membrane repolarization during atrial cardiac muscle cell action potential (GO:0098914)	4	1	.09	+	10.72	8.90E-02
regulation of atrial cardiac muscle cell action potential (GO:0098910)	4	1	.09	+	10.72	8.90E-02
regulation of AV node cell action potential (GO:0098904)	4	1	.09	+	10.72	8.90E-02
Golgi reassembly (GO:0090168)	4	1	.09	+	10.72	8.90E-02
regulation of axon extension involved in regeneration (GO:0048690)	4	1	.09	+	10.72	8.90E-02
myoblast fate commitment (GO:0048625)	4	1	.09	+	10.72	8.90E-02
embryonic hindgut morphogenesis (GO:0048619)	4	1	.09	+	10.72	8.90E-02
cellular response to potassium ion starvation (GO:0051365)	4	1	.09	+	10.72	8.90E-02
histone glutamine methylation (GO:1990258)	4	1	.09	+	10.72	8.90E-02
steroid hormone secretion (GO:0035929)	4	1	.09	+	10.72	8.90E-02
anterograde neuronal dense core vesicle transport (GO:1990048)	4	1	.09	+	10.72	8.90E-02
negative regulation of leukocyte adhesion to vascular endothelial cell (GO:1904995)	4	1	.09	+	10.72	8.90E-02
malate-aspartate shuttle (GO:0043490)	4	1	.09	+	10.72	8.90E-02
oviduct epithelium development (GO:0035846)	4	1	.09	+	10.72	8.90E-02
telomerase holoenzyme complex assembly (GO:1905323)	4	1	.09	+	10.72	8.90E-02
negative regulation of protein localization to centrosome (GO:1904780)	4	1	.09	+	10.72	8.90E-02
negative regulation of myofibroblast differentiation (GO:1904761)	4	1	.09	+	10.72	8.90E-02
positive regulation of mRNA polyadenylation (GO:1900365)	4	1	.09	+	10.72	8.90E-02
medium-chain fatty-acyl-CoA metabolic process (GO:0036112)	4	1	.09	+	10.72	8.90E-02
articular cartilage development (GO:0061975)	4	1	.09	+	10.72	8.90E-02
negative regulation of metalloendopeptidase activity (GO:1904684)	4	1	.09	+	10.72	8.90E-02
regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry (GO:1900175)	4	1	.09	+	10.72	8.90E-02
regulation of nodal signaling pathway involved in determination of left/right asymmetry (GO:1900145)	4	1	.09	+	10.72	8.90E-02
tripeptide transmembrane transport (GO:0035443)	4	1	.09	+	10.72	8.90E-02
autocrine signaling (GO:0035425)	8	2	.19	+	10.72	1.53E-02
amino-acid betaine transport (GO:0015838)	8	2	.19	+	10.72	1.53E-02
ketone body biosynthetic process (GO:0046951)	4	1	.09	+	10.72	8.90E-02
negative regulation of microglial cell activation (GO:1903979)	8	2	.19	+	10.72	1.53E-02
cellular response to sodium arsenite (GO:1903936)	4	1	.09	+	10.72	8.90E-02
malate transport (GO:0015743)	4	1	.09	+	10.72	8.90E-02
pyruvate family amino acid metabolic process (GO:0009078)	4	1	.09	+	10.72	8.90E-02
oxaloacetate transport (GO:0015729)	4	1	.09	+	10.72	8.90E-02
regulation of cardiac muscle cell membrane potential (GO:0086036)	8	2	.19	+	10.72	1.53E-02
thiosulfate transport (GO:0015709)	4	1	.09	+	10.72	8.90E-02
membrane repolarization during cardiac muscle cell action potential (GO:0086013)	8	2	.19	+	10.72	1.53E-02
positive regulation of skeletal muscle acetylcholine-gated channel clustering (GO:1904395)	4	1	.09	+	10.72	8.90E-02
microglial cell proliferation (GO:0061518)	8	2	.19	+	10.72	1.53E-02
macrophage proliferation (GO:0061517)	8	2	.19	+	10.72	1.53E-02
cellular response to arsenite ion (GO:1903843)	4	1	.09	+	10.72	8.90E-02
response to arsenite ion (GO:1903842)	4	1	.09	+	10.72	8.90E-02
glutathione transmembrane transport (GO:0034775)	4	1	.09	+	10.72	8.90E-02
positive regulation of bile acid metabolic process (GO:1904253)	4	1	.09	+	10.72	8.90E-02
negative regulation of long-chain fatty acid import across plasma membrane (GO:0010748)	4	1	.09	+	10.72	8.90E-02
negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide (GO:1903751)	4	1	.09	+	10.72	8.90E-02
regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide (GO:1903750)	4	1	.09	+	10.72	8.90E-02
negative regulation of complement-dependent cytotoxicity (GO:1903660)	4	1	.09	+	10.72	8.90E-02
siRNA loading onto RISC involved in RNA interference (GO:0035087)	4	1	.09	+	10.72	8.90E-02
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800)	8	2	.19	+	10.72	1.53E-02
regulation of lung blood pressure (GO:0014916)	4	1	.09	+	10.72	8.90E-02
prostate gland morphogenetic growth (GO:0060737)	4	1	.09	+	10.72	8.90E-02
circadian regulation of translation (GO:0097167)	4	1	.09	+	10.72	8.90E-02
vein smooth muscle contraction (GO:0014826)	4	1	.09	+	10.72	8.90E-02
mammary gland bud morphogenesis (GO:0060648)	4	1	.09	+	10.72	8.90E-02
epithelial cell differentiation involved in mammary gland alveolus development (GO:0061030)	4	1	.09	+	10.72	8.90E-02
mammary gland specification (GO:0060594)	4	1	.09	+	10.72	8.90E-02
positive regulation of prostaglandin-endoperoxide synthase activity (GO:0060585)	4	1	.09	+	10.72	8.90E-02
regulation of prostaglandin-endoperoxide synthase activity (GO:0060584)	4	1	.09	+	10.72	8.90E-02
bundle of His development (GO:0003166)	4	1	.09	+	10.72	8.90E-02
semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287)	12	3	.28	+	10.72	2.95E-03
semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285)	13	3	.30	+	9.90	3.68E-03
planar cell polarity pathway involved in neural tube closure (GO:0090179)	13	3	.30	+	9.90	3.68E-03
pre-miRNA processing (GO:0031054)	13	3	.30	+	9.90	3.68E-03
negative regulation of vasoconstriction (GO:0045906)	13	3	.30	+	9.90	3.68E-03
regulation of cardiac muscle hypertrophy in response to stress (GO:1903242)	9	2	.21	+	9.53	1.91E-02
dense core granule transport (GO:1901950)	9	2	.21	+	9.53	1.91E-02
regulation of lamellipodium morphogenesis (GO:2000392)	9	2	.21	+	9.53	1.91E-02
response to redox state (GO:0051775)	9	2	.21	+	9.53	1.91E-02
response to salt (GO:1902074)	9	2	.21	+	9.53	1.91E-02
cardiac muscle cell membrane repolarization (GO:0099622)	9	2	.21	+	9.53	1.91E-02
regulation of peptidyl-cysteine S-nitrosylation (GO:2000169)	9	2	.21	+	9.53	1.91E-02
dense core granule cytoskeletal transport (GO:0099519)	9	2	.21	+	9.53	1.91E-02
collateral sprouting (GO:0048668)	9	2	.21	+	9.53	1.91E-02
dense core granule localization (GO:0032253)	9	2	.21	+	9.53	1.91E-02
hindgut development (GO:0061525)	9	2	.21	+	9.53	1.91E-02
toll-like receptor 7 signaling pathway (GO:0034154)	5	1	.12	+	8.58	1.10E-01
toll-like receptor 3 signaling pathway (GO:0034138)	10	2	.23	+	8.58	2.33E-02
regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:0002580)	5	1	.12	+	8.58	1.10E-01
positive regulation of melanocyte differentiation (GO:0045636)	5	1	.12	+	8.58	1.10E-01
positive regulation of cell adhesion molecule production (GO:0060355)	5	1	.12	+	8.58	1.10E-01
tricarboxylic acid transport (GO:0006842)	5	1	.12	+	8.58	1.10E-01
positive regulation of cell proliferation in bone marrow (GO:0071864)	10	2	.23	+	8.58	2.33E-02
positive regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001241)	15	3	.35	+	8.58	5.47E-03
regulation of ovulation (GO:0060278)	5	1	.12	+	8.58	1.10E-01
positive regulation of apoptotic DNA fragmentation (GO:1902512)	5	1	.12	+	8.58	1.10E-01
pro-B cell differentiation (GO:0002328)	5	1	.12	+	8.58	1.10E-01
positive regulation of endocytic recycling (GO:2001137)	5	1	.12	+	8.58	1.10E-01
G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger (GO:0007199)	5	1	.12	+	8.58	1.10E-01
positive regulation of apoptotic process involved in mammary gland involution (GO:0060058)	5	1	.12	+	8.58	1.10E-01
neurofilament cytoskeleton organization (GO:0060052)	10	2	.23	+	8.58	2.33E-02
regulation of natural killer cell chemotaxis (GO:2000501)	5	1	.12	+	8.58	1.10E-01
positive regulation of cAMP-dependent protein kinase activity (GO:2000481)	5	1	.12	+	8.58	1.10E-01
non-canonical Wnt signaling pathway via JNK cascade (GO:0038031)	5	1	.12	+	8.58	1.10E-01
neuroblast differentiation (GO:0014016)	5	1	.12	+	8.58	1.10E-01
luteinization (GO:0001553)	10	2	.23	+	8.58	2.33E-02
peripheral nervous system neuron axonogenesis (GO:0048936)	5	1	.12	+	8.58	1.10E-01
ventricular cardiac muscle cell membrane repolarization (GO:0099625)	5	1	.12	+	8.58	1.10E-01
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043)	15	3	.35	+	8.58	5.47E-03
regulation of postsynaptic cytosolic calcium ion concentration (GO:0099566)	5	1	.12	+	8.58	1.10E-01
branching morphogenesis of a nerve (GO:0048755)	5	1	.12	+	8.58	1.10E-01
response to follicle-stimulating hormone (GO:0032354)	10	2	.23	+	8.58	2.33E-02
lipid transport across blood-brain barrier (GO:1990379)	5	1	.12	+	8.58	1.10E-01
protein localization to microtubule end (GO:1905725)	5	1	.12	+	8.58	1.10E-01
regulation of establishment of planar polarity involved in neural tube closure (GO:0090178)	15	3	.35	+	8.58	5.47E-03
regulation of sprouting of injured axon (GO:0048686)	5	1	.12	+	8.58	1.10E-01
smooth muscle cell proliferation (GO:0048659)	5	1	.12	+	8.58	1.10E-01
establishment of meiotic spindle localization (GO:0051295)	5	1	.12	+	8.58	1.10E-01
recognition of apoptotic cell (GO:0043654)	5	1	.12	+	8.58	1.10E-01
glucose import across plasma membrane (GO:0098708)	5	1	.12	+	8.58	1.10E-01
G protein-coupled serotonin receptor signaling pathway (GO:0098664)	10	2	.23	+	8.58	2.33E-02
retrograde neuronal dense core vesicle transport (GO:1990049)	5	1	.12	+	8.58	1.10E-01
regulation of DNA-templated transcription, termination (GO:0031554)	5	1	.12	+	8.58	1.10E-01
synaptic growth at neuromuscular junction (GO:0051124)	5	1	.12	+	8.58	1.10E-01
negative regulation of activation-induced cell death of T cells (GO:0070236)	5	1	.12	+	8.58	1.10E-01
plasma membrane lactate transport (GO:0035879)	5	1	.12	+	8.58	1.10E-01
lactate transmembrane transport (GO:0035873)	5	1	.12	+	8.58	1.10E-01
nuclear envelope disassembly (GO:0051081)	5	1	.12	+	8.58	1.10E-01
detection of virus (GO:0009597)	5	1	.12	+	8.58	1.10E-01
lauric acid metabolic process (GO:0048252)	5	1	.12	+	8.58	1.10E-01
establishment or maintenance of actin cytoskeleton polarity (GO:0030950)	5	1	.12	+	8.58	1.10E-01
protein localization to microtubule plus-end (GO:1904825)	5	1	.12	+	8.58	1.10E-01
positive regulation of glucagon secretion (GO:0070094)	5	1	.12	+	8.58	1.10E-01
regulation of myofibroblast differentiation (GO:1904760)	5	1	.12	+	8.58	1.10E-01
aminophospholipid transport (GO:0015917)	5	1	.12	+	8.58	1.10E-01
long-chain fatty acid import across plasma membrane (GO:0015911)	5	1	.12	+	8.58	1.10E-01
isopentenyl diphosphate biosynthetic process (GO:0009240)	5	1	.12	+	8.58	1.10E-01
regulation of microtubule binding (GO:1904526)	10	2	.23	+	8.58	2.33E-02
regulation of cardiac muscle tissue development (GO:0055024)	5	1	.12	+	8.58	1.10E-01
L-serine transport (GO:0015825)	5	1	.12	+	8.58	1.10E-01
aspartate transmembrane transport (GO:0015810)	10	2	.23	+	8.58	2.33E-02
cellular magnesium ion homeostasis (GO:0010961)	5	1	.12	+	8.58	1.10E-01
regulation of cellular response to heat (GO:1900034)	5	1	.12	+	8.58	1.10E-01
citrate transport (GO:0015746)	5	1	.12	+	8.58	1.10E-01
lactate transport (GO:0015727)	5	1	.12	+	8.58	1.10E-01
atrial cardiac muscle cell to AV node cell signaling (GO:0086026)	10	2	.23	+	8.58	2.33E-02
atrial cardiac muscle cell action potential (GO:0086014)	10	2	.23	+	8.58	2.33E-02
membrane disassembly (GO:0030397)	5	1	.12	+	8.58	1.10E-01
regulation of serine C-palmitoyltransferase activity (GO:1904220)	5	1	.12	+	8.58	1.10E-01
regulation of cardiac conduction (GO:1903779)	10	2	.23	+	8.58	2.33E-02
endocardial cell differentiation (GO:0060956)	5	1	.12	+	8.58	1.10E-01
axonemal central apparatus assembly (GO:1904158)	5	1	.12	+	8.58	1.10E-01
positive regulation of alkaline phosphatase activity (GO:0010694)	5	1	.12	+	8.58	1.10E-01
apoptotic chromosome condensation (GO:0030263)	5	1	.12	+	8.58	1.10E-01
positive regulation of platelet-derived growth factor receptor signaling pathway (GO:0010641)	5	1	.12	+	8.58	1.10E-01
regulation of cardiac muscle adaptation (GO:0010612)	10	2	.23	+	8.58	2.33E-02
cell adhesion involved in heart morphogenesis (GO:0061343)	5	1	.12	+	8.58	1.10E-01
regulation of phosphatidylinositol biosynthetic process (GO:0010511)	5	1	.12	+	8.58	1.10E-01
positive regulation of protein localization to cilium (GO:1903566)	5	1	.12	+	8.58	1.10E-01
isopentenyl diphosphate metabolic process (GO:0046490)	5	1	.12	+	8.58	1.10E-01
late endosome to Golgi transport (GO:0034499)	5	1	.12	+	8.58	1.10E-01
negative regulation of dendritic spine maintenance (GO:1902951)	5	1	.12	+	8.58	1.10E-01
skeletal muscle satellite cell activation (GO:0014719)	5	1	.12	+	8.58	1.10E-01
positive regulation of phospholipid translocation (GO:0061092)	5	1	.12	+	8.58	1.10E-01
oxalate transport (GO:0019532)	5	1	.12	+	8.58	1.10E-01
His-Purkinje system development (GO:0003164)	5	1	.12	+	8.58	1.10E-01
lens fiber cell differentiation (GO:0070306)	26	5	.61	+	8.25	4.05E-04
membrane fission (GO:0090148)	16	3	.37	+	8.04	6.52E-03
vasculogenesis involved in coronary vascular morphogenesis (GO:0060979)	16	3	.37	+	8.04	6.52E-03
production of miRNAs involved in gene silencing by miRNA (GO:0035196)	27	5	.63	+	7.94	4.80E-04
regulation of cell proliferation in bone marrow (GO:0071863)	11	2	.26	+	7.80	2.77E-02
actin filament network formation (GO:0051639)	11	2	.26	+	7.80	2.77E-02
cAMP biosynthetic process (GO:0006171)	11	2	.26	+	7.80	2.77E-02
negative regulation of dendrite morphogenesis (GO:0050774)	11	2	.26	+	7.80	2.77E-02
long-chain fatty-acyl-CoA metabolic process (GO:0035336)	11	2	.26	+	7.80	2.77E-02
atrial cardiac muscle cell to AV node cell communication (GO:0086066)	11	2	.26	+	7.80	2.77E-02
membrane repolarization during action potential (GO:0086011)	11	2	.26	+	7.80	2.77E-02
regulation of nitric oxide mediated signal transduction (GO:0010749)	11	2	.26	+	7.80	2.77E-02
dichotomous subdivision of an epithelial terminal unit (GO:0060600)	11	2	.26	+	7.80	2.77E-02
production of small RNA involved in gene silencing by RNA (GO:0070918)	28	5	.65	+	7.66	5.65E-04
dsRNA processing (GO:0031050)	28	5	.65	+	7.66	5.65E-04
locomotor rhythm (GO:0045475)	17	3	.40	+	7.57	7.69E-03
axon regeneration (GO:0031103)	17	3	.40	+	7.57	7.69E-03
fatty-acyl-CoA metabolic process (GO:0035337)	17	3	.40	+	7.57	7.69E-03
positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511)	29	5	.68	+	7.40	6.61E-04
positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846)	29	5	.68	+	7.40	6.61E-04
vascular associated smooth muscle contraction (GO:0014829)	18	3	.42	+	7.15	8.97E-03
negative regulation of chronic inflammatory response (GO:0002677)	6	1	.14	+	7.15	1.31E-01
optic nerve morphogenesis (GO:0021631)	6	1	.14	+	7.15	1.31E-01
regulation of membrane hyperpolarization (GO:1902630)	6	1	.14	+	7.15	1.31E-01
negative regulation of apoptotic process in bone marrow cell (GO:0071866)	6	1	.14	+	7.15	1.31E-01
regulation of apoptotic process in bone marrow cell (GO:0071865)	6	1	.14	+	7.15	1.31E-01
N-acetylneuraminate catabolic process (GO:0019262)	6	1	.14	+	7.15	1.31E-01
lactate biosynthetic process (GO:0019249)	6	1	.14	+	7.15	1.31E-01
intramembranous ossification (GO:0001957)	6	1	.14	+	7.15	1.31E-01
B-1 B cell differentiation (GO:0001923)	6	1	.14	+	7.15	1.31E-01
serotonin receptor signaling pathway (GO:0007210)	12	2	.28	+	7.15	3.25E-02
polyphosphate catabolic process (GO:0006798)	6	1	.14	+	7.15	1.31E-01
polyphosphate metabolic process (GO:0006797)	6	1	.14	+	7.15	1.31E-01
NADH regeneration (GO:0006735)	6	1	.14	+	7.15	1.31E-01
B cell proliferation involved in immune response (GO:0002322)	6	1	.14	+	7.15	1.31E-01
positive regulation of inositol trisphosphate biosynthetic process (GO:0032962)	6	1	.14	+	7.15	1.31E-01
positive regulation of transforming growth factor beta1 production (GO:0032914)	6	1	.14	+	7.15	1.31E-01
TORC2 signaling (GO:0038203)	6	1	.14	+	7.15	1.31E-01
triglyceride mobilization (GO:0006642)	6	1	.14	+	7.15	1.31E-01
monoacylglycerol biosynthetic process (GO:0006640)	6	1	.14	+	7.15	1.31E-01
positive regulation of skeletal muscle cell differentiation (GO:2001016)	6	1	.14	+	7.15	1.31E-01
negative regulation of skeletal muscle cell differentiation (GO:2001015)	6	1	.14	+	7.15	1.31E-01
oviduct development (GO:0060066)	6	1	.14	+	7.15	1.31E-01
positive regulation of cellular amine metabolic process (GO:0033240)	12	2	.28	+	7.15	3.25E-02
DNA methylation on cytosine (GO:0032776)	6	1	.14	+	7.15	1.31E-01
non-canonical Wnt signaling pathway via MAPK cascade (GO:0038030)	6	1	.14	+	7.15	1.31E-01
negative regulation of serotonin secretion (GO:0014063)	6	1	.14	+	7.15	1.31E-01
regulation of acetylcholine secretion, neurotransmission (GO:0014056)	6	1	.14	+	7.15	1.31E-01
negative regulation of gamma-aminobutyric acid secretion (GO:0014053)	6	1	.14	+	7.15	1.31E-01
manganese ion transmembrane transport (GO:0071421)	6	1	.14	+	7.15	1.31E-01
regulation of L-glutamate import across plasma membrane (GO:0002036)	6	1	.14	+	7.15	1.31E-01
intermediate filament bundle assembly (GO:0045110)	6	1	.14	+	7.15	1.31E-01
glomerular visceral epithelial cell migration (GO:0090521)	6	1	.14	+	7.15	1.31E-01
positive regulation of lamellipodium morphogenesis (GO:2000394)	6	1	.14	+	7.15	1.31E-01
positive regulation of clathrin-dependent endocytosis (GO:2000370)	6	1	.14	+	7.15	1.31E-01
negative regulation of glucocorticoid receptor signaling pathway (GO:2000323)	6	1	.14	+	7.15	1.31E-01
peptidyl-glutamine methylation (GO:0018364)	6	1	.14	+	7.15	1.31E-01
hexose import across plasma membrane (GO:0140271)	6	1	.14	+	7.15	1.31E-01
dehydroascorbic acid transport (GO:0070837)	6	1	.14	+	7.15	1.31E-01
cellular response to salt (GO:1902075)	6	1	.14	+	7.15	1.31E-01
D-aspartate import across plasma membrane (GO:0070779)	6	1	.14	+	7.15	1.31E-01
D-aspartate transport (GO:0070777)	6	1	.14	+	7.15	1.31E-01
regulation of locomotion involved in locomotory behavior (GO:0090325)	6	1	.14	+	7.15	1.31E-01
Cdc42 protein signal transduction (GO:0032488)	6	1	.14	+	7.15	1.31E-01
polar body extrusion after meiotic divisions (GO:0040038)	6	1	.14	+	7.15	1.31E-01
regulation of type B pancreatic cell development (GO:2000074)	6	1	.14	+	7.15	1.31E-01
macropinocytosis (GO:0044351)	6	1	.14	+	7.15	1.31E-01
dendritic transport of messenger ribonucleoprotein complex (GO:0098963)	6	1	.14	+	7.15	1.31E-01
dendritic transport of ribonucleoprotein complex (GO:0098961)	6	1	.14	+	7.15	1.31E-01
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway (GO:0090080)	6	1	.14	+	7.15	1.31E-01
monocyte aggregation (GO:0070487)	6	1	.14	+	7.15	1.31E-01
positive regulation of trophoblast cell migration (GO:1901165)	6	1	.14	+	7.15	1.31E-01
negative regulation of trophoblast cell migration (GO:1901164)	6	1	.14	+	7.15	1.31E-01
carbohydrate import across plasma membrane (GO:0098704)	6	1	.14	+	7.15	1.31E-01
regulation of macrophage proliferation (GO:0120040)	6	1	.14	+	7.15	1.31E-01
microtubule severing (GO:0051013)	6	1	.14	+	7.15	1.31E-01
negative regulation of Golgi to plasma membrane protein transport (GO:0042997)	6	1	.14	+	7.15	1.31E-01
tripeptide transport (GO:0042939)	6	1	.14	+	7.15	1.31E-01
regulation of glutamate receptor signaling pathway (GO:1900449)	6	1	.14	+	7.15	1.31E-01
peptidoglycan metabolic process (GO:0000270)	6	1	.14	+	7.15	1.31E-01
regulation of metalloendopeptidase activity (GO:1904683)	6	1	.14	+	7.15	1.31E-01
circadian sleep/wake cycle (GO:0042745)	6	1	.14	+	7.15	1.31E-01
direct ossification (GO:0036072)	6	1	.14	+	7.15	1.31E-01
negative regulation of metallopeptidase activity (GO:1905049)	6	1	.14	+	7.15	1.31E-01
proline transmembrane transport (GO:0035524)	6	1	.14	+	7.15	1.31E-01
peptidoglycan catabolic process (GO:0009253)	6	1	.14	+	7.15	1.31E-01
glucose catabolic process to pyruvate (GO:0061718)	6	1	.14	+	7.15	1.31E-01
maintenance of protein localization in endoplasmic reticulum (GO:0035437)	12	2	.28	+	7.15	3.25E-02
negative regulation of ruffle assembly (GO:1900028)	6	1	.14	+	7.15	1.31E-01
chemorepulsion of axon (GO:0061643)	6	1	.14	+	7.15	1.31E-01
canonical glycolysis (GO:0061621)	6	1	.14	+	7.15	1.31E-01
C4-dicarboxylate transport (GO:0015740)	24	4	.56	+	7.15	2.59E-03
bradykinin catabolic process (GO:0010815)	6	1	.14	+	7.15	1.31E-01
negative regulation of neuroinflammatory response (GO:0150079)	12	2	.28	+	7.15	3.25E-02
negative regulation of plasminogen activation (GO:0010757)	6	1	.14	+	7.15	1.31E-01
negative regulation of cGMP-mediated signaling (GO:0010754)	6	1	.14	+	7.15	1.31E-01
glutathione transport (GO:0034635)	6	1	.14	+	7.15	1.31E-01
olfactory learning (GO:0008355)	6	1	.14	+	7.15	1.31E-01
positive regulation of DNA catabolic process (GO:1903626)	6	1	.14	+	7.15	1.31E-01
neural plate pattern specification (GO:0060896)	6	1	.14	+	7.15	1.31E-01
smoothened signaling pathway involved in dorsal/ventral neural tube patterning (GO:0060831)	6	1	.14	+	7.15	1.31E-01
negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903588)	6	1	.14	+	7.15	1.31E-01
regulation of membrane tubulation (GO:1903525)	6	1	.14	+	7.15	1.31E-01
urinary bladder smooth muscle contraction (GO:0014832)	12	2	.28	+	7.15	3.25E-02
artery smooth muscle contraction (GO:0014824)	12	2	.28	+	7.15	3.25E-02
negative regulation of T-helper 1 type immune response (GO:0002826)	6	1	.14	+	7.15	1.31E-01
choline metabolic process (GO:0019695)	6	1	.14	+	7.15	1.31E-01
ductus arteriosus closure (GO:0097070)	6	1	.14	+	7.15	1.31E-01
negative regulation of muscle adaptation (GO:0014745)	12	2	.28	+	7.15	3.25E-02
regulation of phospholipid translocation (GO:0061091)	6	1	.14	+	7.15	1.31E-01
forebrain ventricular zone progenitor cell division (GO:0021869)	6	1	.14	+	7.15	1.31E-01
ruffle organization (GO:0031529)	25	4	.58	+	6.86	3.00E-03
regulation of skeletal muscle cell differentiation (GO:2001014)	19	3	.44	+	6.77	1.04E-02
detection of temperature stimulus involved in sensory perception of pain (GO:0050965)	19	3	.44	+	6.77	1.04E-02
oligopeptide transport (GO:0006857)	13	2	.30	+	6.60	3.76E-02
mitotic chromosome condensation (GO:0007076)	13	2	.30	+	6.60	3.76E-02
negative regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0106072)	13	2	.30	+	6.60	3.76E-02
regulation of trophoblast cell migration (GO:1901163)	13	2	.30	+	6.60	3.76E-02
regulation of developmental pigmentation (GO:0048070)	13	2	.30	+	6.60	3.76E-02
negative regulation of substrate adhesion-dependent cell spreading (GO:1900025)	13	2	.30	+	6.60	3.76E-02
positive regulation of glial cell migration (GO:1903977)	13	2	.30	+	6.60	3.76E-02
negative regulation of keratinocyte proliferation (GO:0010839)	13	2	.30	+	6.60	3.76E-02
regulation of neuron projection arborization (GO:0150011)	13	2	.30	+	6.60	3.76E-02
bone trabecula morphogenesis (GO:0061430)	13	2	.30	+	6.60	3.76E-02
tonic smooth muscle contraction (GO:0014820)	13	2	.30	+	6.60	3.76E-02
negative regulation of fatty acid oxidation (GO:0046322)	13	2	.30	+	6.60	3.76E-02
branching involved in salivary gland morphogenesis (GO:0060445)	20	3	.47	+	6.43	1.19E-02
positive regulation of transforming growth factor beta production (GO:0071636)	20	3	.47	+	6.43	1.19E-02
detection of mechanical stimulus involved in sensory perception of pain (GO:0050966)	20	3	.47	+	6.43	1.19E-02
regulation of glial cell migration (GO:1903975)	20	3	.47	+	6.43	1.19E-02
bud elongation involved in lung branching (GO:0060449)	7	1	.16	+	6.13	1.51E-01
negative regulation of toll-like receptor 4 signaling pathway (GO:0034144)	7	1	.16	+	6.13	1.51E-01
substrate-dependent cell migration, cell extension (GO:0006930)	7	1	.16	+	6.13	1.51E-01
negative regulation of antigen processing and presentation (GO:0002578)	7	1	.16	+	6.13	1.51E-01
regulation of melanocyte differentiation (GO:0045634)	7	1	.16	+	6.13	1.51E-01
fatty acid elongation, unsaturated fatty acid (GO:0019368)	7	1	.16	+	6.13	1.51E-01
fatty acid elongation, saturated fatty acid (GO:0019367)	7	1	.16	+	6.13	1.51E-01
axonogenesis involved in innervation (GO:0060385)	7	1	.16	+	6.13	1.51E-01
cAMP metabolic process (GO:0046058)	14	2	.33	+	6.13	4.29E-02
blood vessel maturation (GO:0001955)	7	1	.16	+	6.13	1.51E-01
regulation of cilium beat frequency involved in ciliary motility (GO:0060296)	7	1	.16	+	6.13	1.51E-01
cell proliferation involved in metanephros development (GO:0072203)	7	1	.16	+	6.13	1.51E-01
C21-steroid hormone biosynthetic process (GO:0006700)	7	1	.16	+	6.13	1.51E-01
response to tumor cell (GO:0002347)	7	1	.16	+	6.13	1.51E-01
adenylate cyclase-inhibiting serotonin receptor signaling pathway (GO:0007198)	7	1	.16	+	6.13	1.51E-01
SMAD protein complex assembly (GO:0007183)	7	1	.16	+	6.13	1.51E-01
regulation of inositol trisphosphate biosynthetic process (GO:0032960)	7	1	.16	+	6.13	1.51E-01
ganglioside catabolic process (GO:0006689)	7	1	.16	+	6.13	1.51E-01
positive regulation of dendritic cell chemotaxis (GO:2000510)	7	1	.16	+	6.13	1.51E-01
convergent extension involved in axis elongation (GO:0060028)	7	1	.16	+	6.13	1.51E-01
negative regulation of apoptotic process involved in morphogenesis (GO:1902338)	7	1	.16	+	6.13	1.51E-01
lacrimal gland development (GO:0032808)	7	1	.16	+	6.13	1.51E-01
T-tubule organization (GO:0033292)	7	1	.16	+	6.13	1.51E-01
negative regulation of fibrinolysis (GO:0051918)	7	1	.16	+	6.13	1.51E-01
negative regulation of cellular amine metabolic process (GO:0033239)	7	1	.16	+	6.13	1.51E-01
netrin-activated signaling pathway (GO:0038007)	7	1	.16	+	6.13	1.51E-01
phosphatidylinositol 3-kinase signaling (GO:0014065)	35	5	.82	+	6.13	1.51E-03
protein depalmitoylation (GO:0002084)	7	1	.16	+	6.13	1.51E-01
optic cup morphogenesis involved in camera-type eye development (GO:0002072)	7	1	.16	+	6.13	1.51E-01
cellular response to hydroperoxide (GO:0071447)	7	1	.16	+	6.13	1.51E-01
positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902177)	7	1	.16	+	6.13	1.51E-01
cellular response to cholesterol (GO:0071397)	14	2	.33	+	6.13	4.29E-02
negative regulation of hair follicle development (GO:0051799)	7	1	.16	+	6.13	1.51E-01
DNA methylation-dependent heterochromatin assembly (GO:0006346)	7	1	.16	+	6.13	1.51E-01
negative regulation of cell division (GO:0051782)	14	2	.33	+	6.13	4.29E-02
stress-induced premature senescence (GO:0090400)	7	1	.16	+	6.13	1.51E-01
positive regulation of fibroblast apoptotic process (GO:2000271)	7	1	.16	+	6.13	1.51E-01
cellular response to vitamin (GO:0071295)	7	1	.16	+	6.13	1.51E-01
pointed-end actin filament capping (GO:0051694)	7	1	.16	+	6.13	1.51E-01
positive regulation of axon extension involved in axon guidance (GO:0048842)	7	1	.16	+	6.13	1.51E-01
adhesion of symbiont to host (GO:0044406)	14	2	.33	+	6.13	4.29E-02
negative regulation of fatty acid beta-oxidation (GO:0031999)	7	1	.16	+	6.13	1.51E-01
regulation of somatostatin secretion (GO:0090273)	7	1	.16	+	6.13	1.51E-01
positive regulation of inclusion body assembly (GO:0090261)	7	1	.16	+	6.13	1.51E-01
alanine transport (GO:0032328)	14	2	.33	+	6.13	4.29E-02
response to axon injury (GO:0048678)	35	5	.82	+	6.13	1.51E-03
positive regulation of pigment cell differentiation (GO:0050942)	7	1	.16	+	6.13	1.51E-01
positive regulation of miRNA mediated inhibition of translation (GO:1905618)	7	1	.16	+	6.13	1.51E-01
regulation of miRNA mediated inhibition of translation (GO:1905616)	7	1	.16	+	6.13	1.51E-01
negative regulation of B cell receptor signaling pathway (GO:0050859)	7	1	.16	+	6.13	1.51E-01
circadian behavior (GO:0048512)	28	4	.65	+	6.13	4.47E-03
protein heterotetramerization (GO:0051290)	14	2	.33	+	6.13	4.29E-02
macromolecule depalmitoylation (GO:0098734)	7	1	.16	+	6.13	1.51E-01
negative regulation of fat cell proliferation (GO:0070345)	7	1	.16	+	6.13	1.51E-01
positive regulation of NK T cell activation (GO:0051135)	7	1	.16	+	6.13	1.51E-01
positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)	14	2	.33	+	6.13	4.29E-02
negative regulation of retinoic acid receptor signaling pathway (GO:0048387)	7	1	.16	+	6.13	1.51E-01
protein homotrimerization (GO:0070207)	14	2	.33	+	6.13	4.29E-02
vesicle tethering (GO:0099022)	7	1	.16	+	6.13	1.51E-01
negative regulation of membrane protein ectodomain proteolysis (GO:0051045)	7	1	.16	+	6.13	1.51E-01
negative regulation of amyloid precursor protein biosynthetic process (GO:0042985)	7	1	.16	+	6.13	1.51E-01
otic vesicle formation (GO:0030916)	7	1	.16	+	6.13	1.51E-01
autophagic cell death (GO:0048102)	7	1	.16	+	6.13	1.51E-01
DNA damage response, detection of DNA damage (GO:0042769)	7	1	.16	+	6.13	1.51E-01
cleavage furrow formation (GO:0036089)	7	1	.16	+	6.13	1.51E-01
germ-line stem cell population maintenance (GO:0030718)	7	1	.16	+	6.13	1.51E-01
regulation of nodal signaling pathway (GO:1900107)	7	1	.16	+	6.13	1.51E-01
phosphate ion transmembrane transport (GO:0035435)	14	2	.33	+	6.13	4.29E-02
proline transport (GO:0015824)	7	1	.16	+	6.13	1.51E-01
cellular ketone body metabolic process (GO:0046950)	7	1	.16	+	6.13	1.51E-01
PML body organization (GO:0030578)	7	1	.16	+	6.13	1.51E-01
cellular triglyceride homeostasis (GO:0035356)	7	1	.16	+	6.13	1.51E-01
prostaglandin transport (GO:0015732)	7	1	.16	+	6.13	1.51E-01
photoreceptor cell morphogenesis (GO:0008594)	7	1	.16	+	6.13	1.51E-01
synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185)	7	1	.16	+	6.13	1.51E-01
regulation of protein ADP-ribosylation (GO:0010835)	7	1	.16	+	6.13	1.51E-01
T cell chemotaxis (GO:0010818)	7	1	.16	+	6.13	1.51E-01
amyloid-beta clearance by cellular catabolic process (GO:0150094)	7	1	.16	+	6.13	1.51E-01
positive regulation of neuron projection arborization (GO:0150012)	7	1	.16	+	6.13	1.51E-01
regulation of mRNA export from nucleus (GO:0010793)	7	1	.16	+	6.13	1.51E-01
histone H3-K4 demethylation (GO:0034720)	7	1	.16	+	6.13	1.51E-01
negative regulation of cell morphogenesis involved in differentiation (GO:0010771)	14	2	.33	+	6.13	4.29E-02
regulation of long-chain fatty acid import across plasma membrane (GO:0010746)	7	1	.16	+	6.13	1.51E-01
negative regulation of p38MAPK cascade (GO:1903753)	7	1	.16	+	6.13	1.51E-01
RIG-I signaling pathway (GO:0039529)	7	1	.16	+	6.13	1.51E-01
fatty acid elongation, polyunsaturated fatty acid (GO:0034626)	7	1	.16	+	6.13	1.51E-01
fatty acid elongation, monounsaturated fatty acid (GO:0034625)	7	1	.16	+	6.13	1.51E-01
L-ascorbic acid metabolic process (GO:0019852)	7	1	.16	+	6.13	1.51E-01
retinal pigment epithelium development (GO:0003406)	7	1	.16	+	6.13	1.51E-01
vascular endothelial growth factor production (GO:0010573)	7	1	.16	+	6.13	1.51E-01
negative regulation of glycoprotein biosynthetic process (GO:0010561)	14	2	.33	+	6.13	4.29E-02
cardiac endothelial cell differentiation (GO:0003348)	7	1	.16	+	6.13	1.51E-01
early endosome to Golgi transport (GO:0034498)	7	1	.16	+	6.13	1.51E-01
parallel actin filament bundle assembly (GO:0030046)	7	1	.16	+	6.13	1.51E-01
epithelial cell proliferation involved in salivary gland morphogenesis (GO:0060664)	7	1	.16	+	6.13	1.51E-01
forebrain neuroblast division (GO:0021873)	7	1	.16	+	6.13	1.51E-01
endocardium morphogenesis (GO:0003160)	7	1	.16	+	6.13	1.51E-01
regulation of calcidiol 1-monooxygenase activity (GO:0060558)	7	1	.16	+	6.13	1.51E-01
prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis (GO:0060527)	7	1	.16	+	6.13	1.51E-01
prostate glandular acinus morphogenesis (GO:0060526)	7	1	.16	+	6.13	1.51E-01
positive regulation of epithelial cell proliferation involved in lung morphogenesis (GO:0060501)	7	1	.16	+	6.13	1.51E-01
modified amino acid transport (GO:0072337)	29	4	.68	+	5.92	5.05E-03
entrainment of circadian clock by photoperiod (GO:0043153)	29	4	.68	+	5.92	5.05E-03
detection of temperature stimulus involved in sensory perception (GO:0050961)	22	3	.51	+	5.85	1.53E-02
heart trabecula formation (GO:0060347)	15	2	.35	+	5.72	4.85E-02
regulation of integrin-mediated signaling pathway (GO:2001044)	15	2	.35	+	5.72	4.85E-02
negative regulation of receptor internalization (GO:0002091)	15	2	.35	+	5.72	4.85E-02
G protein-coupled receptor internalization (GO:0002031)	15	2	.35	+	5.72	4.85E-02
histone H3 deacetylation (GO:0070932)	15	2	.35	+	5.72	4.85E-02
actin crosslink formation (GO:0051764)	15	2	.35	+	5.72	4.85E-02
regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)	15	2	.35	+	5.72	4.85E-02
secretory granule localization (GO:0032252)	15	2	.35	+	5.72	4.85E-02
positive regulation of macrophage migration (GO:1905523)	30	4	.70	+	5.72	5.68E-03
photoperiodism (GO:0009648)	30	4	.70	+	5.72	5.68E-03
macrophage chemotaxis (GO:0048246)	15	2	.35	+	5.72	4.85E-02
retrograde protein transport, ER to cytosol (GO:0030970)	15	2	.35	+	5.72	4.85E-02
negative regulation of macrophage activation (GO:0043031)	15	2	.35	+	5.72	4.85E-02
response to gonadotropin (GO:0034698)	15	2	.35	+	5.72	4.85E-02
miRNA metabolic process (GO:0010586)	15	2	.35	+	5.72	4.85E-02
positive regulation of exosomal secretion (GO:1903543)	15	2	.35	+	5.72	4.85E-02
regulation of exosomal secretion (GO:1903541)	15	2	.35	+	5.72	4.85E-02
endoplasmic reticulum to cytosol transport (GO:1903513)	15	2	.35	+	5.72	4.85E-02
urinary tract smooth muscle contraction (GO:0014848)	15	2	.35	+	5.72	4.85E-02
rhythmic behavior (GO:0007622)	30	4	.70	+	5.72	5.68E-03
regulation of Golgi organization (GO:1903358)	15	2	.35	+	5.72	4.85E-02
endocytic recycling (GO:0032456)	38	5	.89	+	5.64	2.16E-03
entrainment of circadian clock (GO:0009649)	31	4	.72	+	5.54	6.36E-03
gene silencing by miRNA (GO:0035195)	39	5	.91	+	5.50	2.41E-03
mammary gland duct morphogenesis (GO:0060603)	39	5	.91	+	5.50	2.41E-03
hindgut morphogenesis (GO:0007442)	8	1	.19	+	5.36	1.70E-01
positive regulation of behavioral fear response (GO:2000987)	8	1	.19	+	5.36	1.70E-01
regulation of toll-like receptor 9 signaling pathway (GO:0034163)	8	1	.19	+	5.36	1.70E-01
cranial suture morphogenesis (GO:0060363)	8	1	.19	+	5.36	1.70E-01
corpus callosum morphogenesis (GO:0021540)	8	1	.19	+	5.36	1.70E-01
Rho protein signal transduction (GO:0007266)	56	7	1.31	+	5.36	4.00E-04
lymphangiogenesis (GO:0001946)	16	2	.37	+	5.36	5.44E-02
transdifferentiation (GO:0060290)	8	1	.19	+	5.36	1.70E-01
myeloid progenitor cell differentiation (GO:0002318)	8	1	.19	+	5.36	1.70E-01
regulation of dendritic cell apoptotic process (GO:2000668)	8	1	.19	+	5.36	1.70E-01
regulation of transforming growth factor beta2 production (GO:0032909)	8	1	.19	+	5.36	1.70E-01
positive regulation of integrin-mediated signaling pathway (GO:2001046)	8	1	.19	+	5.36	1.70E-01
regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586)	8	1	.19	+	5.36	1.70E-01
positive regulation of apoptotic process involved in morphogenesis (GO:1902339)	8	1	.19	+	5.36	1.70E-01
regulation of apoptotic process involved in morphogenesis (GO:1902337)	16	2	.37	+	5.36	5.44E-02
response to vitamin D (GO:0033280)	8	1	.19	+	5.36	1.70E-01
p38MAPK cascade (GO:0038066)	8	1	.19	+	5.36	1.70E-01
negative regulation of focal adhesion assembly (GO:0051895)	16	2	.37	+	5.36	5.44E-02
skeletal muscle acetylcholine-gated channel clustering (GO:0071340)	8	1	.19	+	5.36	1.70E-01
calcium ion export (GO:1901660)	8	1	.19	+	5.36	1.70E-01
axo-dendritic protein transport (GO:0099640)	16	2	.37	+	5.36	5.44E-02
establishment of Golgi localization (GO:0051683)	8	1	.19	+	5.36	1.70E-01
cellular response to arsenic-containing substance (GO:0071243)	16	2	.37	+	5.36	5.44E-02
regulation of ribonucleoprotein complex localization (GO:2000197)	8	1	.19	+	5.36	1.70E-01
negative regulation of multicellular organism growth (GO:0040015)	16	2	.37	+	5.36	5.44E-02
regulation of glutamine family amino acid metabolic process (GO:0000820)	8	1	.19	+	5.36	1.70E-01
negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387)	8	1	.19	+	5.36	1.70E-01
negative regulation of non-canonical Wnt signaling pathway (GO:2000051)	8	1	.19	+	5.36	1.70E-01
DNA catabolic process, exonucleolytic (GO:0000738)	8	1	.19	+	5.36	1.70E-01
histone H3-K36 demethylation (GO:0070544)	8	1	.19	+	5.36	1.70E-01
regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0106070)	16	2	.37	+	5.36	5.44E-02
negative regulation of synaptic transmission, GABAergic (GO:0032229)	8	1	.19	+	5.36	1.70E-01
positive regulation of neurotrophin TRK receptor signaling pathway (GO:0051388)	8	1	.19	+	5.36	1.70E-01
negative regulation of hydrogen peroxide-mediated programmed cell death (GO:1901299)	8	1	.19	+	5.36	1.70E-01
negative regulation of inclusion body assembly (GO:0090084)	8	1	.19	+	5.36	1.70E-01
negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051)	16	2	.37	+	5.36	5.44E-02
positive regulation of extracellular matrix assembly (GO:1901203)	8	1	.19	+	5.36	1.70E-01
chaperone-mediated protein complex assembly (GO:0051131)	16	2	.37	+	5.36	5.44E-02
regulation of activation-induced cell death of T cells (GO:0070235)	8	1	.19	+	5.36	1.70E-01
peptidyl-lysine hydroxylation (GO:0017185)	8	1	.19	+	5.36	1.70E-01
negative regulation of renal sodium excretion (GO:0035814)	8	1	.19	+	5.36	1.70E-01
regulation of modification of postsynaptic actin cytoskeleton (GO:1905274)	8	1	.19	+	5.36	1.70E-01
positive regulation of apoptotic process involved in development (GO:1904747)	8	1	.19	+	5.36	1.70E-01
negative regulation of apoptotic process involved in development (GO:1904746)	8	1	.19	+	5.36	1.70E-01
positive regulation of secondary metabolite biosynthetic process (GO:1900378)	8	1	.19	+	5.36	1.70E-01
oligopeptide transmembrane transport (GO:0035672)	8	1	.19	+	5.36	1.70E-01
membrane protein intracellular domain proteolysis (GO:0031293)	8	1	.19	+	5.36	1.70E-01
positive regulation of developmental pigmentation (GO:0048087)	8	1	.19	+	5.36	1.70E-01
positive regulation of melanin biosynthetic process (GO:0048023)	8	1	.19	+	5.36	1.70E-01
positive regulation of NLRP3 inflammasome complex assembly (GO:1900227)	8	1	.19	+	5.36	1.70E-01
positive regulation of receptor binding (GO:1900122)	8	1	.19	+	5.36	1.70E-01
primary miRNA processing (GO:0031053)	8	1	.19	+	5.36	1.70E-01
detection of stimulus involved in sensory perception of pain (GO:0062149)	32	4	.75	+	5.36	7.09E-03
hemoglobin biosynthetic process (GO:0042541)	8	1	.19	+	5.36	1.70E-01
positive regulation of substrate adhesion-dependent cell spreading (GO:1900026)	40	5	.93	+	5.36	2.68E-03
regulation of substrate adhesion-dependent cell spreading (GO:1900024)	56	7	1.31	+	5.36	4.00E-04
regulation of microglial cell activation (GO:1903978)	16	2	.37	+	5.36	5.44E-02
polyol transport (GO:0015791)	8	1	.19	+	5.36	1.70E-01
SA node cell to atrial cardiac muscle cell communication (GO:0086070)	8	1	.19	+	5.36	1.70E-01
regulation of follicle-stimulating hormone secretion (GO:0046880)	8	1	.19	+	5.36	1.70E-01
SA node cell to atrial cardiac muscle cell signaling (GO:0086018)	8	1	.19	+	5.36	1.70E-01
SA node cell action potential (GO:0086015)	8	1	.19	+	5.36	1.70E-01
ventricular cardiac muscle cell action potential (GO:0086005)	16	2	.37	+	5.36	5.44E-02
cardiac muscle cell action potential involved in contraction (GO:0086002)	32	4	.75	+	5.36	7.09E-03
regulation of skeletal muscle acetylcholine-gated channel clustering (GO:1904393)	8	1	.19	+	5.36	1.70E-01
negative regulation of cell-substrate junction organization (GO:0150118)	16	2	.37	+	5.36	5.44E-02
regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881)	8	1	.19	+	5.36	1.70E-01
quaternary ammonium group transport (GO:0015697)	16	2	.37	+	5.36	5.44E-02
ionotropic glutamate receptor signaling pathway (GO:0035235)	16	2	.37	+	5.36	5.44E-02
vitamin D metabolic process (GO:0042359)	8	1	.19	+	5.36	1.70E-01
vasoconstriction (GO:0042310)	40	5	.93	+	5.36	2.68E-03
negative regulation of norepinephrine secretion (GO:0010700)	8	1	.19	+	5.36	1.70E-01
negative regulation of establishment of protein localization to mitochondrion (GO:1903748)	8	1	.19	+	5.36	1.70E-01
cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528)	8	1	.19	+	5.36	1.70E-01
regulation of mitotic centrosome separation (GO:0046602)	8	1	.19	+	5.36	1.70E-01
regulation of cytoplasmic mRNA processing body assembly (GO:0010603)	8	1	.19	+	5.36	1.70E-01
lymphatic endothelial cell differentiation (GO:0060836)	8	1	.19	+	5.36	1.70E-01
regulation of protein localization to cilium (GO:1903564)	8	1	.19	+	5.36	1.70E-01
dynamin family protein polymerization involved in mitochondrial fission (GO:0003374)	8	1	.19	+	5.36	1.70E-01
dynamin family protein polymerization involved in membrane fission (GO:0003373)	8	1	.19	+	5.36	1.70E-01
mammary gland epithelial cell differentiation (GO:0060644)	16	2	.37	+	5.36	5.44E-02
positive regulation of fear response (GO:1903367)	8	1	.19	+	5.36	1.70E-01
negative regulation of cellular extravasation (GO:0002692)	8	1	.19	+	5.36	1.70E-01
regulation of triglyceride biosynthetic process (GO:0010866)	24	3	.56	+	5.36	1.92E-02
negative regulation of Rho protein signal transduction (GO:0035024)	24	3	.56	+	5.36	1.92E-02
diacylglycerol metabolic process (GO:0046339)	24	3	.56	+	5.36	1.92E-02
trabecula formation (GO:0060343)	25	3	.58	+	5.15	2.14E-02
Wnt signaling pathway, planar cell polarity pathway (GO:0060071)	25	3	.58	+	5.15	2.14E-02
peptide cross-linking (GO:0018149)	25	3	.58	+	5.15	2.14E-02
behavioral response to pain (GO:0048266)	25	3	.58	+	5.15	2.14E-02
neuron projection regeneration (GO:0031102)	25	3	.58	+	5.15	2.14E-02
response to arsenic-containing substance (GO:0046685)	25	3	.58	+	5.15	2.14E-02
negative regulation of glycoprotein metabolic process (GO:1903019)	17	2	.40	+	5.05	6.05E-02
glial cell proliferation (GO:0014009)	17	2	.40	+	5.05	6.05E-02
positive regulation of myoblast fusion (GO:1901741)	17	2	.40	+	5.05	6.05E-02
interleukin-1-mediated signaling pathway (GO:0070498)	17	2	.40	+	5.05	6.05E-02
protein trimerization (GO:0070206)	17	2	.40	+	5.05	6.05E-02
clathrin coat assembly (GO:0048268)	17	2	.40	+	5.05	6.05E-02
regulation of apoptotic process involved in development (GO:1904748)	17	2	.40	+	5.05	6.05E-02
negative regulation of circadian rhythm (GO:0042754)	17	2	.40	+	5.05	6.05E-02
peptide hormone processing (GO:0016486)	17	2	.40	+	5.05	6.05E-02
membrane repolarization (GO:0086009)	17	2	.40	+	5.05	6.05E-02
negative regulation of peptidyl-threonine phosphorylation (GO:0010801)	17	2	.40	+	5.05	6.05E-02
sulfate transport (GO:0008272)	17	2	.40	+	5.05	6.05E-02
craniofacial suture morphogenesis (GO:0097094)	17	2	.40	+	5.05	6.05E-02
positive regulation of extrinsic apoptotic signaling pathway (GO:2001238)	60	7	1.40	+	5.00	5.99E-04
digestive tract morphogenesis (GO:0048546)	52	6	1.21	+	4.95	1.54E-03
positive regulation of macrophage activation (GO:0043032)	26	3	.61	+	4.95	2.36E-02
detection of temperature stimulus (GO:0016048)	26	3	.61	+	4.95	2.36E-02
acylglycerol biosynthetic process (GO:0046463)	26	3	.61	+	4.95	2.36E-02
neutral lipid biosynthetic process (GO:0046460)	26	3	.61	+	4.95	2.36E-02
cell proliferation in forebrain (GO:0021846)	35	4	.82	+	4.90	9.62E-03
ventricular septum morphogenesis (GO:0060412)	44	5	1.03	+	4.87	4.01E-03
chemical synaptic transmission, postsynaptic (GO:0099565)	44	5	1.03	+	4.87	4.01E-03
cerebral cortex regionalization (GO:0021796)	9	1	.21	+	4.77	1.89E-01
striatum development (GO:0021756)	18	2	.42	+	4.77	6.68E-02
lung lobe morphogenesis (GO:0060463)	9	1	.21	+	4.77	1.89E-01
lung lobe development (GO:0060462)	9	1	.21	+	4.77	1.89E-01
positive regulation of penile erection (GO:0060406)	9	1	.21	+	4.77	1.89E-01
positive regulation of dopamine secretion (GO:0033603)	9	1	.21	+	4.77	1.89E-01
central nervous system maturation (GO:0021626)	9	1	.21	+	4.77	1.89E-01
egg activation (GO:0007343)	9	1	.21	+	4.77	1.89E-01
bone trabecula formation (GO:0060346)	9	1	.21	+	4.77	1.89E-01
cellular response to epinephrine stimulus (GO:0071872)	9	1	.21	+	4.77	1.89E-01
response to epinephrine (GO:0071871)	9	1	.21	+	4.77	1.89E-01
phosphate ion transport (GO:0006817)	18	2	.42	+	4.77	6.68E-02
transferrin transport (GO:0033572)	9	1	.21	+	4.77	1.89E-01
G protein-coupled adenosine receptor signaling pathway (GO:0001973)	9	1	.21	+	4.77	1.89E-01
regulation of epithelial cell proliferation involved in lung morphogenesis (GO:2000794)	9	1	.21	+	4.77	1.89E-01
receptor recycling (GO:0001881)	9	1	.21	+	4.77	1.89E-01
neural fold formation (GO:0001842)	9	1	.21	+	4.77	1.89E-01
embryonic process involved in female pregnancy (GO:0060136)	9	1	.21	+	4.77	1.89E-01
otic vesicle morphogenesis (GO:0071600)	9	1	.21	+	4.77	1.89E-01
metaphase/anaphase transition of mitotic cell cycle (GO:0007091)	9	1	.21	+	4.77	1.89E-01
regulation of dendritic cell chemotaxis (GO:2000508)	9	1	.21	+	4.77	1.89E-01
regulation of fibrinolysis (GO:0051917)	9	1	.21	+	4.77	1.89E-01
gastric acid secretion (GO:0001696)	9	1	.21	+	4.77	1.89E-01
meiotic cytokinesis (GO:0033206)	9	1	.21	+	4.77	1.89E-01
metaphase/anaphase transition of cell cycle (GO:0044784)	9	1	.21	+	4.77	1.89E-01
cellular response to UV-A (GO:0071492)	9	1	.21	+	4.77	1.89E-01
ketone body metabolic process (GO:1902224)	9	1	.21	+	4.77	1.89E-01
cellular response to purine-containing compound (GO:0071415)	9	1	.21	+	4.77	1.89E-01
glycogen biosynthetic process (GO:0005978)	18	2	.42	+	4.77	6.68E-02
NADPH oxidation (GO:0070995)	9	1	.21	+	4.77	1.89E-01
cellular response to follicle-stimulating hormone stimulus (GO:0071372)	9	1	.21	+	4.77	1.89E-01
regulation of bile acid biosynthetic process (GO:0070857)	9	1	.21	+	4.77	1.89E-01
regulation of long-chain fatty acid import into cell (GO:0140212)	9	1	.21	+	4.77	1.89E-01
anterograde axonal protein transport (GO:0099641)	9	1	.21	+	4.77	1.89E-01
negative regulation of hematopoietic progenitor cell differentiation (GO:1901533)	9	1	.21	+	4.77	1.89E-01
phosphatidylserine exposure on apoptotic cell surface (GO:0070782)	9	1	.21	+	4.77	1.89E-01
negative regulation of dendrite development (GO:2000171)	9	1	.21	+	4.77	1.89E-01
negative regulation of cell cycle arrest (GO:0071157)	18	2	.42	+	4.77	6.68E-02
serine transport (GO:0032329)	9	1	.21	+	4.77	1.89E-01
regulation of transforming growth factor beta activation (GO:1901388)	9	1	.21	+	4.77	1.89E-01
regulation of pigment cell differentiation (GO:0050932)	9	1	.21	+	4.77	1.89E-01
cellular response to leucine starvation (GO:1990253)	9	1	.21	+	4.77	1.89E-01
positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666)	9	1	.21	+	4.77	1.89E-01
regulation of NK T cell activation (GO:0051133)	9	1	.21	+	4.77	1.89E-01
cellular response to sterol (GO:0036315)	18	2	.42	+	4.77	6.68E-02
protein localization to presynapse (GO:1905383)	9	1	.21	+	4.77	1.89E-01
D-amino acid transport (GO:0042940)	9	1	.21	+	4.77	1.89E-01
establishment or maintenance of cytoskeleton polarity (GO:0030952)	9	1	.21	+	4.77	1.89E-01
enucleate erythrocyte differentiation (GO:0043353)	9	1	.21	+	4.77	1.89E-01
common myeloid progenitor cell proliferation (GO:0035726)	9	1	.21	+	4.77	1.89E-01
regulation of core promoter binding (GO:1904796)	9	1	.21	+	4.77	1.89E-01
cortical actin cytoskeleton organization (GO:0030866)	36	4	.84	+	4.77	1.06E-02
inactivation of MAPK activity (GO:0000188)	18	2	.42	+	4.77	6.68E-02
positive regulation of pseudopodium assembly (GO:0031274)	9	1	.21	+	4.77	1.89E-01
oligosaccharide catabolic process (GO:0009313)	9	1	.21	+	4.77	1.89E-01
phosphatidylinositol-mediated signaling (GO:0048015)	72	8	1.68	+	4.77	3.42E-04
G protein-coupled purinergic receptor signaling pathway (GO:0035588)	9	1	.21	+	4.77	1.89E-01
mRNA transcription (GO:0009299)	18	2	.42	+	4.77	6.68E-02
glucan biosynthetic process (GO:0009250)	18	2	.42	+	4.77	6.68E-02
L-alanine transport (GO:0015808)	9	1	.21	+	4.77	1.89E-01
glycolytic process through glucose-6-phosphate (GO:0061620)	9	1	.21	+	4.77	1.89E-01
regulation of phosphatidylcholine metabolic process (GO:0150172)	9	1	.21	+	4.77	1.89E-01
positive regulation of sequestering of triglyceride (GO:0010890)	9	1	.21	+	4.77	1.89E-01
positive regulation of triglyceride biosynthetic process (GO:0010867)	18	2	.42	+	4.77	6.68E-02
negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)	9	1	.21	+	4.77	1.89E-01
germ cell migration (GO:0008354)	9	1	.21	+	4.77	1.89E-01
regulation of complement-dependent cytotoxicity (GO:1903659)	9	1	.21	+	4.77	1.89E-01
CD40 signaling pathway (GO:0023035)	9	1	.21	+	4.77	1.89E-01
smooth muscle cell migration (GO:0014909)	9	1	.21	+	4.77	1.89E-01
presynaptic membrane assembly (GO:0097105)	9	1	.21	+	4.77	1.89E-01
corticospinal tract morphogenesis (GO:0021957)	9	1	.21	+	4.77	1.89E-01
ventricular compact myocardium morphogenesis (GO:0003223)	9	1	.21	+	4.77	1.89E-01
very-low-density lipoprotein particle assembly (GO:0034379)	9	1	.21	+	4.77	1.89E-01
adipose tissue development (GO:0060612)	36	4	.84	+	4.77	1.06E-02
lateral sprouting from an epithelium (GO:0060601)	9	1	.21	+	4.77	1.89E-01
adherens junction maintenance (GO:0034334)	9	1	.21	+	4.77	1.89E-01
positive regulation of sister chromatid cohesion (GO:0045876)	9	1	.21	+	4.77	1.89E-01
negative regulation of striated muscle tissue development (GO:0045843)	18	2	.42	+	4.77	6.68E-02
visceral serous pericardium development (GO:0061032)	9	1	.21	+	4.77	1.89E-01
mammary gland formation (GO:0060592)	9	1	.21	+	4.77	1.89E-01
morphogenesis of an epithelial bud (GO:0060572)	9	1	.21	+	4.77	1.89E-01
diaphragm development (GO:0060539)	9	1	.21	+	4.77	1.89E-01
negative regulation of G protein-coupled receptor signaling pathway (GO:0045744)	54	6	1.26	+	4.77	1.86E-03
regulation of lamellipodium organization (GO:1902743)	45	5	1.05	+	4.77	4.40E-03
cellular senescence (GO:0090398)	27	3	.63	+	4.77	2.60E-02
post-transcriptional gene silencing by RNA (GO:0035194)	45	5	1.05	+	4.77	4.40E-03
positive regulation of cyclin-dependent protein kinase activity (GO:1904031)	27	3	.63	+	4.77	2.60E-02
actin filament polymerization (GO:0030041)	27	3	.63	+	4.77	2.60E-02
cardiac muscle cell contraction (GO:0086003)	37	4	.86	+	4.64	1.16E-02
cardiac muscle cell action potential (GO:0086001)	37	4	.86	+	4.64	1.16E-02
pharyngeal system development (GO:0060037)	28	3	.65	+	4.60	2.85E-02
fatty acid transmembrane transport (GO:1902001)	28	3	.65	+	4.60	2.85E-02
regulation of ruffle assembly (GO:1900027)	28	3	.65	+	4.60	2.85E-02
regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239)	47	5	1.10	+	4.56	5.27E-03
triglyceride biosynthetic process (GO:0019432)	19	2	.44	+	4.52	7.33E-02
manganese ion transport (GO:0006828)	19	2	.44	+	4.52	7.33E-02
macrophage activation involved in immune response (GO:0002281)	19	2	.44	+	4.52	7.33E-02
excitatory postsynaptic potential (GO:0060079)	38	4	.89	+	4.52	1.27E-02
cellular response to fatty acid (GO:0071398)	19	2	.44	+	4.52	7.33E-02
fatty acid derivative biosynthetic process (GO:1901570)	19	2	.44	+	4.52	7.33E-02
fatty acid derivative metabolic process (GO:1901568)	38	4	.89	+	4.52	1.27E-02
negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037)	19	2	.44	+	4.52	7.33E-02
negative regulation of astrocyte differentiation (GO:0048712)	19	2	.44	+	4.52	7.33E-02
regulation of phospholipid biosynthetic process (GO:0071071)	19	2	.44	+	4.52	7.33E-02
regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664)	19	2	.44	+	4.52	7.33E-02
macrophage migration (GO:1905517)	19	2	.44	+	4.52	7.33E-02
lymph vessel morphogenesis (GO:0036303)	19	2	.44	+	4.52	7.33E-02
retinal ganglion cell axon guidance (GO:0031290)	19	2	.44	+	4.52	7.33E-02
inositol lipid-mediated signaling (GO:0048017)	76	8	1.77	+	4.52	4.87E-04
inositol phosphate-mediated signaling (GO:0048016)	19	2	.44	+	4.52	7.33E-02
L-glutamate transmembrane transport (GO:0015813)	19	2	.44	+	4.52	7.33E-02
transport across blood-brain barrier (GO:0150104)	19	2	.44	+	4.52	7.33E-02
regulation of phospholipid metabolic process (GO:1903725)	38	4	.89	+	4.52	1.27E-02
Golgi to plasma membrane transport (GO:0006893)	48	5	1.12	+	4.47	5.75E-03
ventricular septum development (GO:0003281)	77	8	1.79	+	4.46	5.30E-04
sensory perception of temperature stimulus (GO:0050951)	29	3	.68	+	4.44	3.12E-02
negative regulation of plasma membrane bounded cell projection assembly (GO:0120033)	29	3	.68	+	4.44	3.12E-02
face morphogenesis (GO:0060325)	39	4	.91	+	4.40	1.38E-02
L-amino acid transport (GO:0015807)	49	5	1.14	+	4.38	6.25E-03
primary neural tube formation (GO:0014020)	118	12	2.75	+	4.36	2.87E-05
circadian regulation of gene expression (GO:0032922)	69	7	1.61	+	4.35	1.34E-03
vascular transport (GO:0010232)	20	2	.47	+	4.29	8.01E-02
regulation of dendritic cell antigen processing and presentation (GO:0002604)	10	1	.23	+	4.29	2.08E-01
positive regulation of gluconeogenesis (GO:0045722)	20	2	.47	+	4.29	8.01E-02
cerebellar granule cell differentiation (GO:0021707)	10	1	.23	+	4.29	2.08E-01
lung-associated mesenchyme development (GO:0060484)	10	1	.23	+	4.29	2.08E-01
regulation of vascular associated smooth muscle contraction (GO:0003056)	10	1	.23	+	4.29	2.08E-01
embryonic body morphogenesis (GO:0010172)	10	1	.23	+	4.29	2.08E-01
pinocytosis (GO:0006907)	10	1	.23	+	4.29	2.08E-01
cerebellar granular layer formation (GO:0021684)	10	1	.23	+	4.29	2.08E-01
positive regulation of epidermal cell differentiation (GO:0045606)	20	2	.47	+	4.29	8.01E-02
interkinetic nuclear migration (GO:0022027)	10	1	.23	+	4.29	2.08E-01
positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269)	10	1	.23	+	4.29	2.08E-01
positive regulation of cholesterol biosynthetic process (GO:0045542)	10	1	.23	+	4.29	2.08E-01
floor plate development (GO:0033504)	10	1	.23	+	4.29	2.08E-01
neuron cell-cell adhesion (GO:0007158)	10	1	.23	+	4.29	2.08E-01
neural plate development (GO:0001840)	10	1	.23	+	4.29	2.08E-01
negative regulation of transcription regulatory region DNA binding (GO:2000678)	20	2	.47	+	4.29	8.01E-02
limb bud formation (GO:0060174)	10	1	.23	+	4.29	2.08E-01
cell proliferation involved in kidney development (GO:0072111)	10	1	.23	+	4.29	2.08E-01
SREBP signaling pathway (GO:0032933)	10	1	.23	+	4.29	2.08E-01
positive regulation of activin receptor signaling pathway (GO:0032927)	10	1	.23	+	4.29	2.08E-01
regulation of transforming growth factor beta production (GO:0071634)	40	4	.93	+	4.29	1.50E-02
hard palate development (GO:0060022)	10	1	.23	+	4.29	2.08E-01
negative regulation of natural killer cell activation (GO:0032815)	10	1	.23	+	4.29	2.08E-01
positive regulation of transmission of nerve impulse (GO:0051971)	10	1	.23	+	4.29	2.08E-01
negative regulation of muscle tissue development (GO:1901862)	20	2	.47	+	4.29	8.01E-02
positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838)	10	1	.23	+	4.29	2.08E-01
regulation of hepatic stellate cell activation (GO:2000489)	10	1	.23	+	4.29	2.08E-01
signaling receptor ligand precursor processing (GO:0140448)	20	2	.47	+	4.29	8.01E-02
antiviral innate immune response (GO:0140374)	10	1	.23	+	4.29	2.08E-01
regulation of interleukin-1 alpha production (GO:0032650)	10	1	.23	+	4.29	2.08E-01
negative regulation of protein exit from endoplasmic reticulum (GO:0070862)	10	1	.23	+	4.29	2.08E-01
long-chain fatty acid import into cell (GO:0044539)	10	1	.23	+	4.29	2.08E-01
protein exit from endoplasmic reticulum (GO:0032527)	20	2	.47	+	4.29	8.01E-02
cellular response to leucine (GO:0071233)	10	1	.23	+	4.29	2.08E-01
negative regulation of excitatory postsynaptic potential (GO:0090394)	10	1	.23	+	4.29	2.08E-01
phagosome-lysosome fusion (GO:0090385)	10	1	.23	+	4.29	2.08E-01
response to cholesterol (GO:0070723)	20	2	.47	+	4.29	8.01E-02
positive regulation of histone H3-K9 methylation (GO:0051574)	10	1	.23	+	4.29	2.08E-01
negative regulation of cAMP-mediated signaling (GO:0043951)	30	3	.70	+	4.29	3.39E-02
negative regulation of double-strand break repair via homologous recombination (GO:2000042)	10	1	.23	+	4.29	2.08E-01
response to leptin (GO:0044321)	20	2	.47	+	4.29	8.01E-02
positive regulation of sterol biosynthetic process (GO:0106120)	10	1	.23	+	4.29	2.08E-01
N-acetylneuraminate metabolic process (GO:0006054)	10	1	.23	+	4.29	2.08E-01
positive regulation of phospholipid biosynthetic process (GO:0071073)	10	1	.23	+	4.29	2.08E-01
glucose catabolic process (GO:0006007)	10	1	.23	+	4.29	2.08E-01
regulation of establishment of planar polarity (GO:0090175)	40	4	.93	+	4.29	1.50E-02
Golgi to lysosome transport (GO:0090160)	10	1	.23	+	4.29	2.08E-01
negative regulation of muscle organ development (GO:0048635)	20	2	.47	+	4.29	8.01E-02
positive chemotaxis (GO:0050918)	20	2	.47	+	4.29	8.01E-02
modification of postsynaptic actin cytoskeleton (GO:0098885)	10	1	.23	+	4.29	2.08E-01
embryonic digestive tract morphogenesis (GO:0048557)	20	2	.47	+	4.29	8.01E-02
olefinic compound biosynthetic process (GO:0120255)	10	1	.23	+	4.29	2.08E-01
midbrain dopaminergic neuron differentiation (GO:1904948)	10	1	.23	+	4.29	2.08E-01
presynapse assembly (GO:0099054)	20	2	.47	+	4.29	8.01E-02
alternative mRNA splicing, via spliceosome (GO:0000380)	20	2	.47	+	4.29	8.01E-02
nuclear envelope reassembly (GO:0031468)	10	1	.23	+	4.29	2.08E-01
negative regulation of nitric-oxide synthase activity (GO:0051001)	10	1	.23	+	4.29	2.08E-01
regulation of Golgi to plasma membrane protein transport (GO:0042996)	10	1	.23	+	4.29	2.08E-01
response to water (GO:0009415)	10	1	.23	+	4.29	2.08E-01
behavioral response to cocaine (GO:0048148)	20	2	.47	+	4.29	8.01E-02
regulation of pseudopodium assembly (GO:0031272)	10	1	.23	+	4.29	2.08E-01
response to leucine (GO:0043201)	10	1	.23	+	4.29	2.08E-01
very long-chain fatty acid biosynthetic process (GO:0042761)	10	1	.23	+	4.29	2.08E-01
positive regulation of DNA-directed DNA polymerase activity (GO:1900264)	10	1	.23	+	4.29	2.08E-01
regulation of DNA-directed DNA polymerase activity (GO:1900262)	10	1	.23	+	4.29	2.08E-01
platelet-derived growth factor receptor signaling pathway (GO:0048008)	40	4	.93	+	4.29	1.50E-02
RNA interference (GO:0016246)	10	1	.23	+	4.29	2.08E-01
pharyngeal arch artery morphogenesis (GO:0061626)	10	1	.23	+	4.29	2.08E-01
wound healing, spreading of epidermal cells (GO:0035313)	10	1	.23	+	4.29	2.08E-01
norepinephrine biosynthetic process (GO:0042421)	10	1	.23	+	4.29	2.08E-01
fructose 1,6-bisphosphate metabolic process (GO:0030388)	10	1	.23	+	4.29	2.08E-01
regulation of alkaline phosphatase activity (GO:0010692)	10	1	.23	+	4.29	2.08E-01
behavioral response to nicotine (GO:0035095)	10	1	.23	+	4.29	2.08E-01
desmosome organization (GO:0002934)	10	1	.23	+	4.29	2.08E-01
amelogenesis (GO:0097186)	20	2	.47	+	4.29	8.01E-02
regulation of dopamine metabolic process (GO:0042053)	20	2	.47	+	4.29	8.01E-02
postsynaptic membrane assembly (GO:0097104)	10	1	.23	+	4.29	2.08E-01
presynaptic membrane organization (GO:0097090)	10	1	.23	+	4.29	2.08E-01
dendritic spine maintenance (GO:0097062)	10	1	.23	+	4.29	2.08E-01
posttranscriptional gene silencing (GO:0016441)	50	5	1.17	+	4.29	6.79E-03
neuromuscular junction development (GO:0007528)	50	5	1.17	+	4.29	6.79E-03
neural tube closure (GO:0001843)	111	11	2.59	+	4.25	7.70E-05
tube closure (GO:0060606)	112	11	2.61	+	4.21	8.32E-05
salivary gland morphogenesis (GO:0007435)	31	3	.72	+	4.15	3.68E-02
microglial cell activation (GO:0001774)	31	3	.72	+	4.15	3.68E-02
negative regulation of double-strand break repair (GO:2000780)	21	2	.49	+	4.09	8.70E-02
activation of adenylate cyclase activity (GO:0007190)	21	2	.49	+	4.09	8.70E-02
regulation of double-strand break repair via nonhomologous end joining (GO:2001032)	21	2	.49	+	4.09	8.70E-02
regulation of myoblast fusion (GO:1901739)	21	2	.49	+	4.09	8.70E-02
positive regulation of RNA splicing (GO:0033120)	42	4	.98	+	4.09	1.76E-02
epiboly involved in wound healing (GO:0090505)	21	2	.49	+	4.09	8.70E-02
wound healing, spreading of cells (GO:0044319)	21	2	.49	+	4.09	8.70E-02
positive regulation of histone deacetylation (GO:0031065)	21	2	.49	+	4.09	8.70E-02
cell-cell signaling involved in cardiac conduction (GO:0086019)	21	2	.49	+	4.09	8.70E-02
telomere maintenance via telomere lengthening (GO:0010833)	21	2	.49	+	4.09	8.70E-02
androgen metabolic process (GO:0008209)	21	2	.49	+	4.09	8.70E-02
central nervous system neuron axonogenesis (GO:0021955)	42	4	.98	+	4.09	1.76E-02
vitamin transport (GO:0051180)	32	3	.75	+	4.02	3.98E-02
coronary vasculature morphogenesis (GO:0060977)	32	3	.75	+	4.02	3.98E-02
negative regulation of cardiac muscle hypertrophy (GO:0010614)	32	3	.75	+	4.02	3.98E-02
positive regulation of Rho protein signal transduction (GO:0035025)	32	3	.75	+	4.02	3.98E-02
mammary gland epithelium development (GO:0061180)	64	6	1.49	+	4.02	4.26E-03
protein localization to cell surface (GO:0034394)	32	3	.75	+	4.02	3.98E-02
epidermal growth factor receptor signaling pathway (GO:0007173)	43	4	1.00	+	3.99	1.90E-02
positive regulation of glucose import (GO:0046326)	43	4	1.00	+	3.99	1.90E-02
mammary gland morphogenesis (GO:0060443)	54	5	1.26	+	3.97	9.26E-03
regulation of macrophage activation (GO:0043030)	54	5	1.26	+	3.97	9.26E-03
regulation of B cell differentiation (GO:0045577)	33	3	.77	+	3.90	4.30E-02
negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240)	33	3	.77	+	3.90	4.30E-02
startle response (GO:0001964)	33	3	.77	+	3.90	4.30E-02
negative regulation of signal transduction in absence of ligand (GO:1901099)	33	3	.77	+	3.90	4.30E-02
negative regulation of blood vessel endothelial cell migration (GO:0043537)	33	3	.77	+	3.90	4.30E-02
collagen catabolic process (GO:0030574)	33	3	.77	+	3.90	4.30E-02
regulation of chronic inflammatory response (GO:0002676)	11	1	.26	+	3.90	2.26E-01
negative regulation of DNA repair (GO:0045738)	22	2	.51	+	3.90	9.40E-02
lung saccule development (GO:0060430)	11	1	.26	+	3.90	2.26E-01
regulation of penile erection (GO:0060405)	11	1	.26	+	3.90	2.26E-01
negative regulation of osteoblast proliferation (GO:0033689)	11	1	.26	+	3.90	2.26E-01
regulation of cell adhesion molecule production (GO:0060353)	11	1	.26	+	3.90	2.26E-01
regulation of behavioral fear response (GO:2000822)	11	1	.26	+	3.90	2.26E-01
negative regulation of neuron migration (GO:2001223)	11	1	.26	+	3.90	2.26E-01
negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548)	11	1	.26	+	3.90	2.26E-01
definitive hemopoiesis (GO:0060216)	22	2	.51	+	3.90	9.40E-02
regulation of organelle transport along microtubule (GO:1902513)	11	1	.26	+	3.90	2.26E-01
glutathione biosynthetic process (GO:0006750)	11	1	.26	+	3.90	2.26E-01
cellular response to nitric oxide (GO:0071732)	11	1	.26	+	3.90	2.26E-01
regulation of endocytic recycling (GO:2001135)	11	1	.26	+	3.90	2.26E-01
Leydig cell differentiation (GO:0033327)	11	1	.26	+	3.90	2.26E-01
membrane raft assembly (GO:0001765)	11	1	.26	+	3.90	2.26E-01
micturition (GO:0060073)	11	1	.26	+	3.90	2.26E-01
regulation of cellular amino acid metabolic process (GO:0006521)	11	1	.26	+	3.90	2.26E-01
cellular response to sterol depletion (GO:0071501)	11	1	.26	+	3.90	2.26E-01
response to vitamin (GO:0033273)	22	2	.51	+	3.90	9.40E-02
tRNA 5'-leader removal (GO:0001682)	11	1	.26	+	3.90	2.26E-01
regulation of protein neddylation (GO:2000434)	11	1	.26	+	3.90	2.26E-01
regulation of serotonin secretion (GO:0014062)	11	1	.26	+	3.90	2.26E-01
peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401)	11	1	.26	+	3.90	2.26E-01
epiboly (GO:0090504)	22	2	.51	+	3.90	9.40E-02
regulation of glucocorticoid receptor signaling pathway (GO:2000322)	11	1	.26	+	3.90	2.26E-01
cellular response to ethanol (GO:0071361)	11	1	.26	+	3.90	2.26E-01
postsynaptic endocytosis (GO:0140239)	11	1	.26	+	3.90	2.26E-01
regulation of presynaptic cytosolic calcium ion concentration (GO:0099509)	11	1	.26	+	3.90	2.26E-01
regulation of fatty acid beta-oxidation (GO:0031998)	22	2	.51	+	3.90	9.40E-02
positive regulation of cholesterol metabolic process (GO:0090205)	11	1	.26	+	3.90	2.26E-01
embryonic foregut morphogenesis (GO:0048617)	11	1	.26	+	3.90	2.26E-01
postsynaptic neurotransmitter receptor internalization (GO:0098884)	11	1	.26	+	3.90	2.26E-01
regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619)	11	1	.26	+	3.90	2.26E-01
keratinocyte proliferation (GO:0043616)	11	1	.26	+	3.90	2.26E-01
cytoplasmic sequestering of protein (GO:0051220)	22	2	.51	+	3.90	9.40E-02
L-glutamate import across plasma membrane (GO:0098712)	11	1	.26	+	3.90	2.26E-01
bleb assembly (GO:0032060)	11	1	.26	+	3.90	2.26E-01
positive regulation of fatty acid beta-oxidation (GO:0032000)	11	1	.26	+	3.90	2.26E-01
chondrocyte proliferation (GO:0035988)	11	1	.26	+	3.90	2.26E-01
positive regulation of mRNA 3'-end processing (GO:0031442)	11	1	.26	+	3.90	2.26E-01
enamel mineralization (GO:0070166)	11	1	.26	+	3.90	2.26E-01
regulation of protein localization to centrosome (GO:1904779)	11	1	.26	+	3.90	2.26E-01
glycine transport (GO:0015816)	11	1	.26	+	3.90	2.26E-01
positive regulation of cytokine production involved in inflammatory response (GO:1900017)	22	2	.51	+	3.90	9.40E-02
positive regulation of receptor clustering (GO:1903911)	11	1	.26	+	3.90	2.26E-01
fatty acid elongation (GO:0030497)	11	1	.26	+	3.90	2.26E-01
hormone catabolic process (GO:0042447)	11	1	.26	+	3.90	2.26E-01
dendrite extension (GO:0097484)	11	1	.26	+	3.90	2.26E-01
regulation of plasminogen activation (GO:0010755)	11	1	.26	+	3.90	2.26E-01
poly-N-acetyllactosamine biosynthetic process (GO:0030311)	11	1	.26	+	3.90	2.26E-01
poly-N-acetyllactosamine metabolic process (GO:0030309)	11	1	.26	+	3.90	2.26E-01
regulation of type B pancreatic cell proliferation (GO:0061469)	11	1	.26	+	3.90	2.26E-01
embryonic camera-type eye formation (GO:0060900)	11	1	.26	+	3.90	2.26E-01
plasma membrane tubulation (GO:0097320)	11	1	.26	+	3.90	2.26E-01
maintenance of apical/basal cell polarity (GO:0035090)	11	1	.26	+	3.90	2.26E-01
signal transduction involved in regulation of gene expression (GO:0023019)	22	2	.51	+	3.90	9.40E-02
estrogen metabolic process (GO:0008210)	22	2	.51	+	3.90	9.40E-02
regulation of catecholamine metabolic process (GO:0042069)	22	2	.51	+	3.90	9.40E-02
chemosensory behavior (GO:0007635)	22	2	.51	+	3.90	9.40E-02
low-density lipoprotein particle clearance (GO:0034383)	11	1	.26	+	3.90	2.26E-01
regulation of fear response (GO:1903365)	11	1	.26	+	3.90	2.26E-01
morphogenesis of an epithelial fold (GO:0060571)	22	2	.51	+	3.90	9.40E-02
neural tube formation (GO:0001841)	133	12	3.10	+	3.87	8.87E-05
regulation of transforming growth factor beta receptor signaling pathway (GO:0017015)	111	10	2.59	+	3.86	3.41E-04
outflow tract morphogenesis (GO:0003151)	78	7	1.82	+	3.85	2.64E-03
body morphogenesis (GO:0010171)	56	5	1.31	+	3.83	1.07E-02
carboxylic acid transmembrane transport (GO:1905039)	112	10	2.61	+	3.83	3.66E-04
head morphogenesis (GO:0060323)	45	4	1.05	+	3.81	2.20E-02
negative regulation of stress-activated MAPK cascade (GO:0032873)	45	4	1.05	+	3.81	2.20E-02
regulation of macrophage migration (GO:1905521)	45	4	1.05	+	3.81	2.20E-02
negative regulation of stress-activated protein kinase signaling cascade (GO:0070303)	45	4	1.05	+	3.81	2.20E-02
cellular response to virus (GO:0098586)	45	4	1.05	+	3.81	2.20E-02
regulation of vasoconstriction (GO:0019229)	79	7	1.84	+	3.80	2.83E-03
organic acid transmembrane transport (GO:1903825)	113	10	2.63	+	3.80	3.92E-04
positive regulation of lamellipodium organization (GO:1902745)	34	3	.79	+	3.79	4.62E-02
temperature homeostasis (GO:0001659)	34	3	.79	+	3.79	4.62E-02
regulation of astrocyte differentiation (GO:0048710)	34	3	.79	+	3.79	4.62E-02
regulation of cholesterol metabolic process (GO:0090181)	34	3	.79	+	3.79	4.62E-02
negative regulation of muscle hypertrophy (GO:0014741)	34	3	.79	+	3.79	4.62E-02
regulation of cellular response to transforming growth factor beta stimulus (GO:1903844)	114	10	2.66	+	3.76	4.19E-04
regulation of establishment or maintenance of cell polarity (GO:0032878)	23	2	.54	+	3.73	1.01E-01
cellular response to estradiol stimulus (GO:0071392)	23	2	.54	+	3.73	1.01E-01
muscle cell proliferation (GO:0033002)	23	2	.54	+	3.73	1.01E-01
detection of mechanical stimulus involved in sensory perception (GO:0050974)	46	4	1.07	+	3.73	2.36E-02
protein heterooligomerization (GO:0051291)	23	2	.54	+	3.73	1.01E-01
negative regulation of synaptic transmission (GO:0050805)	69	6	1.61	+	3.73	6.08E-03
dicarboxylic acid transport (GO:0006835)	58	5	1.35	+	3.70	1.23E-02
actin-mediated cell contraction (GO:0070252)	58	5	1.35	+	3.70	1.23E-02
salivary gland development (GO:0007431)	35	3	.82	+	3.68	4.96E-02
negative regulation of glial cell differentiation (GO:0045686)	35	3	.82	+	3.68	4.96E-02
negative regulation of cell-matrix adhesion (GO:0001953)	35	3	.82	+	3.68	4.96E-02
dopaminergic neuron differentiation (GO:0071542)	35	3	.82	+	3.68	4.96E-02
regulation of cellular amine metabolic process (GO:0033238)	35	3	.82	+	3.68	4.96E-02
negative regulation of epithelial to mesenchymal transition (GO:0010719)	35	3	.82	+	3.68	4.96E-02
chromosome condensation (GO:0030261)	35	3	.82	+	3.68	4.96E-02
negative regulation of cold-induced thermogenesis (GO:0120163)	47	4	1.10	+	3.65	2.52E-02
face development (GO:0060324)	59	5	1.38	+	3.64	1.31E-02
cellular response to hydrogen peroxide (GO:0070301)	59	5	1.38	+	3.64	1.31E-02
cardiac septum development (GO:0003279)	118	10	2.75	+	3.64	5.45E-04
coronary vasculature development (GO:0060976)	71	6	1.66	+	3.63	6.94E-03
positive regulation of mRNA processing (GO:0050685)	36	3	.84	+	3.57	5.30E-02
positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707)	36	3	.84	+	3.57	5.30E-02
non-canonical Wnt signaling pathway (GO:0035567)	36	3	.84	+	3.57	5.30E-02
regulation of lamellipodium assembly (GO:0010591)	36	3	.84	+	3.57	5.30E-02
negative regulation of JNK cascade (GO:0046329)	36	3	.84	+	3.57	5.30E-02
regulation of postsynaptic membrane potential (GO:0060078)	60	5	1.40	+	3.57	1.40E-02
positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737)	24	2	.56	+	3.57	1.09E-01
negative regulation of hydrogen peroxide-induced cell death (GO:1903206)	24	2	.56	+	3.57	1.09E-01
foregut morphogenesis (GO:0007440)	12	1	.28	+	3.57	2.44E-01
response to sterol depletion (GO:0006991)	12	1	.28	+	3.57	2.44E-01
substrate-dependent cell migration (GO:0006929)	24	2	.56	+	3.57	1.09E-01
positive regulation of epidermis development (GO:0045684)	24	2	.56	+	3.57	1.09E-01
cerebellar granular layer morphogenesis (GO:0021683)	12	1	.28	+	3.57	2.44E-01
subpallium development (GO:0021544)	24	2	.56	+	3.57	1.09E-01
T cell mediated cytotoxicity (GO:0001913)	12	1	.28	+	3.57	2.44E-01
cyclic purine nucleotide metabolic process (GO:0052652)	24	2	.56	+	3.57	1.09E-01
regulation of apoptotic DNA fragmentation (GO:1902510)	12	1	.28	+	3.57	2.44E-01
positive regulation of phospholipid transport (GO:2001140)	12	1	.28	+	3.57	2.44E-01
activin receptor signaling pathway (GO:0032924)	24	2	.56	+	3.57	1.09E-01
regulation of transforming growth factor beta1 production (GO:0032908)	12	1	.28	+	3.57	2.44E-01
positive regulation of MHC class II biosynthetic process (GO:0045348)	12	1	.28	+	3.57	2.44E-01
positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034)	12	1	.28	+	3.57	2.44E-01
inhibitory postsynaptic potential (GO:0060080)	12	1	.28	+	3.57	2.44E-01
angiogenesis involved in wound healing (GO:0060055)	12	1	.28	+	3.57	2.44E-01
ERBB signaling pathway (GO:0038127)	48	4	1.12	+	3.57	2.70E-02
glycine metabolic process (GO:0006544)	12	1	.28	+	3.57	2.44E-01
L-glutamate import (GO:0051938)	12	1	.28	+	3.57	2.44E-01
regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836)	12	1	.28	+	3.57	2.44E-01
leptin-mediated signaling pathway (GO:0033210)	12	1	.28	+	3.57	2.44E-01
nodal signaling pathway (GO:0038092)	12	1	.28	+	3.57	2.44E-01
positive regulation of interleukin-5 production (GO:0032754)	12	1	.28	+	3.57	2.44E-01
cellular response to acidic pH (GO:0071468)	12	1	.28	+	3.57	2.44E-01
positive regulation of signal transduction by p53 class mediator (GO:1901798)	24	2	.56	+	3.57	1.09E-01
desensitization of G protein-coupled receptor signaling pathway (GO:0002029)	24	2	.56	+	3.57	1.09E-01
calcineurin-NFAT signaling cascade (GO:0033173)	12	1	.28	+	3.57	2.44E-01
left/right axis specification (GO:0070986)	12	1	.28	+	3.57	2.44E-01
nucleosome disassembly (GO:0006337)	12	1	.28	+	3.57	2.44E-01
peripheral nervous system neuron development (GO:0048935)	12	1	.28	+	3.57	2.44E-01
peripheral nervous system neuron differentiation (GO:0048934)	12	1	.28	+	3.57	2.44E-01
positive regulation of multi-organism process (GO:0043902)	24	2	.56	+	3.57	1.09E-01
inositol metabolic process (GO:0006020)	12	1	.28	+	3.57	2.44E-01
dendritic transport (GO:0098935)	12	1	.28	+	3.57	2.44E-01
regulation of hydrogen peroxide-mediated programmed cell death (GO:1901298)	12	1	.28	+	3.57	2.44E-01
retrograde transport, endosome to plasma membrane (GO:1990126)	24	2	.56	+	3.57	1.09E-01
negative regulation of myelination (GO:0031642)	12	1	.28	+	3.57	2.44E-01
catechol-containing compound biosynthetic process (GO:0009713)	24	2	.56	+	3.57	1.09E-01
regulation of fat cell proliferation (GO:0070344)	12	1	.28	+	3.57	2.44E-01
cell death in response to oxidative stress (GO:0036473)	24	2	.56	+	3.57	1.09E-01
presynapse organization (GO:0099172)	24	2	.56	+	3.57	1.09E-01
presynaptic modulation of chemical synaptic transmission (GO:0099171)	12	1	.28	+	3.57	2.44E-01
negative regulation of response to reactive oxygen species (GO:1901032)	24	2	.56	+	3.57	1.09E-01
Golgi inheritance (GO:0048313)	12	1	.28	+	3.57	2.44E-01
post-anal tail morphogenesis (GO:0036342)	24	2	.56	+	3.57	1.09E-01
organelle inheritance (GO:0048308)	12	1	.28	+	3.57	2.44E-01
response to sterol (GO:0036314)	24	2	.56	+	3.57	1.09E-01
chromatin disassembly (GO:0031498)	12	1	.28	+	3.57	2.44E-01
regulation of renal sodium excretion (GO:0035813)	24	2	.56	+	3.57	1.09E-01
synaptic vesicle budding (GO:0070142)	12	1	.28	+	3.57	2.44E-01
positive regulation of defense response to bacterium (GO:1900426)	12	1	.28	+	3.57	2.44E-01
mitochondrial fission (GO:0000266)	24	2	.56	+	3.57	1.09E-01
mRNA transcription by RNA polymerase II (GO:0042789)	12	1	.28	+	3.57	2.44E-01
negative regulation of long-term synaptic potentiation (GO:1900272)	12	1	.28	+	3.57	2.44E-01
negative regulation of mRNA splicing, via spliceosome (GO:0048025)	24	2	.56	+	3.57	1.09E-01
insulin-like growth factor receptor signaling pathway (GO:0048009)	12	1	.28	+	3.57	2.44E-01
purinergic nucleotide receptor signaling pathway (GO:0035590)	12	1	.28	+	3.57	2.44E-01
regulation of metallopeptidase activity (GO:1905048)	12	1	.28	+	3.57	2.44E-01
cyclic nucleotide biosynthetic process (GO:0009190)	24	2	.56	+	3.57	1.09E-01
basic amino acid transport (GO:0015802)	12	1	.28	+	3.57	2.44E-01
regulation of protein K63-linked ubiquitination (GO:1900044)	12	1	.28	+	3.57	2.44E-01
glycolytic process through fructose-6-phosphate (GO:0061615)	12	1	.28	+	3.57	2.44E-01
negative regulation of hippo signaling (GO:0035331)	12	1	.28	+	3.57	2.44E-01
catecholamine biosynthetic process (GO:0042423)	24	2	.56	+	3.57	1.09E-01
dopamine biosynthetic process (GO:0042416)	12	1	.28	+	3.57	2.44E-01
negative regulation of TORC1 signaling (GO:1904262)	12	1	.28	+	3.57	2.44E-01
regulation of bile acid metabolic process (GO:1904251)	12	1	.28	+	3.57	2.44E-01
positive regulation of macrophage chemotaxis (GO:0010759)	24	2	.56	+	3.57	1.09E-01
endocrine hormone secretion (GO:0060986)	12	1	.28	+	3.57	2.44E-01
positive regulation of insulin receptor signaling pathway (GO:0046628)	24	2	.56	+	3.57	1.09E-01
regulation of retrograde protein transport, ER to cytosol (GO:1904152)	12	1	.28	+	3.57	2.44E-01
negative regulation of sprouting angiogenesis (GO:1903671)	12	1	.28	+	3.57	2.44E-01
establishment of blood-brain barrier (GO:0060856)	12	1	.28	+	3.57	2.44E-01
regulation of cilium beat frequency (GO:0003356)	12	1	.28	+	3.57	2.44E-01
monoacylglycerol metabolic process (GO:0046462)	12	1	.28	+	3.57	2.44E-01
regulation of skeletal muscle satellite cell proliferation (GO:0014842)	12	1	.28	+	3.57	2.44E-01
muscle cell migration (GO:0014812)	24	2	.56	+	3.57	1.09E-01
negative adaptation of signaling pathway (GO:0022401)	24	2	.56	+	3.57	1.09E-01
endocardium development (GO:0003157)	12	1	.28	+	3.57	2.44E-01
prostate glandular acinus development (GO:0060525)	12	1	.28	+	3.57	2.44E-01
Ras protein signal transduction (GO:0007265)	133	11	3.10	+	3.55	3.58E-04
regulation of G protein-coupled receptor signaling pathway (GO:0008277)	121	10	2.82	+	3.55	6.60E-04
regulation of Rho protein signal transduction (GO:0035023)	134	11	3.12	+	3.52	3.81E-04
regulation of focal adhesion assembly (GO:0051893)	61	5	1.42	+	3.52	1.50E-02
detection of mechanical stimulus (GO:0050982)	61	5	1.42	+	3.52	1.50E-02
regulation of cell-substrate junction assembly (GO:0090109)	61	5	1.42	+	3.52	1.50E-02
epithelial tube formation (GO:0072175)	160	13	3.73	+	3.49	1.28E-04
blood vessel diameter maintenance (GO:0097746)	160	13	3.73	+	3.49	1.28E-04
regulation of tube diameter (GO:0035296)	160	13	3.73	+	3.49	1.28E-04
lymphocyte chemotaxis (GO:0048247)	37	3	.86	+	3.48	5.66E-02
response to cocaine (GO:0042220)	37	3	.86	+	3.48	5.66E-02
response to ischemia (GO:0002931)	37	3	.86	+	3.48	5.66E-02
negative regulation of smoothened signaling pathway (GO:0045879)	37	3	.86	+	3.48	5.66E-02
positive regulation of axonogenesis (GO:0050772)	99	8	2.31	+	3.47	2.55E-03
regulation of tube size (GO:0035150)	161	13	3.75	+	3.46	1.36E-04
positive regulation of cilium assembly (GO:0045724)	25	2	.58	+	3.43	1.16E-01
positive regulation of syncytium formation by plasma membrane fusion (GO:0060143)	25	2	.58	+	3.43	1.16E-01
lipid import into cell (GO:0140354)	25	2	.58	+	3.43	1.16E-01
regulation of protein deacetylation (GO:0090311)	50	4	1.17	+	3.43	3.06E-02
protein hydroxylation (GO:0018126)	25	2	.58	+	3.43	1.16E-01
regulation of non-canonical Wnt signaling pathway (GO:2000050)	25	2	.58	+	3.43	1.16E-01
positive regulation of mRNA splicing, via spliceosome (GO:0048026)	25	2	.58	+	3.43	1.16E-01
peptide catabolic process (GO:0043171)	25	2	.58	+	3.43	1.16E-01
ketone biosynthetic process (GO:0042181)	25	2	.58	+	3.43	1.16E-01
phosphatidic acid metabolic process (GO:0046473)	25	2	.58	+	3.43	1.16E-01
tube formation (GO:0035148)	176	14	4.10	+	3.41	8.88E-05
semaphorin-plexin signaling pathway (GO:0071526)	38	3	.89	+	3.39	6.04E-02
negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144)	38	3	.89	+	3.39	6.04E-02
regulation of response to reactive oxygen species (GO:1901031)	38	3	.89	+	3.39	6.04E-02
response to pain (GO:0048265)	38	3	.89	+	3.39	6.04E-02
neutral amino acid transport (GO:0015804)	38	3	.89	+	3.39	6.04E-02
regulation of fatty acid oxidation (GO:0046320)	38	3	.89	+	3.39	6.04E-02
regulation of cell morphogenesis involved in differentiation (GO:0010769)	114	9	2.66	+	3.39	1.65E-03
regulation of triglyceride metabolic process (GO:0090207)	51	4	1.19	+	3.36	3.26E-02
neuron apoptotic process (GO:0051402)	51	4	1.19	+	3.36	3.26E-02
chemokine-mediated signaling pathway (GO:0070098)	51	4	1.19	+	3.36	3.26E-02
regulation of striated muscle tissue development (GO:0016202)	51	4	1.19	+	3.36	3.26E-02
trabecula morphogenesis (GO:0061383)	51	4	1.19	+	3.36	3.26E-02
positive regulation of NIK/NF-kappaB signaling (GO:1901224)	64	5	1.49	+	3.35	1.80E-02
cardiac septum morphogenesis (GO:0060411)	77	6	1.79	+	3.34	1.01E-02
embryonic epithelial tube formation (GO:0001838)	154	12	3.59	+	3.34	3.34E-04
amino acid transmembrane transport (GO:0003333)	77	6	1.79	+	3.34	1.01E-02
positive regulation of epidermal growth factor-activated receptor activity (GO:0045741)	13	1	.30	+	3.30	2.62E-01
regulation of glomerular filtration (GO:0003093)	13	1	.30	+	3.30	2.62E-01
branching involved in prostate gland morphogenesis (GO:0060442)	13	1	.30	+	3.30	2.62E-01
positive regulation of erythrocyte differentiation (GO:0045648)	26	2	.61	+	3.30	1.24E-01
positive regulation of keratinocyte differentiation (GO:0045618)	13	1	.30	+	3.30	2.62E-01
pathway-restricted SMAD protein phosphorylation (GO:0060389)	13	1	.30	+	3.30	2.62E-01
optic nerve development (GO:0021554)	13	1	.30	+	3.30	2.62E-01
protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205)	26	2	.61	+	3.30	1.24E-01
positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213)	13	1	.30	+	3.30	2.62E-01
lymphoid progenitor cell differentiation (GO:0002320)	13	1	.30	+	3.30	2.62E-01
regulation of phospholipid transport (GO:2001138)	13	1	.30	+	3.30	2.62E-01
nonribosomal peptide biosynthetic process (GO:0019184)	13	1	.30	+	3.30	2.62E-01
commissural neuron axon guidance (GO:0071679)	13	1	.30	+	3.30	2.62E-01
immunological synapse formation (GO:0001771)	13	1	.30	+	3.30	2.62E-01
otic vesicle development (GO:0071599)	13	1	.30	+	3.30	2.62E-01
regulation of amino acid transport (GO:0051955)	52	4	1.21	+	3.30	3.46E-02
regulation of gamma-aminobutyric acid secretion (GO:0014052)	13	1	.30	+	3.30	2.62E-01
regulation of histone phosphorylation (GO:0033127)	13	1	.30	+	3.30	2.62E-01
ganglioside metabolic process (GO:0001573)	26	2	.61	+	3.30	1.24E-01
regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175)	26	2	.61	+	3.30	1.24E-01
cellular response to reactive nitrogen species (GO:1902170)	13	1	.30	+	3.30	2.62E-01
negative regulation of cilium assembly (GO:1902018)	13	1	.30	+	3.30	2.62E-01
cellular response to lithium ion (GO:0071285)	13	1	.30	+	3.30	2.62E-01
membrane disruption in other organism (GO:0051673)	13	1	.30	+	3.30	2.62E-01
positive regulation of keratinocyte migration (GO:0051549)	13	1	.30	+	3.30	2.62E-01
positive regulation of astrocyte differentiation (GO:0048711)	13	1	.30	+	3.30	2.62E-01
positive regulation of muscle organ development (GO:0048636)	26	2	.61	+	3.30	1.24E-01
positive regulation of positive chemotaxis (GO:0050927)	26	2	.61	+	3.30	1.24E-01
regulation of extracellular matrix assembly (GO:1901201)	13	1	.30	+	3.30	2.62E-01
endocrine process (GO:0050886)	52	4	1.21	+	3.30	3.46E-02
Peyer's patch development (GO:0048541)	13	1	.30	+	3.30	2.62E-01
mucosa-associated lymphoid tissue development (GO:0048537)	13	1	.30	+	3.30	2.62E-01
negative regulation of appetite (GO:0032099)	13	1	.30	+	3.30	2.62E-01
regulation of modification of postsynaptic structure (GO:0099159)	13	1	.30	+	3.30	2.62E-01
tRNA 5'-end processing (GO:0099116)	13	1	.30	+	3.30	2.62E-01
response to magnesium ion (GO:0032026)	13	1	.30	+	3.30	2.62E-01
hemoglobin metabolic process (GO:0020027)	13	1	.30	+	3.30	2.62E-01
negative regulation of JUN kinase activity (GO:0043508)	13	1	.30	+	3.30	2.62E-01
paraxial mesoderm morphogenesis (GO:0048340)	13	1	.30	+	3.30	2.62E-01
regulation of secondary metabolic process (GO:0043455)	13	1	.30	+	3.30	2.62E-01
cytoplasmic sequestering of transcription factor (GO:0042994)	13	1	.30	+	3.30	2.62E-01
response to UV-A (GO:0070141)	13	1	.30	+	3.30	2.62E-01
regulation of glucagon secretion (GO:0070092)	13	1	.30	+	3.30	2.62E-01
toxin metabolic process (GO:0009404)	13	1	.30	+	3.30	2.62E-01
regulation of secondary metabolite biosynthetic process (GO:1900376)	13	1	.30	+	3.30	2.62E-01
regulation of melanin biosynthetic process (GO:0048021)	13	1	.30	+	3.30	2.62E-01
regulation of NLRP3 inflammasome complex assembly (GO:1900225)	13	1	.30	+	3.30	2.62E-01
nucleoside triphosphate catabolic process (GO:0009143)	13	1	.30	+	3.30	2.62E-01
response to caffeine (GO:0031000)	13	1	.30	+	3.30	2.62E-01
regulation of amino acid import across plasma membrane (GO:0010958)	13	1	.30	+	3.30	2.62E-01
regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882)	13	1	.30	+	3.30	2.62E-01
cellular response to forskolin (GO:1904322)	13	1	.30	+	3.30	2.62E-01
response to forskolin (GO:1904321)	13	1	.30	+	3.30	2.62E-01
sleep (GO:0030431)	13	1	.30	+	3.30	2.62E-01
positive regulation of glucose transmembrane transport (GO:0010828)	52	4	1.21	+	3.30	3.46E-02
regulation of neuroinflammatory response (GO:0150077)	26	2	.61	+	3.30	1.24E-01
adrenal gland development (GO:0030325)	26	2	.61	+	3.30	1.24E-01
regulation of amino acid transmembrane transport (GO:1903789)	13	1	.30	+	3.30	2.62E-01
regulation of plasma membrane organization (GO:1903729)	13	1	.30	+	3.30	2.62E-01
chondroitin sulfate metabolic process (GO:0030204)	26	2	.61	+	3.30	1.24E-01
adaptation of signaling pathway (GO:0023058)	26	2	.61	+	3.30	1.24E-01
lipoprotein catabolic process (GO:0042159)	13	1	.30	+	3.30	2.62E-01
regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587)	13	1	.30	+	3.30	2.62E-01
keratinocyte development (GO:0003334)	13	1	.30	+	3.30	2.62E-01
glycosphingolipid catabolic process (GO:0046479)	13	1	.30	+	3.30	2.62E-01
negative regulation of fatty acid metabolic process (GO:0045922)	26	2	.61	+	3.30	1.24E-01
branching involved in labyrinthine layer morphogenesis (GO:0060670)	13	1	.30	+	3.30	2.62E-01
regulation of dendritic spine maintenance (GO:1902950)	13	1	.30	+	3.30	2.62E-01
positive regulation of striated muscle tissue development (GO:0045844)	26	2	.61	+	3.30	1.24E-01
pyramidal neuron development (GO:0021860)	13	1	.30	+	3.30	2.62E-01
peptidyl-proline hydroxylation (GO:0019511)	13	1	.30	+	3.30	2.62E-01
regulation of synaptic transmission, glutamatergic (GO:0051966)	78	6	1.82	+	3.30	1.07E-02
lens development in camera-type eye (GO:0002088)	78	6	1.82	+	3.30	1.07E-02
regulation of renal system process (GO:0098801)	39	3	.91	+	3.30	6.42E-02
acidic amino acid transport (GO:0015800)	39	3	.91	+	3.30	6.42E-02
positive regulation of cell-substrate adhesion (GO:0010811)	130	10	3.03	+	3.30	1.13E-03
response to mechanical stimulus (GO:0009612)	144	11	3.36	+	3.28	6.86E-04
regulation of cell-substrate junction organization (GO:0150116)	66	5	1.54	+	3.25	2.02E-02
collagen metabolic process (GO:0032963)	53	4	1.24	+	3.24	3.67E-02
regulation of systemic arterial blood pressure by hormone (GO:0001990)	40	3	.93	+	3.22	6.81E-02
L-alpha-amino acid transmembrane transport (GO:1902475)	40	3	.93	+	3.22	6.81E-02
acyl-CoA metabolic process (GO:0006637)	80	6	1.86	+	3.22	1.20E-02
regulation of dopamine secretion (GO:0014059)	40	3	.93	+	3.22	6.81E-02
vesicle-mediated transport to the plasma membrane (GO:0098876)	80	6	1.86	+	3.22	1.20E-02
thioester metabolic process (GO:0035383)	80	6	1.86	+	3.22	1.20E-02
regulation of fibroblast migration (GO:0010762)	40	3	.93	+	3.22	6.81E-02
lipid storage (GO:0019915)	40	3	.93	+	3.22	6.81E-02
positive regulation of smooth muscle cell proliferation (GO:0048661)	107	8	2.49	+	3.21	4.06E-03
branching involved in mammary gland duct morphogenesis (GO:0060444)	27	2	.63	+	3.18	1.32E-01
smooth muscle contraction (GO:0006939)	54	4	1.26	+	3.18	3.88E-02
lymph vessel development (GO:0001945)	27	2	.63	+	3.18	1.32E-01
positive regulation of muscle tissue development (GO:1901863)	27	2	.63	+	3.18	1.32E-01
regulation of muscle tissue development (GO:1901861)	54	4	1.26	+	3.18	3.88E-02
positive regulation of focal adhesion assembly (GO:0051894)	27	2	.63	+	3.18	1.32E-01
positive regulation of neuroblast proliferation (GO:0002052)	27	2	.63	+	3.18	1.32E-01
cochlea morphogenesis (GO:0090103)	27	2	.63	+	3.18	1.32E-01
regulation of positive chemotaxis (GO:0050926)	27	2	.63	+	3.18	1.32E-01
axonemal dynein complex assembly (GO:0070286)	27	2	.63	+	3.18	1.32E-01
positive regulation of potassium ion transmembrane transporter activity (GO:1901018)	27	2	.63	+	3.18	1.32E-01
negative regulation of receptor-mediated endocytosis (GO:0048261)	27	2	.63	+	3.18	1.32E-01
neuron cellular homeostasis (GO:0070050)	27	2	.63	+	3.18	1.32E-01
positive regulation of circadian rhythm (GO:0042753)	27	2	.63	+	3.18	1.32E-01
secondary palate development (GO:0062009)	27	2	.63	+	3.18	1.32E-01
positive regulation of dendrite extension (GO:1903861)	27	2	.63	+	3.18	1.32E-01
clathrin-dependent endocytosis (GO:0072583)	27	2	.63	+	3.18	1.32E-01
morphogenesis of embryonic epithelium (GO:0016331)	176	13	4.10	+	3.17	3.17E-04
positive regulation of protein binding (GO:0032092)	95	7	2.21	+	3.16	7.54E-03
negative regulation of epithelial cell migration (GO:0010633)	68	5	1.59	+	3.15	2.26E-02
cellular polysaccharide biosynthetic process (GO:0033692)	41	3	.96	+	3.14	7.21E-02
positive regulation of multicellular organism growth (GO:0040018)	41	3	.96	+	3.14	7.21E-02
positive regulation of potassium ion transmembrane transport (GO:1901381)	41	3	.96	+	3.14	7.21E-02
polysaccharide biosynthetic process (GO:0000271)	41	3	.96	+	3.14	7.21E-02
negative regulation of insulin receptor signaling pathway (GO:0046627)	41	3	.96	+	3.14	7.21E-02
vascular process in circulatory system (GO:0003018)	219	16	5.11	+	3.13	7.63E-05
positive regulation of cell morphogenesis involved in differentiation (GO:0010770)	96	7	2.24	+	3.13	7.96E-03
regulation of muscle organ development (GO:0048634)	55	4	1.28	+	3.12	4.11E-02
positive regulation of organelle assembly (GO:1902117)	69	5	1.61	+	3.11	2.39E-02
negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512)	69	5	1.61	+	3.11	2.39E-02
negative regulation of immunoglobulin production (GO:0002638)	14	1	.33	+	3.06	2.79E-01
response to lithium ion (GO:0010226)	14	1	.33	+	3.06	2.79E-01
glial cell fate commitment (GO:0021781)	14	1	.33	+	3.06	2.79E-01
positive regulation of macrophage differentiation (GO:0045651)	14	1	.33	+	3.06	2.79E-01
glycolipid catabolic process (GO:0019377)	14	1	.33	+	3.06	2.79E-01
regulation of axon guidance (GO:1902667)	14	1	.33	+	3.06	2.79E-01
post-Golgi vesicle-mediated transport (GO:0006892)	84	6	1.96	+	3.06	1.49E-02
positive regulation of podosome assembly (GO:0071803)	14	1	.33	+	3.06	2.79E-01
mammary gland epithelial cell proliferation (GO:0033598)	14	1	.33	+	3.06	2.79E-01
ubiquinone biosynthetic process (GO:0006744)	14	1	.33	+	3.06	2.79E-01
protein-DNA complex disassembly (GO:0032986)	14	1	.33	+	3.06	2.79E-01
negative regulation of transforming growth factor beta production (GO:0071635)	14	1	.33	+	3.06	2.79E-01
nuclear migration (GO:0007097)	28	2	.65	+	3.06	1.39E-01
telomere maintenance via telomerase (GO:0007004)	14	1	.33	+	3.06	2.79E-01
positive regulation of cardiac muscle cell proliferation (GO:0060045)	28	2	.65	+	3.06	1.39E-01
pericardium development (GO:0060039)	28	2	.65	+	3.06	1.39E-01
convergent extension (GO:0060026)	14	1	.33	+	3.06	2.79E-01
negative regulation of monooxygenase activity (GO:0032769)	14	1	.33	+	3.06	2.79E-01
positive regulation of interleukin-13 production (GO:0032736)	14	1	.33	+	3.06	2.79E-01
N-terminal protein amino acid acetylation (GO:0006474)	14	1	.33	+	3.06	2.79E-01
lens morphogenesis in camera-type eye (GO:0002089)	28	2	.65	+	3.06	1.39E-01
cellular response to gonadotropin stimulus (GO:0071371)	14	1	.33	+	3.06	2.79E-01
quinone biosynthetic process (GO:1901663)	14	1	.33	+	3.06	2.79E-01
positive regulation of calcineurin-NFAT signaling cascade (GO:0070886)	14	1	.33	+	3.06	2.79E-01
RNA-dependent DNA biosynthetic process (GO:0006278)	14	1	.33	+	3.06	2.79E-01
regulation of keratinocyte migration (GO:0051547)	14	1	.33	+	3.06	2.79E-01
fructose 6-phosphate metabolic process (GO:0006002)	14	1	.33	+	3.06	2.79E-01
myoblast migration (GO:0051451)	14	1	.33	+	3.06	2.79E-01
negative regulation of axon regeneration (GO:0048681)	14	1	.33	+	3.06	2.79E-01
positive regulation of mitochondrial fission (GO:0090141)	14	1	.33	+	3.06	2.79E-01
regulation of gonadotropin secretion (GO:0032276)	14	1	.33	+	3.06	2.79E-01
positive regulation of calcineurin-mediated signaling (GO:0106058)	14	1	.33	+	3.06	2.79E-01
leukocyte aggregation (GO:0070486)	14	1	.33	+	3.06	2.79E-01
negative regulation of response to nutrient levels (GO:0032108)	14	1	.33	+	3.06	2.79E-01
negative regulation of response to extracellular stimulus (GO:0032105)	14	1	.33	+	3.06	2.79E-01
regulation of lipoprotein metabolic process (GO:0050746)	14	1	.33	+	3.06	2.79E-01
negative regulation of response to food (GO:0032096)	14	1	.33	+	3.06	2.79E-01
modification of postsynaptic structure (GO:0099010)	14	1	.33	+	3.06	2.79E-01
regulation of amyloid precursor protein biosynthetic process (GO:0042984)	14	1	.33	+	3.06	2.79E-01
developmental pigmentation (GO:0048066)	42	3	.98	+	3.06	7.63E-02
retinal metabolic process (GO:0042574)	14	1	.33	+	3.06	2.79E-01
positive regulation of ruffle assembly (GO:1900029)	14	1	.33	+	3.06	2.79E-01
telomere capping (GO:0016233)	14	1	.33	+	3.06	2.79E-01
protein localization to microtubule (GO:0035372)	14	1	.33	+	3.06	2.79E-01
monosaccharide transmembrane transport (GO:0015749)	28	2	.65	+	3.06	1.39E-01
regulation of RNA export from nucleus (GO:0046831)	14	1	.33	+	3.06	2.79E-01
positive regulation of steroid biosynthetic process (GO:0010893)	28	2	.65	+	3.06	1.39E-01
regulation of sequestering of triglyceride (GO:0010889)	14	1	.33	+	3.06	2.79E-01
positive regulation of myotube differentiation (GO:0010831)	14	1	.33	+	3.06	2.79E-01
terpenoid biosynthetic process (GO:0016114)	14	1	.33	+	3.06	2.79E-01
lipid glycosylation (GO:0030259)	14	1	.33	+	3.06	2.79E-01
regulation of DNA catabolic process (GO:1903624)	14	1	.33	+	3.06	2.79E-01
positive regulation of lamellipodium assembly (GO:0010592)	28	2	.65	+	3.06	1.39E-01
activation of cysteine-type endopeptidase activity (GO:0097202)	14	1	.33	+	3.06	2.79E-01
prostate gland growth (GO:0060736)	14	1	.33	+	3.06	2.79E-01
olfactory behavior (GO:0042048)	14	1	.33	+	3.06	2.79E-01
regulation of skeletal muscle cell proliferation (GO:0014857)	14	1	.33	+	3.06	2.79E-01
negative regulation of inflammatory response to antigenic stimulus (GO:0002862)	14	1	.33	+	3.06	2.79E-01
P-body assembly (GO:0033962)	14	1	.33	+	3.06	2.79E-01
amino sugar catabolic process (GO:0046348)	14	1	.33	+	3.06	2.79E-01
positive regulation of alcohol biosynthetic process (GO:1902932)	28	2	.65	+	3.06	1.39E-01
layer formation in cerebral cortex (GO:0021819)	14	1	.33	+	3.06	2.79E-01
regulation of circadian rhythm (GO:0042752)	127	9	2.96	+	3.04	3.36E-03
regulation of multicellular organism growth (GO:0040014)	85	6	1.98	+	3.03	1.57E-02
neural crest cell migration (GO:0001755)	57	4	1.33	+	3.01	4.57E-02
regulation of amine transport (GO:0051952)	114	8	2.66	+	3.01	5.87E-03
regulation of dendrite development (GO:0050773)	129	9	3.01	+	2.99	3.72E-03
regulation of peptidyl-threonine phosphorylation (GO:0010799)	43	3	1.00	+	2.99	8.05E-02
glial cell migration (GO:0008347)	43	3	1.00	+	2.99	8.05E-02
regulation of cell morphogenesis (GO:0022604)	316	22	7.37	+	2.99	7.66E-06
response to alkaloid (GO:0043279)	72	5	1.68	+	2.98	2.80E-02
negative regulation of cell projection organization (GO:0031345)	202	14	4.71	+	2.97	3.56E-04
neural precursor cell proliferation (GO:0061351)	87	6	2.03	+	2.96	1.73E-02
carbohydrate transmembrane transport (GO:0034219)	29	2	.68	+	2.96	1.47E-01
gamma-aminobutyric acid signaling pathway (GO:0007214)	29	2	.68	+	2.96	1.47E-01
blastocyst growth (GO:0001832)	29	2	.68	+	2.96	1.47E-01
positive regulation of amino acid transport (GO:0051957)	29	2	.68	+	2.96	1.47E-01
negative regulation of RNA splicing (GO:0033119)	29	2	.68	+	2.96	1.47E-01
regulation of interleukin-12 production (GO:0032655)	58	4	1.35	+	2.96	4.82E-02
positive regulation of protein deacetylation (GO:0090312)	29	2	.68	+	2.96	1.47E-01
positive regulation of triglyceride metabolic process (GO:0090208)	29	2	.68	+	2.96	1.47E-01
digestive tract development (GO:0048565)	116	8	2.70	+	2.96	6.49E-03
positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552)	29	2	.68	+	2.96	1.47E-01
regulation of histone deacetylation (GO:0031063)	29	2	.68	+	2.96	1.47E-01
Golgi to plasma membrane protein transport (GO:0043001)	29	2	.68	+	2.96	1.47E-01
positive regulation of cellular response to insulin stimulus (GO:1900078)	29	2	.68	+	2.96	1.47E-01
positive regulation of phosphatase activity (GO:0010922)	29	2	.68	+	2.96	1.47E-01
axis elongation (GO:0003401)	29	2	.68	+	2.96	1.47E-01
isoprenoid biosynthetic process (GO:0008299)	29	2	.68	+	2.96	1.47E-01
prostate gland epithelium morphogenesis (GO:0060740)	29	2	.68	+	2.96	1.47E-01
central nervous system projection neuron axonogenesis (GO:0021952)	29	2	.68	+	2.96	1.47E-01
outflow tract septum morphogenesis (GO:0003148)	29	2	.68	+	2.96	1.47E-01
negative regulation of response to oxidative stress (GO:1902883)	29	2	.68	+	2.96	1.47E-01
positive regulation of canonical Wnt signaling pathway (GO:0090263)	102	7	2.38	+	2.94	1.08E-02
cellular response to interleukin-1 (GO:0071347)	73	5	1.70	+	2.94	2.94E-02
behavioral fear response (GO:0001662)	44	3	1.03	+	2.92	8.49E-02
positive regulation of Wnt signaling pathway (GO:0030177)	132	9	3.08	+	2.92	4.30E-03
regulation of glycoprotein biosynthetic process (GO:0010559)	44	3	1.03	+	2.92	8.49E-02
positive regulation of phospholipase activity (GO:0010518)	44	3	1.03	+	2.92	8.49E-02
neural tube development (GO:0021915)	191	13	4.45	+	2.92	6.75E-04
cellular response to catecholamine stimulus (GO:0071870)	59	4	1.38	+	2.91	5.07E-02
cellular response to monoamine stimulus (GO:0071868)	59	4	1.38	+	2.91	5.07E-02
positive regulation of cell-matrix adhesion (GO:0001954)	59	4	1.38	+	2.91	5.07E-02
regulation of cilium assembly (GO:1902017)	59	4	1.38	+	2.91	5.07E-02
actin filament bundle assembly (GO:0051017)	59	4	1.38	+	2.91	5.07E-02
negative regulation of cell-substrate adhesion (GO:0010812)	59	4	1.38	+	2.91	5.07E-02
gene silencing by RNA (GO:0031047)	74	5	1.73	+	2.90	3.09E-02
positive regulation of leukocyte chemotaxis (GO:0002690)	89	6	2.07	+	2.89	1.91E-02
positive regulation of plasma membrane bounded cell projection assembly (GO:0120034)	104	7	2.42	+	2.89	1.19E-02
regulation of cell-matrix adhesion (GO:0001952)	119	8	2.77	+	2.88	7.50E-03
regulation of leukocyte tethering or rolling (GO:1903236)	15	1	.35	+	2.86	2.95E-01
segment specification (GO:0007379)	15	1	.35	+	2.86	2.95E-01
sulfur compound transport (GO:0072348)	45	3	1.05	+	2.86	8.93E-02
response to catecholamine (GO:0071869)	60	4	1.40	+	2.86	5.33E-02
response to monoamine (GO:0071867)	60	4	1.40	+	2.86	5.33E-02
regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267)	15	1	.35	+	2.86	2.95E-01
synaptic transmission, cholinergic (GO:0007271)	15	1	.35	+	2.86	2.95E-01
cell differentiation in hindbrain (GO:0021533)	30	2	.70	+	2.86	1.55E-01
regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211)	15	1	.35	+	2.86	2.95E-01
phagolysosome assembly (GO:0001845)	15	1	.35	+	2.86	2.95E-01
positive regulation of sodium ion transmembrane transporter activity (GO:2000651)	15	1	.35	+	2.86	2.95E-01
cellular response to chemokine (GO:1990869)	60	4	1.40	+	2.86	5.33E-02
response to chemokine (GO:1990868)	60	4	1.40	+	2.86	5.33E-02
negative regulation of cell junction assembly (GO:1901889)	30	2	.70	+	2.86	1.55E-01
negative regulation of tumor necrosis factor production (GO:0032720)	60	4	1.40	+	2.86	5.33E-02
positive regulation of glutamate secretion (GO:0014049)	15	1	.35	+	2.86	2.95E-01
response to hydroperoxide (GO:0033194)	15	1	.35	+	2.86	2.95E-01
action potential (GO:0001508)	90	6	2.10	+	2.86	2.01E-02
medium-chain fatty acid metabolic process (GO:0051791)	15	1	.35	+	2.86	2.95E-01
negative regulation of calcineurin-NFAT signaling cascade (GO:0070885)	15	1	.35	+	2.86	2.95E-01
cellular response to copper ion (GO:0071280)	15	1	.35	+	2.86	2.95E-01
Golgi localization (GO:0051645)	15	1	.35	+	2.86	2.95E-01
positive regulation by host of viral transcription (GO:0043923)	15	1	.35	+	2.86	2.95E-01
regulation of spindle checkpoint (GO:0090231)	15	1	.35	+	2.86	2.95E-01
acetyl-CoA metabolic process (GO:0006084)	30	2	.70	+	2.86	1.55E-01
DNA catabolic process, endonucleolytic (GO:0000737)	15	1	.35	+	2.86	2.95E-01
positive regulation of voltage-gated calcium channel activity (GO:1901387)	15	1	.35	+	2.86	2.95E-01
epithelial cell-cell adhesion (GO:0090136)	15	1	.35	+	2.86	2.95E-01
induction of positive chemotaxis (GO:0050930)	15	1	.35	+	2.86	2.95E-01
negative regulation of calcineurin-mediated signaling (GO:0106057)	15	1	.35	+	2.86	2.95E-01
regulation of synaptic transmission, cholinergic (GO:0032222)	15	1	.35	+	2.86	2.95E-01
embryonic camera-type eye morphogenesis (GO:0048596)	30	2	.70	+	2.86	1.55E-01
lymph node development (GO:0048535)	30	2	.70	+	2.86	1.55E-01
engulfment of apoptotic cell (GO:0043652)	15	1	.35	+	2.86	2.95E-01
calcium ion import across plasma membrane (GO:0098703)	15	1	.35	+	2.86	2.95E-01
regulation of excretion (GO:0044062)	30	2	.70	+	2.86	1.55E-01
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)	15	1	.35	+	2.86	2.95E-01
photoreceptor cell outer segment organization (GO:0035845)	15	1	.35	+	2.86	2.95E-01
cortical cytoskeleton organization (GO:0030865)	60	4	1.40	+	2.86	5.33E-02
very long-chain fatty acid metabolic process (GO:0000038)	30	2	.70	+	2.86	1.55E-01
calcineurin-mediated signaling (GO:0097720)	15	1	.35	+	2.86	2.95E-01
positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)	15	1	.35	+	2.86	2.95E-01
neuron remodeling (GO:0016322)	15	1	.35	+	2.86	2.95E-01
vitamin transmembrane transport (GO:0035461)	15	1	.35	+	2.86	2.95E-01
nucleoside diphosphate catabolic process (GO:0009134)	15	1	.35	+	2.86	2.95E-01
negative regulation of cellular response to insulin stimulus (GO:1900077)	45	3	1.05	+	2.86	8.93E-02
magnesium ion homeostasis (GO:0010960)	15	1	.35	+	2.86	2.95E-01
progesterone metabolic process (GO:0042448)	15	1	.35	+	2.86	2.95E-01
norepinephrine metabolic process (GO:0042415)	15	1	.35	+	2.86	2.95E-01
fibroblast growth factor receptor signaling pathway (GO:0008543)	45	3	1.05	+	2.86	8.93E-02
magnesium ion transport (GO:0015693)	15	1	.35	+	2.86	2.95E-01
fibroblast migration (GO:0010761)	15	1	.35	+	2.86	2.95E-01
positive regulation of phospholipid metabolic process (GO:1903727)	15	1	.35	+	2.86	2.95E-01
cellular response to heat (GO:0034605)	45	3	1.05	+	2.86	8.93E-02
tooth mineralization (GO:0034505)	15	1	.35	+	2.86	2.95E-01
epithelial cell differentiation involved in prostate gland development (GO:0060742)	15	1	.35	+	2.86	2.95E-01
positive regulation of inositol phosphate biosynthetic process (GO:0060732)	15	1	.35	+	2.86	2.95E-01
ncRNA 5'-end processing (GO:0034471)	15	1	.35	+	2.86	2.95E-01
ruffle assembly (GO:0097178)	15	1	.35	+	2.86	2.95E-01
GABAergic neuron differentiation (GO:0097154)	15	1	.35	+	2.86	2.95E-01
mesenchymal cell proliferation (GO:0010463)	15	1	.35	+	2.86	2.95E-01
negative regulation of translational initiation (GO:0045947)	15	1	.35	+	2.86	2.95E-01
regulation of skeletal muscle adaptation (GO:0014733)	15	1	.35	+	2.86	2.95E-01
positive regulation of protein tyrosine kinase activity (GO:0061098)	45	3	1.05	+	2.86	8.93E-02
eyelid development in camera-type eye (GO:0061029)	15	1	.35	+	2.86	2.95E-01
pyramidal neuron differentiation (GO:0021859)	15	1	.35	+	2.86	2.95E-01
regulation of non-motile cilium assembly (GO:1902855)	15	1	.35	+	2.86	2.95E-01
prostate gland morphogenesis (GO:0060512)	30	2	.70	+	2.86	1.55E-01
rhythmic process (GO:0048511)	255	17	5.94	+	2.86	1.37E-04
circadian rhythm (GO:0007623)	135	9	3.15	+	2.86	4.96E-03
small GTPase mediated signal transduction (GO:0007264)	211	14	4.92	+	2.85	5.44E-04
gland morphogenesis (GO:0022612)	121	8	2.82	+	2.84	8.24E-03
regulation of smoothened signaling pathway (GO:0008589)	91	6	2.12	+	2.83	2.10E-02
regulation of insulin receptor signaling pathway (GO:0046626)	76	5	1.77	+	2.82	3.41E-02
lung alveolus development (GO:0048286)	61	4	1.42	+	2.81	5.59E-02
actin filament bundle organization (GO:0061572)	61	4	1.42	+	2.81	5.59E-02
positive regulation of cellular carbohydrate metabolic process (GO:0010676)	61	4	1.42	+	2.81	5.59E-02
negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556)	61	4	1.42	+	2.81	5.59E-02
behavioral defense response (GO:0002209)	46	3	1.07	+	2.80	9.38E-02
phospholipid translocation (GO:0045332)	46	3	1.07	+	2.80	9.38E-02
regulation of plasma membrane bounded cell projection assembly (GO:0120032)	184	12	4.29	+	2.80	1.53E-03
response to hydrogen peroxide (GO:0042542)	92	6	2.14	+	2.80	2.20E-02
positive regulation of glucose metabolic process (GO:0010907)	46	3	1.07	+	2.80	9.38E-02
extrinsic apoptotic signaling pathway (GO:0097191)	92	6	2.14	+	2.80	2.20E-02
regulation of cell-substrate adhesion (GO:0010810)	215	14	5.01	+	2.79	6.52E-04
granulocyte chemotaxis (GO:0071621)	77	5	1.79	+	2.79	3.57E-02
regulation of cell projection assembly (GO:0060491)	186	12	4.34	+	2.77	1.67E-03
regulation of hydrogen peroxide-induced cell death (GO:1903205)	31	2	.72	+	2.77	1.64E-01
monocyte chemotaxis (GO:0002548)	31	2	.72	+	2.77	1.64E-01
regulation of syncytium formation by plasma membrane fusion (GO:0060142)	31	2	.72	+	2.77	1.64E-01
negative regulation of organic acid transport (GO:0032891)	31	2	.72	+	2.77	1.64E-01
negative regulation of interleukin-1 production (GO:0032692)	31	2	.72	+	2.77	1.64E-01
regulation of calcineurin-NFAT signaling cascade (GO:0070884)	31	2	.72	+	2.77	1.64E-01
cellular response to acetylcholine (GO:1905145)	31	2	.72	+	2.77	1.64E-01
response to acetylcholine (GO:1905144)	31	2	.72	+	2.77	1.64E-01
regulation of hair cycle (GO:0042634)	31	2	.72	+	2.77	1.64E-01
regulation of dendrite extension (GO:1903859)	31	2	.72	+	2.77	1.64E-01
organic cation transport (GO:0015695)	31	2	.72	+	2.77	1.64E-01
midbrain development (GO:0030901)	47	3	1.10	+	2.74	9.85E-02
cellular response to dopamine (GO:1903351)	47	3	1.10	+	2.74	9.85E-02
response to dopamine (GO:1903350)	47	3	1.10	+	2.74	9.85E-02
regulation of Ras protein signal transduction (GO:0046578)	235	15	5.48	+	2.74	5.19E-04
axonogenesis (GO:0007409)	346	22	8.07	+	2.73	2.99E-05
response to ethanol (GO:0045471)	63	4	1.47	+	2.72	6.14E-02
neuron death (GO:0070997)	63	4	1.47	+	2.72	6.14E-02
protein transport along microtubule (GO:0098840)	63	4	1.47	+	2.72	6.14E-02
microtubule-based protein transport (GO:0099118)	63	4	1.47	+	2.72	6.14E-02
positive regulation of protein kinase B signaling (GO:0051897)	111	7	2.59	+	2.71	1.64E-02
positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100)	111	7	2.59	+	2.71	1.64E-02
cellular response to leukemia inhibitory factor (GO:1990830)	127	8	2.96	+	2.70	1.08E-02
regulation of cold-induced thermogenesis (GO:0120161)	143	9	3.33	+	2.70	7.11E-03
tube morphogenesis (GO:0035239)	718	45	16.74	+	2.69	3.03E-09
positive regulation of cell size (GO:0045793)	16	1	.37	+	2.68	3.11E-01
phagocytosis, recognition (GO:0006910)	16	1	.37	+	2.68	3.11E-01
antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:0002504)	16	1	.37	+	2.68	3.11E-01
cerebellar cortex formation (GO:0021697)	32	2	.75	+	2.68	1.72E-01
cerebellar granular layer development (GO:0021681)	16	1	.37	+	2.68	3.11E-01
type I interferon signaling pathway (GO:0060337)	16	1	.37	+	2.68	3.11E-01
calcium ion import into cytosol (GO:1902656)	16	1	.37	+	2.68	3.11E-01
secondary alcohol biosynthetic process (GO:1902653)	32	2	.75	+	2.68	1.72E-01
antigen processing and presentation of peptide antigen via MHC class II (GO:0002495)	16	1	.37	+	2.68	3.11E-01
response to testosterone (GO:0033574)	16	1	.37	+	2.68	3.11E-01
regulation of vasculogenesis (GO:2001212)	16	1	.37	+	2.68	3.11E-01
renal system process involved in regulation of blood volume (GO:0001977)	16	1	.37	+	2.68	3.11E-01
ubiquinone metabolic process (GO:0006743)	16	1	.37	+	2.68	3.11E-01
response to nitric oxide (GO:0071731)	16	1	.37	+	2.68	3.11E-01
epithelial cell fate commitment (GO:0072148)	16	1	.37	+	2.68	3.11E-01
cholesterol biosynthetic process (GO:0006695)	32	2	.75	+	2.68	1.72E-01
regulation of MHC class II biosynthetic process (GO:0045346)	16	1	.37	+	2.68	3.11E-01
synapse maturation (GO:0060074)	16	1	.37	+	2.68	3.11E-01
cardiac muscle cell proliferation (GO:0060038)	16	1	.37	+	2.68	3.11E-01
response to leukemia inhibitory factor (GO:1990823)	128	8	2.98	+	2.68	1.13E-02
regulation of cAMP-dependent protein kinase activity (GO:2000479)	16	1	.37	+	2.68	3.11E-01
ganglioside biosynthetic process (GO:0001574)	16	1	.37	+	2.68	3.11E-01
negative regulation of interferon-beta production (GO:0032688)	16	1	.37	+	2.68	3.11E-01
mRNA cleavage (GO:0006379)	16	1	.37	+	2.68	3.11E-01
interleukin-1 beta production (GO:0032611)	16	1	.37	+	2.68	3.11E-01
cellular response to type I interferon (GO:0071357)	16	1	.37	+	2.68	3.11E-01
regulation of fibroblast growth factor receptor signaling pathway (GO:0040036)	32	2	.75	+	2.68	1.72E-01
2-oxoglutarate metabolic process (GO:0006103)	16	1	.37	+	2.68	3.11E-01
embryonic brain development (GO:1990403)	16	1	.37	+	2.68	3.11E-01
negative regulation of oligodendrocyte differentiation (GO:0048715)	16	1	.37	+	2.68	3.11E-01
lactate metabolic process (GO:0006089)	16	1	.37	+	2.68	3.11E-01
negative regulation of neuron projection regeneration (GO:0070571)	16	1	.37	+	2.68	3.11E-01
response to fatty acid (GO:0070542)	32	2	.75	+	2.68	1.72E-01
regulation of skeletal muscle tissue development (GO:0048641)	32	2	.75	+	2.68	1.72E-01
regulation of calcineurin-mediated signaling (GO:0106056)	32	2	.75	+	2.68	1.72E-01
positive regulation of actin filament bundle assembly (GO:0032233)	64	4	1.49	+	2.68	6.43E-02
regulation of inclusion body assembly (GO:0090083)	16	1	.37	+	2.68	3.11E-01
white fat cell differentiation (GO:0050872)	16	1	.37	+	2.68	3.11E-01
regulation of heat generation (GO:0031650)	16	1	.37	+	2.68	3.11E-01
regulation of neurotransmitter receptor localization to postsynaptic specialization membrane (GO:0098696)	16	1	.37	+	2.68	3.11E-01
regulation of retinoic acid receptor signaling pathway (GO:0048385)	16	1	.37	+	2.68	3.11E-01
negative regulation of mRNA processing (GO:0050686)	32	2	.75	+	2.68	1.72E-01
chaperone cofactor-dependent protein refolding (GO:0051085)	32	2	.75	+	2.68	1.72E-01
eosinophil chemotaxis (GO:0048245)	16	1	.37	+	2.68	3.11E-01
regulation of lysosomal lumen pH (GO:0035751)	16	1	.37	+	2.68	3.11E-01
cellular response to hepatocyte growth factor stimulus (GO:0035729)	16	1	.37	+	2.68	3.11E-01
regulation of mRNA polyadenylation (GO:1900363)	16	1	.37	+	2.68	3.11E-01
sodium-independent organic anion transport (GO:0043252)	16	1	.37	+	2.68	3.11E-01
regulation of circadian sleep/wake cycle (GO:0042749)	32	2	.75	+	2.68	1.72E-01
maternal behavior (GO:0042711)	16	1	.37	+	2.68	3.11E-01
fatty acid homeostasis (GO:0055089)	16	1	.37	+	2.68	3.11E-01
neuroblast division (GO:0055057)	16	1	.37	+	2.68	3.11E-01
cell communication involved in cardiac conduction (GO:0086065)	32	2	.75	+	2.68	1.72E-01
positive regulation of cell-substrate junction organization (GO:0150117)	32	2	.75	+	2.68	1.72E-01
cellular response to angiotensin (GO:1904385)	16	1	.37	+	2.68	3.11E-01
protein O-linked mannosylation (GO:0035269)	16	1	.37	+	2.68	3.11E-01
regulation of cGMP-mediated signaling (GO:0010752)	16	1	.37	+	2.68	3.11E-01
stabilization of membrane potential (GO:0030322)	16	1	.37	+	2.68	3.11E-01
cellular response to reactive oxygen species (GO:0034614)	112	7	2.61	+	2.68	1.72E-02
antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886)	16	1	.37	+	2.68	3.11E-01
negative regulation of androgen receptor signaling pathway (GO:0060766)	16	1	.37	+	2.68	3.11E-01
positive regulation of type 2 immune response (GO:0002830)	16	1	.37	+	2.68	3.11E-01
telencephalon regionalization (GO:0021978)	16	1	.37	+	2.68	3.11E-01
glucose import (GO:0046323)	16	1	.37	+	2.68	3.11E-01
MyD88-dependent toll-like receptor signaling pathway (GO:0002755)	16	1	.37	+	2.68	3.11E-01
cytoplasmic pattern recognition receptor signaling pathway (GO:0002753)	16	1	.37	+	2.68	3.11E-01
cardiac conduction system development (GO:0003161)	16	1	.37	+	2.68	3.11E-01
lipid translocation (GO:0034204)	48	3	1.12	+	2.68	1.03E-01
regulation of cardiac muscle cell proliferation (GO:0060043)	48	3	1.12	+	2.68	1.03E-01
morphogenesis of an epithelial sheet (GO:0002011)	48	3	1.12	+	2.68	1.03E-01
regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041)	48	3	1.12	+	2.68	1.03E-01
cochlea development (GO:0090102)	48	3	1.12	+	2.68	1.03E-01
establishment of spindle localization (GO:0051293)	48	3	1.12	+	2.68	1.03E-01
protein destabilization (GO:0031648)	48	3	1.12	+	2.68	1.03E-01
exocrine system development (GO:0035272)	48	3	1.12	+	2.68	1.03E-01
regulation of cell shape (GO:0008360)	145	9	3.38	+	2.66	7.74E-03
digestive system development (GO:0055123)	129	8	3.01	+	2.66	1.17E-02
purine nucleoside bisphosphate metabolic process (GO:0034032)	97	6	2.26	+	2.65	2.76E-02
roof of mouth development (GO:0060021)	97	6	2.26	+	2.65	2.76E-02
ribonucleoside bisphosphate metabolic process (GO:0033875)	97	6	2.26	+	2.65	2.76E-02
nucleoside bisphosphate metabolic process (GO:0033865)	97	6	2.26	+	2.65	2.76E-02
positive regulation of carbohydrate metabolic process (GO:0045913)	81	5	1.89	+	2.65	4.27E-02
positive regulation of Ras protein signal transduction (GO:0046579)	65	4	1.52	+	2.64	6.72E-02
regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044)	49	3	1.14	+	2.63	1.08E-01
regulation of glycoprotein metabolic process (GO:1903018)	49	3	1.14	+	2.63	1.08E-01
regulation of stem cell proliferation (GO:0072091)	49	3	1.14	+	2.63	1.08E-01
activation of GTPase activity (GO:0090630)	98	6	2.28	+	2.63	2.88E-02
regulation of multi-organism process (GO:0043900)	49	3	1.14	+	2.63	1.08E-01
regulation of oligodendrocyte differentiation (GO:0048713)	49	3	1.14	+	2.63	1.08E-01
killing of cells of other organism (GO:0031640)	49	3	1.14	+	2.63	1.08E-01
negative regulation of DNA binding (GO:0043392)	49	3	1.14	+	2.63	1.08E-01
fear response (GO:0042596)	49	3	1.14	+	2.63	1.08E-01
axon development (GO:0061564)	376	23	8.77	+	2.62	3.57E-05
angiogenesis (GO:0001525)	312	19	7.27	+	2.61	1.78E-04
axon guidance (GO:0007411)	230	14	5.36	+	2.61	1.23E-03
mammary gland development (GO:0030879)	148	9	3.45	+	2.61	8.76E-03
regulation of axonogenesis (GO:0050770)	181	11	4.22	+	2.61	4.00E-03
negative regulation of cell motility (GO:2000146)	280	17	6.53	+	2.60	3.97E-04
positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742)	33	2	.77	+	2.60	1.80E-01
neuroblast proliferation (GO:0007405)	33	2	.77	+	2.60	1.80E-01
negative regulation of toll-like receptor signaling pathway (GO:0034122)	33	2	.77	+	2.60	1.80E-01
telencephalon cell migration (GO:0022029)	66	4	1.54	+	2.60	7.02E-02
regulation of nitric oxide biosynthetic process (GO:0045428)	66	4	1.54	+	2.60	7.02E-02
positive regulation of telomerase activity (GO:0051973)	33	2	.77	+	2.60	1.80E-01
nucleus localization (GO:0051647)	33	2	.77	+	2.60	1.80E-01
negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435)	33	2	.77	+	2.60	1.80E-01
regulation of cAMP-mediated signaling (GO:0043949)	66	4	1.54	+	2.60	7.02E-02
positive regulation of lipid kinase activity (GO:0090218)	33	2	.77	+	2.60	1.80E-01
embryonic digestive tract development (GO:0048566)	33	2	.77	+	2.60	1.80E-01
chondroitin sulfate proteoglycan metabolic process (GO:0050654)	33	2	.77	+	2.60	1.80E-01
regulation of catecholamine secretion (GO:0050433)	66	4	1.54	+	2.60	7.02E-02
neuron projection guidance (GO:0097485)	231	14	5.38	+	2.60	1.28E-03
lactation (GO:0007595)	33	2	.77	+	2.60	1.80E-01
negative regulation of GTPase activity (GO:0034260)	33	2	.77	+	2.60	1.80E-01
female gonad development (GO:0008585)	99	6	2.31	+	2.60	3.00E-02
regulation of small GTPase mediated signal transduction (GO:0051056)	265	16	6.18	+	2.59	6.18E-04
regulation of protein kinase B signaling (GO:0051896)	166	10	3.87	+	2.58	6.28E-03
vasculogenesis (GO:0001570)	83	5	1.93	+	2.58	4.66E-02
epithelial tube morphogenesis (GO:0060562)	366	22	8.53	+	2.58	6.76E-05
positive regulation of amine transport (GO:0051954)	50	3	1.17	+	2.57	1.13E-01
negative regulation of gliogenesis (GO:0014014)	50	3	1.17	+	2.57	1.13E-01
glycogen metabolic process (GO:0005977)	50	3	1.17	+	2.57	1.13E-01
cellular glucan metabolic process (GO:0006073)	50	3	1.17	+	2.57	1.13E-01
glucan metabolic process (GO:0044042)	50	3	1.17	+	2.57	1.13E-01
positive regulation of potassium ion transport (GO:0043268)	50	3	1.17	+	2.57	1.13E-01
negative regulation of endothelial cell migration (GO:0010596)	50	3	1.17	+	2.57	1.13E-01
negative regulation of cell migration (GO:0030336)	267	16	6.22	+	2.57	6.68E-04
amino acid transport (GO:0006865)	117	7	2.73	+	2.57	2.12E-02
positive regulation of cell development (GO:0010720)	351	21	8.18	+	2.57	1.05E-04
regulation of nitric oxide metabolic process (GO:0080164)	67	4	1.56	+	2.56	7.33E-02
negative regulation of inflammatory response (GO:0050728)	135	8	3.15	+	2.54	1.50E-02
cell morphogenesis involved in neuron differentiation (GO:0048667)	439	26	10.23	+	2.54	1.92E-05
positive regulation of apoptotic signaling pathway (GO:2001235)	152	9	3.54	+	2.54	1.03E-02
regulation of neurogenesis (GO:0050767)	424	25	9.88	+	2.53	2.98E-05
cerebellar Purkinje cell differentiation (GO:0021702)	17	1	.40	+	2.52	3.27E-01
response to unfolded protein (GO:0006986)	102	6	2.38	+	2.52	3.39E-02
cerebellar Purkinje cell layer development (GO:0021680)	34	2	.79	+	2.52	1.88E-01
ventricular system development (GO:0021591)	34	2	.79	+	2.52	1.88E-01
regulation of neuron migration (GO:2001222)	51	3	1.19	+	2.52	1.18E-01
sperm axoneme assembly (GO:0007288)	17	1	.40	+	2.52	3.27E-01
suckling behavior (GO:0001967)	17	1	.40	+	2.52	3.27E-01
spinal cord motor neuron differentiation (GO:0021522)	34	2	.79	+	2.52	1.88E-01
positive regulation of receptor recycling (GO:0001921)	17	1	.40	+	2.52	3.27E-01
prepulse inhibition (GO:0060134)	17	1	.40	+	2.52	3.27E-01
microtubule depolymerization (GO:0007019)	17	1	.40	+	2.52	3.27E-01
negative regulation of cardiac muscle cell proliferation (GO:0060044)	17	1	.40	+	2.52	3.27E-01
lipid export from cell (GO:0140353)	17	1	.40	+	2.52	3.27E-01
negative regulation of interferon-gamma production (GO:0032689)	34	2	.79	+	2.52	1.88E-01
negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176)	17	1	.40	+	2.52	3.27E-01
regulation of synaptic vesicle exocytosis (GO:2000300)	85	5	1.98	+	2.52	5.06E-02
positive regulation of phosphoprotein phosphatase activity (GO:0032516)	17	1	.40	+	2.52	3.27E-01
RNA 5'-end processing (GO:0000966)	17	1	.40	+	2.52	3.27E-01
positive regulation of lymphocyte chemotaxis (GO:0140131)	17	1	.40	+	2.52	3.27E-01
regulation of neurotransmitter uptake (GO:0051580)	17	1	.40	+	2.52	3.27E-01
embryonic cranial skeleton morphogenesis (GO:0048701)	51	3	1.19	+	2.52	1.18E-01
cellular response to leptin stimulus (GO:0044320)	17	1	.40	+	2.52	3.27E-01
regulation of chondrocyte differentiation (GO:0032330)	51	3	1.19	+	2.52	1.18E-01
protein kinase C signaling (GO:0070528)	17	1	.40	+	2.52	3.27E-01
regulation of nucleobase-containing compound transport (GO:0032239)	17	1	.40	+	2.52	3.27E-01
regulation of neurotrophin TRK receptor signaling pathway (GO:0051386)	17	1	.40	+	2.52	3.27E-01
negative regulation of cellular component movement (GO:0051271)	289	17	6.74	+	2.52	5.63E-04
response to food (GO:0032094)	17	1	.40	+	2.52	3.27E-01
regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)	34	2	.79	+	2.52	1.88E-01
mesodermal cell differentiation (GO:0048333)	17	1	.40	+	2.52	3.27E-01
postsynapse assembly (GO:0099068)	17	1	.40	+	2.52	3.27E-01
regulation of long-term synaptic depression (GO:1900452)	17	1	.40	+	2.52	3.27E-01
regulation of defense response to bacterium (GO:1900424)	17	1	.40	+	2.52	3.27E-01
positive regulation of epithelial cell differentiation (GO:0030858)	51	3	1.19	+	2.52	1.18E-01
maintenance of blood-brain barrier (GO:0035633)	17	1	.40	+	2.52	3.27E-01
drinking behavior (GO:0042756)	17	1	.40	+	2.52	3.27E-01
histone H2A monoubiquitination (GO:0035518)	17	1	.40	+	2.52	3.27E-01
regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)	17	1	.40	+	2.52	3.27E-01
motor behavior (GO:0061744)	17	1	.40	+	2.52	3.27E-01
cyclic nucleotide metabolic process (GO:0009187)	34	2	.79	+	2.52	1.88E-01
nuclear body organization (GO:0030575)	17	1	.40	+	2.52	3.27E-01
regulation of hippo signaling (GO:0035330)	17	1	.40	+	2.52	3.27E-01
bicarbonate transport (GO:0015701)	17	1	.40	+	2.52	3.27E-01
positive regulation of telomere capping (GO:1904355)	17	1	.40	+	2.52	3.27E-01
regulation of keratinocyte proliferation (GO:0010837)	34	2	.79	+	2.52	1.88E-01
regulation of macrophage chemotaxis (GO:0010758)	34	2	.79	+	2.52	1.88E-01
amino acid import across plasma membrane (GO:0089718)	34	2	.79	+	2.52	1.88E-01
development of primary female sexual characteristics (GO:0046545)	102	6	2.38	+	2.52	3.39E-02
platelet activation (GO:0030168)	51	3	1.19	+	2.52	1.18E-01
parental behavior (GO:0060746)	17	1	.40	+	2.52	3.27E-01
actin polymerization or depolymerization (GO:0008154)	51	3	1.19	+	2.52	1.18E-01
maintenance of cell polarity (GO:0030011)	17	1	.40	+	2.52	3.27E-01
eosinophil migration (GO:0072677)	17	1	.40	+	2.52	3.27E-01
short-term memory (GO:0007614)	17	1	.40	+	2.52	3.27E-01
regulation of glucose import (GO:0046324)	68	4	1.59	+	2.52	7.64E-02
positive regulation of GTPase activity (GO:0043547)	223	13	5.20	+	2.50	2.62E-03
liver development (GO:0001889)	103	6	2.40	+	2.50	3.53E-02
cell cycle arrest (GO:0007050)	86	5	2.00	+	2.49	5.27E-02
embryonic pattern specification (GO:0009880)	69	4	1.61	+	2.49	7.96E-02
positive regulation of neurogenesis (GO:0050769)	276	16	6.43	+	2.49	9.42E-04
cardiac ventricle development (GO:0003231)	138	8	3.22	+	2.49	1.69E-02
forebrain cell migration (GO:0021885)	69	4	1.61	+	2.49	7.96E-02
regulation of GTPase activity (GO:0043087)	311	18	7.25	+	2.48	4.72E-04
positive regulation of axon extension (GO:0045773)	52	3	1.21	+	2.47	1.23E-01
spindle localization (GO:0051653)	52	3	1.21	+	2.47	1.23E-01
calcium ion transmembrane transport (GO:0070588)	139	8	3.24	+	2.47	1.76E-02
regulation of organic acid transport (GO:0032890)	87	5	2.03	+	2.47	5.48E-02
somite development (GO:0061053)	87	5	2.03	+	2.47	5.48E-02
peripheral nervous system development (GO:0007422)	70	4	1.63	+	2.45	8.29E-02
positive regulation of double-strand break repair (GO:2000781)	35	2	.82	+	2.45	1.97E-01
regulation of double-strand break repair (GO:2000779)	70	4	1.63	+	2.45	8.29E-02
regulation of cell development (GO:0060284)	560	32	13.05	+	2.45	4.35E-06
membrane assembly (GO:0071709)	35	2	.82	+	2.45	1.97E-01
somitogenesis (GO:0001756)	70	4	1.63	+	2.45	8.29E-02
establishment of spindle orientation (GO:0051294)	35	2	.82	+	2.45	1.97E-01
positive regulation of ERBB signaling pathway (GO:1901186)	35	2	.82	+	2.45	1.97E-01
neutrophil chemotaxis (GO:0030593)	70	4	1.63	+	2.45	8.29E-02
positive regulation of anion transmembrane transport (GO:1903961)	70	4	1.63	+	2.45	8.29E-02
negative regulation of locomotion (GO:0040013)	315	18	7.34	+	2.45	5.47E-04
negative regulation of neuron projection development (GO:0010977)	158	9	3.68	+	2.44	1.29E-02
regulation of glial cell differentiation (GO:0045685)	88	5	2.05	+	2.44	5.70E-02
response to interleukin-1 (GO:0070555)	88	5	2.05	+	2.44	5.70E-02
regulation of JUN kinase activity (GO:0043506)	88	5	2.05	+	2.44	5.70E-02
cell chemotaxis (GO:0060326)	194	11	4.52	+	2.43	6.59E-03
positive regulation of wound healing (GO:0090303)	53	3	1.24	+	2.43	1.28E-01
regulation of gluconeogenesis (GO:0006111)	53	3	1.24	+	2.43	1.28E-01
response to estradiol (GO:0032355)	53	3	1.24	+	2.43	1.28E-01
carboxylic acid transport (GO:0046942)	212	12	4.94	+	2.43	4.72E-03
cellular carbohydrate biosynthetic process (GO:0034637)	53	3	1.24	+	2.43	1.28E-01
negative regulation of Ras protein signal transduction (GO:0046580)	53	3	1.24	+	2.43	1.28E-01
macrophage activation (GO:0042116)	53	3	1.24	+	2.43	1.28E-01
hepaticobiliary system development (GO:0061008)	106	6	2.47	+	2.43	3.96E-02
regulation of dendritic spine morphogenesis (GO:0061001)	53	3	1.24	+	2.43	1.28E-01
neuron projection morphogenesis (GO:0048812)	478	27	11.14	+	2.42	2.99E-05
establishment of cell polarity (GO:0030010)	124	7	2.89	+	2.42	2.78E-02
regulation of cardiac muscle hypertrophy (GO:0010611)	71	4	1.66	+	2.42	8.62E-02
regulation of NIK/NF-kappaB signaling (GO:1901222)	89	5	2.07	+	2.41	5.92E-02
learning (GO:0007612)	178	10	4.15	+	2.41	9.92E-03
positive regulation of leukocyte migration (GO:0002687)	143	8	3.33	+	2.40	2.04E-02
plasma membrane bounded cell projection morphogenesis (GO:0120039)	483	27	11.26	+	2.40	3.56E-05
organic acid transport (GO:0015849)	233	13	5.43	+	2.39	3.77E-03
positive regulation of glycogen biosynthetic process (GO:0045725)	18	1	.42	+	2.38	3.43E-01
positive regulation of catecholamine secretion (GO:0033605)	18	1	.42	+	2.38	3.43E-01
negative regulation of catecholamine secretion (GO:0033604)	18	1	.42	+	2.38	3.43E-01
hexose catabolic process (GO:0019320)	18	1	.42	+	2.38	3.43E-01
regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307)	18	1	.42	+	2.38	3.43E-01
stress granule assembly (GO:0034063)	18	1	.42	+	2.38	3.43E-01
regulation of fat cell differentiation (GO:0045598)	144	8	3.36	+	2.38	2.11E-02
regulation of podosome assembly (GO:0071801)	18	1	.42	+	2.38	3.43E-01
female meiotic nuclear division (GO:0007143)	36	2	.84	+	2.38	2.05E-01
regulation of growth hormone secretion (GO:0060123)	18	1	.42	+	2.38	3.43E-01
natural killer cell differentiation (GO:0001779)	18	1	.42	+	2.38	3.43E-01
regulation of natural killer cell differentiation (GO:0032823)	18	1	.42	+	2.38	3.43E-01
positive regulation of CREB transcription factor activity (GO:0032793)	18	1	.42	+	2.38	3.43E-01
'de novo' protein folding (GO:0006458)	36	2	.84	+	2.38	2.05E-01
osteoblast development (GO:0002076)	18	1	.42	+	2.38	3.43E-01
positive regulation of mesenchymal cell proliferation (GO:0002053)	36	2	.84	+	2.38	2.05E-01
regulation of clathrin-dependent endocytosis (GO:2000369)	18	1	.42	+	2.38	3.43E-01
regulation of interleukin-5 production (GO:0032674)	18	1	.42	+	2.38	3.43E-01
regulation of interleukin-13 production (GO:0032656)	18	1	.42	+	2.38	3.43E-01
interleukin-1 production (GO:0032612)	18	1	.42	+	2.38	3.43E-01
negative regulation of nitric oxide biosynthetic process (GO:0045019)	18	1	.42	+	2.38	3.43E-01
regulation of fibroblast apoptotic process (GO:2000269)	18	1	.42	+	2.38	3.43E-01
peptidyl-proline modification (GO:0018208)	36	2	.84	+	2.38	2.05E-01
neurotransmitter receptor internalization (GO:0099590)	18	1	.42	+	2.38	3.43E-01
regulation of establishment of cell polarity (GO:2000114)	18	1	.42	+	2.38	3.43E-01
positive regulation of protein localization to cell surface (GO:2000010)	18	1	.42	+	2.38	3.43E-01
negative regulation of B cell activation (GO:0050869)	36	2	.84	+	2.38	2.05E-01
regulation of B cell receptor signaling pathway (GO:0050855)	18	1	.42	+	2.38	3.43E-01
cellular response to nutrient (GO:0031670)	18	1	.42	+	2.38	3.43E-01
'de novo' posttranslational protein folding (GO:0051084)	36	2	.84	+	2.38	2.05E-01
positive regulation of small GTPase mediated signal transduction (GO:0051057)	72	4	1.68	+	2.38	8.96E-02
detection of other organism (GO:0098543)	18	1	.42	+	2.38	3.43E-01
regulation of modification of synaptic structure (GO:1905244)	18	1	.42	+	2.38	3.43E-01
response to hepatocyte growth factor (GO:0035728)	18	1	.42	+	2.38	3.43E-01
outer dynein arm assembly (GO:0036158)	18	1	.42	+	2.38	3.43E-01
locomotory exploration behavior (GO:0035641)	18	1	.42	+	2.38	3.43E-01
embryonic eye morphogenesis (GO:0048048)	36	2	.84	+	2.38	2.05E-01
stress fiber assembly (GO:0043149)	18	1	.42	+	2.38	3.43E-01
surfactant homeostasis (GO:0043129)	18	1	.42	+	2.38	3.43E-01
negative regulation of nitric oxide metabolic process (GO:1904406)	18	1	.42	+	2.38	3.43E-01
regulation of inositol phosphate biosynthetic process (GO:0010919)	18	1	.42	+	2.38	3.43E-01
regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880)	18	1	.42	+	2.38	3.43E-01
sterol biosynthetic process (GO:0016126)	36	2	.84	+	2.38	2.05E-01
detection of bacterium (GO:0016045)	18	1	.42	+	2.38	3.43E-01
response to prostaglandin E (GO:0034695)	18	1	.42	+	2.38	3.43E-01
heart trabecula morphogenesis (GO:0061384)	36	2	.84	+	2.38	2.05E-01
striated muscle cell proliferation (GO:0014855)	18	1	.42	+	2.38	3.43E-01
contractile actin filament bundle assembly (GO:0030038)	18	1	.42	+	2.38	3.43E-01
dendritic spine organization (GO:0097061)	36	2	.84	+	2.38	2.05E-01
motor neuron axon guidance (GO:0008045)	36	2	.84	+	2.38	2.05E-01
negative regulation of osteoblast differentiation (GO:0045668)	54	3	1.26	+	2.38	1.33E-01
biological process involved in intraspecies interaction between organisms (GO:0051703)	54	3	1.26	+	2.38	1.33E-01
regulation of dendrite morphogenesis (GO:0048814)	90	5	2.10	+	2.38	6.15E-02
regulation of cell cycle arrest (GO:0071156)	54	3	1.26	+	2.38	1.33E-01
positive regulation of stress fiber assembly (GO:0051496)	54	3	1.26	+	2.38	1.33E-01
nucleotide phosphorylation (GO:0046939)	54	3	1.26	+	2.38	1.33E-01
leukocyte chemotaxis (GO:0030595)	126	7	2.94	+	2.38	2.99E-02
social behavior (GO:0035176)	54	3	1.26	+	2.38	1.33E-01
actin filament-based movement (GO:0030048)	90	5	2.10	+	2.38	6.15E-02
response to nutrient (GO:0007584)	54	3	1.26	+	2.38	1.33E-01
circulatory system process (GO:0003013)	434	24	10.12	+	2.37	1.13E-04
cell projection morphogenesis (GO:0048858)	489	27	11.40	+	2.37	4.38E-05
actin filament-based process (GO:0030029)	562	31	13.10	+	2.37	1.22E-05
phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200)	91	5	2.12	+	2.36	6.38E-02
regulation of extrinsic apoptotic signaling pathway (GO:2001236)	164	9	3.82	+	2.35	1.61E-02
branching morphogenesis of an epithelial tube (GO:0048754)	164	9	3.82	+	2.35	1.61E-02
pattern recognition receptor signaling pathway (GO:0002221)	73	4	1.70	+	2.35	9.31E-02
positive regulation of JUN kinase activity (GO:0043507)	73	4	1.70	+	2.35	9.31E-02
regulation of muscle hypertrophy (GO:0014743)	73	4	1.70	+	2.35	9.31E-02
blood circulation (GO:0008015)	403	22	9.39	+	2.34	2.58E-04
toll-like receptor signaling pathway (GO:0002224)	55	3	1.28	+	2.34	1.39E-01
camera-type eye morphogenesis (GO:0048593)	147	8	3.43	+	2.33	2.35E-02
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092)	239	13	5.57	+	2.33	4.64E-03
granulocyte migration (GO:0097530)	92	5	2.14	+	2.33	6.62E-02
developmental growth involved in morphogenesis (GO:0060560)	129	7	3.01	+	2.33	3.33E-02
positive regulation of nervous system development (GO:0051962)	332	18	7.74	+	2.33	9.87E-04
cellular response to oxidative stress (GO:0034599)	203	11	4.73	+	2.32	9.05E-03
regulation of blood circulation (GO:1903522)	240	13	5.59	+	2.32	4.80E-03
regulation of nervous system development (GO:0051960)	517	28	12.05	+	2.32	4.41E-05
cardiac muscle contraction (GO:0060048)	74	4	1.73	+	2.32	9.66E-02
protein folding (GO:0006457)	148	8	3.45	+	2.32	2.43E-02
cellular polysaccharide metabolic process (GO:0044264)	74	4	1.73	+	2.32	9.66E-02
amine biosynthetic process (GO:0009309)	37	2	.86	+	2.32	2.14E-01
response to temperature stimulus (GO:0009266)	148	8	3.45	+	2.32	2.43E-02
cellular biogenic amine biosynthetic process (GO:0042401)	37	2	.86	+	2.32	2.14E-01
dendritic spine development (GO:0060996)	37	2	.86	+	2.32	2.14E-01
response to alcohol (GO:0097305)	148	8	3.45	+	2.32	2.43E-02
positive regulation of steroid metabolic process (GO:0045940)	37	2	.86	+	2.32	2.14E-01
negative regulation of mitotic nuclear division (GO:0045839)	37	2	.86	+	2.32	2.14E-01
muscle contraction (GO:0006936)	185	10	4.31	+	2.32	1.27E-02
ameboidal-type cell migration (GO:0001667)	185	10	4.31	+	2.32	1.27E-02
cardiac chamber development (GO:0003205)	185	10	4.31	+	2.32	1.27E-02
multi-multicellular organism process (GO:0044706)	167	9	3.89	+	2.31	1.78E-02
negative regulation of lymphocyte differentiation (GO:0045620)	56	3	1.31	+	2.30	1.44E-01
protein stabilization (GO:0050821)	168	9	3.92	+	2.30	1.85E-02
regulation of phospholipase activity (GO:0010517)	56	3	1.31	+	2.30	1.44E-01
regulation of membrane lipid distribution (GO:0097035)	56	3	1.31	+	2.30	1.44E-01
actin cytoskeleton organization (GO:0030036)	505	27	11.77	+	2.29	7.45E-05
positive regulation of protein serine/threonine kinase activity (GO:0071902)	262	14	6.11	+	2.29	3.93E-03
response to amino acid (GO:0043200)	75	4	1.75	+	2.29	1.00E-01
cellular response to alcohol (GO:0097306)	75	4	1.75	+	2.29	1.00E-01
peptidyl-tyrosine phosphorylation (GO:0018108)	94	5	2.19	+	2.28	7.10E-02
regulation of epithelial to mesenchymal transition (GO:0010717)	94	5	2.19	+	2.28	7.10E-02
erythrocyte differentiation (GO:0030218)	94	5	2.19	+	2.28	7.10E-02
tissue remodeling (GO:0048771)	113	6	2.63	+	2.28	5.10E-02
regulation of leukocyte chemotaxis (GO:0002688)	113	6	2.63	+	2.28	5.10E-02
morphogenesis of an epithelium (GO:0002009)	510	27	11.89	+	2.27	8.74E-05
negative regulation of gluconeogenesis (GO:0045721)	19	1	.44	+	2.26	3.58E-01
cerebellar Purkinje cell layer formation (GO:0021694)	19	1	.44	+	2.26	3.58E-01
Golgi to vacuole transport (GO:0006896)	19	1	.44	+	2.26	3.58E-01
specification of animal organ identity (GO:0010092)	19	1	.44	+	2.26	3.58E-01
corpus callosum development (GO:0022038)	19	1	.44	+	2.26	3.58E-01
positive regulation of B cell differentiation (GO:0045579)	19	1	.44	+	2.26	3.58E-01
regulation of cholesterol biosynthetic process (GO:0045540)	19	1	.44	+	2.26	3.58E-01
positive regulation of lipase activity (GO:0060193)	57	3	1.33	+	2.26	1.49E-01
negative regulation of amyloid-beta formation (GO:1902430)	19	1	.44	+	2.26	3.58E-01
Sertoli cell development (GO:0060009)	19	1	.44	+	2.26	3.58E-01
negative regulation of amine transport (GO:0051953)	38	2	.89	+	2.26	2.22E-01
cell-cell junction maintenance (GO:0045217)	19	1	.44	+	2.26	3.58E-01
positive regulation of lymphocyte migration (GO:2000403)	38	2	.89	+	2.26	2.22E-01
regulation of norepinephrine secretion (GO:0014061)	19	1	.44	+	2.26	3.58E-01
Schwann cell differentiation (GO:0014037)	38	2	.89	+	2.26	2.22E-01
bone maturation (GO:0070977)	19	1	.44	+	2.26	3.58E-01
negative regulation of interleukin-12 production (GO:0032695)	19	1	.44	+	2.26	3.58E-01
epidermis morphogenesis (GO:0048730)	38	2	.89	+	2.26	2.22E-01
regulation of sterol biosynthetic process (GO:0106118)	19	1	.44	+	2.26	3.58E-01
regulation of synaptic transmission, GABAergic (GO:0032228)	38	2	.89	+	2.26	2.22E-01
negative regulation of telomere maintenance via telomerase (GO:0032211)	19	1	.44	+	2.26	3.58E-01
neurotransmitter reuptake (GO:0098810)	19	1	.44	+	2.26	3.58E-01
regulation of cell migration involved in sprouting angiogenesis (GO:0090049)	38	2	.89	+	2.26	2.22E-01
linoleic acid metabolic process (GO:0043651)	19	1	.44	+	2.26	3.58E-01
protein complex oligomerization (GO:0051259)	209	11	4.87	+	2.26	1.11E-02
enteric nervous system development (GO:0048484)	19	1	.44	+	2.26	3.58E-01
regulation of response to food (GO:0032095)	19	1	.44	+	2.26	3.58E-01
regulation of ARF protein signal transduction (GO:0032012)	19	1	.44	+	2.26	3.58E-01
regulation of phosphatidylinositol 3-kinase activity (GO:0043551)	38	2	.89	+	2.26	2.22E-01
plasma membrane phospholipid scrambling (GO:0017121)	19	1	.44	+	2.26	3.58E-01
positive regulation of vascular associated smooth muscle cell migration (GO:1904754)	19	1	.44	+	2.26	3.58E-01
negative regulation of actin filament polymerization (GO:0030837)	57	3	1.33	+	2.26	1.49E-01
long-chain fatty acid biosynthetic process (GO:0042759)	19	1	.44	+	2.26	3.58E-01
regulation of cellular response to insulin stimulus (GO:1900076)	76	4	1.77	+	2.26	1.04E-01
intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631)	19	1	.44	+	2.26	3.58E-01
hippo signaling (GO:0035329)	19	1	.44	+	2.26	3.58E-01
positive regulation of fibroblast migration (GO:0010763)	19	1	.44	+	2.26	3.58E-01
apoptotic nuclear changes (GO:0030262)	19	1	.44	+	2.26	3.58E-01
growth plate cartilage development (GO:0003417)	19	1	.44	+	2.26	3.58E-01
ceramide catabolic process (GO:0046514)	19	1	.44	+	2.26	3.58E-01
mucopolysaccharide metabolic process (GO:1903510)	57	3	1.33	+	2.26	1.49E-01
NAD metabolic process (GO:0019674)	19	1	.44	+	2.26	3.58E-01
plasma lipoprotein particle clearance (GO:0034381)	19	1	.44	+	2.26	3.58E-01
branch elongation of an epithelium (GO:0060602)	19	1	.44	+	2.26	3.58E-01
cell part morphogenesis (GO:0032990)	513	27	11.96	+	2.26	9.61E-05
response to acid chemical (GO:0001101)	95	5	2.21	+	2.26	7.36E-02
positive regulation of cold-induced thermogenesis (GO:0120162)	95	5	2.21	+	2.26	7.36E-02
connective tissue development (GO:0061448)	210	11	4.90	+	2.25	1.14E-02
blood vessel morphogenesis (GO:0048514)	422	22	9.84	+	2.24	4.76E-04
central nervous system neuron differentiation (GO:0021953)	211	11	4.92	+	2.24	1.18E-02
hair follicle development (GO:0001942)	96	5	2.24	+	2.23	7.61E-02
aminoglycan metabolic process (GO:0006022)	96	5	2.24	+	2.23	7.61E-02
regulation of muscle adaptation (GO:0043502)	96	5	2.24	+	2.23	7.61E-02
cell killing (GO:0001906)	77	4	1.79	+	2.23	1.07E-01
polysaccharide metabolic process (GO:0005976)	77	4	1.79	+	2.23	1.07E-01
calcium ion transmembrane import into cytosol (GO:0097553)	58	3	1.35	+	2.22	1.55E-01
female sex differentiation (GO:0046660)	116	6	2.70	+	2.22	5.65E-02
positive regulation of reactive oxygen species biosynthetic process (GO:1903428)	58	3	1.35	+	2.22	1.55E-01
cell aging (GO:0007569)	58	3	1.35	+	2.22	1.55E-01
tube development (GO:0035295)	929	48	21.66	+	2.22	2.99E-07
positive regulation of kinase activity (GO:0033674)	484	25	11.28	+	2.22	2.29E-04
sodium ion transport (GO:0006814)	155	8	3.61	+	2.21	3.07E-02
peptidyl-tyrosine modification (GO:0018212)	97	5	2.26	+	2.21	7.87E-02
regeneration (GO:0031099)	97	5	2.26	+	2.21	7.87E-02
positive regulation of lipid biosynthetic process (GO:0046889)	97	5	2.26	+	2.21	7.87E-02
positive regulation of transferase activity (GO:0051347)	563	29	13.12	+	2.21	7.71E-05
regulation of anatomical structure morphogenesis (GO:0022603)	935	48	21.80	+	2.20	3.59E-07
cell morphogenesis involved in differentiation (GO:0000904)	565	29	13.17	+	2.20	8.19E-05
phenol-containing compound biosynthetic process (GO:0046189)	39	2	.91	+	2.20	2.31E-01
glutamate receptor signaling pathway (GO:0007215)	39	2	.91	+	2.20	2.31E-01
negative regulation of neurogenesis (GO:0050768)	156	8	3.64	+	2.20	3.17E-02
negative regulation of TOR signaling (GO:0032007)	39	2	.91	+	2.20	2.31E-01
positive regulation of calcium ion transmembrane transporter activity (GO:1901021)	39	2	.91	+	2.20	2.31E-01
endosomal transport (GO:0016197)	195	10	4.55	+	2.20	1.76E-02
myeloid leukocyte migration (GO:0097529)	117	6	2.73	+	2.20	5.84E-02
negative regulation of cell development (GO:0010721)	195	10	4.55	+	2.20	1.76E-02
glycosaminoglycan metabolic process (GO:0030203)	78	4	1.82	+	2.20	1.11E-01
morphogenesis of a branching epithelium (GO:0061138)	195	10	4.55	+	2.20	1.76E-02
maintenance of protein localization in organelle (GO:0072595)	39	2	.91	+	2.20	2.31E-01
negative regulation of leukocyte migration (GO:0002686)	39	2	.91	+	2.20	2.31E-01
regulation of neuron projection development (GO:0010975)	527	27	12.28	+	2.20	1.48E-04
female pregnancy (GO:0007565)	137	7	3.19	+	2.19	4.36E-02
taxis (GO:0042330)	470	24	10.96	+	2.19	3.58E-04
acylglycerol metabolic process (GO:0006639)	98	5	2.28	+	2.19	8.14E-02
central nervous system neuron development (GO:0021954)	98	5	2.28	+	2.19	8.14E-02
lung morphogenesis (GO:0060425)	59	3	1.38	+	2.18	1.60E-01
long-term synaptic potentiation (GO:0060291)	59	3	1.38	+	2.18	1.60E-01
aorta development (GO:0035904)	59	3	1.38	+	2.18	1.60E-01
positive regulation of receptor-mediated endocytosis (GO:0048260)	59	3	1.38	+	2.18	1.60E-01
regulation of vascular associated smooth muscle cell proliferation (GO:1904705)	59	3	1.38	+	2.18	1.60E-01
lymphocyte migration (GO:0072676)	59	3	1.38	+	2.18	1.60E-01
positive regulation of cell projection organization (GO:0031346)	414	21	9.65	+	2.18	8.93E-04
positive regulation of response to DNA damage stimulus (GO:2001022)	99	5	2.31	+	2.17	8.41E-02
developmental cell growth (GO:0048588)	99	5	2.31	+	2.17	8.41E-02
skin epidermis development (GO:0098773)	99	5	2.31	+	2.17	8.41E-02
regulation of behavior (GO:0050795)	99	5	2.31	+	2.17	8.41E-02
regulation of cellular response to growth factor stimulus (GO:0090287)	278	14	6.48	+	2.16	6.49E-03
cardiac chamber morphogenesis (GO:0003206)	139	7	3.24	+	2.16	4.64E-02
regulation of cell projection organization (GO:0031344)	716	36	16.69	+	2.16	1.75E-05
head development (GO:0060322)	678	34	15.80	+	2.15	3.17E-05
anatomical structure formation involved in morphogenesis (GO:0048646)	919	46	21.42	+	2.15	1.27E-06
regulation of toll-like receptor 4 signaling pathway (GO:0034143)	20	1	.47	+	2.14	3.73E-01
cellular component disassembly involved in execution phase of apoptosis (GO:0006921)	20	1	.47	+	2.14	3.73E-01
regulation of macrophage differentiation (GO:0045649)	20	1	.47	+	2.14	3.73E-01
acrosome reaction (GO:0007340)	20	1	.47	+	2.14	3.73E-01
regulation of neuroblast proliferation (GO:1902692)	40	2	.93	+	2.14	2.39E-01
positive regulation of neuron migration (GO:2001224)	20	1	.47	+	2.14	3.73E-01
activation of phospholipase C activity (GO:0007202)	20	1	.47	+	2.14	3.73E-01
protein targeting to lysosome (GO:0006622)	20	1	.47	+	2.14	3.73E-01
regulation of sister chromatid cohesion (GO:0007063)	20	1	.47	+	2.14	3.73E-01
cell fate determination (GO:0001709)	40	2	.93	+	2.14	2.39E-01
negative regulation of nervous system development (GO:0051961)	160	8	3.73	+	2.14	3.60E-02
positive regulation of interleukin-12 production (GO:0032735)	40	2	.93	+	2.14	2.39E-01
response to angiotensin (GO:1990776)	20	1	.47	+	2.14	3.73E-01
protein localization to endoplasmic reticulum (GO:0070972)	60	3	1.40	+	2.14	1.66E-01
regulation of lymphocyte chemotaxis (GO:1901623)	20	1	.47	+	2.14	3.73E-01
positive regulation of glycogen metabolic process (GO:0070875)	20	1	.47	+	2.14	3.73E-01
neurotransmitter receptor localization to postsynaptic specialization membrane (GO:0099645)	20	1	.47	+	2.14	3.73E-01
protein localization to postsynaptic specialization membrane (GO:0099633)	20	1	.47	+	2.14	3.73E-01
chemical homeostasis within a tissue (GO:0048875)	20	1	.47	+	2.14	3.73E-01
modification of synaptic structure (GO:0099563)	20	1	.47	+	2.14	3.73E-01
energy reserve metabolic process (GO:0006112)	60	3	1.40	+	2.14	1.66E-01
positive regulation of chondrocyte differentiation (GO:0032332)	20	1	.47	+	2.14	3.73E-01
glycerol metabolic process (GO:0006071)	20	1	.47	+	2.14	3.73E-01
glycosaminoglycan catabolic process (GO:0006027)	20	1	.47	+	2.14	3.73E-01
positive regulation of monocyte chemotaxis (GO:0090026)	20	1	.47	+	2.14	3.73E-01
negative regulation of calcium-mediated signaling (GO:0050849)	20	1	.47	+	2.14	3.73E-01
embryonic axis specification (GO:0000578)	40	2	.93	+	2.14	2.39E-01
post-embryonic development (GO:0009791)	120	6	2.80	+	2.14	6.42E-02
macromolecule deacylation (GO:0098732)	60	3	1.40	+	2.14	1.66E-01
steroid hormone biosynthetic process (GO:0120178)	20	1	.47	+	2.14	3.73E-01
negative regulation of small GTPase mediated signal transduction (GO:0051058)	60	3	1.40	+	2.14	1.66E-01
protein deacylation (GO:0035601)	60	3	1.40	+	2.14	1.66E-01
ribosomal small subunit assembly (GO:0000028)	20	1	.47	+	2.14	3.73E-01
negative regulation of vascular permeability (GO:0043116)	20	1	.47	+	2.14	3.73E-01
positive regulation of hemostasis (GO:1900048)	20	1	.47	+	2.14	3.73E-01
positive regulation of bone mineralization (GO:0030501)	40	2	.93	+	2.14	2.39E-01
regulation of phosphatase activity (GO:0010921)	120	6	2.80	+	2.14	6.42E-02
regulation of receptor clustering (GO:1903909)	20	1	.47	+	2.14	3.73E-01
positive regulation of cell growth (GO:0030307)	180	9	4.20	+	2.14	2.71E-02
regulation of Rac protein signal transduction (GO:0035020)	20	1	.47	+	2.14	3.73E-01
positive regulation of blood coagulation (GO:0030194)	20	1	.47	+	2.14	3.73E-01
negative regulation of smooth muscle contraction (GO:0045986)	20	1	.47	+	2.14	3.73E-01
plasma lipoprotein particle assembly (GO:0034377)	20	1	.47	+	2.14	3.73E-01
positive regulation of fatty acid oxidation (GO:0046321)	20	1	.47	+	2.14	3.73E-01
positive regulation of glycolytic process (GO:0045821)	20	1	.47	+	2.14	3.73E-01
seminiferous tubule development (GO:0072520)	20	1	.47	+	2.14	3.73E-01
heart morphogenesis (GO:0003007)	260	13	6.06	+	2.14	9.03E-03
neutral lipid metabolic process (GO:0006638)	100	5	2.33	+	2.14	8.69E-02
regulation of neurotransmitter transport (GO:0051588)	140	7	3.26	+	2.14	4.79E-02
positive regulation of chemotaxis (GO:0050921)	140	7	3.26	+	2.14	4.79E-02
regulation of RNA splicing (GO:0043484)	140	7	3.26	+	2.14	4.79E-02
artery development (GO:0060840)	100	5	2.33	+	2.14	8.69E-02
hair cycle process (GO:0022405)	100	5	2.33	+	2.14	8.69E-02
molting cycle process (GO:0022404)	100	5	2.33	+	2.14	8.69E-02
regulation of plasma membrane bounded cell projection organization (GO:0120035)	701	35	16.34	+	2.14	2.65E-05
sensory perception of pain (GO:0019233)	101	5	2.35	+	2.12	8.97E-02
odontogenesis (GO:0042476)	101	5	2.35	+	2.12	8.97E-02
regulation of reactive oxygen species biosynthetic process (GO:1903426)	101	5	2.35	+	2.12	8.97E-02
chemotaxis (GO:0006935)	465	23	10.84	+	2.12	7.23E-04
cell morphogenesis (GO:0000902)	729	36	16.99	+	2.12	2.54E-05
neutrophil migration (GO:1990266)	81	4	1.89	+	2.12	1.23E-01
regulation of anatomical structure size (GO:0090066)	547	27	12.75	+	2.12	2.65E-04
negative regulation of epithelial cell proliferation (GO:0050680)	142	7	3.31	+	2.11	5.09E-02
adult locomotory behavior (GO:0008344)	102	5	2.38	+	2.10	9.25E-02
nuclear envelope organization (GO:0006998)	41	2	.96	+	2.09	2.48E-01
branching involved in blood vessel morphogenesis (GO:0001569)	41	2	.96	+	2.09	2.48E-01
regulation of p38MAPK cascade (GO:1900744)	41	2	.96	+	2.09	2.48E-01
protein homooligomerization (GO:0051260)	164	8	3.82	+	2.09	4.05E-02
protein kinase B signaling (GO:0043491)	41	2	.96	+	2.09	2.48E-01
cytosolic transport (GO:0016482)	123	6	2.87	+	2.09	7.05E-02
amino acid import (GO:0043090)	41	2	.96	+	2.09	2.48E-01
regulation of neurotransmitter secretion (GO:0046928)	123	6	2.87	+	2.09	7.05E-02
ovulation cycle process (GO:0022602)	41	2	.96	+	2.09	2.48E-01
epithelial cell migration (GO:0010631)	82	4	1.91	+	2.09	1.27E-01
execution phase of apoptosis (GO:0097194)	41	2	.96	+	2.09	2.48E-01
energy homeostasis (GO:0097009)	41	2	.96	+	2.09	2.48E-01
positive regulation of smoothened signaling pathway (GO:0045880)	41	2	.96	+	2.09	2.48E-01
morphogenesis of a branching structure (GO:0001763)	205	10	4.78	+	2.09	2.38E-02
positive regulation of catalytic activity (GO:0043085)	1067	52	24.87	+	2.09	5.36E-07
neuron projection development (GO:0031175)	698	34	16.27	+	2.09	5.58E-05
generation of neurons (GO:0048699)	1322	64	30.82	+	2.08	2.78E-08
negative regulation of response to DNA damage stimulus (GO:2001021)	62	3	1.45	+	2.08	1.77E-01
cellular response to amino acid stimulus (GO:0071230)	62	3	1.45	+	2.08	1.77E-01
cellular response to fibroblast growth factor stimulus (GO:0044344)	62	3	1.45	+	2.08	1.77E-01
negative regulation of developmental growth (GO:0048640)	124	6	2.89	+	2.08	7.26E-02
ventricular cardiac muscle tissue development (GO:0003229)	62	3	1.45	+	2.08	1.77E-01
neurogenesis (GO:0022008)	1448	70	33.75	+	2.07	5.82E-09
organic anion transport (GO:0015711)	269	13	6.27	+	2.07	1.17E-02
calcium ion transport (GO:0006816)	207	10	4.83	+	2.07	2.52E-02
synapse organization (GO:0050808)	290	14	6.76	+	2.07	9.17E-03
neural crest cell development (GO:0014032)	83	4	1.93	+	2.07	1.31E-01
regulation of smooth muscle cell proliferation (GO:0048660)	166	8	3.87	+	2.07	4.30E-02
locomotion (GO:0040011)	1163	56	27.11	+	2.07	2.73E-07
regulation of mononuclear cell migration (GO:0071675)	104	5	2.42	+	2.06	9.84E-02
negative regulation of angiogenesis (GO:0016525)	104	5	2.42	+	2.06	9.84E-02
regulation of cell migration (GO:0030334)	896	43	20.89	+	2.06	8.08E-06
positive regulation of protein kinase activity (GO:0045860)	417	20	9.72	+	2.06	2.24E-03
positive regulation of growth (GO:0045927)	292	14	6.81	+	2.06	9.70E-03
regulation of epithelial cell migration (GO:0010632)	230	11	5.36	+	2.05	2.08E-02
blood vessel development (GO:0001568)	523	25	12.19	+	2.05	6.99E-04
positive regulation of oxidative stress-induced cell death (GO:1903209)	21	1	.49	+	2.04	3.87E-01
regulation of antigen processing and presentation (GO:0002577)	21	1	.49	+	2.04	3.87E-01
erythrocyte homeostasis (GO:0034101)	105	5	2.45	+	2.04	1.01E-01
cerebellar cortex morphogenesis (GO:0021696)	42	2	.98	+	2.04	2.57E-01
cerebellar Purkinje cell layer morphogenesis (GO:0021692)	21	1	.49	+	2.04	3.87E-01
nervous system process involved in regulation of systemic arterial blood pressure (GO:0001976)	21	1	.49	+	2.04	3.87E-01
regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547)	21	1	.49	+	2.04	3.87E-01
phosphatidylserine metabolic process (GO:0006658)	21	1	.49	+	2.04	3.87E-01
phosphatidic acid biosynthetic process (GO:0006654)	21	1	.49	+	2.04	3.87E-01
positive regulation of mononuclear cell migration (GO:0071677)	63	3	1.47	+	2.04	1.83E-01
catecholamine metabolic process (GO:0006584)	42	2	.98	+	2.04	2.57E-01
positive regulation of sodium ion transmembrane transport (GO:1902307)	21	1	.49	+	2.04	3.87E-01
regulation of sodium ion transmembrane transport (GO:1902305)	63	3	1.47	+	2.04	1.83E-01
negative regulation of amino acid transport (GO:0051956)	21	1	.49	+	2.04	3.87E-01
positive regulation of endothelial cell apoptotic process (GO:2000353)	21	1	.49	+	2.04	3.87E-01
cartilage condensation (GO:0001502)	21	1	.49	+	2.04	3.87E-01
regulation of hair follicle development (GO:0051797)	21	1	.49	+	2.04	3.87E-01
early endosome to late endosome transport (GO:0045022)	21	1	.49	+	2.04	3.87E-01
negative regulation of fatty acid transport (GO:2000192)	21	1	.49	+	2.04	3.87E-01
leukocyte proliferation (GO:0070661)	105	5	2.45	+	2.04	1.01E-01
negative regulation of cytosolic calcium ion concentration (GO:0051481)	21	1	.49	+	2.04	3.87E-01
epithelium migration (GO:0090132)	84	4	1.96	+	2.04	1.35E-01
detection of mechanical stimulus involved in sensory perception of sound (GO:0050910)	21	1	.49	+	2.04	3.87E-01
leukocyte tethering or rolling (GO:0050901)	21	1	.49	+	2.04	3.87E-01
relaxation of muscle (GO:0090075)	21	1	.49	+	2.04	3.87E-01
catechol-containing compound metabolic process (GO:0009712)	42	2	.98	+	2.04	2.57E-01
synaptic vesicle transport (GO:0048489)	42	2	.98	+	2.04	2.57E-01
membrane biogenesis (GO:0044091)	42	2	.98	+	2.04	2.57E-01
response to topologically incorrect protein (GO:0035966)	126	6	2.94	+	2.04	7.70E-02
protein peptidyl-prolyl isomerization (GO:0000413)	21	1	.49	+	2.04	3.87E-01
notochord development (GO:0030903)	21	1	.49	+	2.04	3.87E-01
apoptotic cell clearance (GO:0043277)	42	2	.98	+	2.04	2.57E-01
embryonic camera-type eye development (GO:0031076)	42	2	.98	+	2.04	2.57E-01
response to auditory stimulus (GO:0010996)	21	1	.49	+	2.04	3.87E-01
positive regulation of dendrite development (GO:1900006)	21	1	.49	+	2.04	3.87E-01
regulation of anion transmembrane transport (GO:1903959)	126	6	2.94	+	2.04	7.70E-02
protein mannosylation (GO:0035268)	21	1	.49	+	2.04	3.87E-01
melanocyte differentiation (GO:0030318)	21	1	.49	+	2.04	3.87E-01
dendritic spine morphogenesis (GO:0060997)	21	1	.49	+	2.04	3.87E-01
response to prostaglandin (GO:0034694)	21	1	.49	+	2.04	3.87E-01
response to acidic pH (GO:0010447)	21	1	.49	+	2.04	3.87E-01
positive regulation of translational initiation (GO:0045948)	21	1	.49	+	2.04	3.87E-01
monosaccharide catabolic process (GO:0046365)	21	1	.49	+	2.04	3.87E-01
respiratory gaseous exchange by respiratory system (GO:0007585)	42	2	.98	+	2.04	2.57E-01
regulation of protein stability (GO:0031647)	274	13	6.39	+	2.04	1.34E-02
positive regulation of developmental growth (GO:0048639)	211	10	4.92	+	2.03	2.82E-02
tissue morphogenesis (GO:0048729)	614	29	14.31	+	2.03	3.24E-04
negative regulation of blood vessel morphogenesis (GO:2000181)	106	5	2.47	+	2.02	1.04E-01
regulation of postsynapse organization (GO:0099175)	106	5	2.47	+	2.02	1.04E-01
positive regulation of small molecule metabolic process (GO:0062013)	149	7	3.47	+	2.02	6.25E-02
response to fibroblast growth factor (GO:0071774)	64	3	1.49	+	2.01	1.89E-01
monocarboxylic acid transport (GO:0015718)	128	6	2.98	+	2.01	8.16E-02
axoneme assembly (GO:0035082)	64	3	1.49	+	2.01	1.89E-01
cellular component morphogenesis (GO:0032989)	598	28	13.94	+	2.01	4.68E-04
regulation of cell motility (GO:2000145)	940	44	21.91	+	2.01	1.16E-05
positive regulation of molecular function (GO:0044093)	1433	67	33.40	+	2.01	4.63E-08
negative regulation of vasculature development (GO:1901343)	107	5	2.49	+	2.00	1.07E-01
regulation of actin filament bundle assembly (GO:0032231)	107	5	2.49	+	2.00	1.07E-01
regulation of locomotion (GO:0040012)	987	46	23.01	+	2.00	8.06E-06
cell surface receptor signaling pathway involved in cell-cell signaling (GO:1905114)	279	13	6.50	+	2.00	1.53E-02
multicellular organism aging (GO:0010259)	43	2	1.00	+	2.00	2.65E-01
negative regulation of protein kinase B signaling (GO:0051898)	43	2	1.00	+	2.00	2.65E-01
negative regulation of proteasomal protein catabolic process (GO:1901799)	43	2	1.00	+	2.00	2.65E-01
oligodendrocyte development (GO:0014003)	43	2	1.00	+	2.00	2.65E-01
tissue migration (GO:0090130)	86	4	2.00	+	2.00	1.43E-01
eye morphogenesis (GO:0048592)	172	8	4.01	+	2.00	5.08E-02
protein polymerization (GO:0051258)	86	4	2.00	+	2.00	1.43E-01
detection of abiotic stimulus (GO:0009582)	129	6	3.01	+	2.00	8.39E-02
response to heat (GO:0009408)	86	4	2.00	+	2.00	1.43E-01
positive regulation of cardiac muscle tissue growth (GO:0055023)	43	2	1.00	+	2.00	2.65E-01
male gonad development (GO:0008584)	129	6	3.01	+	2.00	8.39E-02
embryo implantation (GO:0007566)	43	2	1.00	+	2.00	2.65E-01
positive regulation of mRNA metabolic process (GO:1903313)	86	4	2.00	+	2.00	1.43E-01
brain development (GO:0007420)	624	29	14.55	+	1.99	4.19E-04
cellular response to chemical stress (GO:0062197)	237	11	5.52	+	1.99	2.51E-02
gliogenesis (GO:0042063)	237	11	5.52	+	1.99	2.51E-02
memory (GO:0007613)	151	7	3.52	+	1.99	6.60E-02
hair cycle (GO:0042633)	108	5	2.52	+	1.99	1.11E-01
actomyosin structure organization (GO:0031032)	108	5	2.52	+	1.99	1.11E-01
molting cycle (GO:0042303)	108	5	2.52	+	1.99	1.11E-01
negative regulation of cell adhesion (GO:0007162)	281	13	6.55	+	1.98	1.62E-02
regulation of ERK1 and ERK2 cascade (GO:0070372)	303	14	7.06	+	1.98	1.30E-02
nervous system development (GO:0007399)	2014	93	46.95	+	1.98	1.06E-10
calcium ion transport into cytosol (GO:0060402)	65	3	1.52	+	1.98	1.95E-01
regulation of actin filament organization (GO:0110053)	260	12	6.06	+	1.98	2.07E-02
adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193)	65	3	1.52	+	1.98	1.95E-01
establishment or maintenance of cell polarity (GO:0007163)	195	9	4.55	+	1.98	4.15E-02
positive regulation of neural precursor cell proliferation (GO:2000179)	65	3	1.52	+	1.98	1.95E-01
detection of external stimulus (GO:0009581)	130	6	3.03	+	1.98	8.63E-02
cell migration (GO:0016477)	845	39	19.70	+	1.98	5.02E-05
protein autophosphorylation (GO:0046777)	195	9	4.55	+	1.98	4.15E-02
development of primary male sexual characteristics (GO:0046546)	130	6	3.03	+	1.98	8.63E-02
protein localization to plasma membrane (GO:0072659)	195	9	4.55	+	1.98	4.15E-02
regulation of cell cycle G1/S phase transition (GO:1902806)	130	6	3.03	+	1.98	8.63E-02
regulation of cellular component movement (GO:0051270)	1020	47	23.78	+	1.98	8.54E-06
cell-cell adhesion (GO:0098609)	391	18	9.11	+	1.97	5.48E-03
muscle system process (GO:0003012)	239	11	5.57	+	1.97	2.65E-02
locomotory behavior (GO:0007626)	239	11	5.57	+	1.97	2.65E-02
heart contraction (GO:0060047)	87	4	2.03	+	1.97	1.48E-01
fatty acid transport (GO:0015908)	87	4	2.03	+	1.97	1.48E-01
flagellated sperm motility (GO:0030317)	87	4	2.03	+	1.97	1.48E-01
antigen processing and presentation (GO:0019882)	87	4	2.03	+	1.97	1.48E-01
embryonic placenta development (GO:0001892)	109	5	2.54	+	1.97	1.14E-01
regulation of carbohydrate biosynthetic process (GO:0043255)	109	5	2.54	+	1.97	1.14E-01
movement of cell or subcellular component (GO:0006928)	1374	63	32.03	+	1.97	2.45E-07
positive regulation of hydrolase activity (GO:0051345)	524	24	12.22	+	1.96	1.56E-03
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169)	350	16	8.16	+	1.96	9.09E-03
adult behavior (GO:0030534)	175	8	4.08	+	1.96	5.51E-02
localization of cell (GO:0051674)	965	44	22.50	+	1.96	2.17E-05
cell motility (GO:0048870)	965	44	22.50	+	1.96	2.17E-05
regulation of fatty acid transport (GO:2000191)	66	3	1.54	+	1.95	2.01E-01
regulation of cellular ketone metabolic process (GO:0010565)	132	6	3.08	+	1.95	9.11E-02
trachea development (GO:0060438)	22	1	.51	+	1.95	4.01E-01
positive regulation of extracellular matrix organization (GO:1903055)	22	1	.51	+	1.95	4.01E-01
histone H2A ubiquitination (GO:0033522)	22	1	.51	+	1.95	4.01E-01
blood vessel remodeling (GO:0001974)	44	2	1.03	+	1.95	2.74E-01
regulation of endothelial cell chemotaxis (GO:2001026)	22	1	.51	+	1.95	4.01E-01
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230)	22	1	.51	+	1.95	4.01E-01
mesenchymal cell development (GO:0014031)	88	4	2.05	+	1.95	1.52E-01
cellular extravasation (GO:0045123)	44	2	1.03	+	1.95	2.74E-01
positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770)	22	1	.51	+	1.95	4.01E-01
DNA catabolic process (GO:0006308)	22	1	.51	+	1.95	4.01E-01
cellular response to alkaloid (GO:0071312)	22	1	.51	+	1.95	4.01E-01
regulation of cardiac muscle cell membrane repolarization (GO:0099623)	22	1	.51	+	1.95	4.01E-01
neural nucleus development (GO:0048857)	22	1	.51	+	1.95	4.01E-01
protein localization to cytoskeleton (GO:0044380)	44	2	1.03	+	1.95	2.74E-01
vesicle-mediated transport between endosomal compartments (GO:0098927)	22	1	.51	+	1.95	4.01E-01
regulation of cardiac muscle cell action potential (GO:0098901)	22	1	.51	+	1.95	4.01E-01
muscle organ morphogenesis (GO:0048644)	88	4	2.05	+	1.95	1.52E-01
spleen development (GO:0048536)	44	2	1.03	+	1.95	2.74E-01
positive regulation of coagulation (GO:0050820)	22	1	.51	+	1.95	4.01E-01
cell aggregation (GO:0098743)	22	1	.51	+	1.95	4.01E-01
regulation of appetite (GO:0032098)	22	1	.51	+	1.95	4.01E-01
regulation of postsynaptic neurotransmitter receptor internalization (GO:0099149)	22	1	.51	+	1.95	4.01E-01
regulation of respiratory gaseous exchange (GO:0043576)	22	1	.51	+	1.95	4.01E-01
membrane raft organization (GO:0031579)	22	1	.51	+	1.95	4.01E-01
paraxial mesoderm development (GO:0048339)	22	1	.51	+	1.95	4.01E-01
N-terminal protein amino acid modification (GO:0031365)	22	1	.51	+	1.95	4.01E-01
positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003)	22	1	.51	+	1.95	4.01E-01
negative regulation of histone methylation (GO:0031061)	22	1	.51	+	1.95	4.01E-01
regulation of axon extension (GO:0030516)	110	5	2.56	+	1.95	1.17E-01
positive regulation of cholesterol efflux (GO:0010875)	22	1	.51	+	1.95	4.01E-01
mannosylation (GO:0097502)	22	1	.51	+	1.95	4.01E-01
regulation of glucose transmembrane transport (GO:0010827)	88	4	2.05	+	1.95	1.52E-01
hyaluronan metabolic process (GO:0030212)	22	1	.51	+	1.95	4.01E-01
mammary gland lobule development (GO:0061377)	22	1	.51	+	1.95	4.01E-01
associative learning (GO:0008306)	110	5	2.56	+	1.95	1.17E-01
cellular response to glucose starvation (GO:0042149)	44	2	1.03	+	1.95	2.74E-01
mammary gland alveolus development (GO:0060749)	22	1	.51	+	1.95	4.01E-01
phasic smooth muscle contraction (GO:0014821)	22	1	.51	+	1.95	4.01E-01
regulation of mesenchymal cell proliferation (GO:0010464)	44	2	1.03	+	1.95	2.74E-01
T cell migration (GO:0072678)	22	1	.51	+	1.95	4.01E-01
negative regulation of amyloid precursor protein catabolic process (GO:1902992)	22	1	.51	+	1.95	4.01E-01
response to type I interferon (GO:0034340)	22	1	.51	+	1.95	4.01E-01
retrograde axonal transport (GO:0008090)	22	1	.51	+	1.95	4.01E-01
anterograde axonal transport (GO:0008089)	44	2	1.03	+	1.95	2.74E-01
regulation of heart contraction (GO:0008016)	176	8	4.10	+	1.95	5.66E-02
positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895)	44	2	1.03	+	1.95	2.74E-01
cell projection organization (GO:0030030)	1105	50	25.76	+	1.94	7.02E-06
forebrain development (GO:0030900)	376	17	8.77	+	1.94	8.09E-03
vasculature development (GO:0001944)	553	25	12.89	+	1.94	1.50E-03
regulation of actin polymerization or depolymerization (GO:0008064)	177	8	4.13	+	1.94	5.81E-02
myelination (GO:0042552)	111	5	2.59	+	1.93	1.20E-01
cell growth (GO:0016049)	111	5	2.59	+	1.93	1.20E-01
regulation of stress-activated MAPK cascade (GO:0032872)	178	8	4.15	+	1.93	5.96E-02
stem cell development (GO:0048864)	89	4	2.07	+	1.93	1.56E-01
negative regulation of dephosphorylation (GO:0035305)	89	4	2.07	+	1.93	1.56E-01
positive regulation of DNA repair (GO:0045739)	67	3	1.56	+	1.92	2.07E-01
positive regulation of fat cell differentiation (GO:0045600)	67	3	1.56	+	1.92	2.07E-01
neuron projection extension (GO:1990138)	67	3	1.56	+	1.92	2.07E-01
negative regulation of axonogenesis (GO:0050771)	67	3	1.56	+	1.92	2.07E-01
regulation of neuronal synaptic plasticity (GO:0048168)	67	3	1.56	+	1.92	2.07E-01
carbohydrate transport (GO:0008643)	67	3	1.56	+	1.92	2.07E-01
regulation of DNA repair (GO:0006282)	112	5	2.61	+	1.92	1.24E-01
lipid localization (GO:0010876)	336	15	7.83	+	1.92	1.37E-02
behavior (GO:0007610)	672	30	15.67	+	1.92	6.38E-04
plasma membrane bounded cell projection organization (GO:0120036)	1053	47	24.55	+	1.91	1.90E-05
gland development (GO:0048732)	426	19	9.93	+	1.91	6.08E-03
developmental growth (GO:0048589)	426	19	9.93	+	1.91	6.08E-03
maintenance of location (GO:0051235)	157	7	3.66	+	1.91	7.74E-02
negative regulation of transcription by RNA polymerase II (GO:0000122)	854	38	19.91	+	1.91	1.32E-04
positive regulation of DNA replication (GO:0045740)	45	2	1.05	+	1.91	2.82E-01
regulation of erythrocyte differentiation (GO:0045646)	45	2	1.05	+	1.91	2.82E-01
iron ion transport (GO:0006826)	45	2	1.05	+	1.91	2.82E-01
multicellular organismal response to stress (GO:0033555)	90	4	2.10	+	1.91	1.61E-01
positive regulation of nitric oxide biosynthetic process (GO:0045429)	45	2	1.05	+	1.91	2.82E-01
regulation of monooxygenase activity (GO:0032768)	45	2	1.05	+	1.91	2.82E-01
regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618)	45	2	1.05	+	1.91	2.82E-01
prostate gland development (GO:0030850)	45	2	1.05	+	1.91	2.82E-01
regulation of actin filament length (GO:0030832)	180	8	4.20	+	1.91	6.27E-02
hindlimb morphogenesis (GO:0035137)	45	2	1.05	+	1.91	2.82E-01
negative regulation of endocytosis (GO:0045806)	45	2	1.05	+	1.91	2.82E-01
regulation of response to oxidative stress (GO:1902882)	90	4	2.10	+	1.91	1.61E-01
phagocytosis (GO:0006909)	135	6	3.15	+	1.91	9.87E-02
regulation of developmental growth (GO:0048638)	383	17	8.93	+	1.90	9.58E-03
neuron development (GO:0048666)	857	38	19.98	+	1.90	1.41E-04
regulation of blood pressure (GO:0008217)	203	9	4.73	+	1.90	5.10E-02
cartilage development (GO:0051216)	158	7	3.68	+	1.90	7.94E-02
ensheathment of neurons (GO:0007272)	113	5	2.63	+	1.90	1.27E-01
regulation of G1/S transition of mitotic cell cycle (GO:2000045)	113	5	2.63	+	1.90	1.27E-01
axon ensheathment (GO:0008366)	113	5	2.63	+	1.90	1.27E-01
regulation of stress-activated protein kinase signaling cascade (GO:0070302)	181	8	4.22	+	1.90	6.43E-02
actin filament organization (GO:0007015)	249	11	5.80	+	1.90	3.40E-02
inorganic anion transmembrane transport (GO:0098661)	68	3	1.59	+	1.89	2.13E-01
positive regulation of MAP kinase activity (GO:0043406)	204	9	4.76	+	1.89	5.23E-02
camera-type eye development (GO:0043010)	340	15	7.93	+	1.89	1.51E-02
regulation of cartilage development (GO:0061035)	68	3	1.59	+	1.89	2.13E-01
regulation of system process (GO:0044057)	590	26	13.75	+	1.89	1.72E-03
neural crest cell differentiation (GO:0014033)	91	4	2.12	+	1.89	1.65E-01
regulation of blood vessel endothelial cell migration (GO:0043535)	91	4	2.12	+	1.89	1.65E-01
sperm motility (GO:0097722)	91	4	2.12	+	1.89	1.65E-01
negative regulation of small molecule metabolic process (GO:0062014)	91	4	2.12	+	1.89	1.65E-01
multicellular organism growth (GO:0035264)	114	5	2.66	+	1.88	1.30E-01
dendrite development (GO:0016358)	137	6	3.19	+	1.88	1.04E-01
regulation of MAPK cascade (GO:0043408)	685	30	15.97	+	1.88	8.61E-04
positive regulation of cellular component movement (GO:0051272)	571	25	13.31	+	1.88	2.28E-03
epidermis development (GO:0008544)	252	11	5.87	+	1.87	3.66E-02
heart development (GO:0007507)	551	24	12.84	+	1.87	2.95E-03
circulatory system development (GO:0072359)	896	39	20.89	+	1.87	1.68E-04
alditol metabolic process (GO:0019400)	23	1	.54	+	1.87	4.15E-01
positive regulation of heart growth (GO:0060421)	46	2	1.07	+	1.87	2.91E-01
leukocyte migration involved in inflammatory response (GO:0002523)	23	1	.54	+	1.87	4.15E-01
regulation of receptor localization to synapse (GO:1902683)	23	1	.54	+	1.87	4.15E-01
negative regulation of protein localization to plasma membrane (GO:1903077)	23	1	.54	+	1.87	4.15E-01
cilium movement involved in cell motility (GO:0060294)	92	4	2.14	+	1.87	1.69E-01
protein-lipid complex assembly (GO:0065005)	23	1	.54	+	1.87	4.15E-01
glycosphingolipid metabolic process (GO:0006687)	46	2	1.07	+	1.87	2.91E-01
endosome organization (GO:0007032)	46	2	1.07	+	1.87	2.91E-01
regulation of transmission of nerve impulse (GO:0051969)	23	1	.54	+	1.87	4.15E-01
glycoprotein catabolic process (GO:0006516)	23	1	.54	+	1.87	4.15E-01
membrane protein ectodomain proteolysis (GO:0006509)	23	1	.54	+	1.87	4.15E-01
positive regulation of interferon-alpha production (GO:0032727)	23	1	.54	+	1.87	4.15E-01
cellular response to pH (GO:0071467)	23	1	.54	+	1.87	4.15E-01
negative regulation of nuclear division (GO:0051784)	46	2	1.07	+	1.87	2.91E-01
transcytosis (GO:0045056)	23	1	.54	+	1.87	4.15E-01
animal organ maturation (GO:0048799)	23	1	.54	+	1.87	4.15E-01
negative regulation of chondrocyte differentiation (GO:0032331)	23	1	.54	+	1.87	4.15E-01
regulation of mitochondrial fission (GO:0090140)	23	1	.54	+	1.87	4.15E-01
positive regulation of skeletal muscle tissue development (GO:0048643)	23	1	.54	+	1.87	4.15E-01
negative regulation of nervous system process (GO:0031645)	23	1	.54	+	1.87	4.15E-01
maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)	23	1	.54	+	1.87	4.15E-01
endodermal cell differentiation (GO:0035987)	23	1	.54	+	1.87	4.15E-01
regulation of membrane protein ectodomain proteolysis (GO:0051043)	23	1	.54	+	1.87	4.15E-01
transition metal ion transport (GO:0000041)	92	4	2.14	+	1.87	1.69E-01
response to interferon-alpha (GO:0035455)	23	1	.54	+	1.87	4.15E-01
positive regulation of nitric oxide metabolic process (GO:1904407)	46	2	1.07	+	1.87	2.91E-01
positive regulation of protein processing (GO:0010954)	23	1	.54	+	1.87	4.15E-01
left/right pattern formation (GO:0060972)	23	1	.54	+	1.87	4.15E-01
regulation of canonical Wnt signaling pathway (GO:0060828)	230	10	5.36	+	1.87	4.58E-02
amyloid-beta clearance (GO:0097242)	23	1	.54	+	1.87	4.15E-01
ammonium ion metabolic process (GO:0097164)	23	1	.54	+	1.87	4.15E-01
response to fluid shear stress (GO:0034405)	23	1	.54	+	1.87	4.15E-01
dorsal/ventral neural tube patterning (GO:0021904)	23	1	.54	+	1.87	4.15E-01
regulation of leukocyte migration (GO:0002685)	207	9	4.83	+	1.87	5.62E-02
growth (GO:0040007)	438	19	10.21	+	1.86	8.03E-03
anion transmembrane transport (GO:0098656)	300	13	6.99	+	1.86	2.57E-02
learning or memory (GO:0007611)	300	13	6.99	+	1.86	2.57E-02
ribonucleoprotein complex assembly (GO:0022618)	162	7	3.78	+	1.85	8.78E-02
regulation of endothelial cell migration (GO:0010594)	162	7	3.78	+	1.85	8.78E-02
positive regulation of cell motility (GO:2000147)	556	24	12.96	+	1.85	3.30E-03
regulation of cell junction assembly (GO:1901888)	209	9	4.87	+	1.85	5.90E-02
regulation of MAP kinase activity (GO:0043405)	279	12	6.50	+	1.85	3.29E-02
lysosomal transport (GO:0007041)	93	4	2.17	+	1.85	1.74E-01
cellular response to interferon-gamma (GO:0071346)	93	4	2.17	+	1.85	1.74E-01
regulation of stress fiber assembly (GO:0051492)	93	4	2.17	+	1.85	1.74E-01
epithelial cell proliferation (GO:0050673)	93	4	2.17	+	1.85	1.74E-01
positive regulation of binding (GO:0051099)	186	8	4.34	+	1.85	7.27E-02
response to reactive oxygen species (GO:0000302)	163	7	3.80	+	1.84	8.99E-02
neuron differentiation (GO:0030182)	1050	45	24.48	+	1.84	7.44E-05
positive regulation of response to wounding (GO:1903036)	70	3	1.63	+	1.84	2.25E-01
triglyceride metabolic process (GO:0006641)	70	3	1.63	+	1.84	2.25E-01
negative regulation of MAP kinase activity (GO:0043407)	70	3	1.63	+	1.84	2.25E-01
positive regulation of cell migration (GO:0030335)	537	23	12.52	+	1.84	4.36E-03
Notch signaling pathway (GO:0007219)	117	5	2.73	+	1.83	1.41E-01
fat cell differentiation (GO:0045444)	117	5	2.73	+	1.83	1.41E-01
regulation of gliogenesis (GO:0014013)	117	5	2.73	+	1.83	1.41E-01
skin development (GO:0043588)	234	10	5.45	+	1.83	5.03E-02
protein-containing complex assembly (GO:0065003)	937	40	21.84	+	1.83	2.05E-04
regulation of tumor necrosis factor production (GO:0032680)	164	7	3.82	+	1.83	9.21E-02
positive regulation of lipid metabolic process (GO:0045834)	164	7	3.82	+	1.83	9.21E-02
I-kappaB kinase/NF-kappaB signaling (GO:0007249)	47	2	1.10	+	1.83	2.99E-01
heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157)	47	2	1.10	+	1.83	2.99E-01
maternal process involved in female pregnancy (GO:0060135)	47	2	1.10	+	1.83	2.99E-01
cell cycle G2/M phase transition (GO:0044839)	47	2	1.10	+	1.83	2.99E-01
regulation of telomerase activity (GO:0051972)	47	2	1.10	+	1.83	2.99E-01
maintenance of protein location (GO:0045185)	94	4	2.19	+	1.83	1.79E-01
regulation of filopodium assembly (GO:0051489)	47	2	1.10	+	1.83	2.99E-01
neuron projection organization (GO:0106027)	47	2	1.10	+	1.83	2.99E-01
positive regulation of biomineral tissue development (GO:0070169)	47	2	1.10	+	1.83	2.99E-01
histone deacetylation (GO:0016575)	47	2	1.10	+	1.83	2.99E-01
negative regulation of axon extension (GO:0030517)	47	2	1.10	+	1.83	2.99E-01
regulation of cytokine production involved in inflammatory response (GO:1900015)	47	2	1.10	+	1.83	2.99E-01
positive regulation of epithelial to mesenchymal transition (GO:0010718)	47	2	1.10	+	1.83	2.99E-01
bone mineralization (GO:0030282)	47	2	1.10	+	1.83	2.99E-01
endocardial cushion development (GO:0003197)	47	2	1.10	+	1.83	2.99E-01
positive regulation of cysteine-type endopeptidase activity (GO:2001056)	141	6	3.29	+	1.83	1.15E-01
stem cell differentiation (GO:0048863)	165	7	3.85	+	1.82	9.43E-02
regulation of receptor-mediated endocytosis (GO:0048259)	118	5	2.75	+	1.82	1.44E-01
response to interferon-gamma (GO:0034341)	118	5	2.75	+	1.82	1.44E-01
regulation of synapse structure or activity (GO:0050803)	260	11	6.06	+	1.81	4.40E-02
cranial skeletal system development (GO:1904888)	71	3	1.66	+	1.81	2.31E-01
positive regulation of ERK1 and ERK2 cascade (GO:0070374)	213	9	4.97	+	1.81	6.47E-02
regulation of dephosphorylation (GO:0035303)	166	7	3.87	+	1.81	9.66E-02
regulation of tumor necrosis factor superfamily cytokine production (GO:1903555)	166	7	3.87	+	1.81	9.66E-02
regulation of fatty acid metabolic process (GO:0019217)	95	4	2.21	+	1.81	1.83E-01
regulation of heart rate (GO:0002027)	95	4	2.21	+	1.81	1.83E-01
regulation of organelle assembly (GO:1902115)	190	8	4.43	+	1.81	7.98E-02
positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731)	190	8	4.43	+	1.81	7.98E-02
regulation of intracellular signal transduction (GO:1902531)	1522	64	35.48	+	1.80	3.56E-06
response to oxidative stress (GO:0006979)	333	14	7.76	+	1.80	2.64E-02
cognition (GO:0050890)	333	14	7.76	+	1.80	2.64E-02
positive regulation of locomotion (GO:0040017)	571	24	13.31	+	1.80	4.57E-03
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101)	119	5	2.77	+	1.80	1.48E-01
gene silencing (GO:0016458)	119	5	2.77	+	1.80	1.48E-01
respiratory system development (GO:0060541)	239	10	5.57	+	1.79	5.63E-02
chordate embryonic development (GO:0043009)	789	33	18.39	+	1.79	1.03E-03
hippocampus development (GO:0021766)	72	3	1.68	+	1.79	2.37E-01
negative regulation of protein polymerization (GO:0032272)	72	3	1.68	+	1.79	2.37E-01
nucleoside diphosphate metabolic process (GO:0009132)	72	3	1.68	+	1.79	2.37E-01
negative regulation of cellular amide metabolic process (GO:0034249)	144	6	3.36	+	1.79	1.23E-01
regulation of systemic arterial blood pressure (GO:0003073)	120	5	2.80	+	1.79	1.51E-01
placenta development (GO:0001890)	168	7	3.92	+	1.79	1.01E-01
positive regulation of systemic arterial blood pressure (GO:0003084)	24	1	.56	+	1.79	4.29E-01
mesenchyme development (GO:0060485)	216	9	5.04	+	1.79	6.92E-02
respiratory system process (GO:0003016)	24	1	.56	+	1.79	4.29E-01
cardiac epithelial to mesenchymal transition (GO:0060317)	24	1	.56	+	1.79	4.29E-01
positive regulation of biomineralization (GO:0110151)	48	2	1.12	+	1.79	3.08E-01
central nervous system myelination (GO:0022010)	24	1	.56	+	1.79	4.29E-01
neuromuscular synaptic transmission (GO:0007274)	24	1	.56	+	1.79	4.29E-01
regulation of cilium movement involved in cell motility (GO:0060295)	24	1	.56	+	1.79	4.29E-01
fat-soluble vitamin metabolic process (GO:0006775)	24	1	.56	+	1.79	4.29E-01
folic acid-containing compound metabolic process (GO:0006760)	24	1	.56	+	1.79	4.29E-01
Sertoli cell differentiation (GO:0060008)	24	1	.56	+	1.79	4.29E-01
intermediate filament cytoskeleton organization (GO:0045104)	48	2	1.12	+	1.79	3.08E-01
negative regulation of interleukin-1 beta production (GO:0032691)	24	1	.56	+	1.79	4.29E-01
neurotransmitter uptake (GO:0001504)	24	1	.56	+	1.79	4.29E-01
peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231)	24	1	.56	+	1.79	4.29E-01
peptidyl-L-cysteine S-palmitoylation (GO:0018230)	24	1	.56	+	1.79	4.29E-01
regulation of cilium-dependent cell motility (GO:1902019)	24	1	.56	+	1.79	4.29E-01
phagosome maturation (GO:0090382)	24	1	.56	+	1.79	4.29E-01
regulation of histone H3-K9 methylation (GO:0051570)	24	1	.56	+	1.79	4.29E-01
positive regulation of protein autophosphorylation (GO:0031954)	24	1	.56	+	1.79	4.29E-01
gluconeogenesis (GO:0006094)	24	1	.56	+	1.79	4.29E-01
axon ensheathment in central nervous system (GO:0032291)	24	1	.56	+	1.79	4.29E-01
heterochromatin assembly (GO:0031507)	24	1	.56	+	1.79	4.29E-01
detection of external biotic stimulus (GO:0098581)	24	1	.56	+	1.79	4.29E-01
establishment of protein localization to plasma membrane (GO:0061951)	48	2	1.12	+	1.79	3.08E-01
long-chain fatty acid transport (GO:0015909)	48	2	1.12	+	1.79	3.08E-01
leukocyte adhesion to vascular endothelial cell (GO:0061756)	24	1	.56	+	1.79	4.29E-01
negative regulation of protein localization to cell periphery (GO:1904376)	24	1	.56	+	1.79	4.29E-01
positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862)	48	2	1.12	+	1.79	3.08E-01
retina layer formation (GO:0010842)	24	1	.56	+	1.79	4.29E-01
synaptic vesicle localization (GO:0097479)	48	2	1.12	+	1.79	3.08E-01
cellular hormone metabolic process (GO:0034754)	96	4	2.24	+	1.79	1.88E-01
hematopoietic stem cell homeostasis (GO:0061484)	24	1	.56	+	1.79	4.29E-01
regulation of establishment of protein localization to mitochondrion (GO:1903747)	24	1	.56	+	1.79	4.29E-01
positive regulation of glycoprotein biosynthetic process (GO:0010560)	24	1	.56	+	1.79	4.29E-01
neuronal stem cell population maintenance (GO:0097150)	24	1	.56	+	1.79	4.29E-01
positive regulation of transcription by RNA polymerase I (GO:0045943)	24	1	.56	+	1.79	4.29E-01
regulation of protein polyubiquitination (GO:1902914)	24	1	.56	+	1.79	4.29E-01
myoblast fusion (GO:0007520)	24	1	.56	+	1.79	4.29E-01
response to wounding (GO:0009611)	313	13	7.30	+	1.78	3.44E-02
positive regulation of protein phosphorylation (GO:0001934)	771	32	17.97	+	1.78	1.39E-03
telencephalon development (GO:0021537)	241	10	5.62	+	1.78	5.89E-02
ribonucleoprotein complex subunit organization (GO:0071826)	169	7	3.94	+	1.78	1.03E-01
positive regulation of intracellular signal transduction (GO:1902533)	918	38	21.40	+	1.78	5.29E-04
cellular carbohydrate metabolic process (GO:0044262)	145	6	3.38	+	1.78	1.26E-01
skeletal system morphogenesis (GO:0048705)	242	10	5.64	+	1.77	6.02E-02
regulation of supramolecular fiber organization (GO:1902903)	363	15	8.46	+	1.77	2.52E-02
regulation of protein serine/threonine kinase activity (GO:0071900)	412	17	9.60	+	1.77	1.82E-02
epithelium development (GO:0060429)	1020	42	23.78	+	1.77	3.00E-04
cytoskeleton organization (GO:0007010)	1045	43	24.36	+	1.77	2.58E-04
positive regulation of phosphorylation (GO:0042327)	851	35	19.84	+	1.76	9.77E-04
regulation of oxidative stress-induced cell death (GO:1903201)	73	3	1.70	+	1.76	2.43E-01
regulation of receptor internalization (GO:0002090)	73	3	1.70	+	1.76	2.43E-01
embryo development ending in birth or egg hatching (GO:0009792)	805	33	18.77	+	1.76	1.43E-03
negative regulation of translation (GO:0017148)	122	5	2.84	+	1.76	1.59E-01
protein processing (GO:0016485)	171	7	3.99	+	1.76	1.08E-01
cellular calcium ion homeostasis (GO:0006874)	440	18	10.26	+	1.75	1.66E-02
embryonic organ development (GO:0048568)	489	20	11.40	+	1.75	1.20E-02
enzyme linked receptor protein signaling pathway (GO:0007167)	538	22	12.54	+	1.75	8.73E-03
limbic system development (GO:0021761)	98	4	2.28	+	1.75	1.97E-01
negative regulation of oxidative stress-induced cell death (GO:1903202)	49	2	1.14	+	1.75	3.16E-01
positive regulation of glial cell differentiation (GO:0045687)	49	2	1.14	+	1.75	3.16E-01
intermediate filament-based process (GO:0045103)	49	2	1.14	+	1.75	3.16E-01
negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059)	49	2	1.14	+	1.75	3.16E-01
regulation of telomere maintenance via telomerase (GO:0032210)	49	2	1.14	+	1.75	3.16E-01
regulation of DNA-templated transcription in response to stress (GO:0043620)	49	2	1.14	+	1.75	3.16E-01
negative regulation of epithelial cell differentiation (GO:0030857)	49	2	1.14	+	1.75	3.16E-01
collagen fibril organization (GO:0030199)	49	2	1.14	+	1.75	3.16E-01
regulation of Wnt signaling pathway (GO:0030111)	294	12	6.85	+	1.75	4.56E-02
negative regulation of intracellular signal transduction (GO:1902532)	491	20	11.45	+	1.75	1.25E-02
negative regulation of MAPK cascade (GO:0043409)	172	7	4.01	+	1.75	1.11E-01
G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)	222	9	5.18	+	1.74	7.89E-02
positive regulation of DNA biosynthetic process (GO:2000573)	74	3	1.73	+	1.74	2.49E-01
cellular response to acid chemical (GO:0071229)	74	3	1.73	+	1.74	2.49E-01
cytoskeleton-dependent cytokinesis (GO:0061640)	74	3	1.73	+	1.74	2.49E-01
retrograde transport, endosome to Golgi (GO:0042147)	74	3	1.73	+	1.74	2.49E-01
axo-dendritic transport (GO:0008088)	74	3	1.73	+	1.74	2.49E-01
regulation of protein tyrosine kinase activity (GO:0061097)	74	3	1.73	+	1.74	2.49E-01
protein localization to cell periphery (GO:1990778)	247	10	5.76	+	1.74	6.69E-02
heart process (GO:0003015)	99	4	2.31	+	1.73	2.02E-01
positive regulation of developmental process (GO:0051094)	1363	55	31.77	+	1.73	5.69E-05
regulation of extent of cell growth (GO:0061387)	124	5	2.89	+	1.73	1.66E-01
sensory organ morphogenesis (GO:0090596)	298	12	6.95	+	1.73	4.95E-02
positive regulation of signal transduction (GO:0009967)	1442	58	33.61	+	1.73	3.82E-05
regulation of response to DNA damage stimulus (GO:2001020)	199	8	4.64	+	1.72	9.73E-02
regulation of developmental process (GO:0050793)	2413	97	56.25	+	1.72	4.82E-08
regulation of synapse organization (GO:0050807)	249	10	5.80	+	1.72	6.97E-02
renal system process involved in regulation of systemic arterial blood pressure (GO:0003071)	25	1	.58	+	1.72	4.42E-01
axonal fasciculation (GO:0007413)	25	1	.58	+	1.72	4.42E-01
ER-nucleus signaling pathway (GO:0006984)	25	1	.58	+	1.72	4.42E-01
bone morphogenesis (GO:0060349)	100	4	2.33	+	1.72	2.07E-01
telencephalon glial cell migration (GO:0022030)	25	1	.58	+	1.72	4.42E-01
ventral spinal cord development (GO:0021517)	50	2	1.17	+	1.72	3.25E-01
cilium-dependent cell motility (GO:0060285)	100	4	2.33	+	1.72	2.07E-01
trophectodermal cell differentiation (GO:0001829)	25	1	.58	+	1.72	4.42E-01
positive regulation of interleukin-4 production (GO:0032753)	25	1	.58	+	1.72	4.42E-01
cellular response to gamma radiation (GO:0071480)	25	1	.58	+	1.72	4.42E-01
regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143)	75	3	1.75	+	1.72	2.55E-01
cilium or flagellum-dependent cell motility (GO:0001539)	100	4	2.33	+	1.72	2.07E-01
cellular response to interleukin-4 (GO:0071353)	25	1	.58	+	1.72	4.42E-01
regulation of protein exit from endoplasmic reticulum (GO:0070861)	25	1	.58	+	1.72	4.42E-01
dendrite morphogenesis (GO:0048813)	75	3	1.75	+	1.72	2.55E-01
negative regulation of type I interferon production (GO:0032480)	25	1	.58	+	1.72	4.42E-01
positive regulation of oligodendrocyte differentiation (GO:0048714)	25	1	.58	+	1.72	4.42E-01
neuron projection fasciculation (GO:0106030)	25	1	.58	+	1.72	4.42E-01
regulation of lipid kinase activity (GO:0043550)	50	2	1.17	+	1.72	3.25E-01
histone lysine demethylation (GO:0070076)	25	1	.58	+	1.72	4.42E-01
histone demethylation (GO:0016577)	25	1	.58	+	1.72	4.42E-01
glucose transmembrane transport (GO:1904659)	25	1	.58	+	1.72	4.42E-01
negative regulation of telomere maintenance via telomere lengthening (GO:1904357)	25	1	.58	+	1.72	4.42E-01
positive regulation of lipid storage (GO:0010884)	25	1	.58	+	1.72	4.42E-01
segmentation (GO:0035282)	100	4	2.33	+	1.72	2.07E-01
regulation of protein kinase A signaling (GO:0010738)	25	1	.58	+	1.72	4.42E-01
response to copper ion (GO:0046688)	25	1	.58	+	1.72	4.42E-01
regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640)	25	1	.58	+	1.72	4.42E-01
negative regulation of viral entry into host cell (GO:0046597)	25	1	.58	+	1.72	4.42E-01
regulation of androgen receptor signaling pathway (GO:0060765)	25	1	.58	+	1.72	4.42E-01
regulation of microtubule-based movement (GO:0060632)	50	2	1.17	+	1.72	3.25E-01
regulation of alcohol biosynthetic process (GO:1902930)	50	2	1.17	+	1.72	3.25E-01
regulation of plasma lipoprotein particle levels (GO:0097006)	50	2	1.17	+	1.72	3.25E-01
positive regulation of protein maturation (GO:1903319)	25	1	.58	+	1.72	4.42E-01
cerebral cortex radial glia guided migration (GO:0021801)	25	1	.58	+	1.72	4.42E-01
regulation of cell differentiation (GO:0045595)	1527	61	35.60	+	1.71	2.87E-05
positive regulation of epithelial cell migration (GO:0010634)	151	6	3.52	+	1.70	1.44E-01
positive regulation of DNA-binding transcription factor activity (GO:0051091)	252	10	5.87	+	1.70	7.41E-02
regulation of glucose metabolic process (GO:0010906)	126	5	2.94	+	1.70	1.74E-01
lipid transport (GO:0006869)	303	12	7.06	+	1.70	5.47E-02
cell population proliferation (GO:0008283)	531	21	12.38	+	1.70	1.44E-02
regulation of lipase activity (GO:0060191)	76	3	1.77	+	1.69	2.62E-01
embryonic morphogenesis (GO:0048598)	608	24	14.17	+	1.69	9.48E-03
negative regulation of ERK1 and ERK2 cascade (GO:0070373)	76	3	1.77	+	1.69	2.62E-01
phospholipid transport (GO:0015914)	76	3	1.77	+	1.69	2.62E-01
regulation of cardiac muscle tissue growth (GO:0055021)	76	3	1.77	+	1.69	2.62E-01
regulation of cyclin-dependent protein kinase activity (GO:1904029)	76	3	1.77	+	1.69	2.62E-01
aging (GO:0007568)	152	6	3.54	+	1.69	1.47E-01
calcium ion homeostasis (GO:0055074)	456	18	10.63	+	1.69	2.27E-02
regulation of kinase activity (GO:0043549)	736	29	17.16	+	1.69	4.71E-03
negative regulation of growth (GO:0045926)	254	10	5.92	+	1.69	7.72E-02
regulation of cell adhesion (GO:0030155)	712	28	16.60	+	1.69	5.58E-03
eye development (GO:0001654)	382	15	8.90	+	1.68	3.68E-02
central nervous system development (GO:0007417)	841	33	19.60	+	1.68	2.83E-03
cranial nerve development (GO:0021545)	51	2	1.19	+	1.68	3.33E-01
regulation of transcription regulatory region DNA binding (GO:2000677)	51	2	1.19	+	1.68	3.33E-01
protein deacetylation (GO:0006476)	51	2	1.19	+	1.68	3.33E-01
nucleoside diphosphate phosphorylation (GO:0006165)	51	2	1.19	+	1.68	3.33E-01
negative regulation of cell communication (GO:0010648)	1275	50	29.72	+	1.68	2.48E-04
cardiac conduction (GO:0061337)	51	2	1.19	+	1.68	3.33E-01
regulation of transferase activity (GO:0051338)	843	33	19.65	+	1.68	2.93E-03
negative regulation of signaling (GO:0023057)	1279	50	29.82	+	1.68	2.67E-04
positive regulation of phosphorus metabolic process (GO:0010562)	921	36	21.47	+	1.68	1.97E-03
positive regulation of phosphate metabolic process (GO:0045937)	921	36	21.47	+	1.68	1.97E-03
RNA splicing (GO:0008380)	307	12	7.16	+	1.68	5.91E-02
positive regulation of cell differentiation (GO:0045597)	898	35	20.93	+	1.67	2.37E-03
cytosolic calcium ion transport (GO:0060401)	77	3	1.79	+	1.67	2.68E-01
regulation of bone mineralization (GO:0030500)	77	3	1.79	+	1.67	2.68E-01
negative regulation of phosphatase activity (GO:0010923)	77	3	1.79	+	1.67	2.68E-01
odontogenesis of dentin-containing tooth (GO:0042475)	77	3	1.79	+	1.67	2.68E-01
visual system development (GO:0150063)	385	15	8.97	+	1.67	3.89E-02
regulation of angiogenesis (GO:0045765)	283	11	6.60	+	1.67	7.08E-02
regulation of cytosolic calcium ion concentration (GO:0051480)	335	13	7.81	+	1.66	5.33E-02
cellular divalent inorganic cation homeostasis (GO:0072503)	465	18	10.84	+	1.66	2.68E-02
sensory system development (GO:0048880)	389	15	9.07	+	1.65	4.19E-02
positive regulation of blood pressure (GO:0045777)	52	2	1.21	+	1.65	3.42E-01
cerebral cortex cell migration (GO:0021795)	52	2	1.21	+	1.65	3.42E-01
striated muscle contraction (GO:0006941)	104	4	2.42	+	1.65	2.26E-01
regulation of epidermal cell differentiation (GO:0045604)	52	2	1.21	+	1.65	3.42E-01
positive regulation of glycoprotein metabolic process (GO:1903020)	26	1	.61	+	1.65	4.55E-01
basement membrane organization (GO:0071711)	26	1	.61	+	1.65	4.55E-01
glycosphingolipid biosynthetic process (GO:0006688)	26	1	.61	+	1.65	4.55E-01
regulation of activin receptor signaling pathway (GO:0032925)	26	1	.61	+	1.65	4.55E-01
regulation of glutamate secretion (GO:0014048)	26	1	.61	+	1.65	4.55E-01
intermediate filament organization (GO:0045109)	26	1	.61	+	1.65	4.55E-01
mRNA splice site selection (GO:0006376)	26	1	.61	+	1.65	4.55E-01
regulation of nitric-oxide synthase biosynthetic process (GO:0051769)	26	1	.61	+	1.65	4.55E-01
transepithelial transport (GO:0070633)	26	1	.61	+	1.65	4.55E-01
positive regulation of ubiquitin-protein transferase activity (GO:0051443)	26	1	.61	+	1.65	4.55E-01
negative regulation of lipid catabolic process (GO:0050995)	26	1	.61	+	1.65	4.55E-01
negative regulation of oxidoreductase activity (GO:0051354)	26	1	.61	+	1.65	4.55E-01
positive regulation of oxidoreductase activity (GO:0051353)	52	2	1.21	+	1.65	3.42E-01
regulation of monocyte chemotaxis (GO:0090025)	26	1	.61	+	1.65	4.55E-01
regulation of response to nutrient levels (GO:0032107)	26	1	.61	+	1.65	4.55E-01
regulation of response to extracellular stimulus (GO:0032104)	26	1	.61	+	1.65	4.55E-01
non-motile cilium assembly (GO:1905515)	52	2	1.21	+	1.65	3.42E-01
negative regulation of T cell apoptotic process (GO:0070233)	26	1	.61	+	1.65	4.55E-01
regulation of mRNA 3'-end processing (GO:0031440)	26	1	.61	+	1.65	4.55E-01
regulation of receptor binding (GO:1900120)	26	1	.61	+	1.65	4.55E-01
hexose transmembrane transport (GO:0008645)	26	1	.61	+	1.65	4.55E-01
lipid phosphorylation (GO:0046834)	52	2	1.21	+	1.65	3.42E-01
regulation of telomere capping (GO:1904353)	26	1	.61	+	1.65	4.55E-01
positive regulation of protein import into nucleus (GO:0042307)	52	2	1.21	+	1.65	3.42E-01
lung development (GO:0030324)	208	8	4.85	+	1.65	1.17E-01
positive regulation of endothelial cell migration (GO:0010595)	104	4	2.42	+	1.65	2.26E-01
labyrinthine layer morphogenesis (GO:0060713)	26	1	.61	+	1.65	4.55E-01
negative regulation of cytokine production (GO:0001818)	260	10	6.06	+	1.65	8.67E-02
inner ear receptor cell differentiation (GO:0060113)	78	3	1.82	+	1.65	2.74E-01
canonical Wnt signaling pathway (GO:0060070)	78	3	1.82	+	1.65	2.74E-01
regulation of cytokinesis (GO:0032465)	78	3	1.82	+	1.65	2.74E-01
protein-containing complex subunit organization (GO:0043933)	1066	41	24.85	+	1.65	1.31E-03
mesenchymal cell differentiation (GO:0048762)	156	6	3.64	+	1.65	1.60E-01
protein tetramerization (GO:0051262)	78	3	1.82	+	1.65	2.74E-01
male sex differentiation (GO:0046661)	156	6	3.64	+	1.65	1.60E-01
regulation of JNK cascade (GO:0046328)	130	5	3.03	+	1.65	1.89E-01
regulation of vasculature development (GO:1901342)	287	11	6.69	+	1.64	7.64E-02
metal ion transport (GO:0030001)	287	11	6.69	+	1.64	7.64E-02
cytokine-mediated signaling pathway (GO:0019221)	261	10	6.08	+	1.64	8.83E-02
positive regulation of ion transmembrane transport (GO:0034767)	235	9	5.48	+	1.64	1.02E-01
positive regulation of transmembrane transport (GO:0034764)	235	9	5.48	+	1.64	1.02E-01
negative regulation of defense response (GO:0031348)	209	8	4.87	+	1.64	1.19E-01
skeletal system development (GO:0001501)	471	18	10.98	+	1.64	2.99E-02
negative regulation of cellular component organization (GO:0051129)	707	27	16.48	+	1.64	9.25E-03
apoptotic signaling pathway (GO:0097190)	262	10	6.11	+	1.64	9.00E-02
regulation of cellular component size (GO:0032535)	393	15	9.16	+	1.64	4.51E-02
negative regulation of signal transduction (GO:0009968)	1154	44	26.90	+	1.64	1.04E-03
regulation of actomyosin structure organization (GO:0110020)	105	4	2.45	+	1.63	2.31E-01
homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156)	105	4	2.45	+	1.63	2.31E-01
positive regulation of reactive oxygen species metabolic process (GO:2000379)	105	4	2.45	+	1.63	2.31E-01
embryonic skeletal system morphogenesis (GO:0048704)	105	4	2.45	+	1.63	2.31E-01
sulfur compound metabolic process (GO:0006790)	263	10	6.13	+	1.63	9.17E-02
positive regulation of cell cycle (GO:0045787)	342	13	7.97	+	1.63	6.07E-02
negative regulation of developmental process (GO:0051093)	921	35	21.47	+	1.63	3.53E-03
isoprenoid metabolic process (GO:0006720)	79	3	1.84	+	1.63	2.80E-01
centrosome cycle (GO:0007098)	79	3	1.84	+	1.63	2.80E-01
anatomical structure morphogenesis (GO:0009653)	2187	83	50.98	+	1.63	5.60E-06
mRNA metabolic process (GO:0016071)	501	19	11.68	+	1.63	2.80E-02
respiratory tube development (GO:0030323)	211	8	4.92	+	1.63	1.24E-01
negative regulation of multicellular organismal process (GO:0051241)	1056	40	24.62	+	1.62	1.96E-03
negative regulation of protein-containing complex assembly (GO:0031333)	132	5	3.08	+	1.62	1.97E-01
cilium movement (GO:0003341)	132	5	3.08	+	1.62	1.97E-01
regulation of muscle system process (GO:0090257)	238	9	5.55	+	1.62	1.08E-01
positive regulation of cytosolic calcium ion concentration (GO:0007204)	291	11	6.78	+	1.62	8.22E-02
regulation of actin cytoskeleton organization (GO:0032956)	344	13	8.02	+	1.62	6.29E-02
positive regulation of MAPK cascade (GO:0043410)	503	19	11.73	+	1.62	2.89E-02
positive regulation of cell communication (GO:0010647)	1643	62	38.30	+	1.62	1.23E-04
cerebellum morphogenesis (GO:0021587)	53	2	1.24	+	1.62	3.50E-01
vitamin metabolic process (GO:0006766)	53	2	1.24	+	1.62	3.50E-01
positive regulation of organic acid transport (GO:0032892)	53	2	1.24	+	1.62	3.50E-01
regulation of cell division (GO:0051302)	159	6	3.71	+	1.62	1.70E-01
plasma membrane invagination (GO:0099024)	53	2	1.24	+	1.62	3.50E-01
antigen processing and presentation of peptide antigen (GO:0048002)	53	2	1.24	+	1.62	3.50E-01
regulation of microtubule polymerization (GO:0031113)	53	2	1.24	+	1.62	3.50E-01
ventricular cardiac muscle tissue morphogenesis (GO:0055010)	53	2	1.24	+	1.62	3.50E-01
cell junction organization (GO:0034330)	477	18	11.12	+	1.62	3.32E-02
negative regulation of transcription, DNA-templated (GO:0045892)	1140	43	26.57	+	1.62	1.45E-03
system development (GO:0048731)	3986	150	92.92	+	1.61	1.62E-10
myeloid cell homeostasis (GO:0002262)	133	5	3.10	+	1.61	2.01E-01
neuromuscular process (GO:0050905)	133	5	3.10	+	1.61	2.01E-01
negative regulation of nucleic acid-templated transcription (GO:1903507)	1144	43	26.67	+	1.61	1.55E-03
positive regulation of signaling (GO:0023056)	1650	62	38.46	+	1.61	1.38E-04
negative regulation of RNA biosynthetic process (GO:1902679)	1145	43	26.69	+	1.61	1.57E-03
transforming growth factor beta receptor signaling pathway (GO:0007179)	80	3	1.86	+	1.61	2.87E-01
cytokinesis (GO:0000910)	80	3	1.86	+	1.61	2.87E-01
response to virus (GO:0009615)	240	9	5.59	+	1.61	1.12E-01
regulation of actin filament polymerization (GO:0030833)	160	6	3.73	+	1.61	1.73E-01
antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844)	80	3	1.86	+	1.61	2.87E-01
regulation of dendritic spine development (GO:0060998)	80	3	1.86	+	1.61	2.87E-01
regulation of cellular carbohydrate metabolic process (GO:0010675)	160	6	3.73	+	1.61	1.73E-01
regulation of binding (GO:0051098)	374	14	8.72	+	1.61	5.86E-02
supramolecular fiber organization (GO:0097435)	481	18	11.21	+	1.61	3.55E-02
regulation of steroid metabolic process (GO:0019218)	107	4	2.49	+	1.60	2.41E-01
microtubule-based movement (GO:0007018)	321	12	7.48	+	1.60	7.64E-02
regulation of chemotaxis (GO:0050920)	214	8	4.99	+	1.60	1.31E-01
regulation of protein binding (GO:0043393)	214	8	4.99	+	1.60	1.31E-01
regulation of potassium ion transport (GO:0043266)	107	4	2.49	+	1.60	2.41E-01
gonad development (GO:0008406)	214	8	4.99	+	1.60	1.31E-01
intracellular signal transduction (GO:0035556)	1288	48	30.02	+	1.60	9.88E-04
positive regulation of endopeptidase activity (GO:0010950)	161	6	3.75	+	1.60	1.77E-01
regulation of protein kinase activity (GO:0045859)	644	24	15.01	+	1.60	1.77E-02
negative regulation of leukocyte activation (GO:0002695)	188	7	4.38	+	1.60	1.53E-01
negative regulation of neuron death (GO:1901215)	242	9	5.64	+	1.60	1.17E-01
positive regulation of protein modification process (GO:0031401)	995	37	23.19	+	1.60	3.87E-03
negative regulation of RNA metabolic process (GO:0051253)	1239	46	28.88	+	1.59	1.36E-03
positive regulation of cell adhesion (GO:0045785)	431	16	10.05	+	1.59	4.83E-02
sensory organ development (GO:0007423)	593	22	13.82	+	1.59	2.36E-02
cell surface receptor signaling pathway (GO:0007166)	1619	60	37.74	+	1.59	2.58E-04
Golgi vesicle transport (GO:0048193)	243	9	5.66	+	1.59	1.19E-01
muscle tissue morphogenesis (GO:0060415)	81	3	1.89	+	1.59	2.93E-01
regulation of osteoblast proliferation (GO:0033688)	27	1	.63	+	1.59	4.67E-01
hexose biosynthetic process (GO:0019319)	27	1	.63	+	1.59	4.67E-01
antigen processing and presentation of exogenous peptide antigen (GO:0002478)	27	1	.63	+	1.59	4.67E-01
cell differentiation in spinal cord (GO:0021515)	54	2	1.26	+	1.59	3.59E-01
glutathione metabolic process (GO:0006749)	54	2	1.26	+	1.59	3.59E-01
NADH metabolic process (GO:0006734)	27	1	.63	+	1.59	4.67E-01
mononuclear cell migration (GO:0071674)	81	3	1.89	+	1.59	2.93E-01
myeloid cell activation involved in immune response (GO:0002275)	54	2	1.26	+	1.59	3.59E-01
regulation of granulocyte chemotaxis (GO:0071622)	54	2	1.26	+	1.59	3.59E-01
regulation of endothelial cell apoptotic process (GO:2000351)	54	2	1.26	+	1.59	3.59E-01
actin nucleation (GO:0045010)	27	1	.63	+	1.59	4.67E-01
cellular response to cadmium ion (GO:0071276)	27	1	.63	+	1.59	4.67E-01
negative regulation of cellular macromolecule biosynthetic process (GO:2000113)	1323	49	30.84	+	1.59	9.96E-04
purine nucleotide metabolic process (GO:0006163)	270	10	6.29	+	1.59	1.04E-01
positive regulation of calcium ion import (GO:0090280)	27	1	.63	+	1.59	4.67E-01
response to interleukin-4 (GO:0070670)	27	1	.63	+	1.59	4.67E-01
aminoglycan catabolic process (GO:0006026)	27	1	.63	+	1.59	4.67E-01
regulation of protein polymerization (GO:0032271)	216	8	5.04	+	1.59	1.36E-01
import across plasma membrane (GO:0098739)	135	5	3.15	+	1.59	2.09E-01
zymogen activation (GO:0031638)	54	2	1.26	+	1.59	3.59E-01
maturation of LSU-rRNA (GO:0000470)	27	1	.63	+	1.59	4.67E-01
vascular associated smooth muscle cell differentiation (GO:0035886)	27	1	.63	+	1.59	4.67E-01
thyroid gland development (GO:0030878)	27	1	.63	+	1.59	4.67E-01
animal organ regeneration (GO:0031100)	27	1	.63	+	1.59	4.67E-01
ovulation cycle (GO:0042698)	54	2	1.26	+	1.59	3.59E-01
positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531)	54	2	1.26	+	1.59	3.59E-01
negative regulation of protein processing (GO:0010955)	27	1	.63	+	1.59	4.67E-01
positive regulation of peptidyl-threonine phosphorylation (GO:0010800)	27	1	.63	+	1.59	4.67E-01
negative regulation of cellular protein localization (GO:1903828)	108	4	2.52	+	1.59	2.46E-01
determination of adult lifespan (GO:0008340)	27	1	.63	+	1.59	4.67E-01
endochondral bone growth (GO:0003416)	27	1	.63	+	1.59	4.67E-01
chaperone-mediated protein folding (GO:0061077)	54	2	1.26	+	1.59	3.59E-01
forebrain regionalization (GO:0021871)	27	1	.63	+	1.59	4.67E-01
body fluid secretion (GO:0007589)	54	2	1.26	+	1.59	3.59E-01
positive regulation of dendritic spine morphogenesis (GO:0061003)	27	1	.63	+	1.59	4.67E-01
negative regulation of protein maturation (GO:1903318)	27	1	.63	+	1.59	4.67E-01
response to abiotic stimulus (GO:0009628)	897	33	20.91	+	1.58	7.25E-03
negative regulation of response to stimulus (GO:0048585)	1523	56	35.50	+	1.58	5.08E-04
regulation of cellular component biogenesis (GO:0044087)	925	34	21.56	+	1.58	6.55E-03
divalent inorganic cation homeostasis (GO:0072507)	490	18	11.42	+	1.58	4.12E-02
development of primary sexual characteristics (GO:0045137)	218	8	5.08	+	1.57	1.41E-01
negative regulation of macromolecule biosynthetic process (GO:0010558)	1337	49	31.17	+	1.57	1.24E-03
negative regulation of cellular biosynthetic process (GO:0031327)	1393	51	32.47	+	1.57	1.01E-03
regulation of catalytic activity (GO:0050790)	1803	66	42.03	+	1.57	1.73E-04
synapse assembly (GO:0007416)	82	3	1.91	+	1.57	2.99E-01
nerve development (GO:0021675)	82	3	1.91	+	1.57	2.99E-01
positive regulation of cellular component organization (GO:0051130)	1148	42	26.76	+	1.57	2.85E-03
negative regulation of mRNA metabolic process (GO:1903312)	82	3	1.91	+	1.57	2.99E-01
regulation of membrane potential (GO:0042391)	438	16	10.21	+	1.57	5.42E-02
regulation of signal transduction (GO:0009966)	2685	98	62.59	+	1.57	3.39E-06
establishment of vesicle localization (GO:0051650)	137	5	3.19	+	1.57	2.18E-01
regulation of carbohydrate metabolic process (GO:0006109)	192	7	4.48	+	1.56	1.65E-01
animal organ morphogenesis (GO:0009887)	1016	37	23.68	+	1.56	5.38E-03
regulation of cell growth (GO:0001558)	412	15	9.60	+	1.56	6.22E-02
positive regulation of ossification (GO:0045778)	55	2	1.28	+	1.56	3.67E-01
regulation of protein localization to plasma membrane (GO:1903076)	110	4	2.56	+	1.56	2.56E-01
Golgi organization (GO:0007030)	110	4	2.56	+	1.56	2.56E-01
coagulation (GO:0050817)	110	4	2.56	+	1.56	2.56E-01
positive regulation of dendrite morphogenesis (GO:0050775)	55	2	1.28	+	1.56	3.67E-01
positive regulation of blood vessel endothelial cell migration (GO:0043536)	55	2	1.28	+	1.56	3.67E-01
regulation of long-term synaptic potentiation (GO:1900271)	55	2	1.28	+	1.56	3.67E-01
positive regulation of dephosphorylation (GO:0035306)	55	2	1.28	+	1.56	3.67E-01
blood coagulation (GO:0007596)	110	4	2.56	+	1.56	2.56E-01
regulation of cellular response to stress (GO:0080135)	605	22	14.10	+	1.56	2.85E-02
negative regulation of cell differentiation (GO:0045596)	661	24	15.41	+	1.56	2.32E-02
ossification (GO:0001503)	221	8	5.15	+	1.55	1.48E-01
regulation of heart growth (GO:0060420)	83	3	1.93	+	1.55	3.06E-01
regulation of cellular response to oxidative stress (GO:1900407)	83	3	1.93	+	1.55	3.06E-01
positive regulation of calcium ion transmembrane transport (GO:1904427)	83	3	1.93	+	1.55	3.06E-01
cellular response to UV (GO:0034644)	83	3	1.93	+	1.55	3.06E-01
keratinocyte differentiation (GO:0030216)	83	3	1.93	+	1.55	3.06E-01
cellular protein-containing complex assembly (GO:0034622)	609	22	14.20	+	1.55	3.04E-02
positive regulation of transcription by RNA polymerase II (GO:0045944)	1164	42	27.13	+	1.55	3.63E-03
regulation of actin filament-based process (GO:0032970)	389	14	9.07	+	1.54	7.51E-02
negative regulation of nucleobase-containing compound metabolic process (GO:0045934)	1334	48	31.10	+	1.54	2.01E-03
regulation of multicellular organismal development (GO:2000026)	1390	50	32.40	+	1.54	1.63E-03
positive regulation of angiogenesis (GO:0045766)	167	6	3.89	+	1.54	1.98E-01
positive regulation of cellular component biogenesis (GO:0044089)	501	18	11.68	+	1.54	4.90E-02
positive regulation of vasculature development (GO:1904018)	167	6	3.89	+	1.54	1.98E-01
positive regulation of biosynthetic process (GO:0009891)	1810	65	42.19	+	1.54	3.28E-04
mRNA processing (GO:0006397)	390	14	9.09	+	1.54	7.63E-02
epithelial cell development (GO:0002064)	223	8	5.20	+	1.54	1.54E-01
purine ribonucleotide metabolic process (GO:0009150)	251	9	5.85	+	1.54	1.36E-01
positive regulation of cellular protein metabolic process (GO:0032270)	1340	48	31.24	+	1.54	2.19E-03
regulation of hydrolase activity (GO:0051336)	978	35	22.80	+	1.54	8.64E-03
multicellular organism development (GO:0007275)	4562	163	106.35	+	1.53	8.65E-10
adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188)	196	7	4.57	+	1.53	1.77E-01
mRNA splicing, via spliceosome (GO:0000398)	196	7	4.57	+	1.53	1.77E-01
RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)	196	7	4.57	+	1.53	1.77E-01
RNA splicing, via transesterification reactions (GO:0000375)	196	7	4.57	+	1.53	1.77E-01
innervation (GO:0060384)	28	1	.65	+	1.53	4.80E-01
water-soluble vitamin metabolic process (GO:0006767)	28	1	.65	+	1.53	4.80E-01
regulation of epidermal growth factor-activated receptor activity (GO:0007176)	28	1	.65	+	1.53	4.80E-01
leukocyte cell-cell adhesion (GO:0007159)	56	2	1.31	+	1.53	3.75E-01
positive regulation of monooxygenase activity (GO:0032770)	28	1	.65	+	1.53	4.80E-01
regulation of lymphocyte migration (GO:2000401)	56	2	1.31	+	1.53	3.75E-01
regulation of interferon-alpha production (GO:0032647)	28	1	.65	+	1.53	4.80E-01
regulation of hematopoietic progenitor cell differentiation (GO:1901532)	28	1	.65	+	1.53	4.80E-01
regulation of neural precursor cell proliferation (GO:2000177)	112	4	2.61	+	1.53	2.66E-01
cellular component maintenance (GO:0043954)	56	2	1.31	+	1.53	3.75E-01
TOR signaling (GO:0031929)	28	1	.65	+	1.53	4.80E-01
axonal transport (GO:0098930)	56	2	1.31	+	1.53	3.75E-01
platelet aggregation (GO:0070527)	28	1	.65	+	1.53	4.80E-01
intestinal absorption (GO:0050892)	28	1	.65	+	1.53	4.80E-01
negative regulation of antigen receptor-mediated signaling pathway (GO:0050858)	28	1	.65	+	1.53	4.80E-01
positive regulation of p38MAPK cascade (GO:1900745)	28	1	.65	+	1.53	4.80E-01
regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994)	28	1	.65	+	1.53	4.80E-01
regulation of vascular associated smooth muscle cell migration (GO:1904752)	28	1	.65	+	1.53	4.80E-01
energy derivation by oxidation of organic compounds (GO:0015980)	168	6	3.92	+	1.53	2.01E-01
negative regulation of viral life cycle (GO:1903901)	28	1	.65	+	1.53	4.80E-01
dopamine metabolic process (GO:0042417)	28	1	.65	+	1.53	4.80E-01
acid secretion (GO:0046717)	28	1	.65	+	1.53	4.80E-01
embryonic heart tube development (GO:0035050)	84	3	1.96	+	1.53	3.12E-01
insulin receptor signaling pathway (GO:0008286)	56	2	1.31	+	1.53	3.75E-01
positive regulation of heart rate (GO:0010460)	28	1	.65	+	1.53	4.80E-01
hemostasis (GO:0007599)	112	4	2.61	+	1.53	2.66E-01
regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893)	56	2	1.31	+	1.53	3.75E-01
positive regulation of cellular biosynthetic process (GO:0031328)	1768	63	41.21	+	1.53	5.01E-04
cellular response to cytokine stimulus (GO:0071345)	618	22	14.41	+	1.53	3.48E-02
negative regulation of biosynthetic process (GO:0009890)	1433	51	33.40	+	1.53	1.83E-03
modulation of chemical synaptic transmission (GO:0050804)	506	18	11.80	+	1.53	5.29E-02
regulation of neuron death (GO:1901214)	366	13	8.53	+	1.52	9.07E-02
regulation of trans-synaptic signaling (GO:0099177)	507	18	11.82	+	1.52	5.37E-02
positive regulation of NF-kappaB transcription factor activity (GO:0051092)	141	5	3.29	+	1.52	2.35E-01
regulation of growth (GO:0040008)	677	24	15.78	+	1.52	2.96E-02
negative regulation of cell population proliferation (GO:0008285)	677	24	15.78	+	1.52	2.96E-02
regulation of DNA-binding transcription factor activity (GO:0051090)	395	14	9.21	+	1.52	8.25E-02
anatomical structure development (GO:0048856)	4855	172	113.18	+	1.52	3.87E-10
protein maturation (GO:0051604)	226	8	5.27	+	1.52	1.62E-01
inner ear morphogenesis (GO:0042472)	113	4	2.63	+	1.52	2.71E-01
negative regulation of secretion (GO:0051048)	198	7	4.62	+	1.52	1.83E-01
biological adhesion (GO:0022610)	793	28	18.49	+	1.51	2.07E-02
regulation of potassium ion transmembrane transport (GO:1901379)	85	3	1.98	+	1.51	3.18E-01
positive regulation of peptidase activity (GO:0010952)	170	6	3.96	+	1.51	2.08E-01
mechanoreceptor differentiation (GO:0042490)	85	3	1.98	+	1.51	3.18E-01
regulation of signaling (GO:0023051)	3091	109	72.05	+	1.51	3.89E-06
cell-cell signaling by wnt (GO:0198738)	227	8	5.29	+	1.51	1.64E-01
Wnt signaling pathway (GO:0016055)	227	8	5.29	+	1.51	1.64E-01
blastocyst development (GO:0001824)	142	5	3.31	+	1.51	2.39E-01
neuron migration (GO:0001764)	142	5	3.31	+	1.51	2.39E-01
positive regulation of protein metabolic process (GO:0051247)	1420	50	33.10	+	1.51	2.51E-03
ion transmembrane transport (GO:0034220)	711	25	16.57	+	1.51	2.91E-02
regulation of cell communication (GO:0010646)	3078	108	71.75	+	1.51	5.51E-06
negative regulation of fat cell differentiation (GO:0045599)	57	2	1.33	+	1.51	3.84E-01
hindbrain morphogenesis (GO:0021575)	57	2	1.33	+	1.51	3.84E-01
activation of MAPK activity (GO:0000187)	114	4	2.66	+	1.51	2.76E-01
receptor clustering (GO:0043113)	57	2	1.33	+	1.51	3.84E-01
cell death (GO:0008219)	857	30	19.98	+	1.50	1.89E-02
cellular response to extracellular stimulus (GO:0031668)	200	7	4.66	+	1.50	1.89E-01
negative regulation of gene expression (GO:0010629)	1773	62	41.33	+	1.50	8.91E-04
regulation of multicellular organismal process (GO:0051239)	2662	93	62.05	+	1.50	3.64E-05
positive regulation of macromolecule biosynthetic process (GO:0010557)	1664	58	38.79	+	1.50	1.42E-03
regulation of hormone secretion (GO:0046883)	287	10	6.69	+	1.49	1.38E-01
positive regulation of cell junction assembly (GO:1901890)	115	4	2.68	+	1.49	2.81E-01
negative regulation of protein catabolic process (GO:0042177)	115	4	2.68	+	1.49	2.81E-01
cell differentiation (GO:0030154)	3336	116	77.77	+	1.49	3.27E-06
developmental process (GO:0032502)	5218	181	121.64	+	1.49	5.20E-10
regulation of lipid metabolic process (GO:0019216)	346	12	8.07	+	1.49	1.15E-01
regulation of molecular function (GO:0065009)	2452	85	57.16	+	1.49	1.13E-04
leukocyte migration (GO:0050900)	202	7	4.71	+	1.49	1.96E-01
regulation of mitotic cell cycle (GO:0007346)	433	15	10.09	+	1.49	8.59E-02
regulation of cell cycle (GO:0051726)	924	32	21.54	+	1.49	1.79E-02
apoptotic process (GO:0006915)	780	27	18.18	+	1.48	2.84E-02
cellular metal ion homeostasis (GO:0006875)	549	19	12.80	+	1.48	5.92E-02
kidney development (GO:0001822)	289	10	6.74	+	1.48	1.42E-01
embryo development (GO:0009790)	1156	40	26.95	+	1.48	8.80E-03
cellular developmental process (GO:0048869)	3385	117	78.91	+	1.48	3.90E-06
negative regulation of neuron differentiation (GO:0045665)	87	3	2.03	+	1.48	3.31E-01
biomineralization (GO:0110148)	87	3	2.03	+	1.48	3.31E-01
biomineral tissue development (GO:0031214)	87	3	2.03	+	1.48	3.31E-01
protein localization to Golgi apparatus (GO:0034067)	29	1	.68	+	1.48	4.92E-01
regulation of apoptotic signaling pathway (GO:2001233)	377	13	8.79	+	1.48	1.07E-01
regulation of receptor recycling (GO:0001919)	29	1	.68	+	1.48	4.92E-01
mature B cell differentiation (GO:0002335)	29	1	.68	+	1.48	4.92E-01
cell adhesion (GO:0007155)	783	27	18.25	+	1.48	2.95E-02
blastocyst formation (GO:0001825)	58	2	1.35	+	1.48	3.92E-01
positive regulation of stem cell proliferation (GO:2000648)	29	1	.68	+	1.48	4.92E-01
regulation of protein localization to synapse (GO:1902473)	29	1	.68	+	1.48	4.92E-01
acetylcholine receptor signaling pathway (GO:0095500)	29	1	.68	+	1.48	4.92E-01
regulation of synapse assembly (GO:0051963)	116	4	2.70	+	1.48	2.87E-01
protein demethylation (GO:0006482)	29	1	.68	+	1.48	4.92E-01
cellular response to external stimulus (GO:0071496)	232	8	5.41	+	1.48	1.78E-01
regulation of circadian sleep/wake cycle, sleep (GO:0045187)	29	1	.68	+	1.48	4.92E-01
regulation of DNA biosynthetic process (GO:2000278)	116	4	2.70	+	1.48	2.87E-01
negative regulation of leukocyte apoptotic process (GO:2000107)	58	2	1.35	+	1.48	3.92E-01
negative regulation of behavior (GO:0048521)	29	1	.68	+	1.48	4.92E-01
positive regulation of RNA metabolic process (GO:0051254)	1537	53	35.83	+	1.48	2.87E-03
negative regulation of cell killing (GO:0031342)	29	1	.68	+	1.48	4.92E-01
establishment of mitotic spindle orientation (GO:0000132)	29	1	.68	+	1.48	4.92E-01
positive regulation of long-term synaptic potentiation (GO:1900273)	29	1	.68	+	1.48	4.92E-01
autophagosome assembly (GO:0000045)	58	2	1.35	+	1.48	3.92E-01
positive regulation of protein import (GO:1904591)	58	2	1.35	+	1.48	3.92E-01
pteridine-containing compound metabolic process (GO:0042558)	29	1	.68	+	1.48	4.92E-01
regulation of telomere maintenance via telomere lengthening (GO:1904356)	58	2	1.35	+	1.48	3.92E-01
positive regulation of phospholipase C activity (GO:0010863)	29	1	.68	+	1.48	4.92E-01
regulation of cell size (GO:0008361)	203	7	4.73	+	1.48	1.99E-01
sphingolipid catabolic process (GO:0030149)	29	1	.68	+	1.48	4.92E-01
protein dealkylation (GO:0008214)	29	1	.68	+	1.48	4.92E-01
histone monoubiquitination (GO:0010390)	29	1	.68	+	1.48	4.92E-01
positive regulation of cartilage development (GO:0061036)	29	1	.68	+	1.48	4.92E-01
tissue development (GO:0009888)	1625	56	37.88	+	1.48	2.21E-03
embryonic organ morphogenesis (GO:0048562)	320	11	7.46	+	1.47	1.32E-01
positive regulation of nucleobase-containing compound metabolic process (GO:0045935)	1690	58	39.40	+	1.47	2.02E-03
regulation of epithelial cell differentiation (GO:0030856)	146	5	3.40	+	1.47	2.56E-01
regulation of cellular component organization (GO:0051128)	2338	80	54.50	+	1.47	2.83E-04
regulation of localization (GO:0032879)	2695	92	62.82	+	1.46	9.52E-05
regulation of oxidoreductase activity (GO:0051341)	88	3	2.05	+	1.46	3.37E-01
negative regulation of neuron apoptotic process (GO:0043524)	176	6	4.10	+	1.46	2.30E-01
negative regulation of hormone secretion (GO:0046888)	88	3	2.05	+	1.46	3.37E-01
positive regulation of response to biotic stimulus (GO:0002833)	147	5	3.43	+	1.46	2.60E-01
purine-containing compound metabolic process (GO:0072521)	294	10	6.85	+	1.46	1.53E-01
positive regulation of cellular metabolic process (GO:0031325)	2971	101	69.26	+	1.46	4.54E-05
regulation of secretion (GO:0051046)	706	24	16.46	+	1.46	4.42E-02
inner ear development (GO:0048839)	206	7	4.80	+	1.46	2.09E-01
positive regulation of nucleic acid-templated transcription (GO:1903508)	1442	49	33.61	+	1.46	5.43E-03
positive regulation of transcription, DNA-templated (GO:0045893)	1442	49	33.61	+	1.46	5.43E-03
microtubule cytoskeleton organization (GO:0000226)	471	16	10.98	+	1.46	8.87E-02
regulation of protein phosphorylation (GO:0001932)	1119	38	26.09	+	1.46	1.38E-02
positive regulation of RNA biosynthetic process (GO:1902680)	1443	49	33.64	+	1.46	5.50E-03
regulation of cytoskeleton organization (GO:0051493)	501	17	11.68	+	1.46	8.18E-02
response to osmotic stress (GO:0006970)	59	2	1.38	+	1.45	4.00E-01
regulation of epidermis development (GO:0045682)	59	2	1.38	+	1.45	4.00E-01
negative regulation of G1/S transition of mitotic cell cycle (GO:2000134)	59	2	1.38	+	1.45	4.00E-01
ear development (GO:0043583)	236	8	5.50	+	1.45	1.89E-01
regulation of DNA binding (GO:0051101)	118	4	2.75	+	1.45	2.97E-01
positive regulation of organ growth (GO:0046622)	59	2	1.38	+	1.45	4.00E-01
membrane invagination (GO:0010324)	59	2	1.38	+	1.45	4.00E-01
cell development (GO:0048468)	1682	57	39.21	+	1.45	2.90E-03
positive regulation of response to external stimulus (GO:0032103)	384	13	8.95	+	1.45	1.18E-01
positive regulation of response to stimulus (GO:0048584)	1951	66	45.48	+	1.45	1.39E-03
endocytosis (GO:0006897)	355	12	8.28	+	1.45	1.31E-01
reproductive structure development (GO:0048608)	445	15	10.37	+	1.45	1.02E-01
positive regulation of endothelial cell proliferation (GO:0001938)	89	3	2.07	+	1.45	3.44E-01
regulation of insulin secretion (GO:0050796)	178	6	4.15	+	1.45	2.38E-01
pigmentation (GO:0043473)	89	3	2.07	+	1.45	3.44E-01
in utero embryonic development (GO:0001701)	505	17	11.77	+	1.44	8.64E-02
response to inorganic substance (GO:0010035)	416	14	9.70	+	1.44	1.12E-01
response to drug (GO:0042493)	238	8	5.55	+	1.44	1.95E-01
vesicle localization (GO:0051648)	149	5	3.47	+	1.44	2.69E-01
transmembrane transport (GO:0055085)	894	30	20.84	+	1.44	3.09E-02
regulation of response to stimulus (GO:0048583)	3518	118	82.01	+	1.44	1.46E-05
negative regulation of cell activation (GO:0050866)	209	7	4.87	+	1.44	2.18E-01
animal organ development (GO:0048513)	3017	101	70.33	+	1.44	8.30E-05
ribonucleotide metabolic process (GO:0009259)	269	9	6.27	+	1.44	1.80E-01
cellular response to organic cyclic compound (GO:0071407)	359	12	8.37	+	1.43	1.38E-01
reproductive system development (GO:0061458)	449	15	10.47	+	1.43	1.07E-01
regulation of phosphate metabolic process (GO:0019220)	1437	48	33.50	+	1.43	8.02E-03
regulation of phosphorus metabolic process (GO:0051174)	1438	48	33.52	+	1.43	8.12E-03
cranial nerve morphogenesis (GO:0021602)	30	1	.70	+	1.43	5.03E-01
endochondral bone morphogenesis (GO:0060350)	60	2	1.40	+	1.43	4.08E-01
regulation of membrane repolarization (GO:0060306)	30	1	.70	+	1.43	5.03E-01
myelination in peripheral nervous system (GO:0022011)	30	1	.70	+	1.43	5.03E-01
postsynaptic membrane organization (GO:0001941)	30	1	.70	+	1.43	5.03E-01
terpenoid metabolic process (GO:0006721)	60	2	1.40	+	1.43	4.08E-01
positive regulation of gene silencing by miRNA (GO:2000637)	30	1	.70	+	1.43	5.03E-01
sphingolipid metabolic process (GO:0006665)	120	4	2.80	+	1.43	3.07E-01
cellular response to ionizing radiation (GO:0071479)	60	2	1.40	+	1.43	4.08E-01
regulation of translational initiation (GO:0006446)	60	2	1.40	+	1.43	4.08E-01
tricarboxylic acid cycle (GO:0006099)	30	1	.70	+	1.43	5.03E-01
positive regulation of filopodium assembly (GO:0051491)	30	1	.70	+	1.43	5.03E-01
peripheral nervous system axon ensheathment (GO:0032292)	30	1	.70	+	1.43	5.03E-01
defense response to fungus (GO:0050832)	30	1	.70	+	1.43	5.03E-01
ERK1 and ERK2 cascade (GO:0070371)	30	1	.70	+	1.43	5.03E-01
negative regulation of protein localization to membrane (GO:1905476)	30	1	.70	+	1.43	5.03E-01
regulation of potassium ion transmembrane transporter activity (GO:1901016)	60	2	1.40	+	1.43	4.08E-01
regulation of postsynaptic membrane neurotransmitter receptor levels (GO:0099072)	60	2	1.40	+	1.43	4.08E-01
xenobiotic transport (GO:0042908)	30	1	.70	+	1.43	5.03E-01
negative regulation of cardiac muscle tissue growth (GO:0055022)	30	1	.70	+	1.43	5.03E-01
hormone biosynthetic process (GO:0042446)	30	1	.70	+	1.43	5.03E-01
response to nicotine (GO:0035094)	30	1	.70	+	1.43	5.03E-01
C21-steroid hormone metabolic process (GO:0008207)	30	1	.70	+	1.43	5.03E-01
epithelial cilium movement involved in extracellular fluid movement (GO:0003351)	30	1	.70	+	1.43	5.03E-01
regulation of T-helper 1 type immune response (GO:0002825)	30	1	.70	+	1.43	5.03E-01
negative regulation of muscle contraction (GO:0045932)	30	1	.70	+	1.43	5.03E-01
negative regulation of heart growth (GO:0061117)	30	1	.70	+	1.43	5.03E-01
embryonic placenta morphogenesis (GO:0060669)	30	1	.70	+	1.43	5.03E-01
negative regulation of cartilage development (GO:0061037)	30	1	.70	+	1.43	5.03E-01
forebrain neuron differentiation (GO:0021879)	60	2	1.40	+	1.43	4.08E-01
excretion (GO:0007588)	30	1	.70	+	1.43	5.03E-01
organelle fission (GO:0048285)	300	10	6.99	+	1.43	1.67E-01
positive regulation of nitrogen compound metabolic process (GO:0051173)	2765	92	64.46	+	1.43	2.35E-04
negative regulation of response to external stimulus (GO:0032102)	362	12	8.44	+	1.42	1.44E-01
cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742)	181	6	4.22	+	1.42	2.49E-01
import into cell (GO:0098657)	181	6	4.22	+	1.42	2.49E-01
regulation of response to stress (GO:0080134)	1177	39	27.44	+	1.42	1.81E-02
regulation of secretion by cell (GO:1903530)	634	21	14.78	+	1.42	7.05E-02
cellular response to radiation (GO:0071478)	151	5	3.52	+	1.42	2.78E-01
ureteric bud development (GO:0001657)	91	3	2.12	+	1.41	3.56E-01
regulation of sodium ion transport (GO:0002028)	91	3	2.12	+	1.41	3.56E-01
negative regulation of leukocyte proliferation (GO:0070664)	91	3	2.12	+	1.41	3.56E-01
microtubule organizing center organization (GO:0031023)	91	3	2.12	+	1.41	3.56E-01
regulation of lipid biosynthetic process (GO:0046890)	182	6	4.24	+	1.41	2.53E-01
positive regulation of metabolic process (GO:0009893)	3428	113	79.91	+	1.41	5.13E-05
cell-cell signaling (GO:0007267)	789	26	18.39	+	1.41	5.06E-02
plasma membrane bounded cell projection assembly (GO:0120031)	334	11	7.79	+	1.41	1.62E-01
programmed cell death (GO:0012501)	820	27	19.12	+	1.41	4.74E-02
cilium assembly (GO:0060271)	243	8	5.66	+	1.41	2.10E-01
renal system development (GO:0072001)	304	10	7.09	+	1.41	1.77E-01
regulation of transcription by RNA polymerase II (GO:0006357)	2189	72	51.03	+	1.41	1.73E-03
cellular response to oxygen-containing compound (GO:1901701)	852	28	19.86	+	1.41	4.49E-02
microtubule-based process (GO:0007017)	701	23	16.34	+	1.41	6.56E-02
negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051)	61	2	1.42	+	1.41	4.16E-01
inner ear receptor cell development (GO:0060119)	61	2	1.42	+	1.41	4.16E-01
mesoderm formation (GO:0001707)	61	2	1.42	+	1.41	4.16E-01
inorganic anion transport (GO:0015698)	122	4	2.84	+	1.41	3.18E-01
regulation of wound healing (GO:0061041)	122	4	2.84	+	1.41	3.18E-01
defense response to symbiont (GO:0140546)	183	6	4.27	+	1.41	2.57E-01
defense response to virus (GO:0051607)	183	6	4.27	+	1.41	2.57E-01
cation transport (GO:0006812)	702	23	16.36	+	1.41	6.64E-02
positive regulation of cellular process (GO:0048522)	5193	170	121.05	+	1.40	2.13E-07
negative regulation of DNA-binding transcription factor activity (GO:0043433)	153	5	3.57	+	1.40	2.87E-01
positive regulation of multicellular organismal process (GO:0051240)	1500	49	34.97	+	1.40	1.10E-02
response to external stimulus (GO:0009605)	2021	66	47.11	+	1.40	3.24E-03
regulation of small molecule metabolic process (GO:0062012)	337	11	7.86	+	1.40	1.68E-01
mesonephric tubule development (GO:0072164)	92	3	2.14	+	1.40	3.63E-01
mesonephric epithelium development (GO:0072163)	92	3	2.14	+	1.40	3.63E-01
dorsal/ventral pattern formation (GO:0009953)	92	3	2.14	+	1.40	3.63E-01
axis specification (GO:0009798)	92	3	2.14	+	1.40	3.63E-01
postsynapse organization (GO:0099173)	92	3	2.14	+	1.40	3.63E-01
lymphocyte proliferation (GO:0046651)	92	3	2.14	+	1.40	3.63E-01
positive regulation of supramolecular fiber organization (GO:1902905)	184	6	4.29	+	1.40	2.61E-01
positive regulation of macromolecule metabolic process (GO:0010604)	3134	102	73.06	+	1.40	2.21E-04
regulation of biological quality (GO:0065008)	3754	122	87.51	+	1.39	4.27E-05
hormone metabolic process (GO:0042445)	154	5	3.59	+	1.39	2.91E-01
cellular component assembly (GO:0022607)	1880	61	43.83	+	1.39	5.35E-03
regulation of neurotransmitter levels (GO:0001505)	247	8	5.76	+	1.39	2.22E-01
cilium organization (GO:0044782)	278	9	6.48	+	1.39	2.05E-01
metal ion homeostasis (GO:0055065)	618	20	14.41	+	1.39	9.06E-02
response to cytokine (GO:0034097)	711	23	16.57	+	1.39	7.39E-02
regulation of phosphorylation (GO:0042325)	1268	41	29.56	+	1.39	2.22E-02
regulation of anion transport (GO:0044070)	867	28	20.21	+	1.39	5.35E-02
glial cell differentiation (GO:0010001)	186	6	4.34	+	1.38	2.69E-01
mononuclear cell proliferation (GO:0032943)	93	3	2.17	+	1.38	3.69E-01
regulation of interleukin-1 production (GO:0032652)	93	3	2.17	+	1.38	3.69E-01
regulation of protein localization to membrane (GO:1905475)	186	6	4.34	+	1.38	2.69E-01
inorganic ion transmembrane transport (GO:0098660)	465	15	10.84	+	1.38	1.32E-01
regulation of biomineral tissue development (GO:0070167)	93	3	2.17	+	1.38	3.69E-01
ribose phosphate metabolic process (GO:0019693)	279	9	6.50	+	1.38	2.07E-01
positive regulation of G protein-coupled receptor signaling pathway (GO:0045745)	31	1	.72	+	1.38	5.15E-01
vesicle targeting (GO:0006903)	31	1	.72	+	1.38	5.15E-01
negative regulation of myoblast differentiation (GO:0045662)	31	1	.72	+	1.38	5.15E-01
regulation of keratinocyte differentiation (GO:0045616)	31	1	.72	+	1.38	5.15E-01
regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393)	62	2	1.45	+	1.38	4.24E-01
endochondral ossification (GO:0001958)	31	1	.72	+	1.38	5.15E-01
heart looping (GO:0001947)	62	2	1.45	+	1.38	4.24E-01
adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189)	124	4	2.89	+	1.38	3.28E-01
positive regulation of posttranscriptional gene silencing (GO:0060148)	31	1	.72	+	1.38	5.15E-01
regulation of cell cycle checkpoint (GO:1901976)	31	1	.72	+	1.38	5.15E-01
positive regulation of receptor internalization (GO:0002092)	31	1	.72	+	1.38	5.15E-01
regulation of the force of heart contraction (GO:0002026)	31	1	.72	+	1.38	5.15E-01
regulation of glycogen biosynthetic process (GO:0005979)	31	1	.72	+	1.38	5.15E-01
ovarian follicle development (GO:0001541)	62	2	1.45	+	1.38	4.24E-01
regulation of interleukin-4 production (GO:0032673)	31	1	.72	+	1.38	5.15E-01
quinone metabolic process (GO:1901661)	31	1	.72	+	1.38	5.15E-01
positive regulation of cytokinesis (GO:0032467)	31	1	.72	+	1.38	5.15E-01
negative regulation of peptide hormone secretion (GO:0090278)	62	2	1.45	+	1.38	4.24E-01
regulation of protein processing (GO:0070613)	62	2	1.45	+	1.38	4.24E-01
positive regulation of lipid catabolic process (GO:0050996)	31	1	.72	+	1.38	5.15E-01
pigment cell differentiation (GO:0050931)	31	1	.72	+	1.38	5.15E-01
positive regulation of telomere maintenance via telomerase (GO:0032212)	31	1	.72	+	1.38	5.15E-01
bone growth (GO:0098868)	31	1	.72	+	1.38	5.15E-01
negative regulation of canonical Wnt signaling pathway (GO:0090090)	124	4	2.89	+	1.38	3.28E-01
lipopolysaccharide-mediated signaling pathway (GO:0031663)	31	1	.72	+	1.38	5.15E-01
endothelial cell migration (GO:0043542)	62	2	1.45	+	1.38	4.24E-01
blood vessel endothelial cell migration (GO:0043534)	31	1	.72	+	1.38	5.15E-01
mitotic cytokinesis (GO:0000281)	62	2	1.45	+	1.38	4.24E-01
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280)	124	4	2.89	+	1.38	3.28E-01
replacement ossification (GO:0036075)	31	1	.72	+	1.38	5.15E-01
ephrin receptor signaling pathway (GO:0048013)	31	1	.72	+	1.38	5.15E-01
regulation of glucan biosynthetic process (GO:0010962)	31	1	.72	+	1.38	5.15E-01
regulation of cholesterol efflux (GO:0010874)	31	1	.72	+	1.38	5.15E-01
regulation of type 2 immune response (GO:0002828)	31	1	.72	+	1.38	5.15E-01
cellular response to chemical stimulus (GO:0070887)	2235	72	52.10	+	1.38	2.92E-03
RNA processing (GO:0006396)	714	23	16.64	+	1.38	7.65E-02
cellular response to lipid (GO:0071396)	373	12	8.70	+	1.38	1.66E-01
urogenital system development (GO:0001655)	343	11	8.00	+	1.38	1.82E-01
pallium development (GO:0021543)	156	5	3.64	+	1.37	3.00E-01
negative regulation of lymphocyte activation (GO:0051250)	156	5	3.64	+	1.37	3.00E-01
negative regulation of immune system process (GO:0002683)	406	13	9.46	+	1.37	1.58E-01
positive regulation of lipid localization (GO:1905954)	125	4	2.91	+	1.37	3.33E-01
regulation of ossification (GO:0030278)	125	4	2.91	+	1.37	3.33E-01
steroid biosynthetic process (GO:0006694)	94	3	2.19	+	1.37	3.75E-01
response to hypoxia (GO:0001666)	188	6	4.38	+	1.37	2.77E-01
sensory perception of mechanical stimulus (GO:0050954)	188	6	4.38	+	1.37	2.77E-01
glucose homeostasis (GO:0042593)	188	6	4.38	+	1.37	2.77E-01
regulation of protein secretion (GO:0050708)	282	9	6.57	+	1.37	2.16E-01
organic hydroxy compound biosynthetic process (GO:1901617)	157	5	3.66	+	1.37	3.05E-01
positive regulation of biological process (GO:0048518)	5653	180	131.78	+	1.37	5.05E-07
regulation of peptide hormone secretion (GO:0090276)	220	7	5.13	+	1.36	2.56E-01
positive regulation of translation (GO:0045727)	126	4	2.94	+	1.36	3.39E-01
cerebellar cortex development (GO:0021695)	63	2	1.47	+	1.36	4.32E-01
carbohydrate homeostasis (GO:0033500)	189	6	4.41	+	1.36	2.81E-01
regulation of B cell activation (GO:0050864)	126	4	2.94	+	1.36	3.39E-01
autophagosome organization (GO:1905037)	63	2	1.47	+	1.36	4.32E-01
negative regulation of cell cycle G1/S phase transition (GO:1902807)	63	2	1.47	+	1.36	4.32E-01
developmental process involved in reproduction (GO:0003006)	914	29	21.31	+	1.36	5.98E-02
regulation of cysteine-type endopeptidase activity (GO:2000116)	221	7	5.15	+	1.36	2.60E-01
regulation of protein modification process (GO:0031399)	1484	47	34.59	+	1.36	2.07E-02
negative regulation of binding (GO:0051100)	158	5	3.68	+	1.36	3.09E-01
regulation of biomineralization (GO:0110149)	95	3	2.21	+	1.35	3.81E-01
spinal cord development (GO:0021510)	95	3	2.21	+	1.35	3.81E-01
mesonephros development (GO:0001823)	95	3	2.21	+	1.35	3.81E-01
microtubule bundle formation (GO:0001578)	95	3	2.21	+	1.35	3.81E-01
positive regulation of reproductive process (GO:2000243)	95	3	2.21	+	1.35	3.81E-01
positive regulation of apoptotic process (GO:0043065)	570	18	13.29	+	1.35	1.22E-01
DNA packaging (GO:0006323)	127	4	2.96	+	1.35	3.44E-01
regulation of animal organ morphogenesis (GO:2000027)	127	4	2.96	+	1.35	3.44E-01
regulation of peptidyl-tyrosine phosphorylation (GO:0050730)	254	8	5.92	+	1.35	2.44E-01
protein phosphorylation (GO:0006468)	636	20	14.83	+	1.35	1.11E-01
positive regulation of cation transmembrane transport (GO:1904064)	159	5	3.71	+	1.35	3.14E-01
cell projection assembly (GO:0030031)	350	11	8.16	+	1.35	1.98E-01
limb development (GO:0060173)	191	6	4.45	+	1.35	2.88E-01
appendage development (GO:0048736)	191	6	4.45	+	1.35	2.88E-01
anatomical structure maturation (GO:0071695)	223	7	5.20	+	1.35	2.67E-01
regulation of synaptic plasticity (GO:0048167)	223	7	5.20	+	1.35	2.67E-01
generation of precursor metabolites and energy (GO:0006091)	255	8	5.94	+	1.35	2.47E-01
regulation of peptide secretion (GO:0002791)	319	10	7.44	+	1.34	2.15E-01
regionalization (GO:0003002)	351	11	8.18	+	1.34	2.01E-01
establishment of localization in cell (GO:0051649)	1437	45	33.50	+	1.34	2.76E-02
epithelial tube branching involved in lung morphogenesis (GO:0060441)	32	1	.75	+	1.34	5.26E-01
regulation of toll-like receptor signaling pathway (GO:0034121)	64	2	1.49	+	1.34	4.40E-01
cell volume homeostasis (GO:0006884)	32	1	.75	+	1.34	5.26E-01
regulation of response to wounding (GO:1903034)	160	5	3.73	+	1.34	3.18E-01
nucleoside phosphate metabolic process (GO:0006753)	352	11	8.21	+	1.34	2.03E-01
myoblast differentiation (GO:0045445)	32	1	.75	+	1.34	5.26E-01
epithelial to mesenchymal transition (GO:0001837)	64	2	1.49	+	1.34	4.40E-01
regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229)	32	1	.75	+	1.34	5.26E-01
negative regulation of endothelial cell apoptotic process (GO:2000352)	32	1	.75	+	1.34	5.26E-01
protein palmitoylation (GO:0018345)	32	1	.75	+	1.34	5.26E-01
regulation of transcription by RNA polymerase I (GO:0006356)	32	1	.75	+	1.34	5.26E-01
cell-cell fusion (GO:0140253)	32	1	.75	+	1.34	5.26E-01
maintenance of protein location in cell (GO:0032507)	64	2	1.49	+	1.34	4.40E-01
actin filament capping (GO:0051693)	32	1	.75	+	1.34	5.26E-01
cellular response to mechanical stimulus (GO:0071260)	32	1	.75	+	1.34	5.26E-01
positive regulation of cAMP-mediated signaling (GO:0043950)	32	1	.75	+	1.34	5.26E-01
syncytium formation by plasma membrane fusion (GO:0000768)	32	1	.75	+	1.34	5.26E-01
regulation of lipid catabolic process (GO:0050994)	64	2	1.49	+	1.34	4.40E-01
spliceosomal snRNP assembly (GO:0000387)	32	1	.75	+	1.34	5.26E-01
serine family amino acid metabolic process (GO:0009069)	32	1	.75	+	1.34	5.26E-01
negative regulation of cardiac muscle cell apoptotic process (GO:0010667)	32	1	.75	+	1.34	5.26E-01
digestive system process (GO:0022600)	64	2	1.49	+	1.34	4.40E-01
plasma membrane organization (GO:0007009)	96	3	2.24	+	1.34	3.88E-01
receptor metabolic process (GO:0043112)	96	3	2.24	+	1.34	3.88E-01
negative regulation of cellular process (GO:0048523)	4513	141	105.20	+	1.34	5.76E-05
localization (GO:0051179)	4489	140	104.64	+	1.34	6.81E-05
negative regulation of cell cycle (GO:0045786)	385	12	8.97	+	1.34	1.92E-01
regulation of organelle organization (GO:0033043)	1124	35	26.20	+	1.34	5.17E-02
regulation of cell population proliferation (GO:0042127)	1639	51	38.21	+	1.33	2.18E-02
posttranscriptional regulation of gene expression (GO:0010608)	418	13	9.74	+	1.33	1.82E-01
negative regulation of cell growth (GO:0030308)	193	6	4.50	+	1.33	2.96E-01
cellular component biogenesis (GO:0044085)	2092	65	48.77	+	1.33	1.03E-02
regulation of translation (GO:0006417)	322	10	7.51	+	1.33	2.23E-01
cellular cation homeostasis (GO:0030003)	613	19	14.29	+	1.33	1.30E-01
cellular chemical homeostasis (GO:0055082)	710	22	16.55	+	1.33	1.10E-01
positive regulation of interleukin-6 production (GO:0032755)	97	3	2.26	+	1.33	3.94E-01
response to decreased oxygen levels (GO:0036293)	194	6	4.52	+	1.33	3.00E-01
carbohydrate biosynthetic process (GO:0016051)	97	3	2.26	+	1.33	3.94E-01
establishment of organelle localization (GO:0051656)	324	10	7.55	+	1.32	2.28E-01
positive regulation of programmed cell death (GO:0043068)	584	18	13.61	+	1.32	1.43E-01
regulation of cellular biosynthetic process (GO:0031326)	3473	107	80.96	+	1.32	1.11E-03
negative regulation of cellular metabolic process (GO:0031324)	2307	71	53.78	+	1.32	9.06E-03
SMAD protein signal transduction (GO:0060395)	65	2	1.52	+	1.32	4.48E-01
vesicle cytoskeletal trafficking (GO:0099518)	65	2	1.52	+	1.32	4.48E-01
mesoderm morphogenesis (GO:0048332)	65	2	1.52	+	1.32	4.48E-01
regulation of cardiac muscle contraction (GO:0055117)	65	2	1.52	+	1.32	4.48E-01
regulation of protein maturation (GO:1903317)	65	2	1.52	+	1.32	4.48E-01
regulation of nucleobase-containing compound metabolic process (GO:0019219)	3320	102	77.39	+	1.32	1.65E-03
negative regulation of nitrogen compound metabolic process (GO:0051172)	2116	65	49.33	+	1.32	1.30E-02
regulation of RNA metabolic process (GO:0051252)	3100	95	72.26	+	1.31	2.68E-03
negative regulation of macromolecule metabolic process (GO:0010605)	2480	76	57.81	+	1.31	7.64E-03
positive regulation of cell death (GO:0010942)	653	20	15.22	+	1.31	1.33E-01
cellular response to light stimulus (GO:0071482)	98	3	2.28	+	1.31	4.00E-01
regulation of reactive oxygen species metabolic process (GO:2000377)	196	6	4.57	+	1.31	3.08E-01
regulation of lipid localization (GO:1905952)	196	6	4.57	+	1.31	3.08E-01
regulation of mRNA splicing, via spliceosome (GO:0048024)	98	3	2.28	+	1.31	4.00E-01
organ growth (GO:0035265)	98	3	2.28	+	1.31	4.00E-01
regulation of hormone levels (GO:0010817)	523	16	12.19	+	1.31	1.67E-01
regulation of endothelial cell proliferation (GO:0001936)	131	4	3.05	+	1.31	3.65E-01
regulation of transcription, DNA-templated (GO:0006355)	2852	87	66.48	+	1.31	4.75E-03
regulation of lipid transport (GO:0032368)	164	5	3.82	+	1.31	3.36E-01
detection of stimulus involved in sensory perception (GO:0050906)	164	5	3.82	+	1.31	3.36E-01
regulation of cellular macromolecule biosynthetic process (GO:2000112)	3280	100	76.46	+	1.31	2.36E-03
regulation of biosynthetic process (GO:0009889)	3545	108	82.64	+	1.31	1.53E-03
regulation of nucleic acid-templated transcription (GO:1903506)	2856	87	66.58	+	1.31	4.94E-03
regulation of RNA biosynthetic process (GO:2001141)	2859	87	66.65	+	1.31	5.08E-03
negative regulation of metabolic process (GO:0009892)	2728	83	63.59	+	1.31	6.29E-03
detection of stimulus (GO:0051606)	263	8	6.13	+	1.30	2.73E-01
regulation of neuron apoptotic process (GO:0043523)	263	8	6.13	+	1.30	2.73E-01
response to chemical (GO:0042221)	3266	99	76.13	+	1.30	2.99E-03
negative regulation of Notch signaling pathway (GO:0045746)	33	1	.77	+	1.30	5.37E-01
extracellular transport (GO:0006858)	33	1	.77	+	1.30	5.37E-01
female gamete generation (GO:0007292)	132	4	3.08	+	1.30	3.70E-01
regulation of mitotic spindle organization (GO:0060236)	33	1	.77	+	1.30	5.37E-01
NADP metabolic process (GO:0006739)	33	1	.77	+	1.30	5.37E-01
blastocyst hatching (GO:0001835)	33	1	.77	+	1.30	5.37E-01
organism emergence from protective structure (GO:0071684)	33	1	.77	+	1.30	5.37E-01
vacuolar transport (GO:0007034)	132	4	3.08	+	1.30	3.70E-01
gastrulation with mouth forming second (GO:0001702)	33	1	.77	+	1.30	5.37E-01
positive regulation of T cell migration (GO:2000406)	33	1	.77	+	1.30	5.37E-01
Schwann cell development (GO:0014044)	33	1	.77	+	1.30	5.37E-01
regulation of axon extension involved in axon guidance (GO:0048841)	33	1	.77	+	1.30	5.37E-01
establishment of mitotic spindle localization (GO:0040001)	33	1	.77	+	1.30	5.37E-01
positive regulation of cell cycle arrest (GO:0071158)	33	1	.77	+	1.30	5.37E-01
positive regulation of cholesterol transport (GO:0032376)	33	1	.77	+	1.30	5.37E-01
positive regulation of sterol transport (GO:0032373)	33	1	.77	+	1.30	5.37E-01
regulation of axon regeneration (GO:0048679)	33	1	.77	+	1.30	5.37E-01
centrosome duplication (GO:0051298)	33	1	.77	+	1.30	5.37E-01
maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)	33	1	.77	+	1.30	5.37E-01
regulation of smooth muscle cell differentiation (GO:0051150)	33	1	.77	+	1.30	5.37E-01
regulation of phospholipase C activity (GO:1900274)	33	1	.77	+	1.30	5.37E-01
cytoplasmic microtubule organization (GO:0031122)	66	2	1.54	+	1.30	4.55E-01
hair follicle morphogenesis (GO:0031069)	33	1	.77	+	1.30	5.37E-01
hatching (GO:0035188)	33	1	.77	+	1.30	5.37E-01
steroid metabolic process (GO:0008202)	231	7	5.38	+	1.30	2.95E-01
regulation of cilium movement (GO:0003352)	33	1	.77	+	1.30	5.37E-01
membrane lipid catabolic process (GO:0046466)	33	1	.77	+	1.30	5.37E-01
regulation of inflammatory response to antigenic stimulus (GO:0002861)	33	1	.77	+	1.30	5.37E-01
regulation of TORC1 signaling (GO:1903432)	33	1	.77	+	1.30	5.37E-01
monosaccharide biosynthetic process (GO:0046364)	33	1	.77	+	1.30	5.37E-01
negative regulation of cellular response to growth factor stimulus (GO:0090288)	99	3	2.31	+	1.30	4.06E-01
limb morphogenesis (GO:0035108)	165	5	3.85	+	1.30	3.41E-01
appendage morphogenesis (GO:0035107)	165	5	3.85	+	1.30	3.41E-01
protein localization to membrane (GO:0072657)	429	13	10.00	+	1.30	2.06E-01
cellular ion homeostasis (GO:0006873)	628	19	14.64	+	1.30	1.52E-01
regulation of epithelial cell proliferation (GO:0050678)	364	11	8.49	+	1.30	2.33E-01
response to light stimulus (GO:0009416)	298	9	6.95	+	1.30	2.63E-01
regulation of macromolecule biosynthetic process (GO:0010556)	3312	100	77.21	+	1.30	3.19E-03
positive regulation of cell population proliferation (GO:0008284)	961	29	22.40	+	1.29	9.61E-02
regulation of exocytosis (GO:0017157)	232	7	5.41	+	1.29	2.99E-01
bone development (GO:0060348)	199	6	4.64	+	1.29	3.21E-01
positive regulation of cytoskeleton organization (GO:0051495)	199	6	4.64	+	1.29	3.21E-01
regulation of protein localization to cell periphery (GO:1904375)	133	4	3.10	+	1.29	3.75E-01
muscle organ development (GO:0007517)	266	8	6.20	+	1.29	2.83E-01
positive regulation of gene expression (GO:0010628)	2164	65	50.45	+	1.29	2.01E-02
negative regulation of extrinsic apoptotic signaling pathway (GO:2001237)	100	3	2.33	+	1.29	4.12E-01
positive regulation of histone modification (GO:0031058)	100	3	2.33	+	1.29	4.12E-01
response to oxygen-containing compound (GO:1901700)	1234	37	28.77	+	1.29	7.15E-02
negative regulation of biological process (GO:0048519)	4936	148	115.06	+	1.29	2.65E-04
organic substance transport (GO:0071702)	1771	53	41.28	+	1.28	3.65E-02
cellular response to organic substance (GO:0071310)	1706	51	39.77	+	1.28	4.05E-02
regulation of smooth muscle contraction (GO:0006940)	67	2	1.56	+	1.28	4.63E-01
positive regulation of calcium ion transport (GO:0051928)	134	4	3.12	+	1.28	3.81E-01
regulation of signal transduction by p53 class mediator (GO:1901796)	67	2	1.56	+	1.28	4.63E-01
receptor internalization (GO:0031623)	67	2	1.56	+	1.28	4.63E-01
embryonic digit morphogenesis (GO:0042733)	67	2	1.56	+	1.28	4.63E-01
ear morphogenesis (GO:0042471)	134	4	3.12	+	1.28	3.81E-01
determination of heart left/right asymmetry (GO:0061371)	67	2	1.56	+	1.28	4.63E-01
response to insulin (GO:0032868)	168	5	3.92	+	1.28	3.55E-01
cellular component organization (GO:0016043)	4606	137	107.37	+	1.28	7.34E-04
sex differentiation (GO:0007548)	269	8	6.27	+	1.28	2.93E-01
regulation of ion transport (GO:0043269)	1312	39	30.58	+	1.28	7.23E-02
positive regulation of DNA metabolic process (GO:0051054)	202	6	4.71	+	1.27	3.33E-01
feeding behavior (GO:0007631)	101	3	2.35	+	1.27	4.19E-01
negative regulation of transport (GO:0051051)	472	14	11.00	+	1.27	2.17E-01
muscle structure development (GO:0061061)	472	14	11.00	+	1.27	2.17E-01
vacuole organization (GO:0007033)	135	4	3.15	+	1.27	3.86E-01
regulation of nuclear division (GO:0051783)	135	4	3.15	+	1.27	3.86E-01
regulation of mRNA processing (GO:0050684)	135	4	3.15	+	1.27	3.86E-01
lipid catabolic process (GO:0016042)	270	8	6.29	+	1.27	2.97E-01
stem cell population maintenance (GO:0019827)	135	4	3.15	+	1.27	3.86E-01
anion transport (GO:0006820)	1867	55	43.52	+	1.26	4.29E-02
syncytium formation (GO:0006949)	34	1	.79	+	1.26	5.48E-01
endoderm formation (GO:0001706)	34	1	.79	+	1.26	5.48E-01
glycerolipid biosynthetic process (GO:0045017)	136	4	3.17	+	1.26	3.91E-01
cytokinetic process (GO:0032506)	34	1	.79	+	1.26	5.48E-01
positive regulation of lipid transport (GO:0032370)	102	3	2.38	+	1.26	4.25E-01
regulation of nitric-oxide synthase activity (GO:0050999)	34	1	.79	+	1.26	5.48E-01
negative regulation of telomere maintenance (GO:0032205)	34	1	.79	+	1.26	5.48E-01
triglyceride homeostasis (GO:0070328)	34	1	.79	+	1.26	5.48E-01
maturation of 5.8S rRNA (GO:0000460)	34	1	.79	+	1.26	5.48E-01
positive regulation of protein localization to membrane (GO:1905477)	102	3	2.38	+	1.26	4.25E-01
actin cytoskeleton reorganization (GO:0031532)	68	2	1.59	+	1.26	4.71E-01
detection of biotic stimulus (GO:0009595)	34	1	.79	+	1.26	5.48E-01
mRNA transport (GO:0051028)	102	3	2.38	+	1.26	4.25E-01
exploration behavior (GO:0035640)	34	1	.79	+	1.26	5.48E-01
mitotic sister chromatid segregation (GO:0000070)	102	3	2.38	+	1.26	4.25E-01
acylglycerol homeostasis (GO:0055090)	34	1	.79	+	1.26	5.48E-01
cardiac muscle tissue growth (GO:0055017)	34	1	.79	+	1.26	5.48E-01
negative regulation of cell cycle process (GO:0010948)	204	6	4.76	+	1.26	3.41E-01
antigen processing and presentation of exogenous antigen (GO:0019884)	34	1	.79	+	1.26	5.48E-01
negative regulation of secretion by cell (GO:1903531)	170	5	3.96	+	1.26	3.64E-01
wound healing (GO:0042060)	238	7	5.55	+	1.26	3.21E-01
regulation of epidermal growth factor receptor signaling pathway (GO:0042058)	68	2	1.59	+	1.26	4.71E-01
negative regulation of DNA recombination (GO:0045910)	34	1	.79	+	1.26	5.48E-01
cell junction maintenance (GO:0034331)	34	1	.79	+	1.26	5.48E-01
establishment of endothelial barrier (GO:0061028)	34	1	.79	+	1.26	5.48E-01
cellular response to abiotic stimulus (GO:0071214)	239	7	5.57	+	1.26	3.25E-01
cellular response to environmental stimulus (GO:0104004)	239	7	5.57	+	1.26	3.25E-01
cellular component organization or biogenesis (GO:0071840)	4788	140	111.61	+	1.25	1.29E-03
potassium ion transmembrane transport (GO:0071805)	137	4	3.19	+	1.25	3.96E-01
ion transport (GO:0006811)	2398	70	55.90	+	1.25	2.81E-02
nucleotide metabolic process (GO:0009117)	343	10	8.00	+	1.25	2.82E-01
olefinic compound metabolic process (GO:0120254)	103	3	2.40	+	1.25	4.31E-01
inorganic cation transmembrane transport (GO:0098662)	412	12	9.60	+	1.25	2.57E-01
regulation of cellular metabolic process (GO:0031323)	5255	153	122.50	+	1.25	7.93E-04
carbohydrate metabolic process (GO:0005975)	378	11	8.81	+	1.25	2.70E-01
regulation of cellular amide metabolic process (GO:0034248)	378	11	8.81	+	1.25	2.70E-01
pattern specification process (GO:0007389)	447	13	10.42	+	1.25	2.48E-01
cellular response to nutrient levels (GO:0031669)	172	5	4.01	+	1.25	3.73E-01
response to hormone (GO:0009725)	551	16	12.84	+	1.25	2.20E-01
ribonucleoprotein complex biogenesis (GO:0022613)	379	11	8.83	+	1.25	2.73E-01
regulation of cellular protein metabolic process (GO:0032268)	2207	64	51.45	+	1.24	3.95E-02
embryonic skeletal system development (GO:0048706)	138	4	3.22	+	1.24	4.01E-01
proteoglycan metabolic process (GO:0006029)	69	2	1.61	+	1.24	4.78E-01
maintenance of cell number (GO:0098727)	138	4	3.22	+	1.24	4.01E-01
cardiac muscle tissue morphogenesis (GO:0055008)	69	2	1.61	+	1.24	4.78E-01
intracellular transport (GO:0046907)	1104	32	25.74	+	1.24	1.22E-01
embryonic heart tube morphogenesis (GO:0003143)	69	2	1.61	+	1.24	4.78E-01
transport (GO:0006810)	3209	93	74.81	+	1.24	1.37E-02
cation homeostasis (GO:0055080)	691	20	16.11	+	1.24	1.91E-01
negative regulation of anion transport (GO:1903792)	242	7	5.64	+	1.24	3.36E-01
cellular homeostasis (GO:0019725)	830	24	19.35	+	1.24	1.66E-01
regulation of nitrogen compound metabolic process (GO:0051171)	4880	141	113.76	+	1.24	2.00E-03
regulation of primary metabolic process (GO:0080090)	5054	146	117.81	+	1.24	1.59E-03
positive regulation of organelle organization (GO:0010638)	554	16	12.91	+	1.24	2.26E-01
regulation of mitotic nuclear division (GO:0007088)	104	3	2.42	+	1.24	4.37E-01
negative regulation of leukocyte differentiation (GO:1902106)	104	3	2.42	+	1.24	4.37E-01
regulation of protein-containing complex assembly (GO:0043254)	416	12	9.70	+	1.24	2.68E-01
positive regulation of neuron projection development (GO:0010976)	208	6	4.85	+	1.24	3.57E-01
organophosphate ester transport (GO:0015748)	104	3	2.42	+	1.24	4.37E-01
reproductive process (GO:0022414)	1318	38	30.72	+	1.24	1.05E-01
regulation of gene expression (GO:0010468)	4130	119	96.28	+	1.24	5.76E-03
reproduction (GO:0000003)	1319	38	30.75	+	1.24	1.05E-01
embryonic limb morphogenesis (GO:0030326)	139	4	3.24	+	1.23	4.07E-01
embryonic appendage morphogenesis (GO:0035113)	139	4	3.24	+	1.23	4.07E-01
positive regulation of chromosome organization (GO:2001252)	174	5	4.06	+	1.23	3.82E-01
phosphorylation (GO:0016310)	873	25	20.35	+	1.23	1.72E-01
establishment of localization (GO:0051234)	3355	96	78.21	+	1.23	1.69E-02
multicellular organismal process (GO:0032501)	6893	197	160.68	+	1.23	1.89E-04
endoderm development (GO:0007492)	70	2	1.63	+	1.23	4.86E-01
membrane protein proteolysis (GO:0033619)	35	1	.82	+	1.23	5.58E-01
cartilage development involved in endochondral bone morphogenesis (GO:0060351)	35	1	.82	+	1.23	5.58E-01
receptor signaling pathway via JAK-STAT (GO:0007259)	35	1	.82	+	1.23	5.58E-01
leukocyte mediated cytotoxicity (GO:0001909)	35	1	.82	+	1.23	5.58E-01
prostaglandin metabolic process (GO:0006693)	35	1	.82	+	1.23	5.58E-01
prostanoid metabolic process (GO:0006692)	35	1	.82	+	1.23	5.58E-01
protein targeting to vacuole (GO:0006623)	35	1	.82	+	1.23	5.58E-01
lysosome organization (GO:0007040)	70	2	1.63	+	1.23	4.86E-01
signal transduction in absence of ligand (GO:0038034)	35	1	.82	+	1.23	5.58E-01
regulation of DNA replication (GO:0006275)	105	3	2.45	+	1.23	4.43E-01
homeostasis of number of cells (GO:0048872)	280	8	6.53	+	1.23	3.31E-01
artery morphogenesis (GO:0048844)	70	2	1.63	+	1.23	4.86E-01
regulation of meiotic nuclear division (GO:0040020)	35	1	.82	+	1.23	5.58E-01
oligodendrocyte differentiation (GO:0048709)	70	2	1.63	+	1.23	4.86E-01
positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482)	35	1	.82	+	1.23	5.58E-01
axon extension (GO:0048675)	35	1	.82	+	1.23	5.58E-01
response to oxygen levels (GO:0070482)	210	6	4.90	+	1.23	3.66E-01
B cell receptor signaling pathway (GO:0050853)	35	1	.82	+	1.23	5.58E-01
regulation of long-term neuronal synaptic plasticity (GO:0048169)	35	1	.82	+	1.23	5.58E-01
negative regulation of fibroblast proliferation (GO:0048147)	35	1	.82	+	1.23	5.58E-01
regulation of tyrosine phosphorylation of STAT protein (GO:0042509)	70	2	1.63	+	1.23	4.86E-01
regulation of heart rate by cardiac conduction (GO:0086091)	35	1	.82	+	1.23	5.58E-01
negative regulation of protein dephosphorylation (GO:0035308)	35	1	.82	+	1.23	5.58E-01
positive regulation of nucleocytoplasmic transport (GO:0046824)	70	2	1.63	+	1.23	4.86E-01
positive regulation of telomere maintenance via telomere lengthening (GO:1904358)	35	1	.82	+	1.23	5.58E-01
cellular modified amino acid biosynthetic process (GO:0042398)	35	1	.82	+	1.23	5.58E-01
viral entry into host cell (GO:0046718)	35	1	.82	+	1.23	5.58E-01
embryonic hindlimb morphogenesis (GO:0035116)	35	1	.82	+	1.23	5.58E-01
negative regulation of striated muscle cell apoptotic process (GO:0010664)	35	1	.82	+	1.23	5.58E-01
negative regulation of T cell proliferation (GO:0042130)	70	2	1.63	+	1.23	4.86E-01
extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192)	35	1	.82	+	1.23	5.58E-01
dendritic cell differentiation (GO:0097028)	35	1	.82	+	1.23	5.58E-01
negative regulation of production of molecular mediator of immune response (GO:0002701)	35	1	.82	+	1.23	5.58E-01
forebrain neuron development (GO:0021884)	35	1	.82	+	1.23	5.58E-01
regulation of regulated secretory pathway (GO:1903305)	175	5	4.08	+	1.23	3.87E-01
lytic vacuole organization (GO:0080171)	70	2	1.63	+	1.23	4.86E-01
response to organic substance (GO:0010033)	2382	68	55.53	+	1.22	4.52E-02
lipid metabolic process (GO:0006629)	1051	30	24.50	+	1.22	1.49E-01
response to organic cyclic compound (GO:0014070)	597	17	13.92	+	1.22	2.34E-01
inorganic ion homeostasis (GO:0098771)	704	20	16.41	+	1.22	2.14E-01
negative regulation of establishment of protein localization (GO:1904950)	141	4	3.29	+	1.22	4.17E-01
regulation of macromolecule metabolic process (GO:0060255)	5432	154	126.63	+	1.22	2.46E-03
multi-organism reproductive process (GO:0044703)	882	25	20.56	+	1.22	1.84E-01
response to extracellular stimulus (GO:0009991)	353	10	8.23	+	1.22	3.11E-01
negative regulation of hemopoiesis (GO:1903707)	106	3	2.47	+	1.21	4.49E-01
regulation of metabolic process (GO:0019222)	5906	167	137.68	+	1.21	1.57E-03
regulation of protein metabolic process (GO:0051246)	2370	67	55.25	+	1.21	5.50E-02
nitrogen compound transport (GO:0071705)	1452	41	33.85	+	1.21	1.18E-01
vesicle-mediated transport (GO:0016192)	1063	30	24.78	+	1.21	1.64E-01
RNA transport (GO:0050658)	142	4	3.31	+	1.21	4.22E-01
nucleic acid transport (GO:0050657)	142	4	3.31	+	1.21	4.22E-01
epithelial cell differentiation (GO:0030855)	497	14	11.59	+	1.21	2.74E-01
ubiquitin-dependent ERAD pathway (GO:0030433)	71	2	1.66	+	1.21	4.93E-01
negative regulation of cellular protein catabolic process (GO:1903363)	71	2	1.66	+	1.21	4.93E-01
regulation of cellular protein localization (GO:1903827)	533	15	12.42	+	1.21	2.65E-01
regulation of cell cycle process (GO:0010564)	569	16	13.26	+	1.21	2.58E-01
regulation of transport (GO:0051049)	1779	50	41.47	+	1.21	9.69E-02
second-messenger-mediated signaling (GO:0019932)	285	8	6.64	+	1.20	3.48E-01
protein localization to cell junction (GO:1902414)	107	3	2.49	+	1.20	4.55E-01
regulation of interferon-gamma production (GO:0032649)	107	3	2.49	+	1.20	4.55E-01
positive regulation of innate immune response (GO:0045089)	107	3	2.49	+	1.20	4.55E-01
response to radiation (GO:0009314)	394	11	9.18	+	1.20	3.15E-01
multi-organism process (GO:0051704)	899	25	20.96	+	1.19	2.10E-01
macromolecule localization (GO:0033036)	2195	61	51.17	+	1.19	8.44E-02
receptor-mediated endocytosis (GO:0006898)	144	4	3.36	+	1.19	4.32E-01
plasma lipoprotein particle organization (GO:0071827)	36	1	.84	+	1.19	5.68E-01
activation of JUN kinase activity (GO:0007257)	36	1	.84	+	1.19	5.68E-01
icosanoid transport (GO:0071715)	36	1	.84	+	1.19	5.68E-01
activation of innate immune response (GO:0002218)	36	1	.84	+	1.19	5.68E-01
cellular glucose homeostasis (GO:0001678)	72	2	1.68	+	1.19	5.00E-01
regulation of actin cytoskeleton reorganization (GO:2000249)	36	1	.84	+	1.19	5.68E-01
entry into host (GO:0044409)	36	1	.84	+	1.19	5.68E-01
regulation of stem cell population maintenance (GO:2000036)	36	1	.84	+	1.19	5.68E-01
telomere maintenance (GO:0000723)	72	2	1.68	+	1.19	5.00E-01
telomere organization (GO:0032200)	72	2	1.68	+	1.19	5.00E-01
positive regulation of calcium-mediated signaling (GO:0050850)	36	1	.84	+	1.19	5.68E-01
establishment of RNA localization (GO:0051236)	144	4	3.36	+	1.19	4.32E-01
positive regulation of purine nucleotide metabolic process (GO:1900544)	36	1	.84	+	1.19	5.68E-01
regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079)	72	2	1.68	+	1.19	5.00E-01
receptor signaling pathway via STAT (GO:0097696)	36	1	.84	+	1.19	5.68E-01
positive regulation of BMP signaling pathway (GO:0030513)	36	1	.84	+	1.19	5.68E-01
regulation of cardiac muscle cell contraction (GO:0086004)	36	1	.84	+	1.19	5.68E-01
protein localization to lysosome (GO:0061462)	36	1	.84	+	1.19	5.68E-01
cAMP-mediated signaling (GO:0019933)	144	4	3.36	+	1.19	4.32E-01
sphingolipid biosynthetic process (GO:0030148)	72	2	1.68	+	1.19	5.00E-01
regulation of double-strand break repair via homologous recombination (GO:0010569)	36	1	.84	+	1.19	5.68E-01
icosanoid biosynthetic process (GO:0046456)	36	1	.84	+	1.19	5.68E-01
positive regulation of nucleotide metabolic process (GO:0045981)	36	1	.84	+	1.19	5.68E-01
negative regulation of reactive oxygen species biosynthetic process (GO:1903427)	36	1	.84	+	1.19	5.68E-01
placenta blood vessel development (GO:0060674)	36	1	.84	+	1.19	5.68E-01
forebrain generation of neurons (GO:0021872)	72	2	1.68	+	1.19	5.00E-01
cell differentiation involved in kidney development (GO:0061005)	36	1	.84	+	1.19	5.68E-01
transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178)	180	5	4.20	+	1.19	4.10E-01
cellular respiration (GO:0045333)	108	3	2.52	+	1.19	4.61E-01
regulation of sequestering of calcium ion (GO:0051282)	108	3	2.52	+	1.19	4.61E-01
regulation of inflammatory response (GO:0050727)	324	9	7.55	+	1.19	3.45E-01
cytoskeleton-dependent intracellular transport (GO:0030705)	180	5	4.20	+	1.19	4.10E-01
antimicrobial humoral response (GO:0019730)	108	3	2.52	+	1.19	4.61E-01
microtubule-based transport (GO:0099111)	181	5	4.22	+	1.19	4.14E-01
regulation of protein localization (GO:0032880)	869	24	20.26	+	1.18	2.25E-01
epidermal cell differentiation (GO:0009913)	145	4	3.38	+	1.18	4.38E-01
membrane organization (GO:0061024)	581	16	13.54	+	1.18	2.84E-01
cerebral cortex development (GO:0021987)	109	3	2.54	+	1.18	4.67E-01
spermatogenesis (GO:0007283)	473	13	11.03	+	1.18	3.13E-01
regulation of cell death (GO:0010941)	1602	44	37.34	+	1.18	1.46E-01
regulation of calcium-mediated signaling (GO:0050848)	73	2	1.70	+	1.18	5.08E-01
regulation of ERBB signaling pathway (GO:1901184)	73	2	1.70	+	1.18	5.08E-01
regulation of protein import into nucleus (GO:0042306)	73	2	1.70	+	1.18	5.08E-01
cellular response to unfolded protein (GO:0034620)	73	2	1.70	+	1.18	5.08E-01
cellular ketone metabolic process (GO:0042180)	73	2	1.70	+	1.18	5.08E-01
negative regulation of DNA metabolic process (GO:0051053)	110	3	2.56	+	1.17	4.73E-01
cholesterol metabolic process (GO:0008203)	110	3	2.56	+	1.17	4.73E-01
cellular response to starvation (GO:0009267)	147	4	3.43	+	1.17	4.48E-01
positive regulation of secretion by cell (GO:1903532)	331	9	7.72	+	1.17	3.68E-01
cell fate commitment (GO:0045165)	258	7	6.01	+	1.16	3.96E-01
positive regulation of cellular protein localization (GO:1903829)	258	7	6.01	+	1.16	3.96E-01
multicellular organismal reproductive process (GO:0048609)	738	20	17.20	+	1.16	2.77E-01
nucleobase-containing small molecule metabolic process (GO:0055086)	406	11	9.46	+	1.16	3.50E-01
regulation of cellular localization (GO:0060341)	813	22	18.95	+	1.16	2.67E-01
regulation of response to external stimulus (GO:0032101)	850	23	19.81	+	1.16	2.61E-01
cerebral cortex radially oriented cell migration (GO:0021799)	37	1	.86	+	1.16	5.78E-01
glial cell development (GO:0021782)	111	3	2.59	+	1.16	4.79E-01
heart growth (GO:0060419)	37	1	.86	+	1.16	5.78E-01
antigen processing and presentation of peptide antigen via MHC class I (GO:0002474)	37	1	.86	+	1.16	5.78E-01
positive regulation of gliogenesis (GO:0014015)	74	2	1.73	+	1.16	5.15E-01
regulation of glycogen metabolic process (GO:0070873)	37	1	.86	+	1.16	5.78E-01
heterochromatin organization (GO:0070828)	37	1	.86	+	1.16	5.78E-01
regulation of amyloid-beta formation (GO:1902003)	37	1	.86	+	1.16	5.78E-01
regulation of spindle organization (GO:0090224)	37	1	.86	+	1.16	5.78E-01
mitotic nuclear division (GO:0140014)	148	4	3.45	+	1.16	4.53E-01
regulation of voltage-gated calcium channel activity (GO:1901385)	37	1	.86	+	1.16	5.78E-01
proximal/distal pattern formation (GO:0009954)	37	1	.86	+	1.16	5.78E-01
regulation of neuron projection regeneration (GO:0070570)	37	1	.86	+	1.16	5.78E-01
regulation of steroid biosynthetic process (GO:0050810)	74	2	1.73	+	1.16	5.15E-01
G1/S transition of mitotic cell cycle (GO:0000082)	74	2	1.73	+	1.16	5.15E-01
positive regulation of G1/S transition of mitotic cell cycle (GO:1900087)	37	1	.86	+	1.16	5.78E-01
response to cadmium ion (GO:0046686)	37	1	.86	+	1.16	5.78E-01
regulation of sprouting angiogenesis (GO:1903670)	37	1	.86	+	1.16	5.78E-01
positive regulation of epithelial cell apoptotic process (GO:1904037)	37	1	.86	+	1.16	5.78E-01
positive regulation of ATP metabolic process (GO:1903580)	37	1	.86	+	1.16	5.78E-01
visual behavior (GO:0007632)	74	2	1.73	+	1.16	5.15E-01
regulation of cellular extravasation (GO:0002691)	37	1	.86	+	1.16	5.78E-01
response to nitrogen compound (GO:1901698)	815	22	19.00	+	1.16	2.71E-01
regulation of establishment of protein localization (GO:0070201)	556	15	12.96	+	1.16	3.19E-01
cellular response to stimulus (GO:0051716)	5972	161	139.21	+	1.16	1.44E-02
response to stress (GO:0006950)	2827	76	65.90	+	1.15	1.01E-01
cation transmembrane transport (GO:0098655)	447	12	10.42	+	1.15	3.51E-01
ion homeostasis (GO:0050801)	746	20	17.39	+	1.15	2.93E-01
regulation of neuron differentiation (GO:0045664)	224	6	5.22	+	1.15	4.23E-01
positive regulation of ion transmembrane transporter activity (GO:0032414)	112	3	2.61	+	1.15	4.85E-01
membrane fusion (GO:0061025)	112	3	2.61	+	1.15	4.85E-01
microtubule cytoskeleton organization involved in mitosis (GO:1902850)	112	3	2.61	+	1.15	4.85E-01
cellular localization (GO:0051641)	2058	55	47.97	+	1.15	1.58E-01
developmental maturation (GO:0021700)	262	7	6.11	+	1.15	4.11E-01
chemical synaptic transmission (GO:0007268)	337	9	7.86	+	1.15	3.87E-01
anterograde trans-synaptic signaling (GO:0098916)	337	9	7.86	+	1.15	3.87E-01
regulation of cellular process (GO:0050794)	10382	277	242.02	+	1.14	2.98E-04
chemical homeostasis (GO:0048878)	1087	29	25.34	+	1.14	2.53E-01
smoothened signaling pathway (GO:0007224)	75	2	1.75	+	1.14	5.22E-01
retina morphogenesis in camera-type eye (GO:0060042)	75	2	1.75	+	1.14	5.22E-01
positive regulation of synapse assembly (GO:0051965)	75	2	1.75	+	1.14	5.22E-01
regulation of interleukin-6 production (GO:0032675)	150	4	3.50	+	1.14	4.63E-01
biological process involved in interaction with host (GO:0051701)	75	2	1.75	+	1.14	5.22E-01
anterior/posterior pattern specification (GO:0009952)	225	6	5.25	+	1.14	4.27E-01
regulation of microtubule cytoskeleton organization (GO:0070507)	150	4	3.50	+	1.14	4.63E-01
positive regulation of phagocytosis (GO:0050766)	75	2	1.75	+	1.14	5.22E-01
regulation of protein catabolic process (GO:0042176)	375	10	8.74	+	1.14	3.78E-01
biological regulation (GO:0065007)	11414	304	266.07	+	1.14	5.77E-05
multicellular organism reproduction (GO:0032504)	751	20	17.51	+	1.14	3.03E-01
extracellular matrix organization (GO:0030198)	263	7	6.13	+	1.14	4.15E-01
endomembrane system organization (GO:0010256)	376	10	8.77	+	1.14	3.81E-01
regulation of ion transmembrane transport (GO:0034765)	564	15	13.15	+	1.14	3.39E-01
cellular response to nitrogen compound (GO:1901699)	489	13	11.40	+	1.14	3.55E-01
positive regulation of chromatin organization (GO:1905269)	113	3	2.63	+	1.14	4.91E-01
negative regulation of cellular catabolic process (GO:0031330)	226	6	5.27	+	1.14	4.31E-01
external encapsulating structure organization (GO:0045229)	264	7	6.15	+	1.14	4.19E-01
extracellular structure organization (GO:0043062)	264	7	6.15	+	1.14	4.19E-01
transport along microtubule (GO:0010970)	151	4	3.52	+	1.14	4.68E-01
signal transduction (GO:0007165)	4383	116	102.17	+	1.14	6.64E-02
regulation of protein transport (GO:0051223)	529	14	12.33	+	1.14	3.53E-01
regulation of biological process (GO:0050789)	10854	287	253.02	+	1.13	3.70E-04
cellular response to stress (GO:0033554)	1362	36	31.75	+	1.13	2.40E-01
activation of protein kinase activity (GO:0032147)	227	6	5.29	+	1.13	4.35E-01
male gamete generation (GO:0048232)	492	13	11.47	+	1.13	3.63E-01
regulation of peptide transport (GO:0090087)	568	15	13.24	+	1.13	3.48E-01
regulation of transmembrane transport (GO:0034762)	568	15	13.24	+	1.13	3.48E-01
homeostatic process (GO:0042592)	1629	43	37.97	+	1.13	2.18E-01
olfactory bulb development (GO:0021772)	38	1	.89	+	1.13	5.88E-01
activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919)	76	2	1.77	+	1.13	5.29E-01
positive regulation of neuron differentiation (GO:0045666)	114	3	2.66	+	1.13	4.96E-01
cell cycle G1/S phase transition (GO:0044843)	76	2	1.77	+	1.13	5.29E-01
positive regulation of synaptic transmission, glutamatergic (GO:0051968)	38	1	.89	+	1.13	5.88E-01
regulation of interleukin-1 beta production (GO:0032651)	76	2	1.77	+	1.13	5.29E-01
negative regulation of organelle assembly (GO:1902116)	38	1	.89	+	1.13	5.88E-01
peptidyl-threonine phosphorylation (GO:0018107)	76	2	1.77	+	1.13	5.29E-01
regulation of protein localization to cell surface (GO:2000008)	38	1	.89	+	1.13	5.88E-01
non-recombinational repair (GO:0000726)	38	1	.89	+	1.13	5.88E-01
stress-activated MAPK cascade (GO:0051403)	76	2	1.77	+	1.13	5.29E-01
brown fat cell differentiation (GO:0050873)	38	1	.89	+	1.13	5.88E-01
protein depolymerization (GO:0051261)	38	1	.89	+	1.13	5.88E-01
release of sequestered calcium ion into cytosol (GO:0051209)	38	1	.89	+	1.13	5.88E-01
response to peptide hormone (GO:0043434)	266	7	6.20	+	1.13	4.26E-01
negative regulation of potassium ion transport (GO:0043267)	38	1	.89	+	1.13	5.88E-01
oligosaccharide metabolic process (GO:0009311)	38	1	.89	+	1.13	5.88E-01
lipid homeostasis (GO:0055088)	152	4	3.54	+	1.13	4.73E-01
fatty acid catabolic process (GO:0009062)	76	2	1.77	+	1.13	5.29E-01
calcium-mediated signaling (GO:0019722)	114	3	2.66	+	1.13	4.96E-01
regulation of protein modification by small protein conjugation or removal (GO:1903320)	228	6	5.31	+	1.13	4.39E-01
response to organonitrogen compound (GO:0010243)	723	19	16.85	+	1.13	3.30E-01
peptide transport (GO:0015833)	1181	31	27.53	+	1.13	2.73E-01
response to stimulus (GO:0050896)	7507	197	175.00	+	1.13	1.71E-02
regulation of apoptotic process (GO:0042981)	1412	37	32.92	+	1.12	2.53E-01
regulation of muscle contraction (GO:0006937)	153	4	3.57	+	1.12	4.78E-01
nucleus organization (GO:0006997)	115	3	2.68	+	1.12	5.02E-01
negative regulation of ion transport (GO:0043271)	345	9	8.04	+	1.12	4.13E-01
positive regulation of ion transport (GO:0043270)	691	18	16.11	+	1.12	3.49E-01
cellular lipid metabolic process (GO:0044255)	807	21	18.81	+	1.12	3.34E-01
regulation of defense response (GO:0031347)	538	14	12.54	+	1.12	3.76E-01
positive regulation of cell division (GO:0051781)	77	2	1.79	+	1.11	5.36E-01
regulation of release of sequestered calcium ion into cytosol (GO:0051279)	77	2	1.79	+	1.11	5.36E-01
protein localization to synapse (GO:0035418)	77	2	1.79	+	1.11	5.36E-01
regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178)	77	2	1.79	+	1.11	5.36E-01
positive regulation of cellular amide metabolic process (GO:0034250)	154	4	3.59	+	1.11	4.83E-01
gamete generation (GO:0007276)	618	16	14.41	+	1.11	3.70E-01
negative regulation of protein serine/threonine kinase activity (GO:0071901)	116	3	2.70	+	1.11	5.08E-01
regulation of organ growth (GO:0046620)	116	3	2.70	+	1.11	5.08E-01
cellular process (GO:0009987)	13701	354	319.39	+	1.11	2.52E-05
cellular response to organonitrogen compound (GO:0071417)	426	11	9.93	+	1.11	4.08E-01
positive regulation of hormone secretion (GO:0046887)	155	4	3.61	+	1.11	4.88E-01
negative regulation of Wnt signaling pathway (GO:0030178)	155	4	3.61	+	1.11	4.88E-01
RNA metabolic process (GO:0016070)	1125	29	26.23	+	1.11	3.15E-01
regulation of protein ubiquitination (GO:0031396)	194	5	4.52	+	1.11	4.73E-01
amide transport (GO:0042886)	1204	31	28.07	+	1.10	3.10E-01
response to lipid (GO:0033993)	585	15	13.64	+	1.10	3.91E-01
T cell mediated immunity (GO:0002456)	39	1	.91	+	1.10	5.98E-01
protein-lipid complex subunit organization (GO:0071825)	39	1	.91	+	1.10	5.98E-01
ATP generation from ADP (GO:0006757)	39	1	.91	+	1.10	5.98E-01
cell cycle phase transition (GO:0044770)	156	4	3.64	+	1.10	4.93E-01
metal ion export (GO:0070839)	39	1	.91	+	1.10	5.98E-01
homeostasis of number of cells within a tissue (GO:0048873)	39	1	.91	+	1.10	5.98E-01
peptidyl-cysteine modification (GO:0018198)	39	1	.91	+	1.10	5.98E-01
glycolytic process (GO:0006096)	39	1	.91	+	1.10	5.98E-01
negative regulation of sequestering of calcium ion (GO:0051283)	39	1	.91	+	1.10	5.98E-01
negative regulation of lymphocyte apoptotic process (GO:0070229)	39	1	.91	+	1.10	5.98E-01
histone ubiquitination (GO:0016574)	39	1	.91	+	1.10	5.98E-01
negative regulation of actin filament depolymerization (GO:0030835)	39	1	.91	+	1.10	5.98E-01
response to amyloid-beta (GO:1904645)	39	1	.91	+	1.10	5.98E-01
iron ion homeostasis (GO:0055072)	78	2	1.82	+	1.10	5.43E-01
organic hydroxy compound transport (GO:0015850)	117	3	2.73	+	1.10	5.14E-01
BMP signaling pathway (GO:0030509)	78	2	1.82	+	1.10	5.43E-01
sterol metabolic process (GO:0016125)	117	3	2.73	+	1.10	5.14E-01
carbohydrate catabolic process (GO:0016052)	78	2	1.82	+	1.10	5.43E-01
positive regulation of cardiac muscle hypertrophy (GO:0010613)	39	1	.91	+	1.10	5.98E-01
cardiac ventricle morphogenesis (GO:0003208)	78	2	1.82	+	1.10	5.43E-01
positive regulation of muscle hypertrophy (GO:0014742)	39	1	.91	+	1.10	5.98E-01
regulation of programmed cell death (GO:0043067)	1446	37	33.71	+	1.10	3.01E-01
anatomical structure homeostasis (GO:0060249)	313	8	7.30	+	1.10	4.46E-01
regulation of chromosome organization (GO:0033044)	274	7	6.39	+	1.10	4.56E-01
cell communication (GO:0007154)	4778	122	111.38	+	1.10	1.32E-01
organelle assembly (GO:0070925)	627	16	14.62	+	1.09	3.92E-01
regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281)	196	5	4.57	+	1.09	4.82E-01
cellular modified amino acid metabolic process (GO:0006575)	157	4	3.66	+	1.09	4.98E-01
cellular response to transforming growth factor beta stimulus (GO:0071560)	118	3	2.75	+	1.09	5.19E-01
regulation of nucleocytoplasmic transport (GO:0046822)	118	3	2.75	+	1.09	5.19E-01
positive regulation of mitotic cell cycle (GO:0045931)	118	3	2.75	+	1.09	5.19E-01
glycerolipid metabolic process (GO:0046486)	315	8	7.34	+	1.09	4.53E-01
trans-synaptic signaling (GO:0099537)	355	9	8.28	+	1.09	4.46E-01
positive regulation of cation channel activity (GO:2001259)	79	2	1.84	+	1.09	5.50E-01
endothelial cell differentiation (GO:0045446)	79	2	1.84	+	1.09	5.50E-01
positive regulation of B cell activation (GO:0050871)	79	2	1.84	+	1.09	5.50E-01
regulation of calcium ion transmembrane transporter activity (GO:1901019)	79	2	1.84	+	1.09	5.50E-01
positive regulation of actin filament polymerization (GO:0030838)	79	2	1.84	+	1.09	5.50E-01
regulation of protein import (GO:1904589)	79	2	1.84	+	1.09	5.50E-01
nucleoside triphosphate metabolic process (GO:0009141)	79	2	1.84	+	1.09	5.50E-01
signaling (GO:0023052)	4679	118	109.07	+	1.08	1.74E-01
organelle organization (GO:0006996)	2903	73	67.67	+	1.08	2.58E-01
cell cycle process (GO:0022402)	756	19	17.62	+	1.08	4.02E-01
cellular response to biotic stimulus (GO:0071216)	199	5	4.64	+	1.08	4.95E-01
positive regulation of immunoglobulin production (GO:0002639)	40	1	.93	+	1.07	6.07E-01
secondary alcohol metabolic process (GO:1902652)	120	3	2.80	+	1.07	5.31E-01
potassium ion transport (GO:0006813)	160	4	3.73	+	1.07	5.13E-01
ceramide metabolic process (GO:0006672)	80	2	1.86	+	1.07	5.57E-01
hematopoietic progenitor cell differentiation (GO:0002244)	120	3	2.80	+	1.07	5.31E-01
reproductive behavior (GO:0019098)	40	1	.93	+	1.07	6.07E-01
viral life cycle (GO:0019058)	80	2	1.86	+	1.07	5.57E-01
regulation of polysaccharide biosynthetic process (GO:0032885)	40	1	.93	+	1.07	6.07E-01
cellular biogenic amine metabolic process (GO:0006576)	80	2	1.86	+	1.07	5.57E-01
positive regulation of ATPase activity (GO:0032781)	40	1	.93	+	1.07	6.07E-01
response to ketone (GO:1901654)	120	3	2.80	+	1.07	5.31E-01
negative regulation of DNA biosynthetic process (GO:2000279)	40	1	.93	+	1.07	6.07E-01
movement in host environment (GO:0052126)	40	1	.93	+	1.07	6.07E-01
positive regulation of transporter activity (GO:0032411)	120	3	2.80	+	1.07	5.31E-01
regulation of telomere maintenance (GO:0032204)	80	2	1.86	+	1.07	5.57E-01
positive regulation of behavior (GO:0048520)	40	1	.93	+	1.07	6.07E-01
positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774)	40	1	.93	+	1.07	6.07E-01
eating behavior (GO:0042755)	40	1	.93	+	1.07	6.07E-01
phospholipid biosynthetic process (GO:0008654)	160	4	3.73	+	1.07	5.13E-01
B cell proliferation (GO:0042100)	40	1	.93	+	1.07	6.07E-01
ncRNA processing (GO:0034470)	320	8	7.46	+	1.07	4.70E-01
protein localization to microtubule cytoskeleton (GO:0072698)	40	1	.93	+	1.07	6.07E-01
positive regulation of transport (GO:0051050)	966	24	22.52	+	1.07	4.04E-01
membrane lipid metabolic process (GO:0006643)	161	4	3.75	+	1.07	5.18E-01
response to nutrient levels (GO:0031667)	322	8	7.51	+	1.07	4.77E-01
cellular response to tumor necrosis factor (GO:0071356)	121	3	2.82	+	1.06	5.36E-01
positive regulation of endocytosis (GO:0045807)	121	3	2.82	+	1.06	5.36E-01
regulation of mRNA metabolic process (GO:1903311)	242	6	5.64	+	1.06	4.96E-01
carbohydrate derivative metabolic process (GO:1901135)	767	19	17.88	+	1.06	4.26E-01
regulation of microtubule-based process (GO:0032886)	243	6	5.66	+	1.06	5.00E-01
positive regulation of defense response (GO:0031349)	243	6	5.66	+	1.06	5.00E-01
regulation of striated muscle contraction (GO:0006942)	81	2	1.89	+	1.06	5.63E-01
regulation of tissue remodeling (GO:0034103)	81	2	1.89	+	1.06	5.63E-01
regulation of endopeptidase activity (GO:0052548)	324	8	7.55	+	1.06	4.84E-01
metanephros development (GO:0001656)	81	2	1.89	+	1.06	5.63E-01
cellular amine metabolic process (GO:0044106)	81	2	1.89	+	1.06	5.63E-01
response to endogenous stimulus (GO:0009719)	1053	26	24.55	+	1.06	4.10E-01
negative regulation of protein-containing complex disassembly (GO:0043242)	81	2	1.89	+	1.06	5.63E-01
cell cycle (GO:0007049)	1094	27	25.50	+	1.06	4.08E-01
cellular protein localization (GO:0034613)	1380	34	32.17	+	1.06	3.94E-01
negative regulation of mitotic cell cycle (GO:0045930)	203	5	4.73	+	1.06	5.12E-01
regulation of vesicle-mediated transport (GO:0060627)	569	14	13.26	+	1.06	4.56E-01
determination of left/right symmetry (GO:0007368)	122	3	2.84	+	1.05	5.42E-01
positive regulation of cell cycle process (GO:0090068)	244	6	5.69	+	1.05	5.04E-01
phosphorus metabolic process (GO:0006793)	1587	39	36.99	+	1.05	3.89E-01
regulation of leukocyte activation (GO:0002694)	529	13	12.33	+	1.05	4.62E-01
RNA localization (GO:0006403)	163	4	3.80	+	1.05	5.27E-01
DNA replication (GO:0006260)	163	4	3.80	+	1.05	5.27E-01
cellular response to endogenous stimulus (GO:0071495)	857	21	19.98	+	1.05	4.39E-01
cellular macromolecule localization (GO:0070727)	1388	34	32.36	+	1.05	4.08E-01
response to peptide (GO:1901652)	327	8	7.62	+	1.05	4.94E-01
cellular process involved in reproduction in multicellular organism (GO:0022412)	368	9	8.58	+	1.05	4.88E-01
cellular response to amino acid starvation (GO:0034198)	41	1	.96	+	1.05	6.16E-01
regulation of cellular senescence (GO:2000772)	41	1	.96	+	1.05	6.16E-01
neuropeptide signaling pathway (GO:0007218)	82	2	1.91	+	1.05	5.70E-01
response to transforming growth factor beta (GO:0071559)	123	3	2.87	+	1.05	5.47E-01
cell-cell junction organization (GO:0045216)	164	4	3.82	+	1.05	5.32E-01
positive regulation of fatty acid transport (GO:2000193)	41	1	.96	+	1.05	6.16E-01
amino sugar metabolic process (GO:0006040)	41	1	.96	+	1.05	6.16E-01
animal organ formation (GO:0048645)	41	1	.96	+	1.05	6.16E-01
negative regulation of catabolic process (GO:0009895)	287	7	6.69	+	1.05	5.04E-01
positive regulation of release of sequestered calcium ion into cytosol (GO:0051281)	41	1	.96	+	1.05	6.16E-01
oogenesis (GO:0048477)	82	2	1.91	+	1.05	5.70E-01
cell maturation (GO:0048469)	164	4	3.82	+	1.05	5.32E-01
mRNA stabilization (GO:0048255)	41	1	.96	+	1.05	6.16E-01
neuron maturation (GO:0042551)	41	1	.96	+	1.05	6.16E-01
positive regulation of protein dephosphorylation (GO:0035307)	41	1	.96	+	1.05	6.16E-01
phosphatidylinositol phosphorylation (GO:0046854)	41	1	.96	+	1.05	6.16E-01
positive regulation of sodium ion transport (GO:0010765)	41	1	.96	+	1.05	6.16E-01
olfactory lobe development (GO:0021988)	41	1	.96	+	1.05	6.16E-01
positive regulation of heart contraction (GO:0045823)	41	1	.96	+	1.05	6.16E-01
digestion (GO:0007586)	82	2	1.91	+	1.05	5.70E-01
peptidyl-serine modification (GO:0018209)	205	5	4.78	+	1.05	5.21E-01
protein transport (GO:0015031)	1150	28	26.81	+	1.04	4.34E-01
regulation of body fluid levels (GO:0050878)	329	8	7.67	+	1.04	5.01E-01
establishment of protein localization (GO:0045184)	1235	30	28.79	+	1.04	4.35E-01
response to lipopolysaccharide (GO:0032496)	247	6	5.76	+	1.04	5.16E-01
nucleobase-containing compound metabolic process (GO:0006139)	2018	49	47.04	+	1.04	4.03E-01
phosphate-containing compound metabolic process (GO:0006796)	1565	38	36.48	+	1.04	4.21E-01
positive regulation of anion transport (GO:1903793)	495	12	11.54	+	1.04	4.86E-01
cyclic-nucleotide-mediated signaling (GO:0019935)	165	4	3.85	+	1.04	5.37E-01
regulation of catabolic process (GO:0009894)	826	20	19.26	+	1.04	4.63E-01
sister chromatid segregation (GO:0000819)	124	3	2.89	+	1.04	5.53E-01
organic substance metabolic process (GO:0071704)	6383	154	148.80	+	1.03	3.14E-01
localization within membrane (GO:0051668)	83	2	1.93	+	1.03	5.77E-01
multicellular organismal homeostasis (GO:0048871)	332	8	7.74	+	1.03	5.11E-01
inorganic ion import across plasma membrane (GO:0099587)	83	2	1.93	+	1.03	5.77E-01
regulation of type I interferon production (GO:0032479)	83	2	1.93	+	1.03	5.77E-01
DNA conformation change (GO:0071103)	166	4	3.87	+	1.03	5.41E-01
spindle assembly (GO:0051225)	83	2	1.93	+	1.03	5.77E-01
inorganic cation import across plasma membrane (GO:0098659)	83	2	1.93	+	1.03	5.77E-01
hormone secretion (GO:0046879)	83	2	1.93	+	1.03	5.77E-01
response to calcium ion (GO:0051592)	125	3	2.91	+	1.03	5.58E-01
proteolysis (GO:0006508)	1042	25	24.29	+	1.03	4.70E-01
cellular response to lipopolysaccharide (GO:0071222)	167	4	3.89	+	1.03	5.46E-01
positive regulation of synaptic transmission (GO:0050806)	167	4	3.89	+	1.03	5.46E-01
positive regulation of proteolysis (GO:0045862)	335	8	7.81	+	1.02	5.21E-01
primary metabolic process (GO:0044238)	5879	140	137.05	+	1.02	3.97E-01
negative regulation of response to wounding (GO:1903035)	84	2	1.96	+	1.02	5.83E-01
neural tube patterning (GO:0021532)	42	1	.98	+	1.02	6.25E-01
glycolipid metabolic process (GO:0006664)	84	2	1.96	+	1.02	5.83E-01
mitotic spindle organization (GO:0007052)	84	2	1.96	+	1.02	5.83E-01
neurotransmitter receptor transport (GO:0099637)	42	1	.98	+	1.02	6.25E-01
potassium ion import across plasma membrane (GO:1990573)	42	1	.98	+	1.02	6.25E-01
negative regulation of intracellular protein transport (GO:0090317)	42	1	.98	+	1.02	6.25E-01
regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434)	126	3	2.94	+	1.02	5.63E-01
negative regulation of lipid transport (GO:0032369)	42	1	.98	+	1.02	6.25E-01
postsynaptic signal transduction (GO:0098926)	42	1	.98	+	1.02	6.25E-01
negative chemotaxis (GO:0050919)	42	1	.98	+	1.02	6.25E-01
response to pH (GO:0009268)	42	1	.98	+	1.02	6.25E-01
vesicle transport along microtubule (GO:0047496)	42	1	.98	+	1.02	6.25E-01
ATP-dependent chromatin remodeling (GO:0043044)	42	1	.98	+	1.02	6.25E-01
positive regulation of histone methylation (GO:0031062)	42	1	.98	+	1.02	6.25E-01
response to starvation (GO:0042594)	168	4	3.92	+	1.02	5.51E-01
regulation of Notch signaling pathway (GO:0008593)	84	2	1.96	+	1.02	5.83E-01
regulation of myotube differentiation (GO:0010830)	42	1	.98	+	1.02	6.25E-01
vasodilation (GO:0042311)	42	1	.98	+	1.02	6.25E-01
negative regulation of organ growth (GO:0046621)	42	1	.98	+	1.02	6.25E-01
negative regulation of ossification (GO:0030279)	42	1	.98	+	1.02	6.25E-01
protein localization to nucleus (GO:0034504)	168	4	3.92	+	1.02	5.51E-01
positive regulation of secretion (GO:0051047)	380	9	8.86	+	1.02	5.27E-01
sexual reproduction (GO:0019953)	760	18	17.72	+	1.02	5.06E-01
protein localization (GO:0008104)	1858	44	43.31	+	1.02	4.80E-01
metabolic process (GO:0008152)	6758	160	157.54	+	1.02	4.20E-01
regulation of immune system process (GO:0002682)	1228	29	28.63	+	1.01	4.99E-01
intracellular protein transport (GO:0006886)	722	17	16.83	+	1.01	5.18E-01
biological_process (GO:0008150)	17339	408	404.19	+	1.01	2.09E-01
cell fate specification (GO:0001708)	85	2	1.98	+	1.01	5.90E-01
peptidyl-threonine modification (GO:0018210)	85	2	1.98	+	1.01	5.90E-01
double-strand break repair via homologous recombination (GO:0000724)	85	2	1.98	+	1.01	5.90E-01
negative regulation of lymphocyte proliferation (GO:0050672)	85	2	1.98	+	1.01	5.90E-01
sodium ion transmembrane transport (GO:0035725)	85	2	1.98	+	1.01	5.90E-01
cholesterol homeostasis (GO:0042632)	85	2	1.98	+	1.01	5.90E-01
intracellular receptor signaling pathway (GO:0030522)	85	2	1.98	+	1.01	5.90E-01
liposaccharide metabolic process (GO:1903509)	85	2	1.98	+	1.01	5.90E-01
cellular aromatic compound metabolic process (GO:0006725)	2210	52	51.52	+	1.01	4.94E-01
nucleic acid metabolic process (GO:0090304)	1615	38	37.65	+	1.01	5.01E-01
nitrogen compound metabolic process (GO:0006807)	5359	126	124.92	+	1.01	4.73E-01
heterocycle metabolic process (GO:0046483)	2132	50	49.70	+	1.01	5.04E-01
determination of bilateral symmetry (GO:0009855)	128	3	2.98	+	1.01	5.74E-01
organelle localization (GO:0051640)	470	11	10.96	+	1.00	5.36E-01
regulation of DNA metabolic process (GO:0051052)	342	8	7.97	+	1.00	5.44E-01
system process (GO:0003008)	2523	59	58.81	+	1.00	5.11E-01
retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)	43	1	1.00	-	1.00	7.35E-01
regulation of extracellular matrix organization (GO:1903053)	43	1	1.00	-	1.00	7.35E-01
negative regulation of endothelial cell proliferation (GO:0001937)	43	1	1.00	-	1.00	7.35E-01
negative regulation of mononuclear cell proliferation (GO:0032945)	86	2	2.00	-	1.00	6.75E-01
cellular response to insulin stimulus (GO:0032869)	129	3	3.01	-	1.00	6.46E-01
regulation of natural killer cell activation (GO:0032814)	43	1	1.00	-	1.00	7.35E-01
lysosome localization (GO:0032418)	43	1	1.00	-	1.00	7.35E-01
recombinational repair (GO:0000725)	86	2	2.00	-	1.00	6.75E-01
calcium ion import (GO:0070509)	43	1	1.00	-	1.00	7.35E-01
specification of symmetry (GO:0009799)	129	3	3.01	-	1.00	6.46E-01
regulation of T cell apoptotic process (GO:0070232)	43	1	1.00	-	1.00	7.35E-01
spliceosomal complex assembly (GO:0000245)	43	1	1.00	-	1.00	7.35E-01
G2/M transition of mitotic cell cycle (GO:0000086)	43	1	1.00	-	1.00	7.35E-01
sterol homeostasis (GO:0055092)	86	2	2.00	-	1.00	6.75E-01
regulation of fatty acid biosynthetic process (GO:0042304)	43	1	1.00	-	1.00	7.35E-01
protein localization to postsynaptic membrane (GO:1903539)	43	1	1.00	-	1.00	7.35E-01
negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002823)	43	1	1.00	-	1.00	7.35E-01
regulation of proteasomal protein catabolic process (GO:0061136)	172	4	4.01	-	1.00	6.27E-01
cellular metabolic process (GO:0044237)	5944	138	138.56	-	1.00	5.00E-01
organic cyclic compound metabolic process (GO:1901360)	2416	56	56.32	-	.99	5.17E-01
synaptic signaling (GO:0099536)	389	9	9.07	-	.99	5.78E-01
negative regulation of protein metabolic process (GO:0051248)	952	22	22.19	-	.99	5.40E-01
cell activation (GO:0001775)	606	14	14.13	-	.99	5.57E-01
lipid biosynthetic process (GO:0008610)	434	10	10.12	-	.99	5.68E-01
negative regulation of viral process (GO:0048525)	87	2	2.03	-	.99	6.69E-01
ERAD pathway (GO:0036503)	87	2	2.03	-	.99	6.69E-01
regulation of pattern recognition receptor signaling pathway (GO:0062207)	87	2	2.03	-	.99	6.69E-01
positive regulation of catabolic process (GO:0009896)	435	10	10.14	-	.99	5.65E-01
negative regulation of leukocyte cell-cell adhesion (GO:1903038)	131	3	3.05	-	.98	6.35E-01
myeloid leukocyte activation (GO:0002274)	131	3	3.05	-	.98	6.35E-01
peptidyl-amino acid modification (GO:0018193)	703	16	16.39	-	.98	5.27E-01
kidney epithelium development (GO:0072073)	132	3	3.08	-	.97	6.30E-01
regulation of calcium ion transport (GO:0051924)	264	6	6.15	-	.97	5.81E-01
lung epithelium development (GO:0060428)	44	1	1.03	-	.97	7.26E-01
phenol-containing compound metabolic process (GO:0018958)	88	2	2.05	-	.97	6.63E-01
homotypic cell-cell adhesion (GO:0034109)	44	1	1.03	-	.97	7.26E-01
phagocytosis, engulfment (GO:0006911)	44	1	1.03	-	.97	7.26E-01
regulation of actin filament-based movement (GO:1903115)	44	1	1.03	-	.97	7.26E-01
inner ear receptor cell stereocilium organization (GO:0060122)	44	1	1.03	-	.97	7.26E-01
protein export from nucleus (GO:0006611)	88	2	2.05	-	.97	6.63E-01
regulation of T cell migration (GO:2000404)	44	1	1.03	-	.97	7.26E-01
positive regulation of signaling receptor activity (GO:2000273)	44	1	1.03	-	.97	7.26E-01
maintenance of location in cell (GO:0051651)	88	2	2.05	-	.97	6.63E-01
regulation of DNA-dependent DNA replication (GO:0090329)	44	1	1.03	-	.97	7.26E-01
mitotic spindle assembly (GO:0090307)	44	1	1.03	-	.97	7.26E-01
regulation of protein autophosphorylation (GO:0031952)	44	1	1.03	-	.97	7.26E-01
amine metabolic process (GO:0009308)	88	2	2.05	-	.97	6.63E-01
negative regulation of histone modification (GO:0031057)	44	1	1.03	-	.97	7.26E-01
negative regulation of anion transmembrane transport (GO:1903960)	44	1	1.03	-	.97	7.26E-01
regulation of protein dephosphorylation (GO:0035304)	88	2	2.05	-	.97	6.63E-01
positive regulation of blood circulation (GO:1903524)	44	1	1.03	-	.97	7.26E-01
positive regulation of mitotic nuclear division (GO:0045840)	44	1	1.03	-	.97	7.26E-01
regulation of cell activation (GO:0050865)	572	13	13.33	-	.97	5.36E-01
macromolecule metabolic process (GO:0043170)	4843	110	112.90	-	.97	3.99E-01
biological process involved in interspecies interaction between organisms (GO:0044419)	1277	29	29.77	-	.97	4.91E-01
organophosphate metabolic process (GO:0019637)	705	16	16.43	-	.97	5.22E-01
cellular nitrogen compound metabolic process (GO:0034641)	2606	59	60.75	-	.97	4.38E-01
cellular response to molecule of bacterial origin (GO:0071219)	177	4	4.13	-	.97	6.04E-01
regulation of nervous system process (GO:0031644)	177	4	4.13	-	.97	6.04E-01
response to biotic stimulus (GO:0009607)	1152	26	26.85	-	.97	4.83E-01
cell recognition (GO:0008037)	133	3	3.10	-	.97	6.25E-01
phospholipid metabolic process (GO:0006644)	311	7	7.25	-	.97	5.61E-01
DNA repair (GO:0006281)	400	9	9.32	-	.97	5.44E-01
response to molecule of bacterial origin (GO:0002237)	267	6	6.22	-	.96	5.70E-01
nuclear division (GO:0000280)	267	6	6.22	-	.96	5.70E-01
alcohol biosynthetic process (GO:0046165)	89	2	2.07	-	.96	6.56E-01
regulation of smooth muscle cell migration (GO:0014910)	89	2	2.07	-	.96	6.56E-01
endothelium development (GO:0003158)	89	2	2.07	-	.96	6.56E-01
regulation of endocytosis (GO:0030100)	223	5	5.20	-	.96	5.81E-01
cellular amide metabolic process (GO:0043603)	626	14	14.59	-	.96	5.07E-01
cellular response to hormone stimulus (GO:0032870)	358	8	8.35	-	.96	5.44E-01
cellular response to peptide hormone stimulus (GO:0071375)	179	4	4.17	-	.96	5.95E-01
cellular response to inorganic substance (GO:0071241)	179	4	4.17	-	.96	5.95E-01
negative regulation of apoptotic signaling pathway (GO:2001234)	224	5	5.22	-	.96	5.77E-01
response to other organism (GO:0051707)	1120	25	26.11	-	.96	4.63E-01
response to external biotic stimulus (GO:0043207)	1122	25	26.16	-	.96	4.59E-01
immune system process (GO:0002376)	1890	42	44.06	-	.95	4.10E-01
photoreceptor cell maintenance (GO:0045494)	45	1	1.05	-	.95	7.18E-01
response to amino acid starvation (GO:1990928)	45	1	1.05	-	.95	7.18E-01
osteoblast differentiation (GO:0001649)	90	2	2.10	-	.95	6.50E-01
glandular epithelial cell differentiation (GO:0002067)	45	1	1.05	-	.95	7.18E-01
DNA methylation (GO:0006306)	45	1	1.05	-	.95	7.18E-01
DNA alkylation (GO:0006305)	45	1	1.05	-	.95	7.18E-01
brain morphogenesis (GO:0048854)	45	1	1.05	-	.95	7.18E-01
glucose metabolic process (GO:0006006)	90	2	2.10	-	.95	6.50E-01
response to fungus (GO:0009620)	45	1	1.05	-	.95	7.18E-01
response to exogenous dsRNA (GO:0043330)	45	1	1.05	-	.95	7.18E-01
negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124)	45	1	1.05	-	.95	7.18E-01
regulation of vascular permeability (GO:0043114)	45	1	1.05	-	.95	7.18E-01
regulation of microtubule polymerization or depolymerization (GO:0031110)	90	2	2.10	-	.95	6.50E-01
response to interferon-beta (GO:0035456)	45	1	1.05	-	.95	7.18E-01
maturation of SSU-rRNA (GO:0030490)	45	1	1.05	-	.95	7.18E-01
secondary metabolic process (GO:0019748)	45	1	1.05	-	.95	7.18E-01
adult walking behavior (GO:0007628)	45	1	1.05	-	.95	7.18E-01
regulation of amyloid precursor protein catabolic process (GO:1902991)	45	1	1.05	-	.95	7.18E-01
adherens junction organization (GO:0034332)	45	1	1.05	-	.95	7.18E-01
response to gamma radiation (GO:0010332)	45	1	1.05	-	.95	7.18E-01
carbohydrate derivative catabolic process (GO:1901136)	135	3	3.15	-	.95	6.14E-01
gene expression (GO:0010467)	1713	38	39.93	-	.95	4.14E-01
nucleobase-containing compound transport (GO:0015931)	181	4	4.22	-	.95	5.86E-01
regulation of osteoblast differentiation (GO:0045667)	136	3	3.17	-	.95	6.09E-01
organic hydroxy compound metabolic process (GO:1901615)	408	9	9.51	-	.95	5.20E-01
negative regulation of protein transport (GO:0051224)	136	3	3.17	-	.95	6.09E-01
immune response (GO:0006955)	1043	23	24.31	-	.95	4.44E-01
regulation of cellular catabolic process (GO:0031329)	682	15	15.90	-	.94	4.75E-01
regulation of lymphocyte differentiation (GO:0045619)	182	4	4.24	-	.94	5.81E-01
chloride transport (GO:0006821)	91	2	2.12	-	.94	6.44E-01
hormone transport (GO:0009914)	91	2	2.12	-	.94	6.44E-01
cell division (GO:0051301)	455	10	10.61	-	.94	5.07E-01
hormone-mediated signaling pathway (GO:0009755)	91	2	2.12	-	.94	6.44E-01
organonitrogen compound metabolic process (GO:1901564)	4051	89	94.43	-	.94	2.85E-01
regulation of cytokine production (GO:0001817)	683	15	15.92	-	.94	4.73E-01
RNA catabolic process (GO:0006401)	137	3	3.19	-	.94	6.04E-01
monosaccharide metabolic process (GO:0005996)	137	3	3.19	-	.94	6.04E-01
response to UV (GO:0009411)	137	3	3.19	-	.94	6.04E-01
regulation of metal ion transport (GO:0010959)	274	6	6.39	-	.94	5.44E-01
fatty acid metabolic process (GO:0006631)	320	7	7.46	-	.94	5.30E-01
negative regulation of intrinsic apoptotic signaling pathway (GO:2001243)	92	2	2.14	-	.93	6.37E-01
cellular response to BMP stimulus (GO:0071773)	92	2	2.14	-	.93	6.37E-01
response to BMP (GO:0071772)	92	2	2.14	-	.93	6.37E-01
positive regulation of protein acetylation (GO:1901985)	46	1	1.07	-	.93	7.09E-01
regulation of polysaccharide metabolic process (GO:0032881)	46	1	1.07	-	.93	7.09E-01
branching involved in ureteric bud morphogenesis (GO:0001658)	46	1	1.07	-	.93	7.09E-01
histone H3 acetylation (GO:0043966)	46	1	1.07	-	.93	7.09E-01
regulation of hormone metabolic process (GO:0032350)	46	1	1.07	-	.93	7.09E-01
bone remodeling (GO:0046849)	46	1	1.07	-	.93	7.09E-01
endosome to lysosome transport (GO:0008333)	46	1	1.07	-	.93	7.09E-01
regulation of viral entry into host cell (GO:0046596)	46	1	1.07	-	.93	7.09E-01
epithelial cell morphogenesis (GO:0003382)	46	1	1.07	-	.93	7.09E-01
T cell proliferation (GO:0042098)	46	1	1.07	-	.93	7.09E-01
intraciliary transport (GO:0042073)	46	1	1.07	-	.93	7.09E-01
positive regulation of fatty acid metabolic process (GO:0045923)	46	1	1.07	-	.93	7.09E-01
establishment of protein localization to vacuole (GO:0072666)	46	1	1.07	-	.93	7.09E-01
positive regulation of cell cycle G1/S phase transition (GO:1902808)	46	1	1.07	-	.93	7.09E-01
glycoprotein metabolic process (GO:0009100)	276	6	6.43	-	.93	5.36E-01
negative regulation of organelle organization (GO:0010639)	323	7	7.53	-	.93	5.20E-01
positive regulation of cellular catabolic process (GO:0031331)	370	8	8.63	-	.93	5.05E-01
glycosylation (GO:0070085)	185	4	4.31	-	.93	5.68E-01
formation of primary germ layer (GO:0001704)	93	2	2.17	-	.92	6.31E-01
positive regulation of protein localization to nucleus (GO:1900182)	93	2	2.17	-	.92	6.31E-01
negative regulation of peptide secretion (GO:0002792)	93	2	2.17	-	.92	6.31E-01
regulation of muscle cell differentiation (GO:0051147)	140	3	3.26	-	.92	5.88E-01
viral process (GO:0016032)	140	3	3.26	-	.92	5.88E-01
regulation of reproductive process (GO:2000241)	187	4	4.36	-	.92	5.59E-01
negative regulation of cell-cell adhesion (GO:0022408)	187	4	4.36	-	.92	5.59E-01
negative regulation of cellular protein metabolic process (GO:0032269)	890	19	20.75	-	.92	4.02E-01
ADP metabolic process (GO:0046031)	47	1	1.10	-	.91	7.01E-01
protein-containing complex disassembly (GO:0032984)	94	2	2.19	-	.91	6.25E-01
walking behavior (GO:0090659)	47	1	1.10	-	.91	7.01E-01
negative regulation of viral genome replication (GO:0045071)	47	1	1.10	-	.91	7.01E-01
regulation of cell aging (GO:0090342)	47	1	1.10	-	.91	7.01E-01
regulation of glycolytic process (GO:0006110)	47	1	1.10	-	.91	7.01E-01
regulation of calcium ion import (GO:0090279)	47	1	1.10	-	.91	7.01E-01
aminoglycan biosynthetic process (GO:0006023)	47	1	1.10	-	.91	7.01E-01
regulation of TOR signaling (GO:0032006)	94	2	2.19	-	.91	6.25E-01
histone acetylation (GO:0016573)	94	2	2.19	-	.91	6.25E-01
stress-activated protein kinase signaling cascade (GO:0031098)	94	2	2.19	-	.91	6.25E-01
regulation of gene silencing by miRNA (GO:0060964)	47	1	1.10	-	.91	7.01E-01
positive regulation of vasoconstriction (GO:0045907)	47	1	1.10	-	.91	7.01E-01
heart valve morphogenesis (GO:0003179)	47	1	1.10	-	.91	7.01E-01
biological process involved in symbiotic interaction (GO:0044403)	236	5	5.50	-	.91	5.28E-01
regulation of cellular protein catabolic process (GO:1903362)	236	5	5.50	-	.91	5.28E-01
rRNA processing (GO:0006364)	189	4	4.41	-	.91	5.50E-01
gastrulation (GO:0007369)	142	3	3.31	-	.91	5.78E-01
spindle organization (GO:0007051)	142	3	3.31	-	.91	5.78E-01
MAPK cascade (GO:0000165)	142	3	3.31	-	.91	5.78E-01
regulation of response to biotic stimulus (GO:0002831)	284	6	6.62	-	.91	5.07E-01
cellular protein modification process (GO:0006464)	2131	45	49.68	-	.91	2.68E-01
protein modification process (GO:0036211)	2131	45	49.68	-	.91	2.68E-01
monocarboxylic acid catabolic process (GO:0072329)	95	2	2.21	-	.90	6.19E-01
protein import into nucleus (GO:0006606)	95	2	2.21	-	.90	6.19E-01
response to glucose (GO:0009749)	95	2	2.21	-	.90	6.19E-01
cellular response to topologically incorrect protein (GO:0035967)	95	2	2.21	-	.90	6.19E-01
regulation of epithelial cell apoptotic process (GO:1904035)	95	2	2.21	-	.90	6.19E-01
nucleobase-containing compound catabolic process (GO:0034655)	238	5	5.55	-	.90	5.20E-01
regulation of cell cycle phase transition (GO:1901987)	286	6	6.67	-	.90	5.00E-01
response to tumor necrosis factor (GO:0034612)	143	3	3.33	-	.90	5.73E-01
leukocyte activation (GO:0045321)	526	11	12.26	-	.90	4.30E-01
defense response (GO:0006952)	1150	24	26.81	-	.90	3.31E-01
myeloid cell differentiation (GO:0030099)	240	5	5.59	-	.89	5.12E-01
mesenchyme morphogenesis (GO:0072132)	48	1	1.12	-	.89	6.92E-01
positive regulation of interleukin-1 beta production (GO:0032731)	48	1	1.12	-	.89	6.92E-01
negative regulation of interleukin-6 production (GO:0032715)	48	1	1.12	-	.89	6.92E-01
regulation of endocrine process (GO:0044060)	48	1	1.12	-	.89	6.92E-01
RNA stabilization (GO:0043489)	48	1	1.12	-	.89	6.92E-01
regulation of BMP signaling pathway (GO:0030510)	96	2	2.24	-	.89	6.12E-01
regulation of lipid storage (GO:0010883)	48	1	1.12	-	.89	6.92E-01
tissue regeneration (GO:0042246)	48	1	1.12	-	.89	6.92E-01
negative regulation of cellular carbohydrate metabolic process (GO:0010677)	48	1	1.12	-	.89	6.92E-01
somatic stem cell population maintenance (GO:0035019)	48	1	1.12	-	.89	6.92E-01
negative regulation of adaptive immune response (GO:0002820)	48	1	1.12	-	.89	6.92E-01
protein localization to organelle (GO:0033365)	625	13	14.57	-	.89	4.03E-01
protein metabolic process (GO:0019538)	3223	67	75.13	-	.89	1.66E-01
innate immune response (GO:0045087)	581	12	13.54	-	.89	4.02E-01
DNA metabolic process (GO:0006259)	581	12	13.54	-	.89	4.02E-01
negative regulation of cell death (GO:0060548)	1017	21	23.71	-	.89	3.29E-01
protein deubiquitination (GO:0016579)	97	2	2.26	-	.88	6.06E-01
ncRNA metabolic process (GO:0034660)	388	8	9.04	-	.88	4.48E-01
positive regulation of exocytosis (GO:0045921)	97	2	2.26	-	.88	6.06E-01
immune system development (GO:0002520)	728	15	16.97	-	.88	3.70E-01
mitotic cell cycle phase transition (GO:0044772)	146	3	3.40	-	.88	5.57E-01
skeletal muscle organ development (GO:0060538)	146	3	3.40	-	.88	5.57E-01
nucleocytoplasmic transport (GO:0006913)	195	4	4.55	-	.88	5.23E-01
nuclear transport (GO:0051169)	195	4	4.55	-	.88	5.23E-01
glycerophospholipid metabolic process (GO:0006650)	244	5	5.69	-	.88	4.96E-01
positive regulation of immune system process (GO:0002684)	781	16	18.21	-	.88	3.53E-01
catabolic process (GO:0009056)	1665	34	38.81	-	.88	2.37E-01
B cell activation involved in immune response (GO:0002312)	49	1	1.14	-	.88	6.84E-01
glomerulus development (GO:0032835)	49	1	1.14	-	.88	6.84E-01
cellular response to glucose stimulus (GO:0071333)	49	1	1.14	-	.88	6.84E-01
regulation of leukocyte apoptotic process (GO:2000106)	98	2	2.28	-	.88	6.00E-01
regulation of ubiquitin-protein transferase activity (GO:0051438)	49	1	1.14	-	.88	6.84E-01
positive regulation of nervous system process (GO:0031646)	49	1	1.14	-	.88	6.84E-01
response to hexose (GO:0009746)	98	2	2.28	-	.88	6.00E-01
protein localization to postsynapse (GO:0062237)	49	1	1.14	-	.88	6.84E-01
nucleoside triphosphate biosynthetic process (GO:0009142)	49	1	1.14	-	.88	6.84E-01
rRNA metabolic process (GO:0016072)	196	4	4.57	-	.88	5.18E-01
ceramide biosynthetic process (GO:0046513)	49	1	1.14	-	.88	6.84E-01
polyol metabolic process (GO:0019751)	98	2	2.28	-	.88	6.00E-01
negative regulation of lipid metabolic process (GO:0045833)	98	2	2.28	-	.88	6.00E-01
lipid modification (GO:0030258)	197	4	4.59	-	.87	5.14E-01
hemopoiesis (GO:0030097)	641	13	14.94	-	.87	3.65E-01
regulation of peptidase activity (GO:0052547)	395	8	9.21	-	.87	4.27E-01
unsaturated fatty acid metabolic process (GO:0033559)	99	2	2.31	-	.87	5.94E-01
import into nucleus (GO:0051170)	99	2	2.31	-	.87	5.94E-01
nuclear export (GO:0051168)	99	2	2.31	-	.87	5.94E-01
negative regulation of protein modification process (GO:0031400)	495	10	11.54	-	.87	3.95E-01
response to monosaccharide (GO:0034284)	99	2	2.31	-	.87	5.94E-01
organic substance catabolic process (GO:1901575)	1386	28	32.31	-	.87	2.47E-01
negative regulation of protein kinase activity (GO:0006469)	199	4	4.64	-	.86	5.05E-01
small molecule metabolic process (GO:0044281)	1344	27	31.33	-	.86	2.43E-01
hematopoietic or lymphoid organ development (GO:0048534)	697	14	16.25	-	.86	3.41E-01
mitotic cell cycle process (GO:1903047)	450	9	10.49	-	.86	3.96E-01
regulation of posttranscriptional gene silencing (GO:0060147)	50	1	1.17	-	.86	6.75E-01
positive regulation of tumor necrosis factor production (GO:0032760)	100	2	2.33	-	.86	5.88E-01
internal protein amino acid acetylation (GO:0006475)	100	2	2.33	-	.86	5.88E-01
response to purine-containing compound (GO:0014074)	100	2	2.33	-	.86	5.88E-01
internal peptidyl-lysine acetylation (GO:0018393)	100	2	2.33	-	.86	5.88E-01
bicellular tight junction assembly (GO:0070830)	50	1	1.17	-	.86	6.75E-01
cellular aldehyde metabolic process (GO:0006081)	50	1	1.17	-	.86	6.75E-01
positive regulation of telomere maintenance (GO:0032206)	50	1	1.17	-	.86	6.75E-01
response to estrogen (GO:0043627)	50	1	1.17	-	.86	6.75E-01
cellular protein complex disassembly (GO:0043624)	50	1	1.17	-	.86	6.75E-01
smooth muscle cell differentiation (GO:0051145)	50	1	1.17	-	.86	6.75E-01
regulation of actin filament depolymerization (GO:0030834)	50	1	1.17	-	.86	6.75E-01
cellular response to drug (GO:0035690)	50	1	1.17	-	.86	6.75E-01
establishment or maintenance of apical/basal cell polarity (GO:0035088)	50	1	1.17	-	.86	6.75E-01
establishment or maintenance of bipolar cell polarity (GO:0061245)	50	1	1.17	-	.86	6.75E-01
receptor localization to synapse (GO:0097120)	50	1	1.17	-	.86	6.75E-01
cellular macromolecule metabolic process (GO:0044260)	3706	74	86.39	-	.86	7.37E-02
proteasomal protein catabolic process (GO:0010498)	301	6	7.02	-	.86	4.46E-01
tissue homeostasis (GO:0001894)	201	4	4.69	-	.85	4.97E-01
regulation of cation transmembrane transport (GO:1904062)	352	7	8.21	-	.85	4.23E-01
immune effector process (GO:0002252)	453	9	10.56	-	.85	3.88E-01
renal system process (GO:0003014)	101	2	2.35	-	.85	5.81E-01
positive regulation of myeloid cell differentiation (GO:0045639)	101	2	2.35	-	.85	5.81E-01
positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557)	101	2	2.35	-	.85	5.81E-01
macromolecule catabolic process (GO:0009057)	810	16	18.88	-	.85	2.96E-01
regulation of peptidyl-serine phosphorylation (GO:0033135)	152	3	3.54	-	.85	5.27E-01
regulation of intracellular transport (GO:0032386)	304	6	7.09	-	.85	4.36E-01
organophosphate biosynthetic process (GO:0090407)	355	7	8.28	-	.85	4.14E-01
protein-containing complex localization (GO:0031503)	203	4	4.73	-	.85	4.88E-01
macromolecule modification (GO:0043412)	2289	45	53.36	-	.84	1.23E-01
cellular response to DNA damage stimulus (GO:0006974)	611	12	14.24	-	.84	3.31E-01
negative regulation of immune response (GO:0050777)	153	3	3.57	-	.84	5.22E-01
negative regulation of mRNA catabolic process (GO:1902373)	51	1	1.19	-	.84	6.67E-01
modulation by symbiont of entry into host (GO:0052372)	51	1	1.19	-	.84	6.67E-01
peptidyl-lysine acetylation (GO:0018394)	102	2	2.38	-	.84	5.75E-01
cellular response to hexose stimulus (GO:0071331)	51	1	1.19	-	.84	6.67E-01
protein homotetramerization (GO:0051289)	51	1	1.19	-	.84	6.67E-01
response to dsRNA (GO:0043331)	51	1	1.19	-	.84	6.67E-01
microtubule polymerization or depolymerization (GO:0031109)	51	1	1.19	-	.84	6.67E-01
purine ribonucleoside diphosphate metabolic process (GO:0009179)	51	1	1.19	-	.84	6.67E-01
purine nucleoside diphosphate metabolic process (GO:0009135)	51	1	1.19	-	.84	6.67E-01
regulation of gene silencing by RNA (GO:0060966)	51	1	1.19	-	.84	6.67E-01
negative regulation of insulin secretion (GO:0046676)	51	1	1.19	-	.84	6.67E-01
natural killer cell activation (GO:0030101)	51	1	1.19	-	.84	6.67E-01
neuron recognition (GO:0008038)	51	1	1.19	-	.84	6.67E-01
positive regulation of mRNA catabolic process (GO:0061014)	51	1	1.19	-	.84	6.67E-01
regulation of proteolysis involved in cellular protein catabolic process (GO:1903050)	205	4	4.78	-	.84	4.79E-01
cellular component disassembly (GO:0022411)	205	4	4.78	-	.84	4.79E-01
regulation of mitotic cell cycle phase transition (GO:1901990)	257	5	5.99	-	.83	4.46E-01
regulation of phagocytosis (GO:0050764)	103	2	2.40	-	.83	5.69E-01
positive regulation of epithelial cell proliferation (GO:0050679)	206	4	4.80	-	.83	4.75E-01
regulation of calcium ion transport into cytosol (GO:0010522)	103	2	2.40	-	.83	5.69E-01
regulation of ubiquitin-dependent protein catabolic process (GO:2000058)	155	3	3.61	-	.83	5.12E-01
organic cyclic compound biosynthetic process (GO:1901362)	775	15	18.07	-	.83	2.76E-01
regulation of histone modification (GO:0031056)	155	3	3.61	-	.83	5.12E-01
negative regulation of molecular function (GO:0044092)	982	19	22.89	-	.83	2.38E-01
cellular macromolecule catabolic process (GO:0044265)	724	14	16.88	-	.83	2.86E-01
cerebellum development (GO:0021549)	104	2	2.42	-	.82	5.63E-01
chloride transmembrane transport (GO:1902476)	52	1	1.21	-	.82	6.58E-01
long-chain fatty acid metabolic process (GO:0001676)	104	2	2.42	-	.82	5.63E-01
protein O-linked glycosylation (GO:0006493)	52	1	1.21	-	.82	6.58E-01
cellular response to monosaccharide stimulus (GO:0071326)	52	1	1.21	-	.82	6.58E-01
presynaptic endocytosis (GO:0140238)	52	1	1.21	-	.82	6.58E-01
positive regulation of type I interferon production (GO:0032481)	52	1	1.21	-	.82	6.58E-01
synaptic vesicle endocytosis (GO:0048488)	52	1	1.21	-	.82	6.58E-01
autonomic nervous system development (GO:0048483)	52	1	1.21	-	.82	6.58E-01
tight junction assembly (GO:0120192)	52	1	1.21	-	.82	6.58E-01
response to endoplasmic reticulum stress (GO:0034976)	208	4	4.85	-	.82	4.67E-01
cholesterol transport (GO:0030301)	52	1	1.21	-	.82	6.58E-01
phosphatidylcholine metabolic process (GO:0046470)	52	1	1.21	-	.82	6.58E-01
mitotic cell cycle (GO:0000278)	520	10	12.12	-	.82	3.31E-01
negative regulation of apoptotic process (GO:0043066)	884	17	20.61	-	.82	2.47E-01
regulation of proteolysis (GO:0030162)	677	13	15.78	-	.82	2.88E-01
muscle cell differentiation (GO:0042692)	261	5	6.08	-	.82	4.31E-01
retina development in camera-type eye (GO:0060041)	157	3	3.66	-	.82	5.02E-01
cellular response to metal ion (GO:0071248)	157	3	3.66	-	.82	5.02E-01
negative regulation of cytoskeleton organization (GO:0051494)	157	3	3.66	-	.82	5.02E-01
histone modification (GO:0016570)	315	6	7.34	-	.82	3.98E-01
protein acylation (GO:0043543)	158	3	3.68	-	.81	4.97E-01
sensory perception of sound (GO:0007605)	158	3	3.68	-	.81	4.97E-01
visual perception (GO:0007601)	158	3	3.68	-	.81	4.97E-01
regulation of lymphocyte activation (GO:0051249)	422	8	9.84	-	.81	3.49E-01
lymphocyte activation (GO:0046649)	422	8	9.84	-	.81	3.49E-01
cellular protein metabolic process (GO:0044267)	2697	51	62.87	-	.81	5.70E-02
regulation of sodium ion transmembrane transporter activity (GO:2000649)	53	1	1.24	-	.81	6.50E-01
fatty acid beta-oxidation (GO:0006635)	53	1	1.24	-	.81	6.50E-01
regulation of sensory perception of pain (GO:0051930)	53	1	1.24	-	.81	6.50E-01
demethylation (GO:0070988)	53	1	1.24	-	.81	6.50E-01
retinoid metabolic process (GO:0001523)	53	1	1.24	-	.81	6.50E-01
transcription by RNA polymerase II (GO:0006366)	159	3	3.71	-	.81	4.92E-01
regulation of phosphoprotein phosphatase activity (GO:0043666)	53	1	1.24	-	.81	6.50E-01
endoplasmic reticulum unfolded protein response (GO:0030968)	53	1	1.24	-	.81	6.50E-01
sterol transport (GO:0015918)	53	1	1.24	-	.81	6.50E-01
regulation of collagen metabolic process (GO:0010712)	53	1	1.24	-	.81	6.50E-01
regulation of cardiac muscle cell apoptotic process (GO:0010665)	53	1	1.24	-	.81	6.50E-01
membrane lipid biosynthetic process (GO:0046467)	106	2	2.47	-	.81	5.51E-01
negative regulation of carbohydrate metabolic process (GO:0045912)	53	1	1.24	-	.81	6.50E-01
negative regulation of supramolecular fiber organization (GO:1902904)	159	3	3.71	-	.81	4.92E-01
negative regulation of programmed cell death (GO:0043069)	904	17	21.07	-	.81	2.16E-01
positive regulation of protein catabolic process (GO:0045732)	213	4	4.97	-	.81	4.46E-01
protein targeting (GO:0006605)	213	4	4.97	-	.81	4.46E-01
regulation of intrinsic apoptotic signaling pathway (GO:2001242)	160	3	3.73	-	.80	4.87E-01
covalent chromatin modification (GO:0016569)	320	6	7.46	-	.80	3.82E-01
germ cell development (GO:0007281)	267	5	6.22	-	.80	4.09E-01
mesoderm development (GO:0007498)	107	2	2.49	-	.80	5.45E-01
response to toxic substance (GO:0009636)	107	2	2.49	-	.80	5.45E-01
positive regulation of protein ubiquitination (GO:0031398)	107	2	2.49	-	.80	5.45E-01
purine ribonucleotide biosynthetic process (GO:0009152)	107	2	2.49	-	.80	5.45E-01
defense response to other organism (GO:0098542)	803	15	18.72	-	.80	2.28E-01
cellular nitrogen compound catabolic process (GO:0044270)	268	5	6.25	-	.80	4.05E-01
heterocycle catabolic process (GO:0046700)	268	5	6.25	-	.80	4.05E-01
regulation of calcium ion transmembrane transport (GO:1903169)	161	3	3.75	-	.80	4.82E-01
positive regulation of cytokine production (GO:0001819)	430	8	10.02	-	.80	3.27E-01
positive regulation of protein-containing complex assembly (GO:0031334)	215	4	5.01	-	.80	4.37E-01
organic acid metabolic process (GO:0006082)	753	14	17.55	-	.80	2.33E-01
ribosome biogenesis (GO:0042254)	269	5	6.27	-	.80	4.02E-01
cellular biosynthetic process (GO:0044249)	1886	35	43.96	-	.80	8.55E-02
cellular iron ion homeostasis (GO:0006879)	54	1	1.26	-	.79	6.41E-01
regulation of sensory perception (GO:0051931)	54	1	1.26	-	.79	6.41E-01
protein N-linked glycosylation (GO:0006487)	54	1	1.26	-	.79	6.41E-01
alcohol metabolic process (GO:0006066)	270	5	6.29	-	.79	3.98E-01
regulation of meiotic cell cycle (GO:0051445)	54	1	1.26	-	.79	6.41E-01
sensory perception of light stimulus (GO:0050953)	162	3	3.78	-	.79	4.78E-01
modulation of excitatory postsynaptic potential (GO:0098815)	54	1	1.26	-	.79	6.41E-01
tight junction organization (GO:0120193)	54	1	1.26	-	.79	6.41E-01
positive regulation of striated muscle cell differentiation (GO:0051155)	54	1	1.26	-	.79	6.41E-01
hindbrain development (GO:0030902)	162	3	3.78	-	.79	4.78E-01
chromatin organization involved in negative regulation of transcription (GO:0097549)	54	1	1.26	-	.79	6.41E-01
negative regulation of epithelial cell apoptotic process (GO:1904036)	54	1	1.26	-	.79	6.41E-01
negative regulation of hydrolase activity (GO:0051346)	380	7	8.86	-	.79	3.38E-01
nucleoside phosphate biosynthetic process (GO:1901293)	163	3	3.80	-	.79	4.73E-01
lymphocyte differentiation (GO:0030098)	272	5	6.34	-	.79	3.91E-01
organic substance biosynthetic process (GO:1901576)	1959	36	45.67	-	.79	7.19E-02
nucleic acid phosphodiester bond hydrolysis (GO:0090305)	109	2	2.54	-	.79	5.33E-01
modulation of process of other organism (GO:0035821)	109	2	2.54	-	.79	5.33E-01
macroautophagy (GO:0016236)	109	2	2.54	-	.79	5.33E-01
lipoprotein metabolic process (GO:0042157)	109	2	2.54	-	.79	5.33E-01
response to metal ion (GO:0010038)	273	5	6.36	-	.79	3.88E-01
biosynthetic process (GO:0009058)	2022	37	47.14	-	.78	6.46E-02
negative regulation of kinase activity (GO:0033673)	219	4	5.11	-	.78	4.21E-01
retina homeostasis (GO:0001895)	55	1	1.28	-	.78	6.33E-01
endothelial cell development (GO:0001885)	55	1	1.28	-	.78	6.33E-01
sprouting angiogenesis (GO:0002040)	55	1	1.28	-	.78	6.33E-01
regulation of interferon-beta production (GO:0032648)	55	1	1.28	-	.78	6.33E-01
nucleosome assembly (GO:0006334)	55	1	1.28	-	.78	6.33E-01
astrocyte differentiation (GO:0048708)	55	1	1.28	-	.78	6.33E-01
negative regulation of chemotaxis (GO:0050922)	55	1	1.28	-	.78	6.33E-01
thymus development (GO:0048538)	55	1	1.28	-	.78	6.33E-01
defense response to Gram-positive bacterium (GO:0050830)	110	2	2.56	-	.78	5.27E-01
diterpenoid metabolic process (GO:0016101)	55	1	1.28	-	.78	6.33E-01
T cell activation (GO:0042110)	275	5	6.41	-	.78	3.81E-01
substrate adhesion-dependent cell spreading (GO:0034446)	55	1	1.28	-	.78	6.33E-01
protein catabolic process (GO:0030163)	609	11	14.20	-	.77	2.39E-01
oxoacid metabolic process (GO:0043436)	720	13	16.78	-	.77	2.10E-01
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161)	277	5	6.46	-	.77	3.74E-01
Unclassified (UNCLASSIFIED)	721	13	16.81	-	.77	2.09E-01
icosanoid metabolic process (GO:0006690)	111	2	2.59	-	.77	5.21E-01
multicellular organismal signaling (GO:0035637)	111	2	2.59	-	.77	5.21E-01
cellular response to growth factor stimulus (GO:0071363)	389	7	9.07	-	.77	3.13E-01
aromatic compound biosynthetic process (GO:0019438)	668	12	15.57	-	.77	2.18E-01
spermatid differentiation (GO:0048515)	167	3	3.89	-	.77	4.54E-01
chromosome organization (GO:0051276)	836	15	19.49	-	.77	1.78E-01
small molecule biosynthetic process (GO:0044283)	446	8	10.40	-	.77	2.87E-01
inflammatory response (GO:0006954)	448	8	10.44	-	.77	2.82E-01
vesicle budding from membrane (GO:0006900)	56	1	1.31	-	.77	6.25E-01
DNA biosynthetic process (GO:0071897)	56	1	1.31	-	.77	6.25E-01
regulation of mast cell activation (GO:0033003)	56	1	1.31	-	.77	6.25E-01
regulation of cholesterol transport (GO:0032374)	56	1	1.31	-	.77	6.25E-01
regulation of sterol transport (GO:0032371)	56	1	1.31	-	.77	6.25E-01
positive regulation of protein polymerization (GO:0032273)	112	2	2.61	-	.77	5.15E-01
regulation of myelination (GO:0031641)	56	1	1.31	-	.77	6.25E-01
regulation of alternative mRNA splicing, via spliceosome (GO:0000381)	56	1	1.31	-	.77	6.25E-01
negative regulation of chromatin organization (GO:1905268)	56	1	1.31	-	.77	6.25E-01
ribonucleoside diphosphate metabolic process (GO:0009185)	56	1	1.31	-	.77	6.25E-01
regulation of striated muscle cell apoptotic process (GO:0010662)	56	1	1.31	-	.77	6.25E-01
negative regulation of muscle cell apoptotic process (GO:0010656)	56	1	1.31	-	.77	6.25E-01
cellular response to peptide (GO:1901653)	225	4	5.25	-	.76	3.97E-01
monocarboxylic acid metabolic process (GO:0032787)	452	8	10.54	-	.76	2.73E-01
mRNA catabolic process (GO:0006402)	113	2	2.63	-	.76	5.09E-01
response to carbohydrate (GO:0009743)	113	2	2.63	-	.76	5.09E-01
B cell differentiation (GO:0030183)	113	2	2.63	-	.76	5.09E-01
leukocyte activation involved in immune response (GO:0002366)	170	3	3.96	-	.76	4.40E-01
positive regulation of intracellular transport (GO:0032388)	170	3	3.96	-	.76	4.40E-01
signal release (GO:0023061)	170	3	3.96	-	.76	4.40E-01
positive regulation of interleukin-1 production (GO:0032732)	57	1	1.33	-	.75	6.16E-01
protein glycosylation (GO:0006486)	171	3	3.99	-	.75	4.35E-01
modulation by host of symbiont process (GO:0051851)	57	1	1.33	-	.75	6.16E-01
negative regulation of intracellular transport (GO:0032387)	57	1	1.33	-	.75	6.16E-01
carbohydrate derivative transport (GO:1901264)	57	1	1.33	-	.75	6.16E-01
regulation of carbohydrate catabolic process (GO:0043470)	57	1	1.33	-	.75	6.16E-01
macromolecule glycosylation (GO:0043413)	171	3	3.99	-	.75	4.35E-01
positive regulation of DNA binding (GO:0043388)	57	1	1.33	-	.75	6.16E-01
positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123)	114	2	2.66	-	.75	5.04E-01
regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122)	171	3	3.99	-	.75	4.35E-01
regulation of mitotic sister chromatid separation (GO:0010965)	57	1	1.33	-	.75	6.16E-01
photoreceptor cell development (GO:0042461)	57	1	1.33	-	.75	6.16E-01
protein localization to vacuole (GO:0072665)	57	1	1.33	-	.75	6.16E-01
ureteric bud morphogenesis (GO:0060675)	57	1	1.33	-	.75	6.16E-01
heart valve development (GO:0003170)	57	1	1.33	-	.75	6.16E-01
aromatic compound catabolic process (GO:0019439)	286	5	6.67	-	.75	3.43E-01
vesicle organization (GO:0016050)	229	4	5.34	-	.75	3.82E-01
ribonucleotide biosynthetic process (GO:0009260)	115	2	2.68	-	.75	4.98E-01
peptide secretion (GO:0002790)	115	2	2.68	-	.75	4.98E-01
cell junction assembly (GO:0034329)	230	4	5.36	-	.75	3.78E-01
response to growth factor (GO:0070848)	403	7	9.39	-	.75	2.77E-01
transcription, DNA-templated (GO:0006351)	288	5	6.71	-	.74	3.37E-01
cell activation involved in immune response (GO:0002263)	173	3	4.03	-	.74	4.26E-01
T cell differentiation (GO:0030217)	173	3	4.03	-	.74	4.26E-01
nucleic acid-templated transcription (GO:0097659)	289	5	6.74	-	.74	3.34E-01
secretion (GO:0046903)	463	8	10.79	-	.74	2.47E-01
regulation of innate immune response (GO:0045088)	174	3	4.06	-	.74	4.22E-01
cell-substrate adhesion (GO:0031589)	174	3	4.06	-	.74	4.22E-01
metencephalon development (GO:0022037)	116	2	2.70	-	.74	4.92E-01
mesonephric tubule morphogenesis (GO:0072171)	58	1	1.35	-	.74	6.08E-01
positive regulation of stress-activated MAPK cascade (GO:0032874)	116	2	2.70	-	.74	4.92E-01
DNA methylation or demethylation (GO:0044728)	58	1	1.35	-	.74	6.08E-01
negative regulation of lipid localization (GO:1905953)	58	1	1.35	-	.74	6.08E-01
positive regulation of peptide hormone secretion (GO:0090277)	116	2	2.70	-	.74	4.92E-01
protein modification by small protein removal (GO:0070646)	116	2	2.70	-	.74	4.92E-01
skeletal muscle cell differentiation (GO:0035914)	58	1	1.35	-	.74	6.08E-01
aerobic respiration (GO:0009060)	58	1	1.35	-	.74	6.08E-01
purine nucleotide biosynthetic process (GO:0006164)	117	2	2.73	-	.73	4.86E-01
transition metal ion homeostasis (GO:0055076)	117	2	2.73	-	.73	4.86E-01
carboxylic acid metabolic process (GO:0019752)	703	12	16.39	-	.73	1.64E-01
positive regulation of peptide secretion (GO:0002793)	176	3	4.10	-	.73	4.13E-01
nucleobase-containing compound biosynthetic process (GO:0034654)	588	10	13.71	-	.73	1.92E-01
nervous system process (GO:0050877)	2005	34	46.74	-	.73	2.50E-02
response to ionizing radiation (GO:0010212)	118	2	2.75	-	.73	4.81E-01
RNA biosynthetic process (GO:0032774)	295	5	6.88	-	.73	3.15E-01
protein acetylation (GO:0006473)	118	2	2.75	-	.73	4.81E-01
regulation of leukocyte differentiation (GO:1902105)	295	5	6.88	-	.73	3.15E-01
regulation of action potential (GO:0098900)	59	1	1.38	-	.73	6.00E-01
positive regulation of stress-activated protein kinase signaling cascade (GO:0070304)	118	2	2.75	-	.73	4.81E-01
negative regulation of muscle cell differentiation (GO:0051148)	59	1	1.38	-	.73	6.00E-01
regulation of ATPase activity (GO:0043462)	59	1	1.38	-	.73	6.00E-01
apical junction assembly (GO:0043297)	59	1	1.38	-	.73	6.00E-01
positive regulation of macroautophagy (GO:0016239)	59	1	1.38	-	.73	6.00E-01
myofibril assembly (GO:0030239)	59	1	1.38	-	.73	6.00E-01
labyrinthine layer development (GO:0060711)	59	1	1.38	-	.73	6.00E-01
organonitrogen compound catabolic process (GO:1901565)	890	15	20.75	-	.72	1.15E-01
cellular lipid catabolic process (GO:0044242)	178	3	4.15	-	.72	4.04E-01
proteolysis involved in cellular protein catabolic process (GO:0051603)	535	9	12.47	-	.72	2.00E-01
hexose metabolic process (GO:0019318)	119	2	2.77	-	.72	4.75E-01
regulation of cell-cell adhesion (GO:0022407)	417	7	9.72	-	.72	2.43E-01
G protein-coupled receptor signaling pathway (GO:0007186)	1734	29	40.42	-	.72	3.10E-02
positive regulation of protein localization to plasma membrane (GO:1903078)	60	1	1.40	-	.71	5.92E-01
protein monoubiquitination (GO:0006513)	60	1	1.40	-	.71	5.92E-01
negative regulation of calcium ion transport (GO:0051926)	60	1	1.40	-	.71	5.92E-01
positive regulation of peptidyl-serine phosphorylation (GO:0033138)	120	2	2.80	-	.71	4.69E-01
positive regulation of nuclear division (GO:0051785)	60	1	1.40	-	.71	5.92E-01
cellular response to carbohydrate stimulus (GO:0071322)	60	1	1.40	-	.71	5.92E-01
negative regulation of T cell activation (GO:0050868)	120	2	2.80	-	.71	4.69E-01
synaptic vesicle recycling (GO:0036465)	60	1	1.40	-	.71	5.92E-01
regulation of protein-containing complex disassembly (GO:0043244)	120	2	2.80	-	.71	4.69E-01
glycolipid biosynthetic process (GO:0009247)	60	1	1.40	-	.71	5.92E-01
respiratory electron transport chain (GO:0022904)	60	1	1.40	-	.71	5.92E-01
positive regulation of mitochondrion organization (GO:0010822)	60	1	1.40	-	.71	5.92E-01
carboxylic acid catabolic process (GO:0046395)	180	3	4.20	-	.71	3.95E-01
negative regulation of catalytic activity (GO:0043086)	661	11	15.41	-	.71	1.54E-01
regulation of hemopoiesis (GO:1903706)	362	6	8.44	-	.71	2.60E-01
response to bacterium (GO:0009617)	604	10	14.08	-	.71	1.66E-01
ribose phosphate biosynthetic process (GO:0046390)	121	2	2.82	-	.71	4.64E-01
establishment of protein localization to membrane (GO:0090150)	182	3	4.24	-	.71	3.86E-01
negative regulation of blood pressure (GO:0045776)	61	1	1.42	-	.70	5.84E-01
regulation of myoblast differentiation (GO:0045661)	61	1	1.42	-	.70	5.84E-01
negative regulation of RNA catabolic process (GO:1902369)	61	1	1.42	-	.70	5.84E-01
regulation of antigen receptor-mediated signaling pathway (GO:0050854)	61	1	1.42	-	.70	5.84E-01
drug metabolic process (GO:0017144)	61	1	1.42	-	.70	5.84E-01
regulation of bone remodeling (GO:0046850)	61	1	1.42	-	.70	5.84E-01
positive regulation of dendritic spine development (GO:0060999)	61	1	1.42	-	.70	5.84E-01
ribosome assembly (GO:0042255)	61	1	1.42	-	.70	5.84E-01
positive regulation of autophagy (GO:0010508)	122	2	2.84	-	.70	4.58E-01
purine-containing compound biosynthetic process (GO:0072522)	122	2	2.84	-	.70	4.58E-01
peptidyl-serine phosphorylation (GO:0018105)	184	3	4.29	-	.70	3.78E-01
regulation of mRNA catabolic process (GO:0061013)	123	2	2.87	-	.70	4.53E-01
mononuclear cell differentiation (GO:1903131)	308	5	7.18	-	.70	2.76E-01
humoral immune response (GO:0006959)	185	3	4.31	-	.70	3.74E-01
chromatin organization (GO:0006325)	558	9	13.01	-	.69	1.61E-01
neurotransmitter transport (GO:0006836)	124	2	2.89	-	.69	4.47E-01
JNK cascade (GO:0007254)	62	1	1.45	-	.69	5.76E-01
positive regulation of smooth muscle cell migration (GO:0014911)	62	1	1.45	-	.69	5.76E-01
myotube differentiation (GO:0014902)	62	1	1.45	-	.69	5.76E-01
positive regulation of calcium ion transport into cytosol (GO:0010524)	62	1	1.45	-	.69	5.76E-01
cellular protein catabolic process (GO:0044257)	559	9	13.03	-	.69	1.60E-01
cardiac muscle tissue development (GO:0048738)	187	3	4.36	-	.69	3.65E-01
negative regulation of transferase activity (GO:0051348)	250	4	5.83	-	.69	3.07E-01
cellular catabolic process (GO:0044248)	1438	23	33.52	-	.69	3.06E-02
organic cyclic compound catabolic process (GO:1901361)	313	5	7.30	-	.69	2.62E-01
striated muscle tissue development (GO:0014706)	313	5	7.30	-	.69	2.62E-01
organic acid catabolic process (GO:0016054)	188	3	4.38	-	.68	3.61E-01
cell redox homeostasis (GO:0045454)	63	1	1.47	-	.68	5.68E-01
regulation of sister chromatid segregation (GO:0033045)	63	1	1.47	-	.68	5.68E-01
pyruvate metabolic process (GO:0006090)	63	1	1.47	-	.68	5.68E-01
positive regulation of neuron death (GO:1901216)	126	2	2.94	-	.68	4.37E-01
regulation of blood coagulation (GO:0030193)	63	1	1.47	-	.68	5.68E-01
regulation of immune response (GO:0050776)	634	10	14.78	-	.68	1.25E-01
single fertilization (GO:0007338)	127	2	2.96	-	.68	4.31E-01
regulation of myeloid leukocyte differentiation (GO:0002761)	127	2	2.96	-	.68	4.31E-01
regulation of immunoglobulin production (GO:0002637)	64	1	1.49	-	.67	5.60E-01
arachidonic acid metabolic process (GO:0019369)	64	1	1.49	-	.67	5.60E-01
positive regulation of intrinsic apoptotic signaling pathway (GO:2001244)	64	1	1.49	-	.67	5.60E-01
negative regulation of mitotic cell cycle phase transition (GO:1901991)	128	2	2.98	-	.67	4.26E-01
nephron development (GO:0072006)	128	2	2.98	-	.67	4.26E-01
negative regulation of reproductive process (GO:2000242)	64	1	1.49	-	.67	5.60E-01
regulation of chromosome separation (GO:1905818)	64	1	1.49	-	.67	5.60E-01
cell-cell recognition (GO:0009988)	64	1	1.49	-	.67	5.60E-01
regulation of hemostasis (GO:1900046)	64	1	1.49	-	.67	5.60E-01
electron transport chain (GO:0022900)	64	1	1.49	-	.67	5.60E-01
regulation of gene silencing (GO:0060968)	64	1	1.49	-	.67	5.60E-01
peptide hormone secretion (GO:0030072)	64	1	1.49	-	.67	5.60E-01
regulation of chromatin organization (GO:1902275)	192	3	4.48	-	.67	3.45E-01
nuclear chromosome segregation (GO:0098813)	192	3	4.48	-	.67	3.45E-01
positive regulation of protein modification by small protein conjugation or removal (GO:1903322)	129	2	3.01	-	.67	4.21E-01
cellular macromolecule biosynthetic process (GO:0034645)	1097	17	25.57	-	.66	4.37E-02
positive regulation of leukocyte activation (GO:0002696)	323	5	7.53	-	.66	2.36E-01
T cell differentiation in thymus (GO:0033077)	65	1	1.52	-	.66	5.52E-01
regulation of generation of precursor metabolites and energy (GO:0043467)	130	2	3.03	-	.66	4.16E-01
ribosomal large subunit biogenesis (GO:0042273)	65	1	1.52	-	.66	5.52E-01
cardiocyte differentiation (GO:0035051)	130	2	3.03	-	.66	4.16E-01
heterocycle biosynthetic process (GO:0018130)	651	10	15.18	-	.66	1.06E-01
macromolecule biosynthetic process (GO:0009059)	1109	17	25.85	-	.66	3.89E-02
ubiquitin-dependent protein catabolic process (GO:0006511)	458	7	10.68	-	.66	1.62E-01
RNA phosphodiester bond hydrolysis (GO:0090501)	66	1	1.54	-	.65	5.45E-01
positive regulation of protein localization to cell periphery (GO:1904377)	66	1	1.54	-	.65	5.45E-01
positive regulation of alpha-beta T cell activation (GO:0046635)	66	1	1.54	-	.65	5.45E-01
chromatin organization involved in regulation of transcription (GO:0034401)	66	1	1.54	-	.65	5.45E-01
regulation of morphogenesis of a branching structure (GO:0060688)	66	1	1.54	-	.65	5.45E-01
positive regulation of myeloid leukocyte differentiation (GO:0002763)	66	1	1.54	-	.65	5.45E-01
regulation of myeloid cell differentiation (GO:0045637)	198	3	4.62	-	.65	3.22E-01
muscle tissue development (GO:0060537)	331	5	7.72	-	.65	2.16E-01
chondrocyte differentiation (GO:0002062)	67	1	1.56	-	.64	5.37E-01
protein autoubiquitination (GO:0051865)	67	1	1.56	-	.64	5.37E-01
negative regulation of reactive oxygen species metabolic process (GO:2000378)	67	1	1.56	-	.64	5.37E-01
chromatin remodeling (GO:0006338)	134	2	3.12	-	.64	3.95E-01
regulation of coagulation (GO:0050818)	67	1	1.56	-	.64	5.37E-01
regulation of lymphocyte apoptotic process (GO:0070228)	67	1	1.56	-	.64	5.37E-01
modification-dependent protein catabolic process (GO:0019941)	469	7	10.93	-	.64	1.44E-01
negative regulation of wound healing (GO:0061045)	67	1	1.56	-	.64	5.37E-01
negative regulation of immune effector process (GO:0002698)	134	2	3.12	-	.64	3.95E-01
positive regulation of cell activation (GO:0050867)	337	5	7.86	-	.64	2.02E-01
nephron tubule morphogenesis (GO:0072078)	68	1	1.59	-	.63	5.29E-01
positive regulation of chemokine production (GO:0032722)	68	1	1.59	-	.63	5.29E-01
positive regulation of intracellular protein transport (GO:0090316)	136	2	3.17	-	.63	3.85E-01
neuromuscular process controlling balance (GO:0050885)	68	1	1.59	-	.63	5.29E-01
negative regulation of NF-kappaB transcription factor activity (GO:0032088)	68	1	1.59	-	.63	5.29E-01
ribosomal small subunit biogenesis (GO:0042274)	68	1	1.59	-	.63	5.29E-01
skeletal muscle tissue development (GO:0007519)	136	2	3.17	-	.63	3.85E-01
negative regulation of phosphorus metabolic process (GO:0010563)	477	7	11.12	-	.63	1.32E-01
negative regulation of phosphate metabolic process (GO:0045936)	477	7	11.12	-	.63	1.32E-01
modification-dependent macromolecule catabolic process (GO:0043632)	478	7	11.14	-	.63	1.31E-01
endocrine system development (GO:0035270)	137	2	3.19	-	.63	3.80E-01
regulation of histone methylation (GO:0031060)	69	1	1.61	-	.62	5.22E-01
regulation of signaling receptor activity (GO:0010469)	138	2	3.22	-	.62	3.75E-01
positive regulation of cellular protein catabolic process (GO:1903364)	138	2	3.22	-	.62	3.75E-01
regulation of protein localization to nucleus (GO:1900180)	139	2	3.24	-	.62	3.71E-01
regulation of intracellular protein transport (GO:0033157)	209	3	4.87	-	.62	2.82E-01
diencephalon development (GO:0021536)	70	1	1.63	-	.61	5.14E-01
nephron epithelium morphogenesis (GO:0072088)	70	1	1.63	-	.61	5.14E-01
mitochondrial transmembrane transport (GO:1990542)	70	1	1.63	-	.61	5.14E-01
regulation of intracellular pH (GO:0051453)	70	1	1.63	-	.61	5.14E-01
visual learning (GO:0008542)	70	1	1.63	-	.61	5.14E-01
neural retina development (GO:0003407)	70	1	1.63	-	.61	5.14E-01
photoreceptor cell differentiation (GO:0046530)	70	1	1.63	-	.61	5.14E-01
monocarboxylic acid biosynthetic process (GO:0072330)	141	2	3.29	-	.61	3.61E-01
protein import (GO:0017038)	141	2	3.29	-	.61	3.61E-01
secretion by cell (GO:0032940)	354	5	8.25	-	.61	1.67E-01
vesicle fusion (GO:0006906)	71	1	1.66	-	.60	5.07E-01
organelle transport along microtubule (GO:0072384)	71	1	1.66	-	.60	5.07E-01
nephron morphogenesis (GO:0072028)	71	1	1.66	-	.60	5.07E-01
DNA modification (GO:0006304)	71	1	1.66	-	.60	5.07E-01
neuron fate commitment (GO:0048663)	71	1	1.66	-	.60	5.07E-01
carbohydrate derivative biosynthetic process (GO:1901137)	426	6	9.93	-	.60	1.32E-01
positive regulation of muscle cell differentiation (GO:0051149)	71	1	1.66	-	.60	5.07E-01
striated muscle cell differentiation (GO:0051146)	213	3	4.97	-	.60	2.68E-01
negative regulation of cell cycle phase transition (GO:1901988)	143	2	3.33	-	.60	3.52E-01
meiotic nuclear division (GO:0140013)	143	2	3.33	-	.60	3.52E-01
small molecule catabolic process (GO:0044282)	286	4	6.67	-	.60	2.03E-01
negative regulation of chromosome organization (GO:2001251)	72	1	1.68	-	.60	5.00E-01
negative regulation of protein depolymerization (GO:1901880)	72	1	1.68	-	.60	5.00E-01
carboxylic acid biosynthetic process (GO:0046394)	216	3	5.04	-	.60	2.58E-01
positive regulation of interferon-gamma production (GO:0032729)	73	1	1.70	-	.59	4.92E-01
positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068)	73	1	1.70	-	.59	4.92E-01
regulation of viral genome replication (GO:0045069)	73	1	1.70	-	.59	4.92E-01
positive regulation of protein transport (GO:0051222)	292	4	6.81	-	.59	1.89E-01
establishment of protein localization to organelle (GO:0072594)	294	4	6.85	-	.58	1.85E-01
glycoprotein biosynthetic process (GO:0009101)	221	3	5.15	-	.58	2.43E-01
regulation of osteoclast differentiation (GO:0045670)	74	1	1.73	-	.58	4.85E-01
negative regulation of protein ubiquitination (GO:0031397)	74	1	1.73	-	.58	4.85E-01
negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154)	74	1	1.73	-	.58	4.85E-01
cardiac cell development (GO:0055006)	74	1	1.73	-	.58	4.85E-01
organic acid biosynthetic process (GO:0016053)	222	3	5.18	-	.58	2.40E-01
renal tubule morphogenesis (GO:0061333)	74	1	1.73	-	.58	4.85E-01
leukocyte differentiation (GO:0002521)	370	5	8.63	-	.58	1.38E-01
positive regulation of protein secretion (GO:0050714)	149	2	3.47	-	.58	3.25E-01
fatty acid oxidation (GO:0019395)	75	1	1.75	-	.57	4.78E-01
cytokine production (GO:0001816)	150	2	3.50	-	.57	3.20E-01
regulation of response to endoplasmic reticulum stress (GO:1905897)	75	1	1.75	-	.57	4.78E-01
regulation of purine nucleotide metabolic process (GO:1900542)	75	1	1.75	-	.57	4.78E-01
protein ubiquitination (GO:0016567)	451	6	10.51	-	.57	9.81E-02
protein modification by small protein conjugation or removal (GO:0070647)	603	8	14.06	-	.57	5.73E-02
cellular nitrogen compound biosynthetic process (GO:0044271)	1056	14	24.62	-	.57	1.28E-02
regulation of leukocyte cell-cell adhesion (GO:1903037)	303	4	7.06	-	.57	1.65E-01
endoplasmic reticulum organization (GO:0007029)	76	1	1.77	-	.56	4.71E-01
cellular response to calcium ion (GO:0071277)	76	1	1.77	-	.56	4.71E-01
regulation of nucleotide metabolic process (GO:0006140)	76	1	1.77	-	.56	4.71E-01
organelle membrane fusion (GO:0090174)	76	1	1.77	-	.56	4.71E-01
nucleoside phosphate catabolic process (GO:1901292)	76	1	1.77	-	.56	4.71E-01
dicarboxylic acid metabolic process (GO:0043648)	76	1	1.77	-	.56	4.71E-01
alpha-amino acid metabolic process (GO:1901605)	153	2	3.57	-	.56	3.08E-01
peptidyl-lysine modification (GO:0018205)	230	3	5.36	-	.56	2.16E-01
positive regulation of establishment of protein localization (GO:1904951)	307	4	7.16	-	.56	1.57E-01
integrin-mediated signaling pathway (GO:0007229)	77	1	1.79	-	.56	4.64E-01
regulation of viral process (GO:0050792)	155	2	3.61	-	.55	2.99E-01
regulation of protein acetylation (GO:1901983)	78	1	1.82	-	.55	4.57E-01
modulation of process of other organism involved in symbiotic interaction (GO:0051817)	78	1	1.82	-	.55	4.57E-01
response to glucocorticoid (GO:0051384)	78	1	1.82	-	.55	4.57E-01
regulation of cellular pH (GO:0030641)	78	1	1.82	-	.55	4.57E-01
spermatid development (GO:0007286)	158	2	3.68	-	.54	2.87E-01
protein targeting to membrane (GO:0006612)	79	1	1.84	-	.54	4.50E-01
regulation of chromosome segregation (GO:0051983)	79	1	1.84	-	.54	4.50E-01
histone methylation (GO:0016571)	79	1	1.84	-	.54	4.50E-01
nucleotide biosynthetic process (GO:0009165)	158	2	3.68	-	.54	2.87E-01
negative regulation of proteolysis (GO:0045861)	316	4	7.37	-	.54	1.40E-01
meiotic cell cycle process (GO:1903046)	159	2	3.71	-	.54	2.83E-01
export from cell (GO:0140352)	399	5	9.30	-	.54	9.61E-02
double-strand break repair (GO:0006302)	160	2	3.73	-	.54	2.79E-01
sulfur compound biosynthetic process (GO:0044272)	80	1	1.86	-	.54	4.43E-01
muscle cell development (GO:0055001)	160	2	3.73	-	.54	2.79E-01
negative regulation of endopeptidase activity (GO:0010951)	161	2	3.75	-	.53	2.75E-01
columnar/cuboidal epithelial cell differentiation (GO:0002065)	81	1	1.89	-	.53	4.37E-01
negative regulation of cysteine-type endopeptidase activity (GO:2000117)	81	1	1.89	-	.53	4.37E-01
positive regulation of neuron apoptotic process (GO:0043525)	81	1	1.89	-	.53	4.37E-01
lipid oxidation (GO:0034440)	81	1	1.89	-	.53	4.37E-01
regulation of leukocyte proliferation (GO:0070663)	244	3	5.69	-	.53	1.79E-01
protein modification by small protein conjugation (GO:0032446)	491	6	11.45	-	.52	5.96E-02
neurotransmitter secretion (GO:0007269)	82	1	1.91	-	.52	4.30E-01
nephron tubule development (GO:0072080)	82	1	1.91	-	.52	4.30E-01
cellular response to hypoxia (GO:0071456)	82	1	1.91	-	.52	4.30E-01
cellular response to ketone (GO:1901655)	82	1	1.91	-	.52	4.30E-01
biological process involved in interaction with symbiont (GO:0051702)	82	1	1.91	-	.52	4.30E-01
signal release from synapse (GO:0099643)	82	1	1.91	-	.52	4.30E-01
negative regulation of protein secretion (GO:0050709)	82	1	1.91	-	.52	4.30E-01
chromosome segregation (GO:0007059)	248	3	5.78	-	.52	1.70E-01
negative regulation of protein phosphorylation (GO:0001933)	332	4	7.74	-	.52	1.13E-01
protein lipidation (GO:0006497)	83	1	1.93	-	.52	4.23E-01
positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436)	83	1	1.93	-	.52	4.23E-01
regulation of ion transmembrane transporter activity (GO:0032412)	249	3	5.80	-	.52	1.68E-01
B cell activation (GO:0042113)	167	2	3.89	-	.51	2.53E-01
mitochondrial transport (GO:0006839)	168	2	3.92	-	.51	2.49E-01
xenobiotic metabolic process (GO:0006805)	84	1	1.96	-	.51	4.17E-01
positive regulation of mitotic cell cycle phase transition (GO:1901992)	84	1	1.96	-	.51	4.17E-01
regulation of biological process involved in symbiotic interaction (GO:0043903)	168	2	3.92	-	.51	2.49E-01
peptide metabolic process (GO:0006518)	421	5	9.81	-	.51	7.21E-02
response to corticosteroid (GO:0031960)	85	1	1.98	-	.50	4.10E-01
defense response to Gram-negative bacterium (GO:0050829)	85	1	1.98	-	.50	4.10E-01
positive regulation of insulin secretion (GO:0032024)	85	1	1.98	-	.50	4.10E-01
chromatin assembly (GO:0031497)	85	1	1.98	-	.50	4.10E-01
regulation of DNA recombination (GO:0000018)	85	1	1.98	-	.50	4.10E-01
regulation of ATP metabolic process (GO:1903578)	85	1	1.98	-	.50	4.10E-01
negative regulation of protein modification by small protein conjugation or removal (GO:1903321)	85	1	1.98	-	.50	4.10E-01
organonitrogen compound biosynthetic process (GO:1901566)	1020	12	23.78	-	.50	5.06E-03
regulation of T cell proliferation (GO:0042129)	171	2	3.99	-	.50	2.39E-01
regulation of cation channel activity (GO:2001257)	172	2	4.01	-	.50	2.35E-01
positive regulation of leukocyte differentiation (GO:1902107)	172	2	4.01	-	.50	2.35E-01
cellular response to decreased oxygen levels (GO:0036294)	86	1	2.00	-	.50	4.04E-01
positive regulation of hemopoiesis (GO:1903708)	172	2	4.01	-	.50	2.35E-01
positive regulation of cell-cell adhesion (GO:0022409)	258	3	6.01	-	.50	1.48E-01
regulation of transmembrane transporter activity (GO:0022898)	259	3	6.04	-	.50	1.46E-01
fertilization (GO:0009566)	173	2	4.03	-	.50	2.32E-01
positive regulation of lymphocyte activation (GO:0051251)	264	3	6.15	-	.49	1.36E-01
regulation of protein depolymerization (GO:1901879)	88	1	2.05	-	.49	3.92E-01
cellular response to xenobiotic stimulus (GO:0071466)	88	1	2.05	-	.49	3.92E-01
renal tubule development (GO:0061326)	88	1	2.05	-	.49	3.92E-01
lipoprotein biosynthetic process (GO:0042158)	88	1	2.05	-	.49	3.92E-01
positive regulation of immune response (GO:0050778)	444	5	10.35	-	.48	5.29E-02
kidney morphogenesis (GO:0060993)	89	1	2.07	-	.48	3.85E-01
mitochondrial membrane organization (GO:0007006)	90	1	2.10	-	.48	3.79E-01
cellular transition metal ion homeostasis (GO:0046916)	90	1	2.10	-	.48	3.79E-01
regulation of macroautophagy (GO:0016241)	90	1	2.10	-	.48	3.79E-01
nucleosome organization (GO:0034728)	90	1	2.10	-	.48	3.79E-01
regulation of transporter activity (GO:0032409)	270	3	6.29	-	.48	1.25E-01
leukocyte homeostasis (GO:0001776)	91	1	2.12	-	.47	3.73E-01
organelle fusion (GO:0048284)	91	1	2.12	-	.47	3.73E-01
sensory perception (GO:0007600)	1561	17	36.39	-	.47	1.67E-04
regulation of chemokine production (GO:0032642)	92	1	2.14	-	.47	3.68E-01
nuclear-transcribed mRNA catabolic process (GO:0000956)	92	1	2.14	-	.47	3.68E-01
nucleobase-containing small molecule biosynthetic process (GO:0034404)	92	1	2.14	-	.47	3.68E-01
mitochondrion organization (GO:0007005)	370	4	8.63	-	.46	6.70E-02
DNA recombination (GO:0006310)	186	2	4.34	-	.46	1.91E-01
response to xenobiotic stimulus (GO:0009410)	94	1	2.19	-	.46	3.56E-01
protein secretion (GO:0009306)	94	1	2.19	-	.46	3.56E-01
regulation of muscle cell apoptotic process (GO:0010660)	94	1	2.19	-	.46	3.56E-01
regulation of pH (GO:0006885)	95	1	2.21	-	.45	3.50E-01
establishment of protein localization to extracellular region (GO:0035592)	95	1	2.21	-	.45	3.50E-01
positive regulation of production of molecular mediator of immune response (GO:0002702)	95	1	2.21	-	.45	3.50E-01
negative regulation of phosphorylation (GO:0042326)	383	4	8.93	-	.45	5.56E-02
positive regulation of cell cycle phase transition (GO:1901989)	96	1	2.24	-	.45	3.45E-01
nephron epithelium development (GO:0072009)	96	1	2.24	-	.45	3.45E-01
regulation of phosphatidylinositol 3-kinase signaling (GO:0014066)	96	1	2.24	-	.45	3.45E-01
positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060)	97	1	2.26	-	.44	3.39E-01
regulation of striated muscle cell differentiation (GO:0051153)	97	1	2.26	-	.44	3.39E-01
response to pheromone (GO:0019236)	98	1	2.28	-	.44	3.34E-01
negative regulation of protein binding (GO:0032091)	99	1	2.31	-	.43	3.28E-01
cellular component assembly involved in morphogenesis (GO:0010927)	99	1	2.31	-	.43	3.28E-01
regulation of mRNA stability (GO:0043488)	100	1	2.33	-	.43	3.23E-01
macromolecule methylation (GO:0043414)	201	2	4.69	-	.43	1.52E-01
protein localization to extracellular region (GO:0071692)	101	1	2.35	-	.42	3.18E-01
cellular response to oxygen levels (GO:0071453)	101	1	2.35	-	.42	3.18E-01
chromatin assembly or disassembly (GO:0006333)	101	1	2.35	-	.42	3.18E-01
regulation of alpha-beta T cell activation (GO:0046634)	101	1	2.35	-	.42	3.18E-01
reactive oxygen species metabolic process (GO:0072593)	101	1	2.35	-	.42	3.18E-01
endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888)	102	1	2.38	-	.42	3.12E-01
fatty acid biosynthetic process (GO:0006633)	102	1	2.38	-	.42	3.12E-01
positive regulation of proteasomal protein catabolic process (GO:1901800)	102	1	2.38	-	.42	3.12E-01
activation of immune response (GO:0002253)	206	2	4.80	-	.42	1.41E-01
regulation of T cell activation (GO:0050863)	310	3	7.23	-	.42	6.90E-02
striated muscle cell development (GO:0055002)	104	1	2.42	-	.41	3.02E-01
regulation of cytokine-mediated signaling pathway (GO:0001959)	105	1	2.45	-	.41	2.97E-01
DNA-dependent DNA replication (GO:0006261)	105	1	2.45	-	.41	2.97E-01
cellular monovalent inorganic cation homeostasis (GO:0030004)	105	1	2.45	-	.41	2.97E-01
regulation of fibroblast proliferation (GO:0048145)	106	1	2.47	-	.40	2.92E-01
dephosphorylation (GO:0016311)	213	2	4.97	-	.40	1.26E-01
autophagy (GO:0006914)	214	2	4.99	-	.40	1.24E-01
protein-DNA complex assembly (GO:0065004)	107	1	2.49	-	.40	2.88E-01
process utilizing autophagic mechanism (GO:0061919)	214	2	4.99	-	.40	1.24E-01
tRNA processing (GO:0008033)	107	1	2.49	-	.40	2.88E-01
cell-cell junction assembly (GO:0007043)	110	1	2.56	-	.39	2.73E-01
cellular amino acid metabolic process (GO:0006520)	220	2	5.13	-	.39	1.13E-01
meiotic cell cycle (GO:0051321)	220	2	5.13	-	.39	1.13E-01
regulation of cell killing (GO:0031341)	110	1	2.56	-	.39	2.73E-01
positive regulation of lymphocyte differentiation (GO:0045621)	111	1	2.59	-	.39	2.69E-01
protein methylation (GO:0006479)	111	1	2.59	-	.39	2.69E-01
regulation of RNA stability (GO:0043487)	111	1	2.59	-	.39	2.69E-01
protein alkylation (GO:0008213)	111	1	2.59	-	.39	2.69E-01
regulation of lymphocyte proliferation (GO:0050670)	224	2	5.22	-	.38	1.06E-01
negative regulation of peptidase activity (GO:0010466)	224	2	5.22	-	.38	1.06E-01
antigen receptor-mediated signaling pathway (GO:0050851)	113	1	2.63	-	.38	2.60E-01
regulation of mononuclear cell proliferation (GO:0032944)	227	2	5.29	-	.38	1.01E-01
cell-matrix adhesion (GO:0007160)	114	1	2.66	-	.38	2.56E-01
regulation of response to cytokine stimulus (GO:0060759)	114	1	2.66	-	.38	2.56E-01
regulation of mitochondrion organization (GO:0010821)	115	1	2.68	-	.37	2.51E-01
glycerophospholipid biosynthetic process (GO:0046474)	115	1	2.68	-	.37	2.51E-01
positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052)	118	1	2.75	-	.36	2.39E-01
lymphocyte activation involved in immune response (GO:0002285)	119	1	2.77	-	.36	2.35E-01
synaptic vesicle cycle (GO:0099504)	120	1	2.80	-	.36	2.31E-01
regulation of autophagy (GO:0010506)	241	2	5.62	-	.36	8.00E-02
methylation (GO:0032259)	246	2	5.73	-	.35	7.36E-02
lymphocyte mediated immunity (GO:0002449)	128	1	2.98	-	.34	2.01E-01
positive regulation of inflammatory response (GO:0050729)	128	1	2.98	-	.34	2.01E-01
negative regulation of ion transmembrane transport (GO:0034766)	130	1	3.03	-	.33	1.94E-01
negative regulation of transmembrane transport (GO:0034763)	131	1	3.05	-	.33	1.90E-01
vesicle-mediated transport in synapse (GO:0099003)	133	1	3.10	-	.32	1.84E-01
phosphatidylinositol metabolic process (GO:0046488)	133	1	3.10	-	.32	1.84E-01
defense response to bacterium (GO:0042742)	268	2	6.25	-	.32	5.06E-02
immune response-activating cell surface receptor signaling pathway (GO:0002429)	138	1	3.22	-	.31	1.68E-01
regulation of viral life cycle (GO:1903900)	138	1	3.22	-	.31	1.68E-01
monovalent inorganic cation homeostasis (GO:0055067)	139	1	3.24	-	.31	1.65E-01
immune response-activating signal transduction (GO:0002757)	139	1	3.24	-	.31	1.65E-01
regulation of production of molecular mediator of immune response (GO:0002700)	139	1	3.24	-	.31	1.65E-01
adaptive immune response (GO:0002250)	283	2	6.60	-	.30	3.90E-02
organophosphate catabolic process (GO:0046434)	142	1	3.31	-	.30	1.56E-01
protein-DNA complex subunit organization (GO:0071824)	146	1	3.40	-	.29	1.45E-01
intrinsic apoptotic signaling pathway (GO:0097193)	148	1	3.45	-	.29	1.40E-01
ATP metabolic process (GO:0046034)	149	1	3.47	-	.29	1.38E-01
sensory perception of smell (GO:0007608)	1054	7	24.57	-	.28	2.12E-05
response to steroid hormone (GO:0048545)	151	1	3.52	-	.28	1.33E-01
immune response-regulating cell surface receptor signaling pathway (GO:0002768)	151	1	3.52	-	.28	1.33E-01
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460)	153	1	3.57	-	.28	1.28E-01
tRNA metabolic process (GO:0006399)	153	1	3.57	-	.28	1.28E-01
immune response-regulating signaling pathway (GO:0002764)	154	1	3.59	-	.28	1.26E-01
protein dephosphorylation (GO:0006470)	157	1	3.66	-	.27	1.19E-01
sensory perception of chemical stimulus (GO:0007606)	1151	7	26.83	-	.26	3.58E-06
regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002822)	166	1	3.87	-	.26	1.01E-01
leukocyte mediated immunity (GO:0002443)	168	1	3.92	-	.26	9.68E-02
regulation of adaptive immune response (GO:0002819)	182	1	4.24	-	.24	7.43E-02
positive regulation of T cell activation (GO:0050870)	195	1	4.55	-	.22	5.79E-02
regulation of immune effector process (GO:0002697)	391	2	9.11	-	.22	5.34E-03
amide biosynthetic process (GO:0043604)	399	2	9.30	-	.22	4.58E-03
protein polyubiquitination (GO:0000209)	204	1	4.76	-	.21	4.87E-02
exocytosis (GO:0006887)	212	1	4.94	-	.20	4.16E-02
positive regulation of leukocyte cell-cell adhesion (GO:1903039)	216	1	5.04	-	.20	3.85E-02
positive regulation of immune effector process (GO:0002699)	232	1	5.41	-	.18	2.80E-02
peptide biosynthetic process (GO:0043043)	311	1	7.25	-	.14	5.59E-03
respiratory burst involved in defense response (GO:0002679)	5	0	.12	-	 < 0.01	8.90E-01
response to lead ion (GO:0010288)	10	0	.23	-	 < 0.01	7.92E-01
positive regulation of chronic inflammatory response (GO:0002678)	5	0	.12	-	 < 0.01	8.90E-01
heat acclimation (GO:0010286)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of acute inflammatory response (GO:0002675)	31	0	.72	-	 < 0.01	4.85E-01
negative regulation of acute inflammatory response (GO:0002674)	12	0	.28	-	 < 0.01	7.56E-01
regulation of acute inflammatory response (GO:0002673)	50	0	1.17	-	 < 0.01	3.11E-01
protein hexamerization (GO:0034214)	7	0	.16	-	 < 0.01	8.49E-01
quinolinate catabolic process (GO:0034213)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of T cell anergy (GO:0002669)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of T cell anergy (GO:0002668)	1	0	.02	-	 < 0.01	9.77E-01
regulation of T cell anergy (GO:0002667)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of T cell tolerance induction (GO:0002666)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of T cell tolerance induction (GO:0002665)	1	0	.02	-	 < 0.01	9.77E-01
regulation of T cell tolerance induction (GO:0002664)	11	0	.26	-	 < 0.01	7.74E-01
detoxification of copper ion (GO:0010273)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of B cell tolerance induction (GO:0002663)	2	0	.05	-	 < 0.01	9.54E-01
response to silver ion (GO:0010272)	1	0	.02	-	 < 0.01	9.77E-01
regulation of B cell tolerance induction (GO:0002661)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of peripheral tolerance induction (GO:0002660)	2	0	.05	-	 < 0.01	9.54E-01
amyloid-beta formation (GO:0034205)	10	0	.23	-	 < 0.01	7.92E-01
glycolipid translocation (GO:0034203)	1	0	.02	-	 < 0.01	9.77E-01
response to selenium ion (GO:0010269)	2	0	.05	-	 < 0.01	9.54E-01
regulation of peripheral tolerance induction (GO:0002658)	2	0	.05	-	 < 0.01	9.54E-01
SCF complex assembly (GO:0010265)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of tolerance induction dependent upon immune response (GO:0002654)	2	0	.05	-	 < 0.01	9.54E-01
regulation of tolerance induction dependent upon immune response (GO:0002652)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of tolerance induction to self antigen (GO:0002651)	1	0	.02	-	 < 0.01	9.77E-01
animal organ senescence (GO:0010260)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of chromatin assembly or disassembly (GO:0045799)	11	0	.26	-	 < 0.01	7.74E-01
negative regulation of chromatin assembly or disassembly (GO:0045798)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of intestinal cholesterol absorption (GO:0045797)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of intestinal cholesterol absorption (GO:0045796)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of cell volume (GO:0045795)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of cell volume (GO:0045794)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of cell size (GO:0045792)	13	0	.30	-	 < 0.01	7.38E-01
regulation of tolerance induction to self antigen (GO:0002649)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of central tolerance induction (GO:0002648)	1	0	.02	-	 < 0.01	9.77E-01
NADH dehydrogenase complex assembly (GO:0010257)	44	0	1.03	-	 < 0.01	3.58E-01
regulation of central tolerance induction (GO:0002646)	1	0	.02	-	 < 0.01	9.77E-01
glucose mediated signaling pathway (GO:0010255)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of tolerance induction (GO:0002645)	10	0	.23	-	 < 0.01	7.92E-01
negative regulation of tolerance induction (GO:0002644)	2	0	.05	-	 < 0.01	9.54E-01
regulation of tolerance induction (GO:0002643)	18	0	.42	-	 < 0.01	6.57E-01
positive regulation of bone resorption (GO:0045780)	26	0	.61	-	 < 0.01	5.45E-01
establishment or maintenance of transmembrane electrochemical gradient (GO:0010248)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of germinal center formation (GO:0002636)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of germinal center formation (GO:0002635)	2	0	.05	-	 < 0.01	9.54E-01
regulation of germinal center formation (GO:0002634)	9	0	.21	-	 < 0.01	8.11E-01
negative regulation of granuloma formation (GO:0002632)	1	0	.02	-	 < 0.01	9.77E-01
regulation of granuloma formation (GO:0002631)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of bone resorption (GO:0045779)	18	0	.42	-	 < 0.01	6.57E-01
positive regulation of asymmetric cell division (GO:0045770)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of T cell antigen processing and presentation (GO:0002626)	1	0	.02	-	 < 0.01	9.77E-01
regulation of T cell antigen processing and presentation (GO:0002625)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of asymmetric cell division (GO:0045769)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of cellular amino acid metabolic process (GO:0045764)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of adenylate cyclase activity (GO:0045762)	10	0	.23	-	 < 0.01	7.92E-01
regulation of adenylate cyclase activity (GO:0045761)	27	0	.63	-	 < 0.01	5.33E-01
positive regulation of action potential (GO:0045760)	14	0	.33	-	 < 0.01	7.21E-01
negative regulation of macrophage antigen processing and presentation (GO:0002617)	1	0	.02	-	 < 0.01	9.77E-01
regulation of macrophage antigen processing and presentation (GO:0002616)	1	0	.02	-	 < 0.01	9.77E-01
response to UV-C (GO:0010225)	13	0	.30	-	 < 0.01	7.38E-01
response to UV-B (GO:0010224)	16	0	.37	-	 < 0.01	6.89E-01
negative regulation of action potential (GO:0045759)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of Toll signaling pathway (GO:0045751)	1	0	.02	-	 < 0.01	9.77E-01
maintenance of DNA methylation (GO:0010216)	9	0	.21	-	 < 0.01	8.11E-01
positive regulation of dendritic cell antigen processing and presentation (GO:0002606)	7	0	.16	-	 < 0.01	8.49E-01
regulation of hexokinase activity (GO:1903299)	9	0	.21	-	 < 0.01	8.11E-01
negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway (GO:1903298)	6	0	.14	-	 < 0.01	8.69E-01
regulation of hypoxia-induced intrinsic apoptotic signaling pathway (GO:1903297)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of Notch signaling pathway (GO:0045747)	43	0	1.00	-	 < 0.01	3.67E-01
positive regulation of glutamate secretion, neurotransmission (GO:1903296)	4	0	.09	-	 < 0.01	9.11E-01
regulation of glutamate secretion, neurotransmission (GO:1903294)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of fibroblast growth factor receptor signaling pathway (GO:0045743)	8	0	.19	-	 < 0.01	8.30E-01
protein localization to Golgi membrane (GO:1903292)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of potassium ion import across plasma membrane (GO:1903288)	6	0	.14	-	 < 0.01	8.69E-01
arginine catabolic process to proline (GO:0019493)	1	0	.02	-	 < 0.01	9.77E-01
regulation of potassium ion import (GO:1903286)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736)	26	0	.61	-	 < 0.01	5.45E-01
positive regulation of hydrogen peroxide catabolic process (GO:1903285)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of glutathione peroxidase activity (GO:1903284)	1	0	.02	-	 < 0.01	9.77E-01
regulation of glutathione peroxidase activity (GO:1903282)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of calcium:sodium antiporter activity (GO:1903281)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of calcium:sodium antiporter activity (GO:1903280)	1	0	.02	-	 < 0.01	9.77E-01
respiratory burst (GO:0045730)	13	0	.30	-	 < 0.01	7.38E-01
response to glucagon (GO:0033762)	6	0	.14	-	 < 0.01	8.69E-01
forebrain dorsal/ventral pattern formation (GO:0021798)	7	0	.16	-	 < 0.01	8.49E-01
forebrain anterior/posterior pattern specification (GO:0021797)	4	0	.09	-	 < 0.01	9.11E-01
thalamus development (GO:0021794)	13	0	.30	-	 < 0.01	7.38E-01
chemorepulsion of branchiomotor axon (GO:0021793)	1	0	.02	-	 < 0.01	9.77E-01
regulation of calcium:sodium antiporter activity (GO:1903279)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of sodium ion export across plasma membrane (GO:1903278)	4	0	.09	-	 < 0.01	9.11E-01
beta-alanine catabolic process (GO:0019484)	1	0	.02	-	 < 0.01	9.77E-01
respiratory burst after phagocytosis (GO:0045728)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of sodium ion export across plasma membrane (GO:1903277)	1	0	.02	-	 < 0.01	9.77E-01
beta-alanine biosynthetic process (GO:0019483)	1	0	.02	-	 < 0.01	9.77E-01
regulation of sodium ion export across plasma membrane (GO:1903276)	5	0	.12	-	 < 0.01	8.90E-01
beta-alanine metabolic process (GO:0019482)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of integrin biosynthetic process (GO:0045726)	3	0	.07	-	 < 0.01	9.32E-01
L-alanine catabolic process, by transamination (GO:0019481)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of fatty acid biosynthetic process (GO:0045723)	26	0	.61	-	 < 0.01	5.45E-01
negative regulation of integrin biosynthetic process (GO:0045720)	2	0	.05	-	 < 0.01	9.54E-01
ribosome localization (GO:0033750)	14	0	.33	-	 < 0.01	7.21E-01
branchiomotor neuron axon guidance (GO:0021785)	6	0	.14	-	 < 0.01	8.69E-01
postganglionic parasympathetic fiber development (GO:0021784)	2	0	.05	-	 < 0.01	9.54E-01
preganglionic parasympathetic fiber development (GO:0021783)	18	0	.42	-	 < 0.01	6.57E-01
D-amino acid catabolic process (GO:0019478)	2	0	.05	-	 < 0.01	9.54E-01
L-lysine catabolic process (GO:0019477)	2	0	.05	-	 < 0.01	9.54E-01
glial cell fate specification (GO:0021780)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of glycogen biosynthetic process (GO:0045719)	5	0	.12	-	 < 0.01	8.90E-01
L-lysine catabolic process to acetyl-CoA (GO:0019474)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of fatty acid biosynthetic process (GO:0045717)	12	0	.28	-	 < 0.01	7.56E-01
positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265)	9	0	.21	-	 < 0.01	8.11E-01
4-hydroxyproline metabolic process (GO:0019471)	1	0	.02	-	 < 0.01	9.77E-01
4-hydroxyproline catabolic process (GO:0019470)	1	0	.02	-	 < 0.01	9.77E-01
oligodendrocyte cell fate commitment (GO:0021779)	5	0	.12	-	 < 0.01	8.90E-01
oligodendrocyte cell fate specification (GO:0021778)	5	0	.12	-	 < 0.01	8.90E-01
smoothened signaling pathway involved in spinal cord motor neuron cell fate specification (GO:0021776)	3	0	.07	-	 < 0.01	9.32E-01
smoothened signaling pathway involved in ventral spinal cord interneuron specification (GO:0021775)	3	0	.07	-	 < 0.01	9.32E-01
lateral geniculate nucleus development (GO:0021771)	1	0	.02	-	 < 0.01	9.77E-01
exon-exon junction complex disassembly (GO:1903259)	1	0	.02	-	 < 0.01	9.77E-01
glycine decarboxylation via glycine cleavage system (GO:0019464)	3	0	.07	-	 < 0.01	9.32E-01
ectoderm and mesoderm interaction (GO:0007499)	1	0	.02	-	 < 0.01	9.77E-01
multi-ciliated epithelial cell differentiation (GO:1903251)	7	0	.16	-	 < 0.01	8.49E-01
posterior midgut development (GO:0007497)	1	0	.02	-	 < 0.01	9.77E-01
midgut development (GO:0007494)	4	0	.09	-	 < 0.01	9.11E-01
endodermal cell fate determination (GO:0007493)	2	0	.05	-	 < 0.01	9.54E-01
nucleus accumbens development (GO:0021768)	1	0	.02	-	 < 0.01	9.77E-01
amygdala development (GO:0021764)	6	0	.14	-	 < 0.01	8.69E-01
subthalamic nucleus development (GO:0021763)	1	0	.02	-	 < 0.01	9.77E-01
L-cysteine catabolic process to taurine (GO:0019452)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of cardiac muscle hypertrophy in response to stress (GO:1903244)	2	0	.05	-	 < 0.01	9.54E-01
U2-type prespliceosome assembly (GO:1903241)	2	0	.05	-	 < 0.01	9.54E-01
globus pallidus development (GO:0021759)	2	0	.05	-	 < 0.01	9.54E-01
facial nucleus development (GO:0021754)	2	0	.05	-	 < 0.01	9.54E-01
pronephric nephron tubule development (GO:0039020)	2	0	.05	-	 < 0.01	9.54E-01
L-cysteine catabolic process to hypotaurine (GO:0019449)	1	0	.02	-	 < 0.01	9.77E-01
L-cysteine catabolic process (GO:0019448)	3	0	.07	-	 < 0.01	9.32E-01
vestibular nucleus development (GO:0021750)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of leukocyte tethering or rolling (GO:1903238)	11	0	.26	-	 < 0.01	7.74E-01
tryptophan catabolic process to acetyl-CoA (GO:0019442)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of calcium ion-dependent exocytosis of neurotransmitter (GO:1903235)	1	0	.02	-	 < 0.01	9.77E-01
tryptophan catabolic process to kynurenine (GO:0019441)	5	0	.12	-	 < 0.01	8.90E-01
regulation of calcium ion-dependent exocytosis of neurotransmitter (GO:1903233)	4	0	.09	-	 < 0.01	9.11E-01
melanosome assembly (GO:1903232)	5	0	.12	-	 < 0.01	8.90E-01
pronephric nephron development (GO:0039019)	3	0	.07	-	 < 0.01	9.32E-01
pattern specification involved in pronephros development (GO:0039017)	2	0	.05	-	 < 0.01	9.54E-01
cochlear nucleus development (GO:0021747)	4	0	.09	-	 < 0.01	9.11E-01
embryonic skeletal joint development (GO:0072498)	16	0	.37	-	 < 0.01	6.89E-01
principal sensory nucleus of trigeminal nerve development (GO:0021740)	2	0	.05	-	 < 0.01	9.54E-01
mesenchymal stem cell differentiation (GO:0072497)	3	0	.07	-	 < 0.01	9.32E-01
triglyceride catabolic process (GO:0019433)	17	0	.40	-	 < 0.01	6.73E-01
negative regulation of endodermal cell differentiation (GO:1903225)	4	0	.09	-	 < 0.01	9.11E-01
regulation of endodermal cell differentiation (GO:1903224)	5	0	.12	-	 < 0.01	8.90E-01
removal of superoxide radicals (GO:0019430)	11	0	.26	-	 < 0.01	7.74E-01
positive regulation of oxidative stress-induced neuron death (GO:1903223)	10	0	.23	-	 < 0.01	7.92E-01
DNA integration (GO:0015074)	3	0	.07	-	 < 0.01	9.32E-01
pronephric nephron tubule morphogenesis (GO:0039008)	1	0	.02	-	 < 0.01	9.77E-01
pronephric nephron morphogenesis (GO:0039007)	1	0	.02	-	 < 0.01	9.77E-01
phospholipid efflux (GO:0033700)	11	0	.26	-	 < 0.01	7.74E-01
pronephric field specification (GO:0039003)	2	0	.05	-	 < 0.01	9.54E-01
midbrain-hindbrain boundary maturation (GO:0021732)	1	0	.02	-	 < 0.01	9.77E-01
allantoin biosynthetic process (GO:0019428)	1	0	.02	-	 < 0.01	9.77E-01
ammonium transmembrane transport (GO:0072488)	6	0	.14	-	 < 0.01	8.69E-01
acetyl-CoA biosynthetic process from acetate (GO:0019427)	1	0	.02	-	 < 0.01	9.77E-01
trigeminal sensory nucleus development (GO:0021730)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of protein processing involved in protein targeting to mitochondrion (GO:1903217)	1	0	.02	-	 < 0.01	9.77E-01
regulation of protein processing involved in protein targeting to mitochondrion (GO:1903216)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of protein targeting to mitochondrion (GO:1903215)	5	0	.12	-	 < 0.01	8.90E-01
regulation of protein targeting to mitochondrion (GO:1903214)	18	0	.42	-	 < 0.01	6.57E-01
positive regulation of the force of heart contraction by chemical signal (GO:0003099)	4	0	.09	-	 < 0.01	9.11E-01
renal water transport (GO:0003097)	6	0	.14	-	 < 0.01	8.69E-01
renal sodium ion transport (GO:0003096)	7	0	.16	-	 < 0.01	8.49E-01
glomerular filtration (GO:0003094)	12	0	.28	-	 < 0.01	7.56E-01
renal water homeostasis (GO:0003091)	13	0	.30	-	 < 0.01	7.38E-01
medullary reticular formation development (GO:0021723)	1	0	.02	-	 < 0.01	9.77E-01
superior olivary nucleus maturation (GO:0021722)	2	0	.05	-	 < 0.01	9.54E-01
sulfur oxidation (GO:0019417)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of hydrogen peroxide-induced neuron death (GO:1903208)	6	0	.14	-	 < 0.01	8.69E-01
regulation of hydrogen peroxide-induced neuron death (GO:1903207)	6	0	.14	-	 < 0.01	8.69E-01
acetate biosynthetic process (GO:0019413)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of oxidative stress-induced neuron death (GO:1903204)	20	0	.47	-	 < 0.01	6.27E-01
regulation of oxidative stress-induced neuron death (GO:1903203)	31	0	.72	-	 < 0.01	4.85E-01
positive regulation of L-dopa decarboxylase activity (GO:1903200)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of systemic arterial blood pressure (GO:0003085)	29	0	.68	-	 < 0.01	5.08E-01
negative regulation of renal output by angiotensin (GO:0003083)	1	0	.02	-	 < 0.01	9.77E-01
superior olivary nucleus development (GO:0021718)	2	0	.05	-	 < 0.01	9.54E-01
regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081)	26	0	.61	-	 < 0.01	5.45E-01
dolichol biosynthetic process (GO:0019408)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of behavioral fear response (GO:2000986)	1	0	.02	-	 < 0.01	9.77E-01
hexitol catabolic process (GO:0019407)	1	0	.02	-	 < 0.01	9.77E-01
hexitol biosynthetic process (GO:0019406)	1	0	.02	-	 < 0.01	9.77E-01
alditol catabolic process (GO:0019405)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of inner ear receptor cell differentiation (GO:2000982)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of inner ear receptor cell differentiation (GO:2000981)	4	0	.09	-	 < 0.01	9.11E-01
galactitol metabolic process (GO:0019402)	1	0	.02	-	 < 0.01	9.77E-01
regulation of inner ear receptor cell differentiation (GO:2000980)	10	0	.23	-	 < 0.01	7.92E-01
alditol biosynthetic process (GO:0019401)	7	0	.16	-	 < 0.01	8.49E-01
ectodermal digestive tract development (GO:0007439)	2	0	.05	-	 < 0.01	9.54E-01
mesenchymal-epithelial cell signaling involved in lung development (GO:0060496)	1	0	.02	-	 < 0.01	9.77E-01
cell-cell signaling involved in lung development (GO:0060495)	2	0	.05	-	 < 0.01	9.54E-01
lung induction (GO:0060492)	3	0	.07	-	 < 0.01	9.32E-01
lateral sprouting involved in lung morphogenesis (GO:0060490)	2	0	.05	-	 < 0.01	9.54E-01
renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure (GO:0003072)	6	0	.14	-	 < 0.01	8.69E-01
regulation of systemic arterial blood pressure by neurotransmitter (GO:0003070)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of forebrain neuron differentiation (GO:2000979)	1	0	.02	-	 < 0.01	9.77E-01
locus ceruleus development (GO:0021703)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of forebrain neuron differentiation (GO:2000978)	4	0	.09	-	 < 0.01	9.11E-01
regulation of forebrain neuron differentiation (GO:2000977)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of pro-B cell differentiation (GO:2000975)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of pro-B cell differentiation (GO:2000974)	3	0	.07	-	 < 0.01	9.32E-01
regulation of pro-B cell differentiation (GO:2000973)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of detection of glucose (GO:2000971)	1	0	.02	-	 < 0.01	9.77E-01
regulation of detection of glucose (GO:2000970)	1	0	.02	-	 < 0.01	9.77E-01
planar dichotomous subdivision of terminal units involved in lung branching morphogenesis (GO:0060489)	2	0	.05	-	 < 0.01	9.54E-01
orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis (GO:0060488)	2	0	.05	-	 < 0.01	9.54E-01
lung epithelial cell differentiation (GO:0060487)	32	0	.75	-	 < 0.01	4.74E-01
club cell differentiation (GO:0060486)	4	0	.09	-	 < 0.01	9.11E-01
lobar bronchus development (GO:0060482)	5	0	.12	-	 < 0.01	8.90E-01
lobar bronchus epithelium development (GO:0060481)	4	0	.09	-	 < 0.01	9.11E-01
acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure (GO:0003069)	1	0	.02	-	 < 0.01	9.77E-01
lung goblet cell differentiation (GO:0060480)	3	0	.07	-	 < 0.01	9.32E-01
regulation of systemic arterial blood pressure by acetylcholine (GO:0003068)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of heart rate by epinephrine (GO:0003065)	1	0	.02	-	 < 0.01	9.77E-01
regulation of heart rate by chemical signal (GO:0003062)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of the force of heart contraction by norepinephrine (GO:0003061)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of AMPA receptor activity (GO:2000969)	9	0	.21	-	 < 0.01	8.11E-01
lung cell differentiation (GO:0060479)	33	0	.77	-	 < 0.01	4.63E-01
ventral midline development (GO:0007418)	5	0	.12	-	 < 0.01	8.90E-01
acrosomal vesicle exocytosis (GO:0060478)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of flagellated sperm motility involved in capacitation (GO:0060474)	3	0	.07	-	 < 0.01	9.32E-01
axon target recognition (GO:0007412)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of the force of heart contraction by epinephrine (GO:0003059)	1	0	.02	-	 < 0.01	9.77E-01
regulation of the force of heart contraction by chemical signal (GO:0003057)	7	0	.16	-	 < 0.01	8.49E-01
angiotensin-mediated drinking behavior (GO:0003051)	3	0	.07	-	 < 0.01	9.32E-01
signal transduction involved in mitotic G2 DNA damage checkpoint (GO:0072434)	1	0	.02	-	 < 0.01	9.77E-01
signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431)	11	0	.26	-	 < 0.01	7.74E-01
prevention of polyspermy (GO:0060468)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of fertilization (GO:0060467)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of neuroblast proliferation (GO:0007406)	9	0	.21	-	 < 0.01	8.11E-01
heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)	5	0	.12	-	 < 0.01	8.90E-01
activation of meiosis involved in egg activation (GO:0060466)	2	0	.05	-	 < 0.01	9.54E-01
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)	7	0	.16	-	 < 0.01	8.49E-01
pharynx development (GO:0060465)	2	0	.05	-	 < 0.01	9.54E-01
lung lobe formation (GO:0060464)	1	0	.02	-	 < 0.01	9.77E-01
heparan sulfate proteoglycan biosynthetic process (GO:0015012)	19	0	.44	-	 < 0.01	6.42E-01
ganglion mother cell fate determination (GO:0007402)	1	0	.02	-	 < 0.01	9.77E-01
right lung morphogenesis (GO:0060461)	1	0	.02	-	 < 0.01	9.77E-01
neuroblast fate determination (GO:0007400)	1	0	.02	-	 < 0.01	9.77E-01
left lung morphogenesis (GO:0060460)	3	0	.07	-	 < 0.01	9.32E-01
acetaldehyde biosynthetic process (GO:0046186)	1	0	.02	-	 < 0.01	9.77E-01
aldehyde catabolic process (GO:0046185)	14	0	.33	-	 < 0.01	7.21E-01
response to intra-S DNA damage checkpoint signaling (GO:0072429)	3	0	.07	-	 < 0.01	9.32E-01
aldehyde biosynthetic process (GO:0046184)	10	0	.23	-	 < 0.01	7.92E-01
signal transduction involved in intra-S DNA damage checkpoint (GO:0072428)	1	0	.02	-	 < 0.01	9.77E-01
signal transduction involved in G2 DNA damage checkpoint (GO:0072425)	11	0	.26	-	 < 0.01	7.74E-01
response to DNA damage checkpoint signaling (GO:0072423)	5	0	.12	-	 < 0.01	8.90E-01
signal transduction involved in DNA damage checkpoint (GO:0072422)	26	0	.61	-	 < 0.01	5.45E-01
detection of DNA damage stimulus involved in DNA damage checkpoint (GO:0072421)	1	0	.02	-	 < 0.01	9.77E-01
left lung development (GO:0060459)	4	0	.09	-	 < 0.01	9.11E-01
right lung development (GO:0060458)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of digestive system process (GO:0060457)	19	0	.44	-	 < 0.01	6.42E-01
positive regulation of digestive system process (GO:0060456)	20	0	.47	-	 < 0.01	6.27E-01
somatic sex determination (GO:0018993)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of gastric acid secretion (GO:0060455)	8	0	.19	-	 < 0.01	8.30E-01
germ-line sex determination (GO:0018992)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of gastric acid secretion (GO:0060454)	3	0	.07	-	 < 0.01	9.32E-01
regulation of gastric acid secretion (GO:0060453)	12	0	.28	-	 < 0.01	7.56E-01
positive regulation of cardiac muscle contraction (GO:0060452)	9	0	.21	-	 < 0.01	8.11E-01
positive regulation of hindgut contraction (GO:0060450)	2	0	.05	-	 < 0.01	9.54E-01
detection of oxygen (GO:0003032)	3	0	.07	-	 < 0.01	9.32E-01
detection of carbon dioxide (GO:0003031)	1	0	.02	-	 < 0.01	9.77E-01
D-gluconate catabolic process (GO:0046177)	2	0	.05	-	 < 0.01	9.54E-01
aldonic acid catabolic process (GO:0046176)	2	0	.05	-	 < 0.01	9.54E-01
polyol catabolic process (GO:0046174)	20	0	.47	-	 < 0.01	6.27E-01
polyol biosynthetic process (GO:0046173)	47	0	1.10	-	 < 0.01	3.34E-01
signal transduction involved in mitotic cell cycle checkpoint (GO:0072413)	15	0	.35	-	 < 0.01	7.05E-01
dichotomous subdivision of terminal units involved in lung branching (GO:0060448)	3	0	.07	-	 < 0.01	9.32E-01
bud outgrowth involved in lung branching (GO:0060447)	4	0	.09	-	 < 0.01	9.11E-01
mitochondrial large ribosomal subunit assembly (GO:1902775)	3	0	.07	-	 < 0.01	9.32E-01
late endosome to lysosome transport (GO:1902774)	3	0	.07	-	 < 0.01	9.32E-01
detection of hypoxic conditions in blood by carotid body chemoreceptor signaling (GO:0003029)	1	0	.02	-	 < 0.01	9.77E-01
trachea formation (GO:0060440)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of choline O-acetyltransferase activity (GO:1902771)	1	0	.02	-	 < 0.01	9.77E-01
regulation of systemic arterial blood pressure by carotid body chemoreceptor signaling (GO:0003027)	1	0	.02	-	 < 0.01	9.77E-01
regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback (GO:0003026)	1	0	.02	-	 < 0.01	9.77E-01
regulation of systemic arterial blood pressure by baroreceptor feedback (GO:0003025)	7	0	.16	-	 < 0.01	8.49E-01
glycerol-3-phosphate catabolic process (GO:0046168)	2	0	.05	-	 < 0.01	9.54E-01
glycerol-3-phosphate biosynthetic process (GO:0046167)	4	0	.09	-	 < 0.01	9.11E-01
glyceraldehyde-3-phosphate biosynthetic process (GO:0046166)	2	0	.05	-	 < 0.01	9.54E-01
alcohol catabolic process (GO:0046164)	40	0	.93	-	 < 0.01	3.93E-01
heme a metabolic process (GO:0046160)	2	0	.05	-	 < 0.01	9.54E-01
activation of protein kinase A activity (GO:0034199)	4	0	.09	-	 < 0.01	9.11E-01
response to DNA integrity checkpoint signaling (GO:0072402)	5	0	.12	-	 < 0.01	8.90E-01
trichloroethylene metabolic process (GO:0018979)	1	0	.02	-	 < 0.01	9.77E-01
triglyceride transport (GO:0034197)	4	0	.09	-	 < 0.01	9.11E-01
signal transduction involved in DNA integrity checkpoint (GO:0072401)	26	0	.61	-	 < 0.01	5.45E-01
acylglycerol transport (GO:0034196)	4	0	.09	-	 < 0.01	9.11E-01
trachea morphogenesis (GO:0060439)	12	0	.28	-	 < 0.01	7.56E-01
regulation of choline O-acetyltransferase activity (GO:1902769)	1	0	.02	-	 < 0.01	9.77E-01
lung growth (GO:0060437)	7	0	.16	-	 < 0.01	8.49E-01
bronchiole morphogenesis (GO:0060436)	1	0	.02	-	 < 0.01	9.77E-01
bronchiole development (GO:0060435)	6	0	.14	-	 < 0.01	8.69E-01
bronchus morphogenesis (GO:0060434)	2	0	.05	-	 < 0.01	9.54E-01
bronchus development (GO:0060433)	10	0	.23	-	 < 0.01	7.92E-01
lung pattern specification process (GO:0060432)	1	0	.02	-	 < 0.01	9.77E-01
primary lung bud formation (GO:0060431)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of chondrocyte development (GO:1902761)	1	0	.02	-	 < 0.01	9.77E-01
lymph circulation (GO:0003017)	2	0	.05	-	 < 0.01	9.54E-01
involuntary skeletal muscle contraction (GO:0003011)	4	0	.09	-	 < 0.01	9.11E-01
voluntary skeletal muscle contraction (GO:0003010)	2	0	.05	-	 < 0.01	9.54E-01
mRNA methylation (GO:0080009)	13	0	.30	-	 < 0.01	7.38E-01
rhodopsin metabolic process (GO:0046154)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of sterol import (GO:2000911)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of sterol import (GO:2000910)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of maintenance of mitotic sister chromatid cohesion (GO:0034183)	2	0	.05	-	 < 0.01	9.54E-01
lung connective tissue development (GO:0060427)	1	0	.02	-	 < 0.01	9.77E-01
propylene metabolic process (GO:0018964)	1	0	.02	-	 < 0.01	9.77E-01
regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182)	6	0	.14	-	 < 0.01	8.69E-01
lung vasculature development (GO:0060426)	9	0	.21	-	 < 0.01	8.11E-01
positive regulation of toll-like receptor 13 signaling pathway (GO:0034181)	1	0	.02	-	 < 0.01	9.77E-01
4-nitrophenol metabolic process (GO:0018960)	2	0	.05	-	 < 0.01	9.54E-01
nuclear pore organization (GO:0006999)	14	0	.33	-	 < 0.01	7.21E-01
skeletal muscle contraction (GO:0003009)	29	0	.68	-	 < 0.01	5.08E-01
positive regulation of cell cycle G2/M phase transition (GO:1902751)	30	0	.70	-	 < 0.01	4.97E-01
negative regulation of cell cycle G2/M phase transition (GO:1902750)	53	0	1.24	-	 < 0.01	2.90E-01
cellular response to nitrogen starvation (GO:0006995)	9	0	.21	-	 < 0.01	8.11E-01
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response (GO:0006990)	3	0	.07	-	 < 0.01	9.32E-01
pigment catabolic process (GO:0046149)	4	0	.09	-	 < 0.01	9.11E-01
pigment biosynthetic process (GO:0046148)	44	0	1.03	-	 < 0.01	3.58E-01
regulation of sterol import (GO:2000909)	6	0	.14	-	 < 0.01	8.69E-01
tetrahydrobiopterin metabolic process (GO:0046146)	7	0	.16	-	 < 0.01	8.49E-01
D-alanine family amino acid metabolic process (GO:0046144)	1	0	.02	-	 < 0.01	9.77E-01
regulation of toll-like receptor 13 signaling pathway (GO:0034179)	1	0	.02	-	 < 0.01	9.77E-01
toll-like receptor 13 signaling pathway (GO:0034178)	1	0	.02	-	 < 0.01	9.77E-01
regulation of cell cycle G2/M phase transition (GO:1902749)	95	0	2.21	-	 < 0.01	1.09E-01
response to growth hormone (GO:0060416)	14	0	.33	-	 < 0.01	7.21E-01
imidazole-containing compound catabolic process (GO:0052805)	1	0	.02	-	 < 0.01	9.77E-01
aorta smooth muscle tissue morphogenesis (GO:0060414)	4	0	.09	-	 < 0.01	9.11E-01
atrial septum morphogenesis (GO:0060413)	16	0	.37	-	 < 0.01	6.89E-01
imidazole-containing compound metabolic process (GO:0052803)	4	0	.09	-	 < 0.01	9.11E-01
apoptotic process involved in development (GO:1902742)	27	0	.63	-	 < 0.01	5.33E-01
ER overload response (GO:0006983)	12	0	.28	-	 < 0.01	7.56E-01
response to lipid hydroperoxide (GO:0006982)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of vitamin metabolic process (GO:0046137)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of vitamin metabolic process (GO:0046136)	4	0	.09	-	 < 0.01	9.11E-01
pyrimidine nucleoside catabolic process (GO:0046135)	8	0	.19	-	 < 0.01	8.30E-01
pyrimidine ribonucleoside catabolic process (GO:0046133)	6	0	.14	-	 < 0.01	8.69E-01
pyrimidine ribonucleoside metabolic process (GO:0046131)	6	0	.14	-	 < 0.01	8.69E-01
purine ribonucleoside catabolic process (GO:0046130)	13	0	.30	-	 < 0.01	7.38E-01
positive regulation of toll-like receptor 9 signaling pathway (GO:0034165)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of acetylcholine metabolic process (GO:0060409)	2	0	.05	-	 < 0.01	9.54E-01
regulation of acetylcholine metabolic process (GO:0060408)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of penile erection (GO:0060407)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of toll-like receptor 8 signaling pathway (GO:0034161)	2	0	.05	-	 < 0.01	9.54E-01
axonemal microtubule depolymerization (GO:0060404)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of chondrocyte proliferation (GO:1902732)	8	0	.19	-	 < 0.01	8.30E-01
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)	12	0	.28	-	 < 0.01	7.56E-01
negative regulation of growth hormone receptor signaling pathway (GO:0060400)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of chondrocyte proliferation (GO:1902731)	3	0	.07	-	 < 0.01	9.32E-01
DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)	10	0	.23	-	 < 0.01	7.92E-01
positive regulation of proteoglycan biosynthetic process (GO:1902730)	5	0	.12	-	 < 0.01	8.90E-01
DNA damage induced protein phosphorylation (GO:0006975)	6	0	.14	-	 < 0.01	8.69E-01
hyperosmotic response (GO:0006972)	16	0	.37	-	 < 0.01	6.89E-01
hypotonic response (GO:0006971)	9	0	.21	-	 < 0.01	8.11E-01
purine ribonucleoside biosynthetic process (GO:0046129)	20	0	.47	-	 < 0.01	6.27E-01
purine ribonucleoside metabolic process (GO:0046128)	55	0	1.28	-	 < 0.01	2.77E-01
pyrimidine deoxyribonucleoside catabolic process (GO:0046127)	1	0	.02	-	 < 0.01	9.77E-01
pyrimidine deoxyribonucleoside metabolic process (GO:0046125)	4	0	.09	-	 < 0.01	9.11E-01
purine deoxyribonucleoside catabolic process (GO:0046124)	2	0	.05	-	 < 0.01	9.54E-01
purine deoxyribonucleoside metabolic process (GO:0046122)	3	0	.07	-	 < 0.01	9.32E-01
deoxyribonucleoside catabolic process (GO:0046121)	4	0	.09	-	 < 0.01	9.11E-01
regulation of toll-like receptor 8 signaling pathway (GO:0034159)	2	0	.05	-	 < 0.01	9.54E-01
toll-like receptor 8 signaling pathway (GO:0034158)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of toll-like receptor 7 signaling pathway (GO:0034157)	5	0	.12	-	 < 0.01	8.90E-01
regulation of toll-like receptor 7 signaling pathway (GO:0034155)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of proteoglycan biosynthetic process (GO:1902729)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of growth factor dependent skeletal muscle satellite cell proliferation (GO:1902728)	2	0	.05	-	 < 0.01	9.54E-01
toll-like receptor 6 signaling pathway (GO:0034150)	1	0	.02	-	 < 0.01	9.77E-01
naphthalene metabolic process (GO:0018931)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of skeletal muscle satellite cell proliferation (GO:1902724)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of prolactin secretion (GO:1902722)	3	0	.07	-	 < 0.01	9.32E-01
cellular defense response (GO:0006968)	13	0	.30	-	 < 0.01	7.38E-01
negative regulation of prolactin secretion (GO:1902721)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria (GO:0006965)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of antibacterial peptide biosynthetic process (GO:0006963)	1	0	.02	-	 < 0.01	9.77E-01
guanosine catabolic process (GO:0046115)	1	0	.02	-	 < 0.01	9.77E-01
nucleobase catabolic process (GO:0046113)	11	0	.26	-	 < 0.01	7.74E-01
nucleobase biosynthetic process (GO:0046112)	14	0	.33	-	 < 0.01	7.21E-01
xanthine biosynthetic process (GO:0046111)	1	0	.02	-	 < 0.01	9.77E-01
xanthine metabolic process (GO:0046110)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of toll-like receptor 5 signaling pathway (GO:0034148)	1	0	.02	-	 < 0.01	9.77E-01
regulation of toll-like receptor 5 signaling pathway (GO:0034147)	1	0	.02	-	 < 0.01	9.77E-01
toll-like receptor 5 signaling pathway (GO:0034146)	1	0	.02	-	 < 0.01	9.77E-01
protein localization to spindle pole body (GO:0071988)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of toll-like receptor 4 signaling pathway (GO:0034145)	11	0	.26	-	 < 0.01	7.74E-01
multivesicular body sorting pathway (GO:0071985)	34	0	.79	-	 < 0.01	4.52E-01
mandelate metabolic process (GO:0018924)	1	0	.02	-	 < 0.01	9.77E-01
toll-like receptor 4 signaling pathway (GO:0034142)	18	0	.42	-	 < 0.01	6.57E-01
positive regulation of toll-like receptor 3 signaling pathway (GO:0034141)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of toll-like receptor 3 signaling pathway (GO:0034140)	3	0	.07	-	 < 0.01	9.32E-01
complement activation, classical pathway (GO:0006958)	29	0	.68	-	 < 0.01	5.08E-01
complement activation, alternative pathway (GO:0006957)	11	0	.26	-	 < 0.01	7.74E-01
complement activation (GO:0006956)	40	0	.93	-	 < 0.01	3.93E-01
acute-phase response (GO:0006953)	33	0	.77	-	 < 0.01	4.63E-01
uridine metabolic process (GO:0046108)	2	0	.05	-	 < 0.01	9.54E-01
thymidine metabolic process (GO:0046104)	3	0	.07	-	 < 0.01	9.32E-01
inosine biosynthetic process (GO:0046103)	3	0	.07	-	 < 0.01	9.32E-01
inosine metabolic process (GO:0046102)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of antigen processing and presentation of peptide antigen via MHC class I (GO:0002591)	1	0	.02	-	 < 0.01	9.77E-01
hypoxanthine biosynthetic process (GO:0046101)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of antigen processing and presentation of peptide antigen via MHC class I (GO:0002590)	2	0	.05	-	 < 0.01	9.54E-01
hypoxanthine metabolic process (GO:0046100)	4	0	.09	-	 < 0.01	9.11E-01
regulation of toll-like receptor 3 signaling pathway (GO:0034139)	9	0	.21	-	 < 0.01	8.11E-01
positive regulation of toll-like receptor 2 signaling pathway (GO:0034137)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of toll-like receptor 2 signaling pathway (GO:0034136)	5	0	.12	-	 < 0.01	8.90E-01
regulation of toll-like receptor 2 signaling pathway (GO:0034135)	11	0	.26	-	 < 0.01	7.74E-01
nitrobenzene metabolic process (GO:0018916)	4	0	.09	-	 < 0.01	9.11E-01
cell gliding (GO:0071976)	1	0	.02	-	 < 0.01	9.77E-01
toll-like receptor 1 signaling pathway (GO:0034130)	1	0	.02	-	 < 0.01	9.77E-01
extracellular exosome assembly (GO:0071971)	1	0	.02	-	 < 0.01	9.77E-01
induction by virus of host cell-cell fusion (GO:0006948)	1	0	.02	-	 < 0.01	9.77E-01
regulation of antigen processing and presentation of peptide antigen via MHC class I (GO:0002589)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of antigen processing and presentation of peptide antigen via MHC class II (GO:0002588)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of antigen processing and presentation of peptide antigen via MHC class II (GO:0002587)	2	0	.05	-	 < 0.01	9.54E-01
regulation of antigen processing and presentation of peptide antigen via MHC class II (GO:0002586)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of antigen processing and presentation of peptide antigen (GO:0002585)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of antigen processing and presentation of peptide antigen (GO:0002584)	4	0	.09	-	 < 0.01	9.11E-01
response to ozone (GO:0010193)	1	0	.02	-	 < 0.01	9.77E-01
regulation of antigen processing and presentation of peptide antigen (GO:0002583)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II (GO:0002582)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034128)	1	0	.02	-	 < 0.01	9.77E-01
regulation of MyD88-independent toll-like receptor signaling pathway (GO:0034127)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of MyD88-dependent toll-like receptor signaling pathway (GO:0034125)	2	0	.05	-	 < 0.01	9.54E-01
regulation of MyD88-dependent toll-like receptor signaling pathway (GO:0034124)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of toll-like receptor signaling pathway (GO:0034123)	27	0	.63	-	 < 0.01	5.33E-01
ether metabolic process (GO:0018904)	23	0	.54	-	 < 0.01	5.85E-01
establishment or maintenance of cell polarity regulating cell shape (GO:0071963)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of erythrocyte aggregation (GO:0034120)	1	0	.02	-	 < 0.01	9.77E-01
mitotic sister chromatid cohesion, centromeric (GO:0071962)	3	0	.07	-	 < 0.01	9.32E-01
dichloromethane metabolic process (GO:0018900)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of cell adhesion involved in substrate-bound cell migration (GO:0006933)	3	0	.07	-	 < 0.01	9.32E-01
substrate-dependent cell migration, cell attachment to substrate (GO:0006931)	3	0	.07	-	 < 0.01	9.32E-01
vitamin E biosynthetic process (GO:0010189)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of antigen processing and presentation (GO:0002579)	12	0	.28	-	 < 0.01	7.56E-01
platelet degranulation (GO:0002576)	7	0	.16	-	 < 0.01	8.49E-01
basophil chemotaxis (GO:0002575)	1	0	.02	-	 < 0.01	9.77E-01
myeloid leukocyte differentiation (GO:0002573)	117	0	2.73	-	 < 0.01	6.48E-02
sugar mediated signaling pathway (GO:0010182)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of erythrocyte aggregation (GO:0034119)	1	0	.02	-	 < 0.01	9.77E-01
regulation of erythrocyte aggregation (GO:0034118)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of heterotypic cell-cell adhesion (GO:0034116)	14	0	.33	-	 < 0.01	7.21E-01
negative regulation of heterotypic cell-cell adhesion (GO:0034115)	11	0	.26	-	 < 0.01	7.74E-01
regulation of heterotypic cell-cell adhesion (GO:0034114)	25	0	.58	-	 < 0.01	5.58E-01
heterotypic cell-cell adhesion (GO:0034113)	29	0	.68	-	 < 0.01	5.08E-01
recycling endosome to Golgi transport (GO:0071955)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of homotypic cell-cell adhesion (GO:0034112)	8	0	.19	-	 < 0.01	8.30E-01
chemokine (C-C motif) ligand 11 production (GO:0071954)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of homotypic cell-cell adhesion (GO:0034111)	19	0	.44	-	 < 0.01	6.42E-01
regulation of homotypic cell-cell adhesion (GO:0034110)	34	0	.79	-	 < 0.01	4.52E-01
conversion of methionyl-tRNA to N-formyl-methionyl-tRNA (GO:0071951)	1	0	.02	-	 < 0.01	9.77E-01
inflammatory cell apoptotic process (GO:0006925)	8	0	.19	-	 < 0.01	8.30E-01
activation-induced cell death of T cells (GO:0006924)	7	0	.16	-	 < 0.01	8.49E-01
somatic diversification of T cell receptor genes (GO:0002568)	5	0	.12	-	 < 0.01	8.90E-01
somatic diversification of immune receptors via somatic mutation (GO:0002566)	13	0	.30	-	 < 0.01	7.38E-01
somatic diversification of immune receptors via germline recombination within a single locus (GO:0002562)	37	0	.86	-	 < 0.01	4.22E-01
basophil degranulation (GO:0002561)	1	0	.02	-	 < 0.01	9.77E-01
basophil mediated immunity (GO:0002560)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of erythrocyte clearance (GO:0034107)	1	0	.02	-	 < 0.01	9.77E-01
regulation of erythrocyte clearance (GO:0034106)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of tissue remodeling (GO:0034105)	8	0	.19	-	 < 0.01	8.30E-01
protein deubiquitination involved in ubiquitin-dependent protein catabolic process (GO:0071947)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of tissue remodeling (GO:0034104)	26	0	.61	-	 < 0.01	5.45E-01
nitrogen cycle metabolic process (GO:0071941)	10	0	.23	-	 < 0.01	7.92E-01
response to X-ray (GO:0010165)	24	0	.56	-	 < 0.01	5.71E-01
serotonin secretion by platelet (GO:0002554)	3	0	.07	-	 < 0.01	9.32E-01
histamine secretion by mast cell (GO:0002553)	5	0	.12	-	 < 0.01	8.90E-01
serotonin secretion by mast cell (GO:0002552)	1	0	.02	-	 < 0.01	9.77E-01
mast cell chemotaxis (GO:0002551)	5	0	.12	-	 < 0.01	8.90E-01
formation of animal organ boundary (GO:0010160)	1	0	.02	-	 < 0.01	9.77E-01
vitamin A import (GO:0071939)	2	0	.05	-	 < 0.01	9.54E-01
vitamin A transport (GO:0071938)	2	0	.05	-	 < 0.01	9.54E-01
thiamine transmembrane transport (GO:0071934)	2	0	.05	-	 < 0.01	9.54E-01
replication fork reversal (GO:0071932)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0071931)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0071930)	3	0	.07	-	 < 0.01	9.32E-01
vesicle docking involved in exocytosis (GO:0006904)	42	0	.98	-	 < 0.01	3.75E-01
vesicle coating (GO:0006901)	11	0	.26	-	 < 0.01	7.74E-01
specification of animal organ position (GO:0010159)	3	0	.07	-	 < 0.01	9.32E-01
regulation of proton transport (GO:0010155)	24	0	.56	-	 < 0.01	5.71E-01
chronic inflammatory response (GO:0002544)	8	0	.19	-	 < 0.01	8.30E-01
activation of blood coagulation via clotting cascade (GO:0002543)	1	0	.02	-	 < 0.01	9.77E-01
Factor XII activation (GO:0002542)	1	0	.02	-	 < 0.01	9.77E-01
activation of plasma proteins involved in acute inflammatory response (GO:0002541)	1	0	.02	-	 < 0.01	9.77E-01
leukotriene production involved in inflammatory response (GO:0002540)	2	0	.05	-	 < 0.01	9.54E-01
alpha-tubulin acetylation (GO:0071929)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of epidermis development (GO:0045683)	15	0	.35	-	 < 0.01	7.05E-01
endocannabinoid signaling pathway (GO:0071926)	3	0	.07	-	 < 0.01	9.32E-01
regulation of cohesin loading (GO:0071922)	5	0	.12	-	 < 0.01	8.90E-01
cohesin loading (GO:0071921)	2	0	.05	-	 < 0.01	9.54E-01
prostaglandin production involved in inflammatory response (GO:0002539)	1	0	.02	-	 < 0.01	9.77E-01
arachidonic acid metabolite production involved in inflammatory response (GO:0002538)	3	0	.07	-	 < 0.01	9.32E-01
nitric oxide production involved in inflammatory response (GO:0002537)	2	0	.05	-	 < 0.01	9.54E-01
respiratory burst involved in inflammatory response (GO:0002536)	1	0	.02	-	 < 0.01	9.77E-01
cytokine production involved in inflammatory response (GO:0002534)	4	0	.09	-	 < 0.01	9.11E-01
production of molecular mediator involved in inflammatory response (GO:0002532)	24	0	.56	-	 < 0.01	5.71E-01
G-quadruplex DNA formation (GO:0071919)	1	0	.02	-	 < 0.01	9.77E-01
urea transmembrane transport (GO:0071918)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of osteoclast differentiation (GO:0045672)	33	0	.77	-	 < 0.01	4.63E-01
negative regulation of osteoclast differentiation (GO:0045671)	30	0	.70	-	 < 0.01	4.97E-01
synchronous neurotransmitter secretion (GO:0071911)	1	0	.02	-	 < 0.01	9.77E-01
determination of liver left/right asymmetry (GO:0071910)	6	0	.14	-	 < 0.01	8.69E-01
pyrimidine ribonucleotide salvage (GO:0010138)	1	0	.02	-	 < 0.01	9.77E-01
regulation of vascular permeability involved in acute inflammatory response (GO:0002528)	4	0	.09	-	 < 0.01	9.11E-01
acute inflammatory response (GO:0002526)	65	0	1.52	-	 < 0.01	2.19E-01
acute inflammatory response to non-antigenic stimulus (GO:0002525)	1	0	.02	-	 < 0.01	9.77E-01
hypersensitivity (GO:0002524)	4	0	.09	-	 < 0.01	9.11E-01
proline catabolic process to glutamate (GO:0010133)	3	0	.07	-	 < 0.01	9.32E-01
leukocyte migration involved in immune response (GO:0002522)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of osteoblast differentiation (GO:0045669)	70	0	1.63	-	 < 0.01	1.95E-01
determination of stomach left/right asymmetry (GO:0071909)	1	0	.02	-	 < 0.01	9.77E-01
determination of intestine left/right asymmetry (GO:0071908)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of myoblast differentiation (GO:0045663)	26	0	.61	-	 < 0.01	5.45E-01
determination of digestive tract left/right asymmetry (GO:0071907)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of neutrophil differentiation (GO:0045660)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of osteoblast proliferation (GO:0033690)	14	0	.33	-	 < 0.01	7.21E-01
natural killer cell tolerance induction (GO:0002519)	2	0	.05	-	 < 0.01	9.54E-01
lymphocyte chemotaxis across high endothelial venule (GO:0002518)	2	0	.05	-	 < 0.01	9.54E-01
T cell tolerance induction (GO:0002517)	2	0	.05	-	 < 0.01	9.54E-01
phenylacetate catabolic process (GO:0010124)	3	0	.07	-	 < 0.01	9.32E-01
B cell tolerance induction (GO:0002514)	1	0	.02	-	 < 0.01	9.77E-01
tolerance induction to self antigen (GO:0002513)	6	0	.14	-	 < 0.01	8.69E-01
arginine catabolic process to proline via ornithine (GO:0010121)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of neutrophil differentiation (GO:0045659)	2	0	.05	-	 < 0.01	9.54E-01
regulation of neutrophil differentiation (GO:0045658)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of monocyte differentiation (GO:0045657)	9	0	.21	-	 < 0.01	8.11E-01
negative regulation of monocyte differentiation (GO:0045656)	7	0	.16	-	 < 0.01	8.49E-01
regulation of monocyte differentiation (GO:0045655)	16	0	.37	-	 < 0.01	6.89E-01
positive regulation of megakaryocyte differentiation (GO:0045654)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of megakaryocyte differentiation (GO:0045653)	4	0	.09	-	 < 0.01	9.11E-01
regulation of megakaryocyte differentiation (GO:0045652)	18	0	.42	-	 < 0.01	6.57E-01
negative regulation of macrophage differentiation (GO:0045650)	6	0	.14	-	 < 0.01	8.69E-01
osteoblast proliferation (GO:0033687)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of luteinizing hormone secretion (GO:0033686)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of luteinizing hormone secretion (GO:0033685)	5	0	.12	-	 < 0.01	8.90E-01
regulation of luteinizing hormone secretion (GO:0033684)	8	0	.19	-	 < 0.01	8.30E-01
nucleotide-excision repair, DNA incision (GO:0033683)	9	0	.21	-	 < 0.01	8.11E-01
central tolerance induction to self antigen (GO:0002509)	1	0	.02	-	 < 0.01	9.77E-01
central tolerance induction (GO:0002508)	2	0	.05	-	 < 0.01	9.54E-01
tolerance induction (GO:0002507)	15	0	.35	-	 < 0.01	7.05E-01
peptide antigen assembly with MHC class II protein complex (GO:0002503)	1	0	.02	-	 < 0.01	9.77E-01
regulation of L-dopa decarboxylase activity (GO:1903198)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of L-dopa biosynthetic process (GO:1903197)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of erythrocyte differentiation (GO:0045647)	11	0	.26	-	 < 0.01	7.74E-01
regulation of L-dopa biosynthetic process (GO:1903195)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of eosinophil differentiation (GO:0045645)	2	0	.05	-	 < 0.01	9.54E-01
regulation of eosinophil differentiation (GO:0045643)	2	0	.05	-	 < 0.01	9.54E-01
glyoxal metabolic process (GO:1903189)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of myeloid cell differentiation (GO:0045638)	81	0	1.89	-	 < 0.01	1.51E-01
glucuronoside catabolic process (GO:0019391)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of mechanoreceptor differentiation (GO:0045633)	1	0	.02	-	 < 0.01	9.77E-01
regulation of SUMO transferase activity (GO:1903182)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of mechanoreceptor differentiation (GO:0045632)	4	0	.09	-	 < 0.01	9.11E-01
regulation of mechanoreceptor differentiation (GO:0045631)	10	0	.23	-	 < 0.01	7.92E-01
positive regulation of T-helper 2 cell differentiation (GO:0045630)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation by symbiont of host apoptotic process (GO:0033668)	3	0	.07	-	 < 0.01	9.32E-01
cerebellar cortex maturation (GO:0021699)	3	0	.07	-	 < 0.01	9.32E-01
cerebellar cortex structural organization (GO:0021698)	3	0	.07	-	 < 0.01	9.32E-01
cerebellar Purkinje cell layer structural organization (GO:0021693)	2	0	.05	-	 < 0.01	9.54E-01
glucuronoside metabolic process (GO:0019389)	3	0	.07	-	 < 0.01	9.32E-01
galactose catabolic process (GO:0019388)	5	0	.12	-	 < 0.01	8.90E-01
cerebellar Purkinje cell layer maturation (GO:0021691)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of T-helper 2 cell differentiation (GO:0045629)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of tyrosine 3-monooxygenase activity (GO:1903178)	1	0	.02	-	 < 0.01	9.77E-01
regulation of T-helper 2 cell differentiation (GO:0045628)	13	0	.30	-	 < 0.01	7.38E-01
positive regulation of T-helper 1 cell differentiation (GO:0045627)	8	0	.19	-	 < 0.01	8.30E-01
regulation of tyrosine 3-monooxygenase activity (GO:1903176)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of T-helper 1 cell differentiation (GO:0045626)	3	0	.07	-	 < 0.01	9.32E-01
regulation of T-helper 1 cell differentiation (GO:0045625)	12	0	.28	-	 < 0.01	7.56E-01
positive regulation of T-helper cell differentiation (GO:0045624)	21	0	.49	-	 < 0.01	6.13E-01
fatty alcohol metabolic process (GO:1903173)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of T-helper cell differentiation (GO:0045623)	20	0	.47	-	 < 0.01	6.27E-01
regulation of T-helper cell differentiation (GO:0045622)	36	0	.84	-	 < 0.01	4.32E-01
negative regulation of calcium ion transmembrane transport (GO:1903170)	39	0	.91	-	 < 0.01	4.02E-01
cerebellar molecular layer formation (GO:0021688)	1	0	.02	-	 < 0.01	9.77E-01
cerebellar molecular layer morphogenesis (GO:0021687)	2	0	.05	-	 < 0.01	9.54E-01
cerebellar granular layer maturation (GO:0021686)	1	0	.02	-	 < 0.01	9.77E-01
cerebellar granular layer structural organization (GO:0021685)	1	0	.02	-	 < 0.01	9.77E-01
nerve maturation (GO:0021682)	1	0	.02	-	 < 0.01	9.77E-01
galactolipid catabolic process (GO:0019376)	3	0	.07	-	 < 0.01	9.32E-01
galactolipid biosynthetic process (GO:0019375)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of pyrroline-5-carboxylate reductase activity (GO:1903168)	1	0	.02	-	 < 0.01	9.77E-01
galactolipid metabolic process (GO:0019374)	9	0	.21	-	 < 0.01	8.11E-01
regulation of pyrroline-5-carboxylate reductase activity (GO:1903167)	1	0	.02	-	 < 0.01	9.77E-01
epoxygenase P450 pathway (GO:0019373)	27	0	.63	-	 < 0.01	5.33E-01
negative regulation of keratinocyte differentiation (GO:0045617)	9	0	.21	-	 < 0.01	8.11E-01
cellular response to polycyclic arene (GO:1903166)	1	0	.02	-	 < 0.01	9.77E-01
lipoxygenase pathway (GO:0019372)	11	0	.26	-	 < 0.01	7.74E-01
response to polycyclic arene (GO:1903165)	1	0	.02	-	 < 0.01	9.77E-01
cyclooxygenase pathway (GO:0019371)	3	0	.07	-	 < 0.01	9.32E-01
leukotriene biosynthetic process (GO:0019370)	13	0	.30	-	 < 0.01	7.38E-01
cerebellar molecular layer development (GO:0021679)	3	0	.07	-	 < 0.01	9.32E-01
third ventricle development (GO:0021678)	5	0	.12	-	 < 0.01	8.90E-01
lysobisphosphatidic acid metabolic process (GO:2001311)	2	0	.05	-	 < 0.01	9.54E-01
lateral ventricle development (GO:0021670)	13	0	.30	-	 < 0.01	7.38E-01
pyridine nucleotide salvage (GO:0019365)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of inner ear auditory receptor cell differentiation (GO:0045609)	1	0	.02	-	 < 0.01	9.77E-01
pyridine nucleotide catabolic process (GO:0019364)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of inner ear auditory receptor cell differentiation (GO:0045608)	4	0	.09	-	 < 0.01	9.11E-01
pyridine nucleotide biosynthetic process (GO:0019363)	19	0	.44	-	 < 0.01	6.42E-01
regulation of inner ear auditory receptor cell differentiation (GO:0045607)	10	0	.23	-	 < 0.01	7.92E-01
pyridine nucleotide metabolic process (GO:0019362)	27	0	.63	-	 < 0.01	5.33E-01
negative regulation of epidermal cell differentiation (GO:0045605)	15	0	.35	-	 < 0.01	7.05E-01
positive regulation of endothelial cell differentiation (GO:0045603)	11	0	.26	-	 < 0.01	7.74E-01
ectoderm development (GO:0007398)	15	0	.35	-	 < 0.01	7.05E-01
negative regulation of endothelial cell differentiation (GO:0045602)	11	0	.26	-	 < 0.01	7.74E-01
regulation of endothelial cell differentiation (GO:0045601)	40	0	.93	-	 < 0.01	3.93E-01
positive regulation of cell-cell adhesion mediated by integrin (GO:0033634)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of cell-cell adhesion mediated by integrin (GO:0033633)	2	0	.05	-	 < 0.01	9.54E-01
regulation of cell-cell adhesion mediated by integrin (GO:0033632)	12	0	.28	-	 < 0.01	7.56E-01
cell-cell adhesion mediated by integrin (GO:0033631)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of cell adhesion mediated by integrin (GO:0033630)	21	0	.49	-	 < 0.01	6.13E-01
lipoxin B4 biosynthetic process (GO:2001306)	1	0	.02	-	 < 0.01	9.77E-01
lipoxin B4 metabolic process (GO:2001304)	1	0	.02	-	 < 0.01	9.77E-01
rhombomere 5 formation (GO:0021666)	1	0	.02	-	 < 0.01	9.77E-01
lipoxin A4 biosynthetic process (GO:2001303)	3	0	.07	-	 < 0.01	9.32E-01
rhombomere 5 structural organization (GO:0021665)	1	0	.02	-	 < 0.01	9.77E-01
lipoxin A4 metabolic process (GO:2001302)	3	0	.07	-	 < 0.01	9.32E-01
rhombomere 5 morphogenesis (GO:0021664)	1	0	.02	-	 < 0.01	9.77E-01
lipoxin biosynthetic process (GO:2001301)	4	0	.09	-	 < 0.01	9.11E-01
lipoxin metabolic process (GO:2001300)	4	0	.09	-	 < 0.01	9.11E-01
nicotinamide nucleotide biosynthetic process (GO:0019359)	16	0	.37	-	 < 0.01	6.89E-01
nicotinate nucleotide salvage (GO:0019358)	1	0	.02	-	 < 0.01	9.77E-01
nicotinate nucleotide biosynthetic process (GO:0019357)	1	0	.02	-	 < 0.01	9.77E-01
rhombomere 3 formation (GO:0021660)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of autophagy of mitochondrion (GO:1903147)	6	0	.14	-	 < 0.01	8.69E-01
regulation of autophagy of mitochondrion (GO:1903146)	20	0	.47	-	 < 0.01	6.27E-01
positive regulation of establishment of endothelial barrier (GO:1903142)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of establishment of endothelial barrier (GO:1903141)	2	0	.05	-	 < 0.01	9.54E-01
regulation of establishment of endothelial barrier (GO:1903140)	18	0	.42	-	 < 0.01	6.57E-01
compartment pattern specification (GO:0007386)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of cell adhesion mediated by integrin (GO:0033629)	8	0	.19	-	 < 0.01	8.30E-01
regulation of cell adhesion mediated by integrin (GO:0033628)	43	0	1.00	-	 < 0.01	3.67E-01
cell adhesion mediated by integrin (GO:0033627)	26	0	.61	-	 < 0.01	5.45E-01
positive regulation of integrin activation by cell surface receptor linked signal transduction (GO:0033626)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of integrin activation (GO:0033625)	13	0	.30	-	 < 0.01	7.38E-01
negative regulation of integrin activation (GO:0033624)	3	0	.07	-	 < 0.01	9.32E-01
regulation of integrin activation (GO:0033623)	19	0	.44	-	 < 0.01	6.42E-01
rhombomere 3 structural organization (GO:0021659)	1	0	.02	-	 < 0.01	9.77E-01
rhombomere 3 morphogenesis (GO:0021658)	2	0	.05	-	 < 0.01	9.54E-01
dolichol metabolic process (GO:0019348)	5	0	.12	-	 < 0.01	8.90E-01
vestibulocochlear nerve formation (GO:0021650)	4	0	.09	-	 < 0.01	9.11E-01
transsulfuration (GO:0019346)	5	0	.12	-	 < 0.01	8.90E-01
cysteine biosynthetic process (GO:0019344)	3	0	.07	-	 < 0.01	9.32E-01
cysteine biosynthetic process via cystathionine (GO:0019343)	2	0	.05	-	 < 0.01	9.54E-01
dibenzo-p-dioxin catabolic process (GO:0019341)	1	0	.02	-	 < 0.01	9.77E-01
mitochondrial cytochrome c oxidase assembly (GO:0033617)	14	0	.33	-	 < 0.01	7.21E-01
ventral midline determination (GO:0007371)	1	0	.02	-	 < 0.01	9.77E-01
mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615)	5	0	.12	-	 < 0.01	8.90E-01
vestibulocochlear nerve structural organization (GO:0021649)	2	0	.05	-	 < 0.01	9.54E-01
vestibulocochlear nerve morphogenesis (GO:0021648)	6	0	.14	-	 < 0.01	8.69E-01
vagus nerve morphogenesis (GO:0021644)	2	0	.05	-	 < 0.01	9.54E-01
trochlear nerve formation (GO:0021642)	1	0	.02	-	 < 0.01	9.77E-01
phenol-containing compound catabolic process (GO:0019336)	10	0	.23	-	 < 0.01	7.92E-01
response to cell cycle checkpoint signaling (GO:0072396)	5	0	.12	-	 < 0.01	8.90E-01
signal transduction involved in cell cycle checkpoint (GO:0072395)	28	0	.65	-	 < 0.01	5.20E-01
detection of stimulus involved in cell cycle checkpoint (GO:0072394)	1	0	.02	-	 < 0.01	9.77E-01
microtubule anchoring at microtubule organizing center (GO:0072393)	12	0	.28	-	 < 0.01	7.56E-01
negative regulation of centriole-centriole cohesion (GO:1903126)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation (GO:1903125)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of TRAIL-activated apoptotic signaling pathway (GO:1903122)	1	0	.02	-	 < 0.01	9.77E-01
oxalate metabolic process (GO:0033609)	1	0	.02	-	 < 0.01	9.77E-01
chemokine receptor transport within lipid bilayer (GO:0033606)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of dopamine secretion (GO:0033602)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of mammary gland epithelial cell proliferation (GO:0033601)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of mammary gland epithelial cell proliferation (GO:0033600)	6	0	.14	-	 < 0.01	8.69E-01
trochlear nerve morphogenesis (GO:0021639)	1	0	.02	-	 < 0.01	9.77E-01
trigeminal nerve structural organization (GO:0021637)	5	0	.12	-	 < 0.01	8.90E-01
trigeminal nerve morphogenesis (GO:0021636)	5	0	.12	-	 < 0.01	8.90E-01
optic nerve structural organization (GO:0021633)	2	0	.05	-	 < 0.01	9.54E-01
flavin adenine dinucleotide catabolic process (GO:0072389)	1	0	.02	-	 < 0.01	9.77E-01
flavin adenine dinucleotide biosynthetic process (GO:0072388)	1	0	.02	-	 < 0.01	9.77E-01
flavin adenine dinucleotide metabolic process (GO:0072387)	2	0	.05	-	 < 0.01	9.54E-01
plus-end-directed organelle transport along microtubule (GO:0072386)	4	0	.09	-	 < 0.01	9.11E-01
protein localization to actin cytoskeleton (GO:1903119)	1	0	.02	-	 < 0.01	9.77E-01
minus-end-directed organelle transport along microtubule (GO:0072385)	4	0	.09	-	 < 0.01	9.11E-01
urate homeostasis (GO:1903118)	1	0	.02	-	 < 0.01	9.77E-01
pentose catabolic process (GO:0019323)	3	0	.07	-	 < 0.01	9.32E-01
plus-end-directed vesicle transport along microtubule (GO:0072383)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of actin filament-based movement (GO:1903116)	3	0	.07	-	 < 0.01	9.32E-01
pentose biosynthetic process (GO:0019322)	2	0	.05	-	 < 0.01	9.54E-01
minus-end-directed vesicle transport along microtubule (GO:0072382)	1	0	.02	-	 < 0.01	9.77E-01
pentose metabolic process (GO:0019321)	13	0	.30	-	 < 0.01	7.38E-01
thorax and anterior abdomen determination (GO:0007356)	3	0	.07	-	 < 0.01	9.32E-01
zygotic determination of anterior/posterior axis, embryo (GO:0007354)	5	0	.12	-	 < 0.01	8.90E-01
zygotic specification of dorsal/ventral axis (GO:0007352)	2	0	.05	-	 < 0.01	9.54E-01
tripartite regional subdivision (GO:0007351)	15	0	.35	-	 < 0.01	7.05E-01
blastoderm segmentation (GO:0007350)	19	0	.44	-	 < 0.01	6.42E-01
olfactory nerve structural organization (GO:0021629)	1	0	.02	-	 < 0.01	9.77E-01
olfactory nerve morphogenesis (GO:0021627)	1	0	.02	-	 < 0.01	9.77E-01
oculomotor nerve formation (GO:0021623)	2	0	.05	-	 < 0.01	9.54E-01
oculomotor nerve morphogenesis (GO:0021622)	2	0	.05	-	 < 0.01	9.54E-01
blood coagulation, fibrin clot formation (GO:0072378)	8	0	.19	-	 < 0.01	8.30E-01
amylopectin metabolic process (GO:2000896)	1	0	.02	-	 < 0.01	9.77E-01
blood coagulation, common pathway (GO:0072377)	1	0	.02	-	 < 0.01	9.77E-01
protein activation cascade (GO:0072376)	12	0	.28	-	 < 0.01	7.56E-01
positive regulation of mitochondrial transcription (GO:1903109)	3	0	.07	-	 < 0.01	9.32E-01
regulation of mitochondrial transcription (GO:1903108)	4	0	.09	-	 < 0.01	9.11E-01
inositol catabolic process (GO:0019310)	1	0	.02	-	 < 0.01	9.77E-01
1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate metabolic process (GO:1903100)	1	0	.02	-	 < 0.01	9.77E-01
fusion of sperm to egg plasma membrane involved in single fertilization (GO:0007342)	15	0	.35	-	 < 0.01	7.05E-01
penetration of zona pellucida (GO:0007341)	9	0	.21	-	 < 0.01	8.11E-01
hypoglossal nerve morphogenesis (GO:0021618)	1	0	.02	-	 < 0.01	9.77E-01
glossopharyngeal nerve morphogenesis (GO:0021615)	4	0	.09	-	 < 0.01	9.11E-01
mannose catabolic process (GO:0019309)	1	0	.02	-	 < 0.01	9.77E-01
facial nerve structural organization (GO:0021612)	10	0	.23	-	 < 0.01	7.92E-01
facial nerve morphogenesis (GO:0021610)	12	0	.28	-	 < 0.01	7.56E-01
D-ribose catabolic process (GO:0019303)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of dipeptide transport (GO:2000880)	2	0	.05	-	 < 0.01	9.54E-01
binding of sperm to zona pellucida (GO:0007339)	42	0	.98	-	 < 0.01	3.75E-01
positive regulation of growth hormone receptor signaling pathway (GO:0060399)	3	0	.07	-	 < 0.01	9.32E-01
regulation of growth hormone receptor signaling pathway (GO:0060398)	5	0	.12	-	 < 0.01	8.90E-01
growth hormone receptor signaling pathway via JAK-STAT (GO:0060397)	5	0	.12	-	 < 0.01	8.90E-01
growth hormone receptor signaling pathway (GO:0060396)	11	0	.26	-	 < 0.01	7.74E-01
negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394)	13	0	.30	-	 < 0.01	7.38E-01
negative regulation of SMAD protein signal transduction (GO:0060392)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of SMAD protein signal transduction (GO:0060391)	15	0	.35	-	 < 0.01	7.05E-01
regulation of SMAD protein signal transduction (GO:0060390)	25	0	.58	-	 < 0.01	5.58E-01
cranial nerve structural organization (GO:0021604)	13	0	.30	-	 < 0.01	7.38E-01
cranial nerve formation (GO:0021603)	8	0	.19	-	 < 0.01	8.30E-01
positive regulation of oligopeptide transport (GO:2000878)	2	0	.05	-	 < 0.01	9.54E-01
chromosome passenger complex localization to kinetochore (GO:0072356)	2	0	.05	-	 < 0.01	9.54E-01
histone H3-T3 phosphorylation (GO:0072355)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of progesterone secretion (GO:2000872)	2	0	.05	-	 < 0.01	9.54E-01
regulation of progesterone secretion (GO:2000870)	3	0	.07	-	 < 0.01	9.32E-01
tricarboxylic acid metabolic process (GO:0072350)	14	0	.33	-	 < 0.01	7.21E-01
synapse assembly involved in innervation (GO:0060386)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of DNA strand elongation (GO:0060383)	1	0	.02	-	 < 0.01	9.77E-01
regulation of DNA strand elongation (GO:0060382)	2	0	.05	-	 < 0.01	9.54E-01
sperm displacement (GO:0007321)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of single-stranded telomeric DNA binding (GO:0060381)	1	0	.02	-	 < 0.01	9.77E-01
insemination (GO:0007320)	13	0	.30	-	 < 0.01	7.38E-01
regulation of single-stranded telomeric DNA binding (GO:0060380)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of estradiol secretion (GO:2000866)	2	0	.05	-	 < 0.01	9.54E-01
response to anesthetic (GO:0072347)	3	0	.07	-	 < 0.01	9.32E-01
regulation of estradiol secretion (GO:2000864)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of estrogen secretion (GO:2000863)	1	0	.02	-	 < 0.01	9.77E-01
rescue of stalled ribosome (GO:0072344)	3	0	.07	-	 < 0.01	9.32E-01
regulation of estrogen secretion (GO:2000861)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of aldosterone secretion (GO:2000860)	3	0	.07	-	 < 0.01	9.32E-01
cardiac muscle cell myoblast differentiation (GO:0060379)	8	0	.19	-	 < 0.01	8.30E-01
regulation of brood size (GO:0060378)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of mast cell differentiation (GO:0060377)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of mast cell differentiation (GO:0060376)	3	0	.07	-	 < 0.01	9.32E-01
pole plasm assembly (GO:0007315)	3	0	.07	-	 < 0.01	9.32E-01
regulation of mast cell differentiation (GO:0060375)	5	0	.12	-	 < 0.01	8.90E-01
oocyte anterior/posterior axis specification (GO:0007314)	3	0	.07	-	 < 0.01	9.32E-01
mast cell differentiation (GO:0060374)	2	0	.05	-	 < 0.01	9.54E-01
regulation of ventricular cardiac muscle cell membrane depolarization (GO:0060373)	7	0	.16	-	 < 0.01	8.49E-01
regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372)	6	0	.14	-	 < 0.01	8.69E-01
regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371)	8	0	.19	-	 < 0.01	8.30E-01
susceptibility to T cell mediated cytotoxicity (GO:0060370)	1	0	.02	-	 < 0.01	9.77E-01
guanine biosynthetic process (GO:0046099)	1	0	.02	-	 < 0.01	9.77E-01
guanine metabolic process (GO:0046098)	3	0	.07	-	 < 0.01	9.32E-01
regulation of aldosterone secretion (GO:2000858)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of mineralocorticoid secretion (GO:2000857)	3	0	.07	-	 < 0.01	9.32E-01
deoxyinosine metabolic process (GO:0046094)	1	0	.02	-	 < 0.01	9.77E-01
cellular lactam metabolic process (GO:0072338)	2	0	.05	-	 < 0.01	9.54E-01
regulation of mineralocorticoid secretion (GO:2000855)	7	0	.16	-	 < 0.01	8.49E-01
deoxycytidine metabolic process (GO:0046092)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of corticosterone secretion (GO:2000854)	2	0	.05	-	 < 0.01	9.54E-01
deoxyadenosine metabolic process (GO:0046090)	1	0	.02	-	 < 0.01	9.77E-01
UDP-galactose transmembrane transport (GO:0072334)	2	0	.05	-	 < 0.01	9.54E-01
regulation of corticosterone secretion (GO:2000852)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of glucocorticoid secretion (GO:2000851)	5	0	.12	-	 < 0.01	8.90E-01
intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332)	50	0	1.17	-	 < 0.01	3.11E-01
negative regulation of glucocorticoid secretion (GO:2000850)	3	0	.07	-	 < 0.01	9.32E-01
signal transduction by p53 class mediator (GO:0072331)	73	0	1.70	-	 < 0.01	1.82E-01
positive regulation of Fc receptor mediated stimulatory signaling pathway (GO:0060369)	7	0	.16	-	 < 0.01	8.49E-01
oocyte axis specification (GO:0007309)	3	0	.07	-	 < 0.01	9.32E-01
regulation of Fc receptor mediated stimulatory signaling pathway (GO:0060368)	12	0	.28	-	 < 0.01	7.56E-01
oocyte construction (GO:0007308)	3	0	.07	-	 < 0.01	9.32E-01
sagittal suture morphogenesis (GO:0060367)	1	0	.02	-	 < 0.01	9.77E-01
lambdoid suture morphogenesis (GO:0060366)	1	0	.02	-	 < 0.01	9.77E-01
frontal suture morphogenesis (GO:0060364)	2	0	.05	-	 < 0.01	9.54E-01
respiratory basal cell differentiation (GO:1902691)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of NAD metabolic process (GO:1902690)	1	0	.02	-	 < 0.01	9.77E-01
cytidine metabolic process (GO:0046087)	4	0	.09	-	 < 0.01	9.11E-01
regulation of glucocorticoid secretion (GO:2000849)	10	0	.23	-	 < 0.01	7.92E-01
adenosine biosynthetic process (GO:0046086)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of corticosteroid hormone secretion (GO:2000848)	8	0	.19	-	 < 0.01	8.30E-01
adenosine metabolic process (GO:0046085)	14	0	.33	-	 < 0.01	7.21E-01
negative regulation of corticosteroid hormone secretion (GO:2000847)	3	0	.07	-	 < 0.01	9.32E-01
adenine biosynthetic process (GO:0046084)	3	0	.07	-	 < 0.01	9.32E-01
regulation of corticosteroid hormone secretion (GO:2000846)	17	0	.40	-	 < 0.01	6.73E-01
adenine metabolic process (GO:0046083)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of testosterone secretion (GO:2000845)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of testosterone secretion (GO:2000844)	1	0	.02	-	 < 0.01	9.77E-01
dUTP catabolic process (GO:0046081)	1	0	.02	-	 < 0.01	9.77E-01
regulation of testosterone secretion (GO:2000843)	3	0	.07	-	 < 0.01	9.32E-01
dUTP metabolic process (GO:0046080)	1	0	.02	-	 < 0.01	9.77E-01
chaperone-mediated protein transport (GO:0072321)	9	0	.21	-	 < 0.01	8.11E-01
response to ammonium ion (GO:0060359)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of leucine import (GO:0060358)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of NAD metabolic process (GO:1902689)	1	0	.02	-	 < 0.01	9.77E-01
regulation of leucine import (GO:0060357)	2	0	.05	-	 < 0.01	9.54E-01
regulation of NAD metabolic process (GO:1902688)	2	0	.05	-	 < 0.01	9.54E-01
dibenzo-p-dioxin metabolic process (GO:0018894)	2	0	.05	-	 < 0.01	9.54E-01
inositol phosphorylation (GO:0052746)	2	0	.05	-	 < 0.01	9.54E-01
mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686)	13	0	.30	-	 < 0.01	7.38E-01
negative regulation of cell adhesion molecule production (GO:0060354)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of receptor localization to synapse (GO:1902685)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of receptor localization to synapse (GO:1902684)	1	0	.02	-	 < 0.01	9.77E-01
cell adhesion molecule production (GO:0060352)	3	0	.07	-	 < 0.01	9.32E-01
dUMP catabolic process (GO:0046079)	7	0	.16	-	 < 0.01	8.49E-01
dUMP metabolic process (GO:0046078)	9	0	.21	-	 < 0.01	8.11E-01
dUDP metabolic process (GO:0046077)	3	0	.07	-	 < 0.01	9.32E-01
dTTP metabolic process (GO:0046075)	3	0	.07	-	 < 0.01	9.32E-01
vesicle uncoating (GO:0072319)	8	0	.19	-	 < 0.01	8.30E-01
dTMP catabolic process (GO:0046074)	7	0	.16	-	 < 0.01	8.49E-01
clathrin coat disassembly (GO:0072318)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of androgen secretion (GO:2000836)	1	0	.02	-	 < 0.01	9.77E-01
dTMP metabolic process (GO:0046073)	10	0	.23	-	 < 0.01	7.92E-01
dTDP metabolic process (GO:0046072)	2	0	.05	-	 < 0.01	9.54E-01
regulation of androgen secretion (GO:2000834)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of steroid hormone secretion (GO:2000833)	12	0	.28	-	 < 0.01	7.56E-01
dGTP metabolic process (GO:0046070)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of steroid hormone secretion (GO:2000832)	3	0	.07	-	 < 0.01	9.32E-01
metanephric glomerular epithelial cell development (GO:0072313)	1	0	.02	-	 < 0.01	9.77E-01
regulation of steroid hormone secretion (GO:2000831)	22	0	.51	-	 < 0.01	5.99E-01
metanephric glomerular epithelial cell differentiation (GO:0072312)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of parathyroid hormone secretion (GO:2000830)	2	0	.05	-	 < 0.01	9.54E-01
glomerular epithelial cell differentiation (GO:0072311)	14	0	.33	-	 < 0.01	7.21E-01
glomerular epithelial cell development (GO:0072310)	8	0	.19	-	 < 0.01	8.30E-01
spleen trabecula formation (GO:0060345)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of type I interferon-mediated signaling pathway (GO:0060340)	12	0	.28	-	 < 0.01	7.56E-01
cGMP catabolic process (GO:0046069)	4	0	.09	-	 < 0.01	9.11E-01
cGMP metabolic process (GO:0046068)	18	0	.42	-	 < 0.01	6.57E-01
dGDP catabolic process (GO:0046067)	1	0	.02	-	 < 0.01	9.77E-01
dGDP metabolic process (GO:0046066)	2	0	.05	-	 < 0.01	9.54E-01
regulation of parathyroid hormone secretion (GO:2000828)	3	0	.07	-	 < 0.01	9.32E-01
dCTP metabolic process (GO:0046065)	1	0	.02	-	 < 0.01	9.77E-01
mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis (GO:0072309)	1	0	.02	-	 < 0.01	9.77E-01
mitochondrial RNA surveillance (GO:2000827)	1	0	.02	-	 < 0.01	9.77E-01
regulation of heart morphogenesis (GO:2000826)	9	0	.21	-	 < 0.01	8.11E-01
dCMP metabolic process (GO:0046063)	8	0	.19	-	 < 0.01	8.30E-01
regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of androgen receptor activity (GO:2000825)	3	0	.07	-	 < 0.01	9.32E-01
dCDP metabolic process (GO:0046062)	1	0	.02	-	 < 0.01	9.77E-01
dATP catabolic process (GO:0046061)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis (GO:0072305)	2	0	.05	-	 < 0.01	9.54E-01
dATP metabolic process (GO:0046060)	8	0	.19	-	 < 0.01	8.30E-01
regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis (GO:0072304)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of glomerular metanephric mesangial cell proliferation (GO:0072303)	1	0	.02	-	 < 0.01	9.77E-01
regulation of grooming behavior (GO:2000821)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of metanephric glomerular mesangial cell proliferation (GO:0072302)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation (GO:2000820)	3	0	.07	-	 < 0.01	9.32E-01
regulation of metanephric glomerular mesangial cell proliferation (GO:0072301)	2	0	.05	-	 < 0.01	9.54E-01
biphenyl metabolic process (GO:0018879)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of maintenance of meiotic sister chromatid cohesion (GO:0034096)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of metanephric glomerulus development (GO:0072300)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of type I interferon-mediated signaling pathway (GO:0060339)	13	0	.30	-	 < 0.01	7.38E-01
regulation of type I interferon-mediated signaling pathway (GO:0060338)	25	0	.58	-	 < 0.01	5.58E-01
regulation of maintenance of meiotic sister chromatid cohesion (GO:0034094)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of axon guidance (GO:1902668)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of maintenance of sister chromatid cohesion (GO:0034093)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of maintenance of sister chromatid cohesion (GO:0034092)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of interferon-gamma-mediated signaling pathway (GO:0060335)	6	0	.14	-	 < 0.01	8.69E-01
regulation of maintenance of sister chromatid cohesion (GO:0034091)	7	0	.16	-	 < 0.01	8.49E-01
regulation of interferon-gamma-mediated signaling pathway (GO:0060334)	14	0	.33	-	 < 0.01	7.21E-01
arsonoacetate metabolic process (GO:0018872)	2	0	.05	-	 < 0.01	9.54E-01
interferon-gamma-mediated signaling pathway (GO:0060333)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of response to interferon-gamma (GO:0060332)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of response to interferon-gamma (GO:0060331)	6	0	.14	-	 < 0.01	8.69E-01
regulation of response to interferon-gamma (GO:0060330)	14	0	.33	-	 < 0.01	7.21E-01
dAMP catabolic process (GO:0046059)	5	0	.12	-	 < 0.01	8.90E-01
dADP catabolic process (GO:0046057)	1	0	.02	-	 < 0.01	9.77E-01
regulation of nucleotide-excision repair (GO:2000819)	4	0	.09	-	 < 0.01	9.11E-01
dADP metabolic process (GO:0046056)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of myoblast proliferation (GO:2000818)	1	0	.02	-	 < 0.01	9.77E-01
dGMP catabolic process (GO:0046055)	7	0	.16	-	 < 0.01	8.49E-01
dGMP metabolic process (GO:0046054)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of mitotic sister chromatid separation (GO:2000816)	28	0	.65	-	 < 0.01	5.20E-01
dAMP metabolic process (GO:0046053)	5	0	.12	-	 < 0.01	8.90E-01
regulation of mRNA stability involved in response to oxidative stress (GO:2000815)	2	0	.05	-	 < 0.01	9.54E-01
UTP catabolic process (GO:0046052)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of barbed-end actin filament capping (GO:2000814)	2	0	.05	-	 < 0.01	9.54E-01
UTP metabolic process (GO:0046051)	10	0	.23	-	 < 0.01	7.92E-01
UMP catabolic process (GO:0046050)	7	0	.16	-	 < 0.01	8.49E-01
regulation of barbed-end actin filament capping (GO:2000812)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of anoikis (GO:2000811)	15	0	.35	-	 < 0.01	7.05E-01
regulation of bicellular tight junction assembly (GO:2000810)	23	0	.54	-	 < 0.01	5.85E-01
maintenance of mitotic sister chromatid cohesion (GO:0034088)	4	0	.09	-	 < 0.01	9.11E-01
establishment of mitotic sister chromatid cohesion (GO:0034087)	2	0	.05	-	 < 0.01	9.54E-01
maintenance of sister chromatid cohesion (GO:0034086)	4	0	.09	-	 < 0.01	9.11E-01
establishment of sister chromatid cohesion (GO:0034085)	4	0	.09	-	 < 0.01	9.11E-01
cytoplasmic actin-based contraction involved in cell motility (GO:0060327)	2	0	.05	-	 < 0.01	9.54E-01
CENP-A containing nucleosome assembly (GO:0034080)	5	0	.12	-	 < 0.01	8.90E-01
Golgi to endosome transport (GO:0006895)	11	0	.26	-	 < 0.01	7.74E-01
intra-Golgi vesicle-mediated transport (GO:0006891)	27	0	.63	-	 < 0.01	5.33E-01
UMP metabolic process (GO:0046049)	10	0	.23	-	 < 0.01	7.92E-01
UDP metabolic process (GO:0046048)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of synaptic vesicle clustering (GO:2000809)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of synaptic vesicle clustering (GO:2000808)	1	0	.02	-	 < 0.01	9.77E-01
regulation of synaptic vesicle clustering (GO:2000807)	10	0	.23	-	 < 0.01	7.92E-01
positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled (GO:2000806)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of termination of RNA polymerase II transcription, poly(A)-coupled (GO:2000805)	2	0	.05	-	 < 0.01	9.54E-01
regulation of termination of RNA polymerase II transcription, poly(A)-coupled (GO:2000804)	3	0	.07	-	 < 0.01	9.32E-01
ITP metabolic process (GO:0046041)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation (GO:2000802)	1	0	.02	-	 < 0.01	9.77E-01
IMP metabolic process (GO:0046040)	14	0	.33	-	 < 0.01	7.21E-01
regulation of endocardial cushion to mesenchymal transition involved in heart valve formation (GO:2000800)	1	0	.02	-	 < 0.01	9.77E-01
primitive erythrocyte differentiation (GO:0060319)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315)	6	0	.14	-	 < 0.01	8.69E-01
regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314)	17	0	.40	-	 < 0.01	6.73E-01
tertiary alcohol biosynthetic process (GO:1902645)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of blood vessel remodeling (GO:0060313)	2	0	.05	-	 < 0.01	9.54E-01
tertiary alcohol metabolic process (GO:1902644)	14	0	.33	-	 < 0.01	7.21E-01
regulation of blood vessel remodeling (GO:0060312)	9	0	.21	-	 < 0.01	8.11E-01
negative regulation of elastin catabolic process (GO:0060311)	1	0	.02	-	 < 0.01	9.77E-01
regulation of elastin catabolic process (GO:0060310)	1	0	.02	-	 < 0.01	9.77E-01
cellular sodium ion homeostasis (GO:0006883)	24	0	.56	-	 < 0.01	5.71E-01
cellular zinc ion homeostasis (GO:0006882)	25	0	.58	-	 < 0.01	5.58E-01
intracellular sequestering of iron ion (GO:0006880)	4	0	.09	-	 < 0.01	9.11E-01
GTP metabolic process (GO:0046039)	26	0	.61	-	 < 0.01	5.45E-01
GMP catabolic process (GO:0046038)	8	0	.19	-	 < 0.01	8.30E-01
GMP metabolic process (GO:0046037)	12	0	.28	-	 < 0.01	7.56E-01
CTP metabolic process (GO:0046036)	9	0	.21	-	 < 0.01	8.11E-01
CMP metabolic process (GO:0046035)	8	0	.19	-	 < 0.01	8.30E-01
AMP metabolic process (GO:0046033)	19	0	.44	-	 < 0.01	6.42E-01
ADP catabolic process (GO:0046032)	4	0	.09	-	 < 0.01	9.11E-01
methylguanosine-cap decapping (GO:0110156)	12	0	.28	-	 < 0.01	7.56E-01
elastin catabolic process (GO:0060309)	3	0	.07	-	 < 0.01	9.32E-01
NAD-cap decapping (GO:0110155)	2	0	.05	-	 < 0.01	9.54E-01
RNA decapping (GO:0110154)	14	0	.33	-	 < 0.01	7.21E-01
regulation of cell diameter (GO:0060305)	1	0	.02	-	 < 0.01	9.77E-01
regulation of phosphatidylinositol dephosphorylation (GO:0060304)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of biomineralization (GO:0110150)	27	0	.63	-	 < 0.01	5.33E-01
1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate biosynthetic process (GO:1902635)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of cytokine activity (GO:0060302)	2	0	.05	-	 < 0.01	9.54E-01
1-phosphatidyl-1D-myo-inositol 4,5-bisphosphate metabolic process (GO:1902633)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of membrane hyperpolarization (GO:1902632)	1	0	.02	-	 < 0.01	9.77E-01
regulation of cytokine activity (GO:0060300)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of membrane hyperpolarization (GO:1902631)	2	0	.05	-	 < 0.01	9.54E-01
cellular copper ion homeostasis (GO:0006878)	14	0	.33	-	 < 0.01	7.21E-01
cellular cadmium ion homeostasis (GO:0006876)	2	0	.05	-	 < 0.01	9.54E-01
response to anoxia (GO:0034059)	1	0	.02	-	 < 0.01	9.77E-01
endosomal vesicle fusion (GO:0034058)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of estrogen receptor binding (GO:0071899)	3	0	.07	-	 < 0.01	9.32E-01
regulation of estrogen receptor binding (GO:0071898)	3	0	.07	-	 < 0.01	9.32E-01
protein localization to adherens junction (GO:0071896)	5	0	.12	-	 < 0.01	8.90E-01
regulation of mRNA stability involved in cellular response to UV (GO:1902629)	1	0	.02	-	 < 0.01	9.77E-01
odontoblast differentiation (GO:0071895)	4	0	.09	-	 < 0.01	9.11E-01
histone H2B conserved C-terminal lysine ubiquitination (GO:0071894)	1	0	.02	-	 < 0.01	9.77E-01
BMP signaling pathway involved in nephric duct formation (GO:0071893)	1	0	.02	-	 < 0.01	9.77E-01
assembly of large subunit precursor of preribosome (GO:1902626)	3	0	.07	-	 < 0.01	9.32E-01
programmed cell death induced by symbiont (GO:0034050)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of neutrophil migration (GO:1902624)	33	0	.77	-	 < 0.01	4.63E-01
negative regulation of neutrophil migration (GO:1902623)	4	0	.09	-	 < 0.01	9.11E-01
regulation of neutrophil migration (GO:1902622)	45	0	1.05	-	 < 0.01	3.50E-01
pyrimidine nucleotide transport (GO:0006864)	2	0	.05	-	 < 0.01	9.54E-01
purine nucleobase transport (GO:0006863)	3	0	.07	-	 < 0.01	9.32E-01
nucleotide transport (GO:0006862)	22	0	.51	-	 < 0.01	5.99E-01
positive regulation of transcription by glucose (GO:0046016)	4	0	.09	-	 < 0.01	9.11E-01
regulation of transcription by glucose (GO:0046015)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of T cell homeostatic proliferation (GO:0046014)	1	0	.02	-	 < 0.01	9.77E-01
regulation of T cell homeostatic proliferation (GO:0046013)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of circadian sleep/wake cycle, non-REM sleep (GO:0046010)	9	0	.21	-	 < 0.01	8.11E-01
macrophage apoptotic process (GO:0071888)	1	0	.02	-	 < 0.01	9.77E-01
Norrin signaling pathway (GO:0110135)	4	0	.09	-	 < 0.01	9.11E-01
leukocyte apoptotic process (GO:0071887)	28	0	.65	-	 < 0.01	5.20E-01
cellular response to fluoride (GO:1902618)	1	0	.02	-	 < 0.01	9.77E-01
response to fluoride (GO:1902617)	2	0	.05	-	 < 0.01	9.54E-01
phospholipase C-activating adrenergic receptor signaling pathway (GO:0071882)	1	0	.02	-	 < 0.01	9.77E-01
adenylate cyclase-inhibiting adrenergic receptor signaling pathway (GO:0071881)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of anti-Mullerian hormone signaling pathway (GO:1902613)	1	0	.02	-	 < 0.01	9.77E-01
adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880)	20	0	.47	-	 < 0.01	6.27E-01
regulation of anti-Mullerian hormone signaling pathway (GO:1902612)	1	0	.02	-	 < 0.01	9.77E-01
drug transmembrane transport (GO:0006855)	9	0	.21	-	 < 0.01	8.11E-01
mitochondrial calcium ion transmembrane transport (GO:0006851)	11	0	.26	-	 < 0.01	7.74E-01
mitochondrial pyruvate transmembrane transport (GO:0006850)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of activated T cell proliferation (GO:0046007)	14	0	.33	-	 < 0.01	7.21E-01
regulation of activated T cell proliferation (GO:0046006)	41	0	.96	-	 < 0.01	3.84E-01
positive regulation of circadian sleep/wake cycle, REM sleep (GO:0046005)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071879)	2	0	.05	-	 < 0.01	9.54E-01
purine ribonucleoside bisphosphate biosynthetic process (GO:0034036)	2	0	.05	-	 < 0.01	9.54E-01
purine ribonucleoside bisphosphate metabolic process (GO:0034035)	7	0	.16	-	 < 0.01	8.49E-01
regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway (GO:0071877)	1	0	.02	-	 < 0.01	9.77E-01
purine nucleoside bisphosphate catabolic process (GO:0034034)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of large conductance calcium-activated potassium channel activity (GO:1902608)	3	0	.07	-	 < 0.01	9.32E-01
purine nucleoside bisphosphate biosynthetic process (GO:0034033)	31	0	.72	-	 < 0.01	4.85E-01
adrenergic receptor signaling pathway (GO:0071875)	22	0	.51	-	 < 0.01	5.99E-01
negative regulation of large conductance calcium-activated potassium channel activity (GO:1902607)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to norepinephrine stimulus (GO:0071874)	2	0	.05	-	 < 0.01	9.54E-01
regulation of large conductance calcium-activated potassium channel activity (GO:1902606)	4	0	.09	-	 < 0.01	9.11E-01
ribonucleoside bisphosphate catabolic process (GO:0034031)	6	0	.14	-	 < 0.01	8.69E-01
response to norepinephrine (GO:0071873)	3	0	.07	-	 < 0.01	9.32E-01
heterotrimeric G-protein complex assembly (GO:1902605)	1	0	.02	-	 < 0.01	9.77E-01
ribonucleoside bisphosphate biosynthetic process (GO:0034030)	31	0	.72	-	 < 0.01	4.85E-01
carnitine transmembrane transport (GO:1902603)	2	0	.05	-	 < 0.01	9.54E-01
pyruvate transport (GO:0006848)	4	0	.09	-	 < 0.01	9.11E-01
proton transmembrane transport (GO:1902600)	60	0	1.40	-	 < 0.01	2.46E-01
acyl carnitine transport (GO:0006844)	4	0	.09	-	 < 0.01	9.11E-01
mitochondrial citrate transmembrane transport (GO:0006843)	1	0	.02	-	 < 0.01	9.77E-01
antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent (GO:0002489)	2	0	.05	-	 < 0.01	9.54E-01
antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway (GO:0002488)	2	0	.05	-	 < 0.01	9.54E-01
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)	20	0	.47	-	 < 0.01	6.27E-01
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-dependent (GO:0002485)	3	0	.07	-	 < 0.01	9.32E-01
antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484)	21	0	.49	-	 < 0.01	6.13E-01
antigen processing and presentation of endogenous peptide antigen (GO:0002483)	27	0	.63	-	 < 0.01	5.33E-01
antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent (GO:0002481)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of lipid transporter activity (GO:0110114)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of lipid transporter activity (GO:0110113)	2	0	.05	-	 < 0.01	9.54E-01
regulation of lipid transporter activity (GO:0110112)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of animal organ morphogenesis (GO:0110111)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of animal organ morphogenesis (GO:0110110)	37	0	.86	-	 < 0.01	4.22E-01
serotonin transport (GO:0006837)	14	0	.33	-	 < 0.01	7.21E-01
water transport (GO:0006833)	17	0	.40	-	 < 0.01	6.73E-01
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)	2	0	.05	-	 < 0.01	9.54E-01
antigen processing and presentation of exogenous peptide antigen via MHC class Ib (GO:0002477)	4	0	.09	-	 < 0.01	9.11E-01
antigen processing and presentation of endogenous peptide antigen via MHC class Ib (GO:0002476)	21	0	.49	-	 < 0.01	6.13E-01
polarity specification of proximal/distal axis (GO:0010085)	2	0	.05	-	 < 0.01	9.54E-01
antigen processing and presentation via MHC class Ib (GO:0002475)	26	0	.61	-	 < 0.01	5.45E-01
plasmacytoid dendritic cell antigen processing and presentation (GO:0002470)	1	0	.02	-	 < 0.01	9.77E-01
mRNA alternative polyadenylation (GO:0110104)	4	0	.09	-	 < 0.01	9.11E-01
response to triglyceride (GO:0034014)	1	0	.02	-	 < 0.01	9.77E-01
mitotic cell cycle arrest (GO:0071850)	12	0	.28	-	 < 0.01	7.56E-01
zinc ion transport (GO:0006829)	29	0	.68	-	 < 0.01	5.08E-01
copper ion transport (GO:0006825)	14	0	.33	-	 < 0.01	7.21E-01
cobalt ion transport (GO:0006824)	6	0	.14	-	 < 0.01	8.69E-01
dendritic cell antigen processing and presentation (GO:0002468)	2	0	.05	-	 < 0.01	9.54E-01
germinal center formation (GO:0002467)	7	0	.16	-	 < 0.01	8.49E-01
peripheral tolerance induction (GO:0002465)	2	0	.05	-	 < 0.01	9.54E-01
tolerance induction to nonself antigen (GO:0002462)	1	0	.02	-	 < 0.01	9.77E-01
tolerance induction dependent upon immune response (GO:0002461)	3	0	.07	-	 < 0.01	9.32E-01
zygote asymmetric cell division (GO:0010070)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling (GO:0071848)	2	0	.05	-	 < 0.01	9.54E-01
TNFSF11-mediated signaling pathway (GO:0071847)	6	0	.14	-	 < 0.01	8.69E-01
actin filament debranching (GO:0071846)	2	0	.05	-	 < 0.01	9.54E-01
peripheral T cell tolerance induction (GO:0002458)	1	0	.02	-	 < 0.01	9.77E-01
T cell antigen processing and presentation (GO:0002457)	5	0	.12	-	 < 0.01	8.90E-01
humoral immune response mediated by circulating immunoglobulin (GO:0002455)	34	0	.79	-	 < 0.01	4.52E-01
peripheral B cell tolerance induction (GO:0002451)	1	0	.02	-	 < 0.01	9.77E-01
apoptotic process in bone marrow cell (GO:0071839)	1	0	.02	-	 < 0.01	9.77E-01
cell proliferation in bone marrow (GO:0071838)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of regulatory T cell differentiation (GO:0045591)	13	0	.30	-	 < 0.01	7.38E-01
negative regulation of regulatory T cell differentiation (GO:0045590)	7	0	.16	-	 < 0.01	8.49E-01
intermediate-density lipoprotein particle clearance (GO:0071831)	1	0	.02	-	 < 0.01	9.77E-01
tangential migration from the subventricular zone to the olfactory bulb (GO:0022028)	9	0	.21	-	 < 0.01	8.11E-01
triglyceride-rich lipoprotein particle clearance (GO:0071830)	4	0	.09	-	 < 0.01	9.11E-01
nitric oxide biosynthetic process (GO:0006809)	13	0	.30	-	 < 0.01	7.38E-01
regulation of nitrogen utilization (GO:0006808)	3	0	.07	-	 < 0.01	9.32E-01
malonyl-CoA biosynthetic process (GO:2001295)	1	0	.02	-	 < 0.01	9.77E-01
malonyl-CoA catabolic process (GO:2001294)	1	0	.02	-	 < 0.01	9.77E-01
superoxide metabolic process (GO:0006801)	33	0	.77	-	 < 0.01	4.63E-01
malonyl-CoA metabolic process (GO:2001293)	2	0	.05	-	 < 0.01	9.54E-01
mast cell mediated immunity (GO:0002448)	20	0	.47	-	 < 0.01	6.27E-01
eosinophil mediated immunity (GO:0002447)	2	0	.05	-	 < 0.01	9.54E-01
neutrophil mediated immunity (GO:0002446)	20	0	.47	-	 < 0.01	6.27E-01
type II hypersensitivity (GO:0002445)	2	0	.05	-	 < 0.01	9.54E-01
myeloid leukocyte mediated immunity (GO:0002444)	44	0	1.03	-	 < 0.01	3.58E-01
serotonin secretion involved in inflammatory response (GO:0002442)	4	0	.09	-	 < 0.01	9.11E-01
histamine secretion involved in inflammatory response (GO:0002441)	5	0	.12	-	 < 0.01	8.90E-01
regulation of regulatory T cell differentiation (GO:0045589)	28	0	.65	-	 < 0.01	5.20E-01
production of molecular mediator of immune response (GO:0002440)	90	0	2.10	-	 < 0.01	1.22E-01
positive regulation of gamma-delta T cell differentiation (GO:0045588)	9	0	.21	-	 < 0.01	8.11E-01
regulation of gamma-delta T cell differentiation (GO:0045586)	12	0	.28	-	 < 0.01	7.56E-01
positive regulation of cytotoxic T cell differentiation (GO:0045585)	3	0	.07	-	 < 0.01	9.32E-01
regulation of cytotoxic T cell differentiation (GO:0045583)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of T cell differentiation (GO:0045582)	95	0	2.21	-	 < 0.01	1.09E-01
negative regulation of T cell differentiation (GO:0045581)	47	0	1.10	-	 < 0.01	3.34E-01
regulation of T cell differentiation (GO:0045580)	149	0	3.47	-	 < 0.01	3.06E-02
lateral ganglionic eminence cell proliferation (GO:0022018)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of caveolin-mediated endocytosis (GO:2001288)	4	0	.09	-	 < 0.01	9.11E-01
pallium cell proliferation in forebrain (GO:0022013)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of caveolin-mediated endocytosis (GO:2001287)	2	0	.05	-	 < 0.01	9.54E-01
subpallium cell proliferation in forebrain (GO:0022012)	1	0	.02	-	 < 0.01	9.77E-01
regulation of caveolin-mediated endocytosis (GO:2001286)	7	0	.16	-	 < 0.01	8.49E-01
chronic inflammatory response to antigenic stimulus (GO:0002439)	2	0	.05	-	 < 0.01	9.54E-01
acute inflammatory response to antigenic stimulus (GO:0002438)	11	0	.26	-	 < 0.01	7.74E-01
inflammatory response to antigenic stimulus (GO:0002437)	35	0	.82	-	 < 0.01	4.42E-01
response to mycotoxin (GO:0010046)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of unsaturated fatty acid biosynthetic process (GO:2001280)	11	0	.26	-	 < 0.01	7.74E-01
response to nickel cation (GO:0010045)	2	0	.05	-	 < 0.01	9.54E-01
response to aluminum ion (GO:0010044)	2	0	.05	-	 < 0.01	9.54E-01
immune complex clearance (GO:0002434)	3	0	.07	-	 < 0.01	9.32E-01
response to zinc ion (GO:0010043)	33	0	.77	-	 < 0.01	4.63E-01
immune response-regulating cell surface receptor signaling pathway involved in phagocytosis (GO:0002433)	2	0	.05	-	 < 0.01	9.54E-01
response to manganese ion (GO:0010042)	9	0	.21	-	 < 0.01	8.11E-01
granuloma formation (GO:0002432)	2	0	.05	-	 < 0.01	9.54E-01
response to iron(III) ion (GO:0010041)	2	0	.05	-	 < 0.01	9.54E-01
Fc receptor mediated stimulatory signaling pathway (GO:0002431)	6	0	.14	-	 < 0.01	8.69E-01
response to iron(II) ion (GO:0010040)	4	0	.09	-	 < 0.01	9.11E-01
complement receptor mediated signaling pathway (GO:0002430)	12	0	.28	-	 < 0.01	7.56E-01
mast cell activation (GO:0045576)	28	0	.65	-	 < 0.01	5.20E-01
basophil activation (GO:0045575)	4	0	.09	-	 < 0.01	9.11E-01
tail-anchored membrane protein insertion into ER membrane (GO:0071816)	12	0	.28	-	 < 0.01	7.56E-01
positive regulation of fever generation by positive regulation of prostaglandin secretion (GO:0071812)	2	0	.05	-	 < 0.01	9.54E-01
central nervous system vasculogenesis (GO:0022009)	5	0	.12	-	 < 0.01	8.90E-01
convergent extension involved in neural plate elongation (GO:0022007)	3	0	.07	-	 < 0.01	9.32E-01
zona limitans intrathalamica formation (GO:0022006)	1	0	.02	-	 < 0.01	9.77E-01
regulation of unsaturated fatty acid biosynthetic process (GO:2001279)	14	0	.33	-	 < 0.01	7.21E-01
midbrain-hindbrain boundary maturation during brain development (GO:0022004)	1	0	.02	-	 < 0.01	9.77E-01
response to iron ion (GO:0010039)	19	0	.44	-	 < 0.01	6.42E-01
positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001272)	2	0	.05	-	 < 0.01	9.54E-01
antigen processing and presentation of peptide antigen via MHC class Ib (GO:0002428)	22	0	.51	-	 < 0.01	5.99E-01
response to carbon dioxide (GO:0010037)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001271)	3	0	.07	-	 < 0.01	9.32E-01
regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001270)	5	0	.12	-	 < 0.01	8.90E-01
immunoglobulin production in mucosal tissue (GO:0002426)	1	0	.02	-	 < 0.01	9.77E-01
meiotic chromosome condensation (GO:0010032)	7	0	.16	-	 < 0.01	8.49E-01
protein transmembrane transport (GO:0071806)	49	0	1.14	-	 < 0.01	3.19E-01
regulation of mammary gland epithelial cell proliferation (GO:0033599)	18	0	.42	-	 < 0.01	6.57E-01
negative regulation of podosome assembly (GO:0071802)	1	0	.02	-	 < 0.01	9.77E-01
podosome assembly (GO:0071800)	3	0	.07	-	 < 0.01	9.32E-01
response to genistein (GO:0033595)	2	0	.05	-	 < 0.01	9.54E-01
response to hydroxyisoflavone (GO:0033594)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001268)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of semaphorin-plexin signaling pathway (GO:2001262)	1	0	.02	-	 < 0.01	9.77E-01
immune response to tumor cell (GO:0002418)	2	0	.05	-	 < 0.01	9.54E-01
regulation of semaphorin-plexin signaling pathway (GO:2001260)	3	0	.07	-	 < 0.01	9.32E-01
immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor (GO:0002415)	2	0	.05	-	 < 0.01	9.54E-01
immunoglobulin transcytosis in epithelial cells (GO:0002414)	3	0	.07	-	 < 0.01	9.32E-01
antigen transcytosis by M cells in mucosal-associated lymphoid tissue (GO:0002412)	1	0	.02	-	 < 0.01	9.77E-01
amylopectin biosynthetic process (GO:0010021)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of cation channel activity (GO:2001258)	41	0	.96	-	 < 0.01	3.84E-01
protein galactosylation at cell surface (GO:0033580)	1	0	.02	-	 < 0.01	9.77E-01
regulation of store-operated calcium entry (GO:2001256)	13	0	.30	-	 < 0.01	7.38E-01
positive regulation of histone H3-K36 trimethylation (GO:2001255)	2	0	.05	-	 < 0.01	9.54E-01
regulation of histone H3-K36 trimethylation (GO:2001253)	3	0	.07	-	 < 0.01	9.32E-01
myeloid dendritic cell chemotaxis (GO:0002408)	4	0	.09	-	 < 0.01	9.11E-01
red or far-red light signaling pathway (GO:0010017)	1	0	.02	-	 < 0.01	9.77E-01
dendritic cell chemotaxis (GO:0002407)	9	0	.21	-	 < 0.01	8.11E-01
positive regulation of ammonia assimilation cycle (GO:2001250)	1	0	.02	-	 < 0.01	9.77E-01
antigen sampling by M cells in mucosal-associated lymphoid tissue (GO:0002406)	1	0	.02	-	 < 0.01	9.77E-01
antigen sampling in mucosal-associated lymphoid tissue (GO:0002404)	1	0	.02	-	 < 0.01	9.77E-01
protein localization to meiotic spindle midzone (GO:1903096)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of protein K48-linked deubiquitination (GO:1903094)	2	0	.05	-	 < 0.01	9.54E-01
regulation of protein K48-linked deubiquitination (GO:1903093)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of cholesterol biosynthetic process (GO:0045541)	5	0	.12	-	 < 0.01	8.90E-01
protein glycosylation in Golgi (GO:0033578)	2	0	.05	-	 < 0.01	9.54E-01
protein glycosylation in endoplasmic reticulum (GO:0033577)	3	0	.07	-	 < 0.01	9.32E-01
protein glycosylation at cell surface (GO:0033575)	1	0	.02	-	 < 0.01	9.77E-01
regulation of ammonia assimilation cycle (GO:2001248)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of phosphatidylcholine biosynthetic process (GO:2001247)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of phosphatidylcholine biosynthetic process (GO:2001246)	1	0	.02	-	 < 0.01	9.77E-01
regulation of phosphatidylcholine biosynthetic process (GO:2001245)	5	0	.12	-	 < 0.01	8.90E-01
cardioblast differentiation (GO:0010002)	10	0	.23	-	 < 0.01	7.92E-01
tyrosine biosynthetic process, by oxidation of phenylalanine (GO:0019293)	1	0	.02	-	 < 0.01	9.77E-01
siderophore biosynthetic process (GO:0019290)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of C-C chemokine receptor CCR7 signaling pathway (GO:1903082)	1	0	.02	-	 < 0.01	9.77E-01
regulation of C-C chemokine receptor CCR7 signaling pathway (GO:1903080)	1	0	.02	-	 < 0.01	9.77E-01
DNA replication, Okazaki fragment processing (GO:0033567)	2	0	.05	-	 < 0.01	9.54E-01
gamma-tubulin complex localization (GO:0033566)	3	0	.07	-	 < 0.01	9.32E-01
dorsal/ventral axon guidance (GO:0033563)	4	0	.09	-	 < 0.01	9.11E-01
regulation of water loss via skin (GO:0033561)	32	0	.75	-	 < 0.01	4.74E-01
abducens nerve formation (GO:0021599)	2	0	.05	-	 < 0.01	9.54E-01
abducens nerve morphogenesis (GO:0021598)	2	0	.05	-	 < 0.01	9.54E-01
rhombomere structural organization (GO:0021595)	1	0	.02	-	 < 0.01	9.77E-01
rhombomere formation (GO:0021594)	1	0	.02	-	 < 0.01	9.77E-01
rhombomere morphogenesis (GO:0021593)	3	0	.07	-	 < 0.01	9.32E-01
fourth ventricle development (GO:0021592)	2	0	.05	-	 < 0.01	9.54E-01
cerebellum maturation (GO:0021590)	4	0	.09	-	 < 0.01	9.11E-01
glycine betaine biosynthetic process from choline (GO:0019285)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of death-inducing signaling complex assembly (GO:1903073)	1	0	.02	-	 < 0.01	9.77E-01
regulation of death-inducing signaling complex assembly (GO:1903072)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903070)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of response to gamma radiation (GO:2001229)	1	0	.02	-	 < 0.01	9.77E-01
regulation of response to gamma radiation (GO:2001228)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of chloride transport (GO:2001226)	2	0	.05	-	 < 0.01	9.54E-01
cerebellum structural organization (GO:0021589)	2	0	.05	-	 < 0.01	9.54E-01
regulation of chloride transport (GO:2001225)	10	0	.23	-	 < 0.01	7.92E-01
cerebellum formation (GO:0021588)	1	0	.02	-	 < 0.01	9.77E-01
pons maturation (GO:0021586)	3	0	.07	-	 < 0.01	9.32E-01
regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069)	8	0	.19	-	 < 0.01	8.30E-01
UDP-N-acetylgalactosamine metabolic process (GO:0019276)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of protein lipidation (GO:1903061)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of protein lipidation (GO:1903060)	2	0	.05	-	 < 0.01	9.54E-01
fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540)	5	0	.12	-	 < 0.01	8.90E-01
hindbrain maturation (GO:0021578)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of vasculogenesis (GO:2001214)	11	0	.26	-	 < 0.01	7.74E-01
hindbrain structural organization (GO:0021577)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of vasculogenesis (GO:2001213)	2	0	.05	-	 < 0.01	9.54E-01
hindbrain formation (GO:0021576)	1	0	.02	-	 < 0.01	9.77E-01
rhombomere 6 development (GO:0021572)	1	0	.02	-	 < 0.01	9.77E-01
rhombomere 5 development (GO:0021571)	4	0	.09	-	 < 0.01	9.11E-01
rhombomere 4 development (GO:0021570)	3	0	.07	-	 < 0.01	9.32E-01
regulation of protein lipidation (GO:1903059)	7	0	.16	-	 < 0.01	8.49E-01
renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure (GO:0001999)	3	0	.07	-	 < 0.01	9.32E-01
glycine biosynthetic process, by transamination of glyoxylate (GO:0019265)	2	0	.05	-	 < 0.01	9.54E-01
angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure (GO:0001998)	4	0	.09	-	 < 0.01	9.11E-01
glycine biosynthetic process from serine (GO:0019264)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of the force of heart contraction by epinephrine-norepinephrine (GO:0001997)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of extracellular matrix organization (GO:1903054)	9	0	.21	-	 < 0.01	8.11E-01
norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure (GO:0001994)	3	0	.07	-	 < 0.01	9.32E-01
regulation of systemic arterial blood pressure by norepinephrine-epinephrine (GO:0001993)	8	0	.19	-	 < 0.01	8.30E-01
regulation of systemic arterial blood pressure by vasopressin (GO:0001992)	5	0	.12	-	 < 0.01	8.90E-01
regulation of systemic arterial blood pressure by circulatory renin-angiotensin (GO:0001991)	12	0	.28	-	 < 0.01	7.56E-01
vitellogenesis (GO:0007296)	4	0	.09	-	 < 0.01	9.11E-01
fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539)	10	0	.23	-	 < 0.01	7.92E-01
spermatid nucleus elongation (GO:0007290)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of transcription elongation by RNA polymerase I (GO:2001208)	1	0	.02	-	 < 0.01	9.77E-01
regulation of transcription elongation from RNA polymerase I promoter (GO:2001207)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of osteoclast development (GO:2001206)	5	0	.12	-	 < 0.01	8.90E-01
rhombomere 3 development (GO:0021569)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of osteoclast development (GO:2001205)	4	0	.09	-	 < 0.01	9.11E-01
rhombomere 2 development (GO:0021568)	2	0	.05	-	 < 0.01	9.54E-01
regulation of osteoclast development (GO:2001204)	11	0	.26	-	 < 0.01	7.74E-01
hypoglossal nerve development (GO:0021566)	1	0	.02	-	 < 0.01	9.77E-01
vagus nerve development (GO:0021564)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of dendritic cell differentiation (GO:2001200)	3	0	.07	-	 < 0.01	9.32E-01
glossopharyngeal nerve development (GO:0021563)	5	0	.12	-	 < 0.01	8.90E-01
vestibulocochlear nerve development (GO:0021562)	9	0	.21	-	 < 0.01	8.11E-01
facial nerve development (GO:0021561)	12	0	.28	-	 < 0.01	7.56E-01
abducens nerve development (GO:0021560)	2	0	.05	-	 < 0.01	9.54E-01
regulation of acetylcholine-gated cation channel activity (GO:1903048)	2	0	.05	-	 < 0.01	9.54E-01
glucose 1-phosphate metabolic process (GO:0019255)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure (GO:0001988)	1	0	.02	-	 < 0.01	9.77E-01
carnitine metabolic process, CoA-linked (GO:0019254)	3	0	.07	-	 < 0.01	9.32E-01
vasoconstriction of artery involved in baroreceptor response to lowering of systemic arterial blood pressure (GO:0001987)	1	0	.02	-	 < 0.01	9.77E-01
neural crest cell migration involved in sympathetic nervous system development (GO:1903045)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of the force of heart contraction involved in baroreceptor response to increased systemic arterial blood pressure (GO:0001986)	1	0	.02	-	 < 0.01	9.77E-01
protein localization to membrane raft (GO:1903044)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure (GO:0001985)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of chondrocyte hypertrophy (GO:1903043)	1	0	.02	-	 < 0.01	9.77E-01
artery vasodilation involved in baroreceptor response to increased systemic arterial blood pressure (GO:0001984)	1	0	.02	-	 < 0.01	9.77E-01
baroreceptor response to increased systemic arterial blood pressure (GO:0001983)	3	0	.07	-	 < 0.01	9.32E-01
spermatid nucleus differentiation (GO:0007289)	21	0	.49	-	 < 0.01	6.13E-01
regulation of chondrocyte hypertrophy (GO:1903041)	1	0	.02	-	 < 0.01	9.77E-01
baroreceptor response to decreased systemic arterial blood pressure (GO:0001982)	2	0	.05	-	 < 0.01	9.54E-01
primary spermatocyte growth (GO:0007285)	1	0	.02	-	 < 0.01	9.77E-01
spermatogonial cell division (GO:0007284)	4	0	.09	-	 < 0.01	9.11E-01
histone H2B ubiquitination (GO:0033523)	10	0	.23	-	 < 0.01	7.92E-01
trigeminal nerve development (GO:0021559)	11	0	.26	-	 < 0.01	7.74E-01
trochlear nerve development (GO:0021558)	3	0	.07	-	 < 0.01	9.32E-01
oculomotor nerve development (GO:0021557)	4	0	.09	-	 < 0.01	9.11E-01
midbrain-hindbrain boundary morphogenesis (GO:0021555)	4	0	.09	-	 < 0.01	9.11E-01
olfactory nerve development (GO:0021553)	3	0	.07	-	 < 0.01	9.32E-01
central nervous system morphogenesis (GO:0021551)	2	0	.05	-	 < 0.01	9.54E-01
medulla oblongata development (GO:0021550)	3	0	.07	-	 < 0.01	9.32E-01
regulation of systemic arterial blood pressure by chemoreceptor signaling (GO:0001979)	1	0	.02	-	 < 0.01	9.77E-01
regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback (GO:0001978)	5	0	.12	-	 < 0.01	8.90E-01
lactate biosynthetic process from pyruvate (GO:0019244)	4	0	.09	-	 < 0.01	9.11E-01
methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione (GO:0019243)	4	0	.09	-	 < 0.01	9.11E-01
methylglyoxal biosynthetic process (GO:0019242)	1	0	.02	-	 < 0.01	9.77E-01
response to amphetamine (GO:0001975)	20	0	.47	-	 < 0.01	6.27E-01
citrulline biosynthetic process (GO:0019240)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of activation of membrane attack complex (GO:0001971)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of activation of membrane attack complex (GO:0001970)	2	0	.05	-	 < 0.01	9.54E-01
neuron-neuron synaptic transmission (GO:0007270)	10	0	.23	-	 < 0.01	7.92E-01
L-lysine catabolic process to acetyl-CoA via L-pipecolate (GO:0033514)	1	0	.02	-	 < 0.01	9.77E-01
pons development (GO:0021548)	13	0	.30	-	 < 0.01	7.38E-01
midbrain-hindbrain boundary initiation (GO:0021547)	1	0	.02	-	 < 0.01	9.77E-01
rhombomere development (GO:0021546)	9	0	.21	-	 < 0.01	8.11E-01
dentate gyrus development (GO:0021542)	18	0	.42	-	 < 0.01	6.57E-01
ammon gyrus development (GO:0021541)	1	0	.02	-	 < 0.01	9.77E-01
regulation of metanephric glomerulus development (GO:0072298)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of opsonization (GO:1903028)	2	0	.05	-	 < 0.01	9.54E-01
regulation of activation of membrane attack complex (GO:0001969)	4	0	.09	-	 < 0.01	9.11E-01
regulation of opsonization (GO:1903027)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903026)	5	0	.12	-	 < 0.01	8.90E-01
regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025)	12	0	.28	-	 < 0.01	7.56E-01
proprioception (GO:0019230)	5	0	.12	-	 < 0.01	8.90E-01
synaptic transmission, dopaminergic (GO:0001963)	14	0	.33	-	 < 0.01	7.21E-01
positive regulation of cytokine-mediated signaling pathway (GO:0001961)	45	0	1.05	-	 < 0.01	3.50E-01
negative regulation of cytokine-mediated signaling pathway (GO:0001960)	50	0	1.17	-	 < 0.01	3.11E-01
nitric oxide mediated signal transduction (GO:0007263)	14	0	.33	-	 < 0.01	7.21E-01
floor plate morphogenesis (GO:0033505)	4	0	.09	-	 < 0.01	9.11E-01
tyrosine phosphorylation of STAT protein (GO:0007260)	10	0	.23	-	 < 0.01	7.92E-01
subthalamus development (GO:0021539)	2	0	.05	-	 < 0.01	9.54E-01
epithalamus development (GO:0021538)	3	0	.07	-	 < 0.01	9.32E-01
cell migration in hindbrain (GO:0021535)	21	0	.49	-	 < 0.01	6.13E-01
cell proliferation in hindbrain (GO:0021534)	8	0	.19	-	 < 0.01	8.30E-01
metanephric nephron tubule formation (GO:0072289)	4	0	.09	-	 < 0.01	9.11E-01
neuronal action potential (GO:0019228)	34	0	.79	-	 < 0.01	4.52E-01
neuronal action potential propagation (GO:0019227)	11	0	.26	-	 < 0.01	7.74E-01
spinal cord oligodendrocyte cell fate specification (GO:0021530)	3	0	.07	-	 < 0.01	9.32E-01
transmission of nerve impulse (GO:0019226)	64	0	1.49	-	 < 0.01	2.24E-01
metanephric connecting tubule development (GO:0072286)	1	0	.02	-	 < 0.01	9.77E-01
mesenchymal to epithelial transition involved in metanephric renal vesicle formation (GO:0072285)	1	0	.02	-	 < 0.01	9.77E-01
metanephric S-shaped body morphogenesis (GO:0072284)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of exo-alpha-sialidase activity (GO:1903016)	2	0	.05	-	 < 0.01	9.54E-01
metanephric renal vesicle morphogenesis (GO:0072283)	10	0	.23	-	 < 0.01	7.92E-01
regulation of exo-alpha-sialidase activity (GO:1903015)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of neurotransmitter secretion (GO:0001956)	21	0	.49	-	 < 0.01	6.13E-01
metanephric nephron tubule morphogenesis (GO:0072282)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of bone development (GO:1903012)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of bone development (GO:1903011)	2	0	.05	-	 < 0.01	9.54E-01
JUN phosphorylation (GO:0007258)	4	0	.09	-	 < 0.01	9.11E-01
regulation of bone development (GO:1903010)	8	0	.19	-	 < 0.01	8.30E-01
intestinal D-glucose absorption (GO:0001951)	3	0	.07	-	 < 0.01	9.32E-01
activation of JNKK activity (GO:0007256)	7	0	.16	-	 < 0.01	8.49E-01
cytoplasmic sequestering of NF-kappaB (GO:0007253)	5	0	.12	-	 < 0.01	8.90E-01
I-kappaB phosphorylation (GO:0007252)	12	0	.28	-	 < 0.01	7.56E-01
activation of NF-kappaB-inducing kinase activity (GO:0007250)	15	0	.35	-	 < 0.01	7.05E-01
spinal cord oligodendrocyte cell differentiation (GO:0021529)	5	0	.12	-	 < 0.01	8.90E-01
commissural neuron differentiation in spinal cord (GO:0021528)	1	0	.02	-	 < 0.01	9.77E-01
spinal cord association neuron differentiation (GO:0021527)	13	0	.30	-	 < 0.01	7.38E-01
medial motor column neuron differentiation (GO:0021526)	2	0	.05	-	 < 0.01	9.54E-01
visceral motor neuron differentiation (GO:0021524)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of amniotic stem cell differentiation (GO:2000798)	1	0	.02	-	 < 0.01	9.77E-01
somatic motor neuron differentiation (GO:0021523)	5	0	.12	-	 < 0.01	8.90E-01
regulation of amniotic stem cell differentiation (GO:2000797)	1	0	.02	-	 < 0.01	9.77E-01
ventral spinal cord interneuron specification (GO:0021521)	8	0	.19	-	 < 0.01	8.30E-01
metanephric comma-shaped body morphogenesis (GO:0072278)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of epithelial cell proliferation involved in lung morphogenesis (GO:2000795)	1	0	.02	-	 < 0.01	9.77E-01
spinal cord motor neuron cell fate specification (GO:0021520)	10	0	.23	-	 < 0.01	7.92E-01
metanephric glomerular capillary formation (GO:0072277)	3	0	.07	-	 < 0.01	9.32E-01
metanephric glomerulus vasculature morphogenesis (GO:0072276)	3	0	.07	-	 < 0.01	9.32E-01
organelle disassembly (GO:1903008)	65	0	1.52	-	 < 0.01	2.19E-01
cell proliferation involved in heart valve development (GO:2000793)	1	0	.02	-	 < 0.01	9.77E-01
sebaceous gland cell differentiation (GO:0001949)	3	0	.07	-	 < 0.01	9.32E-01
metanephric glomerulus morphogenesis (GO:0072275)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of Lys63-specific deubiquitinase activity (GO:1903007)	1	0	.02	-	 < 0.01	9.77E-01
metanephric glomerular basement membrane development (GO:0072274)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of protein K63-linked deubiquitination (GO:1903006)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of mesenchymal cell proliferation involved in lung development (GO:2000791)	2	0	.05	-	 < 0.01	9.54E-01
metanephric nephron morphogenesis (GO:0072273)	18	0	.42	-	 < 0.01	6.57E-01
regulation of mesenchymal cell proliferation involved in lung development (GO:2000790)	2	0	.05	-	 < 0.01	9.54E-01
proximal/distal pattern formation involved in metanephric nephron development (GO:0072272)	2	0	.05	-	 < 0.01	9.54E-01
regulation of protein K63-linked deubiquitination (GO:1903004)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of protein deubiquitination (GO:1903003)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of lipid transport across blood-brain barrier (GO:1903002)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of lipid transport across blood-brain barrier (GO:1903001)	1	0	.02	-	 < 0.01	9.77E-01
regulation of lipid transport across blood-brain barrier (GO:1903000)	1	0	.02	-	 < 0.01	9.77E-01
cellular glucuronidation (GO:0052695)	3	0	.07	-	 < 0.01	9.32E-01
dorsal spinal cord development (GO:0021516)	20	0	.47	-	 < 0.01	6.27E-01
ventral spinal cord interneuron differentiation (GO:0021514)	14	0	.33	-	 < 0.01	7.21E-01
spinal cord dorsal/ventral patterning (GO:0021513)	21	0	.49	-	 < 0.01	6.13E-01
spinal cord anterior/posterior patterning (GO:0021512)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of autophagosome assembly (GO:2000786)	10	0	.23	-	 < 0.01	7.92E-01
spinal cord patterning (GO:0021511)	23	0	.54	-	 < 0.01	5.85E-01
pattern specification involved in metanephros development (GO:0072268)	4	0	.09	-	 < 0.01	9.11E-01
regulation of autophagosome assembly (GO:2000785)	34	0	.79	-	 < 0.01	4.52E-01
metanephric capsule specification (GO:0072267)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of establishment of cell polarity regulating cell shape (GO:2000784)	1	0	.02	-	 < 0.01	9.77E-01
metanephric capsule formation (GO:0072266)	1	0	.02	-	 < 0.01	9.77E-01
metanephric capsule morphogenesis (GO:0072265)	1	0	.02	-	 < 0.01	9.77E-01
regulation of establishment of cell polarity regulating cell shape (GO:2000782)	1	0	.02	-	 < 0.01	9.77E-01
metanephric glomerular endothelium development (GO:0072264)	1	0	.02	-	 < 0.01	9.77E-01
metanephric glomerular mesangial cell proliferation involved in metanephros development (GO:0072262)	2	0	.05	-	 < 0.01	9.54E-01
endothelial cell proliferation (GO:0001935)	20	0	.47	-	 < 0.01	6.27E-01
negative regulation of sarcomere organization (GO:0060299)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of sarcomere organization (GO:0060298)	5	0	.12	-	 < 0.01	8.90E-01
regulation of sarcomere organization (GO:0060297)	10	0	.23	-	 < 0.01	7.92E-01
long-term synaptic depression (GO:0060292)	20	0	.47	-	 < 0.01	6.27E-01
osmosensory signaling pathway (GO:0007231)	2	0	.05	-	 < 0.01	9.54E-01
roof plate formation (GO:0021509)	1	0	.02	-	 < 0.01	9.77E-01
floor plate formation (GO:0021508)	3	0	.07	-	 < 0.01	9.32E-01
anterior neuropore closure (GO:0021506)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia (GO:2000777)	2	0	.05	-	 < 0.01	9.54E-01
neural fold elevation formation (GO:0021502)	3	0	.07	-	 < 0.01	9.32E-01
metanephric interstitial fibroblast development (GO:0072259)	1	0	.02	-	 < 0.01	9.77E-01
prechordal plate formation (GO:0021501)	1	0	.02	-	 < 0.01	9.77E-01
metanephric interstitial fibroblast differentiation (GO:0072258)	1	0	.02	-	 < 0.01	9.77E-01
histone H3-S10 phosphorylation involved in chromosome condensation (GO:2000775)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of cellular senescence (GO:2000774)	9	0	.21	-	 < 0.01	8.11E-01
negative regulation of cellular senescence (GO:2000773)	20	0	.47	-	 < 0.01	6.27E-01
metanephric glomerular mesangial cell development (GO:0072255)	1	0	.02	-	 < 0.01	9.77E-01
regulation of exocyst assembly (GO:0001928)	2	0	.05	-	 < 0.01	9.54E-01
metanephric glomerular mesangial cell differentiation (GO:0072254)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of establishment or maintenance of cell polarity regulating cell shape (GO:2000771)	2	0	.05	-	 < 0.01	9.54E-01
B-1 B cell homeostasis (GO:0001922)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of hh target transcription factor activity (GO:0007228)	3	0	.07	-	 < 0.01	9.32E-01
signal transduction downstream of smoothened (GO:0007227)	4	0	.09	-	 < 0.01	9.11E-01
epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of receptor recycling (GO:0001920)	4	0	.09	-	 < 0.01	9.11E-01
patched ligand maturation (GO:0007225)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of oocyte development (GO:0060283)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of oocyte development (GO:0060282)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of transcription of Notch receptor target (GO:0007221)	6	0	.14	-	 < 0.01	8.69E-01
regulation of oocyte development (GO:0060281)	3	0	.07	-	 < 0.01	9.32E-01
Notch receptor processing (GO:0007220)	10	0	.23	-	 < 0.01	7.92E-01
negative regulation of ovulation (GO:0060280)	1	0	.02	-	 < 0.01	9.77E-01
regulation of establishment or maintenance of cell polarity regulating cell shape (GO:2000769)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of nephron tubule epithelial cell differentiation (GO:2000768)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of cytoplasmic translation (GO:2000767)	10	0	.23	-	 < 0.01	7.92E-01
metanephric glomerular visceral epithelial cell development (GO:0072249)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of cytoplasmic translation (GO:2000766)	8	0	.19	-	 < 0.01	8.30E-01
metanephric glomerular visceral epithelial cell differentiation (GO:0072248)	1	0	.02	-	 < 0.01	9.77E-01
regulation of cytoplasmic translation (GO:2000765)	19	0	.44	-	 < 0.01	6.42E-01
positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis (GO:2000764)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process (GO:2000763)	1	0	.02	-	 < 0.01	9.77E-01
metanephric glomerular epithelium development (GO:0072244)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of N-terminal peptidyl-lysine acetylation (GO:2000761)	1	0	.02	-	 < 0.01	9.77E-01
metanephric nephron epithelium development (GO:0072243)	15	0	.35	-	 < 0.01	7.05E-01
positive regulation of T cell mediated cytotoxicity (GO:0001916)	38	0	.89	-	 < 0.01	4.12E-01
negative regulation of T cell mediated cytotoxicity (GO:0001915)	7	0	.16	-	 < 0.01	8.49E-01
regulation of T cell mediated cytotoxicity (GO:0001914)	45	0	1.05	-	 < 0.01	3.50E-01
metanephric DCT cell differentiation (GO:0072240)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of leukocyte mediated cytotoxicity (GO:0001912)	67	0	1.56	-	 < 0.01	2.09E-01
negative regulation of leukocyte mediated cytotoxicity (GO:0001911)	25	0	.58	-	 < 0.01	5.58E-01
tachykinin receptor signaling pathway (GO:0007217)	6	0	.14	-	 < 0.01	8.69E-01
regulation of leukocyte mediated cytotoxicity (GO:0001910)	91	0	2.12	-	 < 0.01	1.19E-01
G protein-coupled glutamate receptor signaling pathway (GO:0007216)	16	0	.37	-	 < 0.01	6.89E-01
G protein-coupled acetylcholine receptor signaling pathway (GO:0007213)	12	0	.28	-	 < 0.01	7.56E-01
dopamine receptor signaling pathway (GO:0007212)	29	0	.68	-	 < 0.01	5.08E-01
embryonic skeletal joint morphogenesis (GO:0060272)	13	0	.30	-	 < 0.01	7.38E-01
regulation of N-terminal peptidyl-lysine acetylation (GO:2000759)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of peptidyl-lysine acetylation (GO:2000758)	37	0	.86	-	 < 0.01	4.22E-01
negative regulation of peptidyl-lysine acetylation (GO:2000757)	23	0	.54	-	 < 0.01	5.85E-01
metanephric glomerulus vasculature development (GO:0072239)	6	0	.14	-	 < 0.01	8.69E-01
regulation of peptidyl-lysine acetylation (GO:2000756)	68	0	1.59	-	 < 0.01	2.04E-01
positive regulation of sphingomyelin catabolic process (GO:2000755)	2	0	.05	-	 < 0.01	9.54E-01
metanephric proximal tubule development (GO:0072237)	1	0	.02	-	 < 0.01	9.77E-01
regulation of sphingomyelin catabolic process (GO:2000754)	2	0	.05	-	 < 0.01	9.54E-01
metanephric loop of Henle development (GO:0072236)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of glucosylceramide catabolic process (GO:2000753)	1	0	.02	-	 < 0.01	9.77E-01
metanephric distal tubule development (GO:0072235)	5	0	.12	-	 < 0.01	8.90E-01
regulation of glucosylceramide catabolic process (GO:2000752)	1	0	.02	-	 < 0.01	9.77E-01
metanephric nephron tubule development (GO:0072234)	13	0	.30	-	 < 0.01	7.38E-01
histone H3-T3 phosphorylation involved in chromosome passenger complex localization to kinetochore (GO:2000751)	1	0	.02	-	 < 0.01	9.77E-01
killing by symbiont of host cells (GO:0001907)	3	0	.07	-	 < 0.01	9.32E-01
metanephric thick ascending limb development (GO:0072233)	2	0	.05	-	 < 0.01	9.54E-01
metanephric proximal convoluted tubule segment 2 development (GO:0072232)	1	0	.02	-	 < 0.01	9.77E-01
activation of membrane attack complex (GO:0001905)	1	0	.02	-	 < 0.01	9.77E-01
metanephric proximal straight tubule development (GO:0072230)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of respiratory burst (GO:0060268)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of respiratory burst (GO:0060267)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of respiratory burst involved in inflammatory response (GO:0060266)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of respiratory burst involved in inflammatory response (GO:0060265)	2	0	.05	-	 < 0.01	9.54E-01
regulation of DNA replication origin binding (GO:1902595)	2	0	.05	-	 < 0.01	9.54E-01
regulation of respiratory burst involved in inflammatory response (GO:0060264)	6	0	.14	-	 < 0.01	8.69E-01
regulation of respiratory burst (GO:0060263)	14	0	.33	-	 < 0.01	7.21E-01
negative regulation of N-terminal protein palmitoylation (GO:0060262)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261)	35	0	.82	-	 < 0.01	4.42E-01
monoacylglycerol catabolic process (GO:0052651)	6	0	.14	-	 < 0.01	8.69E-01
regulation of transcription initiation from RNA polymerase II promoter (GO:0060260)	40	0	.93	-	 < 0.01	3.93E-01
metanephric proximal convoluted tubule development (GO:0072229)	1	0	.02	-	 < 0.01	9.77E-01
metanephric macula densa development (GO:0072227)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of anterior head development (GO:2000744)	2	0	.05	-	 < 0.01	9.54E-01
regulation of anterior head development (GO:2000742)	2	0	.05	-	 < 0.01	9.54E-01
metanephric glomerulus development (GO:0072224)	8	0	.19	-	 < 0.01	8.30E-01
positive regulation of mesenchymal stem cell differentiation (GO:2000741)	4	0	.09	-	 < 0.01	9.11E-01
metanephric glomerular mesangium development (GO:0072223)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of mesenchymal stem cell differentiation (GO:2000740)	1	0	.02	-	 < 0.01	9.77E-01
metanephric distal convoluted tubule development (GO:0072221)	5	0	.12	-	 < 0.01	8.90E-01
metanephric descending thin limb development (GO:0072220)	1	0	.02	-	 < 0.01	9.77E-01
regulation of feeding behavior (GO:0060259)	40	0	.93	-	 < 0.01	3.93E-01
alditol phosphate metabolic process (GO:0052646)	13	0	.30	-	 < 0.01	7.38E-01
regulation of N-terminal protein palmitoylation (GO:0060254)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of glial cell proliferation (GO:0060253)	16	0	.37	-	 < 0.01	6.89E-01
positive regulation of glial cell proliferation (GO:0060252)	21	0	.49	-	 < 0.01	6.13E-01
regulation of glial cell proliferation (GO:0060251)	39	0	.91	-	 < 0.01	4.02E-01
regulation of mesenchymal stem cell differentiation (GO:2000739)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of stem cell differentiation (GO:2000738)	19	0	.44	-	 < 0.01	6.42E-01
negative regulation of stem cell differentiation (GO:2000737)	21	0	.49	-	 < 0.01	6.13E-01
regulation of stem cell differentiation (GO:2000736)	54	0	1.26	-	 < 0.01	2.83E-01
metanephric ascending thin limb development (GO:0072218)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of metanephros development (GO:0072217)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation (GO:2000734)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of metanephros development (GO:0072216)	3	0	.07	-	 < 0.01	9.32E-01
regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation (GO:2000733)	1	0	.02	-	 < 0.01	9.77E-01
regulation of metanephros development (GO:0072215)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of calcium import into the mitochondrion (GO:0110099)	2	0	.05	-	 < 0.01	9.54E-01
metanephric capsule development (GO:0072213)	1	0	.02	-	 < 0.01	9.77E-01
regulation of termination of RNA polymerase I transcription (GO:2000730)	1	0	.02	-	 < 0.01	9.77E-01
regulation of calcium import into the mitochondrion (GO:0110097)	3	0	.07	-	 < 0.01	9.32E-01
cellular response to aldehyde (GO:0110096)	14	0	.33	-	 < 0.01	7.21E-01
metanephric nephron development (GO:0072210)	30	0	.70	-	 < 0.01	4.97E-01
cellular detoxification of aldehyde (GO:0110095)	9	0	.21	-	 < 0.01	8.11E-01
multi-organism localization (GO:1902579)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of nuclear cell cycle DNA replication (GO:1902576)	1	0	.02	-	 < 0.01	9.77E-01
detection of cell density (GO:0060245)	8	0	.19	-	 < 0.01	8.30E-01
positive regulation of hippocampal neuron apoptotic process (GO:0110090)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of cell proliferation involved in contact inhibition (GO:0060244)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of cell growth involved in contact inhibition (GO:0060243)	1	0	.02	-	 < 0.01	9.77E-01
contact inhibition (GO:0060242)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of serine-type peptidase activity (GO:1902572)	4	0	.09	-	 < 0.01	9.11E-01
regulation of serine-type peptidase activity (GO:1902571)	4	0	.09	-	 < 0.01	9.11E-01
protein localization to nucleolus (GO:1902570)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of mesenchymal cell proliferation involved in ureter development (GO:2000729)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of cardiac muscle cell differentiation (GO:2000727)	10	0	.23	-	 < 0.01	7.92E-01
metanephric mesangial cell differentiation (GO:0072209)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of cardiac muscle cell differentiation (GO:2000726)	8	0	.19	-	 < 0.01	8.30E-01
metanephric smooth muscle tissue development (GO:0072208)	1	0	.02	-	 < 0.01	9.77E-01
regulation of cardiac muscle cell differentiation (GO:2000725)	18	0	.42	-	 < 0.01	6.57E-01
metanephric epithelium development (GO:0072207)	20	0	.47	-	 < 0.01	6.27E-01
positive regulation of cardiac vascular smooth muscle cell differentiation (GO:2000724)	2	0	.05	-	 < 0.01	9.54E-01
metanephric juxtaglomerular apparatus development (GO:0072206)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of cardiac vascular smooth muscle cell differentiation (GO:2000723)	1	0	.02	-	 < 0.01	9.77E-01
metanephric collecting duct development (GO:0072205)	7	0	.16	-	 < 0.01	8.49E-01
regulation of cardiac vascular smooth muscle cell differentiation (GO:2000722)	3	0	.07	-	 < 0.01	9.32E-01
cell-cell signaling involved in metanephros development (GO:0072204)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation (GO:2000721)	3	0	.07	-	 < 0.01	9.32E-01
cell differentiation involved in metanephros development (GO:0072202)	14	0	.33	-	 < 0.01	7.21E-01
negative regulation of mesenchymal cell proliferation (GO:0072201)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of mesenchymal cell proliferation involved in ureter development (GO:0072200)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of activation of Janus kinase activity (GO:1902569)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of eosinophil activation (GO:1902568)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of eosinophil activation (GO:1902567)	2	0	.05	-	 < 0.01	9.54E-01
regulation of eosinophil activation (GO:1902566)	4	0	.09	-	 < 0.01	9.11E-01
lens induction in camera-type eye (GO:0060235)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of neutrophil activation (GO:1902565)	7	0	.16	-	 < 0.01	8.49E-01
neuroblast delamination (GO:0060234)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of neutrophil activation (GO:1902564)	4	0	.09	-	 < 0.01	9.11E-01
regulation of neutrophil activation (GO:1902563)	13	0	.30	-	 < 0.01	7.38E-01
delamination (GO:0060232)	3	0	.07	-	 < 0.01	9.32E-01
mesenchymal to epithelial transition (GO:0060231)	14	0	.33	-	 < 0.01	7.21E-01
positive regulation of maintenance of meiotic sister chromatid cohesion, centromeric (GO:2000711)	1	0	.02	-	 < 0.01	9.77E-01
vesicle-mediated intercellular transport (GO:0110077)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of ferroptosis (GO:0110076)	2	0	.05	-	 < 0.01	9.54E-01
regulation of ferroptosis (GO:0110075)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of retinal cone cell fate commitment (GO:0060226)	1	0	.02	-	 < 0.01	9.77E-01
retinal rod cell fate commitment (GO:0060223)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of catalase activity (GO:1902553)	1	0	.02	-	 < 0.01	9.77E-01
regulation of retinal cone cell fate commitment (GO:0060222)	1	0	.02	-	 < 0.01	9.77E-01
retinal rod cell differentiation (GO:0060221)	18	0	.42	-	 < 0.01	6.57E-01
regulation of catalase activity (GO:1902551)	1	0	.02	-	 < 0.01	9.77E-01
camera-type eye photoreceptor cell fate commitment (GO:0060220)	2	0	.05	-	 < 0.01	9.54E-01
regulation of maintenance of meiotic sister chromatid cohesion, centromeric (GO:2000709)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of dense core granule biogenesis (GO:2000707)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of dense core granule biogenesis (GO:2000706)	1	0	.02	-	 < 0.01	9.77E-01
regulation of dense core granule biogenesis (GO:2000705)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation (GO:2000703)	1	0	.02	-	 < 0.01	9.77E-01
regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation (GO:2000702)	1	0	.02	-	 < 0.01	9.77E-01
camera-type eye photoreceptor cell differentiation (GO:0060219)	34	0	.79	-	 < 0.01	4.52E-01
hematopoietic stem cell differentiation (GO:0060218)	15	0	.35	-	 < 0.01	7.05E-01
hemangioblast cell differentiation (GO:0060217)	1	0	.02	-	 < 0.01	9.77E-01
regulation of angiotensin-activated signaling pathway (GO:0110061)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of DNA N-glycosylase activity (GO:1902546)	1	0	.02	-	 < 0.01	9.77E-01
primitive hemopoiesis (GO:0060215)	7	0	.16	-	 < 0.01	8.49E-01
regulation of DNA N-glycosylase activity (GO:1902544)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060212)	3	0	.07	-	 < 0.01	9.32E-01
heme oxidation (GO:0006788)	2	0	.05	-	 < 0.01	9.54E-01
porphyrin-containing compound catabolic process (GO:0006787)	4	0	.09	-	 < 0.01	9.11E-01
heme A biosynthetic process (GO:0006784)	2	0	.05	-	 < 0.01	9.54E-01
heme biosynthetic process (GO:0006783)	22	0	.51	-	 < 0.01	5.99E-01
protoporphyrinogen IX biosynthetic process (GO:0006782)	2	0	.05	-	 < 0.01	9.54E-01
uroporphyrinogen III biosynthetic process (GO:0006780)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of blood vessel endothelial cell differentiation (GO:0110059)	1	0	.02	-	 < 0.01	9.77E-01
regulation of blood vessel endothelial cell differentiation (GO:0110057)	1	0	.02	-	 < 0.01	9.77E-01
estrous cycle phase (GO:0060206)	1	0	.02	-	 < 0.01	9.77E-01
metabolite repair (GO:0110051)	1	0	.02	-	 < 0.01	9.77E-01
porphyrin-containing compound biosynthetic process (GO:0006779)	27	0	.63	-	 < 0.01	5.33E-01
porphyrin-containing compound metabolic process (GO:0006778)	39	0	.91	-	 < 0.01	4.02E-01
positive regulation of protein linear polyubiquitination (GO:1902530)	1	0	.02	-	 < 0.01	9.77E-01
Mo-molybdopterin cofactor biosynthetic process (GO:0006777)	6	0	.14	-	 < 0.01	8.69E-01
vitamin A metabolic process (GO:0006776)	3	0	.07	-	 < 0.01	9.32E-01
thiamine metabolic process (GO:0006772)	3	0	.07	-	 < 0.01	9.32E-01
riboflavin metabolic process (GO:0006771)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to prostaglandin D stimulus (GO:0071799)	3	0	.07	-	 < 0.01	9.32E-01
response to prostaglandin D (GO:0071798)	3	0	.07	-	 < 0.01	9.32E-01
regulation of protein linear polyubiquitination (GO:1902528)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of protein monoubiquitination (GO:1902527)	4	0	.09	-	 < 0.01	9.11E-01
regulation of protein monoubiquitination (GO:1902525)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of protein K48-linked ubiquitination (GO:1902524)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of protein K63-linked ubiquitination (GO:1902523)	4	0	.09	-	 < 0.01	9.11E-01
biotin metabolic process (GO:0006768)	1	0	.02	-	 < 0.01	9.77E-01
endoplasmic reticulum tubular network maintenance (GO:0071788)	1	0	.02	-	 < 0.01	9.77E-01
endoplasmic reticulum tubular network formation (GO:0071787)	4	0	.09	-	 < 0.01	9.11E-01
endoplasmic reticulum tubular network organization (GO:0071786)	16	0	.37	-	 < 0.01	6.89E-01
positive regulation of G2/MI transition of meiotic cell cycle (GO:0110032)	3	0	.07	-	 < 0.01	9.32E-01
regulation of G2/MI transition of meiotic cell cycle (GO:0110030)	3	0	.07	-	 < 0.01	9.32E-01
regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514)	12	0	.28	-	 < 0.01	7.56E-01
negative regulation of apoptotic DNA fragmentation (GO:1902511)	3	0	.07	-	 < 0.01	9.32E-01
AMP phosphorylation (GO:0006756)	1	0	.02	-	 < 0.01	9.77E-01
ATP biosynthetic process (GO:0006754)	27	0	.63	-	 < 0.01	5.33E-01
glutathione catabolic process (GO:0006751)	6	0	.14	-	 < 0.01	8.69E-01
MHC class II protein complex assembly (GO:0002399)	1	0	.02	-	 < 0.01	9.77E-01
MHC class Ib protein complex assembly (GO:0002398)	1	0	.02	-	 < 0.01	9.77E-01
immune response in nasopharyngeal-associated lymphoid tissue (GO:0002395)	3	0	.07	-	 < 0.01	9.32E-01
regulation of DNA strand resection involved in replication fork processing (GO:0110026)	1	0	.02	-	 < 0.01	9.77E-01
DNA strand resection involved in replication fork processing (GO:0110025)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of cardiac muscle myoblast proliferation (GO:0110024)	3	0	.07	-	 < 0.01	9.32E-01
regulation of cardiac muscle myoblast proliferation (GO:0110022)	3	0	.07	-	 < 0.01	9.32E-01
regulation of signal transduction involved in mitotic G2 DNA damage checkpoint (GO:1902504)	1	0	.02	-	 < 0.01	9.77E-01
FAD biosynthetic process (GO:0006747)	1	0	.02	-	 < 0.01	9.77E-01
NADP catabolic process (GO:0006742)	6	0	.14	-	 < 0.01	8.69E-01
NADP biosynthetic process (GO:0006741)	4	0	.09	-	 < 0.01	9.11E-01
NADPH regeneration (GO:0006740)	10	0	.23	-	 < 0.01	7.92E-01
immune response in gut-associated lymphoid tissue (GO:0002387)	3	0	.07	-	 < 0.01	9.32E-01
mucosal immune response (GO:0002385)	43	0	1.00	-	 < 0.01	3.67E-01
hepatic immune response (GO:0002384)	1	0	.02	-	 < 0.01	9.77E-01
immune response in brain or nervous system (GO:0002383)	1	0	.02	-	 < 0.01	9.77E-01
immunoglobulin production involved in immunoglobulin-mediated immune response (GO:0002381)	29	0	.68	-	 < 0.01	5.08E-01
cap-independent translational initiation of linear mRNA (GO:0110017)	2	0	.05	-	 < 0.01	9.54E-01
nuclear inner membrane organization (GO:0071765)	1	0	.02	-	 < 0.01	9.77E-01
nuclear membrane organization (GO:0071763)	11	0	.26	-	 < 0.01	7.74E-01
regulation of basement membrane organization (GO:0110011)	5	0	.12	-	 < 0.01	8.90E-01
one-carbon metabolic process (GO:0006730)	39	0	.91	-	 < 0.01	4.02E-01
immunoglobulin production (GO:0002377)	65	0	1.52	-	 < 0.01	2.19E-01
dendritic cell cytokine production (GO:0002371)	1	0	.02	-	 < 0.01	9.77E-01
ncRNA deadenylation (GO:0110008)	1	0	.02	-	 < 0.01	9.77E-01
tetrahydrobiopterin biosynthetic process (GO:0006729)	7	0	.16	-	 < 0.01	8.49E-01
T cell cytokine production (GO:0002369)	13	0	.30	-	 < 0.01	7.38E-01
cytokine production involved in immune response (GO:0002367)	25	0	.58	-	 < 0.01	5.58E-01
gamma-delta T cell lineage commitment (GO:0002365)	1	0	.02	-	 < 0.01	9.77E-01
NK T cell lineage commitment (GO:0002364)	1	0	.02	-	 < 0.01	9.77E-01
alpha-beta T cell lineage commitment (GO:0002363)	18	0	.42	-	 < 0.01	6.57E-01
CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment (GO:0002362)	3	0	.07	-	 < 0.01	9.32E-01
CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation (GO:0002361)	6	0	.14	-	 < 0.01	8.69E-01
T cell lineage commitment (GO:0002360)	27	0	.63	-	 < 0.01	5.33E-01
sesquiterpenoid metabolic process (GO:0006714)	3	0	.07	-	 < 0.01	9.32E-01
glucocorticoid catabolic process (GO:0006713)	2	0	.05	-	 < 0.01	9.54E-01
estrogen catabolic process (GO:0006711)	1	0	.02	-	 < 0.01	9.77E-01
androgen catabolic process (GO:0006710)	4	0	.09	-	 < 0.01	9.11E-01
B cell homeostatic proliferation (GO:0002358)	2	0	.05	-	 < 0.01	9.54E-01
defense response to tumor cell (GO:0002357)	4	0	.09	-	 < 0.01	9.11E-01
detection of tumor cell (GO:0002355)	1	0	.02	-	 < 0.01	9.77E-01
plasma kallikrein-kinin cascade (GO:0002353)	2	0	.05	-	 < 0.01	9.54E-01
B cell negative selection (GO:0002352)	2	0	.05	-	 < 0.01	9.54E-01
serotonin production involved in inflammatory response (GO:0002351)	4	0	.09	-	 < 0.01	9.11E-01
transcriptional activation by promoter-enhancer looping (GO:0071733)	4	0	.09	-	 < 0.01	9.11E-01
progesterone catabolic process (GO:0006709)	1	0	.02	-	 < 0.01	9.77E-01
cholesterol catabolic process (GO:0006707)	10	0	.23	-	 < 0.01	7.92E-01
negative regulation of dendritic cell differentiation (GO:2001199)	4	0	.09	-	 < 0.01	9.11E-01
steroid catabolic process (GO:0006706)	25	0	.58	-	 < 0.01	5.58E-01
regulation of dendritic cell differentiation (GO:2001198)	7	0	.16	-	 < 0.01	8.49E-01
mineralocorticoid biosynthetic process (GO:0006705)	4	0	.09	-	 < 0.01	9.11E-01
glucocorticoid biosynthetic process (GO:0006704)	8	0	.19	-	 < 0.01	8.30E-01
estrogen biosynthetic process (GO:0006703)	7	0	.16	-	 < 0.01	8.49E-01
androgen biosynthetic process (GO:0006702)	6	0	.14	-	 < 0.01	8.69E-01
histamine production involved in inflammatory response (GO:0002349)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:2001190)	1	0	.02	-	 < 0.01	9.77E-01
B cell affinity maturation (GO:0002344)	2	0	.05	-	 < 0.01	9.54E-01
peripheral B cell selection (GO:0002343)	2	0	.05	-	 < 0.01	9.54E-01
cellular response to triacyl bacterial lipopeptide (GO:0071727)	3	0	.07	-	 < 0.01	9.32E-01
cellular response to diacyl bacterial lipopeptide (GO:0071726)	4	0	.09	-	 < 0.01	9.11E-01
response to triacyl bacterial lipopeptide (GO:0071725)	3	0	.07	-	 < 0.01	9.32E-01
response to diacyl bacterial lipopeptide (GO:0071724)	4	0	.09	-	 < 0.01	9.11E-01
sodium-independent prostaglandin transport (GO:0071720)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:2001189)	2	0	.05	-	 < 0.01	9.54E-01
regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:2001188)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)	9	0	.21	-	 < 0.01	8.11E-01
negative regulation of CD8-positive, alpha-beta T cell activation (GO:2001186)	4	0	.09	-	 < 0.01	9.11E-01
regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)	17	0	.40	-	 < 0.01	6.73E-01
B cell selection (GO:0002339)	4	0	.09	-	 < 0.01	9.11E-01
B-1 B cell lineage commitment (GO:0002336)	1	0	.02	-	 < 0.01	9.77E-01
transitional one stage B cell differentiation (GO:0002333)	1	0	.02	-	 < 0.01	9.77E-01
transitional stage B cell differentiation (GO:0002332)	1	0	.02	-	 < 0.01	9.77E-01
pre-B cell allelic exclusion (GO:0002331)	3	0	.07	-	 < 0.01	9.32E-01
sodium-independent icosanoid transport (GO:0071718)	2	0	.05	-	 < 0.01	9.54E-01
response to ether (GO:0045472)	10	0	.23	-	 < 0.01	7.92E-01
leukotriene transport (GO:0071716)	6	0	.14	-	 < 0.01	8.69E-01
ER-associated misfolded protein catabolic process (GO:0071712)	14	0	.33	-	 < 0.01	7.21E-01
positive regulation of mediator complex assembly (GO:2001178)	1	0	.02	-	 < 0.01	9.77E-01
regulation of mediator complex assembly (GO:2001176)	1	0	.02	-	 < 0.01	9.77E-01
regulation of histone H2B conserved C-terminal lysine ubiquitination (GO:2001173)	1	0	.02	-	 < 0.01	9.77E-01
pre-B cell differentiation (GO:0002329)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of ATP biosynthetic process (GO:2001171)	12	0	.28	-	 < 0.01	7.56E-01
immature B cell differentiation (GO:0002327)	11	0	.26	-	 < 0.01	7.74E-01
negative regulation of ATP biosynthetic process (GO:2001170)	4	0	.09	-	 < 0.01	9.11E-01
B cell lineage commitment (GO:0002326)	6	0	.14	-	 < 0.01	8.69E-01
natural killer cell activation involved in immune response (GO:0002323)	22	0	.51	-	 < 0.01	5.99E-01
immunoglobulin heavy chain V-D-J recombination (GO:0071707)	3	0	.07	-	 < 0.01	9.32E-01
tumor necrosis factor superfamily cytokine production (GO:0071706)	8	0	.19	-	 < 0.01	8.30E-01
galactose catabolic process via UDP-galactose (GO:0033499)	4	0	.09	-	 < 0.01	9.11E-01
regulation of MAPK export from nucleus (GO:0071701)	1	0	.02	-	 < 0.01	9.77E-01
regulation of ATP biosynthetic process (GO:2001169)	18	0	.42	-	 < 0.01	6.57E-01
positive regulation of histone H2B ubiquitination (GO:2001168)	4	0	.09	-	 < 0.01	9.11E-01
cholesterol biosynthetic process via lathosterol (GO:0033490)	1	0	.02	-	 < 0.01	9.77E-01
regulation of histone H2B ubiquitination (GO:2001166)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues (GO:2001165)	1	0	.02	-	 < 0.01	9.77E-01
regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues (GO:2001163)	1	0	.02	-	 < 0.01	9.77E-01
memory B cell differentiation (GO:0002319)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of histone H3-K79 methylation (GO:2001162)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of histone H3-K79 methylation (GO:2001161)	1	0	.02	-	 < 0.01	9.77E-01
plasma cell differentiation (GO:0002317)	4	0	.09	-	 < 0.01	9.11E-01
regulation of histone H3-K79 methylation (GO:2001160)	3	0	.07	-	 < 0.01	9.32E-01
follicular B cell differentiation (GO:0002316)	1	0	.02	-	 < 0.01	9.77E-01
marginal zone B cell differentiation (GO:0002315)	10	0	.23	-	 < 0.01	7.92E-01
germinal center B cell differentiation (GO:0002314)	6	0	.14	-	 < 0.01	8.69E-01
mature B cell differentiation involved in immune response (GO:0002313)	22	0	.51	-	 < 0.01	5.99E-01
bone resorption (GO:0045453)	26	0	.61	-	 < 0.01	5.45E-01
cholesterol biosynthetic process via 24,25-dihydrolanosterol (GO:0033488)	1	0	.02	-	 < 0.01	9.77E-01
nitric oxide homeostasis (GO:0033484)	2	0	.05	-	 < 0.01	9.54E-01
gas homeostasis (GO:0033483)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of renal water transport (GO:2001153)	1	0	.02	-	 < 0.01	9.77E-01
T cell proliferation involved in immune response (GO:0002309)	4	0	.09	-	 < 0.01	9.11E-01
regulation of renal water transport (GO:2001151)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of dipeptide transmembrane transport (GO:2001150)	2	0	.05	-	 < 0.01	9.54E-01
CD8-positive, gamma-delta intraepithelial T cell differentiation (GO:0002305)	3	0	.07	-	 < 0.01	9.32E-01
gamma-delta intraepithelial T cell differentiation (GO:0002304)	3	0	.07	-	 < 0.01	9.32E-01
CD8-positive, alpha-beta T cell differentiation involved in immune response (GO:0002302)	2	0	.05	-	 < 0.01	9.54E-01
CD8-positive, alpha-beta intraepithelial T cell differentiation (GO:0002300)	1	0	.02	-	 < 0.01	9.77E-01
S-methylmethionine metabolic process (GO:0033477)	1	0	.02	-	 < 0.01	9.77E-01
regulation of dipeptide transmembrane transport (GO:2001148)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity (GO:2001145)	1	0	.02	-	 < 0.01	9.77E-01
regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity (GO:2001144)	1	0	.02	-	 < 0.01	9.77E-01
nicotinate transport (GO:2001142)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of phospholipid transport (GO:2001139)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of endocytic recycling (GO:2001136)	1	0	.02	-	 < 0.01	9.77E-01
intracellular protein transmembrane transport (GO:0065002)	47	0	1.10	-	 < 0.01	3.34E-01
specification of axis polarity (GO:0065001)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of cellular response to hepatocyte growth factor stimulus (GO:2001113)	1	0	.02	-	 < 0.01	9.77E-01
regulation of cellular response to hepatocyte growth factor stimulus (GO:2001112)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of lens epithelial cell proliferation (GO:2001111)	2	0	.05	-	 < 0.01	9.54E-01
maternal placenta development (GO:0001893)	32	0	.75	-	 < 0.01	4.74E-01
adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197)	7	0	.16	-	 < 0.01	8.49E-01
adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathway (GO:0007196)	4	0	.09	-	 < 0.01	9.11E-01
adenylate cyclase-inhibiting dopamine receptor signaling pathway (GO:0007195)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of adenylate cyclase activity (GO:0007194)	13	0	.30	-	 < 0.01	7.38E-01
adenylate cyclase-activating serotonin receptor signaling pathway (GO:0007192)	1	0	.02	-	 < 0.01	9.77E-01
adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191)	10	0	.23	-	 < 0.01	7.92E-01
regulation of lens epithelial cell proliferation (GO:2001109)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of Rho guanyl-nucleotide exchange factor activity (GO:2001108)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of Rho guanyl-nucleotide exchange factor activity (GO:2001107)	1	0	.02	-	 < 0.01	9.77E-01
regulation of Rho guanyl-nucleotide exchange factor activity (GO:2001106)	2	0	.05	-	 < 0.01	9.54E-01
selenium compound metabolic process (GO:0001887)	3	0	.07	-	 < 0.01	9.32E-01
endothelial cell morphogenesis (GO:0001886)	16	0	.37	-	 < 0.01	6.89E-01
Mullerian duct regression (GO:0001880)	4	0	.09	-	 < 0.01	9.11E-01
common-partner SMAD protein phosphorylation (GO:0007182)	6	0	.14	-	 < 0.01	8.69E-01
detection of yeast (GO:0001879)	1	0	.02	-	 < 0.01	9.77E-01
response to yeast (GO:0001878)	11	0	.26	-	 < 0.01	7.74E-01
negative regulation of epidermal growth factor-activated receptor activity (GO:0007175)	13	0	.30	-	 < 0.01	7.38E-01
epidermal growth factor catabolic process (GO:0007174)	1	0	.02	-	 < 0.01	9.77E-01
signal complex assembly (GO:0007172)	2	0	.05	-	 < 0.01	9.54E-01
regulation of mesenchymal cell proliferation involved in ureter development (GO:0072199)	4	0	.09	-	 < 0.01	9.11E-01
mesenchymal cell proliferation involved in ureter development (GO:0072198)	1	0	.02	-	 < 0.01	9.77E-01
ureter morphogenesis (GO:0072197)	9	0	.21	-	 < 0.01	8.11E-01
negative regulation of complement activation, lectin pathway (GO:0001869)	2	0	.05	-	 < 0.01	9.54E-01
kidney smooth muscle cell differentiation (GO:0072195)	1	0	.02	-	 < 0.01	9.77E-01
regulation of complement activation, lectin pathway (GO:0001868)	2	0	.05	-	 < 0.01	9.54E-01
kidney smooth muscle tissue development (GO:0072194)	2	0	.05	-	 < 0.01	9.54E-01
complement activation, lectin pathway (GO:0001867)	9	0	.21	-	 < 0.01	8.11E-01
ureter smooth muscle cell differentiation (GO:0072193)	4	0	.09	-	 < 0.01	9.11E-01
NK T cell proliferation (GO:0001866)	2	0	.05	-	 < 0.01	9.54E-01
ureter epithelial cell differentiation (GO:0072192)	1	0	.02	-	 < 0.01	9.77E-01
NK T cell differentiation (GO:0001865)	6	0	.14	-	 < 0.01	8.69E-01
ureter smooth muscle development (GO:0072191)	4	0	.09	-	 < 0.01	9.11E-01
ureter urothelium development (GO:0072190)	3	0	.07	-	 < 0.01	9.32E-01
receptor guanylyl cyclase signaling pathway (GO:0007168)	12	0	.28	-	 < 0.01	7.56E-01
establishment of tissue polarity (GO:0007164)	29	0	.68	-	 < 0.01	5.08E-01
calcium-independent cell-matrix adhesion (GO:0007161)	3	0	.07	-	 < 0.01	9.32E-01
ureter development (GO:0072189)	19	0	.44	-	 < 0.01	6.42E-01
metanephric cap morphogenesis (GO:0072186)	1	0	.02	-	 < 0.01	9.77E-01
metanephric cap development (GO:0072185)	1	0	.02	-	 < 0.01	9.77E-01
renal vesicle progenitor cell differentiation (GO:0072184)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of nephron tubule epithelial cell differentiation (GO:0072183)	1	0	.02	-	 < 0.01	9.77E-01
regulation of nephron tubule epithelial cell differentiation (GO:0072182)	11	0	.26	-	 < 0.01	7.74E-01
mesonephric duct formation (GO:0072181)	2	0	.05	-	 < 0.01	9.54E-01
mesonephric duct morphogenesis (GO:0072180)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of epithelial cell differentiation involved in kidney development (GO:2000698)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of epithelial cell differentiation involved in kidney development (GO:2000697)	5	0	.12	-	 < 0.01	8.90E-01
nephric duct formation (GO:0072179)	5	0	.12	-	 < 0.01	8.90E-01
regulation of epithelial cell differentiation involved in kidney development (GO:2000696)	17	0	.40	-	 < 0.01	6.73E-01
nephric duct morphogenesis (GO:0072178)	11	0	.26	-	 < 0.01	7.74E-01
mesonephric duct development (GO:0072177)	6	0	.14	-	 < 0.01	8.69E-01
nephric duct development (GO:0072176)	12	0	.28	-	 < 0.01	7.56E-01
metanephric tubule formation (GO:0072174)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of cardiac muscle cell myoblast differentiation (GO:2000691)	1	0	.02	-	 < 0.01	9.77E-01
metanephric tubule morphogenesis (GO:0072173)	10	0	.23	-	 < 0.01	7.92E-01
regulation of cardiac muscle cell myoblast differentiation (GO:2000690)	1	0	.02	-	 < 0.01	9.77E-01
mesonephric tubule formation (GO:0072172)	10	0	.23	-	 < 0.01	7.92E-01
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:0001844)	1	0	.02	-	 < 0.01	9.77E-01
metanephric tubule development (GO:0072170)	18	0	.42	-	 < 0.01	6.57E-01
female meiosis II (GO:0007147)	2	0	.05	-	 < 0.01	9.54E-01
female meiosis I (GO:0007144)	11	0	.26	-	 < 0.01	7.74E-01
male meiosis I (GO:0007141)	22	0	.51	-	 < 0.01	5.99E-01
male meiotic nuclear division (GO:0007140)	47	0	1.10	-	 < 0.01	3.34E-01
specification of posterior mesonephric tubule identity (GO:0072169)	1	0	.02	-	 < 0.01	9.77E-01
specification of anterior mesonephric tubule identity (GO:0072168)	1	0	.02	-	 < 0.01	9.77E-01
specification of mesonephric tubule identity (GO:0072167)	1	0	.02	-	 < 0.01	9.77E-01
posterior mesonephric tubule development (GO:0072166)	2	0	.05	-	 < 0.01	9.54E-01
regulation of cellular response to X-ray (GO:2000683)	1	0	.02	-	 < 0.01	9.77E-01
neural plate morphogenesis (GO:0001839)	7	0	.16	-	 < 0.01	8.49E-01
anterior mesonephric tubule development (GO:0072165)	1	0	.02	-	 < 0.01	9.77E-01
release of cytochrome c from mitochondria (GO:0001836)	20	0	.47	-	 < 0.01	6.27E-01
male somatic sex determination (GO:0019102)	1	0	.02	-	 < 0.01	9.77E-01
metanephric mesenchymal cell differentiation (GO:0072162)	4	0	.09	-	 < 0.01	9.11E-01
female somatic sex determination (GO:0019101)	1	0	.02	-	 < 0.01	9.77E-01
mesenchymal cell differentiation involved in kidney development (GO:0072161)	7	0	.16	-	 < 0.01	8.49E-01
trophectodermal cell proliferation (GO:0001834)	4	0	.09	-	 < 0.01	9.11E-01
male germ-line sex determination (GO:0019100)	2	0	.05	-	 < 0.01	9.54E-01
nephron tubule epithelial cell differentiation (GO:0072160)	2	0	.05	-	 < 0.01	9.54E-01
inner cell mass cell proliferation (GO:0001833)	18	0	.42	-	 < 0.01	6.57E-01
trophectodermal cellular morphogenesis (GO:0001831)	3	0	.07	-	 < 0.01	9.32E-01
cloacal septation (GO:0060197)	2	0	.05	-	 < 0.01	9.54E-01
trophectodermal cell fate commitment (GO:0001830)	2	0	.05	-	 < 0.01	9.54E-01
meiosis II (GO:0007135)	13	0	.30	-	 < 0.01	7.38E-01
negative regulation of lipase activity (GO:0060192)	17	0	.40	-	 < 0.01	6.73E-01
reciprocal meiotic recombination (GO:0007131)	43	0	1.00	-	 < 0.01	3.67E-01
synaptonemal complex assembly (GO:0007130)	21	0	.49	-	 < 0.01	6.13E-01
positive regulation of transcription regulatory region DNA binding (GO:2000679)	25	0	.58	-	 < 0.01	5.58E-01
positive regulation of type B pancreatic cell apoptotic process (GO:2000676)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of type B pancreatic cell apoptotic process (GO:2000675)	7	0	.16	-	 < 0.01	8.49E-01
regulation of type B pancreatic cell apoptotic process (GO:2000674)	13	0	.30	-	 < 0.01	7.38E-01
distal tubule morphogenesis (GO:0072156)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of motor neuron apoptotic process (GO:2000672)	6	0	.14	-	 < 0.01	8.69E-01
inner cell mass cellular morphogenesis (GO:0001828)	3	0	.07	-	 < 0.01	9.32E-01
regulation of motor neuron apoptotic process (GO:2000671)	8	0	.19	-	 < 0.01	8.30E-01
inner cell mass cell fate commitment (GO:0001827)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of dendritic cell apoptotic process (GO:2000670)	4	0	.09	-	 < 0.01	9.11E-01
inner cell mass cell differentiation (GO:0001826)	8	0	.19	-	 < 0.01	8.30E-01
homologous chromosome pairing at meiosis (GO:0007129)	45	0	1.05	-	 < 0.01	3.50E-01
meiotic prophase I (GO:0007128)	11	0	.26	-	 < 0.01	7.74E-01
histamine secretion (GO:0001821)	11	0	.26	-	 < 0.01	7.74E-01
meiosis I (GO:0007127)	102	0	2.38	-	 < 0.01	9.21E-02
serotonin secretion (GO:0001820)	7	0	.16	-	 < 0.01	8.49E-01
cell cycle switching (GO:0060184)	3	0	.07	-	 < 0.01	9.32E-01
apelin receptor signaling pathway (GO:0060183)	1	0	.02	-	 < 0.01	9.77E-01
female mating behavior (GO:0060180)	12	0	.28	-	 < 0.01	7.56E-01
glomerular mesangial cell development (GO:0072144)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of interleukin-1-mediated signaling pathway (GO:2000661)	1	0	.02	-	 < 0.01	9.77E-01
mesangial cell development (GO:0072143)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of interleukin-1-mediated signaling pathway (GO:2000660)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of antibody-dependent cellular cytotoxicity (GO:0001815)	1	0	.02	-	 < 0.01	9.77E-01
renal interstitial fibroblast development (GO:0072141)	2	0	.05	-	 < 0.01	9.54E-01
regulation of antibody-dependent cellular cytotoxicity (GO:0001813)	1	0	.02	-	 < 0.01	9.77E-01
male mating behavior (GO:0060179)	8	0	.19	-	 < 0.01	8.30E-01
positive regulation of type I hypersensitivity (GO:0001812)	4	0	.09	-	 < 0.01	9.11E-01
regulation of exocyst localization (GO:0060178)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of type I hypersensitivity (GO:0001811)	1	0	.02	-	 < 0.01	9.77E-01
regulation of angiotensin metabolic process (GO:0060177)	3	0	.07	-	 < 0.01	9.32E-01
regulation of type I hypersensitivity (GO:0001810)	5	0	.12	-	 < 0.01	8.90E-01
endomitotic cell cycle (GO:0007113)	2	0	.05	-	 < 0.01	9.54E-01
male meiosis cytokinesis (GO:0007112)	1	0	.02	-	 < 0.01	9.77E-01
ribonucleoprotein complex disassembly (GO:0032988)	7	0	.16	-	 < 0.01	8.49E-01
regulation of interleukin-1-mediated signaling pathway (GO:2000659)	7	0	.16	-	 < 0.01	8.49E-01
mitochondrial respiratory chain complex I assembly (GO:0032981)	44	0	1.03	-	 < 0.01	3.58E-01
negative regulation of apolipoprotein binding (GO:2000657)	1	0	.02	-	 < 0.01	9.77E-01
glomerular parietal epithelial cell differentiation (GO:0072139)	1	0	.02	-	 < 0.01	9.77E-01
regulation of apolipoprotein binding (GO:2000656)	1	0	.02	-	 < 0.01	9.77E-01
mesenchymal cell proliferation involved in ureteric bud development (GO:0072138)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of cellular response to testosterone stimulus (GO:2000655)	1	0	.02	-	 < 0.01	9.77E-01
condensed mesenchymal cell proliferation (GO:0072137)	3	0	.07	-	 < 0.01	9.32E-01
regulation of cellular response to testosterone stimulus (GO:2000654)	1	0	.02	-	 < 0.01	9.77E-01
metanephric mesenchymal cell proliferation involved in metanephros development (GO:0072136)	2	0	.05	-	 < 0.01	9.54E-01
regulation of genetic imprinting (GO:2000653)	8	0	.19	-	 < 0.01	8.30E-01
positive regulation of type IV hypersensitivity (GO:0001809)	1	0	.02	-	 < 0.01	9.77E-01
kidney mesenchymal cell proliferation (GO:0072135)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of type IV hypersensitivity (GO:0001808)	2	0	.05	-	 < 0.01	9.54E-01
nephrogenic mesenchyme morphogenesis (GO:0072134)	2	0	.05	-	 < 0.01	9.54E-01
regulation of type IV hypersensitivity (GO:0001807)	4	0	.09	-	 < 0.01	9.11E-01
metanephric mesenchyme morphogenesis (GO:0072133)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of sodium ion transmembrane transporter activity (GO:2000650)	13	0	.30	-	 < 0.01	7.38E-01
type IV hypersensitivity (GO:0001806)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of type III hypersensitivity (GO:0001805)	4	0	.09	-	 < 0.01	9.11E-01
kidney mesenchyme morphogenesis (GO:0072131)	3	0	.07	-	 < 0.01	9.32E-01
renal capsule specification (GO:0072130)	1	0	.02	-	 < 0.01	9.77E-01
regulation of type III hypersensitivity (GO:0001803)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of adenosine receptor signaling pathway (GO:0060169)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of protein autoubiquitination (GO:1902499)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of adenosine receptor signaling pathway (GO:0060168)	3	0	.07	-	 < 0.01	9.32E-01
regulation of adenosine receptor signaling pathway (GO:0060167)	4	0	.09	-	 < 0.01	9.11E-01
olfactory pit development (GO:0060166)	3	0	.07	-	 < 0.01	9.32E-01
regulation of timing of subpallium neuron differentiation (GO:0060165)	1	0	.02	-	 < 0.01	9.77E-01
regulation of timing of neuron differentiation (GO:0060164)	5	0	.12	-	 < 0.01	8.90E-01
subpallium neuron fate commitment (GO:0060163)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of dopamine receptor signaling pathway (GO:0060161)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of sperm capacitation (GO:1902491)	1	0	.02	-	 < 0.01	9.77E-01
mitotic centrosome separation (GO:0007100)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of dopamine receptor signaling pathway (GO:0060160)	4	0	.09	-	 < 0.01	9.11E-01
regulation of sperm capacitation (GO:1902490)	2	0	.05	-	 < 0.01	9.54E-01
protein insertion into mitochondrial inner membrane from matrix (GO:0032979)	3	0	.07	-	 < 0.01	9.32E-01
protein insertion into membrane from inner side (GO:0032978)	4	0	.09	-	 < 0.01	9.11E-01
release of matrix enzymes from mitochondria (GO:0032976)	1	0	.02	-	 < 0.01	9.77E-01
amino acid transmembrane export from vacuole (GO:0032974)	1	0	.02	-	 < 0.01	9.77E-01
amino acid export across plasma membrane (GO:0032973)	1	0	.02	-	 < 0.01	9.77E-01
regulation of muscle filament sliding speed (GO:0032972)	2	0	.05	-	 < 0.01	9.54E-01
regulation of muscle filament sliding (GO:0032971)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of stem cell proliferation (GO:2000647)	6	0	.14	-	 < 0.01	8.69E-01
renal capsule formation (GO:0072129)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of receptor catabolic process (GO:2000646)	8	0	.19	-	 < 0.01	8.30E-01
renal capsule morphogenesis (GO:0072128)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of receptor catabolic process (GO:2000645)	3	0	.07	-	 < 0.01	9.32E-01
renal capsule development (GO:0072127)	1	0	.02	-	 < 0.01	9.77E-01
regulation of receptor catabolic process (GO:2000644)	12	0	.28	-	 < 0.01	7.56E-01
positive regulation of glomerular mesangial cell proliferation (GO:0072126)	8	0	.19	-	 < 0.01	8.30E-01
positive regulation of early endosome to late endosome transport (GO:2000643)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of glomerular mesangial cell proliferation (GO:0072125)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of early endosome to late endosome transport (GO:2000642)	2	0	.05	-	 < 0.01	9.54E-01
regulation of glomerular mesangial cell proliferation (GO:0072124)	12	0	.28	-	 < 0.01	7.56E-01
regulation of early endosome to late endosome transport (GO:2000641)	18	0	.42	-	 < 0.01	6.57E-01
positive regulation of SREBP signaling pathway (GO:2000640)	1	0	.02	-	 < 0.01	9.77E-01
regulation of dopamine receptor signaling pathway (GO:0060159)	11	0	.26	-	 < 0.01	7.74E-01
phospholipase C-activating dopamine receptor signaling pathway (GO:0060158)	8	0	.19	-	 < 0.01	8.30E-01
urinary bladder development (GO:0060157)	5	0	.12	-	 < 0.01	8.90E-01
milk ejection reflex (GO:0060156)	1	0	.02	-	 < 0.01	9.77E-01
platelet dense granule organization (GO:0060155)	5	0	.12	-	 < 0.01	8.90E-01
cytotoxic T cell pyroptotic process (GO:1902483)	1	0	.02	-	 < 0.01	9.77E-01
microtubule-based peroxisome localization (GO:0060152)	2	0	.05	-	 < 0.01	9.54E-01
peroxisome localization (GO:0060151)	2	0	.05	-	 < 0.01	9.54E-01
protein localization to mitotic spindle (GO:1902480)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968)	16	0	.37	-	 < 0.01	6.89E-01
positive regulation of collagen biosynthetic process (GO:0032967)	30	0	.70	-	 < 0.01	4.97E-01
negative regulation of collagen biosynthetic process (GO:0032966)	17	0	.40	-	 < 0.01	6.73E-01
regulation of collagen biosynthetic process (GO:0032965)	47	0	1.10	-	 < 0.01	3.34E-01
collagen biosynthetic process (GO:0032964)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of SREBP signaling pathway (GO:2000639)	2	0	.05	-	 < 0.01	9.54E-01
regulation of SREBP signaling pathway (GO:2000638)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of primary miRNA processing (GO:2000635)	4	0	.09	-	 < 0.01	9.11E-01
regulation of primary miRNA processing (GO:2000634)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of pre-miRNA processing (GO:2000632)	2	0	.05	-	 < 0.01	9.54E-01
pronephros morphogenesis (GO:0072114)	2	0	.05	-	 < 0.01	9.54E-01
regulation of pre-miRNA processing (GO:2000631)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of miRNA metabolic process (GO:2000630)	7	0	.16	-	 < 0.01	8.49E-01
glomerular visceral epithelial cell differentiation (GO:0072112)	14	0	.33	-	 < 0.01	7.21E-01
glomerular mesangial cell proliferation (GO:0072110)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of posttranscriptional gene silencing (GO:0060149)	21	0	.49	-	 < 0.01	6.13E-01
positive regulation of protein localization to synapse (GO:1902474)	9	0	.21	-	 < 0.01	8.11E-01
inositol trisphosphate biosynthetic process (GO:0032959)	4	0	.09	-	 < 0.01	9.11E-01
inositol phosphate biosynthetic process (GO:0032958)	15	0	.35	-	 < 0.01	7.05E-01
inositol trisphosphate metabolic process (GO:0032957)	10	0	.23	-	 < 0.01	7.92E-01
regulation of cytokinetic process (GO:0032954)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of miRNA metabolic process (GO:2000629)	1	0	.02	-	 < 0.01	9.77E-01
regulation of miRNA metabolic process (GO:2000628)	12	0	.28	-	 < 0.01	7.56E-01
positive regulation of miRNA catabolic process (GO:2000627)	3	0	.07	-	 < 0.01	9.32E-01
glomerular mesangium development (GO:0072109)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0072108)	4	0	.09	-	 < 0.01	9.11E-01
regulation of miRNA catabolic process (GO:2000625)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of ureteric bud formation (GO:0072107)	4	0	.09	-	 < 0.01	9.11E-01
regulation of ureteric bud formation (GO:0072106)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:2000623)	4	0	.09	-	 < 0.01	9.11E-01
ureteric peristalsis (GO:0072105)	3	0	.07	-	 < 0.01	9.32E-01
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:2000622)	4	0	.09	-	 < 0.01	9.11E-01
glomerular capillary formation (GO:0072104)	6	0	.14	-	 < 0.01	8.69E-01
glomerulus vasculature morphogenesis (GO:0072103)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of histone H4-K16 acetylation (GO:2000620)	2	0	.05	-	 < 0.01	9.54E-01
glomerulus morphogenesis (GO:0072102)	11	0	.26	-	 < 0.01	7.74E-01
specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway (GO:0072101)	1	0	.02	-	 < 0.01	9.77E-01
specification of ureteric bud anterior/posterior symmetry (GO:0072100)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of apoptotic process by virus (GO:0060139)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of histone H3-K27 trimethylation (GO:1902466)	3	0	.07	-	 < 0.01	9.32E-01
regulation of histone H3-K27 trimethylation (GO:1902464)	3	0	.07	-	 < 0.01	9.32E-01
somatotropin secreting cell development (GO:0060133)	2	0	.05	-	 < 0.01	9.54E-01
protein localization to cell leading edge (GO:1902463)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of mesenchymal stem cell proliferation (GO:1902462)	5	0	.12	-	 < 0.01	8.90E-01
regulation of mesenchymal stem cell proliferation (GO:1902460)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of mononuclear cell proliferation (GO:0032946)	137	0	3.19	-	 < 0.01	4.05E-02
negative regulation of histone H4-K16 acetylation (GO:2000619)	4	0	.09	-	 < 0.01	9.11E-01
regulation of histone H4-K16 acetylation (GO:2000618)	7	0	.16	-	 < 0.01	8.49E-01
secretion by tissue (GO:0032941)	18	0	.42	-	 < 0.01	6.57E-01
positive regulation of histone H3-K9 acetylation (GO:2000617)	9	0	.21	-	 < 0.01	8.11E-01
negative regulation of histone H3-K9 acetylation (GO:2000616)	1	0	.02	-	 < 0.01	9.77E-01
regulation of histone H3-K9 acetylation (GO:2000615)	12	0	.28	-	 < 0.01	7.56E-01
positive regulation of thyroid-stimulating hormone secretion (GO:2000614)	1	0	.02	-	 < 0.01	9.77E-01
regulation of thyroid-stimulating hormone secretion (GO:2000612)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of thyroid hormone generation (GO:2000611)	4	0	.09	-	 < 0.01	9.11E-01
thyroid-stimulating hormone-secreting cell differentiation (GO:0060129)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of stem cell population maintenance (GO:1902459)	12	0	.28	-	 < 0.01	7.56E-01
corticotropin hormone secreting cell differentiation (GO:0060128)	3	0	.07	-	 < 0.01	9.32E-01
somatotropin secreting cell differentiation (GO:0060126)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of stem cell population maintenance (GO:1902455)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of growth hormone secretion (GO:0060124)	11	0	.26	-	 < 0.01	7.74E-01
bile acid biosynthetic process (GO:0006699)	14	0	.33	-	 < 0.01	7.21E-01
vestibular receptor cell stereocilium organization (GO:0060121)	1	0	.02	-	 < 0.01	9.77E-01
inner ear receptor cell fate commitment (GO:0060120)	5	0	.12	-	 < 0.01	8.90E-01
ergosterol biosynthetic process (GO:0006696)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of translation in response to oxidative stress (GO:0032938)	1	0	.02	-	 < 0.01	9.77E-01
leukotriene metabolic process (GO:0006691)	23	0	.54	-	 < 0.01	5.85E-01
regulation of thyroid hormone generation (GO:2000609)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of cell proliferation involved in mesonephros development (GO:2000607)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of superoxide anion generation (GO:0032930)	22	0	.51	-	 < 0.01	5.99E-01
regulation of cell proliferation involved in mesonephros development (GO:2000606)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601)	11	0	.26	-	 < 0.01	7.74E-01
vestibular receptor cell development (GO:0060118)	3	0	.07	-	 < 0.01	9.32E-01
auditory receptor cell development (GO:0060117)	30	0	.70	-	 < 0.01	4.97E-01
vestibular receptor cell morphogenesis (GO:0060116)	2	0	.05	-	 < 0.01	9.54E-01
regulation of mitochondrial membrane permeability involved in programmed necrotic cell death (GO:1902445)	3	0	.07	-	 < 0.01	9.32E-01
vestibular receptor cell differentiation (GO:0060114)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of ripoptosome assembly involved in necroptotic process (GO:1902443)	2	0	.05	-	 < 0.01	9.54E-01
generation of ovulation cycle rhythm (GO:0060112)	3	0	.07	-	 < 0.01	9.32E-01
regulation of ripoptosome assembly involved in necroptotic process (GO:1902442)	2	0	.05	-	 < 0.01	9.54E-01
protein localization to mitotic spindle pole body (GO:1902440)	1	0	.02	-	 < 0.01	9.77E-01
sphingomyelin biosynthetic process (GO:0006686)	9	0	.21	-	 < 0.01	8.11E-01
sphingomyelin catabolic process (GO:0006685)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of superoxide anion generation (GO:0032929)	5	0	.12	-	 < 0.01	8.90E-01
sphingomyelin metabolic process (GO:0006684)	17	0	.40	-	 < 0.01	6.73E-01
regulation of superoxide anion generation (GO:0032928)	26	0	.61	-	 < 0.01	5.45E-01
galactosylceramide catabolic process (GO:0006683)	2	0	.05	-	 < 0.01	9.54E-01
galactosylceramide biosynthetic process (GO:0006682)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of activin receptor signaling pathway (GO:0032926)	12	0	.28	-	 < 0.01	7.56E-01
galactosylceramide metabolic process (GO:0006681)	8	0	.19	-	 < 0.01	8.30E-01
glucosylceramide catabolic process (GO:0006680)	2	0	.05	-	 < 0.01	9.54E-01
putrescine acetylation (GO:0032920)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of male mating behavior (GO:1902437)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of male mating behavior (GO:1902436)	1	0	.02	-	 < 0.01	9.77E-01
regulation of male mating behavior (GO:1902435)	3	0	.07	-	 < 0.01	9.32E-01
glucosylceramide biosynthetic process (GO:0006679)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of phagocytosis, engulfment (GO:0060101)	2	0	.05	-	 < 0.01	9.54E-01
glucosylceramide metabolic process (GO:0006678)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of phagocytosis, engulfment (GO:0060100)	16	0	.37	-	 < 0.01	6.89E-01
glycosylceramide metabolic process (GO:0006677)	15	0	.35	-	 < 0.01	7.05E-01
spermine acetylation (GO:0032919)	1	0	.02	-	 < 0.01	9.77E-01
spermidine acetylation (GO:0032918)	2	0	.05	-	 < 0.01	9.54E-01
polyamine acetylation (GO:0032917)	2	0	.05	-	 < 0.01	9.54E-01
phytosphingosine metabolic process (GO:0006671)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of transforming growth factor beta2 production (GO:0032915)	2	0	.05	-	 < 0.01	9.54E-01
sphingosine metabolic process (GO:0006670)	19	0	.44	-	 < 0.01	6.42E-01
negative regulation of transforming growth factor beta3 production (GO:0032913)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of transforming growth factor beta2 production (GO:0032912)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of transforming growth factor beta1 production (GO:0032911)	7	0	.16	-	 < 0.01	8.49E-01
olfactory placode morphogenesis (GO:0071699)	4	0	.09	-	 < 0.01	9.11E-01
olfactory placode development (GO:0071698)	4	0	.09	-	 < 0.01	9.11E-01
ectodermal placode morphogenesis (GO:0071697)	15	0	.35	-	 < 0.01	7.05E-01
ectodermal placode development (GO:0071696)	16	0	.37	-	 < 0.01	6.89E-01
maintenance of protein location in extracellular region (GO:0071694)	6	0	.14	-	 < 0.01	8.69E-01
deactivation of mitotic spindle assembly checkpoint (GO:1902426)	2	0	.05	-	 < 0.01	9.54E-01
protein transport within extracellular region (GO:0071693)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of attachment of mitotic spindle microtubules to kinetochore (GO:1902425)	3	0	.07	-	 < 0.01	9.32E-01
cardiac muscle thin filament assembly (GO:0071691)	3	0	.07	-	 < 0.01	9.32E-01
regulation of attachment of mitotic spindle microtubules to kinetochore (GO:1902423)	3	0	.07	-	 < 0.01	9.32E-01
sphinganine-1-phosphate biosynthetic process (GO:0006669)	1	0	.02	-	 < 0.01	9.77E-01
sphinganine-1-phosphate metabolic process (GO:0006668)	2	0	.05	-	 < 0.01	9.54E-01
sphinganine metabolic process (GO:0006667)	3	0	.07	-	 < 0.01	9.32E-01
3-keto-sphinganine metabolic process (GO:0006666)	1	0	.02	-	 < 0.01	9.77E-01
platelet activating factor biosynthetic process (GO:0006663)	5	0	.12	-	 < 0.01	8.90E-01
glycerol ether metabolic process (GO:0006662)	19	0	.44	-	 < 0.01	6.42E-01
phosphatidylinositol biosynthetic process (GO:0006661)	57	0	1.33	-	 < 0.01	2.64E-01
phosphatidylserine catabolic process (GO:0006660)	4	0	.09	-	 < 0.01	9.11E-01
nerve growth factor production (GO:0032902)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of neurotrophin production (GO:0032901)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of neurotrophin production (GO:0032900)	1	0	.02	-	 < 0.01	9.77E-01
TORC1 signaling (GO:0038202)	9	0	.21	-	 < 0.01	8.11E-01
striated muscle myosin thick filament assembly (GO:0071688)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of mRNA binding (GO:1902416)	8	0	.19	-	 < 0.01	8.30E-01
regulation of mRNA binding (GO:1902415)	10	0	.23	-	 < 0.01	7.92E-01
cellular response to indole-3-methanol (GO:0071681)	5	0	.12	-	 < 0.01	8.90E-01
response to indole-3-methanol (GO:0071680)	5	0	.12	-	 < 0.01	8.90E-01
regulation of mitotic cytokinesis (GO:1902412)	5	0	.12	-	 < 0.01	8.90E-01
phosphatidylserine biosynthetic process (GO:0006659)	4	0	.09	-	 < 0.01	9.11E-01
mitotic cytokinetic process (GO:1902410)	19	0	.44	-	 < 0.01	6.42E-01
CDP-choline pathway (GO:0006657)	2	0	.05	-	 < 0.01	9.54E-01
phosphatidylcholine biosynthetic process (GO:0006656)	16	0	.37	-	 < 0.01	6.89E-01
phosphatidylglycerol biosynthetic process (GO:0006655)	9	0	.21	-	 < 0.01	8.11E-01
1,2-diacyl-sn-glycero-3-phosphocholine metabolic process (GO:0006653)	1	0	.02	-	 < 0.01	9.77E-01
alpha-beta intraepithelial T cell differentiation (GO:0002299)	1	0	.02	-	 < 0.01	9.77E-01
T-helper 1 cell lineage commitment (GO:0002296)	4	0	.09	-	 < 0.01	9.11E-01
T-helper cell lineage commitment (GO:0002295)	13	0	.30	-	 < 0.01	7.38E-01
CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294)	33	0	.77	-	 < 0.01	4.63E-01
alpha-beta T cell differentiation involved in immune response (GO:0002293)	35	0	.82	-	 < 0.01	4.42E-01
T cell differentiation involved in immune response (GO:0002292)	39	0	.91	-	 < 0.01	4.02E-01
T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell (GO:0002291)	4	0	.09	-	 < 0.01	9.11E-01
olfactory bulb axon guidance (GO:0071678)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of mononuclear cell migration (GO:0071676)	16	0	.37	-	 < 0.01	6.89E-01
positive regulation of smooth muscle cell chemotaxis (GO:0071673)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of smooth muscle cell chemotaxis (GO:0071672)	3	0	.07	-	 < 0.01	9.32E-01
regulation of smooth muscle cell chemotaxis (GO:0071671)	6	0	.14	-	 < 0.01	8.69E-01
signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403)	13	0	.30	-	 < 0.01	7.38E-01
smooth muscle cell chemotaxis (GO:0071670)	2	0	.05	-	 < 0.01	9.54E-01
signal transduction involved in mitotic DNA damage checkpoint (GO:1902402)	13	0	.30	-	 < 0.01	7.38E-01
phospholipid transfer to membrane (GO:0006649)	2	0	.05	-	 < 0.01	9.54E-01
intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400)	11	0	.26	-	 < 0.01	7.74E-01
phosphatidylethanolamine biosynthetic process (GO:0006646)	10	0	.23	-	 < 0.01	7.92E-01
alpha-beta T cell activation involved in immune response (GO:0002287)	36	0	.84	-	 < 0.01	4.32E-01
T cell activation involved in immune response (GO:0002286)	72	0	1.68	-	 < 0.01	1.86E-01
neutrophil activation involved in immune response (GO:0002283)	11	0	.26	-	 < 0.01	7.74E-01
monocyte activation involved in immune response (GO:0002280)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of granzyme B production (GO:0071663)	3	0	.07	-	 < 0.01	9.32E-01
regulation of granzyme B production (GO:0071661)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of IP-10 production (GO:0071660)	1	0	.02	-	 < 0.01	9.77E-01
unsaturated fatty acid biosynthetic process (GO:0006636)	28	0	.65	-	 < 0.01	5.20E-01
tRNA demethylation (GO:1990983)	1	0	.02	-	 < 0.01	9.77E-01
mast cell activation involved in immune response (GO:0002279)	19	0	.44	-	 < 0.01	6.42E-01
eosinophil activation involved in immune response (GO:0002278)	2	0	.05	-	 < 0.01	9.54E-01
myeloid dendritic cell activation involved in immune response (GO:0002277)	3	0	.07	-	 < 0.01	9.32E-01
basophil activation involved in immune response (GO:0002276)	3	0	.07	-	 < 0.01	9.32E-01
plasmacytoid dendritic cell differentiation (GO:0002273)	1	0	.02	-	 < 0.01	9.77E-01
plasmacytoid dendritic cell activation (GO:0002270)	3	0	.07	-	 < 0.01	9.32E-01
regulation of IP-10 production (GO:0071658)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of granulocyte colony-stimulating factor production (GO:0071657)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of granulocyte colony-stimulating factor production (GO:0071656)	1	0	.02	-	 < 0.01	9.77E-01
regulation of granulocyte colony-stimulating factor production (GO:0071655)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of chemokine (C-C motif) ligand 1 production (GO:0071654)	1	0	.02	-	 < 0.01	9.77E-01
regulation of chemokine (C-C motif) ligand 1 production (GO:0071652)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of chemokine (C-C motif) ligand 5 production (GO:0071651)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of chemokine (C-C motif) ligand 5 production (GO:0071650)	4	0	.09	-	 < 0.01	9.11E-01
protein processing involved in protein targeting to mitochondrion (GO:0006627)	5	0	.12	-	 < 0.01	8.90E-01
protein targeting to mitochondrion (GO:0006626)	53	0	1.24	-	 < 0.01	2.90E-01
protein targeting to peroxisome (GO:0006625)	18	0	.42	-	 < 0.01	6.57E-01
vacuolar protein processing (GO:0006624)	3	0	.07	-	 < 0.01	9.32E-01
leukocyte activation involved in inflammatory response (GO:0002269)	3	0	.07	-	 < 0.01	9.32E-01
posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620)	13	0	.30	-	 < 0.01	7.38E-01
follicular dendritic cell differentiation (GO:0002268)	2	0	.05	-	 < 0.01	9.54E-01
follicular dendritic cell activation (GO:0002266)	2	0	.05	-	 < 0.01	9.54E-01
astrocyte activation involved in immune response (GO:0002265)	4	0	.09	-	 < 0.01	9.11E-01
lymphocyte homeostasis (GO:0002260)	65	0	1.52	-	 < 0.01	2.19E-01
regulation of chemokine (C-C motif) ligand 5 production (GO:0071649)	9	0	.21	-	 < 0.01	8.11E-01
negative regulation of chemokine (C-C motif) ligand 4 production (GO:0071644)	1	0	.02	-	 < 0.01	9.77E-01
regulation of chemokine (C-C motif) ligand 4 production (GO:0071643)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of macrophage inflammatory protein 1 alpha production (GO:0071642)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of macrophage inflammatory protein 1 alpha production (GO:0071641)	3	0	.07	-	 < 0.01	9.32E-01
regulation of macrophage inflammatory protein 1 alpha production (GO:0071640)	6	0	.14	-	 < 0.01	8.69E-01
modulation by host of viral RNA-binding transcription factor activity (GO:1990969)	1	0	.02	-	 < 0.01	9.77E-01
SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition (GO:0006617)	1	0	.02	-	 < 0.01	9.77E-01
modulation by host of RNA binding by virus (GO:1990968)	1	0	.02	-	 < 0.01	9.77E-01
SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)	7	0	.16	-	 < 0.01	8.49E-01
ATP generation from poly-ADP-D-ribose (GO:1990966)	4	0	.09	-	 < 0.01	9.11E-01
SRP-dependent cotranslational protein targeting to membrane (GO:0006614)	15	0	.35	-	 < 0.01	7.05E-01
cotranslational protein targeting to membrane (GO:0006613)	16	0	.37	-	 < 0.01	6.89E-01
establishment of blood-retinal barrier (GO:1990963)	2	0	.05	-	 < 0.01	9.54E-01
xenobiotic transport across blood-brain barrier (GO:1990962)	5	0	.12	-	 < 0.01	8.90E-01
ribosomal protein import into nucleus (GO:0006610)	3	0	.07	-	 < 0.01	9.32E-01
xenobiotic detoxification by transmembrane export across the plasma membrane (GO:1990961)	8	0	.19	-	 < 0.01	8.30E-01
basophil homeostasis (GO:1990960)	1	0	.02	-	 < 0.01	9.77E-01
tissue kallikrein-kinin cascade (GO:0002255)	1	0	.02	-	 < 0.01	9.77E-01
kinin cascade (GO:0002254)	3	0	.07	-	 < 0.01	9.32E-01
organ or tissue specific immune response (GO:0002251)	47	0	1.10	-	 < 0.01	3.34E-01
positive regulation of monocyte chemotactic protein-1 production (GO:0071639)	12	0	.28	-	 < 0.01	7.56E-01
negative regulation of monocyte chemotactic protein-1 production (GO:0071638)	6	0	.14	-	 < 0.01	8.69E-01
regulation of monocyte chemotactic protein-1 production (GO:0071637)	18	0	.42	-	 < 0.01	6.57E-01
nuclear protein quality control by the ubiquitin-proteasome system (GO:0071630)	2	0	.05	-	 < 0.01	9.54E-01
homogentisate metabolic process (GO:1901999)	1	0	.02	-	 < 0.01	9.77E-01
toxin transport (GO:1901998)	45	0	1.05	-	 < 0.01	3.50E-01
eosinophil homeostasis (GO:1990959)	1	0	.02	-	 < 0.01	9.77E-01
NLS-bearing protein import into nucleus (GO:0006607)	10	0	.23	-	 < 0.01	7.92E-01
positive regulation of meiotic cell cycle phase transition (GO:1901995)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of meiotic cell cycle phase transition (GO:1901994)	4	0	.09	-	 < 0.01	9.11E-01
phosphocreatine metabolic process (GO:0006603)	4	0	.09	-	 < 0.01	9.11E-01
regulation of meiotic cell cycle phase transition (GO:1901993)	8	0	.19	-	 < 0.01	8.30E-01
intramanchette transport (GO:1990953)	1	0	.02	-	 < 0.01	9.77E-01
creatine biosynthetic process (GO:0006601)	2	0	.05	-	 < 0.01	9.54E-01
creatine metabolic process (GO:0006600)	2	0	.05	-	 < 0.01	9.54E-01
connective tissue replacement involved in inflammatory response wound healing (GO:0002248)	5	0	.12	-	 < 0.01	8.90E-01
wound healing involved in inflammatory response (GO:0002246)	8	0	.19	-	 < 0.01	8.30E-01
cytoplasm protein quality control by the ubiquitin-proteasome system (GO:0071629)	1	0	.02	-	 < 0.01	9.77E-01
mastication (GO:0071626)	2	0	.05	-	 < 0.01	9.54E-01
vocalization behavior (GO:0071625)	19	0	.44	-	 < 0.01	6.42E-01
positive regulation of granulocyte chemotaxis (GO:0071624)	27	0	.63	-	 < 0.01	5.33E-01
negative regulation of granulocyte chemotaxis (GO:0071623)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of protein acetylation (GO:1901984)	25	0	.58	-	 < 0.01	5.58E-01
positive regulation of inward rectifier potassium channel activity (GO:1901980)	1	0	.02	-	 < 0.01	9.77E-01
response to molecule of fungal origin (GO:0002238)	6	0	.14	-	 < 0.01	8.69E-01
leukocyte chemotaxis involved in inflammatory response (GO:0002232)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of defense response to virus by host (GO:0002230)	31	0	.72	-	 < 0.01	4.85E-01
acyl-CoA biosynthetic process (GO:0071616)	21	0	.49	-	 < 0.01	6.13E-01
regulation of inward rectifier potassium channel activity (GO:1901979)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of cell cycle checkpoint (GO:1901978)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of cell cycle checkpoint (GO:1901977)	8	0	.19	-	 < 0.01	8.30E-01
peptidyl-aspartic acid autophosphorylation (GO:1990938)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of metanephric ureteric bud development (GO:2001076)	1	0	.02	-	 < 0.01	9.77E-01
regulation of metanephric ureteric bud development (GO:2001074)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of mitotic sister chromatid separation (GO:1901970)	13	0	.30	-	 < 0.01	7.38E-01
natural killer cell mediated immunity (GO:0002228)	14	0	.33	-	 < 0.01	7.21E-01
innate immune response in mucosa (GO:0002227)	33	0	.77	-	 < 0.01	4.63E-01
positive regulation of antimicrobial peptide production (GO:0002225)	6	0	.14	-	 < 0.01	8.69E-01
stimulatory C-type lectin receptor signaling pathway (GO:0002223)	4	0	.09	-	 < 0.01	9.11E-01
stimulatory killer cell immunoglobulin-like receptor signaling pathway (GO:0002222)	1	0	.02	-	 < 0.01	9.77E-01
innate immune response activating cell surface receptor signaling pathway (GO:0002220)	7	0	.16	-	 < 0.01	8.49E-01
chemokine (C-C motif) ligand 5 production (GO:0071609)	1	0	.02	-	 < 0.01	9.77E-01
macrophage inflammatory protein-1 alpha production (GO:0071608)	1	0	.02	-	 < 0.01	9.77E-01
transforming growth factor beta production (GO:0071604)	3	0	.07	-	 < 0.01	9.32E-01
endothelial cell-cell adhesion (GO:0071603)	2	0	.05	-	 < 0.01	9.54E-01
phytosphingosine biosynthetic process (GO:0071602)	1	0	.02	-	 < 0.01	9.77E-01
beta-alanine biosynthetic process via 3-ureidopropionate (GO:0033396)	1	0	.02	-	 < 0.01	9.77E-01
calcium ion regulated lysosome exocytosis (GO:1990927)	2	0	.05	-	 < 0.01	9.54E-01
short-term synaptic potentiation (GO:1990926)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of cell proliferation involved in outflow tract morphogenesis (GO:1901964)	1	0	.02	-	 < 0.01	9.77E-01
regulation of cell proliferation involved in outflow tract morphogenesis (GO:1901963)	3	0	.07	-	 < 0.01	9.32E-01
defense response to nematode (GO:0002215)	3	0	.07	-	 < 0.01	9.32E-01
putrescine biosynthetic process from arginine, using agmatinase (GO:0033389)	1	0	.02	-	 < 0.01	9.77E-01
putrescine biosynthetic process from arginine (GO:0033388)	1	0	.02	-	 < 0.01	9.77E-01
putrescine biosynthetic process from ornithine (GO:0033387)	3	0	.07	-	 < 0.01	9.32E-01
double-strand break repair involved in meiotic recombination (GO:1990918)	6	0	.14	-	 < 0.01	8.69E-01
maintenance of granzyme B location in T cell secretory granule (GO:0033382)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of retrograde dense core granule transport (GO:1901956)	1	0	.02	-	 < 0.01	9.77E-01
reactive nitrogen species metabolic process (GO:2001057)	20	0	.47	-	 < 0.01	6.27E-01
granzyme B localization to T cell secretory granule (GO:0033380)	1	0	.02	-	 < 0.01	9.77E-01
regulation of retrograde dense core granule transport (GO:1901954)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of anterograde dense core granule transport (GO:1901953)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of mesenchymal cell apoptotic process (GO:2001055)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of mesenchymal cell apoptotic process (GO:2001054)	12	0	.28	-	 < 0.01	7.56E-01
regulation of anterograde dense core granule transport (GO:1901951)	3	0	.07	-	 < 0.01	9.32E-01
regulation of mesenchymal cell apoptotic process (GO:2001053)	15	0	.35	-	 < 0.01	7.05E-01
response to psychosocial stress (GO:1990911)	2	0	.05	-	 < 0.01	9.54E-01
somatic diversification of immunoglobulins involved in immune response (GO:0002208)	20	0	.47	-	 < 0.01	6.27E-01
positive regulation of tendon cell differentiation (GO:2001051)	1	0	.02	-	 < 0.01	9.77E-01
somatic recombination of immunoglobulin genes involved in immune response (GO:0002204)	20	0	.47	-	 < 0.01	6.27E-01
somatic diversification of immune receptors (GO:0002200)	43	0	1.00	-	 < 0.01	3.67E-01
negative regulation of MHC class II biosynthetic process (GO:0045347)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of MHC class I biosynthetic process (GO:0045344)	1	0	.02	-	 < 0.01	9.77E-01
MHC class II biosynthetic process (GO:0045342)	1	0	.02	-	 < 0.01	9.77E-01
maintenance of protease location in T cell secretory granule (GO:0033379)	1	0	.02	-	 < 0.01	9.77E-01
maintenance of protein location in T cell secretory granule (GO:0033377)	1	0	.02	-	 < 0.01	9.77E-01
protease localization to T cell secretory granule (GO:0033375)	1	0	.02	-	 < 0.01	9.77E-01
protein localization to T cell secretory granule (GO:0033374)	1	0	.02	-	 < 0.01	9.77E-01
maintenance of protease location in mast cell secretory granule (GO:0033373)	1	0	.02	-	 < 0.01	9.77E-01
regulation of tendon cell differentiation (GO:2001049)	1	0	.02	-	 < 0.01	9.77E-01
T cell secretory granule organization (GO:0033371)	1	0	.02	-	 < 0.01	9.77E-01
maintenance of protein location in mast cell secretory granule (GO:0033370)	1	0	.02	-	 < 0.01	9.77E-01
protease localization to mast cell secretory granule (GO:0033368)	1	0	.02	-	 < 0.01	9.77E-01
protein localization to mast cell secretory granule (GO:0033367)	1	0	.02	-	 < 0.01	9.77E-01
protein localization to secretory granule (GO:0033366)	4	0	.09	-	 < 0.01	9.11E-01
mast cell secretory granule organization (GO:0033364)	2	0	.05	-	 < 0.01	9.54E-01
secretory granule organization (GO:0033363)	34	0	.79	-	 < 0.01	4.52E-01
regulation of cellular response to drug (GO:2001038)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of tongue muscle cell differentiation (GO:2001037)	2	0	.05	-	 < 0.01	9.54E-01
regulation of tongue muscle cell differentiation (GO:2001035)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of cellular glucuronidation (GO:2001031)	1	0	.02	-	 < 0.01	9.77E-01
transformation of host cell by virus (GO:0019087)	4	0	.09	-	 < 0.01	9.11E-01
late viral transcription (GO:0019086)	3	0	.07	-	 < 0.01	9.32E-01
early viral transcription (GO:0019085)	2	0	.05	-	 < 0.01	9.54E-01
carnitine biosynthetic process (GO:0045329)	3	0	.07	-	 < 0.01	9.32E-01
viral transcription (GO:0019083)	5	0	.12	-	 < 0.01	8.90E-01
viral protein processing (GO:0019082)	2	0	.05	-	 < 0.01	9.54E-01
viral translation (GO:0019081)	14	0	.33	-	 < 0.01	7.21E-01
viral gene expression (GO:0019080)	21	0	.49	-	 < 0.01	6.13E-01
late endosome to vacuole transport (GO:0045324)	20	0	.47	-	 < 0.01	6.27E-01
S-adenosylmethionine cycle (GO:0033353)	4	0	.09	-	 < 0.01	9.11E-01
regulation of cellular glucuronidation (GO:2001029)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of endothelial cell chemotaxis (GO:2001028)	17	0	.40	-	 < 0.01	6.73E-01
positive regulation of response to drug (GO:2001025)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of response to drug (GO:2001024)	2	0	.05	-	 < 0.01	9.54E-01
regulation of response to drug (GO:2001023)	6	0	.14	-	 < 0.01	8.69E-01
viral genome replication (GO:0019079)	18	0	.42	-	 < 0.01	6.57E-01
viral release from host cell (GO:0019076)	4	0	.09	-	 < 0.01	9.11E-01
virus maturation (GO:0019075)	2	0	.05	-	 < 0.01	9.54E-01
viral RNA genome packaging (GO:0019074)	2	0	.05	-	 < 0.01	9.54E-01
viral genome packaging (GO:0019072)	2	0	.05	-	 < 0.01	9.54E-01
asparagine catabolic process via L-aspartate (GO:0033345)	1	0	.02	-	 < 0.01	9.77E-01
cholesterol efflux (GO:0033344)	24	0	.56	-	 < 0.01	5.71E-01
positive regulation of collagen binding (GO:0033343)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of retrograde axon cargo transport (GO:2001019)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of collagen binding (GO:0033342)	1	0	.02	-	 < 0.01	9.77E-01
regulation of collagen binding (GO:0033341)	2	0	.05	-	 < 0.01	9.54E-01
regulation of retrograde axon cargo transport (GO:2001017)	2	0	.05	-	 < 0.01	9.54E-01
adenosine 5'-(hexahydrogen pentaphosphate) catabolic process (GO:1901911)	4	0	.09	-	 < 0.01	9.11E-01
epithelial cell proliferation involved in renal tubule morphogenesis (GO:2001013)	4	0	.09	-	 < 0.01	9.11E-01
adenosine 5'-(hexahydrogen pentaphosphate) metabolic process (GO:1901910)	4	0	.09	-	 < 0.01	9.11E-01
mesenchymal cell differentiation involved in renal system development (GO:2001012)	7	0	.16	-	 < 0.01	8.49E-01
virion assembly (GO:0019068)	22	0	.51	-	 < 0.01	5.99E-01
receptor-mediated endocytosis of virus by host cell (GO:0019065)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of type IIa hypersensitivity (GO:0001798)	5	0	.12	-	 < 0.01	8.90E-01
fusion of virus membrane with host plasma membrane (GO:0019064)	3	0	.07	-	 < 0.01	9.32E-01
regulation of type IIa hypersensitivity (GO:0001796)	5	0	.12	-	 < 0.01	8.90E-01
type IIa hypersensitivity (GO:0001794)	2	0	.05	-	 < 0.01	9.54E-01
centriole replication (GO:0007099)	21	0	.49	-	 < 0.01	6.13E-01
regulation of exit from mitosis (GO:0007096)	12	0	.28	-	 < 0.01	7.56E-01
mitotic G2 DNA damage checkpoint (GO:0007095)	22	0	.51	-	 < 0.01	5.99E-01
mitotic spindle assembly checkpoint (GO:0007094)	25	0	.58	-	 < 0.01	5.58E-01
mitotic cell cycle checkpoint (GO:0007093)	107	0	2.49	-	 < 0.01	8.19E-02
diadenosine hexaphosphate catabolic process (GO:1901909)	4	0	.09	-	 < 0.01	9.11E-01
diadenosine hexaphosphate metabolic process (GO:1901908)	4	0	.09	-	 < 0.01	9.11E-01
diadenosine pentaphosphate catabolic process (GO:1901907)	4	0	.09	-	 < 0.01	9.11E-01
diadenosine pentaphosphate metabolic process (GO:1901906)	4	0	.09	-	 < 0.01	9.11E-01
antibody-dependent cellular cytotoxicity (GO:0001788)	2	0	.05	-	 < 0.01	9.54E-01
modulation by virus of host cellular process (GO:0019054)	8	0	.19	-	 < 0.01	8.30E-01
natural killer cell proliferation (GO:0001787)	3	0	.07	-	 < 0.01	9.32E-01
suppression by virus of host apoptotic process (GO:0019050)	2	0	.05	-	 < 0.01	9.54E-01
B cell apoptotic process (GO:0001783)	10	0	.23	-	 < 0.01	7.92E-01
traversing start control point of mitotic cell cycle (GO:0007089)	3	0	.07	-	 < 0.01	9.32E-01
B cell homeostasis (GO:0001782)	32	0	.75	-	 < 0.01	4.74E-01
neutrophil apoptotic process (GO:0001781)	4	0	.09	-	 < 0.01	9.11E-01
neutrophil homeostasis (GO:0001780)	18	0	.42	-	 < 0.01	6.57E-01
mitotic nuclear envelope reassembly (GO:0007084)	3	0	.07	-	 < 0.01	9.32E-01
cerebrospinal fluid secretion (GO:0033326)	3	0	.07	-	 < 0.01	9.32E-01
mitotic metaphase plate congression (GO:0007080)	44	0	1.03	-	 < 0.01	3.58E-01
modulation by virus of host process (GO:0019048)	16	0	.37	-	 < 0.01	6.89E-01
release from viral latency (GO:0019046)	3	0	.07	-	 < 0.01	9.32E-01
latent virus replication (GO:0019045)	3	0	.07	-	 < 0.01	9.32E-01
plasma membrane repair (GO:0001778)	13	0	.30	-	 < 0.01	7.38E-01
T cell homeostatic proliferation (GO:0001777)	1	0	.02	-	 < 0.01	9.77E-01
establishment of viral latency (GO:0019043)	2	0	.05	-	 < 0.01	9.54E-01
viral latency (GO:0019042)	4	0	.09	-	 < 0.01	9.11E-01
telomere maintenance via telomere trimming (GO:0090737)	5	0	.12	-	 < 0.01	8.90E-01
DNA repair complex assembly (GO:0090735)	5	0	.12	-	 < 0.01	8.90E-01
myeloid dendritic cell activation (GO:0001773)	29	0	.68	-	 < 0.01	5.08E-01
mitotic chromosome movement towards spindle pole (GO:0007079)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of transcription involved in exit from mitosis (GO:0007072)	1	0	.02	-	 < 0.01	9.77E-01
meiotic spindle assembly checkpoint (GO:0033316)	1	0	.02	-	 < 0.01	9.77E-01
mitotic DNA replication checkpoint (GO:0033314)	9	0	.21	-	 < 0.01	8.11E-01
meiotic cell cycle checkpoint (GO:0033313)	9	0	.21	-	 < 0.01	8.11E-01
anterior/posterior pattern specification involved in ureteric bud development (GO:0072099)	1	0	.02	-	 < 0.01	9.77E-01
anterior/posterior pattern specification involved in kidney development (GO:0072098)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway (GO:0072097)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of branch elongation involved in ureteric bud branching (GO:0072096)	1	0	.02	-	 < 0.01	9.77E-01
regulation of branch elongation involved in ureteric bud branching (GO:0072095)	4	0	.09	-	 < 0.01	9.11E-01
establishment of T cell polarity (GO:0001768)	7	0	.16	-	 < 0.01	8.49E-01
establishment of lymphocyte polarity (GO:0001767)	7	0	.16	-	 < 0.01	8.49E-01
metanephric renal vesicle formation (GO:0072093)	4	0	.09	-	 < 0.01	9.11E-01
membrane raft polarization (GO:0001766)	1	0	.02	-	 < 0.01	9.77E-01
ureteric bud invasion (GO:0072092)	3	0	.07	-	 < 0.01	9.32E-01
beta-alanine transport (GO:0001762)	1	0	.02	-	 < 0.01	9.77E-01
female meiosis sister chromatid cohesion (GO:0007066)	3	0	.07	-	 < 0.01	9.32E-01
primary adaptive immune response involving T cells and B cells (GO:0090721)	1	0	.02	-	 < 0.01	9.77E-01
male meiosis sister chromatid cohesion (GO:0007065)	1	0	.02	-	 < 0.01	9.77E-01
primary adaptive immune response (GO:0090720)	1	0	.02	-	 < 0.01	9.77E-01
mitotic sister chromatid cohesion (GO:0007064)	19	0	.44	-	 < 0.01	6.42E-01
sister chromatid cohesion (GO:0007062)	41	0	.96	-	 < 0.01	3.84E-01
phytol metabolic process (GO:0033306)	2	0	.05	-	 < 0.01	9.54E-01
male meiosis chromosome segregation (GO:0007060)	3	0	.07	-	 < 0.01	9.32E-01
cell cycle comprising mitosis without cytokinesis (GO:0033301)	1	0	.02	-	 < 0.01	9.77E-01
stem cell proliferation (GO:0072089)	26	0	.61	-	 < 0.01	5.45E-01
renal vesicle development (GO:0072087)	14	0	.33	-	 < 0.01	7.21E-01
specification of loop of Henle identity (GO:0072086)	4	0	.09	-	 < 0.01	9.11E-01
organ induction (GO:0001759)	20	0	.47	-	 < 0.01	6.27E-01
specification of nephron tubule identity (GO:0072081)	5	0	.12	-	 < 0.01	8.90E-01
eye photoreceptor cell differentiation (GO:0001754)	53	0	1.24	-	 < 0.01	2.90E-01
immunological memory formation process (GO:0090715)	2	0	.05	-	 < 0.01	9.54E-01
immunological memory process (GO:0090713)	2	0	.05	-	 < 0.01	9.54E-01
spindle assembly involved in female meiosis I (GO:0007057)	5	0	.12	-	 < 0.01	8.90E-01
spindle assembly involved in female meiosis (GO:0007056)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of optic nerve formation (GO:2000597)	1	0	.02	-	 < 0.01	9.77E-01
nephron tubule formation (GO:0072079)	19	0	.44	-	 < 0.01	6.42E-01
regulation of optic nerve formation (GO:2000595)	1	0	.02	-	 < 0.01	9.77E-01
renal vesicle morphogenesis (GO:0072077)	12	0	.28	-	 < 0.01	7.56E-01
positive regulation of metanephric DCT cell differentiation (GO:2000594)	2	0	.05	-	 < 0.01	9.54E-01
nephrogenic mesenchyme development (GO:0072076)	3	0	.07	-	 < 0.01	9.32E-01
metanephric mesenchyme development (GO:0072075)	10	0	.23	-	 < 0.01	7.92E-01
regulation of metanephric DCT cell differentiation (GO:2000592)	2	0	.05	-	 < 0.01	9.54E-01
kidney mesenchyme development (GO:0072074)	14	0	.33	-	 < 0.01	7.21E-01
positive regulation of metanephric mesenchymal cell migration (GO:2000591)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of metanephric mesenchymal cell migration (GO:2000590)	1	0	.02	-	 < 0.01	9.77E-01
kidney interstitial fibroblast differentiation (GO:0072071)	2	0	.05	-	 < 0.01	9.54E-01
loop of Henle development (GO:0072070)	10	0	.23	-	 < 0.01	7.92E-01
optic placode formation (GO:0001743)	2	0	.05	-	 < 0.01	9.54E-01
cell-substrate junction assembly (GO:0007044)	37	0	.86	-	 < 0.01	4.22E-01
lysosomal lumen acidification (GO:0007042)	12	0	.28	-	 < 0.01	7.56E-01
regulation of metanephric mesenchymal cell migration (GO:2000589)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000587)	4	0	.09	-	 < 0.01	9.11E-01
DCT cell differentiation (GO:0072069)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of platelet-derived growth factor receptor-alpha signaling pathway (GO:2000584)	2	0	.05	-	 < 0.01	9.54E-01
regulation of platelet-derived growth factor receptor-alpha signaling pathway (GO:2000583)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of ATP-dependent microtubule motor activity, plus-end-directed (GO:2000582)	4	0	.09	-	 < 0.01	9.11E-01
morphogenesis of a polarized epithelium (GO:0001738)	51	0	1.19	-	 < 0.01	3.04E-01
regulation of ATP-dependent microtubule motor activity, plus-end-directed (GO:2000580)	4	0	.09	-	 < 0.01	9.11E-01
establishment of planar polarity (GO:0001736)	28	0	.65	-	 < 0.01	5.20E-01
inner medullary collecting duct development (GO:0072061)	3	0	.07	-	 < 0.01	9.32E-01
outer medullary collecting duct development (GO:0072060)	1	0	.02	-	 < 0.01	9.77E-01
protein catabolic process in the vacuole (GO:0007039)	11	0	.26	-	 < 0.01	7.74E-01
regulation of phagocytosis, engulfment (GO:0060099)	19	0	.44	-	 < 0.01	6.42E-01
formation of cytoplasmic translation initiation complex (GO:0001732)	4	0	.09	-	 < 0.01	9.11E-01
formation of translation preinitiation complex (GO:0001731)	12	0	.28	-	 < 0.01	7.56E-01
mitotic cytokinesis checkpoint (GO:0044878)	3	0	.07	-	 < 0.01	9.32E-01
serotonin secretion, neurotransmission (GO:0060096)	1	0	.02	-	 < 0.01	9.77E-01
vacuolar acidification (GO:0007035)	23	0	.54	-	 < 0.01	5.85E-01
peroxisome organization (GO:0007031)	32	0	.75	-	 < 0.01	4.74E-01
lipoprotein localization to membrane (GO:0044873)	1	0	.02	-	 < 0.01	9.77E-01
lipoprotein localization (GO:0044872)	14	0	.33	-	 < 0.01	7.21E-01
negative regulation by host of viral glycoprotein metabolic process (GO:0044871)	2	0	.05	-	 < 0.01	9.54E-01
modulation by host of viral glycoprotein metabolic process (GO:0044870)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of ATP-dependent microtubule motor activity, minus-end-directed (GO:2000578)	1	0	.02	-	 < 0.01	9.77E-01
regulation of ATP-dependent microtubule motor activity, minus-end-directed (GO:2000577)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of microtubule motor activity (GO:2000576)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of microtubule motor activity (GO:2000575)	2	0	.05	-	 < 0.01	9.54E-01
regulation of microtubule motor activity (GO:2000574)	10	0	.23	-	 < 0.01	7.92E-01
positive regulation of interleukin-4-dependent isotype switching to IgE isotypes (GO:2000572)	1	0	.02	-	 < 0.01	9.77E-01
renal outer medulla development (GO:0072054)	2	0	.05	-	 < 0.01	9.54E-01
regulation of interleukin-4-dependent isotype switching to IgE isotypes (GO:2000571)	1	0	.02	-	 < 0.01	9.77E-01
renal inner medulla development (GO:0072053)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of T-helper 2 cell activation (GO:2000570)	2	0	.05	-	 < 0.01	9.54E-01
juxtaglomerular apparatus development (GO:0072051)	2	0	.05	-	 < 0.01	9.54E-01
S-shaped body morphogenesis (GO:0072050)	7	0	.16	-	 < 0.01	8.49E-01
cytoplasm organization (GO:0007028)	13	0	.30	-	 < 0.01	7.38E-01
auditory receptor cell stereocilium organization (GO:0060088)	21	0	.49	-	 < 0.01	6.13E-01
negative regulation by host of viral exo-alpha-sialidase activity (GO:0044869)	2	0	.05	-	 < 0.01	9.54E-01
relaxation of vascular associated smooth muscle (GO:0060087)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of microtubule depolymerization (GO:0007026)	34	0	.79	-	 < 0.01	4.52E-01
modulation by host of viral molecular function (GO:0044868)	3	0	.07	-	 < 0.01	9.32E-01
modulation by host of viral catalytic activity (GO:0044867)	2	0	.05	-	 < 0.01	9.54E-01
modulation by host of viral exo-alpha-sialidase activity (GO:0044866)	2	0	.05	-	 < 0.01	9.54E-01
post-chaperonin tubulin folding pathway (GO:0007023)	5	0	.12	-	 < 0.01	8.90E-01
smooth muscle contraction involved in micturition (GO:0060083)	4	0	.09	-	 < 0.01	9.11E-01
eye blink reflex (GO:0060082)	1	0	.02	-	 < 0.01	9.77E-01
tubulin complex assembly (GO:0007021)	8	0	.19	-	 < 0.01	8.30E-01
membrane hyperpolarization (GO:0060081)	12	0	.28	-	 < 0.01	7.56E-01
microtubule nucleation (GO:0007020)	21	0	.49	-	 < 0.01	6.13E-01
protein transport into plasma membrane raft (GO:0044861)	2	0	.05	-	 < 0.01	9.54E-01
protein localization to plasma membrane raft (GO:0044860)	3	0	.07	-	 < 0.01	9.32E-01
regulation of neurotrophin production (GO:0032899)	3	0	.07	-	 < 0.01	9.32E-01
neurotrophin production (GO:0032898)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of viral transcription (GO:0032897)	15	0	.35	-	 < 0.01	7.05E-01
regulation of T-helper 2 cell activation (GO:2000569)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of memory T cell activation (GO:2000568)	2	0	.05	-	 < 0.01	9.54E-01
regulation of memory T cell activation (GO:2000567)	2	0	.05	-	 < 0.01	9.54E-01
comma-shaped body morphogenesis (GO:0072049)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000566)	4	0	.09	-	 < 0.01	9.11E-01
urokinase plasminogen activator signaling pathway (GO:0038195)	2	0	.05	-	 < 0.01	9.54E-01
renal system pattern specification (GO:0072048)	9	0	.21	-	 < 0.01	8.11E-01
thyroid-stimulating hormone signaling pathway (GO:0038194)	1	0	.02	-	 < 0.01	9.77E-01
proximal/distal pattern formation involved in nephron development (GO:0072047)	5	0	.12	-	 < 0.01	8.90E-01
regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)	7	0	.16	-	 < 0.01	8.49E-01
establishment of planar polarity involved in nephron morphogenesis (GO:0072046)	2	0	.05	-	 < 0.01	9.54E-01
reciprocal homologous recombination (GO:0140527)	43	0	1.00	-	 < 0.01	3.67E-01
positive regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000563)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000562)	8	0	.19	-	 < 0.01	8.30E-01
collecting duct development (GO:0072044)	13	0	.30	-	 < 0.01	7.38E-01
regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)	11	0	.26	-	 < 0.01	7.74E-01
VEGF-activated neuropilin signaling pathway (GO:0038190)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of CD24 production (GO:2000560)	1	0	.02	-	 < 0.01	9.77E-01
endodermal cell fate specification (GO:0001714)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis (GO:0072040)	4	0	.09	-	 < 0.01	9.11E-01
ectodermal cell fate commitment (GO:0001712)	3	0	.07	-	 < 0.01	9.32E-01
endodermal cell fate commitment (GO:0001711)	13	0	.30	-	 < 0.01	7.38E-01
mesodermal cell fate commitment (GO:0001710)	12	0	.28	-	 < 0.01	7.56E-01
plasma membrane raft organization (GO:0044857)	8	0	.19	-	 < 0.01	8.30E-01
regulation of resting membrane potential (GO:0060075)	7	0	.16	-	 < 0.01	8.49E-01
actin ubiquitination (GO:0007014)	1	0	.02	-	 < 0.01	9.77E-01
plasma membrane raft localization (GO:0044856)	1	0	.02	-	 < 0.01	9.77E-01
plasma membrane raft distribution (GO:0044855)	1	0	.02	-	 < 0.01	9.77E-01
plasma membrane raft assembly (GO:0044854)	5	0	.12	-	 < 0.01	8.90E-01
hair cycle phase (GO:0044851)	15	0	.35	-	 < 0.01	7.05E-01
regulation of vacuole fusion, non-autophagic (GO:0032889)	5	0	.12	-	 < 0.01	8.90E-01
regulation of mitotic spindle elongation (GO:0032888)	1	0	.02	-	 < 0.01	9.77E-01
regulation of spindle elongation (GO:0032887)	1	0	.02	-	 < 0.01	9.77E-01
neuropilin signaling pathway (GO:0038189)	3	0	.07	-	 < 0.01	9.32E-01
regulation of CD24 production (GO:2000559)	1	0	.02	-	 < 0.01	9.77E-01
cholecystokinin signaling pathway (GO:0038188)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of immunoglobulin production in mucosal tissue (GO:2000558)	1	0	.02	-	 < 0.01	9.77E-01
regulation of immunoglobulin production in mucosal tissue (GO:2000557)	1	0	.02	-	 < 0.01	9.77E-01
regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis (GO:0072039)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of T-helper 1 cell cytokine production (GO:2000556)	6	0	.14	-	 < 0.01	8.69E-01
intracellular bile acid receptor signaling pathway (GO:0038185)	1	0	.02	-	 < 0.01	9.77E-01
mesenchymal stem cell maintenance involved in nephron morphogenesis (GO:0072038)	3	0	.07	-	 < 0.01	9.32E-01
cell surface bile acid receptor signaling pathway (GO:0038184)	1	0	.02	-	 < 0.01	9.77E-01
regulation of T-helper 1 cell cytokine production (GO:2000554)	6	0	.14	-	 < 0.01	8.69E-01
mesenchymal to epithelial transition involved in renal vesicle formation (GO:0072036)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of T-helper 2 cell cytokine production (GO:2000553)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of T-helper 2 cell cytokine production (GO:2000552)	3	0	.07	-	 < 0.01	9.32E-01
renal vesicle induction (GO:0072034)	3	0	.07	-	 < 0.01	9.32E-01
regulation of T-helper 2 cell cytokine production (GO:2000551)	10	0	.23	-	 < 0.01	7.92E-01
nerve growth factor signaling pathway (GO:0038180)	11	0	.26	-	 < 0.01	7.74E-01
renal vesicle formation (GO:0072033)	6	0	.14	-	 < 0.01	8.69E-01
proximal convoluted tubule segment 2 development (GO:0072032)	1	0	.02	-	 < 0.01	9.77E-01
ectoderm formation (GO:0001705)	5	0	.12	-	 < 0.01	8.90E-01
outer mitochondrial membrane organization (GO:0007008)	5	0	.12	-	 < 0.01	8.90E-01
vagina development (GO:0060068)	12	0	.28	-	 < 0.01	7.56E-01
inner mitochondrial membrane organization (GO:0007007)	25	0	.58	-	 < 0.01	5.58E-01
estrous cycle (GO:0044849)	9	0	.21	-	 < 0.01	8.11E-01
cervix development (GO:0060067)	2	0	.05	-	 < 0.01	9.54E-01
biological phase (GO:0044848)	39	0	.91	-	 < 0.01	4.02E-01
protein localization to bicellular tight junction (GO:1902396)	7	0	.16	-	 < 0.01	8.49E-01
uterus development (GO:0060065)	26	0	.61	-	 < 0.01	5.45E-01
Spemann organizer formation at the anterior end of the primitive streak (GO:0060064)	1	0	.02	-	 < 0.01	9.77E-01
Spemann organizer formation (GO:0060061)	3	0	.07	-	 < 0.01	9.32E-01
nucleolus organization (GO:0007000)	8	0	.19	-	 < 0.01	8.30E-01
post-embryonic retina morphogenesis in camera-type eye (GO:0060060)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of DNA endoreduplication (GO:0032877)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of DNA endoreduplication (GO:0032876)	1	0	.02	-	 < 0.01	9.77E-01
regulation of DNA endoreduplication (GO:0032875)	4	0	.09	-	 < 0.01	9.11E-01
neurotrophin signaling pathway (GO:0038179)	25	0	.58	-	 < 0.01	5.58E-01
positive regulation of dendritic cell dendrite assembly (GO:2000549)	1	0	.02	-	 < 0.01	9.77E-01
complement component C5a signaling pathway (GO:0038178)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of dendritic cell dendrite assembly (GO:2000548)	1	0	.02	-	 < 0.01	9.77E-01
regulation of dendritic cell dendrite assembly (GO:2000547)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000546)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000545)	1	0	.02	-	 < 0.01	9.77E-01
connecting tubule development (GO:0072027)	1	0	.02	-	 < 0.01	9.77E-01
regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000544)	7	0	.16	-	 < 0.01	8.49E-01
granzyme-mediated programmed cell death signaling pathway (GO:0140507)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of gastrulation (GO:2000543)	7	0	.16	-	 < 0.01	8.49E-01
distal convoluted tubule development (GO:0072025)	5	0	.12	-	 < 0.01	8.90E-01
cannabinoid signaling pathway (GO:0038171)	5	0	.12	-	 < 0.01	8.90E-01
macula densa development (GO:0072024)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of protein geranylgeranylation (GO:2000541)	2	0	.05	-	 < 0.01	9.54E-01
thick ascending limb development (GO:0072023)	2	0	.05	-	 < 0.01	9.54E-01
descending thin limb development (GO:0072022)	1	0	.02	-	 < 0.01	9.77E-01
ascending thin limb development (GO:0072021)	2	0	.05	-	 < 0.01	9.54E-01
proximal straight tubule development (GO:0072020)	1	0	.02	-	 < 0.01	9.77E-01
embryonic retina morphogenesis in camera-type eye (GO:0060059)	7	0	.16	-	 < 0.01	8.49E-01
cell quiescence (GO:0044838)	4	0	.09	-	 < 0.01	9.11E-01
mammary gland involution (GO:0060056)	6	0	.14	-	 < 0.01	8.69E-01
actomyosin contractile ring organization (GO:0044837)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of epithelial cell proliferation involved in wound healing (GO:0060054)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of protein glycosylation (GO:0060051)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of protein glycosylation (GO:0060050)	7	0	.16	-	 < 0.01	8.49E-01
modulation by host of viral RNA genome replication (GO:0044830)	4	0	.09	-	 < 0.01	9.11E-01
regulation of protein geranylgeranylation (GO:2000539)	2	0	.05	-	 < 0.01	9.54E-01
epidermal growth factor receptor signaling pathway via I-kappaB kinase/NF-kappaB cascade (GO:0038168)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of B cell chemotaxis (GO:2000538)	2	0	.05	-	 < 0.01	9.54E-01
epidermal growth factor receptor signaling pathway via positive regulation of NF-kappaB transcription factor activity (GO:0038167)	1	0	.02	-	 < 0.01	9.77E-01
regulation of B cell chemotaxis (GO:2000537)	2	0	.05	-	 < 0.01	9.54E-01
angiotensin-activated signaling pathway (GO:0038166)	11	0	.26	-	 < 0.01	7.74E-01
proximal convoluted tubule development (GO:0072019)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of entry of bacterium into host cell (GO:2000536)	1	0	.02	-	 < 0.01	9.77E-01
oncostatin-M-mediated signaling pathway (GO:0038165)	4	0	.09	-	 < 0.01	9.11E-01
regulation of entry of bacterium into host cell (GO:2000535)	5	0	.12	-	 < 0.01	8.90E-01
distal tubule development (GO:0072017)	10	0	.23	-	 < 0.01	7.92E-01
positive regulation of renal albumin absorption (GO:2000534)	1	0	.02	-	 < 0.01	9.77E-01
thrombopoietin-mediated signaling pathway (GO:0038163)	5	0	.12	-	 < 0.01	8.90E-01
erythropoietin-mediated signaling pathway (GO:0038162)	2	0	.05	-	 < 0.01	9.54E-01
glomerular visceral epithelial cell development (GO:0072015)	8	0	.19	-	 < 0.01	8.30E-01
regulation of renal albumin absorption (GO:2000532)	1	0	.02	-	 < 0.01	9.77E-01
prolactin signaling pathway (GO:0038161)	1	0	.02	-	 < 0.01	9.77E-01
proximal tubule development (GO:0072014)	5	0	.12	-	 < 0.01	8.90E-01
CXCL12-activated CXCR4 signaling pathway (GO:0038160)	1	0	.02	-	 < 0.01	9.77E-01
glomerulus vasculature development (GO:0072012)	17	0	.40	-	 < 0.01	6.73E-01
glomerular endothelium development (GO:0072011)	2	0	.05	-	 < 0.01	9.54E-01
glomerular epithelium development (GO:0072010)	16	0	.37	-	 < 0.01	6.89E-01
regulation of protein glycosylation (GO:0060049)	13	0	.30	-	 < 0.01	7.38E-01
VEGF-activated neuropilin signaling pathway involved in axon guidance (GO:1902378)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation by host of viral genome replication (GO:0044829)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation by host of viral genome replication (GO:0044828)	6	0	.14	-	 < 0.01	8.69E-01
regulation of acrosome reaction (GO:0060046)	15	0	.35	-	 < 0.01	7.05E-01
modulation by host of viral genome replication (GO:0044827)	15	0	.35	-	 < 0.01	7.05E-01
regulation of rRNA catabolic process (GO:1902374)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of tRNA catabolic process (GO:1902371)	2	0	.05	-	 < 0.01	9.54E-01
retinal bipolar neuron differentiation (GO:0060040)	9	0	.21	-	 < 0.01	8.11E-01
regulation of tRNA catabolic process (GO:1902370)	2	0	.05	-	 < 0.01	9.54E-01
meiotic telomere tethering at nuclear periphery (GO:0044821)	2	0	.05	-	 < 0.01	9.54E-01
C-X-C chemokine receptor CXCR4 signaling pathway (GO:0038159)	1	0	.02	-	 < 0.01	9.77E-01
granulocyte colony-stimulating factor signaling pathway (GO:0038158)	2	0	.05	-	 < 0.01	9.54E-01
interleukin-3-mediated signaling pathway (GO:0038156)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation (GO:2000526)	1	0	.02	-	 < 0.01	9.77E-01
glomerular mesangial cell differentiation (GO:0072008)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of T cell costimulation (GO:2000525)	4	0	.09	-	 < 0.01	9.11E-01
mesangial cell differentiation (GO:0072007)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of T cell costimulation (GO:2000524)	1	0	.02	-	 < 0.01	9.77E-01
regulation of T cell costimulation (GO:2000523)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of immunological synapse formation (GO:2000522)	2	0	.05	-	 < 0.01	9.54E-01
kidney field specification (GO:0072004)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of immunological synapse formation (GO:2000521)	2	0	.05	-	 < 0.01	9.54E-01
kidney rudiment formation (GO:0072003)	3	0	.07	-	 < 0.01	9.32E-01
regulation of immunological synapse formation (GO:2000520)	4	0	.09	-	 < 0.01	9.11E-01
mitotic G1/S transition checkpoint (GO:0044819)	20	0	.47	-	 < 0.01	6.27E-01
modulation by host of symbiont molecular function (GO:0052428)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of Notch signaling pathway involved in somitogenesis (GO:1902367)	2	0	.05	-	 < 0.01	9.54E-01
mitotic G2/M transition checkpoint (GO:0044818)	34	0	.79	-	 < 0.01	4.52E-01
regulation of Notch signaling pathway involved in somitogenesis (GO:1902366)	2	0	.05	-	 < 0.01	9.54E-01
notochord cell development (GO:0060035)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of protein localization to spindle pole body (GO:1902365)	1	0	.02	-	 < 0.01	9.77E-01
notochord cell differentiation (GO:0060034)	1	0	.02	-	 < 0.01	9.77E-01
anatomical structure regression (GO:0060033)	19	0	.44	-	 < 0.01	6.42E-01
regulation of protein localization to spindle pole body (GO:1902363)	1	0	.02	-	 < 0.01	9.77E-01
notochord regression (GO:0060032)	2	0	.05	-	 < 0.01	9.54E-01
melanocyte apoptotic process (GO:1902362)	1	0	.02	-	 < 0.01	9.77E-01
modulation by host of symbiont catalytic activity (GO:0052422)	3	0	.07	-	 < 0.01	9.32E-01
mediolateral intercalation (GO:0060031)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of cellular pH reduction (GO:0032849)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of cellular pH reduction (GO:0032848)	1	0	.02	-	 < 0.01	9.77E-01
regulation of cellular pH reduction (GO:0032847)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of T-helper 1 cell activation (GO:2000518)	1	0	.02	-	 < 0.01	9.77E-01
regulation of T-helper 1 cell activation (GO:2000517)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)	34	0	.79	-	 < 0.01	4.52E-01
macrophage colony-stimulating factor signaling pathway (GO:0038145)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)	31	0	.72	-	 < 0.01	4.85E-01
regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)	62	0	1.45	-	 < 0.01	2.35E-01
positive regulation of granzyme A production (GO:2000513)	1	0	.02	-	 < 0.01	9.77E-01
regulation of granzyme A production (GO:2000511)	1	0	.02	-	 < 0.01	9.77E-01
convergent extension involved in organogenesis (GO:0060029)	6	0	.14	-	 < 0.01	8.69E-01
metabolism by host of substance in symbiont (GO:0052419)	2	0	.05	-	 < 0.01	9.54E-01
sulfate transmembrane transport (GO:1902358)	1	0	.02	-	 < 0.01	9.77E-01
metabolism by organism of protein in other organism involved in symbiotic interaction (GO:0052418)	1	0	.02	-	 < 0.01	9.77E-01
convergent extension involved in gastrulation (GO:0060027)	7	0	.16	-	 < 0.01	8.49E-01
metabolism by host of symbiont protein (GO:0052417)	1	0	.02	-	 < 0.01	9.77E-01
metabolism by host of symbiont macromolecule (GO:0052416)	2	0	.05	-	 < 0.01	9.54E-01
regulation of synaptic activity (GO:0060025)	2	0	.05	-	 < 0.01	9.54E-01
G-quadruplex DNA unwinding (GO:0044806)	6	0	.14	-	 < 0.01	8.69E-01
rhythmic synaptic transmission (GO:0060024)	6	0	.14	-	 < 0.01	8.69E-01
late nucleophagy (GO:0044805)	5	0	.12	-	 < 0.01	8.90E-01
soft palate development (GO:0060023)	5	0	.12	-	 < 0.01	8.90E-01
autophagy of nucleus (GO:0044804)	14	0	.33	-	 < 0.01	7.21E-01
phosphagen metabolic process (GO:0006599)	4	0	.09	-	 < 0.01	9.11E-01
multi-organism membrane organization (GO:0044803)	6	0	.14	-	 < 0.01	8.69E-01
polyamine catabolic process (GO:0006598)	4	0	.09	-	 < 0.01	9.11E-01
metabolism by organism of cell wall chitin in other organism involved in symbiotic interaction (GO:0052411)	1	0	.02	-	 < 0.01	9.77E-01
Bergmann glial cell differentiation (GO:0060020)	11	0	.26	-	 < 0.01	7.74E-01
cellular response to chloroquine (GO:1902350)	1	0	.02	-	 < 0.01	9.77E-01
spermine biosynthetic process (GO:0006597)	2	0	.05	-	 < 0.01	9.54E-01
metabolism by host of symbiont cell wall chitin (GO:0052410)	1	0	.02	-	 < 0.01	9.77E-01
polyamine biosynthetic process (GO:0006596)	12	0	.28	-	 < 0.01	7.56E-01
multi-organism membrane fusion (GO:0044800)	3	0	.07	-	 < 0.01	9.32E-01
polyamine metabolic process (GO:0006595)	17	0	.40	-	 < 0.01	6.73E-01
ornithine catabolic process (GO:0006593)	1	0	.02	-	 < 0.01	9.77E-01
ornithine biosynthetic process (GO:0006592)	1	0	.02	-	 < 0.01	9.77E-01
glomerular basement membrane development (GO:0032836)	10	0	.23	-	 < 0.01	7.92E-01
ornithine metabolic process (GO:0006591)	9	0	.21	-	 < 0.01	8.11E-01
thyroid hormone generation (GO:0006590)	13	0	.30	-	 < 0.01	7.38E-01
positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response (GO:0032834)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of dendritic cell chemotaxis (GO:2000509)	1	0	.02	-	 < 0.01	9.77E-01
regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response (GO:0032832)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation (GO:0032831)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of blood vessel remodeling (GO:2000504)	4	0	.09	-	 < 0.01	9.11E-01
ERBB2-ERBB3 signaling pathway (GO:0038133)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of natural killer cell chemotaxis (GO:2000502)	1	0	.02	-	 < 0.01	9.77E-01
radial glial cell differentiation (GO:0060019)	14	0	.33	-	 < 0.01	7.21E-01
response to chloroquine (GO:1902349)	3	0	.07	-	 < 0.01	9.32E-01
astrocyte fate commitment (GO:0060018)	4	0	.09	-	 < 0.01	9.11E-01
parathyroid gland development (GO:0060017)	7	0	.16	-	 < 0.01	8.49E-01
metabolism by organism of carbohydrate in other organism involved in symbiotic interaction (GO:0052407)	1	0	.02	-	 < 0.01	9.77E-01
granulosa cell development (GO:0060016)	1	0	.02	-	 < 0.01	9.77E-01
metabolism by host of symbiont carbohydrate (GO:0052406)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation by host of symbiont molecular function (GO:0052405)	5	0	.12	-	 < 0.01	8.90E-01
granulosa cell differentiation (GO:0060014)	2	0	.05	-	 < 0.01	9.54E-01
righting reflex (GO:0060013)	12	0	.28	-	 < 0.01	7.56E-01
negative regulation by host of symbiont catalytic activity (GO:0052403)	2	0	.05	-	 < 0.01	9.54E-01
synaptic transmission, glycinergic (GO:0060012)	7	0	.16	-	 < 0.01	8.49E-01
octopamine biosynthetic process (GO:0006589)	3	0	.07	-	 < 0.01	9.32E-01
Sertoli cell proliferation (GO:0060011)	7	0	.16	-	 < 0.01	8.49E-01
Sertoli cell fate commitment (GO:0060010)	1	0	.02	-	 < 0.01	9.77E-01
serotonin biosynthetic process from tryptophan (GO:0006587)	2	0	.05	-	 < 0.01	9.54E-01
indolalkylamine metabolic process (GO:0006586)	11	0	.26	-	 < 0.01	7.74E-01
dopamine biosynthetic process from tyrosine (GO:0006585)	1	0	.02	-	 < 0.01	9.77E-01
regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation (GO:0032829)	4	0	.09	-	 < 0.01	9.11E-01
melanin biosynthetic process from tyrosine (GO:0006583)	2	0	.05	-	 < 0.01	9.54E-01
melanin metabolic process (GO:0006582)	15	0	.35	-	 < 0.01	7.05E-01
acetylcholine catabolic process (GO:0006581)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of natural killer cell differentiation (GO:0032825)	12	0	.28	-	 < 0.01	7.56E-01
ethanolamine metabolic process (GO:0006580)	2	0	.05	-	 < 0.01	9.54E-01
ERBB3 signaling pathway (GO:0038129)	1	0	.02	-	 < 0.01	9.77E-01
ERBB2 signaling pathway (GO:0038128)	3	0	.07	-	 < 0.01	9.32E-01
toll-like receptor TLR1:TLR2 signaling pathway (GO:0038123)	1	0	.02	-	 < 0.01	9.77E-01
linear vestibuloocular reflex (GO:0060007)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of retinal ganglion cell axon guidance (GO:1902336)	3	0	.07	-	 < 0.01	9.32E-01
vestibular reflex (GO:0060005)	5	0	.12	-	 < 0.01	8.90E-01
reflex (GO:0060004)	26	0	.61	-	 < 0.01	5.45E-01
copper ion export (GO:0060003)	3	0	.07	-	 < 0.01	9.32E-01
amino-acid betaine catabolic process (GO:0006579)	1	0	.02	-	 < 0.01	9.77E-01
amino-acid betaine biosynthetic process (GO:0006578)	4	0	.09	-	 < 0.01	9.11E-01
amino-acid betaine metabolic process (GO:0006577)	15	0	.35	-	 < 0.01	7.05E-01
positive regulation of natural killer cell proliferation (GO:0032819)	7	0	.16	-	 < 0.01	8.49E-01
valine catabolic process (GO:0006574)	4	0	.09	-	 < 0.01	9.11E-01
valine metabolic process (GO:0006573)	7	0	.16	-	 < 0.01	8.49E-01
regulation of natural killer cell proliferation (GO:0032817)	9	0	.21	-	 < 0.01	8.11E-01
tyrosine catabolic process (GO:0006572)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of natural killer cell activation (GO:0032816)	27	0	.63	-	 < 0.01	5.33E-01
tyrosine biosynthetic process (GO:0006571)	1	0	.02	-	 < 0.01	9.77E-01
tyrosine metabolic process (GO:0006570)	12	0	.28	-	 < 0.01	7.56E-01
positive regulation of epinephrine secretion (GO:0032812)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of epinephrine secretion (GO:0032811)	6	0	.14	-	 < 0.01	8.69E-01
chemokine (C-C motif) ligand 21 signaling pathway (GO:0038116)	3	0	.07	-	 < 0.01	9.32E-01
interleukin-8-mediated signaling pathway (GO:0038112)	1	0	.02	-	 < 0.01	9.77E-01
interleukin-2-mediated signaling pathway (GO:0038110)	2	0	.05	-	 < 0.01	9.54E-01
ubiquitin-dependent protein catabolic process via the N-end rule pathway (GO:0071596)	3	0	.07	-	 < 0.01	9.32E-01
thymocyte aggregation (GO:0071594)	1	0	.02	-	 < 0.01	9.77E-01
lymphocyte aggregation (GO:0071593)	5	0	.12	-	 < 0.01	8.90E-01
tryptophan catabolic process (GO:0006569)	7	0	.16	-	 < 0.01	8.49E-01
tryptophan metabolic process (GO:0006568)	11	0	.26	-	 < 0.01	7.74E-01
threonine catabolic process (GO:0006567)	5	0	.12	-	 < 0.01	8.90E-01
threonine metabolic process (GO:0006566)	6	0	.14	-	 < 0.01	8.69E-01
L-serine catabolic process (GO:0006565)	3	0	.07	-	 < 0.01	9.32E-01
L-serine biosynthetic process (GO:0006564)	4	0	.09	-	 < 0.01	9.11E-01
L-serine metabolic process (GO:0006563)	8	0	.19	-	 < 0.01	8.30E-01
proline catabolic process (GO:0006562)	4	0	.09	-	 < 0.01	9.11E-01
proline biosynthetic process (GO:0006561)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of low-density lipoprotein particle receptor catabolic process (GO:0032805)	3	0	.07	-	 < 0.01	9.32E-01
proline metabolic process (GO:0006560)	10	0	.23	-	 < 0.01	7.92E-01
negative regulation of low-density lipoprotein particle receptor catabolic process (GO:0032804)	2	0	.05	-	 < 0.01	9.54E-01
regulation of low-density lipoprotein particle receptor catabolic process (GO:0032803)	6	0	.14	-	 < 0.01	8.69E-01
Kit signaling pathway (GO:0038109)	2	0	.05	-	 < 0.01	9.54E-01
low-density lipoprotein particle receptor catabolic process (GO:0032802)	1	0	.02	-	 < 0.01	9.77E-01
receptor catabolic process (GO:0032801)	17	0	.40	-	 < 0.01	6.73E-01
nodal signaling pathway involved in determination of left/right asymmetry (GO:0038107)	4	0	.09	-	 < 0.01	9.11E-01
sequestering of nodal from receptor via nodal binding (GO:0038101)	1	0	.02	-	 < 0.01	9.77E-01
DNA strand elongation involved in nuclear cell cycle DNA replication (GO:1902319)	1	0	.02	-	 < 0.01	9.77E-01
CAAX-box protein processing (GO:0071586)	2	0	.05	-	 < 0.01	9.54E-01
detoxification of cadmium ion (GO:0071585)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of zinc ion transmembrane import (GO:0071584)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of zinc ion transmembrane transport (GO:0071583)	2	0	.05	-	 < 0.01	9.54E-01
nuclear cell cycle DNA replication initiation (GO:1902315)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of zinc ion transport (GO:0071582)	2	0	.05	-	 < 0.01	9.54E-01
regulation of zinc ion transmembrane import (GO:0071581)	1	0	.02	-	 < 0.01	9.77E-01
regulation of zinc ion transmembrane transport (GO:0071580)	2	0	.05	-	 < 0.01	9.54E-01
L-phenylalanine catabolic process (GO:0006559)	7	0	.16	-	 < 0.01	8.49E-01
regulation of copper ion transmembrane transport (GO:1902311)	1	0	.02	-	 < 0.01	9.77E-01
L-phenylalanine metabolic process (GO:0006558)	9	0	.21	-	 < 0.01	8.11E-01
positive regulation of peptidyl-serine dephosphorylation (GO:1902310)	2	0	.05	-	 < 0.01	9.54E-01
S-adenosylmethionine biosynthetic process (GO:0006556)	4	0	.09	-	 < 0.01	9.11E-01
methionine metabolic process (GO:0006555)	14	0	.33	-	 < 0.01	7.21E-01
lysine catabolic process (GO:0006554)	2	0	.05	-	 < 0.01	9.54E-01
lysine metabolic process (GO:0006553)	3	0	.07	-	 < 0.01	9.32E-01
leucine catabolic process (GO:0006552)	5	0	.12	-	 < 0.01	8.90E-01
leucine metabolic process (GO:0006551)	8	0	.19	-	 < 0.01	8.30E-01
isoleucine catabolic process (GO:0006550)	5	0	.12	-	 < 0.01	8.90E-01
hepatocyte cell migration (GO:0002194)	1	0	.02	-	 < 0.01	9.77E-01
IRES-dependent translational initiation of linear mRNA (GO:0002192)	2	0	.05	-	 < 0.01	9.54E-01
cap-dependent translational initiation (GO:0002191)	1	0	.02	-	 < 0.01	9.77E-01
cap-independent translational initiation (GO:0002190)	2	0	.05	-	 < 0.01	9.54E-01
regulation of zinc ion transport (GO:0071579)	3	0	.07	-	 < 0.01	9.32E-01
zinc ion import across plasma membrane (GO:0071578)	7	0	.16	-	 < 0.01	8.49E-01
zinc ion transmembrane transport (GO:0071577)	21	0	.49	-	 < 0.01	6.13E-01
negative regulation of peptidyl-serine dephosphorylation (GO:1902309)	3	0	.07	-	 < 0.01	9.32E-01
regulation of peptidyl-serine dephosphorylation (GO:1902308)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of sodium ion transmembrane transport (GO:1902306)	14	0	.33	-	 < 0.01	7.21E-01
isoleucine metabolic process (GO:0006549)	8	0	.19	-	 < 0.01	8.30E-01
histidine catabolic process (GO:0006548)	5	0	.12	-	 < 0.01	8.90E-01
histidine metabolic process (GO:0006547)	7	0	.16	-	 < 0.01	8.49E-01
glycine catabolic process (GO:0006546)	3	0	.07	-	 < 0.01	9.32E-01
glycine biosynthetic process (GO:0006545)	5	0	.12	-	 < 0.01	8.90E-01
glutamine catabolic process (GO:0006543)	3	0	.07	-	 < 0.01	9.32E-01
glutamine biosynthetic process (GO:0006542)	1	0	.02	-	 < 0.01	9.77E-01
glutamine metabolic process (GO:0006541)	18	0	.42	-	 < 0.01	6.57E-01
glutamate decarboxylation to succinate (GO:0006540)	1	0	.02	-	 < 0.01	9.77E-01
translation reinitiation (GO:0002188)	4	0	.09	-	 < 0.01	9.11E-01
cytoplasmic translational termination (GO:0002184)	3	0	.07	-	 < 0.01	9.32E-01
cytoplasmic translational initiation (GO:0002183)	21	0	.49	-	 < 0.01	6.13E-01
cytoplasmic translation (GO:0002181)	61	0	1.42	-	 < 0.01	2.41E-01
protein ufmylation (GO:0071569)	6	0	.14	-	 < 0.01	8.69E-01
glutamate catabolic process via 2-oxoglutarate (GO:0006539)	1	0	.02	-	 < 0.01	9.77E-01
glutamate catabolic process (GO:0006538)	5	0	.12	-	 < 0.01	8.90E-01
glutamate biosynthetic process (GO:0006537)	3	0	.07	-	 < 0.01	9.32E-01
regulation of attachment of spindle microtubules to kinetochore (GO:0051988)	13	0	.30	-	 < 0.01	7.38E-01
glutamate metabolic process (GO:0006536)	23	0	.54	-	 < 0.01	5.85E-01
positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987)	7	0	.16	-	 < 0.01	8.49E-01
cysteine biosynthetic process from serine (GO:0006535)	1	0	.02	-	 < 0.01	9.77E-01
cysteine metabolic process (GO:0006534)	11	0	.26	-	 < 0.01	7.74E-01
negative regulation of chromosome segregation (GO:0051985)	31	0	.72	-	 < 0.01	4.85E-01
aspartate catabolic process (GO:0006533)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of chromosome segregation (GO:0051984)	14	0	.33	-	 < 0.01	7.21E-01
RNA acetylation (GO:1990884)	1	0	.02	-	 < 0.01	9.77E-01
aspartate biosynthetic process (GO:0006532)	3	0	.07	-	 < 0.01	9.32E-01
aspartate metabolic process (GO:0006531)	5	0	.12	-	 < 0.01	8.90E-01
rRNA acetylation (GO:1990882)	1	0	.02	-	 < 0.01	9.77E-01
asparagine catabolic process (GO:0006530)	1	0	.02	-	 < 0.01	9.77E-01
male germ cell proliferation (GO:0002176)	3	0	.07	-	 < 0.01	9.32E-01
protein localization to paranode region of axon (GO:0002175)	5	0	.12	-	 < 0.01	8.90E-01
histone H3-K27 demethylation (GO:0071557)	5	0	.12	-	 < 0.01	8.90E-01
cell wall organization or biogenesis (GO:0071554)	4	0	.09	-	 < 0.01	9.11E-01
death-inducing signaling complex assembly (GO:0071550)	1	0	.02	-	 < 0.01	9.77E-01
asparagine biosynthetic process (GO:0006529)	1	0	.02	-	 < 0.01	9.77E-01
asparagine metabolic process (GO:0006528)	5	0	.12	-	 < 0.01	8.90E-01
arginine catabolic process (GO:0006527)	9	0	.21	-	 < 0.01	8.11E-01
arginine biosynthetic process (GO:0006526)	4	0	.09	-	 < 0.01	9.11E-01
arginine metabolic process (GO:0006525)	15	0	.35	-	 < 0.01	7.05E-01
alanine catabolic process (GO:0006524)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of telomerase activity (GO:0051974)	12	0	.28	-	 < 0.01	7.56E-01
negative regulation of transmission of nerve impulse (GO:0051970)	7	0	.16	-	 < 0.01	8.49E-01
cellular response to dexamethasone stimulus (GO:0071549)	24	0	.56	-	 < 0.01	5.71E-01
response to dexamethasone (GO:0071548)	27	0	.63	-	 < 0.01	5.33E-01
inositol phosphate catabolic process (GO:0071545)	17	0	.40	-	 < 0.01	6.73E-01
diphosphoinositol polyphosphate catabolic process (GO:0071544)	1	0	.02	-	 < 0.01	9.77E-01
diphosphoinositol polyphosphate metabolic process (GO:0071543)	4	0	.09	-	 < 0.01	9.11E-01
protein deglycosylation (GO:0006517)	11	0	.26	-	 < 0.01	7.74E-01
protein quality control for misfolded or incompletely synthesized proteins (GO:0006515)	29	0	.68	-	 < 0.01	5.08E-01
negative regulation of synapse assembly (GO:0051964)	8	0	.19	-	 < 0.01	8.30E-01
desmosome assembly (GO:0002159)	4	0	.09	-	 < 0.01	9.11E-01
osteoclast proliferation (GO:0002158)	4	0	.09	-	 < 0.01	9.11E-01
regulation of thyroid hormone mediated signaling pathway (GO:0002155)	5	0	.12	-	 < 0.01	8.90E-01
thyroid hormone mediated signaling pathway (GO:0002154)	3	0	.07	-	 < 0.01	9.32E-01
bile acid conjugation (GO:0002152)	1	0	.02	-	 < 0.01	9.77E-01
otolith mineralization (GO:0045299)	3	0	.07	-	 < 0.01	9.32E-01
protein localization to centrosome (GO:0071539)	24	0	.56	-	 < 0.01	5.71E-01
mRNA cis splicing, via spliceosome (GO:0045292)	16	0	.37	-	 < 0.01	6.89E-01
positive regulation of relaxation of cardiac muscle (GO:1901899)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of relaxation of cardiac muscle (GO:1901898)	2	0	.05	-	 < 0.01	9.54E-01
cellular response to endothelin (GO:1990859)	2	0	.05	-	 < 0.01	9.54E-01
GPI anchor release (GO:0006507)	1	0	.02	-	 < 0.01	9.77E-01
methotrexate transport (GO:0051958)	2	0	.05	-	 < 0.01	9.54E-01
regulation of relaxation of cardiac muscle (GO:1901897)	7	0	.16	-	 < 0.01	8.49E-01
GPI anchor biosynthetic process (GO:0006506)	31	0	.72	-	 < 0.01	4.85E-01
positive regulation of ATPase-coupled calcium transmembrane transporter activity (GO:1901896)	4	0	.09	-	 < 0.01	9.11E-01
GPI anchor metabolic process (GO:0006505)	32	0	.75	-	 < 0.01	4.74E-01
negative regulation of ATPase-coupled calcium transmembrane transporter activity (GO:1901895)	3	0	.07	-	 < 0.01	9.32E-01
regulation of ATPase-coupled calcium transmembrane transporter activity (GO:1901894)	7	0	.16	-	 < 0.01	8.49E-01
C-terminal protein lipidation (GO:0006501)	6	0	.14	-	 < 0.01	8.69E-01
hypochlorous acid biosynthetic process (GO:0002149)	1	0	.02	-	 < 0.01	9.77E-01
N-terminal protein palmitoylation (GO:0006500)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of glutamate uptake involved in transmission of nerve impulse (GO:0051951)	1	0	.02	-	 < 0.01	9.77E-01
hypochlorous acid metabolic process (GO:0002148)	1	0	.02	-	 < 0.01	9.77E-01
tRNA wobble position uridine thiolation (GO:0002143)	4	0	.09	-	 < 0.01	9.11E-01
cementum mineralization (GO:0071529)	1	0	.02	-	 < 0.01	9.77E-01
tRNA re-export from nucleus (GO:0071528)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of catecholamine uptake involved in synaptic transmission (GO:0051945)	1	0	.02	-	 < 0.01	9.77E-01
adaptive thermogenesis (GO:1990845)	22	0	.51	-	 < 0.01	5.99E-01
positive regulation of catecholamine uptake involved in synaptic transmission (GO:0051944)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of amino acid uptake involved in synaptic transmission (GO:0051943)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of protein depolymerization (GO:1901881)	15	0	.35	-	 < 0.01	7.05E-01
retinoic acid biosynthetic process (GO:0002138)	10	0	.23	-	 < 0.01	7.92E-01
regulation of catecholamine uptake involved in synaptic transmission (GO:0051940)	6	0	.14	-	 < 0.01	8.69E-01
maintenance of imprinting at mating-type locus (GO:0071517)	2	0	.05	-	 < 0.01	9.54E-01
genetic imprinting at mating-type locus (GO:0071515)	2	0	.05	-	 < 0.01	9.54E-01
genetic imprinting (GO:0071514)	24	0	.56	-	 < 0.01	5.71E-01
gamma-aminobutyric acid import (GO:0051939)	4	0	.09	-	 < 0.01	9.11E-01
response to endothelin (GO:1990839)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of calcium ion binding (GO:1901877)	2	0	.05	-	 < 0.01	9.54E-01
catecholamine transport (GO:0051937)	14	0	.33	-	 < 0.01	7.21E-01
regulation of calcium ion binding (GO:1901876)	2	0	.05	-	 < 0.01	9.54E-01
glutamate reuptake (GO:0051935)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of post-translational protein modification (GO:1901874)	2	0	.05	-	 < 0.01	9.54E-01
catecholamine uptake involved in synaptic transmission (GO:0051934)	3	0	.07	-	 < 0.01	9.32E-01
regulation of post-translational protein modification (GO:1901873)	3	0	.07	-	 < 0.01	9.32E-01
amino acid neurotransmitter reuptake (GO:0051933)	2	0	.05	-	 < 0.01	9.54E-01
synaptic transmission, GABAergic (GO:0051932)	20	0	.47	-	 < 0.01	6.27E-01
slow axonal transport (GO:1990832)	1	0	.02	-	 < 0.01	9.77E-01
tRNA wobble base cytosine methylation (GO:0002127)	1	0	.02	-	 < 0.01	9.77E-01
maternal aggressive behavior (GO:0002125)	3	0	.07	-	 < 0.01	9.32E-01
territorial aggressive behavior (GO:0002124)	1	0	.02	-	 < 0.01	9.77E-01
inter-male aggressive behavior (GO:0002121)	3	0	.07	-	 < 0.01	9.32E-01
cellular response to mycophenolic acid (GO:0071506)	2	0	.05	-	 < 0.01	9.54E-01
response to mycophenolic acid (GO:0071505)	2	0	.05	-	 < 0.01	9.54E-01
cellular response to heparin (GO:0071504)	4	0	.09	-	 < 0.01	9.11E-01
secretion of lysosomal enzymes (GO:0033299)	7	0	.16	-	 < 0.01	8.49E-01
response to heparin (GO:0071503)	5	0	.12	-	 < 0.01	8.90E-01
cellular response to nitrosative stress (GO:0071500)	4	0	.09	-	 < 0.01	9.11E-01
sulfation (GO:0051923)	22	0	.51	-	 < 0.01	5.99E-01
basic amino acid transmembrane transport (GO:1990822)	9	0	.21	-	 < 0.01	8.11E-01
positive regulation of mitochondrial DNA metabolic process (GO:1901860)	1	0	.02	-	 < 0.01	9.77E-01
aggressive behavior (GO:0002118)	10	0	.23	-	 < 0.01	7.92E-01
store-operated calcium entry (GO:0002115)	9	0	.21	-	 < 0.01	8.11E-01
negative regulation of mitochondrial DNA metabolic process (GO:1901859)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of fibrinolysis (GO:0051919)	3	0	.07	-	 < 0.01	9.32E-01
regulation of mitochondrial DNA metabolic process (GO:1901858)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of cellular respiration (GO:1901857)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of cellular respiration (GO:1901856)	2	0	.05	-	 < 0.01	9.54E-01
tRNA wobble cytosine modification (GO:0002101)	2	0	.05	-	 < 0.01	9.54E-01
tRNA wobble adenosine to inosine editing (GO:0002100)	1	0	.02	-	 < 0.01	9.77E-01
cell proliferation in midbrain (GO:0033278)	5	0	.12	-	 < 0.01	8.90E-01
abortive mitotic cell cycle (GO:0033277)	2	0	.05	-	 < 0.01	9.54E-01
actin-myosin filament sliding (GO:0033275)	9	0	.21	-	 < 0.01	8.11E-01
endoplasmic reticulum tubular network membrane organization (GO:1990809)	4	0	.09	-	 < 0.01	9.11E-01
establishment of pigment granule localization (GO:0051905)	18	0	.42	-	 < 0.01	6.57E-01
regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844)	3	0	.07	-	 < 0.01	9.32E-01
pigment granule transport (GO:0051904)	17	0	.40	-	 < 0.01	6.73E-01
positive regulation of high voltage-gated calcium channel activity (GO:1901843)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of high voltage-gated calcium channel activity (GO:1901842)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of mitochondrial depolarization (GO:0051902)	5	0	.12	-	 < 0.01	8.90E-01
regulation of high voltage-gated calcium channel activity (GO:1901841)	13	0	.30	-	 < 0.01	7.38E-01
positive regulation of mitochondrial depolarization (GO:0051901)	10	0	.23	-	 < 0.01	7.92E-01
regulation of mitochondrial depolarization (GO:0051900)	20	0	.47	-	 < 0.01	6.27E-01
protein palmitoleylation (GO:0045234)	1	0	.02	-	 < 0.01	9.77E-01
RNA localization to nucleus (GO:0090685)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901837)	1	0	.02	-	 < 0.01	9.77E-01
regulation of nuclear cell cycle DNA replication (GO:0033262)	12	0	.28	-	 < 0.01	7.56E-01
positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA (GO:1901835)	1	0	.02	-	 < 0.01	9.77E-01
nuclear DNA replication (GO:0033260)	21	0	.49	-	 < 0.01	6.13E-01
regulation of deadenylation-independent decapping of nuclear-transcribed mRNA (GO:1901834)	1	0	.02	-	 < 0.01	9.77E-01
extracellular polysaccharide biosynthetic process (GO:0045226)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of CD4 production (GO:0045225)	1	0	.02	-	 < 0.01	9.77E-01
calcium ion transmembrane transport via low voltage-gated calcium channel (GO:0090676)	1	0	.02	-	 < 0.01	9.77E-01
intermicrovillar adhesion (GO:0090675)	2	0	.05	-	 < 0.01	9.54E-01
regulation of CD4 production (GO:0045223)	1	0	.02	-	 < 0.01	9.77E-01
endothelial cell-matrix adhesion (GO:0090673)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of FasL production (GO:0045221)	1	0	.02	-	 < 0.01	9.77E-01
telomerase RNA localization (GO:0090672)	1	0	.02	-	 < 0.01	9.77E-01
telomerase RNA localization to Cajal body (GO:0090671)	1	0	.02	-	 < 0.01	9.77E-01
RNA localization to Cajal body (GO:0090670)	5	0	.12	-	 < 0.01	8.90E-01
zeaxanthin biosynthetic process (GO:1901827)	1	0	.02	-	 < 0.01	9.77E-01
zeaxanthin metabolic process (GO:1901825)	1	0	.02	-	 < 0.01	9.77E-01
regulation of FasL production (GO:0045219)	1	0	.02	-	 < 0.01	9.77E-01
telomerase RNA stabilization (GO:0090669)	4	0	.09	-	 < 0.01	9.11E-01
endothelial cell chemotaxis to vascular endothelial growth factor (GO:0090668)	1	0	.02	-	 < 0.01	9.77E-01
cell chemotaxis to vascular endothelial growth factor (GO:0090667)	1	0	.02	-	 < 0.01	9.77E-01
scaRNA localization to Cajal body (GO:0090666)	5	0	.12	-	 < 0.01	8.90E-01
sarcomere organization (GO:0045214)	39	0	.91	-	 < 0.01	4.02E-01
neurotransmitter receptor metabolic process (GO:0045213)	3	0	.07	-	 < 0.01	9.32E-01
galanin-activated signaling pathway (GO:0090663)	1	0	.02	-	 < 0.01	9.77E-01
FasL biosynthetic process (GO:0045210)	1	0	.02	-	 < 0.01	9.77E-01
cerebrospinal fluid circulation (GO:0090660)	9	0	.21	-	 < 0.01	8.11E-01
gastrin-induced gastric acid secretion (GO:0001698)	1	0	.02	-	 < 0.01	9.77E-01
histamine-induced gastric acid secretion (GO:0001697)	1	0	.02	-	 < 0.01	9.77E-01
telomeric loop disassembly (GO:0090657)	8	0	.19	-	 < 0.01	8.30E-01
histamine catabolic process (GO:0001695)	1	0	.02	-	 < 0.01	9.77E-01
t-circle formation (GO:0090656)	5	0	.12	-	 < 0.01	8.90E-01
histamine biosynthetic process (GO:0001694)	2	0	.05	-	 < 0.01	9.54E-01
MAPK export from nucleus (GO:0045204)	1	0	.02	-	 < 0.01	9.77E-01
histamine metabolic process (GO:0001692)	4	0	.09	-	 < 0.01	9.11E-01
establishment of neuroblast polarity (GO:0045200)	3	0	.07	-	 < 0.01	9.32E-01
cellular response to oxygen-glucose deprivation (GO:0090650)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of protein sumoylation (GO:0033235)	16	0	.37	-	 < 0.01	6.89E-01
negative regulation of protein sumoylation (GO:0033234)	9	0	.21	-	 < 0.01	8.11E-01
regulation of protein sumoylation (GO:0033233)	27	0	.63	-	 < 0.01	5.33E-01
carbohydrate export (GO:0033231)	1	0	.02	-	 < 0.01	9.77E-01
beta-glucoside catabolic process (GO:1901805)	1	0	.02	-	 < 0.01	9.77E-01
beta-glucoside metabolic process (GO:1901804)	1	0	.02	-	 < 0.01	9.77E-01
response to oxygen-glucose deprivation (GO:0090649)	3	0	.07	-	 < 0.01	9.32E-01
response to environmental enrichment (GO:0090648)	1	0	.02	-	 < 0.01	9.77E-01
modulation of age-related behavioral decline (GO:0090647)	9	0	.21	-	 < 0.01	8.11E-01
mitochondrial tRNA processing (GO:0090646)	8	0	.19	-	 < 0.01	8.30E-01
tRNA 3'-terminal CCA addition (GO:0001680)	1	0	.02	-	 < 0.01	9.77E-01
dsRNA transport (GO:0033227)	5	0	.12	-	 < 0.01	8.90E-01
acrosome assembly (GO:0001675)	16	0	.37	-	 < 0.01	6.89E-01
regulation of chromatin assembly or disassembly (GO:0001672)	23	0	.54	-	 < 0.01	5.85E-01
iron import into cell (GO:0033212)	7	0	.16	-	 < 0.01	8.49E-01
adiponectin-activated signaling pathway (GO:0033211)	7	0	.16	-	 < 0.01	8.49E-01
conditioned taste aversion (GO:0001661)	5	0	.12	-	 < 0.01	8.90E-01
fever generation (GO:0001660)	5	0	.12	-	 < 0.01	8.90E-01
tumor necrosis factor-mediated signaling pathway (GO:0033209)	39	0	.91	-	 < 0.01	4.02E-01
GCN2-mediated signaling (GO:0140469)	2	0	.05	-	 < 0.01	9.54E-01
HRI-mediated signaling (GO:0140468)	3	0	.07	-	 < 0.01	9.32E-01
integrated stress response signaling (GO:0140467)	8	0	.19	-	 < 0.01	8.30E-01
DNA clamp unloading (GO:0090618)	2	0	.05	-	 < 0.01	9.54E-01
mitochondrial mRNA 3'-end processing (GO:0090616)	1	0	.02	-	 < 0.01	9.77E-01
pericentric heterochromatin organization (GO:0140462)	3	0	.07	-	 < 0.01	9.32E-01
mitochondrial mRNA processing (GO:0090615)	2	0	.05	-	 < 0.01	9.54E-01
ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway (GO:0090611)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation by host of viral process (GO:0044794)	17	0	.40	-	 < 0.01	6.73E-01
negative regulation by host of viral process (GO:0044793)	12	0	.28	-	 < 0.01	7.56E-01
positive regulation by host of viral release from host cell (GO:0044791)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation by host of viral release from host cell (GO:0044790)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of interleukin-18-mediated signaling pathway (GO:2000494)	1	0	.02	-	 < 0.01	9.77E-01
regulation of interleukin-18-mediated signaling pathway (GO:2000492)	1	0	.02	-	 < 0.01	9.77E-01
cytoplasm protein quality control (GO:0140455)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of hepatic stellate cell activation (GO:2000491)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of hepatic stellate cell activation (GO:2000490)	2	0	.05	-	 < 0.01	9.54E-01
protein targeting to Golgi apparatus (GO:0140450)	1	0	.02	-	 < 0.01	9.77E-01
modulation by host of viral release from host cell (GO:0044789)	5	0	.12	-	 < 0.01	8.90E-01
modulation by host of viral process (GO:0044788)	28	0	.65	-	 < 0.01	5.20E-01
cell cycle DNA replication (GO:0044786)	22	0	.51	-	 < 0.01	5.99E-01
G1 DNA damage checkpoint (GO:0044783)	19	0	.44	-	 < 0.01	6.42E-01
negative regulation of glutamine transport (GO:2000486)	1	0	.02	-	 < 0.01	9.77E-01
cytokine precursor processing (GO:0140447)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of cAMP-dependent protein kinase activity (GO:2000480)	8	0	.19	-	 < 0.01	8.30E-01
meiotic spindle checkpoint (GO:0044779)	2	0	.05	-	 < 0.01	9.54E-01
meiotic DNA integrity checkpoint (GO:0044778)	2	0	.05	-	 < 0.01	9.54E-01
mitotic DNA integrity checkpoint (GO:0044774)	59	0	1.38	-	 < 0.01	2.52E-01
mitotic DNA damage checkpoint (GO:0044773)	54	0	1.26	-	 < 0.01	2.83E-01
meiotic cell cycle phase transition (GO:0044771)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of metanephric glomerular visceral epithelial cell development (GO:2000478)	1	0	.02	-	 < 0.01	9.77E-01
regulation of metanephric glomerular visceral epithelial cell development (GO:2000477)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of opioid receptor signaling pathway (GO:2000476)	1	0	.02	-	 < 0.01	9.77E-01
regulation of opioid receptor signaling pathway (GO:2000474)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of hematopoietic stem cell migration (GO:2000473)	2	0	.05	-	 < 0.01	9.54E-01
regulation of hematopoietic stem cell migration (GO:2000471)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of peroxidase activity (GO:2000470)	2	0	.05	-	 < 0.01	9.54E-01
multi-organism transport (GO:0044766)	8	0	.19	-	 < 0.01	8.30E-01
multi-organism cellular process (GO:0044764)	13	0	.30	-	 < 0.01	7.38E-01
suppression of symbiont entry into host by host (GO:0052373)	1	0	.02	-	 < 0.01	9.77E-01
low-density lipoprotein receptor particle metabolic process (GO:0032799)	1	0	.02	-	 < 0.01	9.77E-01
uropod organization (GO:0032796)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of peroxidase activity (GO:2000469)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of CREB transcription factor activity (GO:0032792)	6	0	.14	-	 < 0.01	8.69E-01
sequestering of BMP from receptor via BMP binding (GO:0038098)	3	0	.07	-	 < 0.01	9.32E-01
regulation of peroxidase activity (GO:2000468)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway (GO:0038097)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of glycogen (starch) synthase activity (GO:2000467)	5	0	.12	-	 < 0.01	8.90E-01
ribosome disassembly (GO:0032790)	7	0	.16	-	 < 0.01	8.49E-01
Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of glycogen (starch) synthase activity (GO:2000466)	1	0	.02	-	 < 0.01	9.77E-01
Fc-epsilon receptor signaling pathway (GO:0038095)	4	0	.09	-	 < 0.01	9.11E-01
regulation of glycogen (starch) synthase activity (GO:2000465)	8	0	.19	-	 < 0.01	8.30E-01
Fc-gamma receptor signaling pathway (GO:0038094)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of astrocyte chemotaxis (GO:2000464)	1	0	.02	-	 < 0.01	9.77E-01
Fc receptor signaling pathway (GO:0038093)	11	0	.26	-	 < 0.01	7.74E-01
positive regulation of excitatory postsynaptic potential (GO:2000463)	38	0	.89	-	 < 0.01	4.12E-01
positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway (GO:0038091)	3	0	.07	-	 < 0.01	9.32E-01
endocytic heme import into cell (GO:0140421)	2	0	.05	-	 < 0.01	9.54E-01
heme import into cell (GO:0140420)	2	0	.05	-	 < 0.01	9.54E-01
disruption by organism of cellular component in other organism involved in symbiotic interaction (GO:0052368)	1	0	.02	-	 < 0.01	9.77E-01
disruption by host of symbiont cellular component (GO:0052367)	1	0	.02	-	 < 0.01	9.77E-01
catabolism by host of substance in symbiont (GO:0052364)	2	0	.05	-	 < 0.01	9.54E-01
catabolism by organism of protein in other organism involved in symbiotic interaction (GO:0052363)	1	0	.02	-	 < 0.01	9.77E-01
catabolism by host of symbiont protein (GO:0052362)	1	0	.02	-	 < 0.01	9.77E-01
catabolism by organism of macromolecule in other organism involved in symbiotic interaction (GO:0052361)	2	0	.05	-	 < 0.01	9.54E-01
catabolism by host of symbiont macromolecule (GO:0052360)	2	0	.05	-	 < 0.01	9.54E-01
unsaturated monocarboxylic acid metabolic process (GO:0032789)	3	0	.07	-	 < 0.01	9.32E-01
saturated monocarboxylic acid metabolic process (GO:0032788)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of DNA-templated transcription, elongation (GO:0032786)	27	0	.63	-	 < 0.01	5.33E-01
negative regulation of DNA-templated transcription, elongation (GO:0032785)	13	0	.30	-	 < 0.01	7.38E-01
regulation of DNA-templated transcription, elongation (GO:0032784)	45	0	1.05	-	 < 0.01	3.50E-01
positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089)	9	0	.21	-	 < 0.01	8.11E-01
bile acid secretion (GO:0032782)	6	0	.14	-	 < 0.01	8.69E-01
regulation of astrocyte chemotaxis (GO:2000458)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of ATPase activity (GO:0032780)	17	0	.40	-	 < 0.01	6.73E-01
VEGF-activated platelet-derived growth factor receptor signaling pathway (GO:0038086)	3	0	.07	-	 < 0.01	9.32E-01
vascular endothelial growth factor signaling pathway (GO:0038084)	21	0	.49	-	 < 0.01	6.13E-01
positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation (GO:2000454)	1	0	.02	-	 < 0.01	9.77E-01
peptidyl-tyrosine autophosphorylation (GO:0038083)	37	0	.86	-	 < 0.01	4.22E-01
regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation (GO:2000452)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of CD8-positive, alpha-beta T cell extravasation (GO:2000451)	2	0	.05	-	 < 0.01	9.54E-01
pre-replicative complex assembly involved in cell cycle DNA replication (GO:1902299)	7	0	.16	-	 < 0.01	8.49E-01
cell cycle DNA replication maintenance of fidelity (GO:1902298)	2	0	.05	-	 < 0.01	9.54E-01
DNA strand elongation involved in cell cycle DNA replication (GO:1902296)	1	0	.02	-	 < 0.01	9.77E-01
catabolism by host of symbiont cell wall chitin (GO:0052356)	1	0	.02	-	 < 0.01	9.77E-01
catabolism by organism of carbohydrate in other organism involved in symbiotic interaction (GO:0052354)	1	0	.02	-	 < 0.01	9.77E-01
catabolism by host of symbiont carbohydrate (GO:0052353)	1	0	.02	-	 < 0.01	9.77E-01
cell cycle DNA replication initiation (GO:1902292)	5	0	.12	-	 < 0.01	8.90E-01
protein transmembrane import into intracellular organelle (GO:0044743)	33	0	.77	-	 < 0.01	4.63E-01
DNA methylation on adenine (GO:0032775)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of monophenol monooxygenase activity (GO:0032773)	1	0	.02	-	 < 0.01	9.77E-01
regulation of CD8-positive, alpha-beta T cell extravasation (GO:2000449)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of macrophage migration inhibitory factor signaling pathway (GO:2000448)	2	0	.05	-	 < 0.01	9.54E-01
regulation of monophenol monooxygenase activity (GO:0032771)	1	0	.02	-	 < 0.01	9.77E-01
regulation of macrophage migration inhibitory factor signaling pathway (GO:2000446)	3	0	.07	-	 < 0.01	9.32E-01
neuron projection extension involved in neuron projection guidance (GO:1902284)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of primary amine oxidase activity (GO:1902283)	1	0	.02	-	 < 0.01	9.77E-01
catabolism by organism of cell wall chitin in other organism involved in symbiotic interaction (GO:0052342)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of mast cell cytokine production (GO:0032765)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of mast cell cytokine production (GO:0032764)	2	0	.05	-	 < 0.01	9.54E-01
regulation of mast cell cytokine production (GO:0032763)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of monocyte extravasation (GO:2000439)	3	0	.07	-	 < 0.01	9.32E-01
mast cell cytokine production (GO:0032762)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of monocyte extravasation (GO:2000438)	1	0	.02	-	 < 0.01	9.77E-01
regulation of monocyte extravasation (GO:2000437)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of protein neddylation (GO:2000436)	5	0	.12	-	 < 0.01	8.90E-01
collagen-activated signaling pathway (GO:0038065)	13	0	.30	-	 < 0.01	7.38E-01
negative regulation of protein neddylation (GO:2000435)	5	0	.12	-	 < 0.01	8.90E-01
collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063)	11	0	.26	-	 < 0.01	7.74E-01
NIK/NF-kappaB signaling (GO:0038061)	22	0	.51	-	 < 0.01	5.99E-01
regulation of cytokinesis, actomyosin contractile ring assembly (GO:2000431)	1	0	.02	-	 < 0.01	9.77E-01
nitric oxide-cGMP-mediated signaling pathway (GO:0038060)	1	0	.02	-	 < 0.01	9.77E-01
disruption by organism of cell wall of other organism involved in symbiotic interaction (GO:0052339)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of pancreatic amylase secretion (GO:1902278)	1	0	.02	-	 < 0.01	9.77E-01
disruption by host of symbiont cell wall (GO:0052338)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of pancreatic amylase secretion (GO:1902277)	1	0	.02	-	 < 0.01	9.77E-01
regulation of pancreatic amylase secretion (GO:1902276)	2	0	.05	-	 < 0.01	9.54E-01
DNA demethylation of male pronucleus (GO:0044727)	1	0	.02	-	 < 0.01	9.77E-01
modification by host of symbiont cell wall (GO:0052336)	1	0	.02	-	 < 0.01	9.77E-01
protection of DNA demethylation of female pronucleus (GO:0044726)	1	0	.02	-	 < 0.01	9.77E-01
chromatin reprogramming in the zygote (GO:0044725)	2	0	.05	-	 < 0.01	9.54E-01
modification by organism of cell wall of other organism involved in symbiotic interaction (GO:0052333)	1	0	.02	-	 < 0.01	9.77E-01
(R)-carnitine transmembrane transport (GO:1902270)	1	0	.02	-	 < 0.01	9.77E-01
protein import into peroxisome matrix, substrate release (GO:0044721)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of TRAIL production (GO:0032759)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of interleukin-8 production (GO:0032757)	53	0	1.24	-	 < 0.01	2.90E-01
negative regulation of neutrophil aggregation (GO:2000429)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of interleukin-3 production (GO:0032752)	2	0	.05	-	 < 0.01	9.54E-01
regulation of neutrophil aggregation (GO:2000428)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of apoptotic cell clearance (GO:2000427)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of apoptotic cell clearance (GO:2000426)	1	0	.02	-	 < 0.01	9.77E-01
regulation of apoptotic cell clearance (GO:2000425)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of eosinophil chemotaxis (GO:2000424)	2	0	.05	-	 < 0.01	9.54E-01
regulation of eosinophil chemotaxis (GO:2000422)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of eosinophil extravasation (GO:2000420)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of polyamine transmembrane transport (GO:1902269)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of polyamine transmembrane transport (GO:1902268)	3	0	.07	-	 < 0.01	9.32E-01
regulation of polyamine transmembrane transport (GO:1902267)	5	0	.12	-	 < 0.01	8.90E-01
apoptotic process involved in embryonic digit morphogenesis (GO:1902263)	3	0	.07	-	 < 0.01	9.32E-01
apoptotic process involved in blood vessel morphogenesis (GO:1902262)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of delayed rectifier potassium channel activity (GO:1902261)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of delayed rectifier potassium channel activity (GO:1902260)	10	0	.23	-	 < 0.01	7.92E-01
positive regulation of interleukin-23 production (GO:0032747)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of interleukin-2 production (GO:0032743)	31	0	.72	-	 < 0.01	4.85E-01
regulation of eosinophil extravasation (GO:2000419)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of eosinophil migration (GO:2000418)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of interleukin-18 production (GO:0032741)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of eosinophil migration (GO:2000417)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of interleukin-17 production (GO:0032740)	18	0	.42	-	 < 0.01	6.57E-01
regulation of eosinophil migration (GO:2000416)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of fibronectin-dependent thymocyte migration (GO:2000415)	1	0	.02	-	 < 0.01	9.77E-01
regulation of fibronectin-dependent thymocyte migration (GO:2000413)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of thymocyte migration (GO:2000412)	4	0	.09	-	 < 0.01	9.11E-01
cross-receptor inhibition within G protein-coupled receptor heterodimer (GO:0038041)	2	0	.05	-	 < 0.01	9.54E-01
regulation of thymocyte migration (GO:2000410)	5	0	.12	-	 < 0.01	8.90E-01
regulation of delayed rectifier potassium channel activity (GO:1902259)	18	0	.42	-	 < 0.01	6.57E-01
negative regulation of apoptotic process involved in outflow tract morphogenesis (GO:1902257)	2	0	.05	-	 < 0.01	9.54E-01
regulation of apoptotic process involved in outflow tract morphogenesis (GO:1902256)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902255)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254)	19	0	.44	-	 < 0.01	6.42E-01
regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253)	28	0	.65	-	 < 0.01	5.20E-01
N-terminal protein myristoylation (GO:0006499)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of erythrocyte apoptotic process (GO:1902251)	1	0	.02	-	 < 0.01	9.77E-01
N-terminal protein lipidation (GO:0006498)	5	0	.12	-	 < 0.01	8.90E-01
regulation of erythrocyte apoptotic process (GO:1902250)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of interleukin-16 production (GO:0032739)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of interleukin-15 production (GO:0032738)	1	0	.02	-	 < 0.01	9.77E-01
N-glycan processing (GO:0006491)	16	0	.37	-	 < 0.01	6.89E-01
oligosaccharide-lipid intermediate biosynthetic process (GO:0006490)	12	0	.28	-	 < 0.01	7.56E-01
positive regulation of interleukin-10 production (GO:0032733)	36	0	.84	-	 < 0.01	4.32E-01
positive regulation of T cell extravasation (GO:2000409)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of T cell extravasation (GO:2000408)	1	0	.02	-	 < 0.01	9.77E-01
regulation of T cell extravasation (GO:2000407)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of interleukin-1 alpha production (GO:0032730)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of T cell migration (GO:2000405)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway (GO:0038033)	6	0	.14	-	 < 0.01	8.69E-01
termination of G protein-coupled receptor signaling pathway (GO:0038032)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of lymphocyte migration (GO:2000402)	10	0	.23	-	 < 0.01	7.92E-01
dolichyl diphosphate biosynthetic process (GO:0006489)	3	0	.07	-	 < 0.01	9.32E-01
dolichol-linked oligosaccharide biosynthetic process (GO:0006488)	10	0	.23	-	 < 0.01	7.92E-01
positive regulation of interferon-beta production (GO:0032728)	36	0	.84	-	 < 0.01	4.32E-01
C-terminal protein methylation (GO:0006481)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725)	11	0	.26	-	 < 0.01	7.74E-01
N-terminal protein amino acid methylation (GO:0006480)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of connective tissue growth factor production (GO:0032723)	2	0	.05	-	 < 0.01	9.54E-01
epidermal growth factor receptor signaling pathway via MAPK cascade (GO:0038029)	1	0	.02	-	 < 0.01	9.77E-01
insulin receptor signaling pathway via phosphatidylinositol 3-kinase (GO:0038028)	2	0	.05	-	 < 0.01	9.54E-01
apolipoprotein A-I-mediated signaling pathway (GO:0038027)	4	0	.09	-	 < 0.01	9.11E-01
reelin-mediated signaling pathway (GO:0038026)	8	0	.19	-	 < 0.01	8.30E-01
insulin receptor recycling (GO:0038020)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator (GO:1902239)	1	0	.02	-	 < 0.01	9.77E-01
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator (GO:1902238)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902237)	9	0	.21	-	 < 0.01	8.11E-01
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236)	17	0	.40	-	 < 0.01	6.73E-01
regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235)	27	0	.63	-	 < 0.01	5.33E-01
negative regulation of positive thymic T cell selection (GO:1902233)	1	0	.02	-	 < 0.01	9.77E-01
regulation of positive thymic T cell selection (GO:1902232)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902231)	9	0	.21	-	 < 0.01	8.11E-01
peptidyl-tyrosine sulfation (GO:0006478)	2	0	.05	-	 < 0.01	9.54E-01
protein sulfation (GO:0006477)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of interleukin-8 production (GO:0032717)	15	0	.35	-	 < 0.01	7.05E-01
protein ADP-ribosylation (GO:0006471)	25	0	.58	-	 < 0.01	5.58E-01
negative regulation of interleukin-5 production (GO:0032714)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of interleukin-4 production (GO:0032713)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of interleukin-3 production (GO:0032712)	1	0	.02	-	 < 0.01	9.77E-01
Wnt receptor catabolic process (GO:0038018)	2	0	.05	-	 < 0.01	9.54E-01
insulin receptor internalization (GO:0038016)	2	0	.05	-	 < 0.01	9.54E-01
cellular response to laminar fluid shear stress (GO:0071499)	6	0	.14	-	 < 0.01	8.69E-01
cellular response to fluid shear stress (GO:0071498)	16	0	.37	-	 < 0.01	6.89E-01
cellular response to freezing (GO:0071497)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of macrophage colony-stimulating factor signaling pathway (GO:1902228)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of macrophage colony-stimulating factor signaling pathway (GO:1902227)	2	0	.05	-	 < 0.01	9.54E-01
cellular response to UV-C (GO:0071494)	5	0	.12	-	 < 0.01	8.90E-01
regulation of macrophage colony-stimulating factor signaling pathway (GO:1902226)	3	0	.07	-	 < 0.01	9.32E-01
cellular response to UV-B (GO:0071493)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of acrosome reaction (GO:1902225)	1	0	.02	-	 < 0.01	9.77E-01
erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222)	7	0	.16	-	 < 0.01	8.49E-01
erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221)	9	0	.21	-	 < 0.01	8.11E-01
positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress (GO:1902220)	1	0	.02	-	 < 0.01	9.77E-01
response to amine (GO:0014075)	22	0	.51	-	 < 0.01	5.99E-01
signal peptide processing (GO:0006465)	12	0	.28	-	 < 0.01	7.56E-01
steroid hormone receptor complex assembly (GO:0006463)	1	0	.02	-	 < 0.01	9.77E-01
response to isoquinoline alkaloid (GO:0014072)	18	0	.42	-	 < 0.01	6.57E-01
negative regulation of interleukin-23 production (GO:0032707)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of interleukin-2 production (GO:0032703)	26	0	.61	-	 < 0.01	5.45E-01
regulation of signal transduction by receptor internalization (GO:0038009)	1	0	.02	-	 < 0.01	9.77E-01
TRAF-mediated signal transduction (GO:0038008)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of interleukin-18 production (GO:0032701)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of interleukin-17 production (GO:0032700)	18	0	.42	-	 < 0.01	6.57E-01
opioid receptor signaling pathway (GO:0038003)	5	0	.12	-	 < 0.01	8.90E-01
endocrine signaling (GO:0038002)	1	0	.02	-	 < 0.01	9.77E-01
paracrine signaling (GO:0038001)	6	0	.14	-	 < 0.01	8.69E-01
cellular response to red or far red light (GO:0071489)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress (GO:1902219)	4	0	.09	-	 < 0.01	9.11E-01
cellular response to high light intensity (GO:0071486)	1	0	.02	-	 < 0.01	9.77E-01
regulation of intrinsic apoptotic signaling pathway in response to osmotic stress (GO:1902218)	5	0	.12	-	 < 0.01	8.90E-01
peptidyl-glutamic acid poly-ADP-ribosylation (GO:0018424)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to light intensity (GO:0071484)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of interleukin-4-mediated signaling pathway (GO:1902216)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of interleukin-4-mediated signaling pathway (GO:1902215)	1	0	.02	-	 < 0.01	9.77E-01
regulation of interleukin-4-mediated signaling pathway (GO:1902214)	3	0	.07	-	 < 0.01	9.32E-01
cellular response to X-ray (GO:0071481)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067)	15	0	.35	-	 < 0.01	7.05E-01
positive regulation of serotonin secretion (GO:0014064)	3	0	.07	-	 < 0.01	9.32E-01
translational frameshifting (GO:0006452)	2	0	.05	-	 < 0.01	9.54E-01
translational readthrough (GO:0006451)	6	0	.14	-	 < 0.01	8.69E-01
regulation of epinephrine secretion (GO:0014060)	8	0	.19	-	 < 0.01	8.30E-01
regulation of translational fidelity (GO:0006450)	7	0	.16	-	 < 0.01	8.49E-01
tRNA wobble uridine modification (GO:0002098)	16	0	.37	-	 < 0.01	6.89E-01
tRNA wobble base modification (GO:0002097)	19	0	.44	-	 < 0.01	6.42E-01
auditory receptor cell morphogenesis (GO:0002093)	24	0	.56	-	 < 0.01	5.71E-01
cellular hypotonic salinity response (GO:0071477)	2	0	.05	-	 < 0.01	9.54E-01
cellular hypotonic response (GO:0071476)	7	0	.16	-	 < 0.01	8.49E-01
cellular hyperosmotic salinity response (GO:0071475)	4	0	.09	-	 < 0.01	9.11E-01
cellular hyperosmotic response (GO:0071474)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of interleukin-2-mediated signaling pathway (GO:1902206)	1	0	.02	-	 < 0.01	9.77E-01
regulation of interleukin-2-mediated signaling pathway (GO:1902205)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to salt stress (GO:0071472)	9	0	.21	-	 < 0.01	8.11E-01
positive regulation of hepatocyte growth factor receptor signaling pathway (GO:1902204)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to non-ionic osmotic stress (GO:0071471)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of hepatocyte growth factor receptor signaling pathway (GO:1902203)	1	0	.02	-	 < 0.01	9.77E-01
C-terminal protein amino acid modification (GO:0018410)	13	0	.30	-	 < 0.01	7.38E-01
cellular response to osmotic stress (GO:0071470)	28	0	.65	-	 < 0.01	5.20E-01
regulation of hepatocyte growth factor receptor signaling pathway (GO:1902202)	4	0	.09	-	 < 0.01	9.11E-01
regulation of translational termination (GO:0006449)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of acetylcholine secretion, neurotransmission (GO:0014058)	1	0	.02	-	 < 0.01	9.77E-01
regulation of translational elongation (GO:0006448)	16	0	.37	-	 < 0.01	6.89E-01
positive regulation of acetylcholine secretion, neurotransmission (GO:0014057)	3	0	.07	-	 < 0.01	9.32E-01
membrane depolarization (GO:0051899)	44	0	1.03	-	 < 0.01	3.58E-01
regulation of translational initiation by iron (GO:0006447)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of gamma-aminobutyric acid secretion (GO:0014054)	7	0	.16	-	 < 0.01	8.49E-01
gamma-aminobutyric acid secretion (GO:0014051)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of glutamate secretion (GO:0014050)	9	0	.21	-	 < 0.01	8.11E-01
negative regulation of cardioblast differentiation (GO:0051892)	2	0	.05	-	 < 0.01	9.54E-01
cellular response to glial cell derived neurotrophic factor (GO:1990792)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of cardioblast differentiation (GO:0051891)	6	0	.14	-	 < 0.01	8.69E-01
dorsal root ganglion development (GO:1990791)	6	0	.14	-	 < 0.01	8.69E-01
regulation of cardioblast differentiation (GO:0051890)	8	0	.19	-	 < 0.01	8.30E-01
response to glial cell derived neurotrophic factor (GO:1990790)	1	0	.02	-	 < 0.01	9.77E-01
regulation of respiratory gaseous exchange by nervous system process (GO:0002087)	13	0	.30	-	 < 0.01	7.38E-01
diaphragm contraction (GO:0002086)	3	0	.07	-	 < 0.01	9.32E-01
inhibition of neuroepithelial cell differentiation (GO:0002085)	2	0	.05	-	 < 0.01	9.54E-01
regulation of oxidative phosphorylation (GO:0002082)	26	0	.61	-	 < 0.01	5.45E-01
cellular response to alkaline pH (GO:0071469)	2	0	.05	-	 < 0.01	9.54E-01
protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406)	4	0	.09	-	 < 0.01	9.11E-01
cellular response to hydrostatic pressure (GO:0071464)	2	0	.05	-	 < 0.01	9.54E-01
cellular response to water stimulus (GO:0071462)	4	0	.09	-	 < 0.01	9.11E-01
cellular response to redox state (GO:0071461)	2	0	.05	-	 < 0.01	9.54E-01
peptidyl-proline hydroxylation to 3-hydroxy-L-proline (GO:0018400)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to cell-matrix adhesion (GO:0071460)	2	0	.05	-	 < 0.01	9.54E-01
valyl-tRNA aminoacylation (GO:0006438)	2	0	.05	-	 < 0.01	9.54E-01
glutamate secretion (GO:0014047)	10	0	.23	-	 < 0.01	7.92E-01
tyrosyl-tRNA aminoacylation (GO:0006437)	2	0	.05	-	 < 0.01	9.54E-01
tryptophanyl-tRNA aminoacylation (GO:0006436)	2	0	.05	-	 < 0.01	9.54E-01
establishment of endothelial blood-brain barrier (GO:0014045)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of hh target transcription factor activity (GO:1990787)	1	0	.02	-	 < 0.01	9.77E-01
threonyl-tRNA aminoacylation (GO:0006435)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of timing of anagen (GO:0051886)	2	0	.05	-	 < 0.01	9.54E-01
cellular response to dsDNA (GO:1990786)	2	0	.05	-	 < 0.01	9.54E-01
seryl-tRNA aminoacylation (GO:0006434)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of neuron maturation (GO:0014043)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of timing of anagen (GO:0051885)	2	0	.05	-	 < 0.01	9.54E-01
response to water-immersion restraint stress (GO:1990785)	1	0	.02	-	 < 0.01	9.77E-01
prolyl-tRNA aminoacylation (GO:0006433)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of neuron maturation (GO:0014042)	7	0	.16	-	 < 0.01	8.49E-01
regulation of timing of anagen (GO:0051884)	5	0	.12	-	 < 0.01	8.90E-01
response to dsDNA (GO:1990784)	2	0	.05	-	 < 0.01	9.54E-01
phenylalanyl-tRNA aminoacylation (GO:0006432)	3	0	.07	-	 < 0.01	9.32E-01
regulation of neuron maturation (GO:0014041)	14	0	.33	-	 < 0.01	7.21E-01
killing of cells in other organism involved in symbiotic interaction (GO:0051883)	21	0	.49	-	 < 0.01	6.13E-01
methionyl-tRNA aminoacylation (GO:0006431)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of Schwann cell differentiation (GO:0014040)	4	0	.09	-	 < 0.01	9.11E-01
mitochondrial depolarization (GO:0051882)	3	0	.07	-	 < 0.01	9.32E-01
lysyl-tRNA aminoacylation (GO:0006430)	1	0	.02	-	 < 0.01	9.77E-01
regulation of mitochondrial membrane potential (GO:0051881)	76	0	1.77	-	 < 0.01	1.69E-01
acrosome matrix dispersal (GO:0002077)	1	0	.02	-	 < 0.01	9.77E-01
extraocular skeletal muscle development (GO:0002074)	3	0	.07	-	 < 0.01	9.32E-01
glandular epithelial cell maturation (GO:0002071)	2	0	.05	-	 < 0.01	9.54E-01
epithelial cell maturation (GO:0002070)	16	0	.37	-	 < 0.01	6.89E-01
protein localization to chromosome, centromeric region (GO:0071459)	21	0	.49	-	 < 0.01	6.13E-01
cellular response to hyperoxia (GO:0071455)	5	0	.12	-	 < 0.01	8.90E-01
cellular response to superoxide (GO:0071451)	12	0	.28	-	 < 0.01	7.56E-01
cellular response to oxygen radical (GO:0071450)	12	0	.28	-	 < 0.01	7.56E-01
leucyl-tRNA aminoacylation (GO:0006429)	2	0	.05	-	 < 0.01	9.54E-01
regulation of Schwann cell differentiation (GO:0014038)	4	0	.09	-	 < 0.01	9.11E-01
isoleucyl-tRNA aminoacylation (GO:0006428)	2	0	.05	-	 < 0.01	9.54E-01
histidyl-tRNA aminoacylation (GO:0006427)	2	0	.05	-	 < 0.01	9.54E-01
neural crest cell fate specification (GO:0014036)	1	0	.02	-	 < 0.01	9.77E-01
lateral element assembly (GO:0051878)	2	0	.05	-	 < 0.01	9.54E-01
glycyl-tRNA aminoacylation (GO:0006426)	1	0	.02	-	 < 0.01	9.77E-01
glutaminyl-tRNA aminoacylation (GO:0006425)	1	0	.02	-	 < 0.01	9.77E-01
neural crest cell fate commitment (GO:0014034)	2	0	.05	-	 < 0.01	9.54E-01
glutamyl-tRNA aminoacylation (GO:0006424)	2	0	.05	-	 < 0.01	9.54E-01
pigment granule localization (GO:0051875)	21	0	.49	-	 < 0.01	6.13E-01
cysteinyl-tRNA aminoacylation (GO:0006423)	2	0	.05	-	 < 0.01	9.54E-01
aspartyl-tRNA aminoacylation (GO:0006422)	1	0	.02	-	 < 0.01	9.77E-01
killing by host of symbiont cells (GO:0051873)	18	0	.42	-	 < 0.01	6.57E-01
asparaginyl-tRNA aminoacylation (GO:0006421)	3	0	.07	-	 < 0.01	9.32E-01
columnar/cuboidal epithelial cell maturation (GO:0002069)	4	0	.09	-	 < 0.01	9.11E-01
arginyl-tRNA aminoacylation (GO:0006420)	3	0	.07	-	 < 0.01	9.32E-01
clathrin-dependent extracellular exosome endocytosis (GO:1990771)	1	0	.02	-	 < 0.01	9.77E-01
glandular epithelial cell development (GO:0002068)	20	0	.47	-	 < 0.01	6.27E-01
columnar/cuboidal epithelial cell development (GO:0002066)	36	0	.84	-	 < 0.01	4.32E-01
chondrocyte development (GO:0002063)	24	0	.56	-	 < 0.01	5.71E-01
cellular response to lipid hydroperoxide (GO:0071449)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to pheromone (GO:0071444)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of histone H3-K14 acetylation (GO:0071442)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of histone H3-K14 acetylation (GO:0071441)	1	0	.02	-	 < 0.01	9.77E-01
neural crest formation (GO:0014029)	8	0	.19	-	 < 0.01	8.30E-01
regulation of histone H3-K14 acetylation (GO:0071440)	7	0	.16	-	 < 0.01	8.49E-01
alanyl-tRNA aminoacylation (GO:0006419)	2	0	.05	-	 < 0.01	9.54E-01
notochord formation (GO:0014028)	3	0	.07	-	 < 0.01	9.32E-01
tRNA aminoacylation for protein translation (GO:0006418)	37	0	.86	-	 < 0.01	4.22E-01
general adaptation syndrome, behavioral process (GO:0051867)	1	0	.02	-	 < 0.01	9.77E-01
prostaglandin receptor internalization (GO:1990767)	1	0	.02	-	 < 0.01	9.77E-01
translational termination (GO:0006415)	7	0	.16	-	 < 0.01	8.49E-01
general adaptation syndrome (GO:0051866)	2	0	.05	-	 < 0.01	9.54E-01
translational elongation (GO:0006414)	28	0	.65	-	 < 0.01	5.20E-01
translational initiation (GO:0006413)	54	0	1.26	-	 < 0.01	2.83E-01
neural plate elongation (GO:0014022)	3	0	.07	-	 < 0.01	9.32E-01
myofibroblast contraction (GO:1990764)	1	0	.02	-	 < 0.01	9.77E-01
translation (GO:0006412)	290	0	6.76	-	 < 0.01	1.10E-03
osteoblast fate commitment (GO:0002051)	6	0	.14	-	 < 0.01	8.69E-01
maintenance of epithelial cell apical/basal polarity (GO:0045199)	10	0	.23	-	 < 0.01	7.92E-01
establishment of epithelial cell apical/basal polarity (GO:0045198)	17	0	.40	-	 < 0.01	6.73E-01
establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197)	42	0	.98	-	 < 0.01	3.75E-01
establishment or maintenance of neuroblast polarity (GO:0045196)	3	0	.07	-	 < 0.01	9.32E-01
regulation of isotype switching (GO:0045191)	31	0	.72	-	 < 0.01	4.85E-01
isotype switching (GO:0045190)	20	0	.47	-	 < 0.01	6.27E-01
tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431)	3	0	.07	-	 < 0.01	9.32E-01
tRNA export from nucleus (GO:0006409)	3	0	.07	-	 < 0.01	9.32E-01
snRNA export from nucleus (GO:0006408)	1	0	.02	-	 < 0.01	9.77E-01
neuroblast fate commitment (GO:0014017)	1	0	.02	-	 < 0.01	9.77E-01
rRNA export from nucleus (GO:0006407)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of signal transduction by p53 class mediator (GO:1901797)	29	0	.68	-	 < 0.01	5.08E-01
mitotic sister chromatid biorientation (GO:1990758)	1	0	.02	-	 < 0.01	9.77E-01
mRNA export from nucleus (GO:0006406)	45	0	1.05	-	 < 0.01	3.50E-01
RNA export from nucleus (GO:0006405)	71	0	1.66	-	 < 0.01	1.90E-01
RNA import into nucleus (GO:0006404)	3	0	.07	-	 < 0.01	9.32E-01
Schwann cell proliferation (GO:0014010)	2	0	.05	-	 < 0.01	9.54E-01
tRNA modification (GO:0006400)	67	0	1.56	-	 < 0.01	2.09E-01
blood vessel endothelial cell migration involved in intussusceptive angiogenesis (GO:0002044)	1	0	.02	-	 < 0.01	9.77E-01
blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:0002043)	6	0	.14	-	 < 0.01	8.69E-01
cell migration involved in sprouting angiogenesis (GO:0002042)	20	0	.47	-	 < 0.01	6.27E-01
intussusceptive angiogenesis (GO:0002041)	1	0	.02	-	 < 0.01	9.77E-01
regulation of circadian sleep/wake cycle, non-REM sleep (GO:0045188)	14	0	.33	-	 < 0.01	7.21E-01
zonula adherens assembly (GO:0045186)	2	0	.05	-	 < 0.01	9.54E-01
rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428)	15	0	.35	-	 < 0.01	7.05E-01
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427)	45	0	1.05	-	 < 0.01	3.50E-01
ribonucleoprotein complex export from nucleus (GO:0071426)	62	0	1.45	-	 < 0.01	2.35E-01
hematopoietic stem cell proliferation (GO:0071425)	19	0	.44	-	 < 0.01	6.42E-01
cellular response to histamine (GO:0071420)	8	0	.19	-	 < 0.01	8.30E-01
positive regulation of microglia differentiation (GO:0014008)	1	0	.02	-	 < 0.01	9.77E-01
regulation of microglia differentiation (GO:0014006)	1	0	.02	-	 < 0.01	9.77E-01
cellular detoxification (GO:1990748)	29	0	.68	-	 < 0.01	5.08E-01
microglia development (GO:0014005)	4	0	.09	-	 < 0.01	9.11E-01
microglia differentiation (GO:0014004)	5	0	.12	-	 < 0.01	8.90E-01
astrocyte development (GO:0014002)	33	0	.77	-	 < 0.01	4.63E-01
primary miRNA methylation (GO:1990744)	1	0	.02	-	 < 0.01	9.77E-01
protein sialylation (GO:1990743)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of L-glutamate import across plasma membrane (GO:0002038)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of L-glutamate import across plasma membrane (GO:0002037)	2	0	.05	-	 < 0.01	9.54E-01
brain renin-angiotensin system (GO:0002035)	8	0	.19	-	 < 0.01	8.30E-01
maintenance of blood vessel diameter homeostasis by renin-angiotensin (GO:0002034)	6	0	.14	-	 < 0.01	8.69E-01
angiotensin-mediated vasodilation involved in regulation of systemic arterial blood pressure (GO:0002033)	2	0	.05	-	 < 0.01	9.54E-01
desensitization of G protein-coupled receptor signaling pathway by arrestin (GO:0002032)	2	0	.05	-	 < 0.01	9.54E-01
inhibitory G protein-coupled receptor phosphorylation (GO:0002030)	1	0	.02	-	 < 0.01	9.77E-01
apical protein localization (GO:0045176)	14	0	.33	-	 < 0.01	7.21E-01
basal protein localization (GO:0045175)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to amine stimulus (GO:0071418)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to hydroxyisoflavone (GO:0071413)	2	0	.05	-	 < 0.01	9.54E-01
cellular response to genistein (GO:0071412)	2	0	.05	-	 < 0.01	9.54E-01
cytolysis by host of symbiont cells (GO:0051838)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of synapse structural plasticity (GO:0051835)	4	0	.09	-	 < 0.01	9.11E-01
UV-damage excision repair, DNA incision (GO:1990731)	1	0	.02	-	 < 0.01	9.77E-01
norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure (GO:0002025)	3	0	.07	-	 < 0.01	9.32E-01
diet induced thermogenesis (GO:0002024)	17	0	.40	-	 < 0.01	6.73E-01
reduction of food intake in response to dietary excess (GO:0002023)	5	0	.12	-	 < 0.01	8.90E-01
response to dietary excess (GO:0002021)	34	0	.79	-	 < 0.01	4.52E-01
cell-cell signaling involved in cell fate commitment (GO:0045168)	3	0	.07	-	 < 0.01	9.32E-01
asymmetric protein localization involved in cell fate determination (GO:0045167)	1	0	.02	-	 < 0.01	9.77E-01
clustering of voltage-gated potassium channels (GO:0045163)	4	0	.09	-	 < 0.01	9.11E-01
clustering of voltage-gated sodium channels (GO:0045162)	6	0	.14	-	 < 0.01	8.69E-01
neuronal ion channel clustering (GO:0045161)	12	0	.28	-	 < 0.01	7.56E-01
cellular response to low-density lipoprotein particle stimulus (GO:0071404)	16	0	.37	-	 < 0.01	6.89E-01
cellular response to high density lipoprotein particle stimulus (GO:0071403)	2	0	.05	-	 < 0.01	9.54E-01
response to ATP (GO:0033198)	29	0	.68	-	 < 0.01	5.08E-01
cellular response to lipoprotein particle stimulus (GO:0071402)	26	0	.61	-	 < 0.01	5.45E-01
response to vitamin E (GO:0033197)	2	0	.05	-	 < 0.01	9.54E-01
cellular response to triglyceride (GO:0071401)	1	0	.02	-	 < 0.01	9.77E-01
primary miRNA modification (GO:1990729)	1	0	.02	-	 < 0.01	9.77E-01
regulation of synapse structural plasticity (GO:0051823)	10	0	.23	-	 < 0.01	7.92E-01
regulation of renal output by angiotensin (GO:0002019)	3	0	.07	-	 < 0.01	9.32E-01
renin-angiotensin regulation of aldosterone production (GO:0002018)	4	0	.09	-	 < 0.01	9.11E-01
regulation of blood volume by renal aldosterone (GO:0002017)	3	0	.07	-	 < 0.01	9.32E-01
regulation of blood volume by renin-angiotensin (GO:0002016)	12	0	.28	-	 < 0.01	7.56E-01
response to vitamin A (GO:0033189)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of histone ubiquitination (GO:0033184)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of histone ubiquitination (GO:0033183)	4	0	.09	-	 < 0.01	9.11E-01
regulation of histone ubiquitination (GO:0033182)	13	0	.30	-	 < 0.01	7.38E-01
leukotriene A4 biosynthetic process (GO:1901753)	1	0	.02	-	 < 0.01	9.77E-01
leukotriene A4 metabolic process (GO:1901751)	1	0	.02	-	 < 0.01	9.77E-01
leukotriene D4 biosynthetic process (GO:1901750)	2	0	.05	-	 < 0.01	9.54E-01
xylulose metabolic process (GO:0005997)	3	0	.07	-	 < 0.01	9.32E-01
detection of hypoxic conditions in blood by chemoreceptor signaling (GO:0002007)	1	0	.02	-	 < 0.01	9.77E-01
trehalose catabolic process (GO:0005993)	1	0	.02	-	 < 0.01	9.77E-01
angiotensin maturation (GO:0002003)	3	0	.07	-	 < 0.01	9.32E-01
regulation of angiotensin levels in blood (GO:0002002)	6	0	.14	-	 < 0.01	8.69E-01
trehalose metabolic process (GO:0005991)	2	0	.05	-	 < 0.01	9.54E-01
renin secretion into blood stream (GO:0002001)	2	0	.05	-	 < 0.01	9.54E-01
male anatomical structure morphogenesis (GO:0090598)	5	0	.12	-	 < 0.01	8.90E-01
meiotic sister chromatid segregation (GO:0045144)	11	0	.26	-	 < 0.01	7.74E-01
homologous chromosome segregation (GO:0045143)	57	0	1.33	-	 < 0.01	2.64E-01
inflammatory response to wounding (GO:0090594)	11	0	.26	-	 < 0.01	7.74E-01
meiotic telomere clustering (GO:0045141)	9	0	.21	-	 < 0.01	8.11E-01
leukotriene D4 metabolic process (GO:1901748)	2	0	.05	-	 < 0.01	9.54E-01
presynaptic active zone organization (GO:1990709)	4	0	.09	-	 < 0.01	9.11E-01
cholangiocyte proliferation (GO:1990705)	2	0	.05	-	 < 0.01	9.54E-01
lactose biosynthetic process (GO:0005989)	2	0	.05	-	 < 0.01	9.54E-01
lactose metabolic process (GO:0005988)	2	0	.05	-	 < 0.01	9.54E-01
cytolysis in other organism involved in symbiotic interaction (GO:0051801)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of myoblast fusion (GO:1901740)	3	0	.07	-	 < 0.01	9.32E-01
nucleolar chromatin organization (GO:1990700)	1	0	.02	-	 < 0.01	9.77E-01
sucrose biosynthetic process (GO:0005986)	2	0	.05	-	 < 0.01	9.54E-01
sucrose metabolic process (GO:0005985)	2	0	.05	-	 < 0.01	9.54E-01
disaccharide metabolic process (GO:0005984)	6	0	.14	-	 < 0.01	8.69E-01
regulation of glycogen catabolic process (GO:0005981)	8	0	.19	-	 < 0.01	8.30E-01
glycogen catabolic process (GO:0005980)	10	0	.23	-	 < 0.01	7.92E-01
development of secondary sexual characteristics (GO:0045136)	13	0	.30	-	 < 0.01	7.38E-01
meiotic chromosome segregation (GO:0045132)	84	0	1.96	-	 < 0.01	1.40E-01
histone H3-K9 demethylation (GO:0033169)	13	0	.30	-	 < 0.01	7.38E-01
conversion of ds siRNA to ss siRNA involved in RNA interference (GO:0033168)	1	0	.02	-	 < 0.01	9.77E-01
regulation of vitamin A metabolic process (GO:1901738)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of platelet aggregation (GO:1901731)	2	0	.05	-	 < 0.01	9.54E-01
dsDNA loop formation (GO:0090579)	5	0	.12	-	 < 0.01	8.90E-01
regulation of bone resorption (GO:0045124)	51	0	1.19	-	 < 0.01	3.04E-01
T cell receptor V(D)J recombination (GO:0033153)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of histone deacetylase activity (GO:1901727)	6	0	.14	-	 < 0.01	8.69E-01
immunoglobulin V(D)J recombination (GO:0033152)	8	0	.19	-	 < 0.01	8.30E-01
detection of oxidative stress (GO:0070994)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of histone deacetylase activity (GO:1901726)	2	0	.05	-	 < 0.01	9.54E-01
V(D)J recombination (GO:0033151)	17	0	.40	-	 < 0.01	6.73E-01
regulation of histone deacetylase activity (GO:1901725)	8	0	.19	-	 < 0.01	8.30E-01
positive regulation of cell proliferation involved in kidney development (GO:1901724)	10	0	.23	-	 < 0.01	7.92E-01
negative regulation of cell proliferation involved in kidney development (GO:1901723)	6	0	.14	-	 < 0.01	8.69E-01
regulation of cell proliferation involved in kidney development (GO:1901722)	16	0	.37	-	 < 0.01	6.89E-01
azole transmembrane transport (GO:0045117)	9	0	.21	-	 < 0.01	8.11E-01
protein neddylation (GO:0045116)	13	0	.30	-	 < 0.01	7.38E-01
regulation of integrin biosynthetic process (GO:0045113)	5	0	.12	-	 < 0.01	8.90E-01
integrin biosynthetic process (GO:0045112)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of intracellular estrogen receptor signaling pathway (GO:0033148)	11	0	.26	-	 < 0.01	7.74E-01
negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147)	14	0	.33	-	 < 0.01	7.21E-01
oxidative demethylation (GO:0070989)	18	0	.42	-	 < 0.01	6.57E-01
regulation of intracellular estrogen receptor signaling pathway (GO:0033146)	34	0	.79	-	 < 0.01	4.52E-01
positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145)	17	0	.40	-	 < 0.01	6.73E-01
error-free translesion synthesis (GO:0070987)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141)	20	0	.47	-	 < 0.01	6.27E-01
negative regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033140)	3	0	.07	-	 < 0.01	9.32E-01
L-asparagine metabolic process (GO:0070982)	1	0	.02	-	 < 0.01	9.77E-01
biphenyl catabolic process (GO:0070980)	1	0	.02	-	 < 0.01	9.77E-01
regulation of intermediate filament polymerization or depolymerization (GO:0045108)	1	0	.02	-	 < 0.01	9.77E-01
regulation of membrane permeability (GO:0090559)	65	0	1.52	-	 < 0.01	2.19E-01
establishment of endothelial intestinal barrier (GO:0090557)	12	0	.28	-	 < 0.01	7.56E-01
intermediate filament polymerization or depolymerization (GO:0045105)	2	0	.05	-	 < 0.01	9.54E-01
regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139)	23	0	.54	-	 < 0.01	5.85E-01
negative regulation of peptidyl-serine phosphorylation (GO:0033137)	29	0	.68	-	 < 0.01	5.08E-01
protein K11-linked ubiquitination (GO:0070979)	27	0	.63	-	 < 0.01	5.33E-01
positive regulation of glucokinase activity (GO:0033133)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of glucokinase activity (GO:0033132)	4	0	.09	-	 < 0.01	9.11E-01
mesenchymal cell differentiation involved in bone development (GO:1901706)	2	0	.05	-	 < 0.01	9.54E-01
regulation of glucokinase activity (GO:0033131)	9	0	.21	-	 < 0.01	8.11E-01
protein localization to endoplasmic reticulum exit site (GO:0070973)	6	0	.14	-	 < 0.01	8.69E-01
detection of chemical stimulus involved in sensory perception of sweet taste (GO:0001582)	2	0	.05	-	 < 0.01	9.54E-01
detection of chemical stimulus involved in sensory perception of sour taste (GO:0001581)	2	0	.05	-	 < 0.01	9.54E-01
detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580)	47	0	1.10	-	 < 0.01	3.34E-01
positive regulation of histone phosphorylation (GO:0033129)	9	0	.21	-	 < 0.01	8.11E-01
negative regulation of histone phosphorylation (GO:0033128)	2	0	.05	-	 < 0.01	9.54E-01
nuclear-transcribed mRNA catabolic process, no-go decay (GO:0070966)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of neutrophil mediated killing of fungus (GO:0070965)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of neutrophil mediated killing of gram-negative bacterium (GO:0070963)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of neutrophil mediated killing of bacterium (GO:0070962)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of neutrophil mediated killing of symbiont cell (GO:0070961)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of neutrophil mediated cytotoxicity (GO:0070960)	4	0	.09	-	 < 0.01	9.11E-01
medium-chain fatty acid transport (GO:0001579)	2	0	.05	-	 < 0.01	9.54E-01
globoside biosynthetic process (GO:0001576)	2	0	.05	-	 < 0.01	9.54E-01
globoside metabolic process (GO:0001575)	2	0	.05	-	 < 0.01	9.54E-01
lactosylceramide biosynthetic process (GO:0001572)	1	0	.02	-	 < 0.01	9.77E-01
regulation of neutrophil mediated killing of fungus (GO:0070953)	3	0	.07	-	 < 0.01	9.32E-01
regulation of neutrophil mediated killing of gram-negative bacterium (GO:0070951)	2	0	.05	-	 < 0.01	9.54E-01
regulation of neutrophil mediated killing of bacterium (GO:0070950)	2	0	.05	-	 < 0.01	9.54E-01
cell septum assembly (GO:0090529)	1	0	.02	-	 < 0.01	9.77E-01
actin filament reorganization (GO:0090527)	7	0	.16	-	 < 0.01	8.49E-01
response to protozoan (GO:0001562)	37	0	.86	-	 < 0.01	4.22E-01
fatty acid alpha-oxidation (GO:0001561)	6	0	.14	-	 < 0.01	8.69E-01
vesicle tethering involved in exocytosis (GO:0090522)	1	0	.02	-	 < 0.01	9.77E-01
regulation of cell growth by extracellular stimulus (GO:0001560)	3	0	.07	-	 < 0.01	9.32E-01
sphingolipid mediated signaling pathway (GO:0090520)	10	0	.23	-	 < 0.01	7.92E-01
mitochondrial respiratory chain complex assembly (GO:0033108)	67	0	1.56	-	 < 0.01	2.09E-01
regulation of neutrophil mediated killing of symbiont cell (GO:0070949)	5	0	.12	-	 < 0.01	8.90E-01
regulation of neutrophil mediated cytotoxicity (GO:0070948)	7	0	.16	-	 < 0.01	8.49E-01
neutrophil-mediated killing of fungus (GO:0070947)	2	0	.05	-	 < 0.01	9.54E-01
neutrophil-mediated killing of gram-positive bacterium (GO:0070946)	2	0	.05	-	 < 0.01	9.54E-01
neutrophil-mediated killing of gram-negative bacterium (GO:0070945)	5	0	.12	-	 < 0.01	8.90E-01
neutrophil-mediated killing of bacterium (GO:0070944)	9	0	.21	-	 < 0.01	8.11E-01
neutrophil-mediated killing of symbiont cell (GO:0070943)	9	0	.21	-	 < 0.01	8.11E-01
neutrophil mediated cytotoxicity (GO:0070942)	9	0	.21	-	 < 0.01	8.11E-01
dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940)	5	0	.12	-	 < 0.01	8.90E-01
oocyte maturation (GO:0001556)	20	0	.47	-	 < 0.01	6.27E-01
oocyte growth (GO:0001555)	2	0	.05	-	 < 0.01	9.54E-01
ovarian cumulus expansion (GO:0001550)	3	0	.07	-	 < 0.01	9.32E-01
protein K48-linked ubiquitination (GO:0070936)	55	0	1.28	-	 < 0.01	2.77E-01
tooth eruption (GO:0044691)	5	0	.12	-	 < 0.01	8.90E-01
3'-UTR-mediated mRNA stabilization (GO:0070935)	15	0	.35	-	 < 0.01	7.05E-01
CRD-mediated mRNA stabilization (GO:0070934)	5	0	.12	-	 < 0.01	8.90E-01
histone H4 deacetylation (GO:0070933)	11	0	.26	-	 < 0.01	7.74E-01
negative regulation of thymocyte aggregation (GO:2000399)	1	0	.02	-	 < 0.01	9.77E-01
regulation of thymocyte aggregation (GO:2000398)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of ubiquitin-dependent endocytosis (GO:2000397)	2	0	.05	-	 < 0.01	9.54E-01
regulation of ubiquitin-dependent endocytosis (GO:2000395)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of neutrophil extravasation (GO:2000391)	8	0	.19	-	 < 0.01	8.30E-01
antral ovarian follicle growth (GO:0001547)	7	0	.16	-	 < 0.01	8.49E-01
preantral ovarian follicle growth (GO:0001546)	2	0	.05	-	 < 0.01	9.54E-01
primary ovarian follicle growth (GO:0001545)	3	0	.07	-	 < 0.01	9.32E-01
initiation of primordial ovarian follicle growth (GO:0001544)	2	0	.05	-	 < 0.01	9.54E-01
ovarian follicle rupture (GO:0001543)	3	0	.07	-	 < 0.01	9.32E-01
ovulation from ovarian follicle (GO:0001542)	12	0	.28	-	 < 0.01	7.56E-01
RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)	14	0	.33	-	 < 0.01	7.21E-01
RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)	28	0	.65	-	 < 0.01	5.20E-01
endocardial cushion to mesenchymal transition (GO:0090500)	5	0	.12	-	 < 0.01	8.90E-01
regulation of ATP:ADP antiporter activity (GO:0070926)	1	0	.02	-	 < 0.01	9.77E-01
regulation of production of small RNA involved in gene silencing by RNA (GO:0070920)	26	0	.61	-	 < 0.01	5.45E-01
regulation of neutrophil extravasation (GO:2000389)	9	0	.21	-	 < 0.01	8.11E-01
positive regulation of antral ovarian follicle growth (GO:2000388)	2	0	.05	-	 < 0.01	9.54E-01
regulation of antral ovarian follicle growth (GO:2000387)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of ovarian follicle development (GO:2000386)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of ectoderm development (GO:2000384)	2	0	.05	-	 < 0.01	9.54E-01
regulation of ectoderm development (GO:2000383)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of mesoderm development (GO:2000382)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of mesoderm development (GO:2000381)	4	0	.09	-	 < 0.01	9.11E-01
regulation of mesoderm development (GO:2000380)	7	0	.16	-	 < 0.01	8.49E-01
UV-damage excision repair (GO:0070914)	12	0	.28	-	 < 0.01	7.56E-01
positive regulation of oxygen metabolic process (GO:2000376)	2	0	.05	-	 < 0.01	9.54E-01
regulation of oxygen metabolic process (GO:2000374)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373)	3	0	.07	-	 < 0.01	9.32E-01
regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371)	3	0	.07	-	 < 0.01	9.32E-01
pseudouridine synthesis (GO:0001522)	17	0	.40	-	 < 0.01	6.73E-01
mitochondrial tRNA methylation (GO:0070901)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of interleukin-13 production (GO:0032696)	4	0	.09	-	 < 0.01	9.11E-01
mitochondrial tRNA modification (GO:0070900)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of interleukin-10 production (GO:0032693)	19	0	.44	-	 < 0.01	6.42E-01
positive regulation of acrosomal vesicle exocytosis (GO:2000368)	2	0	.05	-	 < 0.01	9.54E-01
regulation of acrosomal vesicle exocytosis (GO:2000367)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of prostaglandin-E synthase activity (GO:2000363)	2	0	.05	-	 < 0.01	9.54E-01
peptide amidation (GO:0001519)	1	0	.02	-	 < 0.01	9.77E-01
regulation of prostaglandin-E synthase activity (GO:2000361)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of binding of sperm to zona pellucida (GO:2000360)	2	0	.05	-	 < 0.01	9.54E-01
prostaglandin biosynthetic process (GO:0001516)	19	0	.44	-	 < 0.01	6.42E-01
selenocysteine incorporation (GO:0001514)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation by symbiont of host autophagy (GO:0140321)	1	0	.02	-	 < 0.01	9.77E-01
RNA methylation (GO:0001510)	58	0	1.35	-	 < 0.01	2.58E-01
negative regulation of interferon-alpha production (GO:0032687)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of hepatocyte growth factor production (GO:0032686)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of granulocyte macrophage colony-stimulating factor production (GO:0032685)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of connective tissue growth factor production (GO:0032683)	1	0	.02	-	 < 0.01	9.77E-01
regulation of binding of sperm to zona pellucida (GO:2000359)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of chemokine production (GO:0032682)	20	0	.47	-	 < 0.01	6.27E-01
positive regulation of kidney smooth muscle cell differentiation (GO:2000358)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of kidney smooth muscle cell differentiation (GO:2000357)	1	0	.02	-	 < 0.01	9.77E-01
regulation of kidney smooth muscle cell differentiation (GO:2000356)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of ovarian follicle development (GO:2000355)	2	0	.05	-	 < 0.01	9.54E-01
regulation of ovarian follicle development (GO:2000354)	8	0	.19	-	 < 0.01	8.30E-01
positive regulation of CD40 signaling pathway (GO:2000350)	1	0	.02	-	 < 0.01	9.77E-01
histone H3-K4 dimethylation (GO:0044648)	4	0	.09	-	 < 0.01	9.11E-01
regulation of TRAIL production (GO:0032679)	2	0	.05	-	 < 0.01	9.54E-01
regulation of interleukin-8 production (GO:0032677)	70	0	1.63	-	 < 0.01	1.95E-01
negative regulation of CD40 signaling pathway (GO:2000349)	2	0	.05	-	 < 0.01	9.54E-01
regulation of interleukin-3 production (GO:0032672)	3	0	.07	-	 < 0.01	9.32E-01
regulation of CD40 signaling pathway (GO:2000348)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of hepatocyte proliferation (GO:2000347)	14	0	.33	-	 < 0.01	7.21E-01
negative regulation of hepatocyte proliferation (GO:2000346)	5	0	.12	-	 < 0.01	8.90E-01
regulation of hepatocyte proliferation (GO:2000345)	23	0	.54	-	 < 0.01	5.85E-01
positive regulation of acrosome reaction (GO:2000344)	11	0	.26	-	 < 0.01	7.74E-01
positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343)	12	0	.28	-	 < 0.01	7.56E-01
negative regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000342)	2	0	.05	-	 < 0.01	9.54E-01
regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341)	16	0	.37	-	 < 0.01	6.89E-01
positive regulation of chemokine (C-X-C motif) ligand 1 production (GO:2000340)	5	0	.12	-	 < 0.01	8.90E-01
serine import into mitochondrion (GO:0140300)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of viral release from host cell (GO:1902188)	15	0	.35	-	 < 0.01	7.05E-01
peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine (GO:0018395)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of viral release from host cell (GO:1902187)	16	0	.37	-	 < 0.01	6.89E-01
regulation of viral release from host cell (GO:1902186)	31	0	.72	-	 < 0.01	4.85E-01
regulation of interleukin-23 production (GO:0032667)	8	0	.19	-	 < 0.01	8.30E-01
regulation of interleukin-2 production (GO:0032663)	58	0	1.35	-	 < 0.01	2.58E-01
regulation of chemokine (C-X-C motif) ligand 1 production (GO:2000338)	6	0	.14	-	 < 0.01	8.69E-01
regulation of interleukin-18 production (GO:0032661)	8	0	.19	-	 < 0.01	8.30E-01
regulation of interleukin-17 production (GO:0032660)	34	0	.79	-	 < 0.01	4.52E-01
positive regulation of blood microparticle formation (GO:2000334)	2	0	.05	-	 < 0.01	9.54E-01
regulation of blood microparticle formation (GO:2000332)	2	0	.05	-	 < 0.01	9.54E-01
regulation of terminal button organization (GO:2000331)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of T-helper 17 cell lineage commitment (GO:2000330)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of keratinocyte apoptotic process (GO:1902174)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of keratinocyte apoptotic process (GO:1902173)	2	0	.05	-	 < 0.01	9.54E-01
regulation of keratinocyte apoptotic process (GO:1902172)	7	0	.16	-	 < 0.01	8.49E-01
regulation of interleukin-16 production (GO:0032659)	1	0	.02	-	 < 0.01	9.77E-01
regulation of interleukin-15 production (GO:0032658)	1	0	.02	-	 < 0.01	9.77E-01
regulation of interleukin-10 production (GO:0032653)	54	0	1.26	-	 < 0.01	2.83E-01
negative regulation of T-helper 17 cell lineage commitment (GO:2000329)	3	0	.07	-	 < 0.01	9.32E-01
regulation of T-helper 17 cell lineage commitment (GO:2000328)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of glucocorticoid receptor signaling pathway (GO:2000324)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of T-helper 17 cell differentiation (GO:2000321)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of T-helper 17 cell differentiation (GO:2000320)	11	0	.26	-	 < 0.01	7.74E-01
protein myristoylation (GO:0018377)	4	0	.09	-	 < 0.01	9.11E-01
metabolism of macromolecule in other organism involved in symbiotic interaction (GO:0052229)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902167)	2	0	.05	-	 < 0.01	9.54E-01
catabolism of substance in other organism involved in symbiotic interaction (GO:0052227)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166)	10	0	.23	-	 < 0.01	7.92E-01
regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165)	13	0	.30	-	 < 0.01	7.38E-01
positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:1902164)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:1902163)	1	0	.02	-	 < 0.01	9.77E-01
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:1902162)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of cyclic nucleotide-gated ion channel activity (GO:1902161)	1	0	.02	-	 < 0.01	9.77E-01
regulation of hepatocyte growth factor production (GO:0032646)	1	0	.02	-	 < 0.01	9.77E-01
regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645)	13	0	.30	-	 < 0.01	7.38E-01
regulation of connective tissue growth factor production (GO:0032643)	3	0	.07	-	 < 0.01	9.32E-01
regulation of T-helper 17 cell differentiation (GO:2000319)	16	0	.37	-	 < 0.01	6.89E-01
positive regulation of T-helper 17 type immune response (GO:2000318)	8	0	.19	-	 < 0.01	8.30E-01
lymphotoxin A production (GO:0032641)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of T-helper 17 type immune response (GO:2000317)	12	0	.28	-	 < 0.01	7.56E-01
tumor necrosis factor production (GO:0032640)	7	0	.16	-	 < 0.01	8.49E-01
regulation of T-helper 17 type immune response (GO:2000316)	21	0	.49	-	 < 0.01	6.13E-01
negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation (GO:2000314)	2	0	.05	-	 < 0.01	9.54E-01
regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation (GO:2000313)	3	0	.07	-	 < 0.01	9.32E-01
regulation of kainate selective glutamate receptor activity (GO:2000312)	3	0	.07	-	 < 0.01	9.32E-01
regulation of AMPA receptor activity (GO:2000311)	25	0	.58	-	 < 0.01	5.58E-01
regulation of NMDA receptor activity (GO:2000310)	28	0	.65	-	 < 0.01	5.20E-01
regulation of cyclic nucleotide-gated ion channel activity (GO:1902159)	2	0	.05	-	 < 0.01	9.54E-01
metabolism of substance in other organism involved in symbiotic interaction (GO:0052214)	2	0	.05	-	 < 0.01	9.54E-01
mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398)	5	0	.12	-	 < 0.01	8.90E-01
interleukin-9 production (GO:0032638)	1	0	.02	-	 < 0.01	9.77E-01
termination of mitochondrial transcription (GO:0006393)	3	0	.07	-	 < 0.01	9.32E-01
interleukin-8 production (GO:0032637)	5	0	.12	-	 < 0.01	8.90E-01
transcription elongation from mitochondrial promoter (GO:0006392)	1	0	.02	-	 < 0.01	9.77E-01
transcription initiation from mitochondrial promoter (GO:0006391)	4	0	.09	-	 < 0.01	9.11E-01
interleukin-6 production (GO:0032635)	13	0	.30	-	 < 0.01	7.38E-01
mitochondrial transcription (GO:0006390)	14	0	.33	-	 < 0.01	7.21E-01
interleukin-5 production (GO:0032634)	1	0	.02	-	 < 0.01	9.77E-01
interleukin-4 production (GO:0032633)	9	0	.21	-	 < 0.01	8.11E-01
positive regulation of tumor necrosis factor (ligand) superfamily member 11 production (GO:2000309)	2	0	.05	-	 < 0.01	9.54E-01
interleukin-3 production (GO:0032632)	1	0	.02	-	 < 0.01	9.77E-01
regulation of tumor necrosis factor (ligand) superfamily member 11 production (GO:2000307)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of ceramide biosynthetic process (GO:2000304)	6	0	.14	-	 < 0.01	8.69E-01
regulation of ceramide biosynthetic process (GO:2000303)	11	0	.26	-	 < 0.01	7.74E-01
positive regulation of synaptic vesicle exocytosis (GO:2000302)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of synaptic vesicle exocytosis (GO:2000301)	5	0	.12	-	 < 0.01	8.90E-01
protein-pyridoxal-5-phosphate linkage (GO:0018352)	1	0	.02	-	 < 0.01	9.77E-01
modulation of molecular function in other organism involved in symbiotic interaction (GO:0052205)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of molecular function in other organism involved in symbiotic interaction (GO:0052204)	5	0	.12	-	 < 0.01	8.90E-01
induction of synaptic vesicle exocytosis by positive regulation of presynaptic cytosolic calcium ion concentration (GO:0099703)	1	0	.02	-	 < 0.01	9.77E-01
modulation of catalytic activity in other organism involved in symbiotic interaction (GO:0052203)	3	0	.07	-	 < 0.01	9.32E-01
tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)	9	0	.21	-	 < 0.01	8.11E-01
response to host defenses (GO:0052200)	1	0	.02	-	 < 0.01	9.77E-01
termination of RNA polymerase III transcription (GO:0006386)	1	0	.02	-	 < 0.01	9.77E-01
transcription initiation from RNA polymerase III promoter (GO:0006384)	6	0	.14	-	 < 0.01	8.69E-01
transcription by RNA polymerase III (GO:0006383)	22	0	.51	-	 < 0.01	5.99E-01
adenosine to inosine editing (GO:0006382)	8	0	.19	-	 < 0.01	8.30E-01
interleukin-21 production (GO:0032625)	3	0	.07	-	 < 0.01	9.32E-01
interleukin-2 production (GO:0032623)	9	0	.21	-	 < 0.01	8.11E-01
interleukin-17 production (GO:0032620)	7	0	.16	-	 < 0.01	8.49E-01
protein geranylgeranylation (GO:0018344)	6	0	.14	-	 < 0.01	8.69E-01
protein farnesylation (GO:0018343)	4	0	.09	-	 < 0.01	9.11E-01
protein prenylation (GO:0018342)	11	0	.26	-	 < 0.01	7.74E-01
mRNA polyadenylation (GO:0006378)	30	0	.70	-	 < 0.01	4.97E-01
interleukin-15 production (GO:0032618)	1	0	.02	-	 < 0.01	9.77E-01
interleukin-13 production (GO:0032616)	3	0	.07	-	 < 0.01	9.32E-01
interleukin-12 production (GO:0032615)	3	0	.07	-	 < 0.01	9.32E-01
7-methylguanosine mRNA capping (GO:0006370)	5	0	.12	-	 < 0.01	8.90E-01
interleukin-10 production (GO:0032613)	6	0	.14	-	 < 0.01	8.69E-01
interleukin-1 alpha production (GO:0032610)	2	0	.05	-	 < 0.01	9.54E-01
protein succinylation (GO:0018335)	4	0	.09	-	 < 0.01	9.11E-01
cellular response to jasmonic acid stimulus (GO:0071395)	2	0	.05	-	 < 0.01	9.54E-01
cellular response to testosterone stimulus (GO:0071394)	7	0	.16	-	 < 0.01	8.49E-01
cellular response to progesterone stimulus (GO:0071393)	3	0	.07	-	 < 0.01	9.32E-01
cellular response to estrogen stimulus (GO:0071391)	16	0	.37	-	 < 0.01	6.89E-01
termination of RNA polymerase II transcription (GO:0006369)	6	0	.14	-	 < 0.01	8.69E-01
transcription elongation from RNA polymerase II promoter (GO:0006368)	24	0	.56	-	 < 0.01	5.71E-01
transcription initiation from RNA polymerase II promoter (GO:0006367)	30	0	.70	-	 < 0.01	4.97E-01
interferon-gamma production (GO:0032609)	20	0	.47	-	 < 0.01	6.27E-01
interferon-beta production (GO:0032608)	2	0	.05	-	 < 0.01	9.54E-01
termination of RNA polymerase I transcription (GO:0006363)	2	0	.05	-	 < 0.01	9.54E-01
interferon-alpha production (GO:0032607)	5	0	.12	-	 < 0.01	8.90E-01
transcription elongation from RNA polymerase I promoter (GO:0006362)	6	0	.14	-	 < 0.01	8.69E-01
type I interferon production (GO:0032606)	11	0	.26	-	 < 0.01	7.74E-01
transcription initiation from RNA polymerase I promoter (GO:0006361)	7	0	.16	-	 < 0.01	8.49E-01
transcription by RNA polymerase I (GO:0006360)	15	0	.35	-	 < 0.01	7.05E-01
chemokine production (GO:0032602)	10	0	.23	-	 < 0.01	7.92E-01
chemokine receptor transport out of membrane raft (GO:0032600)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to mineralocorticoid stimulus (GO:0071389)	6	0	.14	-	 < 0.01	8.69E-01
cellular response to cortisol stimulus (GO:0071387)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to corticosterone stimulus (GO:0071386)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to glucocorticoid stimulus (GO:0071385)	39	0	.91	-	 < 0.01	4.02E-01
cellular response to corticosteroid stimulus (GO:0071384)	44	0	1.03	-	 < 0.01	3.58E-01
cellular response to steroid hormone stimulus (GO:0071383)	89	0	2.07	-	 < 0.01	1.25E-01
protein tyrosinylation (GO:0018322)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to prostaglandin E stimulus (GO:0071380)	13	0	.30	-	 < 0.01	7.38E-01
regulation of transcription by RNA polymerase III (GO:0006359)	16	0	.37	-	 < 0.01	6.89E-01
positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110)	11	0	.26	-	 < 0.01	7.74E-01
DNA-templated transcription, elongation (GO:0006354)	31	0	.72	-	 < 0.01	4.85E-01
DNA-templated transcription, termination (GO:0006353)	17	0	.40	-	 < 0.01	6.73E-01
DNA-templated transcription, initiation (GO:0006352)	54	0	1.26	-	 < 0.01	2.83E-01
intracellular transport of virus (GO:0075733)	2	0	.05	-	 < 0.01	9.54E-01
viral penetration into host nucleus (GO:0075732)	2	0	.05	-	 < 0.01	9.54E-01
cellular response to prostaglandin stimulus (GO:0071379)	16	0	.37	-	 < 0.01	6.89E-01
cellular response to growth hormone stimulus (GO:0071378)	11	0	.26	-	 < 0.01	7.74E-01
protein C-linked glycosylation via tryptophan (GO:0018317)	4	0	.09	-	 < 0.01	9.11E-01
cellular response to glucagon stimulus (GO:0071377)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902109)	4	0	.09	-	 < 0.01	9.11E-01
cellular response to corticotropin-releasing hormone stimulus (GO:0071376)	4	0	.09	-	 < 0.01	9.11E-01
regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108)	19	0	.44	-	 < 0.01	6.42E-01
molybdenum incorporation into molybdenum-molybdopterin complex (GO:0018315)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to parathyroid hormone stimulus (GO:0071374)	4	0	.09	-	 < 0.01	9.11E-01
cellular response to luteinizing hormone stimulus (GO:0071373)	1	0	.02	-	 < 0.01	9.77E-01
peptidyl-serine ADP-ribosylation (GO:0018312)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of metaphase/anaphase transition of meiotic cell cycle (GO:1902104)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of metaphase/anaphase transition of meiotic cell cycle (GO:1902103)	3	0	.07	-	 < 0.01	9.32E-01
regulation of metaphase/anaphase transition of meiotic cell cycle (GO:1902102)	4	0	.09	-	 < 0.01	9.11E-01
regulation of gene expression by genetic imprinting (GO:0006349)	17	0	.40	-	 < 0.01	6.73E-01
positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101)	14	0	.33	-	 < 0.01	7.21E-01
chromatin silencing at telomere (GO:0006348)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100)	29	0	.68	-	 < 0.01	5.08E-01
positive regulation of hair follicle development (GO:0051798)	12	0	.28	-	 < 0.01	7.56E-01
protein depalmitoleylation (GO:1990697)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of timing of catagen (GO:0051796)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of timing of catagen (GO:0051795)	3	0	.07	-	 < 0.01	9.32E-01
regulation of timing of catagen (GO:0051794)	4	0	.09	-	 < 0.01	9.11E-01
chromatin silencing (GO:0006342)	35	0	.82	-	 < 0.01	4.42E-01
medium-chain fatty acid catabolic process (GO:0051793)	3	0	.07	-	 < 0.01	9.32E-01
medium-chain fatty acid biosynthetic process (GO:0051792)	5	0	.12	-	 < 0.01	8.90E-01
short-chain fatty acid biosynthetic process (GO:0051790)	4	0	.09	-	 < 0.01	9.11E-01
cellular response to epidermal growth factor stimulus (GO:0071364)	41	0	.96	-	 < 0.01	3.84E-01
cellular response to ether (GO:0071362)	8	0	.19	-	 < 0.01	8.30E-01
cellular response to exogenous dsRNA (GO:0071360)	13	0	.30	-	 < 0.01	7.38E-01
response to misfolded protein (GO:0051788)	26	0	.61	-	 < 0.01	5.45E-01
DNA replication-independent nucleosome assembly (GO:0006336)	14	0	.33	-	 < 0.01	7.21E-01
DNA replication-dependent nucleosome assembly (GO:0006335)	8	0	.19	-	 < 0.01	8.30E-01
DNA double-strand break attachment to nuclear envelope (GO:1990683)	2	0	.05	-	 < 0.01	9.54E-01
establishment of integrated proviral latency (GO:0075713)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to dsRNA (GO:0071359)	19	0	.44	-	 < 0.01	6.42E-01
cellular response to interleukin-6 (GO:0071354)	25	0	.58	-	 < 0.01	5.58E-01
cellular response to interleukin-2 (GO:0071352)	2	0	.05	-	 < 0.01	9.54E-01
cellular response to interleukin-18 (GO:0071351)	6	0	.14	-	 < 0.01	8.69E-01
cellular response to interleukin-15 (GO:0071350)	6	0	.14	-	 < 0.01	8.69E-01
histone H4-K12 deacetylation (GO:1990679)	1	0	.02	-	 < 0.01	9.77E-01
histone H4-K16 deacetylation (GO:1990678)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of nitric-oxide synthase biosynthetic process (GO:0051771)	5	0	.12	-	 < 0.01	8.90E-01
cellular response to interleukin-12 (GO:0071349)	4	0	.09	-	 < 0.01	9.11E-01
cellular response to interleukin-11 (GO:0071348)	1	0	.02	-	 < 0.01	9.77E-01
transposition, DNA-mediated (GO:0006313)	1	0	.02	-	 < 0.01	9.77E-01
mitotic recombination (GO:0006312)	19	0	.44	-	 < 0.01	6.42E-01
meiotic gene conversion (GO:0006311)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of hair follicle cell proliferation (GO:0071338)	1	0	.02	-	 < 0.01	9.77E-01
regulation of hair follicle cell proliferation (GO:0071336)	2	0	.05	-	 < 0.01	9.54E-01
regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091)	10	0	.23	-	 < 0.01	7.92E-01
hair follicle cell proliferation (GO:0071335)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to fructose stimulus (GO:0071332)	3	0	.07	-	 < 0.01	9.32E-01
apoptotic DNA fragmentation (GO:0006309)	9	0	.21	-	 < 0.01	8.11E-01
DNA dealkylation involved in DNA repair (GO:0006307)	6	0	.14	-	 < 0.01	8.69E-01
homologous chromosome movement towards spindle pole in meiosis I anaphase (GO:0051758)	1	0	.02	-	 < 0.01	9.77E-01
cannabinoid biosynthetic process (GO:1901696)	1	0	.02	-	 < 0.01	9.77E-01
double-strand break repair via nonhomologous end joining (GO:0006303)	33	0	.77	-	 < 0.01	4.63E-01
meiotic sister chromatid cohesion, centromeric (GO:0051754)	4	0	.09	-	 < 0.01	9.11E-01
sebum secreting cell proliferation (GO:1990654)	1	0	.02	-	 < 0.01	9.77E-01
postreplication repair (GO:0006301)	22	0	.51	-	 < 0.01	5.99E-01
cellular response to sucrose stimulus (GO:0071329)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to disaccharide stimulus (GO:0071324)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to cGMP (GO:0071321)	6	0	.14	-	 < 0.01	8.69E-01
cellular response to cAMP (GO:0071320)	34	0	.79	-	 < 0.01	4.52E-01
glutathione derivative biosynthetic process (GO:1901687)	1	0	.02	-	 < 0.01	9.77E-01
glutathione derivative metabolic process (GO:1901685)	1	0	.02	-	 < 0.01	9.77E-01
arsenate ion transmembrane transport (GO:1901684)	1	0	.02	-	 < 0.01	9.77E-01
response to iron ion starvation (GO:1990641)	2	0	.05	-	 < 0.01	9.54E-01
cellular response to ATP (GO:0071318)	12	0	.28	-	 < 0.01	7.56E-01
cellular response to isoquinoline alkaloid (GO:0071317)	3	0	.07	-	 < 0.01	9.32E-01
cellular response to nicotine (GO:0071316)	6	0	.14	-	 < 0.01	8.69E-01
cellular response to morphine (GO:0071315)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of viral genome replication (GO:0045070)	26	0	.61	-	 < 0.01	5.45E-01
cellular response to cocaine (GO:0071314)	3	0	.07	-	 < 0.01	9.32E-01
cellular response to caffeine (GO:0071313)	6	0	.14	-	 < 0.01	8.69E-01
nucleotide transmembrane transport (GO:1901679)	7	0	.16	-	 < 0.01	8.49E-01
iron coordination entity transport (GO:1901678)	12	0	.28	-	 < 0.01	7.56E-01
positive regulation of histone H3-K27 acetylation (GO:1901676)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of histone H3-K27 acetylation (GO:1901675)	1	0	.02	-	 < 0.01	9.77E-01
reproductive senescence (GO:1990636)	1	0	.02	-	 < 0.01	9.77E-01
regulation of histone H3-K27 acetylation (GO:1901674)	3	0	.07	-	 < 0.01	9.32E-01
regulation of mitotic spindle assembly (GO:1901673)	16	0	.37	-	 < 0.01	6.89E-01
positive regulation of superoxide dismutase activity (GO:1901671)	5	0	.12	-	 < 0.01	8.90E-01
regulatory T cell differentiation (GO:0045066)	7	0	.16	-	 < 0.01	8.49E-01
cytotoxic T cell differentiation (GO:0045065)	1	0	.02	-	 < 0.01	9.77E-01
T-helper 2 cell differentiation (GO:0045064)	4	0	.09	-	 < 0.01	9.11E-01
T-helper 1 cell differentiation (GO:0045063)	11	0	.26	-	 < 0.01	7.74E-01
cellular response to vitamin K (GO:0071307)	2	0	.05	-	 < 0.01	9.54E-01
extrathymic T cell selection (GO:0045062)	2	0	.05	-	 < 0.01	9.54E-01
thymic T cell selection (GO:0045061)	24	0	.56	-	 < 0.01	5.71E-01
negative thymic T cell selection (GO:0045060)	14	0	.33	-	 < 0.01	7.21E-01
cellular response to retinoic acid (GO:0071300)	43	0	1.00	-	 < 0.01	3.67E-01
germline cell cycle switching, mitotic to meiotic cell cycle (GO:0051729)	3	0	.07	-	 < 0.01	9.32E-01
regulation of superoxide dismutase activity (GO:1901668)	6	0	.14	-	 < 0.01	8.69E-01
cell cycle switching, mitotic to meiotic cell cycle (GO:0051728)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of immature T cell proliferation in thymus (GO:0033092)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of NAD+ ADP-ribosyltransferase activity (GO:1901666)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of immature T cell proliferation (GO:0033091)	6	0	.14	-	 < 0.01	8.69E-01
protein de-ADP-ribosylation (GO:0051725)	4	0	.09	-	 < 0.01	9.11E-01
regulation of NAD+ ADP-ribosyltransferase activity (GO:1901664)	3	0	.07	-	 < 0.01	9.32E-01
quinone catabolic process (GO:1901662)	4	0	.09	-	 < 0.01	9.11E-01
positive thymic T cell selection (GO:0045059)	13	0	.30	-	 < 0.01	7.38E-01
T cell selection (GO:0045058)	49	0	1.14	-	 < 0.01	3.19E-01
regulated exocytosis (GO:0045055)	119	0	2.77	-	 < 0.01	6.18E-02
constitutive secretory pathway (GO:0045054)	3	0	.07	-	 < 0.01	9.32E-01
protein retention in Golgi apparatus (GO:0045053)	5	0	.12	-	 < 0.01	8.90E-01
protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050)	9	0	.21	-	 < 0.01	8.11E-01
positive regulation of T cell differentiation in thymus (GO:0033089)	11	0	.26	-	 < 0.01	7.74E-01
negative regulation of immature T cell proliferation in thymus (GO:0033088)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of immature T cell proliferation (GO:0033087)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of T cell differentiation in thymus (GO:0033085)	9	0	.21	-	 < 0.01	8.11E-01
glycosyl compound biosynthetic process (GO:1901659)	23	0	.54	-	 < 0.01	5.85E-01
regulation of immature T cell proliferation in thymus (GO:0033084)	10	0	.23	-	 < 0.01	7.92E-01
glycosyl compound catabolic process (GO:1901658)	30	0	.70	-	 < 0.01	4.97E-01
regulation of immature T cell proliferation (GO:0033083)	12	0	.28	-	 < 0.01	7.56E-01
glycosyl compound metabolic process (GO:1901657)	101	0	2.35	-	 < 0.01	9.43E-02
regulation of extrathymic T cell differentiation (GO:0033082)	1	0	.02	-	 < 0.01	9.77E-01
glycoside transport (GO:1901656)	4	0	.09	-	 < 0.01	9.11E-01
regulation of T cell differentiation in thymus (GO:0033081)	26	0	.61	-	 < 0.01	5.45E-01
immature T cell proliferation in thymus (GO:0033080)	1	0	.02	-	 < 0.01	9.77E-01
cytolysis in other organism (GO:0051715)	6	0	.14	-	 < 0.01	8.69E-01
mitochondrial membrane fusion (GO:1990613)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of killing of cells of other organism (GO:0051712)	12	0	.28	-	 < 0.01	7.56E-01
protein insertion into ER membrane (GO:0045048)	15	0	.35	-	 < 0.01	7.05E-01
protein targeting to ER (GO:0045047)	33	0	.77	-	 < 0.01	4.63E-01
protein import into peroxisome membrane (GO:0045046)	6	0	.14	-	 < 0.01	8.69E-01
mesenchymal cell migration (GO:0090497)	2	0	.05	-	 < 0.01	9.54E-01
dopamine uptake (GO:0090494)	9	0	.21	-	 < 0.01	8.11E-01
catecholamine uptake (GO:0090493)	9	0	.21	-	 < 0.01	8.11E-01
protein import into mitochondrial intermembrane space (GO:0045041)	4	0	.09	-	 < 0.01	9.11E-01
protein insertion into mitochondrial outer membrane (GO:0045040)	4	0	.09	-	 < 0.01	9.11E-01
immature T cell proliferation (GO:0033079)	1	0	.02	-	 < 0.01	9.77E-01
extrathymic T cell differentiation (GO:0033078)	2	0	.05	-	 < 0.01	9.54E-01
regulation of killing of cells of other organism (GO:0051709)	15	0	.35	-	 < 0.01	7.05E-01
positive regulation of synoviocyte proliferation (GO:1901647)	2	0	.05	-	 < 0.01	9.54E-01
regulation of synoviocyte proliferation (GO:1901645)	2	0	.05	-	 < 0.01	9.54E-01
nucleoside transmembrane transport (GO:1901642)	7	0	.16	-	 < 0.01	8.49E-01
protein insertion into mitochondrial inner membrane (GO:0045039)	6	0	.14	-	 < 0.01	8.69E-01
pyrimidine nucleotide-sugar transmembrane transport (GO:0090481)	9	0	.21	-	 < 0.01	8.11E-01
purine nucleotide-sugar transmembrane transport (GO:0090480)	1	0	.02	-	 < 0.01	9.77E-01
XDP catabolic process (GO:1901639)	1	0	.02	-	 < 0.01	9.77E-01
plasma membrane fusion (GO:0045026)	16	0	.37	-	 < 0.01	6.89E-01
dibasic protein processing (GO:0090472)	1	0	.02	-	 < 0.01	9.77E-01
cellular pigmentation (GO:0033059)	41	0	.96	-	 < 0.01	3.84E-01
directional locomotion (GO:0033058)	3	0	.07	-	 < 0.01	9.32E-01
mitochondrial tRNA wobble uridine modification (GO:0070899)	1	0	.02	-	 < 0.01	9.77E-01
RNA polymerase III preinitiation complex assembly (GO:0070898)	1	0	.02	-	 < 0.01	9.77E-01
transcription preinitiation complex assembly (GO:0070897)	15	0	.35	-	 < 0.01	7.05E-01
positive regulation of postsynaptic membrane organization (GO:1901628)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of transposon integration (GO:0070895)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of postsynaptic membrane organization (GO:1901627)	1	0	.02	-	 < 0.01	9.77E-01
regulation of transposon integration (GO:0070894)	2	0	.05	-	 < 0.01	9.54E-01
regulation of postsynaptic membrane organization (GO:1901626)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of lymphocyte chemotaxis (GO:1901624)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning (GO:1901622)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning (GO:1901621)	7	0	.16	-	 < 0.01	8.49E-01
regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning (GO:1901620)	11	0	.26	-	 < 0.01	7.74E-01
mitochondrial magnesium ion transmembrane transport (GO:0045016)	1	0	.02	-	 < 0.01	9.77E-01
glutamate homeostasis (GO:0090461)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of mitotic sister chromatid segregation (GO:0033048)	28	0	.65	-	 < 0.01	5.20E-01
regulation of mitotic sister chromatid segregation (GO:0033047)	41	0	.96	-	 < 0.01	3.84E-01
platelet alpha granule organization (GO:0070889)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of sister chromatid segregation (GO:0033046)	28	0	.65	-	 < 0.01	5.20E-01
organic hydroxy compound catabolic process (GO:1901616)	59	0	1.38	-	 < 0.01	2.52E-01
regulation of proline transport (GO:0070881)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of vesicle transport along microtubule (GO:1901610)	4	0	.09	-	 < 0.01	9.11E-01
DNA deamination (GO:0045006)	7	0	.16	-	 < 0.01	8.49E-01
DNA-dependent DNA replication maintenance of fidelity (GO:0045005)	39	0	.91	-	 < 0.01	4.02E-01
DNA replication proofreading (GO:0045004)	2	0	.05	-	 < 0.01	9.54E-01
double-strand break repair via synthesis-dependent strand annealing (GO:0045003)	8	0	.19	-	 < 0.01	8.30E-01
double-strand break repair via single-strand annealing (GO:0045002)	4	0	.09	-	 < 0.01	9.11E-01
polysaccharide localization (GO:0033037)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of vesicle transport along microtubule (GO:1901609)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of myeloid cell apoptotic process (GO:0033034)	9	0	.21	-	 < 0.01	8.11E-01
regulation of vesicle transport along microtubule (GO:1901608)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of myeloid cell apoptotic process (GO:0033033)	19	0	.44	-	 < 0.01	6.42E-01
alpha-amino acid biosynthetic process (GO:1901607)	52	0	1.21	-	 < 0.01	2.97E-01
regulation of myeloid cell apoptotic process (GO:0033032)	33	0	.77	-	 < 0.01	4.63E-01
negative regulation of glycogen metabolic process (GO:0070874)	7	0	.16	-	 < 0.01	8.49E-01
alpha-amino acid catabolic process (GO:1901606)	66	0	1.54	-	 < 0.01	2.14E-01
positive regulation of neutrophil apoptotic process (GO:0033031)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of neutrophil apoptotic process (GO:0033030)	4	0	.09	-	 < 0.01	9.11E-01
endocytic iron import into cell (GO:0140298)	1	0	.02	-	 < 0.01	9.77E-01
peptidyl-glutamate ADP-deribosylation (GO:0140291)	2	0	.05	-	 < 0.01	9.54E-01
regulation of neutrophil apoptotic process (GO:0033029)	10	0	.23	-	 < 0.01	7.92E-01
myeloid cell apoptotic process (GO:0033028)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of mast cell apoptotic process (GO:0033026)	4	0	.09	-	 < 0.01	9.11E-01
heterochromatin organization involved in chromatin silencing (GO:0070868)	7	0	.16	-	 < 0.01	8.49E-01
regulation of mast cell apoptotic process (GO:0033025)	5	0	.12	-	 < 0.01	8.90E-01
mast cell homeostasis (GO:0033023)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of protein exit from endoplasmic reticulum (GO:0070863)	13	0	.30	-	 < 0.01	7.38E-01
protein mono-ADP-ribosylation (GO:0140289)	11	0	.26	-	 < 0.01	7.74E-01
protein localization to nuclear envelope (GO:0090435)	10	0	.23	-	 < 0.01	7.92E-01
negative regulation of bile acid biosynthetic process (GO:0070858)	2	0	.05	-	 < 0.01	9.54E-01
tetrapyrrole catabolic process (GO:0033015)	5	0	.12	-	 < 0.01	8.90E-01
tetrapyrrole biosynthetic process (GO:0033014)	27	0	.63	-	 < 0.01	5.33E-01
tetrapyrrole metabolic process (GO:0033013)	45	0	1.05	-	 < 0.01	3.50E-01
detection of endogenous biotic stimulus (GO:0090429)	1	0	.02	-	 < 0.01	9.77E-01
activation of meiosis (GO:0090427)	5	0	.12	-	 < 0.01	8.90E-01
acinar cell differentiation (GO:0090425)	1	0	.02	-	 < 0.01	9.77E-01
naphthalene-containing compound metabolic process (GO:0090420)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of mast cell activation involved in immune response (GO:0033008)	23	0	.54	-	 < 0.01	5.85E-01
negative regulation of mast cell activation involved in immune response (GO:0033007)	9	0	.21	-	 < 0.01	8.11E-01
response to epidermal growth factor (GO:0070849)	44	0	1.03	-	 < 0.01	3.58E-01
regulation of mast cell activation involved in immune response (GO:0033006)	39	0	.91	-	 < 0.01	4.02E-01
positive regulation of mast cell activation (GO:0033005)	34	0	.79	-	 < 0.01	4.52E-01
negative regulation of mast cell activation (GO:0033004)	13	0	.30	-	 < 0.01	7.38E-01
Hsp90 deacetylation (GO:0070846)	1	0	.02	-	 < 0.01	9.77E-01
polyubiquitinated misfolded protein transport (GO:0070845)	1	0	.02	-	 < 0.01	9.77E-01
polyubiquitinated protein transport (GO:0070844)	1	0	.02	-	 < 0.01	9.77E-01
misfolded protein transport (GO:0070843)	1	0	.02	-	 < 0.01	9.77E-01
aggresome assembly (GO:0070842)	6	0	.14	-	 < 0.01	8.69E-01
inclusion body assembly (GO:0070841)	7	0	.16	-	 < 0.01	8.49E-01
doxorubicin metabolic process (GO:0044598)	10	0	.23	-	 < 0.01	7.92E-01
daunorubicin metabolic process (GO:0044597)	10	0	.23	-	 < 0.01	7.92E-01
malonate catabolic process (GO:0090410)	1	0	.02	-	 < 0.01	9.77E-01
caveola assembly (GO:0070836)	4	0	.09	-	 < 0.01	9.11E-01
basement membrane assembly (GO:0070831)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of Rho-dependent protein serine/threonine kinase activity (GO:2000299)	3	0	.07	-	 < 0.01	9.32E-01
regulation of Rho-dependent protein serine/threonine kinase activity (GO:2000298)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of synapse maturation (GO:2000297)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of hydrogen peroxide catabolic process (GO:2000296)	1	0	.02	-	 < 0.01	9.77E-01
regulation of hydrogen peroxide catabolic process (GO:2000295)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of defecation (GO:2000293)	2	0	.05	-	 < 0.01	9.54E-01
regulation of defecation (GO:2000292)	2	0	.05	-	 < 0.01	9.54E-01
regulation of myoblast proliferation (GO:2000291)	16	0	.37	-	 < 0.01	6.89E-01
regulation of myotome development (GO:2000290)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of catalytic activity in other organism involved in symbiotic interaction (GO:0052199)	2	0	.05	-	 < 0.01	9.54E-01
oncogene-induced cell senescence (GO:0090402)	1	0	.02	-	 < 0.01	9.77E-01
heterochromatin maintenance (GO:0070829)	6	0	.14	-	 < 0.01	8.69E-01
chromatin maintenance (GO:0070827)	8	0	.19	-	 < 0.01	8.30E-01
butyryl-CoA catabolic process (GO:0044580)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of myoblast proliferation (GO:2000288)	11	0	.26	-	 < 0.01	7.74E-01
positive regulation of myotome development (GO:2000287)	1	0	.02	-	 < 0.01	9.77E-01
receptor internalization involved in canonical Wnt signaling pathway (GO:2000286)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of cellular amino acid biosynthetic process (GO:2000284)	1	0	.02	-	 < 0.01	9.77E-01
protein catabolic process at synapse (GO:0140246)	1	0	.02	-	 < 0.01	9.77E-01
regulation of cellular amino acid biosynthetic process (GO:2000282)	2	0	.05	-	 < 0.01	9.54E-01
regulation of translation at postsynapse (GO:0140245)	4	0	.09	-	 < 0.01	9.11E-01
regulation of translation at presynapse (GO:0140244)	2	0	.05	-	 < 0.01	9.54E-01
regulation of translation at synapse (GO:0140243)	7	0	.16	-	 < 0.01	8.49E-01
modification of cellular component in other organism involved in symbiotic interaction (GO:0052188)	1	0	.02	-	 < 0.01	9.77E-01
modification by host of symbiont cellular component (GO:0052187)	1	0	.02	-	 < 0.01	9.77E-01
modification of structure of other organism involved in symbiotic interaction (GO:0052185)	1	0	.02	-	 < 0.01	9.77E-01
modification by host of symbiont structure (GO:0052183)	1	0	.02	-	 < 0.01	9.77E-01
phosphorylation of RNA polymerase II C-terminal domain (GO:0070816)	9	0	.21	-	 < 0.01	8.11E-01
[2Fe-2S] cluster assembly (GO:0044571)	4	0	.09	-	 < 0.01	9.11E-01
hydrogen sulfide biosynthetic process (GO:0070814)	3	0	.07	-	 < 0.01	9.32E-01
hydrogen sulfide metabolic process (GO:0070813)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of oxidative phosphorylation uncoupler activity (GO:2000277)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of oxidative phosphorylation uncoupler activity (GO:2000276)	2	0	.05	-	 < 0.01	9.54E-01
regulation of oxidative phosphorylation uncoupler activity (GO:2000275)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of signaling receptor activity (GO:2000272)	32	0	.75	-	 < 0.01	4.74E-01
negative regulation of fibroblast apoptotic process (GO:2000270)	8	0	.19	-	 < 0.01	8.30E-01
lateral line system development (GO:0048925)	2	0	.05	-	 < 0.01	9.54E-01
posterior lateral line neuromast hair cell differentiation (GO:0048923)	1	0	.02	-	 < 0.01	9.77E-01
dendritic cell proliferation (GO:0044565)	2	0	.05	-	 < 0.01	9.54E-01
response to defenses of other organism (GO:0052173)	1	0	.02	-	 < 0.01	9.77E-01
protein transport out of membrane raft (GO:0032599)	1	0	.02	-	 < 0.01	9.77E-01
protein transport into membrane raft (GO:0032596)	4	0	.09	-	 < 0.01	9.11E-01
protein transport within lipid bilayer (GO:0032594)	9	0	.21	-	 < 0.01	8.11E-01
regulation of blood coagulation, intrinsic pathway (GO:2000266)	1	0	.02	-	 < 0.01	9.77E-01
posterior lateral line neuromast development (GO:0048919)	1	0	.02	-	 < 0.01	9.77E-01
posterior lateral line development (GO:0048916)	1	0	.02	-	 < 0.01	9.77E-01
posterior lateral line system development (GO:0048915)	1	0	.02	-	 < 0.01	9.77E-01
relaxation of smooth muscle (GO:0044557)	9	0	.21	-	 < 0.01	8.11E-01
secondary metabolite biosynthetic process (GO:0044550)	15	0	.35	-	 < 0.01	7.05E-01
ER-dependent peroxisome organization (GO:0032581)	1	0	.02	-	 < 0.01	9.77E-01
regulation of protein activation cascade (GO:2000257)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of male germ cell proliferation (GO:2000256)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of male germ cell proliferation (GO:2000255)	4	0	.09	-	 < 0.01	9.11E-01
regulation of male germ cell proliferation (GO:2000254)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of feeding behavior (GO:2000253)	12	0	.28	-	 < 0.01	7.56E-01
negative regulation of feeding behavior (GO:2000252)	17	0	.40	-	 < 0.01	6.73E-01
guanine nucleotide transport (GO:0001408)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of actin cytoskeleton reorganization (GO:2000251)	18	0	.42	-	 < 0.01	6.57E-01
positive regulation of long-chain fatty acid import into cell (GO:0140214)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of actin cytoskeleton reorganization (GO:2000250)	1	0	.02	-	 < 0.01	9.77E-01
regulation of metaphase/anaphase transition of cell cycle (GO:1902099)	56	0	1.31	-	 < 0.01	2.71E-01
NLRP3 inflammasome complex assembly (GO:0044546)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of flagellated sperm motility (GO:1902093)	11	0	.26	-	 < 0.01	7.74E-01
positive regulation by symbiont of host apoptotic process (GO:0052151)	3	0	.07	-	 < 0.01	9.32E-01
modulation by symbiont of host apoptotic process (GO:0052150)	5	0	.12	-	 < 0.01	8.90E-01
response to vitamin K (GO:0032571)	3	0	.07	-	 < 0.01	9.32E-01
response to progesterone (GO:0032570)	17	0	.40	-	 < 0.01	6.73E-01
apoptotic process in response to mitochondrial fragmentation (GO:0140208)	1	0	.02	-	 < 0.01	9.77E-01
dipeptide import across plasma membrane (GO:0140206)	5	0	.12	-	 < 0.01	8.90E-01
oligopeptide import across plasma membrane (GO:0140205)	5	0	.12	-	 < 0.01	8.90E-01
protein-chromophore linkage (GO:0018298)	11	0	.26	-	 < 0.01	7.74E-01
protein-FAD linkage (GO:0018293)	1	0	.02	-	 < 0.01	9.77E-01
regulation of circulating fibrinogen levels (GO:0044537)	1	0	.02	-	 < 0.01	9.77E-01
retrograde axonal protein transport (GO:0099642)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of calcium ion import into sarcoplasmic reticulum (GO:1902081)	2	0	.05	-	 < 0.01	9.54E-01
regulation of calcium ion import into sarcoplasmic reticulum (GO:1902080)	2	0	.05	-	 < 0.01	9.54E-01
snRNA methylation (GO:0106349)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of rRNA processing (GO:2000234)	10	0	.23	-	 < 0.01	7.92E-01
negative regulation of rRNA processing (GO:2000233)	2	0	.05	-	 < 0.01	9.54E-01
regulation of rRNA processing (GO:2000232)	14	0	.33	-	 < 0.01	7.21E-01
positive regulation of pancreatic stellate cell proliferation (GO:2000231)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of pancreatic stellate cell proliferation (GO:2000230)	1	0	.02	-	 < 0.01	9.77E-01
neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)	9	0	.21	-	 < 0.01	8.11E-01
endosome to plasma membrane protein transport (GO:0099638)	12	0	.28	-	 < 0.01	7.56E-01
positive regulation of lateral motor column neuron migration (GO:1902078)	1	0	.02	-	 < 0.01	9.77E-01
regulation of mitochondrial mRNA stability (GO:0044528)	4	0	.09	-	 < 0.01	9.11E-01
regulation of lateral motor column neuron migration (GO:1902076)	1	0	.02	-	 < 0.01	9.77E-01
iron incorporation into metallo-sulfur cluster (GO:0018283)	2	0	.05	-	 < 0.01	9.54E-01
metal incorporation into metallo-sulfur cluster (GO:0018282)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of hypoxia-inducible factor-1alpha signaling pathway (GO:1902073)	1	0	.02	-	 < 0.01	9.77E-01
protein sulfhydration (GO:0044524)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of hypoxia-inducible factor-1alpha signaling pathway (GO:1902072)	2	0	.05	-	 < 0.01	9.54E-01
regulation of hypoxia-inducible factor-1alpha signaling pathway (GO:1902071)	3	0	.07	-	 < 0.01	9.32E-01
postsynaptic neurotransmitter receptor cycle (GO:0099630)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of sphingolipid mediated signaling pathway (GO:1902070)	1	0	.02	-	 < 0.01	9.77E-01
regulation of pancreatic stellate cell proliferation (GO:2000229)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of pancreatic A cell differentiation (GO:2000227)	1	0	.02	-	 < 0.01	9.77E-01
regulation of pancreatic A cell differentiation (GO:2000226)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of testosterone biosynthetic process (GO:2000225)	2	0	.05	-	 < 0.01	9.54E-01
regulation of testosterone biosynthetic process (GO:2000224)	4	0	.09	-	 < 0.01	9.11E-01
protein N-linked glycosylation via asparagine (GO:0018279)	17	0	.40	-	 < 0.01	6.73E-01
neurotransmitter receptor diffusion trapping (GO:0099628)	10	0	.23	-	 < 0.01	7.92E-01
regulation of sphingolipid mediated signaling pathway (GO:1902068)	2	0	.05	-	 < 0.01	9.54E-01
neurotransmitter receptor cycle (GO:0099627)	1	0	.02	-	 < 0.01	9.77E-01
response to L-glutamate (GO:1902065)	7	0	.16	-	 < 0.01	8.49E-01
protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine (GO:0018272)	1	0	.02	-	 < 0.01	9.77E-01
regulation of transcription from RNA polymerase II promoter involved in spermatogenesis (GO:1902064)	1	0	.02	-	 < 0.01	9.77E-01
mitochondrial translation (GO:0032543)	49	0	1.14	-	 < 0.01	3.19E-01
positive regulation of glutamate metabolic process (GO:2000213)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of glutamate metabolic process (GO:2000212)	1	0	.02	-	 < 0.01	9.77E-01
regulation of glutamate metabolic process (GO:2000211)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of anoikis (GO:2000210)	5	0	.12	-	 < 0.01	8.90E-01
isopeptide cross-linking (GO:0018262)	1	0	.02	-	 < 0.01	9.77E-01
protein localization to axon (GO:0099612)	11	0	.26	-	 < 0.01	7.74E-01
mismatch repair (GO:0006298)	21	0	.49	-	 < 0.01	6.13E-01
nucleotide-excision repair, DNA gap filling (GO:0006297)	5	0	.12	-	 < 0.01	8.90E-01
modulation of signal transduction in other organism (GO:0044501)	1	0	.02	-	 < 0.01	9.77E-01
nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)	3	0	.07	-	 < 0.01	9.32E-01
nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)	3	0	.07	-	 < 0.01	9.32E-01
nucleotide-excision repair, preincision complex assembly (GO:0006294)	1	0	.02	-	 < 0.01	9.77E-01
regulation of cell projection size (GO:0032536)	14	0	.33	-	 < 0.01	7.21E-01
pyrimidine dimer repair (GO:0006290)	9	0	.21	-	 < 0.01	8.11E-01
regulation of microvillus assembly (GO:0032534)	8	0	.19	-	 < 0.01	8.30E-01
regulation of anoikis (GO:2000209)	20	0	.47	-	 < 0.01	6.27E-01
regulation of microvillus length (GO:0032532)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of ribosomal small subunit export from nucleus (GO:2000208)	1	0	.02	-	 < 0.01	9.77E-01
regulation of microvillus organization (GO:0032530)	15	0	.35	-	 < 0.01	7.05E-01
regulation of ribosomal small subunit export from nucleus (GO:2000206)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of ribosomal subunit export from nucleus (GO:2000202)	1	0	.02	-	 < 0.01	9.77E-01
regulation of ribosomal subunit export from nucleus (GO:2000200)	1	0	.02	-	 < 0.01	9.77E-01
regulation of action potential firing pattern (GO:0099608)	1	0	.02	-	 < 0.01	9.77E-01
lateral attachment of mitotic spindle microtubules to kinetochore (GO:0099607)	1	0	.02	-	 < 0.01	9.77E-01
polyamine transmembrane transport (GO:1902047)	1	0	.02	-	 < 0.01	9.77E-01
microtubule plus-end directed mitotic chromosome migration (GO:0099606)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of Fas signaling pathway (GO:1902045)	1	0	.02	-	 < 0.01	9.77E-01
regulation of Fas signaling pathway (GO:1902044)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042)	30	0	.70	-	 < 0.01	4.97E-01
nucleotide-excision repair (GO:0006289)	51	0	1.19	-	 < 0.01	3.04E-01
regulation of neurotransmitter receptor activity (GO:0099601)	65	0	1.52	-	 < 0.01	2.19E-01
base-excision repair, DNA ligation (GO:0006288)	1	0	.02	-	 < 0.01	9.77E-01
base-excision repair, gap-filling (GO:0006287)	5	0	.12	-	 < 0.01	8.90E-01
base-excision repair, AP site formation (GO:0006285)	4	0	.09	-	 < 0.01	9.11E-01
base-excision repair (GO:0006284)	33	0	.77	-	 < 0.01	4.63E-01
microvillus organization (GO:0032528)	12	0	.28	-	 < 0.01	7.56E-01
transcription-coupled nucleotide-excision repair (GO:0006283)	9	0	.21	-	 < 0.01	8.11E-01
response to retinoic acid (GO:0032526)	79	0	1.84	-	 < 0.01	1.58E-01
somite rostral/caudal axis specification (GO:0032525)	14	0	.33	-	 < 0.01	7.21E-01
protein-DNA covalent cross-linking repair (GO:0106300)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of hematopoietic stem cell differentiation (GO:1902038)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of hematopoietic stem cell differentiation (GO:1902037)	3	0	.07	-	 < 0.01	9.32E-01
regulation of hematopoietic stem cell differentiation (GO:1902036)	10	0	.23	-	 < 0.01	7.92E-01
protein O-linked glycosylation via threonine (GO:0018243)	9	0	.21	-	 < 0.01	8.11E-01
positive regulation of hematopoietic stem cell proliferation (GO:1902035)	7	0	.16	-	 < 0.01	8.49E-01
protein O-linked glycosylation via serine (GO:0018242)	8	0	.19	-	 < 0.01	8.30E-01
regulation of hematopoietic stem cell proliferation (GO:1902033)	10	0	.23	-	 < 0.01	7.92E-01
posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000973)	2	0	.05	-	 < 0.01	9.54E-01
regulation of NADP metabolic process (GO:1902031)	5	0	.12	-	 < 0.01	8.90E-01
transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972)	6	0	.14	-	 < 0.01	8.69E-01
tRNA exon ligation utilizing 2',3' cyclic phosphate of 5'-exon as source of linkage phosphate (GO:0000971)	1	0	.02	-	 < 0.01	9.77E-01
lagging strand elongation (GO:0006273)	4	0	.09	-	 < 0.01	9.11E-01
leading strand elongation (GO:0006272)	4	0	.09	-	 < 0.01	9.11E-01
DNA strand elongation involved in DNA replication (GO:0006271)	13	0	.30	-	 < 0.01	7.38E-01
negative regulation of phosphoprotein phosphatase activity (GO:0032515)	25	0	.58	-	 < 0.01	5.58E-01
DNA replication initiation (GO:0006270)	24	0	.56	-	 < 0.01	5.71E-01
late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511)	14	0	.33	-	 < 0.01	7.21E-01
endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510)	7	0	.16	-	 < 0.01	8.49E-01
tRNA exon ligation (GO:0000968)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to zinc ion (GO:0071294)	14	0	.33	-	 < 0.01	7.21E-01
rRNA 5'-end processing (GO:0000967)	2	0	.05	-	 < 0.01	9.54E-01
L-histidine transport (GO:1902024)	1	0	.02	-	 < 0.01	9.77E-01
mitochondrial RNA 3'-end processing (GO:0000965)	5	0	.12	-	 < 0.01	8.90E-01
L-arginine transport (GO:1902023)	8	0	.19	-	 < 0.01	8.30E-01
mitochondrial RNA 5'-end processing (GO:0000964)	3	0	.07	-	 < 0.01	9.32E-01
L-lysine transport (GO:1902022)	3	0	.07	-	 < 0.01	9.32E-01
mitochondrial RNA processing (GO:0000963)	12	0	.28	-	 < 0.01	7.56E-01
DNA replication, synthesis of RNA primer (GO:0006269)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of mitochondrial RNA catabolic process (GO:0000962)	3	0	.07	-	 < 0.01	9.32E-01
DNA unwinding involved in DNA replication (GO:0006268)	14	0	.33	-	 < 0.01	7.21E-01
negative regulation of cilium-dependent cell motility (GO:1902020)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of mitochondrial RNA catabolic process (GO:0000961)	2	0	.05	-	 < 0.01	9.54E-01
pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267)	7	0	.16	-	 < 0.01	8.49E-01
regulation of mitochondrial RNA catabolic process (GO:0000960)	5	0	.12	-	 < 0.01	8.90E-01
DNA ligation (GO:0006266)	7	0	.16	-	 < 0.01	8.49E-01
DNA topological change (GO:0006265)	7	0	.16	-	 < 0.01	8.49E-01
endosome transport via multivesicular body sorting pathway (GO:0032509)	30	0	.70	-	 < 0.01	4.97E-01
mitochondrial DNA replication (GO:0006264)	9	0	.21	-	 < 0.01	8.11E-01
DNA duplex unwinding (GO:0032508)	30	0	.70	-	 < 0.01	4.97E-01
cellular response to mercury ion (GO:0071288)	4	0	.09	-	 < 0.01	9.11E-01
cellular response to manganese ion (GO:0071287)	4	0	.09	-	 < 0.01	9.11E-01
cellular response to magnesium ion (GO:0071286)	6	0	.14	-	 < 0.01	8.69E-01
mitochondrial RNA metabolic process (GO:0000959)	35	0	.82	-	 < 0.01	4.42E-01
mitochondrial mRNA catabolic process (GO:0000958)	3	0	.07	-	 < 0.01	9.32E-01
mitochondrial RNA catabolic process (GO:0000957)	3	0	.07	-	 < 0.01	9.32E-01
cellular response to iron(III) ion (GO:0071283)	2	0	.05	-	 < 0.01	9.54E-01
cellular response to iron(II) ion (GO:0071282)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to iron ion (GO:0071281)	11	0	.26	-	 < 0.01	7.74E-01
UDP-glucose catabolic process (GO:0006258)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of translation in response to endoplasmic reticulum stress (GO:1902010)	2	0	.05	-	 < 0.01	9.54E-01
UDP catabolic process (GO:0006256)	2	0	.05	-	 < 0.01	9.54E-01
CTP catabolic process (GO:0006254)	1	0	.02	-	 < 0.01	9.77E-01
dCTP catabolic process (GO:0006253)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to cobalt ion (GO:0071279)	1	0	.02	-	 < 0.01	9.77E-01
peptidyl-aspartic acid phosphorylation (GO:0018217)	1	0	.02	-	 < 0.01	9.77E-01
peptidyl-arginine methylation (GO:0018216)	9	0	.21	-	 < 0.01	8.11E-01
protein phosphopantetheinylation (GO:0018215)	27	0	.63	-	 < 0.01	5.33E-01
protein carboxylation (GO:0018214)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of amyloid-beta formation (GO:1902004)	20	0	.47	-	 < 0.01	6.27E-01
peptidyl-tryptophan modification (GO:0018211)	4	0	.09	-	 < 0.01	9.11E-01
dCMP catabolic process (GO:0006249)	8	0	.19	-	 < 0.01	8.30E-01
CMP catabolic process (GO:0006248)	7	0	.16	-	 < 0.01	8.49E-01
homogentisate catabolic process (GO:1902000)	1	0	.02	-	 < 0.01	9.77E-01
protein delipidation (GO:0051697)	1	0	.02	-	 < 0.01	9.77E-01
pyrimidine nucleotide catabolic process (GO:0006244)	15	0	.35	-	 < 0.01	7.05E-01
actin filament uncapping (GO:0051695)	1	0	.02	-	 < 0.01	9.77E-01
CTP biosynthetic process (GO:0006241)	8	0	.19	-	 < 0.01	8.30E-01
cellular oligosaccharide catabolic process (GO:0051692)	1	0	.02	-	 < 0.01	9.77E-01
protein K69-linked ufmylation (GO:1990592)	5	0	.12	-	 < 0.01	8.90E-01
dCDP biosynthetic process (GO:0006240)	1	0	.02	-	 < 0.01	9.77E-01
cellular oligosaccharide metabolic process (GO:0051691)	1	0	.02	-	 < 0.01	9.77E-01
L-methionine salvage (GO:0071267)	7	0	.16	-	 < 0.01	8.49E-01
peptidyl-methionine modification (GO:0018206)	10	0	.23	-	 < 0.01	7.92E-01
L-methionine biosynthetic process (GO:0071265)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of translational initiation in response to starvation (GO:0071264)	2	0	.05	-	 < 0.01	9.54E-01
peptidyl-histidine modification (GO:0018202)	8	0	.19	-	 < 0.01	8.30E-01
regulation of translational initiation in response to starvation (GO:0071262)	2	0	.05	-	 < 0.01	9.54E-01
peptidyl-glycine modification (GO:0018201)	3	0	.07	-	 < 0.01	9.32E-01
peptidyl-glutamic acid modification (GO:0018200)	26	0	.61	-	 < 0.01	5.45E-01
CMP salvage (GO:0006238)	1	0	.02	-	 < 0.01	9.77E-01
dTTP biosynthetic process (GO:0006235)	3	0	.07	-	 < 0.01	9.32E-01
establishment of ER localization (GO:0051686)	1	0	.02	-	 < 0.01	9.77E-01
maintenance of ER location (GO:0051685)	1	0	.02	-	 < 0.01	9.77E-01
dTDP biosynthetic process (GO:0006233)	2	0	.05	-	 < 0.01	9.54E-01
maintenance of Golgi location (GO:0051684)	3	0	.07	-	 < 0.01	9.32E-01
dTMP biosynthetic process (GO:0006231)	3	0	.07	-	 < 0.01	9.32E-01
cellular response to electrical stimulus (GO:0071257)	10	0	.23	-	 < 0.01	7.92E-01
UTP biosynthetic process (GO:0006228)	8	0	.19	-	 < 0.01	8.30E-01
peptidyl-serine trans-autophosphorylation (GO:1990579)	1	0	.02	-	 < 0.01	9.77E-01
dUDP biosynthetic process (GO:0006227)	3	0	.07	-	 < 0.01	9.32E-01
dUMP biosynthetic process (GO:0006226)	2	0	.05	-	 < 0.01	9.54E-01
UDP biosynthetic process (GO:0006225)	1	0	.02	-	 < 0.01	9.77E-01
mitochondrial L-ornithine transmembrane transport (GO:1990575)	3	0	.07	-	 < 0.01	9.32E-01
UMP biosynthetic process (GO:0006222)	3	0	.07	-	 < 0.01	9.32E-01
pyrimidine nucleotide biosynthetic process (GO:0006221)	21	0	.49	-	 < 0.01	6.13E-01
pyrimidine nucleotide metabolic process (GO:0006220)	38	0	.89	-	 < 0.01	4.12E-01
cellular response to chromate (GO:0071247)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to carbon dioxide (GO:0071244)	1	0	.02	-	 < 0.01	9.77E-01
division septum assembly (GO:0000917)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to ammonium ion (GO:0071242)	4	0	.09	-	 < 0.01	9.11E-01
actomyosin contractile ring assembly (GO:0000915)	5	0	.12	-	 < 0.01	8.90E-01
glutamatergic neuron differentiation (GO:1905962)	10	0	.23	-	 < 0.01	7.92E-01
cellular response to food (GO:0071240)	1	0	.02	-	 < 0.01	9.77E-01
assembly of actomyosin apparatus involved in cytokinesis (GO:0000912)	5	0	.12	-	 < 0.01	8.90E-01
uridine catabolic process (GO:0006218)	2	0	.05	-	 < 0.01	9.54E-01
UDP-N-acetylglucosamine transmembrane transport (GO:1990569)	2	0	.05	-	 < 0.01	9.54E-01
cytidine catabolic process (GO:0006216)	4	0	.09	-	 < 0.01	9.11E-01
actin cortical patch localization (GO:0051666)	1	0	.02	-	 < 0.01	9.77E-01
thymidine catabolic process (GO:0006214)	1	0	.02	-	 < 0.01	9.77E-01
membrane raft localization (GO:0051665)	4	0	.09	-	 < 0.01	9.11E-01
pyrimidine nucleoside metabolic process (GO:0006213)	12	0	.28	-	 < 0.01	7.56E-01
nuclear pore localization (GO:0051664)	1	0	.02	-	 < 0.01	9.77E-01
protein polyufmylation (GO:1990564)	5	0	.12	-	 < 0.01	8.90E-01
uracil catabolic process (GO:0006212)	2	0	.05	-	 < 0.01	9.54E-01
5-methylcytosine catabolic process (GO:0006211)	3	0	.07	-	 < 0.01	9.32E-01
thymine catabolic process (GO:0006210)	3	0	.07	-	 < 0.01	9.32E-01
maintenance of centrosome location (GO:0051661)	6	0	.14	-	 < 0.01	8.69E-01
establishment of centrosome localization (GO:0051660)	8	0	.19	-	 < 0.01	8.30E-01
cellular response to antibiotic (GO:0071236)	11	0	.26	-	 < 0.01	7.74E-01
regulation of cellular response to alcohol (GO:1905957)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of endothelial tube morphogenesis (GO:1905956)	2	0	.05	-	 < 0.01	9.54E-01
cellular response to folic acid (GO:0071231)	1	0	.02	-	 < 0.01	9.77E-01
pyrimidine nucleobase catabolic process (GO:0006208)	3	0	.07	-	 < 0.01	9.32E-01
maintenance of mitochondrion location (GO:0051659)	2	0	.05	-	 < 0.01	9.54E-01
'de novo' pyrimidine nucleobase biosynthetic process (GO:0006207)	6	0	.14	-	 < 0.01	8.69E-01
pyrimidine nucleobase metabolic process (GO:0006206)	13	0	.30	-	 < 0.01	7.38E-01
maintenance of organelle location (GO:0051657)	11	0	.26	-	 < 0.01	7.74E-01
IMP catabolic process (GO:0006204)	5	0	.12	-	 < 0.01	8.90E-01
response to capsazepine (GO:1901594)	1	0	.02	-	 < 0.01	9.77E-01
dGTP catabolic process (GO:0006203)	3	0	.07	-	 < 0.01	9.32E-01
establishment of mitochondrion localization (GO:0051654)	25	0	.58	-	 < 0.01	5.58E-01
mitochondrial alpha-ketoglutarate transmembrane transport (GO:1990550)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to molecule of fungal origin (GO:0071226)	3	0	.07	-	 < 0.01	9.32E-01
cellular response to muramyl dipeptide (GO:0071225)	9	0	.21	-	 < 0.01	8.11E-01
cellular response to peptidoglycan (GO:0071224)	7	0	.16	-	 < 0.01	8.49E-01
regulation of response to calcium ion (GO:1905945)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to lipoteichoic acid (GO:0071223)	10	0	.23	-	 < 0.01	7.92E-01
negative regulation of formation of growth cone in injured axon (GO:1905943)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to bacterial lipopeptide (GO:0071221)	6	0	.14	-	 < 0.01	8.69E-01
regulation of formation of growth cone in injured axon (GO:1905942)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to bacterial lipoprotein (GO:0071220)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of gonad development (GO:1905941)	10	0	.23	-	 < 0.01	7.92E-01
negative regulation of gonad development (GO:1905940)	4	0	.09	-	 < 0.01	9.11E-01
mitochondrial NAD transmembrane transport (GO:1990549)	1	0	.02	-	 < 0.01	9.77E-01
mitochondrial FAD transmembrane transport (GO:1990548)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of acid-sensing ion channel activity (GO:1901586)	1	0	.02	-	 < 0.01	9.77E-01
mitochondrion localization (GO:0051646)	50	0	1.17	-	 < 0.01	3.11E-01
regulation of acid-sensing ion channel activity (GO:1901585)	2	0	.05	-	 < 0.01	9.54E-01
mitochondrial tricarboxylic acid transmembrane transport (GO:1990546)	1	0	.02	-	 < 0.01	9.77E-01
mitochondrial ATP transmembrane transport (GO:1990544)	1	0	.02	-	 < 0.01	9.77E-01
endoplasmic reticulum localization (GO:0051643)	10	0	.23	-	 < 0.01	7.92E-01
positive regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901582)	1	0	.02	-	 < 0.01	9.77E-01
centrosome localization (GO:0051642)	31	0	.72	-	 < 0.01	4.85E-01
negative regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901581)	1	0	.02	-	 < 0.01	9.77E-01
regulation of telomeric RNA transcription from RNA pol II promoter (GO:1901580)	1	0	.02	-	 < 0.01	9.77E-01
mitochondrial manganese ion transmembrane transport (GO:1990540)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to misfolded protein (GO:0071218)	24	0	.56	-	 < 0.01	5.71E-01
regulation of gonad development (GO:1905939)	15	0	.35	-	 < 0.01	7.05E-01
positive regulation of germ cell proliferation (GO:1905938)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of germ cell proliferation (GO:1905937)	4	0	.09	-	 < 0.01	9.11E-01
regulation of germ cell proliferation (GO:1905936)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of cell fate determination (GO:1905934)	1	0	.02	-	 < 0.01	9.77E-01
regulation of cell fate determination (GO:1905933)	1	0	.02	-	 < 0.01	9.77E-01
protein targeting to vacuole involved in autophagy (GO:0071211)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching (GO:1905932)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching (GO:1905931)	2	0	.05	-	 < 0.01	9.54E-01
regulation of vascular associated smooth muscle cell differentiation involved in phenotypic switching (GO:1905930)	3	0	.07	-	 < 0.01	9.32E-01
fructose import across plasma membrane (GO:1990539)	1	0	.02	-	 < 0.01	9.77E-01
neuron projection maintenance (GO:1990535)	10	0	.23	-	 < 0.01	7.92E-01
establishment of protein localization to juxtaparanode region of axon (GO:0071206)	1	0	.02	-	 < 0.01	9.77E-01
protein localization to juxtaparanode region of axon (GO:0071205)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of acetylcholine biosynthetic process (GO:1905923)	1	0	.02	-	 < 0.01	9.77E-01
regulation of acetylcholine biosynthetic process (GO:1905921)	1	0	.02	-	 < 0.01	9.77E-01
fatty acid derivative catabolic process (GO:1901569)	12	0	.28	-	 < 0.01	7.56E-01
positive regulation of CoA-transferase activity (GO:1905920)	2	0	.05	-	 < 0.01	9.54E-01
epinephrine uptake (GO:0051625)	2	0	.05	-	 < 0.01	9.54E-01
response to camptothecin (GO:1901563)	5	0	.12	-	 < 0.01	8.90E-01
bone regeneration (GO:1990523)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of norepinephrine uptake (GO:0051622)	1	0	.02	-	 < 0.01	9.77E-01
response to benomyl (GO:1901561)	1	0	.02	-	 < 0.01	9.77E-01
regulation of norepinephrine uptake (GO:0051621)	2	0	.05	-	 < 0.01	9.54E-01
norepinephrine uptake (GO:0051620)	4	0	.09	-	 < 0.01	9.11E-01
regulation of CoA-transferase activity (GO:1905918)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of cell differentiation involved in phenotypic switching (GO:1905917)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of cell differentiation involved in phenotypic switching (GO:1905916)	2	0	.05	-	 < 0.01	9.54E-01
regulation of cell differentiation involved in phenotypic switching (GO:1905915)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of calcium ion export across plasma membrane (GO:1905913)	1	0	.02	-	 < 0.01	9.77E-01
regulation of calcium ion export across plasma membrane (GO:1905912)	2	0	.05	-	 < 0.01	9.54E-01
pyrimidine nucleotide import into mitochondrion (GO:1990519)	2	0	.05	-	 < 0.01	9.54E-01
response to fenofibrate (GO:1901557)	1	0	.02	-	 < 0.01	9.77E-01
histamine uptake (GO:0051615)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of endothelial cell development (GO:1901552)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of serotonin uptake (GO:0051612)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of endothelial cell development (GO:1901551)	2	0	.05	-	 < 0.01	9.54E-01
regulation of serotonin uptake (GO:0051611)	6	0	.14	-	 < 0.01	8.69E-01
regulation of endothelial cell development (GO:1901550)	18	0	.42	-	 < 0.01	6.57E-01
piRNA biosynthetic process (GO:1990511)	4	0	.09	-	 < 0.01	9.11E-01
serotonin uptake (GO:0051610)	7	0	.16	-	 < 0.01	8.49E-01
replicative senescence (GO:0090399)	12	0	.28	-	 < 0.01	7.56E-01
positive regulation of amyloid fibril formation (GO:1905908)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of amyloid fibril formation (GO:1905907)	11	0	.26	-	 < 0.01	7.74E-01
regulation of amyloid fibril formation (GO:1905906)	14	0	.33	-	 < 0.01	7.21E-01
histamine transport (GO:0051608)	14	0	.33	-	 < 0.01	7.21E-01
response to raffinose (GO:1901545)	1	0	.02	-	 < 0.01	9.77E-01
mitotic DNA replication maintenance of fidelity (GO:1990505)	2	0	.05	-	 < 0.01	9.54E-01
dense core granule exocytosis (GO:1990504)	8	0	.19	-	 < 0.01	8.30E-01
response to electrical stimulus (GO:0051602)	22	0	.51	-	 < 0.01	5.99E-01
dense core granule maturation (GO:1990502)	3	0	.07	-	 < 0.01	9.32E-01
exocyst localization (GO:0051601)	7	0	.16	-	 < 0.01	8.49E-01
phagosome-lysosome fusion involved in apoptotic cell clearance (GO:0090389)	1	0	.02	-	 < 0.01	9.77E-01
phagolysosome assembly involved in apoptotic cell clearance (GO:0090387)	2	0	.05	-	 < 0.01	9.54E-01
phagosome maturation involved in apoptotic cell clearance (GO:0090386)	2	0	.05	-	 < 0.01	9.54E-01
phagosome-lysosome docking (GO:0090384)	1	0	.02	-	 < 0.01	9.77E-01
phagosome acidification (GO:0090383)	6	0	.14	-	 < 0.01	8.69E-01
regulation of heart induction (GO:0090381)	6	0	.14	-	 < 0.01	8.69E-01
changes to DNA methylation involved in embryo development (GO:1901538)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of DNA demethylation (GO:1901537)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of DNA demethylation (GO:1901536)	3	0	.07	-	 < 0.01	9.32E-01
regulation of DNA demethylation (GO:1901535)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of hematopoietic progenitor cell differentiation (GO:1901534)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of cholesterol efflux (GO:0090370)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of anion channel activity (GO:1901529)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of mitophagy (GO:1901526)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of mitophagy (GO:1901525)	4	0	.09	-	 < 0.01	9.11E-01
regulation of mitophagy (GO:1901524)	7	0	.16	-	 < 0.01	8.49E-01
icosanoid catabolic process (GO:1901523)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522)	21	0	.49	-	 < 0.01	6.13E-01
negative regulation of mRNA modification (GO:0090367)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of mRNA modification (GO:0090366)	1	0	.02	-	 < 0.01	9.77E-01
regulation of mRNA modification (GO:0090365)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of platelet-derived growth factor production (GO:0090362)	2	0	.05	-	 < 0.01	9.54E-01
regulation of platelet-derived growth factor production (GO:0090361)	3	0	.07	-	 < 0.01	9.32E-01
response to biotin (GO:0070781)	1	0	.02	-	 < 0.01	9.77E-01
efferent axon development in a lateral line nerve (GO:0048894)	1	0	.02	-	 < 0.01	9.77E-01
lateral line nerve development (GO:0048892)	1	0	.02	-	 < 0.01	9.77E-01
L-aspartate transmembrane transport (GO:0070778)	4	0	.09	-	 < 0.01	9.11E-01
regulation of endothelial tube morphogenesis (GO:1901509)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of acylglycerol transport (GO:1901508)	2	0	.05	-	 < 0.01	9.54E-01
regulation of acylglycerol transport (GO:1901506)	2	0	.05	-	 < 0.01	9.54E-01
ether biosynthetic process (GO:1901503)	12	0	.28	-	 < 0.01	7.56E-01
ether catabolic process (GO:1901502)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process (GO:0140196)	1	0	.02	-	 < 0.01	9.77E-01
neuromast hair cell differentiation (GO:0048886)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process (GO:0140194)	1	0	.02	-	 < 0.01	9.77E-01
regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process (GO:0140193)	1	0	.02	-	 < 0.01	9.77E-01
neuromast development (GO:0048884)	1	0	.02	-	 < 0.01	9.77E-01
cellular organofluorine metabolic process (GO:0090346)	1	0	.02	-	 < 0.01	9.77E-01
cellular organohalogen metabolic process (GO:0090345)	1	0	.02	-	 < 0.01	9.77E-01
lateral line development (GO:0048882)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of cell aging (GO:0090344)	25	0	.58	-	 < 0.01	5.58E-01
mechanosensory lateral line system development (GO:0048881)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of cell aging (GO:0090343)	11	0	.26	-	 < 0.01	7.74E-01
negative regulation of secretion of lysosomal enzymes (GO:0090341)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of secretion of lysosomal enzymes (GO:0090340)	1	0	.02	-	 < 0.01	9.77E-01
homeostasis of number of retina cells (GO:0048877)	1	0	.02	-	 < 0.01	9.77E-01
host-mediated regulation of intestinal microbiota composition (GO:0048874)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of brown fat cell differentiation (GO:0090336)	17	0	.40	-	 < 0.01	6.73E-01
regulation of brown fat cell differentiation (GO:0090335)	24	0	.56	-	 < 0.01	5.71E-01
negative regulation of platelet aggregation (GO:0090331)	14	0	.33	-	 < 0.01	7.21E-01
regulation of platelet aggregation (GO:0090330)	23	0	.54	-	 < 0.01	5.85E-01
positive regulation of locomotion involved in locomotory behavior (GO:0090326)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of oxidative phosphorylation (GO:0090324)	9	0	.21	-	 < 0.01	8.11E-01
leukemia inhibitory factor signaling pathway (GO:0048861)	5	0	.12	-	 < 0.01	8.90E-01
regulation of superoxide metabolic process (GO:0090322)	32	0	.75	-	 < 0.01	4.74E-01
positive regulation of chylomicron remnant clearance (GO:0090321)	1	0	.02	-	 < 0.01	9.77E-01
regulation of chylomicron remnant clearance (GO:0090320)	2	0	.05	-	 < 0.01	9.54E-01
response to interleukin-6 (GO:0070741)	27	0	.63	-	 < 0.01	5.33E-01
formation of anatomical boundary (GO:0048859)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of chylomicron remodeling (GO:0090319)	1	0	.02	-	 < 0.01	9.77E-01
regulation of chylomicron remodeling (GO:0090318)	1	0	.02	-	 < 0.01	9.77E-01
adenohypophysis morphogenesis (GO:0048855)	1	0	.02	-	 < 0.01	9.77E-01
forebrain morphogenesis (GO:0048853)	17	0	.40	-	 < 0.01	6.73E-01
negative regulation of protein targeting to membrane (GO:0090315)	5	0	.12	-	 < 0.01	8.90E-01
diencephalon morphogenesis (GO:0048852)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of protein targeting to membrane (GO:0090314)	25	0	.58	-	 < 0.01	5.58E-01
regulation of protein targeting to membrane (GO:0090313)	31	0	.72	-	 < 0.01	4.85E-01
hypophysis morphogenesis (GO:0048850)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of DNA methylation-dependent heterochromatin assembly (GO:0090310)	3	0	.07	-	 < 0.01	9.32E-01
histone H3-K27 methylation (GO:0070734)	8	0	.19	-	 < 0.01	8.30E-01
cAMP transport (GO:0070730)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of ribonucleoprotein complex localization (GO:2000199)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of female gonad development (GO:2000196)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of female gonad development (GO:2000195)	3	0	.07	-	 < 0.01	9.32E-01
regulation of female gonad development (GO:2000194)	8	0	.19	-	 < 0.01	8.30E-01
ammonium import across plasma membrane (GO:0140157)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309)	8	0	.19	-	 < 0.01	8.30E-01
axon extension involved in axon guidance (GO:0048846)	8	0	.19	-	 < 0.01	8.30E-01
regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308)	12	0	.28	-	 < 0.01	7.56E-01
venous blood vessel morphogenesis (GO:0048845)	11	0	.26	-	 < 0.01	7.74E-01
spindle assembly involved in meiosis (GO:0090306)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of axon extension involved in axon guidance (GO:0048843)	27	0	.63	-	 < 0.01	5.33E-01
otolith development (GO:0048840)	9	0	.21	-	 < 0.01	8.11E-01
negative regulation of neural crest formation (GO:0090301)	1	0	.02	-	 < 0.01	9.77E-01
cyclic nucleotide transport (GO:0070729)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of phosphate transmembrane transport (GO:2000187)	1	0	.02	-	 < 0.01	9.77E-01
regulation of phosphate transmembrane transport (GO:2000185)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of progesterone biosynthetic process (GO:2000184)	1	0	.02	-	 < 0.01	9.77E-01
regulation of progesterone biosynthetic process (GO:2000182)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of androgen biosynthetic process (GO:2000180)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of postsynaptic cytosolic calcium concentration (GO:0099588)	1	0	.02	-	 < 0.01	9.77E-01
mismatch repair involved in maintenance of fidelity involved in DNA-dependent DNA replication (GO:0070716)	1	0	.02	-	 < 0.01	9.77E-01
sodium-dependent organic cation transport (GO:0070715)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0106289)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of neural precursor cell proliferation (GO:2000178)	28	0	.65	-	 < 0.01	5.20E-01
regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0106288)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of pro-T cell differentiation (GO:2000176)	1	0	.02	-	 < 0.01	9.77E-01
regulation of pro-T cell differentiation (GO:2000174)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of branching morphogenesis of a nerve (GO:2000173)	4	0	.09	-	 < 0.01	9.11E-01
regulation of branching morphogenesis of a nerve (GO:2000172)	9	0	.21	-	 < 0.01	8.11E-01
positive regulation of peptidyl-cysteine S-nitrosylation (GO:2000170)	3	0	.07	-	 < 0.01	9.32E-01
formation of extrachromosomal circular DNA (GO:0001325)	5	0	.12	-	 < 0.01	8.90E-01
enucleate erythrocyte development (GO:0048822)	2	0	.05	-	 < 0.01	9.54E-01
erythrocyte development (GO:0048821)	38	0	.89	-	 < 0.01	4.12E-01
regulation of translation at postsynapse, modulating synaptic transmission (GO:0099578)	4	0	.09	-	 < 0.01	9.11E-01
hair follicle maturation (GO:0048820)	21	0	.49	-	 < 0.01	6.13E-01
regulation of translation at presynapse, modulating synaptic transmission (GO:0099577)	2	0	.05	-	 < 0.01	9.54E-01
regulation of protein catabolic process at postsynapse, modulating synaptic transmission (GO:0099576)	6	0	.14	-	 < 0.01	8.69E-01
regulation of protein catabolic process at presynapse, modulating synaptic transmission (GO:0099575)	3	0	.07	-	 < 0.01	9.32E-01
detection of peptidoglycan (GO:0032499)	2	0	.05	-	 < 0.01	9.54E-01
detection of muramyl dipeptide (GO:0032498)	1	0	.02	-	 < 0.01	9.77E-01
detection of lipopolysaccharide (GO:0032497)	4	0	.09	-	 < 0.01	9.11E-01
response to muramyl dipeptide (GO:0032495)	18	0	.42	-	 < 0.01	6.57E-01
response to peptidoglycan (GO:0032494)	12	0	.28	-	 < 0.01	7.56E-01
response to bacterial lipoprotein (GO:0032493)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of planar cell polarity pathway involved in neural tube closure (GO:2000168)	1	0	.02	-	 < 0.01	9.77E-01
regulation of planar cell polarity pathway involved in neural tube closure (GO:2000167)	1	0	.02	-	 < 0.01	9.77E-01
detection of molecule of bacterial origin (GO:0032490)	12	0	.28	-	 < 0.01	7.56E-01
negative regulation of planar cell polarity pathway involved in pericardium morphogenesis (GO:2000166)	1	0	.02	-	 < 0.01	9.77E-01
regulation of planar cell polarity pathway involved in pericardium morphogenesis (GO:2000165)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis (GO:2000164)	1	0	.02	-	 < 0.01	9.77E-01
regulation of hair follicle maturation (GO:0048819)	9	0	.21	-	 < 0.01	8.11E-01
regulation of planar cell polarity pathway involved in outflow tract morphogenesis (GO:2000163)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of hair follicle maturation (GO:0048818)	5	0	.12	-	 < 0.01	8.90E-01
cytosol to ERGIC protein transport (GO:0106273)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis (GO:2000162)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of hair follicle maturation (GO:0048817)	3	0	.07	-	 < 0.01	9.32E-01
protein localization to ERGIC (GO:0106272)	1	0	.02	-	 < 0.01	9.77E-01
regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis (GO:2000161)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of planar cell polarity pathway involved in heart morphogenesis (GO:2000160)	1	0	.02	-	 < 0.01	9.77E-01
age-dependent response to reactive oxygen species (GO:0001315)	1	0	.02	-	 < 0.01	9.77E-01
motile cilium assembly (GO:0044458)	23	0	.54	-	 < 0.01	5.85E-01
modification of synaptic structure, modulating synaptic transmission (GO:0099564)	1	0	.02	-	 < 0.01	9.77E-01
maintenance of postsynaptic density structure (GO:0099562)	3	0	.07	-	 < 0.01	9.32E-01
synaptic membrane adhesion (GO:0099560)	27	0	.63	-	 < 0.01	5.33E-01
regulation of Cdc42 protein signal transduction (GO:0032489)	6	0	.14	-	 < 0.01	8.69E-01
regulation of Rap protein signal transduction (GO:0032487)	3	0	.07	-	 < 0.01	9.32E-01
Rap protein signal transduction (GO:0032486)	10	0	.23	-	 < 0.01	7.92E-01
regulation of Ral protein signal transduction (GO:0032485)	3	0	.07	-	 < 0.01	9.32E-01
Ral protein signal transduction (GO:0032484)	2	0	.05	-	 < 0.01	9.54E-01
regulation of Rab protein signal transduction (GO:0032483)	6	0	.14	-	 < 0.01	8.69E-01
regulation of planar cell polarity pathway involved in heart morphogenesis (GO:2000159)	1	0	.02	-	 < 0.01	9.77E-01
Rab protein signal transduction (GO:0032482)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of ubiquitin-specific protease activity (GO:2000158)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of ubiquitin-specific protease activity (GO:2000157)	2	0	.05	-	 < 0.01	9.54E-01
regulation of retrograde vesicle-mediated transport, Golgi to ER (GO:2000156)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of cilium-dependent cell motility (GO:2000155)	11	0	.26	-	 < 0.01	7.74E-01
male genitalia morphogenesis (GO:0048808)	5	0	.12	-	 < 0.01	8.90E-01
regulation of ubiquitin-specific protease activity (GO:2000152)	4	0	.09	-	 < 0.01	9.11E-01
female genitalia morphogenesis (GO:0048807)	3	0	.07	-	 < 0.01	9.32E-01
export across plasma membrane (GO:0140115)	49	0	1.14	-	 < 0.01	3.19E-01
negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis (GO:2000151)	1	0	.02	-	 < 0.01	9.77E-01
genitalia development (GO:0048806)	51	0	1.19	-	 < 0.01	3.04E-01
regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis (GO:2000150)	1	0	.02	-	 < 0.01	9.77E-01
age-dependent response to oxidative stress (GO:0001306)	3	0	.07	-	 < 0.01	9.32E-01
extracellular vesicle biogenesis (GO:0140112)	9	0	.21	-	 < 0.01	8.11E-01
maintenance of synapse structure (GO:0099558)	13	0	.30	-	 < 0.01	7.38E-01
trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission (GO:0099557)	2	0	.05	-	 < 0.01	9.54E-01
trans-synaptic signaling by nitric oxide, modulating synaptic transmission (GO:0099555)	2	0	.05	-	 < 0.01	9.54E-01
trans-synaptic signaling by soluble gas, modulating synaptic transmission (GO:0099554)	2	0	.05	-	 < 0.01	9.54E-01
trans-synaptic signaling by endocannabinoid, modulating synaptic transmission (GO:0099553)	4	0	.09	-	 < 0.01	9.11E-01
trans-synaptic signaling by lipid, modulating synaptic transmission (GO:0099552)	4	0	.09	-	 < 0.01	9.11E-01
trans-synaptic signaling by neuropeptide, modulating synaptic transmission (GO:0099551)	2	0	.05	-	 < 0.01	9.54E-01
trans-synaptic signaling, modulating synaptic transmission (GO:0099550)	14	0	.33	-	 < 0.01	7.21E-01
otolith morphogenesis (GO:0032474)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis (GO:2000149)	1	0	.02	-	 < 0.01	9.77E-01
regulation of planar cell polarity pathway involved in ventricular septum morphogenesis (GO:2000148)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471)	9	0	.21	-	 < 0.01	8.11E-01
positive regulation of endoplasmic reticulum calcium ion concentration (GO:0032470)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of DNA-templated transcription, initiation (GO:2000144)	43	0	1.00	-	 < 0.01	3.67E-01
negative regulation of DNA-templated transcription, initiation (GO:2000143)	5	0	.12	-	 < 0.01	8.90E-01
regulation of DNA-templated transcription, initiation (GO:2000142)	50	0	1.17	-	 < 0.01	3.11E-01
peptidyl-glutamine modification (GO:0018199)	3	0	.07	-	 < 0.01	9.32E-01
peptidyl-aspartic acid modification (GO:0018197)	3	0	.07	-	 < 0.01	9.32E-01
peptidyl-asparagine modification (GO:0018196)	18	0	.42	-	 < 0.01	6.57E-01
trans-synaptic signaling by nitric oxide (GO:0099548)	3	0	.07	-	 < 0.01	9.32E-01
peptidyl-arginine modification (GO:0018195)	22	0	.51	-	 < 0.01	5.99E-01
regulation of translation at synapse, modulating synaptic transmission (GO:0099547)	7	0	.16	-	 < 0.01	8.49E-01
peptidyl-alanine modification (GO:0018194)	1	0	.02	-	 < 0.01	9.77E-01
protein catabolic process, modulating synaptic transmission (GO:0099546)	1	0	.02	-	 < 0.01	9.77E-01
trans-synaptic signaling by trans-synaptic complex (GO:0099545)	9	0	.21	-	 < 0.01	8.11E-01
peptidyl-serine octanoylation (GO:0018191)	1	0	.02	-	 < 0.01	9.77E-01
trans-synaptic signaling by soluble gas (GO:0099543)	3	0	.07	-	 < 0.01	9.32E-01
protein octanoylation (GO:0018190)	1	0	.02	-	 < 0.01	9.77E-01
trans-synaptic signaling by endocannabinoid (GO:0099542)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation by symbiont of host programmed cell death (GO:0052042)	3	0	.07	-	 < 0.01	9.32E-01
trans-synaptic signaling by lipid (GO:0099541)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation by symbiont of host programmed cell death (GO:0052041)	3	0	.07	-	 < 0.01	9.32E-01
trans-synaptic signaling by neuropeptide (GO:0099540)	2	0	.05	-	 < 0.01	9.54E-01
modulation by symbiont of host programmed cell death (GO:0052040)	8	0	.19	-	 < 0.01	8.30E-01
endoplasmic reticulum calcium ion homeostasis (GO:0032469)	28	0	.65	-	 < 0.01	5.20E-01
negative regulation of cytokinesis (GO:0032466)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of protein homooligomerization (GO:0032464)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of protein homooligomerization (GO:0032463)	1	0	.02	-	 < 0.01	9.77E-01
regulation of protein homooligomerization (GO:0032462)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of cell proliferation involved in heart morphogenesis (GO:2000138)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of protein oligomerization (GO:0032461)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of cell proliferation involved in heart morphogenesis (GO:2000137)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of protein oligomerization (GO:0032460)	1	0	.02	-	 < 0.01	9.77E-01
regulation of cell proliferation involved in heart morphogenesis (GO:2000136)	20	0	.47	-	 < 0.01	6.27E-01
synaptic signaling via neuropeptide (GO:0099538)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of presynaptic cytosolic calcium concentration (GO:0099533)	2	0	.05	-	 < 0.01	9.54E-01
synaptic vesicle endosomal processing (GO:0099532)	12	0	.28	-	 < 0.01	7.56E-01
regulation of protein oligomerization (GO:0032459)	4	0	.09	-	 < 0.01	9.11E-01
slow endocytic recycling (GO:0032458)	1	0	.02	-	 < 0.01	9.77E-01
regulation of endocannabinoid signaling pathway (GO:2000124)	3	0	.07	-	 < 0.01	9.32E-01
regulation of removal of superoxide radicals (GO:2000121)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of sodium-dependent phosphate transport (GO:2000120)	3	0	.07	-	 < 0.01	9.32E-01
protein depropionylation (GO:0106230)	2	0	.05	-	 < 0.01	9.54E-01
protein nucleotidylation (GO:0018175)	1	0	.02	-	 < 0.01	9.77E-01
postsynapse to nucleus signaling pathway (GO:0099527)	13	0	.30	-	 < 0.01	7.38E-01
modulation by symbiont of host signal transduction pathway (GO:0052027)	1	0	.02	-	 < 0.01	9.77E-01
presynapse to nucleus signaling pathway (GO:0099526)	3	0	.07	-	 < 0.01	9.32E-01
translocation of molecules into host (GO:0044417)	8	0	.19	-	 < 0.01	8.30E-01
presynaptic dense core vesicle exocytosis (GO:0099525)	6	0	.14	-	 < 0.01	8.69E-01
peptidyl-cysteine oxidation (GO:0018171)	3	0	.07	-	 < 0.01	9.32E-01
protein urmylation (GO:0032447)	2	0	.05	-	 < 0.01	9.54E-01
fructose import (GO:0032445)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of sodium-dependent phosphate transport (GO:2000119)	1	0	.02	-	 < 0.01	9.77E-01
regulation of sodium-dependent phosphate transport (GO:2000118)	5	0	.12	-	 < 0.01	8.90E-01
peptidyl-lysine glutarylation (GO:0106227)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of macrophage apoptotic process (GO:2000111)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of macrophage apoptotic process (GO:2000110)	5	0	.12	-	 < 0.01	8.90E-01
C-terminal protein-tyrosinylation (GO:0018166)	1	0	.02	-	 < 0.01	9.77E-01
synaptic vesicle transport along microtubule (GO:0099517)	15	0	.35	-	 < 0.01	7.05E-01
actin filament-based transport (GO:0099515)	21	0	.49	-	 < 0.01	6.13E-01
synaptic vesicle cytoskeletal transport (GO:0099514)	15	0	.35	-	 < 0.01	7.05E-01
peptidyl-pyrromethane cofactor linkage (GO:0018160)	1	0	.02	-	 < 0.01	9.77E-01
cAMP catabolic process (GO:0006198)	1	0	.02	-	 < 0.01	9.77E-01
AMP catabolic process (GO:0006196)	8	0	.19	-	 < 0.01	8.30E-01
purine nucleotide catabolic process (GO:0006195)	38	0	.89	-	 < 0.01	4.12E-01
melanosome organization (GO:0032438)	18	0	.42	-	 < 0.01	6.57E-01
ITP catabolic process (GO:0006193)	1	0	.02	-	 < 0.01	9.77E-01
regulation of macrophage apoptotic process (GO:2000109)	9	0	.21	-	 < 0.01	8.11E-01
positive regulation of leukocyte apoptotic process (GO:2000108)	34	0	.79	-	 < 0.01	4.52E-01
activation of phospholipase A2 activity (GO:0032431)	1	0	.02	-	 < 0.01	9.77E-01
thermosensory behavior (GO:0040040)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of phospholipase A2 activity (GO:0032430)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of DNA-dependent DNA replication (GO:2000105)	12	0	.28	-	 < 0.01	7.56E-01
negative regulation of DNA-dependent DNA replication (GO:2000104)	11	0	.26	-	 < 0.01	7.74E-01
positive regulation of mammary stem cell proliferation (GO:2000103)	1	0	.02	-	 < 0.01	9.77E-01
regulation of mammary stem cell proliferation (GO:2000101)	1	0	.02	-	 < 0.01	9.77E-01
protein oxidation (GO:0018158)	12	0	.28	-	 < 0.01	7.56E-01
isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine (GO:0018153)	1	0	.02	-	 < 0.01	9.77E-01
calcium-dependent activation of synaptic vesicle fusion (GO:0099502)	4	0	.09	-	 < 0.01	9.11E-01
'de novo' IMP biosynthetic process (GO:0006189)	4	0	.09	-	 < 0.01	9.11E-01
IMP biosynthetic process (GO:0006188)	8	0	.19	-	 < 0.01	8.30E-01
vesicle fusion to plasma membrane (GO:0099500)	13	0	.30	-	 < 0.01	7.38E-01
dGDP biosynthetic process (GO:0006185)	1	0	.02	-	 < 0.01	9.77E-01
regulation of phospholipase A2 activity (GO:0032429)	10	0	.23	-	 < 0.01	7.92E-01
GTP biosynthetic process (GO:0006183)	10	0	.23	-	 < 0.01	7.92E-01
cGMP biosynthetic process (GO:0006182)	12	0	.28	-	 < 0.01	7.56E-01
positive regulation of mismatch repair (GO:0032425)	2	0	.05	-	 < 0.01	9.54E-01
regulation of development, heterochronic (GO:0040034)	13	0	.30	-	 < 0.01	7.38E-01
regulation of mismatch repair (GO:0032423)	3	0	.07	-	 < 0.01	9.32E-01
post-embryonic body morphogenesis (GO:0040032)	1	0	.02	-	 < 0.01	9.77E-01
snRNA modification (GO:0040031)	7	0	.16	-	 < 0.01	8.49E-01
regulation of molecular function, epigenetic (GO:0040030)	2	0	.05	-	 < 0.01	9.54E-01
keratan sulfate biosynthetic process (GO:0018146)	1	0	.02	-	 < 0.01	9.77E-01
guanine salvage (GO:0006178)	1	0	.02	-	 < 0.01	9.77E-01
GMP biosynthetic process (GO:0006177)	4	0	.09	-	 < 0.01	9.11E-01
regulation of gene expression, epigenetic (GO:0040029)	103	0	2.40	-	 < 0.01	9.00E-02
dATP biosynthetic process (GO:0006175)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of sodium:proton antiporter activity (GO:0032417)	3	0	.07	-	 < 0.01	9.32E-01
ADP biosynthetic process (GO:0006172)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of sodium:proton antiporter activity (GO:0032416)	2	0	.05	-	 < 0.01	9.54E-01
regulation of sodium:proton antiporter activity (GO:0032415)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of ion transmembrane transporter activity (GO:0032413)	67	0	1.56	-	 < 0.01	2.09E-01
negative regulation of transporter activity (GO:0032410)	76	0	1.77	-	 < 0.01	1.69E-01
adenine salvage (GO:0006168)	2	0	.05	-	 < 0.01	9.54E-01
AMP biosynthetic process (GO:0006167)	5	0	.12	-	 < 0.01	8.90E-01
purine ribonucleoside salvage (GO:0006166)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of embryonic development (GO:0040019)	23	0	.54	-	 < 0.01	5.85E-01
embryonic cleavage (GO:0040016)	8	0	.19	-	 < 0.01	8.30E-01
deoxyguanosine catabolic process (GO:0006161)	1	0	.02	-	 < 0.01	9.77E-01
melanosome transport (GO:0032402)	16	0	.37	-	 < 0.01	6.89E-01
establishment of melanosome localization (GO:0032401)	17	0	.40	-	 < 0.01	6.73E-01
positive regulation of growth rate (GO:0040010)	4	0	.09	-	 < 0.01	9.11E-01
melanosome localization (GO:0032400)	20	0	.47	-	 < 0.01	6.27E-01
peptidyl-cysteine methylation (GO:0018125)	3	0	.07	-	 < 0.01	9.32E-01
peptidyl-arginine ADP-ribosylation (GO:0018120)	5	0	.12	-	 < 0.01	8.90E-01
deoxyadenosine catabolic process (GO:0006157)	1	0	.02	-	 < 0.01	9.77E-01
regulation of growth rate (GO:0040009)	10	0	.23	-	 < 0.01	7.92E-01
adenosine catabolic process (GO:0006154)	6	0	.14	-	 < 0.01	8.69E-01
purine nucleoside catabolic process (GO:0006152)	13	0	.30	-	 < 0.01	7.38E-01
histone H2A-S1 phosphorylation (GO:0043990)	1	0	.02	-	 < 0.01	9.77E-01
peptidyl-cysteine S-nitrosylation (GO:0018119)	6	0	.14	-	 < 0.01	8.69E-01
protein adenylylation (GO:0018117)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of response to endoplasmic reticulum stress (GO:1905898)	33	0	.77	-	 < 0.01	4.63E-01
positive regulation of cellular response to tunicamycin (GO:1905896)	1	0	.02	-	 < 0.01	9.77E-01
mitotic spindle checkpoint (GO:0071174)	27	0	.63	-	 < 0.01	5.33E-01
negative regulation of cellular response to tunicamycin (GO:1905895)	1	0	.02	-	 < 0.01	9.77E-01
spindle assembly checkpoint (GO:0071173)	25	0	.58	-	 < 0.01	5.58E-01
regulation of cellular response to tunicamycin (GO:1905894)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of cellular response to thapsigargin (GO:1905893)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of cellular response to thapsigargin (GO:1905892)	1	0	.02	-	 < 0.01	9.77E-01
regulation of cellular response to thapsigargin (GO:1905891)	2	0	.05	-	 < 0.01	9.54E-01
deoxyinosine catabolic process (GO:0006149)	1	0	.02	-	 < 0.01	9.77E-01
regulation of cellular response to very-low-density lipoprotein particle stimulus (GO:1905890)	1	0	.02	-	 < 0.01	9.77E-01
inosine catabolic process (GO:0006148)	4	0	.09	-	 < 0.01	9.11E-01
guanine catabolic process (GO:0006147)	1	0	.02	-	 < 0.01	9.77E-01
meiotic recombination checkpoint (GO:0051598)	4	0	.09	-	 < 0.01	9.11E-01
histone H3-S28 phosphorylation (GO:0043988)	3	0	.07	-	 < 0.01	9.32E-01
response to methylmercury (GO:0051597)	2	0	.05	-	 < 0.01	9.54E-01
purine nucleobase catabolic process (GO:0006145)	9	0	.21	-	 < 0.01	8.11E-01
histone H3-S10 phosphorylation (GO:0043987)	6	0	.14	-	 < 0.01	8.69E-01
methylglyoxal catabolic process (GO:0051596)	5	0	.12	-	 < 0.01	8.90E-01
purine nucleobase metabolic process (GO:0006144)	21	0	.49	-	 < 0.01	6.13E-01
response to methylglyoxal (GO:0051595)	3	0	.07	-	 < 0.01	9.32E-01
histone H4-R3 methylation (GO:0043985)	2	0	.05	-	 < 0.01	9.54E-01
detection of glucose (GO:0051594)	2	0	.05	-	 < 0.01	9.54E-01
histone H4-K16 acetylation (GO:0043984)	14	0	.33	-	 < 0.01	7.21E-01
histone H4-K12 acetylation (GO:0043983)	8	0	.19	-	 < 0.01	8.30E-01
histone H4-K8 acetylation (GO:0043982)	15	0	.35	-	 < 0.01	7.05E-01
response to cAMP (GO:0051591)	56	0	1.31	-	 < 0.01	2.71E-01
histone H4-K5 acetylation (GO:0043981)	15	0	.35	-	 < 0.01	7.05E-01
positive regulation of neurotransmitter transport (GO:0051590)	25	0	.58	-	 < 0.01	5.58E-01
histone H2B-K12 acetylation (GO:0043980)	1	0	.02	-	 < 0.01	9.77E-01
viral translational termination-reinitiation (GO:0075525)	5	0	.12	-	 < 0.01	8.90E-01
IRES-dependent viral translational initiation (GO:0075522)	11	0	.26	-	 < 0.01	7.74E-01
establishment of protein localization to chromatin (GO:0071169)	4	0	.09	-	 < 0.01	9.11E-01
protein localization to chromatin (GO:0071168)	20	0	.47	-	 < 0.01	6.27E-01
ribonucleoprotein complex localization (GO:0071166)	63	0	1.47	-	 < 0.01	2.30E-01
positive regulation of triglyceride transport (GO:1905885)	2	0	.05	-	 < 0.01	9.54E-01
protein C-linked glycosylation (GO:0018103)	4	0	.09	-	 < 0.01	9.11E-01
DNA replication preinitiation complex assembly (GO:0071163)	2	0	.05	-	 < 0.01	9.54E-01
regulation of triglyceride transport (GO:1905883)	2	0	.05	-	 < 0.01	9.54E-01
protein citrullination (GO:0018101)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of neurotransmitter transport (GO:0051589)	16	0	.37	-	 < 0.01	6.89E-01
histone H2B-K5 acetylation (GO:0043979)	1	0	.02	-	 < 0.01	9.77E-01
histone H2A-K5 acetylation (GO:0043977)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of dopamine uptake involved in synaptic transmission (GO:0051586)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of dopamine uptake involved in synaptic transmission (GO:0051585)	1	0	.02	-	 < 0.01	9.77E-01
regulation of dopamine uptake involved in synaptic transmission (GO:0051584)	6	0	.14	-	 < 0.01	8.69E-01
dopamine uptake involved in synaptic transmission (GO:0051583)	3	0	.07	-	 < 0.01	9.32E-01
histone H3-K4 acetylation (GO:0043973)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of neurotransmitter uptake (GO:0051582)	4	0	.09	-	 < 0.01	9.11E-01
histone H3-K23 acetylation (GO:0043972)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of neurotransmitter uptake (GO:0051581)	4	0	.09	-	 < 0.01	9.11E-01
mRNA pseudouridine synthesis (GO:1990481)	5	0	.12	-	 < 0.01	8.90E-01
histone H3-K9 acetylation (GO:0043970)	2	0	.05	-	 < 0.01	9.54E-01
clathrin-dependent endocytosis of virus by host cell (GO:0075512)	1	0	.02	-	 < 0.01	9.77E-01
regulation of oogenesis (GO:1905879)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of postsynaptic density organization (GO:1905875)	1	0	.02	-	 < 0.01	9.77E-01
regulation of postsynaptic density organization (GO:1905874)	19	0	.44	-	 < 0.01	6.42E-01
positive regulation of protein localization to cell leading edge (GO:1905873)	1	0	.02	-	 < 0.01	9.77E-01
regulation of protein localization to cell leading edge (GO:1905871)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of 3'-UTR-mediated mRNA stabilization (GO:1905870)	5	0	.12	-	 < 0.01	8.90E-01
glycerophosphate shuttle (GO:0006127)	2	0	.05	-	 < 0.01	9.54E-01
histone H2B acetylation (GO:0043969)	4	0	.09	-	 < 0.01	9.11E-01
histone H2A acetylation (GO:0043968)	17	0	.40	-	 < 0.01	6.73E-01
histone H4 acetylation (GO:0043967)	54	0	1.26	-	 < 0.01	2.83E-01
mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)	9	0	.21	-	 < 0.01	8.11E-01
mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)	9	0	.21	-	 < 0.01	8.11E-01
negative regulation of histone H3-K9 methylation (GO:0051573)	13	0	.30	-	 < 0.01	7.38E-01
mitochondrial electron transport, succinate to ubiquinone (GO:0006121)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of histone H3-K4 methylation (GO:0051572)	6	0	.14	-	 < 0.01	8.69E-01
mitochondrial electron transport, NADH to ubiquinone (GO:0006120)	16	0	.37	-	 < 0.01	6.89E-01
positive regulation of histone H3-K4 methylation (GO:0051571)	17	0	.40	-	 < 0.01	6.73E-01
endocytosis involved in viral entry into host cell (GO:0075509)	6	0	.14	-	 < 0.01	8.69E-01
entry of viral genome into host nucleus through nuclear pore complex via importin (GO:0075506)	2	0	.05	-	 < 0.01	9.54E-01
mRNA export from nucleus in response to heat stress (GO:0031990)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of 3'-UTR-mediated mRNA stabilization (GO:1905869)	1	0	.02	-	 < 0.01	9.77E-01
regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868)	6	0	.14	-	 < 0.01	8.69E-01
epididymis development (GO:1905867)	1	0	.02	-	 < 0.01	9.77E-01
invadopodium organization (GO:1905863)	1	0	.02	-	 < 0.01	9.77E-01
resolution of mitotic recombination intermediates (GO:0071140)	2	0	.05	-	 < 0.01	9.54E-01
oxidative phosphorylation (GO:0006119)	61	0	1.42	-	 < 0.01	2.41E-01
positive regulation of heparan sulfate proteoglycan binding (GO:1905860)	1	0	.02	-	 < 0.01	9.77E-01
regulation of histone H3-K4 methylation (GO:0051569)	29	0	.68	-	 < 0.01	5.08E-01
acetaldehyde metabolic process (GO:0006117)	2	0	.05	-	 < 0.01	9.54E-01
histone H3-K4 methylation (GO:0051568)	28	0	.65	-	 < 0.01	5.20E-01
NADH oxidation (GO:0006116)	6	0	.14	-	 < 0.01	8.69E-01
histone H3-K9 methylation (GO:0051567)	13	0	.30	-	 < 0.01	7.38E-01
glycerol biosynthetic process (GO:0006114)	6	0	.14	-	 < 0.01	8.69E-01
fermentation (GO:0006113)	1	0	.02	-	 < 0.01	9.77E-01
smooth endoplasmic reticulum calcium ion homeostasis (GO:0051563)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of mitochondrial calcium ion concentration (GO:0051562)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of mitochondrial calcium ion concentration (GO:0051561)	9	0	.21	-	 < 0.01	8.11E-01
mitochondrial calcium ion homeostasis (GO:0051560)	21	0	.49	-	 < 0.01	6.13E-01
resolution of recombination intermediates (GO:0071139)	2	0	.05	-	 < 0.01	9.54E-01
regulation of heparan sulfate proteoglycan binding (GO:1905858)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of pentose-phosphate shunt (GO:1905856)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of heparan sulfate binding (GO:1905855)	1	0	.02	-	 < 0.01	9.77E-01
regulation of heparan sulfate binding (GO:1905853)	1	0	.02	-	 < 0.01	9.77E-01
malate metabolic process (GO:0006108)	6	0	.14	-	 < 0.01	8.69E-01
oxaloacetate metabolic process (GO:0006107)	11	0	.26	-	 < 0.01	7.74E-01
fumarate metabolic process (GO:0006106)	2	0	.05	-	 < 0.01	9.54E-01
succinate metabolic process (GO:0006105)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation by host of symbiont catalytic activity (GO:0043947)	1	0	.02	-	 < 0.01	9.77E-01
mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456)	4	0	.09	-	 < 0.01	9.11E-01
succinyl-CoA metabolic process (GO:0006104)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of catalytic activity in other organism involved in symbiotic interaction (GO:0043946)	1	0	.02	-	 < 0.01	9.77E-01
regulation of cysteine metabolic process (GO:1901494)	1	0	.02	-	 < 0.01	9.77E-01
isocitrate metabolic process (GO:0006102)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of lymphangiogenesis (GO:1901492)	3	0	.07	-	 < 0.01	9.32E-01
citrate metabolic process (GO:0006101)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of lymphangiogenesis (GO:1901491)	4	0	.09	-	 < 0.01	9.11E-01
regulation of lymphangiogenesis (GO:1901490)	7	0	.16	-	 < 0.01	8.49E-01
cellular stress response to acidic pH (GO:1990451)	1	0	.02	-	 < 0.01	9.77E-01
regulation of cellular response to gamma radiation (GO:1905843)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of keratinocyte migration (GO:0051548)	1	0	.02	-	 < 0.01	9.77E-01
keratinocyte migration (GO:0051546)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of transcription factor catabolic process (GO:1901485)	4	0	.09	-	 < 0.01	9.11E-01
regulation of transcription factor catabolic process (GO:1901483)	4	0	.09	-	 < 0.01	9.11E-01
peptidyl-threonine autophosphorylation (GO:1990443)	2	0	.05	-	 < 0.01	9.54E-01
elastin biosynthetic process (GO:0051542)	1	0	.02	-	 < 0.01	9.77E-01
intrinsic apoptotic signaling pathway in response to nitrosative stress (GO:1990442)	1	0	.02	-	 < 0.01	9.77E-01
ossification involved in bone remodeling (GO:0043932)	2	0	.05	-	 < 0.01	9.54E-01
elastin metabolic process (GO:0051541)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990441)	5	0	.12	-	 < 0.01	8.90E-01
ossification involved in bone maturation (GO:0043931)	17	0	.40	-	 < 0.01	6.73E-01
positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440)	11	0	.26	-	 < 0.01	7.74E-01
negative regulation of telomeric D-loop disassembly (GO:1905839)	2	0	.05	-	 < 0.01	9.54E-01
regulation of telomeric D-loop disassembly (GO:1905838)	2	0	.05	-	 < 0.01	9.54E-01
cellular response to pyrimidine ribonucleotide (GO:1905835)	1	0	.02	-	 < 0.01	9.77E-01
response to pyrimidine ribonucleotide (GO:1905834)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of spindle assembly (GO:1905832)	5	0	.12	-	 < 0.01	8.90E-01
histone biotinylation (GO:0071110)	1	0	.02	-	 < 0.01	9.77E-01
U6 2'-O-snRNA methylation (GO:1990438)	1	0	.02	-	 < 0.01	9.77E-01
exonucleolytic catabolism of deadenylated mRNA (GO:0043928)	9	0	.21	-	 < 0.01	8.11E-01
snRNA 2'-O-methylation (GO:1990437)	1	0	.02	-	 < 0.01	9.77E-01
pyruvate transmembrane transport (GO:1901475)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation by host of viral transcription (GO:0043922)	12	0	.28	-	 < 0.01	7.56E-01
modulation by host of viral transcription (GO:0043921)	2	0	.05	-	 < 0.01	9.54E-01
mineralocorticoid receptor signaling pathway (GO:0031959)	1	0	.02	-	 < 0.01	9.77E-01
corticosteroid receptor signaling pathway (GO:0031958)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of protein autophosphorylation (GO:0031953)	11	0	.26	-	 < 0.01	7.74E-01
superior temporal gyrus development (GO:0071109)	1	0	.02	-	 < 0.01	9.77E-01
protein K48-linked deubiquitination (GO:0071108)	23	0	.54	-	 < 0.01	5.85E-01
response to parathyroid hormone (GO:0071107)	6	0	.14	-	 < 0.01	8.69E-01
adenosine 3',5'-bisphosphate transmembrane transport (GO:0071106)	1	0	.02	-	 < 0.01	9.77E-01
response to interleukin-11 (GO:0071105)	2	0	.05	-	 < 0.01	9.54E-01
response to interleukin-9 (GO:0071104)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of chromosome separation (GO:1905820)	16	0	.37	-	 < 0.01	6.89E-01
miRNA transport (GO:1990428)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of tetrapyrrole biosynthetic process (GO:1901465)	1	0	.02	-	 < 0.01	9.77E-01
mitotic recombination-dependent replication fork processing (GO:1990426)	2	0	.05	-	 < 0.01	9.54E-01
regulation of tetrapyrrole biosynthetic process (GO:1901463)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of glucocorticoid biosynthetic process (GO:0031948)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of glucocorticoid biosynthetic process (GO:0031947)	5	0	.12	-	 < 0.01	8.90E-01
regulation of glucocorticoid biosynthetic process (GO:0031946)	9	0	.21	-	 < 0.01	8.11E-01
positive regulation of glucocorticoid metabolic process (GO:0031945)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of glucocorticoid metabolic process (GO:0031944)	5	0	.12	-	 < 0.01	8.90E-01
regulation of glucocorticoid metabolic process (GO:0031943)	11	0	.26	-	 < 0.01	7.74E-01
positive regulation of chromatin silencing at telomere (GO:0031940)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of chromosome separation (GO:1905819)	30	0	.70	-	 < 0.01	4.97E-01
response to insulin-like growth factor stimulus (GO:1990418)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to brain-derived neurotrophic factor stimulus (GO:1990416)	5	0	.12	-	 < 0.01	8.90E-01
replication-born double-strand break repair via sister chromatid exchange (GO:1990414)	9	0	.21	-	 < 0.01	8.11E-01
negative regulation of unidimensional cell growth (GO:0051511)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of multi-organism process (GO:0043901)	17	0	.40	-	 < 0.01	6.73E-01
regulation of unidimensional cell growth (GO:0051510)	1	0	.02	-	 < 0.01	9.77E-01
adrenomedullin receptor signaling pathway (GO:1990410)	4	0	.09	-	 < 0.01	9.11E-01
regulation of chromatin silencing at telomere (GO:0031938)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of chromatin silencing (GO:0031937)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of chromatin silencing (GO:0031936)	7	0	.16	-	 < 0.01	8.49E-01
regulation of chromatin silencing (GO:0031935)	12	0	.28	-	 < 0.01	7.56E-01
regulation of neural crest formation (GO:0090299)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of mitochondrial DNA replication (GO:0090298)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of mitochondrial DNA replication (GO:0090297)	1	0	.02	-	 < 0.01	9.77E-01
mitochondria-nucleus signaling pathway (GO:0031930)	2	0	.05	-	 < 0.01	9.54E-01
regulation of mitochondrial DNA replication (GO:0090296)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of synapse organization (GO:1905809)	14	0	.33	-	 < 0.01	7.21E-01
nitrogen catabolite activation of transcription (GO:0090294)	1	0	.02	-	 < 0.01	9.77E-01
nitrogen catabolite regulation of transcription (GO:0090293)	1	0	.02	-	 < 0.01	9.77E-01
nuclear matrix anchoring at nuclear membrane (GO:0090292)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of osteoclast proliferation (GO:0090291)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of osteoclast proliferation (GO:0090290)	4	0	.09	-	 < 0.01	9.11E-01
regulation of cellular response to manganese ion (GO:1905802)	1	0	.02	-	 < 0.01	9.77E-01
calcitonin gene-related peptide receptor signaling pathway (GO:1990408)	2	0	.05	-	 < 0.01	9.54E-01
adenine nucleotide transport (GO:0051503)	14	0	.33	-	 < 0.01	7.21E-01
embryonic liver development (GO:1990402)	2	0	.05	-	 < 0.01	9.54E-01
embryonic lung development (GO:1990401)	2	0	.05	-	 < 0.01	9.54E-01
regulation of osteoclast proliferation (GO:0090289)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of protein glycosylation in Golgi (GO:0090285)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of protein glycosylation in Golgi (GO:0090284)	1	0	.02	-	 < 0.01	9.77E-01
regulation of protein glycosylation in Golgi (GO:0090283)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of transcription involved in G2/M transition of mitotic cell cycle (GO:0090282)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of calcium ion import (GO:0090281)	11	0	.26	-	 < 0.01	7.74E-01
positive regulation of synaptic plasticity (GO:0031915)	14	0	.33	-	 < 0.01	7.21E-01
negative regulation of synaptic plasticity (GO:0031914)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of somatostatin secretion (GO:0090274)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of fibroblast growth factor production (GO:0090272)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of fibroblast growth factor production (GO:0090271)	5	0	.12	-	 < 0.01	8.90E-01
regulation of fibroblast growth factor production (GO:0090270)	9	0	.21	-	 < 0.01	8.11E-01
positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267)	7	0	.16	-	 < 0.01	8.49E-01
regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266)	13	0	.30	-	 < 0.01	7.38E-01
positive regulation of immune complex clearance by monocytes and macrophages (GO:0090265)	3	0	.07	-	 < 0.01	9.32E-01
regulation of immune complex clearance by monocytes and macrophages (GO:0090264)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of retinal ganglion cell axon guidance (GO:0090260)	1	0	.02	-	 < 0.01	9.77E-01
regulation of response to alcohol (GO:1901419)	1	0	.02	-	 < 0.01	9.77E-01
seminal clot liquefaction (GO:0070684)	1	0	.02	-	 < 0.01	9.77E-01
proteasome regulatory particle assembly (GO:0070682)	3	0	.07	-	 < 0.01	9.32E-01
glutaminyl-tRNAGln biosynthesis via transamidation (GO:0070681)	2	0	.05	-	 < 0.01	9.54E-01
regulation of retinal ganglion cell axon guidance (GO:0090259)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of mitochondrial fission (GO:0090258)	4	0	.09	-	 < 0.01	9.11E-01
pronephros development (GO:0048793)	8	0	.19	-	 < 0.01	8.30E-01
spontaneous exocytosis of neurotransmitter (GO:0048792)	2	0	.05	-	 < 0.01	9.54E-01
calcium ion-regulated exocytosis of neurotransmitter (GO:0048791)	18	0	.42	-	 < 0.01	6.57E-01
maintenance of presynaptic active zone structure (GO:0048790)	1	0	.02	-	 < 0.01	9.77E-01
protein localization involved in establishment of planar polarity (GO:0090251)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901409)	1	0	.02	-	 < 0.01	9.77E-01
intralumenal vesicle formation (GO:0070676)	2	0	.05	-	 < 0.01	9.54E-01
regulation of phosphorylation of RNA polymerase II C-terminal domain (GO:1901407)	2	0	.05	-	 < 0.01	9.54E-01
response to interleukin-18 (GO:0070673)	9	0	.21	-	 < 0.01	8.11E-01
response to interleukin-15 (GO:0070672)	8	0	.19	-	 < 0.01	8.30E-01
response to interleukin-12 (GO:0070671)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of tetrapyrrole metabolic process (GO:1901403)	2	0	.05	-	 < 0.01	9.54E-01
regulation of tetrapyrrole metabolic process (GO:1901401)	4	0	.09	-	 < 0.01	9.11E-01
cytoskeletal matrix organization at active zone (GO:0048789)	1	0	.02	-	 < 0.01	9.77E-01
regulation of cell migration involved in somitogenic axis elongation (GO:0090249)	1	0	.02	-	 < 0.01	9.77E-01
convergent extension involved in somitogenesis (GO:0090246)	1	0	.02	-	 < 0.01	9.77E-01
axis elongation involved in somitogenesis (GO:0090245)	4	0	.09	-	 < 0.01	9.11E-01
Wnt signaling pathway involved in somitogenesis (GO:0090244)	4	0	.09	-	 < 0.01	9.11E-01
retinoic acid receptor signaling pathway involved in somitogenesis (GO:0090242)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of histone H4 acetylation (GO:0090241)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of histone H4 acetylation (GO:0090240)	6	0	.14	-	 < 0.01	8.69E-01
response to interleukin-2 (GO:0070669)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of mast cell proliferation (GO:0070668)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of mast cell proliferation (GO:0070667)	3	0	.07	-	 < 0.01	9.32E-01
regulation of mast cell proliferation (GO:0070666)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of leukocyte proliferation (GO:0070665)	149	0	3.47	-	 < 0.01	3.06E-02
regulation of histone H4 acetylation (GO:0090239)	14	0	.33	-	 < 0.01	7.21E-01
positive regulation of arachidonic acid secretion (GO:0090238)	7	0	.16	-	 < 0.01	8.49E-01
regulation of arachidonic acid secretion (GO:0090237)	10	0	.23	-	 < 0.01	7.92E-01
erythrophore differentiation (GO:0048773)	1	0	.02	-	 < 0.01	9.77E-01
regulation of metaphase plate congression (GO:0090235)	8	0	.19	-	 < 0.01	8.30E-01
regulation of kinetochore assembly (GO:0090234)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of spindle checkpoint (GO:0090233)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of spindle checkpoint (GO:0090232)	7	0	.16	-	 < 0.01	8.49E-01
regulation of centromere complex assembly (GO:0090230)	3	0	.07	-	 < 0.01	9.32E-01
nonfunctional rRNA decay (GO:0070651)	1	0	.02	-	 < 0.01	9.77E-01
actin filament bundle distribution (GO:0070650)	1	0	.02	-	 < 0.01	9.77E-01
sarcomerogenesis (GO:0048769)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of lipoprotein transport (GO:0140077)	1	0	.02	-	 < 0.01	9.77E-01
regulation of lipoprotein transport (GO:0140075)	1	0	.02	-	 < 0.01	9.77E-01
cardiac endothelial to mesenchymal transition (GO:0140074)	1	0	.02	-	 < 0.01	9.77E-01
regulation of microtubule nucleation by Ran protein signal transduction (GO:0090226)	1	0	.02	-	 < 0.01	9.77E-01
centrosome-templated microtubule nucleation (GO:0090222)	2	0	.05	-	 < 0.01	9.54E-01
chromosome localization to nuclear envelope involved in homologous chromosome segregation (GO:0090220)	9	0	.21	-	 < 0.01	8.11E-01
vitamin D3 metabolic process (GO:0070640)	5	0	.12	-	 < 0.01	8.90E-01
peptidyl-lysine butyrylation (GO:0140067)	1	0	.02	-	 < 0.01	9.77E-01
peptidyl-lysine crotonylation (GO:0140066)	1	0	.02	-	 < 0.01	9.77E-01
pigment granule maturation (GO:0048757)	10	0	.23	-	 < 0.01	7.92E-01
negative regulation of lipid kinase activity (GO:0090219)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity (GO:0090217)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity (GO:0090216)	1	0	.02	-	 < 0.01	9.77E-01
pigment granule organization (GO:0048753)	19	0	.44	-	 < 0.01	6.42E-01
regulation of 1-phosphatidylinositol-4-phosphate 5-kinase activity (GO:0090215)	4	0	.09	-	 < 0.01	9.11E-01
semicircular canal morphogenesis (GO:0048752)	8	0	.19	-	 < 0.01	8.30E-01
spongiotrophoblast layer developmental growth (GO:0090214)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of establishment of blood-brain barrier (GO:0090212)	2	0	.05	-	 < 0.01	9.54E-01
regulation of establishment of blood-brain barrier (GO:0090210)	3	0	.07	-	 < 0.01	9.32E-01
transepithelial ammonium transport (GO:0070634)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of smooth muscle cell-matrix adhesion (GO:2000098)	2	0	.05	-	 < 0.01	9.54E-01
regulation of smooth muscle cell-matrix adhesion (GO:2000097)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000096)	8	0	.19	-	 < 0.01	8.30E-01
dendrite arborization (GO:0140059)	9	0	.21	-	 < 0.01	8.11E-01
neuron projection arborization (GO:0140058)	14	0	.33	-	 < 0.01	7.21E-01
organelle localization by membrane tethering (GO:0140056)	76	0	1.77	-	 < 0.01	1.69E-01
muscle fiber development (GO:0048747)	55	0	1.28	-	 < 0.01	2.77E-01
negative regulation of triglyceride metabolic process (GO:0090209)	12	0	.28	-	 < 0.01	7.56E-01
smooth muscle tissue development (GO:0048745)	24	0	.56	-	 < 0.01	5.71E-01
mitochondrial gene expression (GO:0140053)	76	0	1.77	-	 < 0.01	1.69E-01
negative regulation of cholesterol metabolic process (GO:0090206)	5	0	.12	-	 < 0.01	8.90E-01
cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052)	9	0	.21	-	 < 0.01	8.11E-01
positive regulation of skeletal muscle fiber development (GO:0048743)	8	0	.19	-	 < 0.01	8.30E-01
positive regulation of endocardial cushion to mesenchymal transition (GO:0140051)	1	0	.02	-	 < 0.01	9.77E-01
regulation of skeletal muscle fiber development (GO:0048742)	13	0	.30	-	 < 0.01	7.38E-01
protein localization to nuclear pore (GO:0090204)	3	0	.07	-	 < 0.01	9.32E-01
skeletal muscle fiber development (GO:0048741)	24	0	.56	-	 < 0.01	5.71E-01
gene looping (GO:0090202)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of release of cytochrome c from mitochondria (GO:0090201)	19	0	.44	-	 < 0.01	6.42E-01
positive regulation of release of cytochrome c from mitochondria (GO:0090200)	25	0	.58	-	 < 0.01	5.58E-01
glucose import in response to insulin stimulus (GO:0044381)	4	0	.09	-	 < 0.01	9.11E-01
zymogen granule exocytosis (GO:0070625)	2	0	.05	-	 < 0.01	9.54E-01
regulation of endocardial cushion to mesenchymal transition (GO:0140049)	1	0	.02	-	 < 0.01	9.77E-01
cardiac muscle fiber development (GO:0048739)	9	0	.21	-	 < 0.01	8.11E-01
positive regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation (GO:2000081)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation (GO:2000080)	1	0	.02	-	 < 0.01	9.77E-01
lipid droplet formation (GO:0140042)	10	0	.23	-	 < 0.01	7.92E-01
sebaceous gland development (GO:0048733)	13	0	.30	-	 < 0.01	7.38E-01
cellular detoxification of methylglyoxal (GO:0140041)	1	0	.02	-	 < 0.01	9.77E-01
regulation of peroxisome size (GO:0044375)	3	0	.07	-	 < 0.01	9.32E-01
regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation (GO:2000079)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of type B pancreatic cell development (GO:2000078)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of type B pancreatic cell development (GO:2000077)	1	0	.02	-	 < 0.01	9.77E-01
cell-cell adhesion in response to extracellular stimulus (GO:0140039)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of molecular function in other organism (GO:0044362)	5	0	.12	-	 < 0.01	8.90E-01
regulation of centromeric sister chromatid cohesion (GO:0070602)	3	0	.07	-	 < 0.01	9.32E-01
centromeric sister chromatid cohesion (GO:0070601)	7	0	.16	-	 < 0.01	8.49E-01
DNA geometric change (GO:0032392)	35	0	.82	-	 < 0.01	4.42E-01
positive regulation of cortisol biosynthetic process (GO:2000066)	1	0	.02	-	 < 0.01	9.77E-01
exocytic process (GO:0140029)	74	0	1.73	-	 < 0.01	1.78E-01
negative regulation of cortisol biosynthetic process (GO:2000065)	4	0	.09	-	 < 0.01	9.11E-01
regulation of cortisol biosynthetic process (GO:2000064)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of ureter smooth muscle cell differentiation (GO:2000063)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of ureter smooth muscle cell differentiation (GO:2000062)	1	0	.02	-	 < 0.01	9.77E-01
regulation of ureter smooth muscle cell differentiation (GO:2000061)	1	0	.02	-	 < 0.01	9.77E-01
mitochondrial ADP transmembrane transport (GO:0140021)	1	0	.02	-	 < 0.01	9.77E-01
modulation of molecular function in other organism (GO:0044359)	7	0	.16	-	 < 0.01	8.49E-01
regulation of rRNA stability (GO:0044357)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of intracellular cholesterol transport (GO:0032385)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of intracellular cholesterol transport (GO:0032384)	2	0	.05	-	 < 0.01	9.54E-01
regulation of intracellular cholesterol transport (GO:0032383)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of intracellular sterol transport (GO:0032382)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of intracellular sterol transport (GO:0032381)	2	0	.05	-	 < 0.01	9.54E-01
regulation of intracellular sterol transport (GO:0032380)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification (GO:2000054)	2	0	.05	-	 < 0.01	9.54E-01
regulation of Wnt signaling pathway involved in dorsal/ventral axis specification (GO:2000053)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of non-canonical Wnt signaling pathway (GO:2000052)	14	0	.33	-	 < 0.01	7.21E-01
histone displacement (GO:0001207)	1	0	.02	-	 < 0.01	9.77E-01
embryonic viscerocranium morphogenesis (GO:0048703)	10	0	.23	-	 < 0.01	7.92E-01
embryonic neurocranium morphogenesis (GO:0048702)	10	0	.23	-	 < 0.01	7.92E-01
fibroblast apoptotic process (GO:0044346)	2	0	.05	-	 < 0.01	9.54E-01
stromal-epithelial cell signaling involved in prostate gland development (GO:0044345)	1	0	.02	-	 < 0.01	9.77E-01
type B pancreatic cell proliferation (GO:0044342)	10	0	.23	-	 < 0.01	7.92E-01
sodium-dependent phosphate transport (GO:0044341)	3	0	.07	-	 < 0.01	9.32E-01
canonical Wnt signaling pathway involved in regulation of cell proliferation (GO:0044340)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of intracellular lipid transport (GO:0032379)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of intracellular lipid transport (GO:0032378)	2	0	.05	-	 < 0.01	9.54E-01
regulation of intracellular lipid transport (GO:0032377)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of cholesterol transport (GO:0032375)	12	0	.28	-	 < 0.01	7.56E-01
positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of sterol transport (GO:0032372)	12	0	.28	-	 < 0.01	7.56E-01
negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048)	7	0	.16	-	 < 0.01	8.49E-01
regulation of cell-cell adhesion mediated by cadherin (GO:2000047)	14	0	.33	-	 < 0.01	7.21E-01
L-aspartate import across plasma membrane (GO:0140009)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of cardiac cell fate specification (GO:2000044)	1	0	.02	-	 < 0.01	9.77E-01
regulation of cardiac cell fate specification (GO:2000043)	2	0	.05	-	 < 0.01	9.54E-01
protein polyglutamylation (GO:0018095)	13	0	.30	-	 < 0.01	7.38E-01
canonical Wnt signaling pathway involved in osteoblast differentiation (GO:0044339)	2	0	.05	-	 < 0.01	9.54E-01
protein polyglycylation (GO:0018094)	3	0	.07	-	 < 0.01	9.32E-01
canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation (GO:0044338)	3	0	.07	-	 < 0.01	9.32E-01
canonical Wnt signaling pathway involved in positive regulation of apoptotic process (GO:0044337)	2	0	.05	-	 < 0.01	9.54E-01
canonical Wnt signaling pathway involved in negative regulation of apoptotic process (GO:0044336)	4	0	.09	-	 < 0.01	9.11E-01
canonical Wnt signaling pathway involved in neural crest cell differentiation (GO:0044335)	1	0	.02	-	 < 0.01	9.77E-01
canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition (GO:0044334)	2	0	.05	-	 < 0.01	9.54E-01
cell-cell adhesion mediated by cadherin (GO:0044331)	9	0	.21	-	 < 0.01	8.11E-01
canonical Wnt signaling pathway involved in positive regulation of wound healing (GO:0044330)	1	0	.02	-	 < 0.01	9.77E-01
intracellular cholesterol transport (GO:0032367)	17	0	.40	-	 < 0.01	6.73E-01
intracellular sterol transport (GO:0032366)	18	0	.42	-	 < 0.01	6.57E-01
intracellular lipid transport (GO:0032365)	26	0	.61	-	 < 0.01	5.45E-01
oxygen homeostasis (GO:0032364)	5	0	.12	-	 < 0.01	8.90E-01
pyridoxal phosphate catabolic process (GO:0032361)	1	0	.02	-	 < 0.01	9.77E-01
regulation of stem cell division (GO:2000035)	13	0	.30	-	 < 0.01	7.38E-01
canonical Wnt signaling pathway involved in positive regulation of cell-cell adhesion (GO:0044329)	1	0	.02	-	 < 0.01	9.77E-01
canonical Wnt signaling pathway involved in positive regulation of endothelial cell migration (GO:0044328)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of hormone biosynthetic process (GO:0032353)	11	0	.26	-	 < 0.01	7.74E-01
positive regulation of hormone metabolic process (GO:0032352)	19	0	.44	-	 < 0.01	6.42E-01
negative regulation of hormone metabolic process (GO:0032351)	12	0	.28	-	 < 0.01	7.56E-01
positive regulation of glycine import across plasma membrane (GO:1900925)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of glycine import across plasma membrane (GO:1900924)	2	0	.05	-	 < 0.01	9.54E-01
regulation of glycine import across plasma membrane (GO:1900923)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of cardiac muscle cell contraction (GO:0106135)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of cardiac muscle cell contraction (GO:0106134)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of male gonad development (GO:2000020)	8	0	.19	-	 < 0.01	8.30E-01
protein K27-linked ubiquitination (GO:0044314)	4	0	.09	-	 < 0.01	9.11E-01
protein K6-linked deubiquitination (GO:0044313)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of aldosterone biosynthetic process (GO:0032349)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of aldosterone biosynthetic process (GO:0032348)	4	0	.09	-	 < 0.01	9.11E-01
regulation of aldosterone biosynthetic process (GO:0032347)	8	0	.19	-	 < 0.01	8.30E-01
positive regulation of aldosterone metabolic process (GO:0032346)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of aldosterone metabolic process (GO:0032345)	4	0	.09	-	 < 0.01	9.11E-01
regulation of aldosterone metabolic process (GO:0032344)	9	0	.21	-	 < 0.01	8.11E-01
negative regulation of male gonad development (GO:2000019)	1	0	.02	-	 < 0.01	9.77E-01
aldosterone biosynthetic process (GO:0032342)	3	0	.07	-	 < 0.01	9.32E-01
regulation of male gonad development (GO:2000018)	10	0	.23	-	 < 0.01	7.92E-01
aldosterone metabolic process (GO:0032341)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of determination of dorsal identity (GO:2000017)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of determination of dorsal identity (GO:2000016)	3	0	.07	-	 < 0.01	9.32E-01
regulation of determination of dorsal identity (GO:2000015)	6	0	.14	-	 < 0.01	8.69E-01
regulation of adaxial/abaxial pattern formation (GO:2000011)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of cobalamin metabolic process (GO:0106121)	1	0	.02	-	 < 0.01	9.77E-01
cytochrome c-heme linkage (GO:0018063)	1	0	.02	-	 < 0.01	9.77E-01
pentose-phosphate shunt (GO:0006098)	9	0	.21	-	 < 0.01	8.11E-01
glyoxylate cycle (GO:0006097)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of protein localization to cell surface (GO:2000009)	11	0	.26	-	 < 0.01	7.74E-01
negative regulation of sterol biosynthetic process (GO:0106119)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of metanephric comma-shaped body morphogenesis (GO:2000007)	1	0	.02	-	 < 0.01	9.77E-01
regulation of metanephric comma-shaped body morphogenesis (GO:2000006)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of metanephric S-shaped body morphogenesis (GO:2000005)	1	0	.02	-	 < 0.01	9.77E-01
regulation of metanephric S-shaped body morphogenesis (GO:2000004)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of DNA damage checkpoint (GO:2000002)	5	0	.12	-	 < 0.01	8.90E-01
regulation of DNA damage checkpoint (GO:2000001)	15	0	.35	-	 < 0.01	7.05E-01
peptidyl-lysine oxidation (GO:0018057)	5	0	.12	-	 < 0.01	8.90E-01
acetyl-CoA biosynthetic process from pyruvate (GO:0006086)	8	0	.19	-	 < 0.01	8.30E-01
acetyl-CoA biosynthetic process (GO:0006085)	15	0	.35	-	 < 0.01	7.05E-01
acetate metabolic process (GO:0006083)	3	0	.07	-	 < 0.01	9.32E-01
molybdopterin cofactor biosynthetic process (GO:0032324)	2	0	.05	-	 < 0.01	9.54E-01
regulation of glutamate receptor clustering (GO:0106104)	9	0	.21	-	 < 0.01	8.11E-01
ER-dependent peroxisome localization (GO:0106101)	1	0	.02	-	 < 0.01	9.77E-01
glycerol-3-phosphate metabolic process (GO:0006072)	11	0	.26	-	 < 0.01	7.74E-01
prostaglandin secretion (GO:0032310)	3	0	.07	-	 < 0.01	9.32E-01
protein amidation (GO:0018032)	1	0	.02	-	 < 0.01	9.77E-01
ethanol oxidation (GO:0006069)	6	0	.14	-	 < 0.01	8.69E-01
ethanol catabolic process (GO:0006068)	5	0	.12	-	 < 0.01	8.90E-01
ethanol metabolic process (GO:0006067)	8	0	.19	-	 < 0.01	8.30E-01
UDP-glucuronate biosynthetic process (GO:0006065)	1	0	.02	-	 < 0.01	9.77E-01
icosanoid secretion (GO:0032309)	27	0	.63	-	 < 0.01	5.33E-01
glucuronate catabolic process (GO:0006064)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of prostaglandin secretion (GO:0032308)	15	0	.35	-	 < 0.01	7.05E-01
uronic acid metabolic process (GO:0006063)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of prostaglandin secretion (GO:0032307)	2	0	.05	-	 < 0.01	9.54E-01
sorbitol catabolic process (GO:0006062)	1	0	.02	-	 < 0.01	9.77E-01
regulation of prostaglandin secretion (GO:0032306)	17	0	.40	-	 < 0.01	6.73E-01
sorbitol biosynthetic process (GO:0006061)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of icosanoid secretion (GO:0032305)	20	0	.47	-	 < 0.01	6.27E-01
sorbitol metabolic process (GO:0006060)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of icosanoid secretion (GO:0032304)	5	0	.12	-	 < 0.01	8.90E-01
regulation of icosanoid secretion (GO:0032303)	25	0	.58	-	 < 0.01	5.58E-01
peptidyl-lysine dimethylation (GO:0018027)	14	0	.33	-	 < 0.01	7.21E-01
peptidyl-lysine monomethylation (GO:0018026)	8	0	.19	-	 < 0.01	8.30E-01
peptidyl-lysine trimethylation (GO:0018023)	31	0	.72	-	 < 0.01	4.85E-01
peptidyl-lysine methylation (GO:0018022)	67	0	1.56	-	 < 0.01	2.09E-01
peptidyl-histidine methylation (GO:0018021)	1	0	.02	-	 < 0.01	9.77E-01
hexitol metabolic process (GO:0006059)	3	0	.07	-	 < 0.01	9.32E-01
mannoprotein biosynthetic process (GO:0006057)	1	0	.02	-	 < 0.01	9.77E-01
mannoprotein metabolic process (GO:0006056)	1	0	.02	-	 < 0.01	9.77E-01
CMP-N-acetylneuraminate biosynthetic process (GO:0006055)	1	0	.02	-	 < 0.01	9.77E-01
N-acetylmannosamine metabolic process (GO:0006051)	1	0	.02	-	 < 0.01	9.77E-01
mannosamine metabolic process (GO:0006050)	1	0	.02	-	 < 0.01	9.77E-01
regulation of intraciliary retrograde transport (GO:1905799)	2	0	.05	-	 < 0.01	9.54E-01
N-terminal peptidyl-proline dimethylation (GO:0018016)	1	0	.02	-	 < 0.01	9.77E-01
RNA 3' uridylation (GO:0071076)	4	0	.09	-	 < 0.01	9.11E-01
N-terminal peptidyl-glycine methylation (GO:0018013)	1	0	.02	-	 < 0.01	9.77E-01
N-terminal peptidyl-alanine trimethylation (GO:0018012)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of phospholipid biosynthetic process (GO:0071072)	5	0	.12	-	 < 0.01	8.90E-01
protein localization to pericentriolar material (GO:1905793)	2	0	.05	-	 < 0.01	9.54E-01
N-terminal peptidyl-alanine methylation (GO:0018011)	1	0	.02	-	 < 0.01	9.77E-01
UDP-N-acetylglucosamine catabolic process (GO:0006049)	1	0	.02	-	 < 0.01	9.77E-01
UDP-N-acetylglucosamine biosynthetic process (GO:0006048)	6	0	.14	-	 < 0.01	8.69E-01
UDP-N-acetylglucosamine metabolic process (GO:0006047)	12	0	.28	-	 < 0.01	7.56E-01
N-acetylglucosamine catabolic process (GO:0006046)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of stress fiber assembly (GO:0051497)	31	0	.72	-	 < 0.01	4.85E-01
N-acetylglucosamine metabolic process (GO:0006044)	16	0	.37	-	 < 0.01	6.89E-01
glucosamine catabolic process (GO:0006043)	2	0	.05	-	 < 0.01	9.54E-01
glucosamine biosynthetic process (GO:0006042)	1	0	.02	-	 < 0.01	9.77E-01
glucosamine metabolic process (GO:0006041)	5	0	.12	-	 < 0.01	8.90E-01
AMPA selective glutamate receptor signaling pathway (GO:0098990)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of filopodium assembly (GO:0051490)	4	0	.09	-	 < 0.01	9.11E-01
protein K33-linked ubiquitination (GO:1990390)	1	0	.02	-	 < 0.01	9.77E-01
N-terminal peptidyl-L-cysteine N-palmitoylation (GO:0018009)	1	0	.02	-	 < 0.01	9.77E-01
N-terminal peptidyl-glycine N-myristoylation (GO:0018008)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of detection of mechanical stimulus involved in sensory perception of touch (GO:1905788)	1	0	.02	-	 < 0.01	9.77E-01
regulation of detection of mechanical stimulus involved in sensory perception of touch (GO:1905787)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of anaphase-promoting complex-dependent catabolic process (GO:1905786)	3	0	.07	-	 < 0.01	9.32E-01
peptidyl-lysine N6-acetylation (GO:0018003)	2	0	.05	-	 < 0.01	9.54E-01
regulation of anaphase-promoting complex-dependent catabolic process (GO:1905784)	3	0	.07	-	 < 0.01	9.32E-01
N-terminal peptidyl-glutamic acid acetylation (GO:0018002)	1	0	.02	-	 < 0.01	9.77E-01
removal of nonhomologous ends (GO:0000735)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of phosphatidylserine exposure on apoptotic cell surface (GO:1905782)	1	0	.02	-	 < 0.01	9.77E-01
DNA strand renaturation (GO:0000733)	3	0	.07	-	 < 0.01	9.32E-01
cell wall chitin catabolic process (GO:0006039)	1	0	.02	-	 < 0.01	9.77E-01
regulation of phosphatidylserine exposure on apoptotic cell surface (GO:1905780)	1	0	.02	-	 < 0.01	9.77E-01
strand displacement (GO:0000732)	1	0	.02	-	 < 0.01	9.77E-01
DNA synthesis involved in DNA repair (GO:0000731)	27	0	.63	-	 < 0.01	5.33E-01
cell wall chitin metabolic process (GO:0006037)	1	0	.02	-	 < 0.01	9.77E-01
DNA recombinase assembly (GO:0000730)	5	0	.12	-	 < 0.01	8.90E-01
mitotic cleavage furrow ingression (GO:1990386)	1	0	.02	-	 < 0.01	9.77E-01
hyaloid vascular plexus regression (GO:1990384)	8	0	.19	-	 < 0.01	8.30E-01
chitin catabolic process (GO:0006032)	7	0	.16	-	 < 0.01	8.49E-01
chitin metabolic process (GO:0006030)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of exonuclease activity (GO:1905778)	2	0	.05	-	 < 0.01	9.54E-01
regulation of exonuclease activity (GO:1905777)	2	0	.05	-	 < 0.01	9.54E-01
DNA double-strand break processing (GO:0000729)	12	0	.28	-	 < 0.01	7.56E-01
positive regulation of DNA helicase activity (GO:1905776)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of DNA helicase activity (GO:1905775)	2	0	.05	-	 < 0.01	9.54E-01
double-strand break repair via break-induced replication (GO:0000727)	11	0	.26	-	 < 0.01	7.74E-01
regulation of DNA helicase activity (GO:1905774)	5	0	.12	-	 < 0.01	8.90E-01
polyadenylation-dependent snoRNA 3'-end processing (GO:0071051)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of mesodermal cell differentiation (GO:1905772)	2	0	.05	-	 < 0.01	9.54E-01
sno(s)RNA polyadenylation (GO:0071050)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of mesodermal cell differentiation (GO:1905771)	3	0	.07	-	 < 0.01	9.32E-01
regulation of mesodermal cell differentiation (GO:1905770)	7	0	.16	-	 < 0.01	8.49E-01
telomere maintenance via recombination (GO:0000722)	15	0	.35	-	 < 0.01	7.05E-01
inhibitory chemical synaptic transmission (GO:0098977)	1	0	.02	-	 < 0.01	9.77E-01
pyrimidine dimer repair by nucleotide-excision repair (GO:0000720)	4	0	.09	-	 < 0.01	9.11E-01
excitatory chemical synaptic transmission (GO:0098976)	4	0	.09	-	 < 0.01	9.11E-01
glycosaminoglycan biosynthetic process (GO:0006024)	36	0	.84	-	 < 0.01	4.32E-01
postsynaptic actin cytoskeleton organization (GO:0098974)	15	0	.35	-	 < 0.01	7.05E-01
anterograde dendritic transport of mitochondrion (GO:0098972)	1	0	.02	-	 < 0.01	9.77E-01
inositol biosynthetic process (GO:0006021)	1	0	.02	-	 < 0.01	9.77E-01
anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971)	4	0	.09	-	 < 0.01	9.11E-01
postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970)	10	0	.23	-	 < 0.01	7.92E-01
nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription (GO:0071049)	2	0	.05	-	 < 0.01	9.54E-01
nuclear retention of unspliced pre-mRNA at the site of transcription (GO:0071048)	2	0	.05	-	 < 0.01	9.54E-01
polyadenylation-dependent mRNA catabolic process (GO:0071047)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of double-stranded telomeric DNA binding (GO:1905768)	1	0	.02	-	 < 0.01	9.77E-01
nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046)	6	0	.14	-	 < 0.01	8.69E-01
regulation of double-stranded telomeric DNA binding (GO:1905767)	1	0	.02	-	 < 0.01	9.77E-01
nuclear histone mRNA catabolic process (GO:0071045)	1	0	.02	-	 < 0.01	9.77E-01
histone mRNA catabolic process (GO:0071044)	10	0	.23	-	 < 0.01	7.92E-01
negative regulation of protection from non-homologous end joining at telomere (GO:1905765)	4	0	.09	-	 < 0.01	9.11E-01
nucleotide-excision repair, DNA duplex unwinding (GO:0000717)	2	0	.05	-	 < 0.01	9.54E-01
CUT metabolic process (GO:0071043)	4	0	.09	-	 < 0.01	9.11E-01
regulation of protection from non-homologous end joining at telomere (GO:1905764)	4	0	.09	-	 < 0.01	9.11E-01
nuclear polyadenylation-dependent mRNA catabolic process (GO:0071042)	4	0	.09	-	 < 0.01	9.11E-01
nucleotide-excision repair, DNA damage recognition (GO:0000715)	3	0	.07	-	 < 0.01	9.32E-01
antisense RNA transcript catabolic process (GO:0071041)	1	0	.02	-	 < 0.01	9.77E-01
nuclear polyadenylation-dependent antisense transcript catabolic process (GO:0071040)	1	0	.02	-	 < 0.01	9.77E-01
neurotransmitter receptor transport to postsynaptic membrane (GO:0098969)	18	0	.42	-	 < 0.01	6.57E-01
resolution of meiotic recombination intermediates (GO:0000712)	15	0	.35	-	 < 0.01	7.05E-01
neurotransmitter receptor transport postsynaptic membrane to endosome (GO:0098968)	1	0	.02	-	 < 0.01	9.77E-01
meiotic DNA repair synthesis (GO:0000711)	4	0	.09	-	 < 0.01	9.11E-01
exocytic insertion of neurotransmitter receptor to postsynaptic membrane (GO:0098967)	8	0	.19	-	 < 0.01	8.30E-01
meiotic mismatch repair (GO:0000710)	5	0	.12	-	 < 0.01	8.90E-01
5-phosphoribose 1-diphosphate biosynthetic process (GO:0006015)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of corticotropin-releasing hormone secretion (GO:0051466)	3	0	.07	-	 < 0.01	9.32E-01
D-ribose metabolic process (GO:0006014)	3	0	.07	-	 < 0.01	9.32E-01
anterograde dendritic transport of messenger ribonucleoprotein complex (GO:0098964)	2	0	.05	-	 < 0.01	9.54E-01
mannose metabolic process (GO:0006013)	11	0	.26	-	 < 0.01	7.74E-01
positive regulation of cortisol secretion (GO:0051464)	4	0	.09	-	 < 0.01	9.11E-01
galactose metabolic process (GO:0006012)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of cortisol secretion (GO:0051463)	1	0	.02	-	 < 0.01	9.77E-01
regulation of postsynaptic neurotransmitter receptor activity (GO:0098962)	19	0	.44	-	 < 0.01	6.42E-01
UDP-glucose metabolic process (GO:0006011)	2	0	.05	-	 < 0.01	9.54E-01
regulation of cortisol secretion (GO:0051462)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of corticotropin secretion (GO:0051461)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of corticotropin secretion (GO:0051460)	1	0	.02	-	 < 0.01	9.77E-01
nuclear polyadenylation-dependent CUT catabolic process (GO:0071039)	1	0	.02	-	 < 0.01	9.77E-01
nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038)	6	0	.14	-	 < 0.01	8.69E-01
nuclear polyadenylation-dependent snRNA catabolic process (GO:0071037)	1	0	.02	-	 < 0.01	9.77E-01
nuclear polyadenylation-dependent snoRNA catabolic process (GO:0071036)	1	0	.02	-	 < 0.01	9.77E-01
nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035)	6	0	.14	-	 < 0.01	8.69E-01
CUT catabolic process (GO:0071034)	4	0	.09	-	 < 0.01	9.11E-01
meiotic DNA recombinase assembly (GO:0000707)	1	0	.02	-	 < 0.01	9.77E-01
nuclear retention of pre-mRNA at the site of transcription (GO:0071033)	5	0	.12	-	 < 0.01	8.90E-01
meiotic DNA double-strand break processing (GO:0000706)	3	0	.07	-	 < 0.01	9.32E-01
nuclear mRNA surveillance of mRNA 3'-end processing (GO:0071031)	2	0	.05	-	 < 0.01	9.54E-01
nuclear mRNA surveillance of spliceosomal pre-mRNA splicing (GO:0071030)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of endosome to plasma membrane protein transport (GO:1905751)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of cardioblast cell fate specification (GO:0009997)	1	0	.02	-	 < 0.01	9.77E-01
regulation of corticotropin secretion (GO:0051459)	8	0	.19	-	 < 0.01	8.30E-01
retrograde axonal transport of mitochondrion (GO:0098958)	3	0	.07	-	 < 0.01	9.32E-01
regulation of transforming growth factor beta3 activation (GO:1901398)	1	0	.02	-	 < 0.01	9.77E-01
stress response to zinc ion (GO:1990359)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of cell fate specification (GO:0009996)	7	0	.16	-	 < 0.01	8.49E-01
corticotropin secretion (GO:0051458)	2	0	.05	-	 < 0.01	9.54E-01
anterograde axonal transport of mitochondrion (GO:0098957)	5	0	.12	-	 < 0.01	8.90E-01
maintenance of protein location in nucleus (GO:0051457)	22	0	.51	-	 < 0.01	5.99E-01
oocyte differentiation (GO:0009994)	42	0	.98	-	 < 0.01	3.75E-01
fucose metabolic process (GO:0006004)	5	0	.12	-	 < 0.01	8.90E-01
monopolar spindle attachment to meiosis I kinetochore (GO:0051455)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of transforming growth factor beta1 activation (GO:1901394)	1	0	.02	-	 < 0.01	9.77E-01
fructose 2,6-bisphosphate metabolic process (GO:0006003)	5	0	.12	-	 < 0.01	8.90E-01
cellular water homeostasis (GO:0009992)	9	0	.21	-	 < 0.01	8.11E-01
intracellular pH elevation (GO:0051454)	6	0	.14	-	 < 0.01	8.69E-01
receptor diffusion trapping (GO:0098953)	10	0	.23	-	 < 0.01	7.92E-01
negative regulation of transforming growth factor beta1 activation (GO:1901393)	1	0	.02	-	 < 0.01	9.77E-01
regulation of transforming growth factor beta1 activation (GO:1901392)	2	0	.05	-	 < 0.01	9.54E-01
fructose catabolic process (GO:0006001)	2	0	.05	-	 < 0.01	9.54E-01
intracellular pH reduction (GO:0051452)	33	0	.77	-	 < 0.01	4.63E-01
fructose metabolic process (GO:0006000)	9	0	.21	-	 < 0.01	8.11E-01
positive regulation of transforming growth factor beta activation (GO:1901390)	2	0	.05	-	 < 0.01	9.54E-01
myoblast proliferation (GO:0051450)	5	0	.12	-	 < 0.01	8.90E-01
nuclear ncRNA surveillance (GO:0071029)	6	0	.14	-	 < 0.01	8.69E-01
nuclear mRNA surveillance (GO:0071028)	12	0	.28	-	 < 0.01	7.56E-01
regulation of endosome to plasma membrane protein transport (GO:1905749)	5	0	.12	-	 < 0.01	8.90E-01
nuclear RNA surveillance (GO:0071027)	12	0	.28	-	 < 0.01	7.56E-01
hard palate morphogenesis (GO:1905748)	2	0	.05	-	 < 0.01	9.54E-01
cytoplasmic RNA surveillance (GO:0071026)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of saliva secretion (GO:1905747)	2	0	.05	-	 < 0.01	9.54E-01
RNA surveillance (GO:0071025)	14	0	.33	-	 < 0.01	7.21E-01
gap junction-mediated intercellular transport (GO:1990349)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of meiotic cell cycle (GO:0051447)	20	0	.47	-	 < 0.01	6.27E-01
negative regulation of voltage-gated calcium channel activity (GO:1901386)	14	0	.33	-	 < 0.01	7.21E-01
positive regulation of meiotic cell cycle (GO:0051446)	27	0	.63	-	 < 0.01	5.33E-01
negative regulation of ubiquitin-protein transferase activity (GO:0051444)	18	0	.42	-	 < 0.01	6.57E-01
neurotransmitter receptor transport, postsynaptic endosome to lysosome (GO:0098943)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of chorionic trophoblast cell proliferation (GO:1901383)	2	0	.05	-	 < 0.01	9.54E-01
retrograde trans-synaptic signaling by trans-synaptic protein complex (GO:0098942)	5	0	.12	-	 < 0.01	8.90E-01
regulation of chorionic trophoblast cell proliferation (GO:1901382)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of potassium ion transmembrane transport (GO:1901380)	26	0	.61	-	 < 0.01	5.45E-01
telomeric 3' overhang formation (GO:0031860)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of L-proline import across plasma membrane (GO:1905737)	1	0	.02	-	 < 0.01	9.77E-01
regulation of L-proline import across plasma membrane (GO:1905735)	1	0	.02	-	 < 0.01	9.77E-01
dendritic transport of mitochondrion (GO:0098939)	2	0	.05	-	 < 0.01	9.54E-01
anterograde dendritic transport (GO:0098937)	7	0	.16	-	 < 0.01	8.49E-01
organic heteropentacyclic compound catabolic process (GO:1901377)	2	0	.05	-	 < 0.01	9.54E-01
organic heteropentacyclic compound metabolic process (GO:1901376)	3	0	.07	-	 < 0.01	9.32E-01
acetate ester transport (GO:1901374)	2	0	.05	-	 < 0.01	9.54E-01
cytidine deamination (GO:0009972)	4	0	.09	-	 < 0.01	9.11E-01
lipid hydroperoxide transport (GO:1901373)	1	0	.02	-	 < 0.01	9.77E-01
presynaptic signal transduction (GO:0098928)	3	0	.07	-	 < 0.01	9.32E-01
retrograde trans-synaptic signaling by nitric oxide, modulating synaptic transmission (GO:0098925)	1	0	.02	-	 < 0.01	9.77E-01
retrograde trans-synaptic signaling by nitric oxide (GO:0098924)	2	0	.05	-	 < 0.01	9.54E-01
retrograde trans-synaptic signaling by soluble gas (GO:0098923)	2	0	.05	-	 < 0.01	9.54E-01
retrograde trans-synaptic signaling by endocannabinoid (GO:0098921)	3	0	.07	-	 < 0.01	9.32E-01
retrograde trans-synaptic signaling by lipid (GO:0098920)	3	0	.07	-	 < 0.01	9.32E-01
protection from non-homologous end joining at telomere (GO:0031848)	6	0	.14	-	 < 0.01	8.69E-01
protein localization to perinuclear region of cytoplasm (GO:1905719)	2	0	.05	-	 < 0.01	9.54E-01
response to phosphatidylethanolamine (GO:1905711)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of membrane permeability (GO:1905710)	20	0	.47	-	 < 0.01	6.27E-01
radial pattern formation (GO:0009956)	1	0	.02	-	 < 0.01	9.77E-01
microtubule nucleation by microtubule organizing center (GO:0051418)	5	0	.12	-	 < 0.01	8.90E-01
retrograde trans-synaptic signaling (GO:0098917)	11	0	.26	-	 < 0.01	7.74E-01
response to rapamycin (GO:1901355)	4	0	.09	-	 < 0.01	9.11E-01
microtubule nucleation by interphase microtubule organizing center (GO:0051415)	1	0	.02	-	 < 0.01	9.77E-01
response to cortisol (GO:0051414)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to insulin-like growth factor stimulus (GO:1990314)	8	0	.19	-	 < 0.01	8.30E-01
membrane depolarization during atrial cardiac muscle cell action potential (GO:0098912)	3	0	.07	-	 < 0.01	9.32E-01
dorsal/ventral axis specification (GO:0009950)	12	0	.28	-	 < 0.01	7.56E-01
response to corticosterone (GO:0051412)	8	0	.19	-	 < 0.01	8.30E-01
regulation of ventricular cardiac muscle cell action potential (GO:0098911)	12	0	.28	-	 < 0.01	7.56E-01
detoxification of nitrogen compound (GO:0051410)	5	0	.12	-	 < 0.01	8.90E-01
regulation of release of cytochrome c from mitochondria (GO:0090199)	44	0	1.03	-	 < 0.01	3.58E-01
negative regulation of membrane permeability (GO:1905709)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of glomerulus development (GO:0090194)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of glomerulus development (GO:0090193)	4	0	.09	-	 < 0.01	9.11E-01
regulation of glomerulus development (GO:0090192)	5	0	.12	-	 < 0.01	8.90E-01
regulation of mitochondrial ATP synthesis coupled proton transport (GO:1905706)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of branching involved in ureteric bud morphogenesis (GO:0090191)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190)	23	0	.54	-	 < 0.01	5.85E-01
positive regulation of inhibitory synapse assembly (GO:1905704)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of inhibitory synapse assembly (GO:1905703)	1	0	.02	-	 < 0.01	9.77E-01
regulation of inhibitory synapse assembly (GO:1905702)	4	0	.09	-	 < 0.01	9.11E-01
polarity specification of anterior/posterior axis (GO:0009949)	2	0	.05	-	 < 0.01	9.54E-01
anterior/posterior axis specification (GO:0009948)	56	0	1.31	-	 < 0.01	2.71E-01
regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909)	5	0	.12	-	 < 0.01	8.90E-01
response to nitrosative stress (GO:0051409)	7	0	.16	-	 < 0.01	8.49E-01
regulation of neuronal action potential (GO:0098908)	10	0	.23	-	 < 0.01	7.92E-01
proximal/distal axis specification (GO:0009946)	4	0	.09	-	 < 0.01	9.11E-01
regulation of Purkinje myocyte action potential (GO:0098906)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of vasculature development involved in avascular cornea development in camera-type eye (GO:1901346)	1	0	.02	-	 < 0.01	9.77E-01
regulation of bundle of His cell action potential (GO:0098905)	2	0	.05	-	 < 0.01	9.54E-01
response to leptomycin B (GO:1901344)	2	0	.05	-	 < 0.01	9.54E-01
regulation of membrane repolarization during action potential (GO:0098903)	6	0	.14	-	 < 0.01	8.69E-01
regulation of membrane depolarization during action potential (GO:0098902)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of store-operated calcium channel activity (GO:1901341)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of store-operated calcium channel activity (GO:1901340)	1	0	.02	-	 < 0.01	9.77E-01
regulation of branching involved in ureteric bud morphogenesis (GO:0090189)	25	0	.58	-	 < 0.01	5.58E-01
negative regulation of pancreatic juice secretion (GO:0090188)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of pancreatic juice secretion (GO:0090187)	2	0	.05	-	 < 0.01	9.54E-01
regulation of pancreatic juice secretion (GO:0090186)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of kidney development (GO:0090185)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of kidney development (GO:0090184)	11	0	.26	-	 < 0.01	7.74E-01
regulation of kidney development (GO:0090183)	35	0	.82	-	 < 0.01	4.42E-01
regulation of secretion of lysosomal enzymes (GO:0090182)	3	0	.07	-	 < 0.01	9.32E-01
regulation of store-operated calcium channel activity (GO:1901339)	10	0	.23	-	 < 0.01	7.92E-01
positive regulation of odontoblast differentiation (GO:1901331)	1	0	.02	-	 < 0.01	9.77E-01
establishment of planar polarity involved in neural tube closure (GO:0090177)	2	0	.05	-	 < 0.01	9.54E-01
microtubule cytoskeleton organization involved in establishment of planar polarity (GO:0090176)	3	0	.07	-	 < 0.01	9.32E-01
chondrocyte morphogenesis (GO:0090171)	1	0	.02	-	 < 0.01	9.77E-01
regulation of Golgi inheritance (GO:0090170)	4	0	.09	-	 < 0.01	9.11E-01
regulation of odontoblast differentiation (GO:1901329)	3	0	.07	-	 < 0.01	9.32E-01
response to cytochalasin B (GO:1901328)	1	0	.02	-	 < 0.01	9.77E-01
dendrite self-avoidance (GO:0070593)	16	0	.37	-	 < 0.01	6.89E-01
positive regulation of heart induction (GO:1901321)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of heart induction (GO:1901320)	1	0	.02	-	 < 0.01	9.77E-01
regulation of spindle assembly (GO:0090169)	23	0	.54	-	 < 0.01	5.85E-01
Golgi disassembly (GO:0090166)	7	0	.16	-	 < 0.01	8.49E-01
asymmetric Golgi ribbon formation (GO:0090164)	2	0	.05	-	 < 0.01	9.54E-01
establishment of epithelial cell polarity (GO:0090162)	34	0	.79	-	 < 0.01	4.52E-01
Golgi ribbon formation (GO:0090161)	14	0	.33	-	 < 0.01	7.21E-01
cellular component macromolecule biosynthetic process (GO:0070589)	1	0	.02	-	 < 0.01	9.77E-01
regulation of cell-cell adhesion involved in gastrulation (GO:0070587)	11	0	.26	-	 < 0.01	7.74E-01
cell-cell adhesion involved in gastrulation (GO:0070586)	1	0	.02	-	 < 0.01	9.77E-01
protein localization to mitochondrion (GO:0070585)	69	0	1.61	-	 < 0.01	2.00E-01
negative regulation of flagellated sperm motility (GO:1901318)	2	0	.05	-	 < 0.01	9.54E-01
mitochondrion morphogenesis (GO:0070584)	24	0	.56	-	 < 0.01	5.71E-01
regulation of flagellated sperm motility (GO:1901317)	17	0	.40	-	 < 0.01	6.73E-01
negative regulation of histone H2A K63-linked ubiquitination (GO:1901315)	4	0	.09	-	 < 0.01	9.11E-01
auditory receptor cell fate commitment (GO:0009912)	5	0	.12	-	 < 0.01	8.90E-01
regulation of histone H2A K63-linked ubiquitination (GO:1901314)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of sterol regulatory element binding protein cleavage (GO:1901310)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of collateral sprouting in absence of injury (GO:0048697)	2	0	.05	-	 < 0.01	9.54E-01
regulation of collateral sprouting in absence of injury (GO:0048696)	2	0	.05	-	 < 0.01	9.54E-01
endoplasmic reticulum membrane organization (GO:0090158)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of collateral sprouting of injured axon (GO:0048694)	2	0	.05	-	 < 0.01	9.54E-01
cellular sphingolipid homeostasis (GO:0090156)	6	0	.14	-	 < 0.01	8.69E-01
regulation of collateral sprouting of injured axon (GO:0048693)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of sphingolipid biosynthetic process (GO:0090155)	6	0	.14	-	 < 0.01	8.69E-01
maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter (GO:0001193)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of sphingolipid biosynthetic process (GO:0090154)	6	0	.14	-	 < 0.01	8.69E-01
maintenance of transcriptional fidelity during DNA-templated transcription elongation (GO:0001192)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of axon extension involved in regeneration (GO:0048691)	3	0	.07	-	 < 0.01	9.32E-01
regulation of sphingolipid biosynthetic process (GO:0090153)	13	0	.30	-	 < 0.01	7.38E-01
establishment of protein localization to mitochondrial membrane involved in mitochondrial fission (GO:0090152)	2	0	.05	-	 < 0.01	9.54E-01
establishment of protein localization to mitochondrial membrane (GO:0090151)	17	0	.40	-	 < 0.01	6.73E-01
regulation of sterol regulatory element binding protein cleavage (GO:1901308)	1	0	.02	-	 < 0.01	9.77E-01
cadmium ion transmembrane transport (GO:0070574)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of spermidine biosynthetic process (GO:1901307)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of neuron projection regeneration (GO:0070572)	15	0	.35	-	 < 0.01	7.05E-01
regulation of spermidine biosynthetic process (GO:1901304)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of cargo loading into COPII-coated vesicle (GO:1901303)	2	0	.05	-	 < 0.01	9.54E-01
regulation of cargo loading into COPII-coated vesicle (GO:1901301)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of hydrogen peroxide-mediated programmed cell death (GO:1901300)	4	0	.09	-	 < 0.01	9.11E-01
RNA polymerase I preinitiation complex assembly (GO:0001188)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of sprouting of injured axon (GO:0048687)	4	0	.09	-	 < 0.01	9.11E-01
mitochondrial membrane fission (GO:0090149)	2	0	.05	-	 < 0.01	9.54E-01
regulation of collateral sprouting of intact axon in response to injury (GO:0048683)	1	0	.02	-	 < 0.01	9.77E-01
sprouting of injured axon (GO:0048682)	1	0	.02	-	 < 0.01	9.77E-01
mitochondrial nucleoid organization (GO:0090144)	1	0	.02	-	 < 0.01	9.77E-01
nucleoid organization (GO:0090143)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of axon regeneration (GO:0048680)	14	0	.33	-	 < 0.01	7.21E-01
positive regulation of vitamin D receptor signaling pathway (GO:0070564)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of vitamin D receptor signaling pathway (GO:0070563)	2	0	.05	-	 < 0.01	9.54E-01
regulation of vitamin D receptor signaling pathway (GO:0070562)	7	0	.16	-	 < 0.01	8.49E-01
protein secretion by platelet (GO:0070560)	1	0	.02	-	 < 0.01	9.77E-01
axon extension involved in regeneration (GO:0048677)	1	0	.02	-	 < 0.01	9.77E-01
regulation of actin cytoskeleton organization by cell-cell adhesion (GO:0090138)	1	0	.02	-	 < 0.01	9.77E-01
transcriptional start site selection at RNA polymerase II promoter (GO:0001174)	1	0	.02	-	 < 0.01	9.77E-01
actin filament branching (GO:0090135)	3	0	.07	-	 < 0.01	9.32E-01
DNA-templated transcriptional start site selection (GO:0001173)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of collateral sprouting (GO:0048672)	14	0	.33	-	 < 0.01	7.21E-01
cell migration involved in mesendoderm migration (GO:0090134)	1	0	.02	-	 < 0.01	9.77E-01
transcription, RNA-templated (GO:0001172)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of collateral sprouting (GO:0048671)	9	0	.21	-	 < 0.01	8.11E-01
mesendoderm migration (GO:0090133)	1	0	.02	-	 < 0.01	9.77E-01
regulation of collateral sprouting (GO:0048670)	23	0	.54	-	 < 0.01	5.85E-01
mesenchyme migration (GO:0090131)	1	0	.02	-	 < 0.01	9.77E-01
detection of mechanical stimulus involved in sensory perception of touch (GO:0050976)	2	0	.05	-	 < 0.01	9.54E-01
sensory perception of touch (GO:0050975)	5	0	.12	-	 < 0.01	8.90E-01
detection of mechanical stimulus involved in equilibrioception (GO:0050973)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of synapse maturation (GO:0090129)	9	0	.21	-	 < 0.01	8.11E-01
regulation of synapse maturation (GO:0090128)	15	0	.35	-	 < 0.01	7.05E-01
neuron fate specification (GO:0048665)	31	0	.72	-	 < 0.01	4.85E-01
neuron fate determination (GO:0048664)	9	0	.21	-	 < 0.01	8.11E-01
protein-containing complex assembly involved in synapse maturation (GO:0090126)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of smooth muscle cell proliferation (GO:0048662)	57	0	1.33	-	 < 0.01	2.64E-01
response to linoleic acid (GO:0070543)	1	0	.02	-	 < 0.01	9.77E-01
detection of chemical stimulus involved in sensory perception of pain (GO:0050968)	3	0	.07	-	 < 0.01	9.32E-01
detection of calcium ion (GO:0005513)	8	0	.19	-	 < 0.01	8.30E-01
detection of light stimulus involved in sensory perception (GO:0050962)	23	0	.54	-	 < 0.01	5.85E-01
detection of temperature stimulus involved in thermoception (GO:0050960)	4	0	.09	-	 < 0.01	9.11E-01
vesicle-mediated cholesterol transport (GO:0090119)	2	0	.05	-	 < 0.01	9.54E-01
receptor-mediated endocytosis involved in cholesterol transport (GO:0090118)	3	0	.07	-	 < 0.01	9.32E-01
C-5 methylation of cytosine (GO:0090116)	2	0	.05	-	 < 0.01	9.54E-01
COPII-coated vesicle budding (GO:0090114)	21	0	.49	-	 < 0.01	6.13E-01
regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis (GO:0090113)	4	0	.09	-	 < 0.01	9.11E-01
COPII-coated vesicle cargo loading (GO:0090110)	12	0	.28	-	 < 0.01	7.56E-01
histone H2A K63-linked deubiquitination (GO:0070537)	3	0	.07	-	 < 0.01	9.32E-01
protein K63-linked deubiquitination (GO:0070536)	29	0	.68	-	 < 0.01	5.08E-01
histone H2A K63-linked ubiquitination (GO:0070535)	2	0	.05	-	 < 0.01	9.54E-01
protein K63-linked ubiquitination (GO:0070534)	43	0	1.00	-	 < 0.01	3.67E-01
equilibrioception (GO:0050957)	9	0	.21	-	 < 0.01	8.11E-01
thermoception (GO:0050955)	8	0	.19	-	 < 0.01	8.30E-01
positive regulation of high-density lipoprotein particle assembly (GO:0090108)	2	0	.05	-	 < 0.01	9.54E-01
regulation of high-density lipoprotein particle assembly (GO:0090107)	3	0	.07	-	 < 0.01	9.32E-01
pancreatic epsilon cell differentiation (GO:0090104)	1	0	.02	-	 < 0.01	9.77E-01
tRNA threonylcarbamoyladenosine metabolic process (GO:0070525)	10	0	.23	-	 < 0.01	7.92E-01
response to ceramide (GO:0106096)	1	0	.02	-	 < 0.01	9.77E-01
glial cell projection elongation (GO:0106091)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of skeletal muscle tissue growth (GO:0048633)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of skeletal muscle tissue growth (GO:0048632)	2	0	.05	-	 < 0.01	9.54E-01
regulation of skeletal muscle tissue growth (GO:0048631)	9	0	.21	-	 < 0.01	8.11E-01
skeletal muscle tissue growth (GO:0048630)	4	0	.09	-	 < 0.01	9.11E-01
cell wall disruption in other organism (GO:0044278)	6	0	.14	-	 < 0.01	8.69E-01
cellular carbohydrate catabolic process (GO:0044275)	20	0	.47	-	 < 0.01	6.27E-01
sulfur compound catabolic process (GO:0044273)	21	0	.49	-	 < 0.01	6.13E-01
positive regulation of histone H4-K20 methylation (GO:0070512)	1	0	.02	-	 < 0.01	9.77E-01
regulation of histone H4-K20 methylation (GO:0070510)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of cell adhesion involved in sprouting angiogenesis (GO:0106089)	1	0	.02	-	 < 0.01	9.77E-01
regulation of cell adhesion involved in sprouting angiogenesis (GO:0106088)	1	0	.02	-	 < 0.01	9.77E-01
myoblast development (GO:0048627)	2	0	.05	-	 < 0.01	9.54E-01
post-embryonic digestive tract morphogenesis (GO:0048621)	1	0	.02	-	 < 0.01	9.77E-01
glycerol ether catabolic process (GO:0044269)	2	0	.05	-	 < 0.01	9.54E-01
protein-DNA complex remodeling (GO:0001120)	2	0	.05	-	 < 0.01	9.54E-01
cholesterol import (GO:0070508)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of DNA-dependent DNA replication initiation (GO:0032298)	2	0	.05	-	 < 0.01	9.54E-01
poly-gamma-glutamate metabolic process (GO:0070500)	1	0	.02	-	 < 0.01	9.77E-01
induction of negative chemotaxis (GO:0050929)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of positive chemotaxis (GO:0050928)	1	0	.02	-	 < 0.01	9.77E-01
peripheral nervous system myelin formation (GO:0032290)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of negative chemotaxis (GO:0050925)	2	0	.05	-	 < 0.01	9.54E-01
histone succinylation (GO:0106077)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of negative chemotaxis (GO:0050924)	1	0	.02	-	 < 0.01	9.77E-01
mitochondrial RNA modification (GO:1900864)	4	0	.09	-	 < 0.01	9.11E-01
regulation of negative chemotaxis (GO:0050923)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0106071)	5	0	.12	-	 < 0.01	8.90E-01
embryonic ectodermal digestive tract morphogenesis (GO:0048613)	1	0	.02	-	 < 0.01	9.77E-01
transcription open complex formation at RNA polymerase II promoter (GO:0001113)	1	0	.02	-	 < 0.01	9.77E-01
DNA-templated transcription open complex formation (GO:0001112)	2	0	.05	-	 < 0.01	9.54E-01
embryonic ectodermal digestive tract development (GO:0048611)	2	0	.05	-	 < 0.01	9.54E-01
intestinal lipid catabolic process (GO:0044258)	1	0	.02	-	 < 0.01	9.77E-01
central nervous system myelin formation (GO:0032289)	5	0	.12	-	 < 0.01	8.90E-01
myelin assembly (GO:0032288)	23	0	.54	-	 < 0.01	5.85E-01
peripheral nervous system myelin maintenance (GO:0032287)	8	0	.19	-	 < 0.01	8.30E-01
central nervous system myelin maintenance (GO:0032286)	4	0	.09	-	 < 0.01	9.11E-01
sensory perception of umami taste (GO:0050917)	6	0	.14	-	 < 0.01	8.69E-01
sensory perception of sweet taste (GO:0050916)	6	0	.14	-	 < 0.01	8.69E-01
sensory perception of sour taste (GO:0050915)	5	0	.12	-	 < 0.01	8.90E-01
sensory perception of bitter taste (GO:0050913)	50	0	1.17	-	 < 0.01	3.11E-01
detection of chemical stimulus involved in sensory perception of taste (GO:0050912)	51	0	1.19	-	 < 0.01	3.04E-01
regulation of cobalamin metabolic process (GO:0106064)	1	0	.02	-	 < 0.01	9.77E-01
detection of chemical stimulus involved in sensory perception of smell (GO:0050911)	28	0	.65	-	 < 0.01	5.20E-01
cellular polysaccharide catabolic process (GO:0044247)	11	0	.26	-	 < 0.01	7.74E-01
lipid digestion (GO:0044241)	11	0	.26	-	 < 0.01	7.74E-01
positive regulation of gonadotropin secretion (GO:0032278)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of gonadotropin secretion (GO:0032277)	9	0	.21	-	 < 0.01	8.11E-01
luteinizing hormone secretion (GO:0032275)	4	0	.09	-	 < 0.01	9.11E-01
gonadotropin secretion (GO:0032274)	4	0	.09	-	 < 0.01	9.11E-01
sensory perception of taste (GO:0050909)	69	0	1.61	-	 < 0.01	2.00E-01
detection of light stimulus involved in visual perception (GO:0050908)	23	0	.54	-	 < 0.01	5.85E-01
detection of chemical stimulus involved in sensory perception (GO:0050907)	83	0	1.93	-	 < 0.01	1.44E-01
diapedesis (GO:0050904)	8	0	.19	-	 < 0.01	8.30E-01
IMP salvage (GO:0032264)	4	0	.09	-	 < 0.01	9.11E-01
GMP salvage (GO:0032263)	1	0	.02	-	 < 0.01	9.77E-01
pyrimidine nucleotide salvage (GO:0032262)	1	0	.02	-	 < 0.01	9.77E-01
regulation of cellular response to osmotic stress (GO:0106049)	10	0	.23	-	 < 0.01	7.92E-01
purine nucleotide salvage (GO:0032261)	6	0	.14	-	 < 0.01	8.69E-01
spermidine deacetylation (GO:0106048)	1	0	.02	-	 < 0.01	9.77E-01
polyamine deacetylation (GO:0106047)	1	0	.02	-	 < 0.01	9.77E-01
guanine deglycation, glyoxal removal (GO:0106046)	1	0	.02	-	 < 0.01	9.77E-01
guanine deglycation, methylglyoxal removal (GO:0106045)	1	0	.02	-	 < 0.01	9.77E-01
guanine deglycation (GO:0106044)	1	0	.02	-	 < 0.01	9.77E-01
regulation of GABA-A receptor activity (GO:0106040)	1	0	.02	-	 < 0.01	9.77E-01
establishment of secretory granule localization (GO:0032254)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of membrane depolarization during cardiac muscle cell action potential (GO:1900827)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of membrane depolarization during cardiac muscle cell action potential (GO:1900826)	1	0	.02	-	 < 0.01	9.77E-01
regulation of membrane depolarization during cardiac muscle cell action potential (GO:1900825)	5	0	.12	-	 < 0.01	8.90E-01
protein maturation by [4Fe-4S] cluster transfer (GO:0106035)	3	0	.07	-	 < 0.01	9.32E-01
protein maturation by [2Fe-2S] cluster transfer (GO:0106034)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of nucleoside transport (GO:0032244)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of nucleoside transport (GO:0032243)	1	0	.02	-	 < 0.01	9.77E-01
regulation of nucleoside transport (GO:0032242)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of nucleobase-containing compound transport (GO:0032241)	6	0	.14	-	 < 0.01	8.69E-01
neuron projection retraction (GO:0106028)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of nucleobase-containing compound transport (GO:0032240)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of vesicle docking (GO:0106022)	1	0	.02	-	 < 0.01	9.77E-01
regulation of vesicle docking (GO:0106020)	4	0	.09	-	 < 0.01	9.11E-01
AMP salvage (GO:0044209)	1	0	.02	-	 < 0.01	9.77E-01
'de novo' AMP biosynthetic process (GO:0044208)	1	0	.02	-	 < 0.01	9.77E-01
UMP salvage (GO:0044206)	1	0	.02	-	 < 0.01	9.77E-01
'de novo' UMP biosynthetic process (GO:0044205)	1	0	.02	-	 < 0.01	9.77E-01
adenosine transport (GO:0032238)	3	0	.07	-	 < 0.01	9.32E-01
activation of store-operated calcium channel activity (GO:0032237)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of actin filament bundle assembly (GO:0032232)	35	0	.82	-	 < 0.01	4.42E-01
positive regulation of synaptic transmission, GABAergic (GO:0032230)	18	0	.42	-	 < 0.01	6.57E-01
positive regulation of inflammatory response to wounding (GO:0106016)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of inflammatory response to wounding (GO:0106015)	4	0	.09	-	 < 0.01	9.11E-01
regulation of inflammatory response to wounding (GO:0106014)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of synaptic transmission, dopaminergic (GO:0032227)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of synaptic transmission, dopaminergic (GO:0032226)	4	0	.09	-	 < 0.01	9.11E-01
regulation of synaptic transmission, dopaminergic (GO:0032225)	11	0	.26	-	 < 0.01	7.74E-01
positive regulation of synaptic transmission, cholinergic (GO:0032224)	10	0	.23	-	 < 0.01	7.92E-01
negative regulation of synaptic transmission, cholinergic (GO:0032223)	1	0	.02	-	 < 0.01	9.77E-01
RNA 5'-cap (guanine-N7)-methylation (GO:0106005)	1	0	.02	-	 < 0.01	9.77E-01
intestinal hexose absorption (GO:0106001)	3	0	.07	-	 < 0.01	9.32E-01
riboflavin transport (GO:0032218)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of telomere maintenance via recombination (GO:0032208)	1	0	.02	-	 < 0.01	9.77E-01
regulation of telomere maintenance via recombination (GO:0032207)	1	0	.02	-	 < 0.01	9.77E-01
telomere formation via telomerase (GO:0032203)	1	0	.02	-	 < 0.01	9.77E-01
telomere assembly (GO:0032202)	4	0	.09	-	 < 0.01	9.11E-01
telomere maintenance via semi-conservative replication (GO:0032201)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of polysome binding (GO:1905698)	1	0	.02	-	 < 0.01	9.77E-01
regulation of polysome binding (GO:1905696)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of phosphatidic acid biosynthetic process (GO:1905695)	1	0	.02	-	 < 0.01	9.77E-01
regulation of phosphatidic acid biosynthetic process (GO:1905693)	2	0	.05	-	 < 0.01	9.54E-01
regulation of nerve growth factor receptor activity (GO:0051394)	1	0	.02	-	 < 0.01	9.77E-01
regulation of plasma membrane repair (GO:1905684)	3	0	.07	-	 < 0.01	9.32E-01
inactivation of MAPKK activity (GO:0051389)	2	0	.05	-	 < 0.01	9.54E-01
neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of neurotrophin TRK receptor signaling pathway (GO:0051387)	5	0	.12	-	 < 0.01	8.90E-01
modification of dendritic spine (GO:0098886)	1	0	.02	-	 < 0.01	9.77E-01
response to mineralocorticoid (GO:0051385)	14	0	.33	-	 < 0.01	7.21E-01
synapse pruning (GO:0098883)	9	0	.21	-	 < 0.01	8.11E-01
kinetochore organization (GO:0051383)	18	0	.42	-	 < 0.01	6.57E-01
kinetochore assembly (GO:0051382)	13	0	.30	-	 < 0.01	7.38E-01
maintenance of postsynaptic specialization structure (GO:0098880)	7	0	.16	-	 < 0.01	8.49E-01
RNA localization to chromatin (GO:1990280)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of adaptive immune memory response (GO:1905676)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of adaptive immune memory response (GO:1905675)	2	0	.05	-	 < 0.01	9.54E-01
regulation of adaptive immune memory response (GO:1905674)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of lysosome organization (GO:1905673)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of lysosome organization (GO:1905672)	1	0	.02	-	 < 0.01	9.77E-01
regulation of lysosome organization (GO:1905671)	5	0	.12	-	 < 0.01	8.90E-01
neurotransmitter receptor transport to plasma membrane (GO:0098877)	20	0	.47	-	 < 0.01	6.27E-01
action potential propagation (GO:0098870)	11	0	.26	-	 < 0.01	7.74E-01
positive regulation of protein localization to endosome (GO:1905668)	9	0	.21	-	 < 0.01	8.11E-01
negative regulation of protein localization to endosome (GO:1905667)	1	0	.02	-	 < 0.01	9.77E-01
regulation of protein localization to endosome (GO:1905666)	10	0	.23	-	 < 0.01	7.92E-01
positive regulation of calcium ion import across plasma membrane (GO:1905665)	8	0	.19	-	 < 0.01	8.30E-01
regulation of calcium ion import across plasma membrane (GO:1905664)	10	0	.23	-	 < 0.01	7.92E-01
positive regulation of telomerase RNA reverse transcriptase activity (GO:1905663)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of telomerase RNA reverse transcriptase activity (GO:1905662)	1	0	.02	-	 < 0.01	9.77E-01
cellular oxidant detoxification (GO:0098869)	13	0	.30	-	 < 0.01	7.38E-01
regulation of telomerase RNA reverse transcriptase activity (GO:1905661)	3	0	.07	-	 < 0.01	9.32E-01
intramembranous bone growth (GO:0098867)	1	0	.02	-	 < 0.01	9.77E-01
response to transition metal nanoparticle (GO:1990267)	1	0	.02	-	 < 0.01	9.77E-01
peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264)	10	0	.23	-	 < 0.01	7.92E-01
anti-Mullerian hormone signaling pathway (GO:1990262)	1	0	.02	-	 < 0.01	9.77E-01
pre-mRNA catabolic process (GO:1990261)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of artery morphogenesis (GO:1905653)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of artery morphogenesis (GO:1905652)	1	0	.02	-	 < 0.01	9.77E-01
regulation of artery morphogenesis (GO:1905651)	8	0	.19	-	 < 0.01	8.30E-01
intestinal lipid absorption (GO:0098856)	9	0	.21	-	 < 0.01	8.11E-01
positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment (GO:1901297)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment (GO:1901296)	1	0	.02	-	 < 0.01	9.77E-01
proprioception involved in equilibrioception (GO:0051355)	1	0	.02	-	 < 0.01	9.77E-01
regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment (GO:1901295)	2	0	.05	-	 < 0.01	9.54E-01
signal clustering (GO:1990256)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of ligase activity (GO:0051352)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of ligase activity (GO:0051351)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of double-strand break repair via single-strand annealing (GO:1901291)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of lyase activity (GO:0051350)	16	0	.37	-	 < 0.01	6.89E-01
positive regulation of DNA methylation (GO:1905643)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of DNA methylation (GO:1905642)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of lyase activity (GO:0051349)	19	0	.44	-	 < 0.01	6.42E-01
post-embryonic animal morphogenesis (GO:0009886)	17	0	.40	-	 < 0.01	6.73E-01
regulation of transcription from RNA polymerase II promoter in response to DNA damage (GO:1990248)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051344)	4	0	.09	-	 < 0.01	9.11E-01
histone H2A-T120 phosphorylation (GO:1990245)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051343)	1	0	.02	-	 < 0.01	9.77E-01
regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342)	5	0	.12	-	 < 0.01	8.90E-01
regulation of ligase activity (GO:0051340)	8	0	.19	-	 < 0.01	8.30E-01
positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1905636)	3	0	.07	-	 < 0.01	9.32E-01
regulation of protein localization to chromatin (GO:1905634)	8	0	.19	-	 < 0.01	8.30E-01
cellular response to glyceraldehyde (GO:1905631)	1	0	.02	-	 < 0.01	9.77E-01
regulation of lyase activity (GO:0051339)	39	0	.91	-	 < 0.01	4.02E-01
folate transmembrane transport (GO:0098838)	6	0	.14	-	 < 0.01	8.69E-01
response to glyceraldehyde (GO:1905630)	1	0	.02	-	 < 0.01	9.77E-01
regulation of serotonin biosynthetic process (GO:1905627)	2	0	.05	-	 < 0.01	9.54E-01
mitotic interphase (GO:0051329)	3	0	.07	-	 < 0.01	9.32E-01
modulation of inhibitory postsynaptic potential (GO:0098828)	9	0	.21	-	 < 0.01	8.11E-01
paranodal junction maintenance (GO:1990227)	1	0	.02	-	 < 0.01	9.77E-01
interphase (GO:0051325)	4	0	.09	-	 < 0.01	9.11E-01
prophase (GO:0051324)	11	0	.26	-	 < 0.01	7.74E-01
metaphase (GO:0051323)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of mRNA cap binding (GO:1905612)	1	0	.02	-	 < 0.01	9.77E-01
G2 phase (GO:0051319)	2	0	.05	-	 < 0.01	9.54E-01
regulation of mRNA cap binding (GO:1905610)	1	0	.02	-	 < 0.01	9.77E-01
G1 phase (GO:0051318)	2	0	.05	-	 < 0.01	9.54E-01
evoked excitatory postsynaptic potential (GO:0098817)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of macrophage colony-stimulating factor production (GO:1901258)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of macrophage colony-stimulating factor production (GO:1901257)	1	0	.02	-	 < 0.01	9.77E-01
attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation (GO:0051316)	2	0	.05	-	 < 0.01	9.54E-01
regulation of macrophage colony-stimulating factor production (GO:1901256)	4	0	.09	-	 < 0.01	9.11E-01
attachment of mitotic spindle microtubules to kinetochore (GO:0051315)	11	0	.26	-	 < 0.01	7.74E-01
spontaneous synaptic transmission (GO:0098814)	10	0	.23	-	 < 0.01	7.92E-01
nucleotide-excision repair involved in interstrand cross-link repair (GO:1901255)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of intracellular transport of viral material (GO:1901254)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of intracellular transport of viral material (GO:1901253)	2	0	.05	-	 < 0.01	9.54E-01
regulation of intracellular transport of viral material (GO:1901252)	3	0	.07	-	 < 0.01	9.32E-01
meiotic metaphase plate congression (GO:0051311)	2	0	.05	-	 < 0.01	9.54E-01
metaphase plate congression (GO:0051310)	55	0	1.28	-	 < 0.01	2.77E-01
negative regulation of lung goblet cell differentiation (GO:1901250)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of metanephric cap mesenchymal cell proliferation (GO:0090096)	1	0	.02	-	 < 0.01	9.77E-01
regulation of metanephric cap mesenchymal cell proliferation (GO:0090095)	1	0	.02	-	 < 0.01	9.77E-01
metanephric cap mesenchymal cell proliferation involved in metanephros development (GO:0090094)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of smooth muscle cell-matrix adhesion (GO:1905609)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of presynapse assembly (GO:1905608)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of presynapse assembly (GO:1905607)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of extracellular matrix disassembly (GO:0090091)	9	0	.21	-	 < 0.01	8.11E-01
regulation of presynapse assembly (GO:1905606)	34	0	.79	-	 < 0.01	4.52E-01
positive regulation of blood-brain barrier permeability (GO:1905605)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of blood-brain barrier permeability (GO:1905604)	3	0	.07	-	 < 0.01	9.32E-01
regulation of blood-brain barrier permeability (GO:1905603)	8	0	.19	-	 < 0.01	8.30E-01
positive regulation of receptor-mediated endocytosis involved in cholesterol transport (GO:1905602)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of receptor-mediated endocytosis involved in cholesterol transport (GO:1905601)	2	0	.05	-	 < 0.01	9.54E-01
female meiosis chromosome separation (GO:0051309)	4	0	.09	-	 < 0.01	9.11E-01
regulation of lung goblet cell differentiation (GO:1901249)	2	0	.05	-	 < 0.01	9.54E-01
regulation of receptor-mediated endocytosis involved in cholesterol transport (GO:1905600)	4	0	.09	-	 < 0.01	9.11E-01
male meiosis chromosome separation (GO:0051308)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of lung ciliated cell differentiation (GO:1901248)	1	0	.02	-	 < 0.01	9.77E-01
meiotic chromosome separation (GO:0051307)	21	0	.49	-	 < 0.01	6.13E-01
mitotic sister chromatid separation (GO:0051306)	4	0	.09	-	 < 0.01	9.11E-01
regulation of lung ciliated cell differentiation (GO:1901246)	1	0	.02	-	 < 0.01	9.77E-01
chromosome movement towards spindle pole (GO:0051305)	5	0	.12	-	 < 0.01	8.90E-01
chromosome separation (GO:0051304)	29	0	.68	-	 < 0.01	5.08E-01
establishment of chromosome localization (GO:0051303)	69	0	1.61	-	 < 0.01	2.00E-01
regulation of dipeptide transport (GO:0090089)	2	0	.05	-	 < 0.01	9.54E-01
regulation of oligopeptide transport (GO:0090088)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of protein deubiquitination (GO:0090086)	4	0	.09	-	 < 0.01	9.11E-01
regulation of protein deubiquitination (GO:0090085)	12	0	.28	-	 < 0.01	7.56E-01
positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway (GO:0090082)	4	0	.09	-	 < 0.01	9.11E-01
regulation of heart induction by regulation of canonical Wnt signaling pathway (GO:0090081)	5	0	.12	-	 < 0.01	8.90E-01
abscission (GO:0009838)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of convergent extension involved in axis elongation (GO:1901233)	1	0	.02	-	 < 0.01	9.77E-01
regulation of convergent extension involved in axis elongation (GO:1901232)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of non-canonical Wnt signaling pathway via JNK cascade (GO:1901231)	1	0	.02	-	 < 0.01	9.77E-01
foam cell differentiation (GO:0090077)	5	0	.12	-	 < 0.01	8.90E-01
relaxation of skeletal muscle (GO:0090076)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of protein homodimerization activity (GO:0090074)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of ribosome biogenesis (GO:0090071)	3	0	.07	-	 < 0.01	9.32E-01
regulation of non-canonical Wnt signaling pathway via JNK cascade (GO:1901229)	1	0	.02	-	 < 0.01	9.77E-01
unidimensional cell growth (GO:0009826)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of thrombin-activated receptor signaling pathway (GO:0070495)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901228)	5	0	.12	-	 < 0.01	8.90E-01
regulation of thrombin-activated receptor signaling pathway (GO:0070494)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901227)	1	0	.02	-	 < 0.01	9.77E-01
thrombin-activated receptor signaling pathway (GO:0070493)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of NIK/NF-kappaB signaling (GO:1901223)	22	0	.51	-	 < 0.01	5.99E-01
alkaloid metabolic process (GO:0009820)	1	0	.02	-	 < 0.01	9.77E-01
regulation of ribosome biogenesis (GO:0090069)	3	0	.07	-	 < 0.01	9.32E-01
regulation of thalamus size (GO:0090067)	1	0	.02	-	 < 0.01	9.77E-01
regulation of production of siRNA involved in RNA interference (GO:0090065)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of microtubule nucleation (GO:0090063)	4	0	.09	-	 < 0.01	9.11E-01
T cell aggregation (GO:0070489)	2	0	.05	-	 < 0.01	9.54E-01
neutrophil aggregation (GO:0070488)	2	0	.05	-	 < 0.01	9.54E-01
detection of hypoxia (GO:0070483)	2	0	.05	-	 < 0.01	9.54E-01
flavonoid metabolic process (GO:0009812)	2	0	.05	-	 < 0.01	9.54E-01
nuclear-transcribed mRNA catabolic process, non-stop decay (GO:0070481)	1	0	.02	-	 < 0.01	9.77E-01
regulation of transcription from RNA polymerase II promoter involved in heart development (GO:1901213)	8	0	.19	-	 < 0.01	8.30E-01
stilbene metabolic process (GO:0009810)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of cardiac chamber formation (GO:1901211)	1	0	.02	-	 < 0.01	9.77E-01
regulation of cardiac chamber formation (GO:1901210)	1	0	.02	-	 < 0.01	9.77E-01
oocyte development (GO:0048599)	38	0	.89	-	 < 0.01	4.12E-01
post-embryonic camera-type eye morphogenesis (GO:0048597)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050)	20	0	.47	-	 < 0.01	6.27E-01
nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay (GO:0070478)	1	0	.02	-	 < 0.01	9.77E-01
rRNA (guanine-N7)-methylation (GO:0070476)	2	0	.05	-	 < 0.01	9.54E-01
rRNA base methylation (GO:0070475)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of heart looping (GO:1901208)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of uterine smooth muscle contraction (GO:0070474)	9	0	.21	-	 < 0.01	8.11E-01
regulation of heart looping (GO:1901207)	1	0	.02	-	 < 0.01	9.77E-01
coumarin metabolic process (GO:0009804)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of uterine smooth muscle contraction (GO:0070473)	2	0	.05	-	 < 0.01	9.54E-01
regulation of uterine smooth muscle contraction (GO:0070472)	12	0	.28	-	 < 0.01	7.56E-01
uterine smooth muscle contraction (GO:0070471)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of extracellular matrix assembly (GO:1901202)	1	0	.02	-	 < 0.01	9.77E-01
determination of affect (GO:0050894)	1	0	.02	-	 < 0.01	9.77E-01
sensory processing (GO:0050893)	2	0	.05	-	 < 0.01	9.54E-01
multicellular organismal water homeostasis (GO:0050891)	54	0	1.26	-	 < 0.01	2.83E-01
positive regulation of deacetylase activity (GO:0090045)	9	0	.21	-	 < 0.01	8.11E-01
positive regulation of tubulin deacetylation (GO:0090044)	1	0	.02	-	 < 0.01	9.77E-01
regulation of tubulin deacetylation (GO:0090043)	12	0	.28	-	 < 0.01	7.56E-01
tubulin deacetylation (GO:0090042)	3	0	.07	-	 < 0.01	9.32E-01
nitrogen catabolite activation of transcription from RNA polymerase II promoter (GO:0001080)	1	0	.02	-	 < 0.01	9.77E-01
plus-end specific microtubule depolymerization (GO:0070462)	1	0	.02	-	 < 0.01	9.77E-01
thyroid-stimulating hormone secretion (GO:0070460)	3	0	.07	-	 < 0.01	9.32E-01
neuromuscular process controlling posture (GO:0050884)	17	0	.40	-	 < 0.01	6.73E-01
musculoskeletal movement, spinal reflex action (GO:0050883)	3	0	.07	-	 < 0.01	9.32E-01
voluntary musculoskeletal movement (GO:0050882)	9	0	.21	-	 < 0.01	8.11E-01
nitrogen catabolite regulation of transcription from RNA polymerase II promoter (GO:0001079)	1	0	.02	-	 < 0.01	9.77E-01
musculoskeletal movement (GO:0050881)	46	0	1.07	-	 < 0.01	3.42E-01
negative regulation of protein kinase C signaling (GO:0090038)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of protein kinase C signaling (GO:0090037)	11	0	.26	-	 < 0.01	7.74E-01
regulation of protein kinase C signaling (GO:0090036)	21	0	.49	-	 < 0.01	6.13E-01
positive regulation of chaperone-mediated protein complex assembly (GO:0090035)	1	0	.02	-	 < 0.01	9.77E-01
regulation of chaperone-mediated protein complex assembly (GO:0090034)	1	0	.02	-	 < 0.01	9.77E-01
notochord morphogenesis (GO:0048570)	10	0	.23	-	 < 0.01	7.92E-01
negative regulation of steroid hormone biosynthetic process (GO:0090032)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of steroid hormone biosynthetic process (GO:0090031)	9	0	.21	-	 < 0.01	8.11E-01
regulation of steroid hormone biosynthetic process (GO:0090030)	20	0	.47	-	 < 0.01	6.27E-01
prolactin secretion (GO:0070459)	3	0	.07	-	 < 0.01	9.32E-01
cellular detoxification of nitrogen compound (GO:0070458)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of heme biosynthetic process (GO:0070455)	1	0	.02	-	 < 0.01	9.77E-01
regulation of heme biosynthetic process (GO:0070453)	3	0	.07	-	 < 0.01	9.32E-01
multicellular organismal movement (GO:0050879)	46	0	1.07	-	 < 0.01	3.42E-01
post-embryonic animal organ development (GO:0048569)	20	0	.47	-	 < 0.01	6.27E-01
ectodermal digestive tract morphogenesis (GO:0048567)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of monocyte chemotaxis (GO:0090027)	5	0	.12	-	 < 0.01	8.90E-01
post-embryonic animal organ morphogenesis (GO:0048563)	10	0	.23	-	 < 0.01	7.92E-01
negative regulation of neutrophil chemotaxis (GO:0090024)	3	0	.07	-	 < 0.01	9.32E-01
establishment of animal organ orientation (GO:0048561)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of neutrophil chemotaxis (GO:0090023)	25	0	.58	-	 < 0.01	5.58E-01
establishment of anatomical structure orientation (GO:0048560)	2	0	.05	-	 < 0.01	9.54E-01
regulation of neutrophil chemotaxis (GO:0090022)	32	0	.75	-	 < 0.01	4.74E-01
positive regulation of oligodendrocyte progenitor proliferation (GO:0070447)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of oligodendrocyte progenitor proliferation (GO:0070446)	1	0	.02	-	 < 0.01	9.77E-01
regulation of oligodendrocyte progenitor proliferation (GO:0070445)	11	0	.26	-	 < 0.01	7.74E-01
positive regulation of T cell receptor signaling pathway (GO:0050862)	16	0	.37	-	 < 0.01	6.89E-01
positive regulation of B cell receptor signaling pathway (GO:0050861)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of T cell receptor signaling pathway (GO:0050860)	21	0	.49	-	 < 0.01	6.13E-01
negative regulation of pinocytosis (GO:0048550)	5	0	.12	-	 < 0.01	8.90E-01
transforming growth factor beta receptor signaling pathway involved in primitive streak formation (GO:0090010)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070434)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070433)	2	0	.05	-	 < 0.01	9.54E-01
regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070432)	6	0	.14	-	 < 0.01	8.69E-01
nucleotide-binding oligomerization domain containing 2 signaling pathway (GO:0070431)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070430)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of antigen receptor-mediated signaling pathway (GO:0050857)	23	0	.54	-	 < 0.01	5.85E-01
regulation of T cell receptor signaling pathway (GO:0050856)	44	0	1.03	-	 < 0.01	3.58E-01
positive regulation of pinocytosis (GO:0048549)	8	0	.19	-	 < 0.01	8.30E-01
T cell receptor signaling pathway (GO:0050852)	85	0	1.98	-	 < 0.01	1.37E-01
regulation of pinocytosis (GO:0048548)	13	0	.30	-	 < 0.01	7.38E-01
primitive streak formation (GO:0090009)	10	0	.23	-	 < 0.01	7.92E-01
negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070429)	1	0	.02	-	 < 0.01	9.77E-01
regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070428)	5	0	.12	-	 < 0.01	8.90E-01
nucleotide-binding oligomerization domain containing 1 signaling pathway (GO:0070427)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070426)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070425)	2	0	.05	-	 < 0.01	9.54E-01
regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424)	8	0	.19	-	 < 0.01	8.30E-01
nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423)	6	0	.14	-	 < 0.01	8.69E-01
antibiotic metabolic process (GO:0016999)	2	0	.05	-	 < 0.01	9.54E-01
cell wall macromolecule catabolic process (GO:0016998)	2	0	.05	-	 < 0.01	9.54E-01
progesterone receptor signaling pathway (GO:0050847)	9	0	.21	-	 < 0.01	8.11E-01
bone marrow development (GO:0048539)	8	0	.19	-	 < 0.01	8.30E-01
anatomical structure arrangement (GO:0048532)	21	0	.49	-	 < 0.01	6.13E-01
cellular response to cold (GO:0070417)	10	0	.23	-	 < 0.01	7.92E-01
positive regulation of heterochromatin organization (GO:0120263)	10	0	.23	-	 < 0.01	7.92E-01
negative regulation of heterochromatin organization (GO:0120262)	5	0	.12	-	 < 0.01	8.90E-01
regulation of heterochromatin organization (GO:0120261)	16	0	.37	-	 < 0.01	6.89E-01
trehalose metabolism in response to stress (GO:0070413)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of viral process (GO:0048524)	63	0	1.47	-	 < 0.01	2.30E-01
olefinic compound catabolic process (GO:0120256)	2	0	.05	-	 < 0.01	9.54E-01
carbamoyl phosphate biosynthetic process (GO:0070409)	1	0	.02	-	 < 0.01	9.77E-01
carbamoyl phosphate metabolic process (GO:0070408)	1	0	.02	-	 < 0.01	9.77E-01
oxidation-dependent protein catabolic process (GO:0070407)	1	0	.02	-	 < 0.01	9.77E-01
hydrocarbon catabolic process (GO:0120253)	2	0	.05	-	 < 0.01	9.54E-01
hydrocarbon metabolic process (GO:0120252)	5	0	.12	-	 < 0.01	8.90E-01
transposition, RNA-mediated (GO:0032197)	2	0	.05	-	 < 0.01	9.54E-01
transposition (GO:0032196)	3	0	.07	-	 < 0.01	9.32E-01
ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate (GO:0032194)	1	0	.02	-	 < 0.01	9.77E-01
regulation of liquid surface tension (GO:0050828)	3	0	.07	-	 < 0.01	9.32E-01
poly(A)+ mRNA export from nucleus (GO:0016973)	21	0	.49	-	 < 0.01	6.13E-01
response to freezing (GO:0050826)	1	0	.02	-	 < 0.01	9.77E-01
peptide antigen stabilization (GO:0050823)	1	0	.02	-	 < 0.01	9.77E-01
peptide stabilization (GO:0050822)	1	0	.02	-	 < 0.01	9.77E-01
histone H3-K14 acetylation (GO:0044154)	9	0	.21	-	 < 0.01	8.11E-01
septin cytoskeleton organization (GO:0032185)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of coagulation (GO:0050819)	46	0	1.07	-	 < 0.01	3.42E-01
doxorubicin transport (GO:1900753)	1	0	.02	-	 < 0.01	9.77E-01
regulation of acyl-CoA biosynthetic process (GO:0050812)	5	0	.12	-	 < 0.01	8.90E-01
regulation of timing of cell differentiation (GO:0048505)	11	0	.26	-	 < 0.01	7.74E-01
negative regulation of development of symbiont involved in interaction with host (GO:0044147)	1	0	.02	-	 < 0.01	9.77E-01
modulation of development of symbiont involved in interaction with host (GO:0044145)	1	0	.02	-	 < 0.01	9.77E-01
glutathione deglycation (GO:0036531)	1	0	.02	-	 < 0.01	9.77E-01
(R)-carnitine transport (GO:1900749)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747)	9	0	.21	-	 < 0.01	8.11E-01
regulation of vascular endothelial growth factor signaling pathway (GO:1900746)	19	0	.44	-	 < 0.01	6.42E-01
circadian sleep/wake cycle, sleep (GO:0050802)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740)	3	0	.07	-	 < 0.01	9.32E-01
protein localization to motile cilium (GO:0120229)	1	0	.02	-	 < 0.01	9.77E-01
protein deglycation, glyoxal removal (GO:0036529)	1	0	.02	-	 < 0.01	9.77E-01
peptidyl-lysine deglycation (GO:0036528)	1	0	.02	-	 < 0.01	9.77E-01
peptidyl-arginine deglycation (GO:0036527)	1	0	.02	-	 < 0.01	9.77E-01
peptidyl-cysteine deglycation (GO:0036526)	1	0	.02	-	 < 0.01	9.77E-01
protein deglycation (GO:0036525)	2	0	.05	-	 < 0.01	9.54E-01
larynx development (GO:0120224)	3	0	.07	-	 < 0.01	9.32E-01
larynx morphogenesis (GO:0120223)	3	0	.07	-	 < 0.01	9.32E-01
regulation of blastocyst development (GO:0120222)	4	0	.09	-	 < 0.01	9.11E-01
maintenance of ciliary planar beating movement pattern (GO:0120221)	1	0	.02	-	 < 0.01	9.77E-01
astrocyte-dopaminergic neuron signaling (GO:0036520)	3	0	.07	-	 < 0.01	9.32E-01
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of phospholipase C-activating G protein-coupled receptor signaling pathway (GO:1900738)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of phospholipase C-activating G protein-coupled receptor signaling pathway (GO:1900737)	1	0	.02	-	 < 0.01	9.77E-01
regulation of phospholipase C-activating G protein-coupled receptor signaling pathway (GO:1900736)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of adenylate cyclase-inhibiting opioid receptor signaling pathway (GO:1900731)	1	0	.02	-	 < 0.01	9.77E-01
chemorepulsion of dopaminergic neuron axon (GO:0036518)	2	0	.05	-	 < 0.01	9.54E-01
chemoattraction of serotonergic neuron axon (GO:0036517)	1	0	.02	-	 < 0.01	9.77E-01
chemoattraction of dopaminergic neuron axon (GO:0036516)	1	0	.02	-	 < 0.01	9.77E-01
serotonergic neuron axon guidance (GO:0036515)	4	0	.09	-	 < 0.01	9.11E-01
dopaminergic neuron axon guidance (GO:0036514)	6	0	.14	-	 < 0.01	8.69E-01
proacrosomal vesicle fusion (GO:0120211)	1	0	.02	-	 < 0.01	9.77E-01
trimming of terminal mannose on C branch (GO:0036510)	1	0	.02	-	 < 0.01	9.77E-01
regulation of adenylate cyclase-inhibiting opioid receptor signaling pathway (GO:1900729)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation by symbiont of entry into host (GO:0075294)	11	0	.26	-	 < 0.01	7.74E-01
positive regulation of uterine smooth muscle relaxation (GO:1900721)	2	0	.05	-	 < 0.01	9.54E-01
trimming of terminal mannose on B branch (GO:0036509)	2	0	.05	-	 < 0.01	9.54E-01
protein alpha-1,2-demannosylation (GO:0036508)	5	0	.12	-	 < 0.01	8.90E-01
protein demannosylation (GO:0036507)	5	0	.12	-	 < 0.01	8.90E-01
maintenance of unfolded protein (GO:0036506)	3	0	.07	-	 < 0.01	9.32E-01
activation of protein kinase B activity (GO:0032148)	22	0	.51	-	 < 0.01	5.99E-01
protein desumoylation (GO:0016926)	11	0	.26	-	 < 0.01	7.74E-01
regulation of uterine smooth muscle relaxation (GO:1900719)	2	0	.05	-	 < 0.01	9.54E-01
protein sumoylation (GO:0016925)	23	0	.54	-	 < 0.01	5.85E-01
cellular alcohol biosynthetic process (GO:0044108)	4	0	.09	-	 < 0.01	9.11E-01
cellular alcohol metabolic process (GO:0044107)	4	0	.09	-	 < 0.01	9.11E-01
sequestering of zinc ion (GO:0032119)	3	0	.07	-	 < 0.01	9.32E-01
regulation of carbohydrate phosphatase activity (GO:0032113)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of response to nutrient levels (GO:0032109)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of response to extracellular stimulus (GO:0032106)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of appetite (GO:0032100)	3	0	.07	-	 < 0.01	9.32E-01
cell dedifferentiation (GO:0043697)	6	0	.14	-	 < 0.01	8.69E-01
dedifferentiation (GO:0043696)	6	0	.14	-	 < 0.01	8.69E-01
reverse cholesterol transport (GO:0043691)	13	0	.30	-	 < 0.01	7.38E-01
positive regulation of low-density lipoprotein receptor activity (GO:1905599)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of low-density lipoprotein receptor activity (GO:1905598)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of low-density lipoprotein particle receptor binding (GO:1905597)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of low-density lipoprotein particle receptor binding (GO:1905596)	1	0	.02	-	 < 0.01	9.77E-01
regulation of low-density lipoprotein particle receptor binding (GO:1905595)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of optical nerve axon regeneration (GO:1905593)	1	0	.02	-	 < 0.01	9.77E-01
regulation of optical nerve axon regeneration (GO:1905591)	1	0	.02	-	 < 0.01	9.77E-01
centrosome separation (GO:0051299)	7	0	.16	-	 < 0.01	8.49E-01
fibronectin fibril organization (GO:1905590)	1	0	.02	-	 < 0.01	9.77E-01
post-translational protein modification (GO:0043687)	21	0	.49	-	 < 0.01	6.13E-01
establishment of meiotic spindle orientation (GO:0051296)	1	0	.02	-	 < 0.01	9.77E-01
co-translational protein modification (GO:0043686)	2	0	.05	-	 < 0.01	9.54E-01
xenophagy (GO:0098792)	4	0	.09	-	 < 0.01	9.11E-01
nuclear pore complex assembly (GO:0051292)	9	0	.21	-	 < 0.01	8.11E-01
induction of programmed cell death (GO:0012502)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of L-arginine import across plasma membrane (GO:1905589)	1	0	.02	-	 < 0.01	9.77E-01
outer hair cell apoptotic process (GO:1905584)	1	0	.02	-	 < 0.01	9.77E-01
pre-mRNA cleavage required for polyadenylation (GO:0098789)	12	0	.28	-	 < 0.01	7.56E-01
positive regulation of low-density lipoprotein particle clearance (GO:1905581)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of ERBB3 signaling pathway (GO:1905580)	1	0	.02	-	 < 0.01	9.77E-01
mRNA cleavage involved in mRNA processing (GO:0098787)	13	0	.30	-	 < 0.01	7.38E-01
positive regulation of sequestering of calcium ion (GO:0051284)	13	0	.30	-	 < 0.01	7.38E-01
ncRNA transcription (GO:0098781)	25	0	.58	-	 < 0.01	5.58E-01
response to mitochondrial depolarisation (GO:0098780)	20	0	.47	-	 < 0.01	6.27E-01
exosomal secretion (GO:1990182)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of release of sequestered calcium ion into cytosol (GO:0051280)	12	0	.28	-	 < 0.01	7.56E-01
mitochondrial tRNA 3'-end processing (GO:1990180)	3	0	.07	-	 < 0.01	9.32E-01
regulation of ERBB3 signaling pathway (GO:1905578)	1	0	.02	-	 < 0.01	9.77E-01
ganglioside GM1 transport to membrane (GO:1905572)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779)	8	0	.19	-	 < 0.01	8.30E-01
protein localization to nucleoplasm (GO:1990173)	2	0	.05	-	 < 0.01	9.54E-01
G protein-coupled receptor catabolic process (GO:1990172)	1	0	.02	-	 < 0.01	9.77E-01
stress response to cadmium ion (GO:1990170)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of vascular endothelial cell proliferation (GO:1905564)	16	0	.37	-	 < 0.01	6.89E-01
negative regulation of vascular endothelial cell proliferation (GO:1905563)	7	0	.16	-	 < 0.01	8.49E-01
regulation of vascular endothelial cell proliferation (GO:1905562)	23	0	.54	-	 < 0.01	5.85E-01
meiotic prometaphase I (GO:0098768)	1	0	.02	-	 < 0.01	9.77E-01
stress response to copper ion (GO:1990169)	6	0	.14	-	 < 0.01	8.69E-01
protein K33-linked deubiquitination (GO:1990168)	4	0	.09	-	 < 0.01	9.11E-01
protein K27-linked deubiquitination (GO:1990167)	3	0	.07	-	 < 0.01	9.32E-01
meiosis I cell cycle phase (GO:0098764)	12	0	.28	-	 < 0.01	7.56E-01
protein localization to site of double-strand break (GO:1990166)	5	0	.12	-	 < 0.01	8.90E-01
mitotic cell cycle phase (GO:0098763)	5	0	.12	-	 < 0.01	8.90E-01
meiotic cell cycle phase (GO:0098762)	12	0	.28	-	 < 0.01	7.56E-01
histone H2A phosphorylation (GO:1990164)	4	0	.09	-	 < 0.01	9.11E-01
mitochondrial fragmentation involved in apoptotic process (GO:0043653)	9	0	.21	-	 < 0.01	8.11E-01
cellular response to interleukin-7 (GO:0098761)	16	0	.37	-	 < 0.01	6.89E-01
response to interleukin-7 (GO:0098760)	16	0	.37	-	 < 0.01	6.89E-01
dicarboxylic acid biosynthetic process (GO:0043650)	12	0	.28	-	 < 0.01	7.56E-01
positive regulation of blood vessel branching (GO:1905555)	3	0	.07	-	 < 0.01	9.32E-01
regulation of blood vessel branching (GO:1905553)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of protein localization to endoplasmic reticulum (GO:1905552)	2	0	.05	-	 < 0.01	9.54E-01
cellular response to interleukin-8 (GO:0098759)	2	0	.05	-	 < 0.01	9.54E-01
response to interleukin-8 (GO:0098758)	2	0	.05	-	 < 0.01	9.54E-01
regulation of protein localization to endoplasmic reticulum (GO:1905550)	2	0	.05	-	 < 0.01	9.54E-01
dicarboxylic acid catabolic process (GO:0043649)	12	0	.28	-	 < 0.01	7.56E-01
meiotic spindle midzone assembly (GO:0051257)	2	0	.05	-	 < 0.01	9.54E-01
regulation of mitotic cell cycle, embryonic (GO:0009794)	5	0	.12	-	 < 0.01	8.90E-01
inositol phosphate metabolic process (GO:0043647)	40	0	.93	-	 < 0.01	3.93E-01
mitotic spindle midzone assembly (GO:0051256)	5	0	.12	-	 < 0.01	8.90E-01
spindle midzone assembly (GO:0051255)	8	0	.19	-	 < 0.01	8.30E-01
detoxification (GO:0098754)	44	0	1.03	-	 < 0.01	3.58E-01
negative regulation of formation of translation preinitiation complex (GO:1901194)	1	0	.02	-	 < 0.01	9.77E-01
regulation of formation of translation preinitiation complex (GO:1901193)	1	0	.02	-	 < 0.01	9.77E-01
bone cell development (GO:0098751)	25	0	.58	-	 < 0.01	5.58E-01
positive regulation of subtelomeric heterochromatin assembly (GO:1905549)	1	0	.02	-	 < 0.01	9.77E-01
regulation of subtelomeric heterochromatin assembly (GO:1905547)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to phenylpropanoid (GO:1905546)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of abscisic acid-activated signaling pathway (GO:0009789)	1	0	.02	-	 < 0.01	9.77E-01
cerebellar neuron development (GO:0098749)	4	0	.09	-	 < 0.01	9.11E-01
regulation of L-arginine import across plasma membrane (GO:1905541)	1	0	.02	-	 < 0.01	9.77E-01
regulation of abscisic acid-activated signaling pathway (GO:0009787)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of ephrin receptor signaling pathway (GO:1901189)	2	0	.05	-	 < 0.01	9.54E-01
regulation of asymmetric cell division (GO:0009786)	6	0	.14	-	 < 0.01	8.69E-01
fast, calcium ion-dependent exocytosis of neurotransmitter (GO:0098746)	1	0	.02	-	 < 0.01	9.77E-01
regulation of ephrin receptor signaling pathway (GO:1901187)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of ERBB signaling pathway (GO:1901185)	28	0	.65	-	 < 0.01	5.20E-01
maintenance of translational fidelity (GO:1990145)	2	0	.05	-	 < 0.01	9.54E-01
polyadenylation-dependent ncRNA catabolic process (GO:0043634)	7	0	.16	-	 < 0.01	8.49E-01
intrinsic apoptotic signaling pathway in response to hypoxia (GO:1990144)	2	0	.05	-	 < 0.01	9.54E-01
polyadenylation-dependent RNA catabolic process (GO:0043633)	8	0	.19	-	 < 0.01	8.30E-01
RNA polyadenylation (GO:0043631)	31	0	.72	-	 < 0.01	4.85E-01
ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process (GO:0043630)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665)	8	0	.19	-	 < 0.01	8.30E-01
positive regulation of eukaryotic translation initiation factor 4F complex assembly (GO:1905537)	1	0	.02	-	 < 0.01	9.77E-01
regulation of eukaryotic translation initiation factor 4F complex assembly (GO:1905535)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of leucine import across plasma membrane (GO:1905533)	2	0	.05	-	 < 0.01	9.54E-01
regulation of leucine import across plasma membrane (GO:1905532)	2	0	.05	-	 < 0.01	9.54E-01
ncRNA polyadenylation (GO:0043629)	1	0	.02	-	 < 0.01	9.77E-01
sequestering of metal ion (GO:0051238)	8	0	.19	-	 < 0.01	8.30E-01
protein insertion into plasma membrane (GO:0098737)	1	0	.02	-	 < 0.01	9.77E-01
ncRNA 3'-end processing (GO:0043628)	36	0	.84	-	 < 0.01	4.32E-01
positive regulation of the force of heart contraction (GO:0098735)	5	0	.12	-	 < 0.01	8.90E-01
epithelial cell apoptotic process involved in palatal shelf morphogenesis (GO:1990134)	1	0	.02	-	 < 0.01	9.77E-01
meiotic spindle elongation (GO:0051232)	1	0	.02	-	 < 0.01	9.77E-01
cortical microtubule organization (GO:0043622)	4	0	.09	-	 < 0.01	9.11E-01
spindle elongation (GO:0051231)	6	0	.14	-	 < 0.01	8.69E-01
spindle disassembly (GO:0051230)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of heat generation (GO:0031652)	13	0	.30	-	 < 0.01	7.38E-01
positive regulation of Golgi lumen acidification (GO:1905528)	1	0	.02	-	 < 0.01	9.77E-01
regulation of Golgi lumen acidification (GO:1905526)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of protein autoubiquitination (GO:1905524)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of macrophage migration (GO:1905522)	10	0	.23	-	 < 0.01	7.92E-01
germline stem cell asymmetric division (GO:0098728)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of presynaptic active zone assembly (GO:1905520)	1	0	.02	-	 < 0.01	9.77E-01
mitotic spindle disassembly (GO:0051228)	2	0	.05	-	 < 0.01	9.54E-01
neural crest cell migration involved in autonomic nervous system development (GO:1901166)	7	0	.16	-	 < 0.01	8.49E-01
astrocyte cell migration (GO:0043615)	6	0	.14	-	 < 0.01	8.69E-01
asymmetric stem cell division (GO:0098722)	5	0	.12	-	 < 0.01	8.90E-01
primary amino compound biosynthetic process (GO:1901162)	4	0	.09	-	 < 0.01	9.11E-01
primary amino compound metabolic process (GO:1901160)	15	0	.35	-	 < 0.01	7.05E-01
regulation of carbohydrate utilization (GO:0043610)	1	0	.02	-	 < 0.01	9.77E-01
messenger ribonucleoprotein complex assembly (GO:1990120)	3	0	.07	-	 < 0.01	9.32E-01
heat generation (GO:0031649)	9	0	.21	-	 < 0.01	8.11E-01
positive regulation of myelination (GO:0031643)	20	0	.47	-	 < 0.01	6.27E-01
regulation of presynaptic active zone assembly (GO:1905518)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of fertilization (GO:1905516)	5	0	.12	-	 < 0.01	8.90E-01
carbohydrate utilization (GO:0009758)	1	0	.02	-	 < 0.01	9.77E-01
sodium ion import across plasma membrane (GO:0098719)	19	0	.44	-	 < 0.01	6.42E-01
hexose mediated signaling (GO:0009757)	3	0	.07	-	 < 0.01	9.32E-01
serine import across plasma membrane (GO:0098718)	1	0	.02	-	 < 0.01	9.77E-01
carbohydrate mediated signaling (GO:0009756)	3	0	.07	-	 < 0.01	9.32E-01
B cell receptor apoptotic signaling pathway (GO:1990117)	1	0	.02	-	 < 0.01	9.77E-01
response to jasmonic acid (GO:0009753)	2	0	.05	-	 < 0.01	9.54E-01
formamide metabolic process (GO:0043606)	1	0	.02	-	 < 0.01	9.77E-01
ribosome-associated ubiquitin-dependent protein catabolic process (GO:1990116)	2	0	.05	-	 < 0.01	9.54E-01
cellular amide catabolic process (GO:0043605)	3	0	.07	-	 < 0.01	9.32E-01
leucine import across plasma membrane (GO:0098713)	3	0	.07	-	 < 0.01	9.32E-01
RNA polymerase II core complex assembly (GO:1990114)	1	0	.02	-	 < 0.01	9.77E-01
response to fructose (GO:0009750)	5	0	.12	-	 < 0.01	8.90E-01
iron ion import across plasma membrane (GO:0098711)	2	0	.05	-	 < 0.01	9.54E-01
nitrate catabolic process (GO:0043602)	1	0	.02	-	 < 0.01	9.77E-01
plasminogen activation (GO:0031639)	10	0	.23	-	 < 0.01	7.92E-01
adenylate cyclase-inhibiting opioid receptor signaling pathway (GO:0031635)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of synaptic vesicle fusion to presynaptic active zone membrane (GO:0031632)	4	0	.09	-	 < 0.01	9.11E-01
regulation of synaptic vesicle fusion to presynaptic active zone membrane (GO:0031630)	10	0	.23	-	 < 0.01	7.92E-01
protein localization to microtubule organizing center (GO:1905508)	25	0	.58	-	 < 0.01	5.58E-01
positive regulation of motile cilium assembly (GO:1905505)	2	0	.05	-	 < 0.01	9.54E-01
regulation of motile cilium assembly (GO:1905503)	2	0	.05	-	 < 0.01	9.54E-01
sequestering of calcium ion (GO:0051208)	3	0	.07	-	 < 0.01	9.32E-01
gene expression involved in extracellular matrix organization (GO:1901148)	1	0	.02	-	 < 0.01	9.77E-01
iron ion import across cell outer membrane (GO:0098706)	3	0	.07	-	 < 0.01	9.32E-01
protein linear deubiquitination (GO:1990108)	2	0	.05	-	 < 0.01	9.54E-01
response to sucrose (GO:0009744)	2	0	.05	-	 < 0.01	9.54E-01
copper ion import across plasma membrane (GO:0098705)	2	0	.05	-	 < 0.01	9.54E-01
protein insertion into membrane (GO:0051205)	38	0	.89	-	 < 0.01	4.12E-01
protein insertion into mitochondrial membrane (GO:0051204)	13	0	.30	-	 < 0.01	7.38E-01
insulin catabolic process (GO:1901143)	3	0	.07	-	 < 0.01	9.32E-01
insulin metabolic process (GO:1901142)	11	0	.26	-	 < 0.01	7.74E-01
neurotransmitter loading into synaptic vesicle (GO:0098700)	8	0	.19	-	 < 0.01	8.30E-01
synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629)	13	0	.30	-	 < 0.01	7.38E-01
telomeric loop formation (GO:0031627)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of fever generation (GO:0031622)	9	0	.21	-	 < 0.01	8.11E-01
regulation of fever generation (GO:0031620)	11	0	.26	-	 < 0.01	7.74E-01
detection of hexose stimulus (GO:0009732)	2	0	.05	-	 < 0.01	9.54E-01
detection of carbohydrate stimulus (GO:0009730)	2	0	.05	-	 < 0.01	9.54E-01
homologous chromosome orientation involved in meiotic metaphase I plate congression (GO:0031619)	1	0	.02	-	 < 0.01	9.77E-01
detection of endogenous stimulus (GO:0009726)	4	0	.09	-	 < 0.01	9.11E-01
detection of lipoteichoic acid (GO:0070392)	1	0	.02	-	 < 0.01	9.77E-01
response to lipoteichoic acid (GO:0070391)	10	0	.23	-	 < 0.01	7.92E-01
tRNA-guanine transglycosylation (GO:0101030)	2	0	.05	-	 < 0.01	9.54E-01
mitotic nuclear membrane organization (GO:0101024)	3	0	.07	-	 < 0.01	9.32E-01
Harderian gland development (GO:0070384)	4	0	.09	-	 < 0.01	9.11E-01
DNA cytosine deamination (GO:0070383)	4	0	.09	-	 < 0.01	9.11E-01
synaptic vesicle membrane organization (GO:0048499)	3	0	.07	-	 < 0.01	9.32E-01
maintenance of animal organ identity (GO:0048496)	5	0	.12	-	 < 0.01	8.90E-01
anterograde synaptic vesicle transport (GO:0048490)	15	0	.35	-	 < 0.01	7.05E-01
negative regulation of ERK5 cascade (GO:0070377)	1	0	.02	-	 < 0.01	9.77E-01
regulation of ERK5 cascade (GO:0070376)	1	0	.02	-	 < 0.01	9.77E-01
ERK5 cascade (GO:0070375)	2	0	.05	-	 < 0.01	9.54E-01
cellular heat acclimation (GO:0070370)	2	0	.05	-	 < 0.01	9.54E-01
activated T cell proliferation (GO:0050798)	8	0	.19	-	 < 0.01	8.30E-01
parasympathetic nervous system development (GO:0048486)	21	0	.49	-	 < 0.01	6.13E-01
sympathetic nervous system development (GO:0048485)	23	0	.54	-	 < 0.01	5.85E-01
positive regulation of hepatocyte differentiation (GO:0070368)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of hepatocyte differentiation (GO:0070367)	1	0	.02	-	 < 0.01	9.77E-01
regulation of hepatocyte differentiation (GO:0070366)	4	0	.09	-	 < 0.01	9.11E-01
hepatocyte differentiation (GO:0070365)	10	0	.23	-	 < 0.01	7.92E-01
detoxification of mercury ion (GO:0050787)	2	0	.05	-	 < 0.01	9.54E-01
replication fork protection (GO:0048478)	6	0	.14	-	 < 0.01	8.69E-01
actin polymerization-dependent cell motility (GO:0070358)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of white fat cell proliferation (GO:0070352)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of white fat cell proliferation (GO:0070351)	1	0	.02	-	 < 0.01	9.77E-01
regulation of white fat cell proliferation (GO:0070350)	4	0	.09	-	 < 0.01	9.11E-01
RNA destabilization (GO:0050779)	35	0	.82	-	 < 0.01	4.42E-01
PERK-mediated unfolded protein response (GO:0036499)	4	0	.09	-	 < 0.01	9.11E-01
IRE1-mediated unfolded protein response (GO:0036498)	6	0	.14	-	 < 0.01	8.69E-01
mucociliary clearance (GO:0120197)	5	0	.12	-	 < 0.01	8.90E-01
regulation of translational initiation by eIF2 alpha dephosphorylation (GO:0036496)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of brown fat cell proliferation (GO:0070349)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of brown fat cell proliferation (GO:0070348)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of translation initiation in response to endoplasmic reticulum stress (GO:0036494)	1	0	.02	-	 < 0.01	9.77E-01
regulation of brown fat cell proliferation (GO:0070347)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of translation in response to endoplasmic reticulum stress (GO:0036493)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of fat cell proliferation (GO:0070346)	4	0	.09	-	 < 0.01	9.11E-01
eiF2alpha phosphorylation in response to endoplasmic reticulum stress (GO:0036492)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of termination of RNA polymerase II transcription (GO:0120191)	2	0	.05	-	 < 0.01	9.54E-01
regulation of translation initiation in response to endoplasmic reticulum stress (GO:0036491)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of bile acid secretion (GO:0120190)	1	0	.02	-	 < 0.01	9.77E-01
regulation of translation in response to endoplasmic reticulum stress (GO:0036490)	8	0	.19	-	 < 0.01	8.30E-01
detection of bacterial lipopeptide (GO:0070340)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of phagocytosis (GO:0050765)	23	0	.54	-	 < 0.01	5.85E-01
positive regulation of bile acid secretion (GO:0120189)	1	0	.02	-	 < 0.01	9.77E-01
regulation of bile acid secretion (GO:0120188)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of protein localization to chromatin (GO:0120187)	1	0	.02	-	 < 0.01	9.77E-01
ventral trunk neural crest cell migration (GO:0036486)	4	0	.09	-	 < 0.01	9.11E-01
response to bacterial lipopeptide (GO:0070339)	6	0	.14	-	 < 0.01	8.69E-01
trunk neural crest cell migration (GO:0036484)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of focal adhesion disassembly (GO:0120183)	6	0	.14	-	 < 0.01	8.69E-01
regulation of focal adhesion disassembly (GO:0120182)	6	0	.14	-	 < 0.01	8.69E-01
focal adhesion disassembly (GO:0120181)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of vacuole organization (GO:0044090)	12	0	.28	-	 < 0.01	7.56E-01
cell-substrate junction disassembly (GO:0120180)	1	0	.02	-	 < 0.01	9.77E-01
regulation of vacuole organization (GO:0044088)	44	0	1.03	-	 < 0.01	3.58E-01
neuron death in response to oxidative stress (GO:0036475)	3	0	.07	-	 < 0.01	9.32E-01
thyroid hormone transport (GO:0070327)	9	0	.21	-	 < 0.01	8.11E-01
trans-synaptic signaling by BDNF (GO:0099191)	4	0	.09	-	 < 0.01	9.11E-01
cellular response to glyoxal (GO:0036471)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of lipoprotein metabolic process (GO:0050748)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of lipoprotein metabolic process (GO:0050747)	5	0	.12	-	 < 0.01	8.90E-01
postsynaptic cytoskeleton organization (GO:0099188)	15	0	.35	-	 < 0.01	7.05E-01
presynaptic cytoskeleton organization (GO:0099187)	1	0	.02	-	 < 0.01	9.77E-01
detection of cold stimulus involved in thermoception (GO:0120169)	1	0	.02	-	 < 0.01	9.77E-01
synaptic vesicle recycling via endosome (GO:0036466)	8	0	.19	-	 < 0.01	8.30E-01
trans-synaptic signaling by BDNF, modulating synaptic transmission (GO:0099183)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of G0 to G1 transition (GO:0070318)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of G0 to G1 transition (GO:0070317)	5	0	.12	-	 < 0.01	8.90E-01
regulation of G0 to G1 transition (GO:0070316)	10	0	.23	-	 < 0.01	7.92E-01
zinc ion import into synaptic vesicle (GO:0099180)	2	0	.05	-	 < 0.01	9.54E-01
TRAIL-activated apoptotic signaling pathway (GO:0036462)	6	0	.14	-	 < 0.01	8.69E-01
G1 to G0 transition involved in cell differentiation (GO:0070315)	2	0	.05	-	 < 0.01	9.54E-01
G1 to G0 transition (GO:0070314)	6	0	.14	-	 < 0.01	8.69E-01
olefin metabolic process (GO:1900673)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732)	52	0	1.21	-	 < 0.01	2.97E-01
regulation of synaptic membrane adhesion (GO:0099179)	6	0	.14	-	 < 0.01	8.69E-01
regulation of retrograde trans-synaptic signaling by endocanabinoid (GO:0099178)	3	0	.07	-	 < 0.01	9.32E-01
modulation by symbiont of host cellular process (GO:0044068)	15	0	.35	-	 < 0.01	7.05E-01
positive regulation of collagen catabolic process (GO:0120158)	1	0	.02	-	 < 0.01	9.77E-01
regulation of presynapse organization (GO:0099174)	38	0	.89	-	 < 0.01	4.12E-01
regulation of respiratory system process (GO:0044065)	15	0	.35	-	 < 0.01	7.05E-01
lens fiber cell morphogenesis (GO:0070309)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of ERBB4 signaling pathway (GO:0120154)	1	0	.02	-	 < 0.01	9.77E-01
postsynaptic modulation of chemical synaptic transmission (GO:0099170)	22	0	.51	-	 < 0.01	5.99E-01
response to cGMP (GO:0070305)	7	0	.16	-	 < 0.01	8.49E-01
cap mRNA methylation (GO:0036451)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of response to food (GO:0032097)	3	0	.07	-	 < 0.01	9.32E-01
regulation of digestive system process (GO:0044058)	49	0	1.14	-	 < 0.01	3.19E-01
synaptic signaling by nitric oxide (GO:0099163)	3	0	.07	-	 < 0.01	9.32E-01
neuronal stem cell division (GO:0036445)	1	0	.02	-	 < 0.01	9.77E-01
regulation of neurotransmitter loading into synaptic vesicle (GO:0099162)	1	0	.02	-	 < 0.01	9.77E-01
calcium import into the mitochondrion (GO:0036444)	6	0	.14	-	 < 0.01	8.69E-01
translocation of peptides or proteins into host cell cytoplasm (GO:0044053)	1	0	.02	-	 < 0.01	9.77E-01
regulation of presynaptic dense core granule exocytosis (GO:0099161)	1	0	.02	-	 < 0.01	9.77E-01
regulation of recycling endosome localization within postsynapse (GO:0099158)	1	0	.02	-	 < 0.01	9.77E-01
cell-cell signaling via exosome (GO:0099156)	1	0	.02	-	 < 0.01	9.77E-01
maintenance of lens transparency (GO:0036438)	5	0	.12	-	 < 0.01	8.90E-01
synaptic transmission, serotonergic (GO:0099153)	1	0	.02	-	 < 0.01	9.77E-01
regulation of neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0099152)	2	0	.05	-	 < 0.01	9.54E-01
regulation of postsynaptic density assembly (GO:0099151)	14	0	.33	-	 < 0.01	7.21E-01
regulation of postsynaptic specialization assembly (GO:0099150)	18	0	.42	-	 < 0.01	6.57E-01
multi-organism carbohydrate catabolic process (GO:0044041)	1	0	.02	-	 < 0.01	9.77E-01
multi-organism carbohydrate metabolic process (GO:0044040)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of endodeoxyribonuclease activity (GO:0032079)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of endodeoxyribonuclease activity (GO:0032078)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of deoxyribonuclease activity (GO:0032077)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of deoxyribonuclease activity (GO:0032076)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of nuclease activity (GO:0032075)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of nuclease activity (GO:0032074)	7	0	.16	-	 < 0.01	8.49E-01
regulation of endodeoxyribonuclease activity (GO:0032071)	7	0	.16	-	 < 0.01	8.49E-01
regulation of deoxyribonuclease activity (GO:0032070)	9	0	.21	-	 < 0.01	8.11E-01
regulation of synaptic vesicle docking (GO:0099148)	1	0	.02	-	 < 0.01	9.77E-01
cell wall macromolecule biosynthetic process (GO:0044038)	1	0	.02	-	 < 0.01	9.77E-01
multi-organism cell wall macromolecule metabolic process (GO:0044037)	1	0	.02	-	 < 0.01	9.77E-01
response to zinc ion starvation (GO:0120127)	2	0	.05	-	 < 0.01	9.54E-01
cell wall macromolecule metabolic process (GO:0044036)	4	0	.09	-	 < 0.01	9.11E-01
response to copper ion starvation (GO:0120126)	1	0	.02	-	 < 0.01	9.77E-01
multi-organism catabolic process (GO:0044035)	2	0	.05	-	 < 0.01	9.54E-01
multi-organism metabolic process (GO:0044033)	5	0	.12	-	 < 0.01	8.90E-01
presynaptic actin cytoskeleton organization (GO:0099140)	1	0	.02	-	 < 0.01	9.77E-01
regulation of DNA methylation (GO:0044030)	24	0	.56	-	 < 0.01	5.71E-01
regulation of nuclease activity (GO:0032069)	26	0	.61	-	 < 0.01	5.45E-01
hypomethylation of CpG island (GO:0044029)	2	0	.05	-	 < 0.01	9.54E-01
DNA hypomethylation (GO:0044028)	2	0	.05	-	 < 0.01	9.54E-01
hypermethylation of CpG island (GO:0044027)	4	0	.09	-	 < 0.01	9.11E-01
T cell meandering migration (GO:0120117)	1	0	.02	-	 < 0.01	9.77E-01
DNA hypermethylation (GO:0044026)	6	0	.14	-	 < 0.01	8.69E-01
tRNA stabilization (GO:0036416)	2	0	.05	-	 < 0.01	9.54E-01
regulation of tRNA stability (GO:0036415)	2	0	.05	-	 < 0.01	9.54E-01
histone citrullination (GO:0036414)	5	0	.12	-	 < 0.01	8.90E-01
histone H3-R26 citrullination (GO:0036413)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of translational initiation in response to stress (GO:0032058)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of translational initiation in response to stress (GO:0032057)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of translation in response to stress (GO:0032056)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of translation in response to stress (GO:0032055)	6	0	.14	-	 < 0.01	8.69E-01
ciliary basal body organization (GO:0032053)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of monocyte aggregation (GO:1900625)	3	0	.07	-	 < 0.01	9.32E-01
regulation of monocyte aggregation (GO:1900623)	3	0	.07	-	 < 0.01	9.32E-01
acetate ester biosynthetic process (GO:1900620)	3	0	.07	-	 < 0.01	9.32E-01
conversion of ds siRNA to ss siRNA (GO:0036404)	1	0	.02	-	 < 0.01	9.77E-01
cardiolipin biosynthetic process (GO:0032049)	8	0	.19	-	 < 0.01	8.30E-01
cardiolipin metabolic process (GO:0032048)	13	0	.30	-	 < 0.01	7.38E-01
acetate ester metabolic process (GO:1900619)	4	0	.09	-	 < 0.01	9.11E-01
mitochondrial DNA metabolic process (GO:0032042)	10	0	.23	-	 < 0.01	7.92E-01
box H/ACA RNA 3'-end processing (GO:0000495)	2	0	.05	-	 < 0.01	9.54E-01
box C/D RNA 3'-end processing (GO:0000494)	3	0	.07	-	 < 0.01	9.32E-01
box H/ACA snoRNP assembly (GO:0000493)	2	0	.05	-	 < 0.01	9.54E-01
modulation by symbiont of host process (GO:0044003)	23	0	.54	-	 < 0.01	5.85E-01
box C/D snoRNP assembly (GO:0000492)	8	0	.19	-	 < 0.01	8.30E-01
small nucleolar ribonucleoprotein complex assembly (GO:0000491)	10	0	.23	-	 < 0.01	7.92E-01
maturation of 5S rRNA (GO:0000481)	1	0	.02	-	 < 0.01	9.77E-01
endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000480)	5	0	.12	-	 < 0.01	8.90E-01
response to cobalt ion (GO:0032025)	2	0	.05	-	 < 0.01	9.54E-01
trypsinogen activation (GO:0032023)	1	0	.02	-	 < 0.01	9.77E-01
ISG15-protein conjugation (GO:0032020)	5	0	.12	-	 < 0.01	8.90E-01
endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)	14	0	.33	-	 < 0.01	7.21E-01
endonucleolytic cleavage involved in rRNA processing (GO:0000478)	14	0	.33	-	 < 0.01	7.21E-01
endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000472)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of ARF protein signal transduction (GO:0032014)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of ARF protein signal transduction (GO:0032013)	1	0	.02	-	 < 0.01	9.77E-01
ARF protein signal transduction (GO:0032011)	1	0	.02	-	 < 0.01	9.77E-01
cleavage involved in rRNA processing (GO:0000469)	26	0	.61	-	 < 0.01	5.45E-01
exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)	9	0	.21	-	 < 0.01	8.11E-01
endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000461)	1	0	.02	-	 < 0.01	9.77E-01
tetrahydrofolate interconversion (GO:0035999)	11	0	.26	-	 < 0.01	7.74E-01
positive regulation of TOR signaling (GO:0032008)	42	0	.98	-	 < 0.01	3.75E-01
detection of muscle stretch (GO:0035995)	4	0	.09	-	 < 0.01	9.11E-01
response to muscle stretch (GO:0035994)	21	0	.49	-	 < 0.01	6.13E-01
deltoid tuberosity development (GO:0035993)	3	0	.07	-	 < 0.01	9.32E-01
tendon formation (GO:0035992)	3	0	.07	-	 < 0.01	9.32E-01
tendon cell differentiation (GO:0035990)	3	0	.07	-	 < 0.01	9.32E-01
exonucleolytic trimming involved in rRNA processing (GO:0000459)	9	0	.21	-	 < 0.01	8.11E-01
enzyme-directed rRNA pseudouridine synthesis (GO:0000455)	5	0	.12	-	 < 0.01	8.90E-01
snoRNA guided rRNA pseudouridine synthesis (GO:0000454)	4	0	.09	-	 < 0.01	9.11E-01
tendon development (GO:0035989)	6	0	.14	-	 < 0.01	8.69E-01
senescence-associated heterochromatin focus assembly (GO:0035986)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to trichostatin A (GO:0035984)	3	0	.07	-	 < 0.01	9.32E-01
response to trichostatin A (GO:0035983)	3	0	.07	-	 < 0.01	9.32E-01
endocytic hemoglobin import into cell (GO:0020028)	2	0	.05	-	 < 0.01	9.54E-01
response to host (GO:0075136)	1	0	.02	-	 < 0.01	9.77E-01
cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000448)	3	0	.07	-	 < 0.01	9.32E-01
endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of branching morphogenesis of a nerve (GO:1905492)	2	0	.05	-	 < 0.01	9.54E-01
postsynaptic specialization assembly (GO:0098698)	12	0	.28	-	 < 0.01	7.56E-01
skin morphogenesis (GO:0043589)	13	0	.30	-	 < 0.01	7.38E-01
histone H2A-S139 phosphorylation (GO:0035978)	1	0	.02	-	 < 0.01	9.77E-01
tongue morphogenesis (GO:0043587)	12	0	.28	-	 < 0.01	7.56E-01
protein deglycosylation involved in glycoprotein catabolic process (GO:0035977)	5	0	.12	-	 < 0.01	8.90E-01
tongue development (GO:0043586)	24	0	.56	-	 < 0.01	5.71E-01
regulation of synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0098694)	1	0	.02	-	 < 0.01	9.77E-01
nose morphogenesis (GO:0043585)	2	0	.05	-	 < 0.01	9.54E-01
regulation of synaptic vesicle cycle (GO:0098693)	12	0	.28	-	 < 0.01	7.56E-01
nose development (GO:0043584)	15	0	.35	-	 < 0.01	7.05E-01
aggrephagy (GO:0035973)	5	0	.12	-	 < 0.01	8.90E-01
calcium-dependent self proteolysis (GO:1990092)	2	0	.05	-	 < 0.01	9.54E-01
sodium-dependent self proteolysis (GO:1990091)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to nerve growth factor stimulus (GO:1990090)	35	0	.82	-	 < 0.01	4.42E-01
peptidyl-threonine dephosphorylation (GO:0035970)	20	0	.47	-	 < 0.01	6.27E-01
positive regulation of motor neuron migration (GO:1905485)	1	0	.02	-	 < 0.01	9.77E-01
carbon catabolite activation of transcription from RNA polymerase II promoter (GO:0000436)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of transcription from RNA polymerase II promoter by galactose (GO:0000435)	1	0	.02	-	 < 0.01	9.77E-01
regulation of motor neuron migration (GO:1905483)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of transcription from RNA polymerase II promoter by glucose (GO:0000432)	3	0	.07	-	 < 0.01	9.32E-01
prosthetic group metabolic process (GO:0051189)	6	0	.14	-	 < 0.01	8.69E-01
regulation of transcription from RNA polymerase II promoter by galactose (GO:0000431)	1	0	.02	-	 < 0.01	9.77E-01
response to nerve growth factor (GO:1990089)	35	0	.82	-	 < 0.01	4.42E-01
regulation of transcription from RNA polymerase II promoter by glucose (GO:0000430)	3	0	.07	-	 < 0.01	9.32E-01
nuclear matrix organization (GO:0043578)	2	0	.05	-	 < 0.01	9.54E-01
lens fiber cell apoptotic process (GO:1990086)	4	0	.09	-	 < 0.01	9.11E-01
cardiolipin acyl-chain remodeling (GO:0035965)	6	0	.14	-	 < 0.01	8.69E-01
peroxisomal transport (GO:0043574)	22	0	.51	-	 < 0.01	5.99E-01
COPI-coated vesicle budding (GO:0035964)	5	0	.12	-	 < 0.01	8.90E-01
cellular response to interleukin-13 (GO:0035963)	3	0	.07	-	 < 0.01	9.32E-01
response to interleukin-13 (GO:0035962)	3	0	.07	-	 < 0.01	9.32E-01
maintenance of DNA repeat elements (GO:0043570)	6	0	.14	-	 < 0.01	8.69E-01
carbon catabolite regulation of transcription from RNA polymerase II promoter (GO:0000429)	4	0	.09	-	 < 0.01	9.11E-01
canonical Wnt signaling pathway involved in stem cell proliferation (GO:1905474)	1	0	.02	-	 < 0.01	9.77E-01
pexophagy (GO:0000425)	1	0	.02	-	 < 0.01	9.77E-01
mitophagy (GO:0000423)	8	0	.19	-	 < 0.01	8.30E-01
autophagy of mitochondrion (GO:0000422)	36	0	.84	-	 < 0.01	4.32E-01
negative regulation of insulin-like growth factor receptor signaling pathway (GO:0043569)	9	0	.21	-	 < 0.01	8.11E-01
cartilage homeostasis (GO:1990079)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568)	10	0	.23	-	 < 0.01	7.92E-01
meiotic sister chromatid cohesion (GO:0051177)	11	0	.26	-	 < 0.01	7.74E-01
regulation of insulin-like growth factor receptor signaling pathway (GO:0043567)	24	0	.56	-	 < 0.01	5.71E-01
positive regulation of sulfur metabolic process (GO:0051176)	4	0	.09	-	 < 0.01	9.11E-01
polyuridylation-dependent mRNA catabolic process (GO:1990074)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to nitrogen levels (GO:0043562)	9	0	.21	-	 < 0.01	8.11E-01
wybutosine biosynthetic process (GO:0031591)	3	0	.07	-	 < 0.01	9.32E-01
wybutosine metabolic process (GO:0031590)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of clathrin-coated pit assembly (GO:1905469)	1	0	.02	-	 < 0.01	9.77E-01
regulation of clathrin-coated pit assembly (GO:1905468)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of histone H3-K36 methylation (GO:0000416)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of DNA duplex unwinding (GO:1905464)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of histone H3-K36 methylation (GO:0000415)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of DNA duplex unwinding (GO:1905463)	3	0	.07	-	 < 0.01	9.32E-01
regulation of histone H3-K36 methylation (GO:0000414)	6	0	.14	-	 < 0.01	8.69E-01
regulation of DNA duplex unwinding (GO:1905462)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of vascular associated smooth muscle cell apoptotic process (GO:1905460)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of transcription by galactose (GO:0000411)	1	0	.02	-	 < 0.01	9.77E-01
regulation of translational initiation in response to stress (GO:0043558)	6	0	.14	-	 < 0.01	8.69E-01
regulation of translation in response to oxidative stress (GO:0043556)	1	0	.02	-	 < 0.01	9.77E-01
mitochondrial mRNA surveillance (GO:0035946)	1	0	.02	-	 < 0.01	9.77E-01
regulation of translation in response to stress (GO:0043555)	14	0	.33	-	 < 0.01	7.21E-01
L-xylitol metabolic process (GO:0051164)	1	0	.02	-	 < 0.01	9.77E-01
mitochondrial ncRNA surveillance (GO:0035945)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of phosphatidylinositol 3-kinase activity (GO:0043553)	3	0	.07	-	 < 0.01	9.32E-01
L-xylitol catabolic process (GO:0051160)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity (GO:0031587)	4	0	.09	-	 < 0.01	9.11E-01
regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity (GO:0031585)	6	0	.14	-	 < 0.01	8.69E-01
activation of phospholipase D activity (GO:0031584)	6	0	.14	-	 < 0.01	8.69E-01
phospholipase D-activating G protein-coupled receptor signaling pathway (GO:0031583)	2	0	.05	-	 < 0.01	9.54E-01
hemidesmosome assembly (GO:0031581)	5	0	.12	-	 < 0.01	8.90E-01
membrane raft distribution (GO:0031580)	3	0	.07	-	 < 0.01	9.32E-01
regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459)	11	0	.26	-	 < 0.01	7.74E-01
positive regulation of lymphoid progenitor cell differentiation (GO:1905458)	2	0	.05	-	 < 0.01	9.54E-01
regulation of transcription by galactose (GO:0000409)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of lymphoid progenitor cell differentiation (GO:1905457)	3	0	.07	-	 < 0.01	9.32E-01
regulation of lymphoid progenitor cell differentiation (GO:1905456)	10	0	.23	-	 < 0.01	7.92E-01
phenylpropanoid metabolic process (GO:0009698)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905451)	5	0	.12	-	 < 0.01	8.90E-01
inorganic anion import across plasma membrane (GO:0098658)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905450)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of autophagosome maturation (GO:1901098)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of autophagosome maturation (GO:1901097)	4	0	.09	-	 < 0.01	9.11E-01
glucose 6-phosphate metabolic process (GO:0051156)	18	0	.42	-	 < 0.01	6.57E-01
regulation of autophagosome maturation (GO:1901096)	12	0	.28	-	 < 0.01	7.56E-01
molybdopterin cofactor metabolic process (GO:0043545)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of striated muscle cell differentiation (GO:0051154)	38	0	.89	-	 < 0.01	4.12E-01
cytokinin biosynthetic process (GO:0009691)	1	0	.02	-	 < 0.01	9.77E-01
cytokinin metabolic process (GO:0009690)	1	0	.02	-	 < 0.01	9.77E-01
corticosterone secretion (GO:0035934)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of smooth muscle cell differentiation (GO:0051152)	15	0	.35	-	 < 0.01	7.05E-01
glucocorticoid secretion (GO:0035933)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of smooth muscle cell differentiation (GO:0051151)	16	0	.37	-	 < 0.01	6.89E-01
aldosterone secretion (GO:0035932)	1	0	.02	-	 < 0.01	9.77E-01
activation of protein kinase C activity (GO:1990051)	5	0	.12	-	 < 0.01	8.90E-01
mineralocorticoid secretion (GO:0035931)	1	0	.02	-	 < 0.01	9.77E-01
corticosteroid hormone secretion (GO:0035930)	2	0	.05	-	 < 0.01	9.54E-01
spindle checkpoint (GO:0031577)	28	0	.65	-	 < 0.01	5.20E-01
intra-S DNA damage checkpoint (GO:0031573)	15	0	.35	-	 < 0.01	7.05E-01
G2 DNA damage checkpoint (GO:0031572)	32	0	.75	-	 < 0.01	4.74E-01
mitotic G1 DNA damage checkpoint (GO:0031571)	18	0	.42	-	 < 0.01	6.57E-01
DNA integrity checkpoint (GO:0031570)	92	0	2.14	-	 < 0.01	1.16E-01
regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of mitochondrial ATP synthesis coupled electron transport (GO:1905448)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of mitochondrial ATP synthesis coupled electron transport (GO:1905447)	1	0	.02	-	 < 0.01	9.77E-01
regulation of mitochondrial ATP synthesis coupled electron transport (GO:1905446)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of clathrin coat assembly (GO:1905445)	4	0	.09	-	 < 0.01	9.11E-01
regulation of clathrin coat assembly (GO:1905443)	4	0	.09	-	 < 0.01	9.11E-01
regulation of actin phosphorylation (GO:0043538)	1	0	.02	-	 < 0.01	9.77E-01
rRNA import into mitochondrion (GO:0035928)	3	0	.07	-	 < 0.01	9.32E-01
benzylpenicillin metabolic process (GO:1901086)	1	0	.02	-	 < 0.01	9.77E-01
RNA import into mitochondrion (GO:0035927)	5	0	.12	-	 < 0.01	8.90E-01
stress-induced mitochondrial fusion (GO:1990046)	2	0	.05	-	 < 0.01	9.54E-01
induced systemic resistance (GO:0009682)	1	0	.02	-	 < 0.01	9.77E-01
protein localization to lipid droplet (GO:1990044)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to vascular endothelial growth factor stimulus (GO:0035924)	40	0	.93	-	 < 0.01	3.93E-01
positive regulation of NK T cell proliferation (GO:0051142)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of relaxation of smooth muscle (GO:1901082)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of NK T cell proliferation (GO:0051141)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of relaxation of smooth muscle (GO:1901081)	1	0	.02	-	 < 0.01	9.77E-01
foramen ovale closure (GO:0035922)	2	0	.05	-	 < 0.01	9.54E-01
regulation of NK T cell proliferation (GO:0051140)	5	0	.12	-	 < 0.01	8.90E-01
regulation of relaxation of smooth muscle (GO:1901080)	4	0	.09	-	 < 0.01	9.11E-01
desmosome disassembly (GO:0035921)	1	0	.02	-	 < 0.01	9.77E-01
non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1905438)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of histone H3-K4 trimethylation (GO:1905437)	2	0	.05	-	 < 0.01	9.54E-01
regulation of histone H3-K4 trimethylation (GO:1905435)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of retrograde trans-synaptic signaling by neuropeptide (GO:1905433)	1	0	.02	-	 < 0.01	9.77E-01
regulation of retrograde trans-synaptic signaling by neuropeptide (GO:1905432)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of relaxation of muscle (GO:1901079)	4	0	.09	-	 < 0.01	9.11E-01
cellular response to glycine (GO:1905430)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of NK T cell differentiation (GO:0051138)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of relaxation of muscle (GO:1901078)	6	0	.14	-	 < 0.01	8.69E-01
regulation of relaxation of muscle (GO:1901077)	17	0	.40	-	 < 0.01	6.73E-01
regulation of NK T cell differentiation (GO:0051136)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of engulfment of apoptotic cell (GO:1901076)	2	0	.05	-	 < 0.01	9.54E-01
calcium ion import into sarcoplasmic reticulum (GO:1990036)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of NK T cell activation (GO:0051134)	2	0	.05	-	 < 0.01	9.54E-01
regulation of engulfment of apoptotic cell (GO:1901074)	3	0	.07	-	 < 0.01	9.32E-01
glucosamine-containing compound biosynthetic process (GO:1901073)	1	0	.02	-	 < 0.01	9.77E-01
calcium ion export across plasma membrane (GO:1990034)	5	0	.12	-	 < 0.01	8.90E-01
NK T cell activation (GO:0051132)	3	0	.07	-	 < 0.01	9.32E-01
glucosamine-containing compound catabolic process (GO:1901072)	10	0	.23	-	 < 0.01	7.92E-01
glucosamine-containing compound metabolic process (GO:1901071)	25	0	.58	-	 < 0.01	5.58E-01
dorsal aorta morphogenesis (GO:0035912)	8	0	.19	-	 < 0.01	8.30E-01
guanosine-containing compound biosynthetic process (GO:1901070)	13	0	.30	-	 < 0.01	7.38E-01
ascending aorta morphogenesis (GO:0035910)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of brain-derived neurotrophic factor-activated receptor activity (GO:0031552)	1	0	.02	-	 < 0.01	9.77E-01
regulation of brain-derived neurotrophic factor-activated receptor activity (GO:0031551)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of brain-derived neurotrophic factor receptor signaling pathway (GO:0031550)	1	0	.02	-	 < 0.01	9.77E-01
response to glycine (GO:1905429)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation (GO:1905426)	2	0	.05	-	 < 0.01	9.54E-01
regulation of Wnt-mediated midbrain dopaminergic neuron differentiation (GO:1905424)	2	0	.05	-	 < 0.01	9.54E-01
trans-Golgi network membrane organization (GO:0098629)	1	0	.02	-	 < 0.01	9.77E-01
guanosine-containing compound catabolic process (GO:1901069)	9	0	.21	-	 < 0.01	8.11E-01
guanosine-containing compound metabolic process (GO:1901068)	36	0	.84	-	 < 0.01	4.32E-01
vasomotion (GO:1990029)	1	0	.02	-	 < 0.01	9.77E-01
aorta morphogenesis (GO:0035909)	31	0	.72	-	 < 0.01	4.85E-01
negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)	15	0	.35	-	 < 0.01	7.05E-01
positive regulation of actin nucleation (GO:0051127)	17	0	.40	-	 < 0.01	6.73E-01
negative regulation of actin nucleation (GO:0051126)	8	0	.19	-	 < 0.01	8.30E-01
dorsal aorta development (GO:0035907)	10	0	.23	-	 < 0.01	7.92E-01
regulation of actin nucleation (GO:0051125)	30	0	.70	-	 < 0.01	4.97E-01
descending aorta development (GO:0035906)	1	0	.02	-	 < 0.01	9.77E-01
ascending aorta development (GO:0035905)	5	0	.12	-	 < 0.01	8.90E-01
RNA polymerase II preinitiation complex assembly (GO:0051123)	10	0	.23	-	 < 0.01	7.92E-01
hepoxilin biosynthetic process (GO:0051122)	9	0	.21	-	 < 0.01	8.11E-01
cellular response to immobilization stress (GO:0035903)	1	0	.02	-	 < 0.01	9.77E-01
hepoxilin metabolic process (GO:0051121)	9	0	.21	-	 < 0.01	8.11E-01
response to immobilization stress (GO:0035902)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of brain-derived neurotrophic factor receptor signaling pathway (GO:0031549)	2	0	.05	-	 < 0.01	9.54E-01
regulation of brain-derived neurotrophic factor receptor signaling pathway (GO:0031548)	3	0	.07	-	 < 0.01	9.32E-01
brain-derived neurotrophic factor receptor signaling pathway (GO:0031547)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of dense core granule exocytosis (GO:1905415)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of dense core granule exocytosis (GO:1905414)	1	0	.02	-	 < 0.01	9.77E-01
regulation of dense core granule exocytosis (GO:1905413)	1	0	.02	-	 < 0.01	9.77E-01
response to salt stress (GO:0009651)	20	0	.47	-	 < 0.01	6.27E-01
mitochondrial DNA repair (GO:0043504)	5	0	.12	-	 < 0.01	8.90E-01
sarcosine catabolic process (GO:1901053)	1	0	.02	-	 < 0.01	9.77E-01
UV protection (GO:0009650)	10	0	.23	-	 < 0.01	7.92E-01
skeletal muscle fiber adaptation (GO:0043503)	3	0	.07	-	 < 0.01	9.32E-01
sarcosine metabolic process (GO:1901052)	2	0	.05	-	 < 0.01	9.54E-01
skeletal muscle adaptation (GO:0043501)	8	0	.19	-	 < 0.01	8.30E-01
muscle adaptation (GO:0043500)	32	0	.75	-	 < 0.01	4.74E-01
positive regulation of exit from mitosis (GO:0031536)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of creatine transmembrane transporter activity (GO:1905408)	2	0	.05	-	 < 0.01	9.54E-01
regulation of creatine transmembrane transporter activity (GO:1905407)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of mitotic cohesin loading (GO:1905406)	1	0	.02	-	 < 0.01	9.77E-01
regulation of mitotic cohesin loading (GO:1905405)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process (GO:1905404)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process (GO:1905403)	2	0	.05	-	 < 0.01	9.54E-01
regulation of activated CD8-positive, alpha-beta T cell apoptotic process (GO:1905402)	3	0	.07	-	 < 0.01	9.32E-01
retinal cell apoptotic process (GO:1990009)	4	0	.09	-	 < 0.01	9.11E-01
response to high light intensity (GO:0009644)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of DNA ligation (GO:0051106)	4	0	.09	-	 < 0.01	9.11E-01
regulation of DNA ligation (GO:0051105)	4	0	.09	-	 < 0.01	9.11E-01
response to light intensity (GO:0009642)	7	0	.16	-	 < 0.01	8.49E-01
DNA ligation involved in DNA repair (GO:0051103)	5	0	.12	-	 < 0.01	8.90E-01
DNA ligation involved in DNA recombination (GO:0051102)	1	0	.02	-	 < 0.01	9.77E-01
inhibition of cysteine-type endopeptidase activity involved in apoptotic process (GO:1990001)	4	0	.09	-	 < 0.01	9.11E-01
amyloid fibril formation (GO:1990000)	11	0	.26	-	 < 0.01	7.74E-01
response to red or far red light (GO:0009639)	1	0	.02	-	 < 0.01	9.77E-01
response to blue light (GO:0009637)	4	0	.09	-	 < 0.01	9.11E-01
response to herbicide (GO:0009635)	1	0	.02	-	 < 0.01	9.77E-01
cold acclimation (GO:0009631)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of response to reactive oxygen species (GO:1901033)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030)	11	0	.26	-	 < 0.01	7.74E-01
response to gravity (GO:0009629)	3	0	.07	-	 < 0.01	9.32E-01
sarcoplasmic reticulum calcium ion transport (GO:0070296)	11	0	.26	-	 < 0.01	7.74E-01
negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901029)	7	0	.16	-	 < 0.01	8.49E-01
renal water absorption (GO:0070295)	5	0	.12	-	 < 0.01	8.90E-01
regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028)	19	0	.44	-	 < 0.01	6.42E-01
renal sodium ion absorption (GO:0070294)	5	0	.12	-	 < 0.01	8.90E-01
response to nematode (GO:0009624)	3	0	.07	-	 < 0.01	9.32E-01
renal absorption (GO:0070293)	16	0	.37	-	 < 0.01	6.89E-01
ripoptosome assembly involved in necroptotic process (GO:1901026)	2	0	.05	-	 < 0.01	9.54E-01
N-acylphosphatidylethanolamine metabolic process (GO:0070292)	4	0	.09	-	 < 0.01	9.11E-01
N-acylethanolamine metabolic process (GO:0070291)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of calcium ion transmembrane transporter activity (GO:1901020)	27	0	.63	-	 < 0.01	5.33E-01
pericentric heterochromatin assembly (GO:0031508)	3	0	.07	-	 < 0.01	9.32E-01
cell wall glycoprotein biosynthetic process (GO:0031506)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of potassium ion transmembrane transporter activity (GO:1901017)	21	0	.49	-	 < 0.01	6.13E-01
intermediate mesodermal cell differentiation (GO:0048392)	1	0	.02	-	 < 0.01	9.77E-01
intermediate mesoderm formation (GO:0048391)	1	0	.02	-	 < 0.01	9.77E-01
intermediate mesoderm morphogenesis (GO:0048390)	1	0	.02	-	 < 0.01	9.77E-01
response to symbiotic bacterium (GO:0009609)	3	0	.07	-	 < 0.01	9.32E-01
extracellular matrix constituent secretion (GO:0070278)	4	0	.09	-	 < 0.01	9.11E-01
response to symbiont (GO:0009608)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of leukocyte adhesion to arterial endothelial cell (GO:1904999)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of leukocyte adhesion to arterial endothelial cell (GO:1904998)	1	0	.02	-	 < 0.01	9.77E-01
regulation of leukocyte adhesion to arterial endothelial cell (GO:1904997)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996)	22	0	.51	-	 < 0.01	5.99E-01
ubiquinone-6 biosynthetic process (GO:1901006)	1	0	.02	-	 < 0.01	9.77E-01
ubiquinone-6 metabolic process (GO:1901004)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of fermentation (GO:1901003)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway (GO:1904992)	1	0	.02	-	 < 0.01	9.77E-01
regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway (GO:1904990)	1	0	.02	-	 < 0.01	9.77E-01
regulation of response to salt stress (GO:1901000)	4	0	.09	-	 < 0.01	9.11E-01
intermediate mesoderm development (GO:0048389)	2	0	.05	-	 < 0.01	9.54E-01
endosomal lumen acidification (GO:0048388)	3	0	.07	-	 < 0.01	9.32E-01
regulation of defense response to virus by host (GO:0050691)	44	0	1.03	-	 < 0.01	3.58E-01
positive regulation of retinoic acid receptor signaling pathway (GO:0048386)	6	0	.14	-	 < 0.01	8.69E-01
retinoic acid receptor signaling pathway (GO:0048384)	18	0	.42	-	 < 0.01	6.57E-01
mesendoderm development (GO:0048382)	11	0	.26	-	 < 0.01	7.74E-01
pyroptosis (GO:0070269)	24	0	.56	-	 < 0.01	5.71E-01
cornification (GO:0070268)	3	0	.07	-	 < 0.01	9.32E-01
oncosis (GO:0070267)	1	0	.02	-	 < 0.01	9.77E-01
necroptotic process (GO:0070266)	21	0	.49	-	 < 0.01	6.13E-01
negative regulation of endothelial cell activation (GO:1904988)	1	0	.02	-	 < 0.01	9.77E-01
necrotic cell death (GO:0070265)	32	0	.75	-	 < 0.01	4.74E-01
regulation of endothelial cell activation (GO:1904987)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of quinolinate biosynthetic process (GO:1904985)	1	0	.02	-	 < 0.01	9.77E-01
peptidyl-serine dephosphorylation (GO:0070262)	13	0	.30	-	 < 0.01	7.38E-01
regulation of quinolinate biosynthetic process (GO:1904984)	1	0	.02	-	 < 0.01	9.77E-01
glycine import into mitochondrion (GO:1904983)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of defense response to virus by host (GO:0050689)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of endosome organization (GO:1904980)	1	0	.02	-	 < 0.01	9.77E-01
regulation of defense response to virus (GO:0050688)	71	0	1.66	-	 < 0.01	1.90E-01
negative regulation of defense response to virus (GO:0050687)	23	0	.54	-	 < 0.01	5.85E-01
regulation of lateral mesodermal cell fate specification (GO:0048378)	2	0	.05	-	 < 0.01	9.54E-01
lateral mesodermal cell differentiation (GO:0048371)	1	0	.02	-	 < 0.01	9.77E-01
lateral mesoderm formation (GO:0048370)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of mucus secretion (GO:0070257)	11	0	.26	-	 < 0.01	7.74E-01
negative regulation of mucus secretion (GO:0070256)	2	0	.05	-	 < 0.01	9.54E-01
regulation of endosome organization (GO:1904978)	1	0	.02	-	 < 0.01	9.77E-01
regulation of mucus secretion (GO:0070255)	14	0	.33	-	 < 0.01	7.21E-01
lymphatic endothelial cell migration (GO:1904977)	2	0	.05	-	 < 0.01	9.54E-01
mucus secretion (GO:0070254)	3	0	.07	-	 < 0.01	9.32E-01
cellular response to bleomycin (GO:1904976)	2	0	.05	-	 < 0.01	9.54E-01
somatostatin secretion (GO:0070253)	2	0	.05	-	 < 0.01	9.54E-01
response to bleomycin (GO:1904975)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of viral translation (GO:1904973)	1	0	.02	-	 < 0.01	9.77E-01
regulation of viral translation (GO:1904971)	1	0	.02	-	 < 0.01	9.77E-01
brush border assembly (GO:1904970)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of urothelial cell proliferation (GO:0050677)	1	0	.02	-	 < 0.01	9.77E-01
regulation of urothelial cell proliferation (GO:0050675)	1	0	.02	-	 < 0.01	9.77E-01
urothelial cell proliferation (GO:0050674)	1	0	.02	-	 < 0.01	9.77E-01
lateral mesoderm morphogenesis (GO:0048369)	1	0	.02	-	 < 0.01	9.77E-01
lateral mesoderm development (GO:0048368)	12	0	.28	-	 < 0.01	7.56E-01
positive regulation of lymphocyte proliferation (GO:0050671)	135	0	3.15	-	 < 0.01	4.25E-02
TCR signalosome assembly (GO:0036399)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of peptidyl-lysine crotonylation (GO:0120094)	1	0	.02	-	 < 0.01	9.77E-01
amylase secretion (GO:0036394)	1	0	.02	-	 < 0.01	9.77E-01
regulation of natural killer cell apoptotic process (GO:0070247)	1	0	.02	-	 < 0.01	9.77E-01
regulation of peptidyl-lysine crotonylation (GO:0120093)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of thymocyte apoptotic process (GO:0070245)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of thymocyte apoptotic process (GO:0070244)	9	0	.21	-	 < 0.01	8.11E-01
regulation of thymocyte apoptotic process (GO:0070243)	16	0	.37	-	 < 0.01	6.89E-01
thymocyte apoptotic process (GO:0070242)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of cytochrome-c oxidase activity (GO:1904960)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of homocysteine metabolic process (GO:0050668)	1	0	.02	-	 < 0.01	9.77E-01
homocysteine metabolic process (GO:0050667)	12	0	.28	-	 < 0.01	7.56E-01
regulation of homocysteine metabolic process (GO:0050666)	1	0	.02	-	 < 0.01	9.77E-01
hydrogen peroxide biosynthetic process (GO:0050665)	10	0	.23	-	 < 0.01	7.92E-01
paraxial mesoderm structural organization (GO:0048352)	1	0	.02	-	 < 0.01	9.77E-01
pre-replicative complex assembly (GO:0036388)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of activation-induced cell death of T cells (GO:0070237)	2	0	.05	-	 < 0.01	9.54E-01
regulation of cytochrome-c oxidase activity (GO:1904959)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of midbrain dopaminergic neuron differentiation (GO:1904958)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of T cell apoptotic process (GO:0070234)	15	0	.35	-	 < 0.01	7.05E-01
regulation of midbrain dopaminergic neuron differentiation (GO:1904956)	5	0	.12	-	 < 0.01	8.90E-01
canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904954)	3	0	.07	-	 < 0.01	9.32E-01
T cell apoptotic process (GO:0070231)	17	0	.40	-	 < 0.01	6.73E-01
Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of lymphocyte apoptotic process (GO:0070230)	21	0	.49	-	 < 0.01	6.13E-01
dermatan sulfate proteoglycan metabolic process (GO:0050655)	7	0	.16	-	 < 0.01	8.49E-01
chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0050653)	1	0	.02	-	 < 0.01	9.77E-01
dermatan sulfate proteoglycan biosynthetic process (GO:0050651)	5	0	.12	-	 < 0.01	8.90E-01
chondroitin sulfate proteoglycan biosynthetic process (GO:0050650)	21	0	.49	-	 < 0.01	6.13E-01
paraxial mesodermal cell fate commitment (GO:0048343)	2	0	.05	-	 < 0.01	9.54E-01
paraxial mesodermal cell differentiation (GO:0048342)	2	0	.05	-	 < 0.01	9.54E-01
paraxial mesoderm formation (GO:0048341)	9	0	.21	-	 < 0.01	8.11E-01
microtubule polymerization based movement (GO:0099098)	1	0	.02	-	 < 0.01	9.77E-01
cell adhesion involved in sprouting angiogenesis (GO:0120078)	1	0	.02	-	 < 0.01	9.77E-01
calcitriol biosynthetic process from calciol (GO:0036378)	3	0	.07	-	 < 0.01	9.32E-01
angiogenic sprout fusion (GO:0120077)	1	0	.02	-	 < 0.01	9.77E-01
sodium ion export across plasma membrane (GO:0036376)	12	0	.28	-	 < 0.01	7.56E-01
calcium export from the mitochondrion (GO:0099093)	1	0	.02	-	 < 0.01	9.77E-01
lymphocyte apoptotic process (GO:0070227)	23	0	.54	-	 < 0.01	5.85E-01
positive regulation of pyloric antrum smooth muscle contraction (GO:0120072)	1	0	.02	-	 < 0.01	9.77E-01
opsin transport (GO:0036372)	1	0	.02	-	 < 0.01	9.77E-01
regulation of pyloric antrum smooth muscle contraction (GO:0120071)	1	0	.02	-	 < 0.01	9.77E-01
folate import into mitochondrion (GO:1904947)	1	0	.02	-	 < 0.01	9.77E-01
mesoderm structural organization (GO:0048338)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of mesodermal cell fate specification (GO:0048337)	1	0	.02	-	 < 0.01	9.77E-01
establishment of endoplasmic reticulum localization to postsynapse (GO:0099089)	1	0	.02	-	 < 0.01	9.77E-01
axonal transport of messenger ribonucleoprotein complex (GO:0099088)	1	0	.02	-	 < 0.01	9.77E-01
anterograde axonal transport of messenger ribonucleoprotein complex (GO:0099087)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of stomach fundus smooth muscle contraction (GO:0120069)	1	0	.02	-	 < 0.01	9.77E-01
transcription factor catabolic process (GO:0036369)	1	0	.02	-	 < 0.01	9.77E-01
regulation of stomach fundus smooth muscle contraction (GO:0120068)	1	0	.02	-	 < 0.01	9.77E-01
light adaption (GO:0036367)	2	0	.05	-	 < 0.01	9.54E-01
postsynaptic specialization organization (GO:0099084)	20	0	.47	-	 < 0.01	6.27E-01
retrograde trans-synaptic signaling by neuropeptide, modulating synaptic transmission (GO:0099083)	1	0	.02	-	 < 0.01	9.77E-01
retrograde trans-synaptic signaling by neuropeptide (GO:0099082)	1	0	.02	-	 < 0.01	9.77E-01
transforming growth factor beta activation (GO:0036363)	1	0	.02	-	 < 0.01	9.77E-01
planar cell polarity pathway involved in axon guidance (GO:1904938)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of gastric emptying (GO:0120061)	2	0	.05	-	 < 0.01	9.54E-01
sensory neuron migration (GO:1904937)	1	0	.02	-	 < 0.01	9.77E-01
regulation of gastric emptying (GO:0120060)	2	0	.05	-	 < 0.01	9.54E-01
interneuron migration (GO:1904936)	8	0	.19	-	 < 0.01	8.30E-01
protein auto-ADP-ribosylation (GO:0070213)	11	0	.26	-	 < 0.01	7.74E-01
positive regulation of cell proliferation in midbrain (GO:1904935)	1	0	.02	-	 < 0.01	9.77E-01
protein poly-ADP-ribosylation (GO:0070212)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of cell proliferation in midbrain (GO:1904934)	1	0	.02	-	 < 0.01	9.77E-01
regulation of cell proliferation in midbrain (GO:1904933)	2	0	.05	-	 < 0.01	9.54E-01
axial mesodermal cell fate specification (GO:0048327)	1	0	.02	-	 < 0.01	9.77E-01
axial mesodermal cell fate commitment (GO:0048322)	1	0	.02	-	 < 0.01	9.77E-01
axial mesodermal cell differentiation (GO:0048321)	1	0	.02	-	 < 0.01	9.77E-01
axial mesoderm formation (GO:0048320)	3	0	.07	-	 < 0.01	9.32E-01
renal potassium excretion (GO:0036359)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of small intestinal transit (GO:0120058)	2	0	.05	-	 < 0.01	9.54E-01
mitochondrion-derived vesicle mediated transport (GO:0099075)	2	0	.05	-	 < 0.01	9.54E-01
regulation of small intestinal transit (GO:0120057)	2	0	.05	-	 < 0.01	9.54E-01
mitochondrion to lysosome transport (GO:0099074)	2	0	.05	-	 < 0.01	9.54E-01
protein heterotrimerization (GO:0070208)	1	0	.02	-	 < 0.01	9.77E-01
histone H2A-K119 monoubiquitination (GO:0036353)	9	0	.21	-	 < 0.01	8.11E-01
histone H2A-K15 ubiquitination (GO:0036352)	1	0	.02	-	 < 0.01	9.77E-01
histone H2A-K13 ubiquitination (GO:0036351)	1	0	.02	-	 < 0.01	9.77E-01
regulation of establishment of protein localization to telomere (GO:0070203)	11	0	.26	-	 < 0.01	7.74E-01
positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925)	12	0	.28	-	 < 0.01	7.56E-01
regulation of establishment of protein localization to chromosome (GO:0070202)	11	0	.26	-	 < 0.01	7.74E-01
negative regulation of mitophagy in response to mitochondrial depolarization (GO:1904924)	1	0	.02	-	 < 0.01	9.77E-01
regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904923)	13	0	.30	-	 < 0.01	7.38E-01
establishment of protein localization to telomere (GO:0070200)	5	0	.12	-	 < 0.01	8.90E-01
axial mesoderm morphogenesis (GO:0048319)	5	0	.12	-	 < 0.01	8.90E-01
axial mesoderm development (GO:0048318)	9	0	.21	-	 < 0.01	8.11E-01
intracellular distribution of mitochondria (GO:0048312)	12	0	.28	-	 < 0.01	7.56E-01
mitochondrion distribution (GO:0048311)	20	0	.47	-	 < 0.01	6.27E-01
snRNA (adenine-N6)-methylation (GO:0120049)	2	0	.05	-	 < 0.01	9.54E-01
stereocilium maintenance (GO:0120045)	2	0	.05	-	 < 0.01	9.54E-01
platelet morphogenesis (GO:0036344)	19	0	.44	-	 < 0.01	6.42E-01
psychomotor behavior (GO:0036343)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of macrophage proliferation (GO:0120041)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of establishment of RNA localization to telomere (GO:1904911)	1	0	.02	-	 < 0.01	9.77E-01
regulation of establishment of RNA localization to telomere (GO:1904910)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of isotype switching to IgG isotypes (GO:0048304)	12	0	.28	-	 < 0.01	7.56E-01
regulation of isotype switching to IgG isotypes (GO:0048302)	16	0	.37	-	 < 0.01	6.89E-01
lymphocyte adhesion to endothelial cell of high endothelial venule (GO:0036339)	1	0	.02	-	 < 0.01	9.77E-01
Fas signaling pathway (GO:0036337)	2	0	.05	-	 < 0.01	9.54E-01
dendritic cell migration (GO:0036336)	14	0	.33	-	 < 0.01	7.21E-01
intestinal stem cell homeostasis (GO:0036335)	3	0	.07	-	 < 0.01	9.32E-01
epidermal stem cell homeostasis (GO:0036334)	2	0	.05	-	 < 0.01	9.54E-01
hepatocyte homeostasis (GO:0036333)	2	0	.05	-	 < 0.01	9.54E-01
vesicle scission (GO:0099050)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric (GO:1904908)	2	0	.05	-	 < 0.01	9.54E-01
regulation of maintenance of mitotic sister chromatid cohesion, telomeric (GO:1904907)	2	0	.05	-	 < 0.01	9.54E-01
avascular cornea development in camera-type eye (GO:0036331)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of endothelial cell-matrix adhesion via fibronectin (GO:1904906)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of endothelial cell-matrix adhesion via fibronectin (GO:1904905)	1	0	.02	-	 < 0.01	9.77E-01
regulation of endothelial cell-matrix adhesion via fibronectin (GO:1904904)	5	0	.12	-	 < 0.01	8.90E-01
ESCRT III complex disassembly (GO:1904903)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of purine nucleotide metabolic process (GO:1900543)	22	0	.51	-	 < 0.01	5.99E-01
vascular endothelial growth factor receptor-3 signaling pathway (GO:0036325)	1	0	.02	-	 < 0.01	9.77E-01
vascular endothelial growth factor receptor-2 signaling pathway (GO:0036324)	5	0	.12	-	 < 0.01	8.90E-01
vesicle tethering to Golgi (GO:0099041)	4	0	.09	-	 < 0.01	9.11E-01
vascular endothelial growth factor receptor-1 signaling pathway (GO:0036323)	1	0	.02	-	 < 0.01	9.77E-01
ceramide translocation (GO:0099040)	3	0	.07	-	 < 0.01	9.32E-01
ghrelin secretion (GO:0036321)	2	0	.05	-	 < 0.01	9.54E-01
palmitic acid biosynthetic process (GO:1900535)	1	0	.02	-	 < 0.01	9.77E-01
palmitic acid metabolic process (GO:1900533)	1	0	.02	-	 < 0.01	9.77E-01
sphingolipid translocation (GO:0099039)	4	0	.09	-	 < 0.01	9.11E-01
SREBP-SCAP complex retention in endoplasmic reticulum (GO:0036316)	2	0	.05	-	 < 0.01	9.54E-01
intermembrane lipid transfer (GO:0120009)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of glutamatergic neuron differentiation (GO:0120008)	1	0	.02	-	 < 0.01	9.77E-01
regulation of glutamatergic neuron differentiation (GO:0120006)	1	0	.02	-	 < 0.01	9.77E-01
embryonic heart tube elongation (GO:0036306)	1	0	.02	-	 < 0.01	9.77E-01
ameloblast differentiation (GO:0036305)	2	0	.05	-	 < 0.01	9.54E-01
umbilical cord morphogenesis (GO:0036304)	2	0	.05	-	 < 0.01	9.54E-01
atrioventricular canal development (GO:0036302)	9	0	.21	-	 < 0.01	8.11E-01
mRNA 5'-splice site recognition (GO:0000395)	5	0	.12	-	 < 0.01	8.90E-01
RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)	10	0	.23	-	 < 0.01	7.92E-01
spliceosomal conformational changes to generate catalytic conformation (GO:0000393)	5	0	.12	-	 < 0.01	8.90E-01
neuronal dense core vesicle exocytosis (GO:0099011)	6	0	.14	-	 < 0.01	8.69E-01
spliceosomal complex disassembly (GO:0000390)	2	0	.05	-	 < 0.01	9.54E-01
modulation by symbiont of host autophagy (GO:0075071)	8	0	.19	-	 < 0.01	8.30E-01
mRNA 3'-splice site recognition (GO:0000389)	2	0	.05	-	 < 0.01	9.54E-01
spliceosome conformational change to release U4 (or U4atac) and U1 (or U11) (GO:0000388)	1	0	.02	-	 < 0.01	9.77E-01
calmodulin dependent kinase signaling pathway (GO:0099004)	5	0	.12	-	 < 0.01	8.90E-01
tRNA-type intron splice site recognition and cleavage (GO:0000379)	3	0	.07	-	 < 0.01	9.32E-01
RNA exon ligation (GO:0000378)	1	0	.02	-	 < 0.01	9.77E-01
parathyroid hormone secretion (GO:0035898)	2	0	.05	-	 < 0.01	9.54E-01
proteolysis in other organism (GO:0035897)	3	0	.07	-	 < 0.01	9.32E-01
exit from host cell (GO:0035891)	4	0	.09	-	 < 0.01	9.11E-01
exit from host (GO:0035890)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation by symbiont of host autophagy (GO:0075044)	8	0	.19	-	 < 0.01	8.30E-01
generation of catalytic spliceosome for second transesterification step (GO:0000350)	2	0	.05	-	 < 0.01	9.54E-01
regulation of protein homodimerization activity (GO:0043496)	1	0	.02	-	 < 0.01	9.77E-01
enteroendocrine cell differentiation (GO:0035883)	23	0	.54	-	 < 0.01	5.85E-01
amacrine cell differentiation (GO:0035881)	6	0	.14	-	 < 0.01	8.69E-01
embryonic nail plate morphogenesis (GO:0035880)	3	0	.07	-	 < 0.01	9.32E-01
generation of catalytic spliceosome for first transesterification step (GO:0000349)	2	0	.05	-	 < 0.01	9.54E-01
cellular response to flavonoid (GO:1905396)	1	0	.02	-	 < 0.01	9.77E-01
response to flavonoid (GO:1905395)	1	0	.02	-	 < 0.01	9.77E-01
learned vocalization behavior or vocal learning (GO:0098598)	10	0	.23	-	 < 0.01	7.92E-01
observational learning (GO:0098597)	9	0	.21	-	 < 0.01	8.11E-01
negative regulation of helicase activity (GO:0051097)	3	0	.07	-	 < 0.01	9.32E-01
imitative learning (GO:0098596)	7	0	.16	-	 < 0.01	8.49E-01
nail development (GO:0035878)	9	0	.21	-	 < 0.01	8.11E-01
positive regulation of helicase activity (GO:0051096)	6	0	.14	-	 < 0.01	8.69E-01
histone exchange (GO:0043486)	20	0	.47	-	 < 0.01	6.27E-01
regulation of helicase activity (GO:0051095)	9	0	.21	-	 < 0.01	8.11E-01
endosome to pigment granule transport (GO:0043485)	10	0	.23	-	 < 0.01	7.92E-01
cellular response to copper ion starvation (GO:0035874)	1	0	.02	-	 < 0.01	9.77E-01
cellular pigment accumulation (GO:0043482)	11	0	.26	-	 < 0.01	7.74E-01
nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)	7	0	.16	-	 < 0.01	8.49E-01
protein K11-linked deubiquitination (GO:0035871)	10	0	.23	-	 < 0.01	7.92E-01
pigment accumulation in tissues (GO:0043480)	1	0	.02	-	 < 0.01	9.77E-01
protein deneddylation (GO:0000338)	9	0	.21	-	 < 0.01	8.11E-01
positive regulation of snRNA transcription by RNA polymerase II (GO:1905382)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of snRNA transcription by RNA polymerase II (GO:1905381)	1	0	.02	-	 < 0.01	9.77E-01
constitutive protein ectodomain proteolysis (GO:0051089)	1	0	.02	-	 < 0.01	9.77E-01
regulation of snRNA transcription by RNA polymerase II (GO:1905380)	5	0	.12	-	 < 0.01	8.90E-01
chaperone mediated protein folding independent of cofactor (GO:0051086)	1	0	.02	-	 < 0.01	9.77E-01
pigment accumulation (GO:0043476)	12	0	.28	-	 < 0.01	7.56E-01
learned vocalization behavior (GO:0098583)	2	0	.05	-	 < 0.01	9.54E-01
cellular response to potassium ion (GO:0035865)	8	0	.19	-	 < 0.01	8.30E-01
pigment metabolic process involved in pigmentation (GO:0043474)	1	0	.02	-	 < 0.01	9.77E-01
innate vocalization behavior (GO:0098582)	2	0	.05	-	 < 0.01	9.54E-01
response to potassium ion (GO:0035864)	8	0	.19	-	 < 0.01	8.30E-01
dITP catabolic process (GO:0035863)	1	0	.02	-	 < 0.01	9.77E-01
dITP metabolic process (GO:0035862)	1	0	.02	-	 < 0.01	9.77E-01
regulation of cellular carbohydrate catabolic process (GO:0043471)	12	0	.28	-	 < 0.01	7.56E-01
glial cell-derived neurotrophic factor receptor signaling pathway (GO:0035860)	5	0	.12	-	 < 0.01	8.90E-01
ceramide phosphoethanolamine biosynthetic process (GO:1905373)	2	0	.05	-	 < 0.01	9.54E-01
ceramide phosphoethanolamine metabolic process (GO:1905371)	2	0	.05	-	 < 0.01	9.54E-01
re-entry into mitotic cell cycle (GO:0000320)	4	0	.09	-	 < 0.01	9.11E-01
regulation of fermentation (GO:0043465)	3	0	.07	-	 < 0.01	9.32E-01
megakaryocyte development (GO:0035855)	19	0	.44	-	 < 0.01	6.42E-01
eosinophil fate commitment (GO:0035854)	2	0	.05	-	 < 0.01	9.54E-01
chromosome passenger complex localization to spindle midzone (GO:0035853)	1	0	.02	-	 < 0.01	9.77E-01
horizontal cell localization (GO:0035852)	1	0	.02	-	 < 0.01	9.77E-01
proton-transporting ATP synthase complex assembly (GO:0043461)	6	0	.14	-	 < 0.01	8.69E-01
epithelial cell differentiation involved in kidney development (GO:0035850)	25	0	.58	-	 < 0.01	5.58E-01
regulation of mating type switching (GO:0031494)	2	0	.05	-	 < 0.01	9.54E-01
regulation of endosomal vesicle fusion (GO:1905364)	1	0	.02	-	 < 0.01	9.77E-01
dihydrolipoamide metabolic process (GO:0051068)	1	0	.02	-	 < 0.01	9.77E-01
nephric duct elongation (GO:0035849)	1	0	.02	-	 < 0.01	9.77E-01
regulation of cellular respiration (GO:0043457)	26	0	.61	-	 < 0.01	5.45E-01
dihydrobiopterin metabolic process (GO:0051066)	1	0	.02	-	 < 0.01	9.77E-01
regulation of pentose-phosphate shunt (GO:0043456)	3	0	.07	-	 < 0.01	9.32E-01
uterine epithelium development (GO:0035847)	2	0	.05	-	 < 0.01	9.54E-01
cloaca development (GO:0035844)	3	0	.07	-	 < 0.01	9.32E-01
protein localization to meiotic spindle (GO:1905359)	1	0	.02	-	 < 0.01	9.77E-01
spine apparatus assembly (GO:1905355)	1	0	.02	-	 < 0.01	9.77E-01
response to oxygen radical (GO:0000305)	16	0	.37	-	 < 0.01	6.89E-01
response to singlet oxygen (GO:0000304)	1	0	.02	-	 < 0.01	9.77E-01
response to superoxide (GO:0000303)	15	0	.35	-	 < 0.01	7.05E-01
cellular alkene metabolic process (GO:0043449)	1	0	.02	-	 < 0.01	9.77E-01
retrograde transport, vesicle recycling within Golgi (GO:0000301)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of lipid biosynthetic process (GO:0051055)	53	0	1.24	-	 < 0.01	2.90E-01
detection of chemical stimulus (GO:0009593)	110	0	2.56	-	 < 0.01	7.64E-02
detection of gravity (GO:0009590)	2	0	.05	-	 < 0.01	9.54E-01
ciliary transition zone assembly (GO:1905349)	2	0	.05	-	 < 0.01	9.54E-01
prostaglandin catabolic process (GO:1905344)	3	0	.07	-	 < 0.01	9.32E-01
detection of UV (GO:0009589)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of protein localization to kinetochore (GO:1905342)	4	0	.09	-	 < 0.01	9.11E-01
N-terminal peptidyl-serine acetylation (GO:0017198)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of protein localization to kinetochore (GO:1905341)	1	0	.02	-	 < 0.01	9.77E-01
N-terminal peptidyl-methionine acetylation (GO:0017196)	7	0	.16	-	 < 0.01	8.49E-01
regulation of protein localization to kinetochore (GO:1905340)	4	0	.09	-	 < 0.01	9.11E-01
red, far-red light phototransduction (GO:0009585)	1	0	.02	-	 < 0.01	9.77E-01
acetoacetic acid metabolic process (GO:0043438)	1	0	.02	-	 < 0.01	9.77E-01
detection of visible light (GO:0009584)	32	0	.75	-	 < 0.01	4.74E-01
detection of light stimulus (GO:0009583)	51	0	1.19	-	 < 0.01	3.04E-01
positive regulation of membrane protein ectodomain proteolysis (GO:0051044)	16	0	.37	-	 < 0.01	6.89E-01
response to corticotropin-releasing hormone (GO:0043435)	4	0	.09	-	 < 0.01	9.11E-01
homologous recombination (GO:0035825)	44	0	1.03	-	 < 0.01	3.58E-01
negative regulation of calcium-independent cell-cell adhesion (GO:0051042)	1	0	.02	-	 < 0.01	9.77E-01
gene conversion (GO:0035822)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of aggrephagy (GO:1905337)	3	0	.07	-	 < 0.01	9.32E-01
regulation of aggrephagy (GO:1905335)	3	0	.07	-	 < 0.01	9.32E-01
regulation of gastric motility (GO:1905333)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of morphogenesis of an epithelium (GO:1905332)	39	0	.91	-	 < 0.01	4.02E-01
negative regulation of morphogenesis of an epithelium (GO:1905331)	8	0	.19	-	 < 0.01	8.30E-01
peptidyl-glutamic acid carboxylation (GO:0017187)	2	0	.05	-	 < 0.01	9.54E-01
regulation of morphogenesis of an epithelium (GO:1905330)	70	0	1.63	-	 < 0.01	1.95E-01
positive regulation of transcription involved in meiotic cell cycle (GO:0051039)	1	0	.02	-	 < 0.01	9.77E-01
peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase (GO:0017186)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of transcription involved in meiotic cell cycle (GO:0051038)	1	0	.02	-	 < 0.01	9.77E-01
regulation of transcription involved in meiotic cell cycle (GO:0051037)	2	0	.05	-	 < 0.01	9.54E-01
de novo centriole assembly involved in multi-ciliated epithelial cell differentiation (GO:0098535)	5	0	.12	-	 < 0.01	8.90E-01
peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183)	6	0	.14	-	 < 0.01	8.69E-01
regulation of endosome size (GO:0051036)	5	0	.12	-	 < 0.01	8.90E-01
centriole assembly (GO:0098534)	25	0	.58	-	 < 0.01	5.58E-01
peptidyl-diphthamide metabolic process (GO:0017182)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of renal sodium excretion (GO:0035815)	14	0	.33	-	 < 0.01	7.21E-01
histone H3-K27 trimethylation (GO:0098532)	6	0	.14	-	 < 0.01	8.69E-01
tRNA transport (GO:0051031)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of strand invasion (GO:0098530)	1	0	.02	-	 < 0.01	9.77E-01
renal sodium excretion (GO:0035812)	2	0	.05	-	 < 0.01	9.54E-01
snRNA transport (GO:0051030)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of urine volume (GO:0035811)	10	0	.23	-	 < 0.01	7.92E-01
anthranilate metabolic process (GO:0043420)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of urine volume (GO:0035810)	13	0	.30	-	 < 0.01	7.38E-01
glycine betaine biosynthetic process (GO:0031456)	1	0	.02	-	 < 0.01	9.77E-01
glycine betaine metabolic process (GO:0031455)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of heterochromatin assembly (GO:0031453)	10	0	.23	-	 < 0.01	7.92E-01
negative regulation of heterochromatin assembly (GO:0031452)	5	0	.12	-	 < 0.01	8.90E-01
tracheoesophageal septum formation (GO:1905327)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of mesenchymal stem cell migration (GO:1905322)	3	0	.07	-	 < 0.01	9.32E-01
neuromuscular junction development, skeletal muscle fiber (GO:0098529)	1	0	.02	-	 < 0.01	9.77E-01
rRNA transport (GO:0051029)	5	0	.12	-	 < 0.01	8.90E-01
regulation of mesenchymal stem cell migration (GO:1905320)	3	0	.07	-	 < 0.01	9.32E-01
skeletal muscle fiber differentiation (GO:0098528)	1	0	.02	-	 < 0.01	9.77E-01
regulation of urine volume (GO:0035809)	27	0	.63	-	 < 0.01	5.33E-01
homocysteine catabolic process (GO:0043418)	2	0	.05	-	 < 0.01	9.54E-01
chiasma assembly (GO:0051026)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of skeletal muscle tissue regeneration (GO:0043417)	1	0	.02	-	 < 0.01	9.77E-01
regulation of skeletal muscle tissue regeneration (GO:0043416)	8	0	.19	-	 < 0.01	8.30E-01
positive regulation of skeletal muscle tissue regeneration (GO:0043415)	5	0	.12	-	 < 0.01	8.90E-01
egg coat formation (GO:0035803)	2	0	.05	-	 < 0.01	9.54E-01
adrenal cortex formation (GO:0035802)	2	0	.05	-	 < 0.01	9.54E-01
adrenal cortex development (GO:0035801)	3	0	.07	-	 < 0.01	9.32E-01
regulation of slow-twitch skeletal muscle fiber contraction (GO:0031449)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of fast-twitch skeletal muscle fiber contraction (GO:0031448)	3	0	.07	-	 < 0.01	9.32E-01
regulation of fast-twitch skeletal muscle fiber contraction (GO:0031446)	3	0	.07	-	 < 0.01	9.32E-01
regulation of heterochromatin assembly (GO:0031445)	16	0	.37	-	 < 0.01	6.89E-01
slow-twitch skeletal muscle fiber contraction (GO:0031444)	1	0	.02	-	 < 0.01	9.77E-01
fast-twitch skeletal muscle fiber contraction (GO:0031443)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of mRNA 3'-end processing (GO:0031441)	8	0	.19	-	 < 0.01	8.30E-01
inferior endocardial cushion morphogenesis (GO:1905317)	1	0	.02	-	 < 0.01	9.77E-01
semi-lunar valve development (GO:1905314)	33	0	.77	-	 < 0.01	4.63E-01
transforming growth factor beta receptor signaling pathway involved in heart development (GO:1905313)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis (GO:1905312)	3	0	.07	-	 < 0.01	9.32E-01
regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis (GO:1905310)	3	0	.07	-	 < 0.01	9.32E-01
barbed-end actin filament capping (GO:0051016)	20	0	.47	-	 < 0.01	6.27E-01
actin filament severing (GO:0051014)	15	0	.35	-	 < 0.01	7.05E-01
skeletal muscle tissue regeneration (GO:0043403)	32	0	.75	-	 < 0.01	4.74E-01
microtubule sliding (GO:0051012)	3	0	.07	-	 < 0.01	9.32E-01
glucocorticoid mediated signaling pathway (GO:0043402)	2	0	.05	-	 < 0.01	9.54E-01
steroid hormone mediated signaling pathway (GO:0043401)	45	0	1.05	-	 < 0.01	3.50E-01
positive regulation of mRNA cleavage (GO:0031439)	1	0	.02	-	 < 0.01	9.77E-01
regulation of mRNA cleavage (GO:0031437)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of cohesin loading (GO:1905309)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of cardiac myofibril assembly (GO:1905305)	1	0	.02	-	 < 0.01	9.77E-01
regulation of cardiac myofibril assembly (GO:1905304)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of macropinocytosis (GO:1905303)	2	0	.05	-	 < 0.01	9.54E-01
regulation of calcium ion-dependent exocytosis (GO:0017158)	43	0	1.00	-	 < 0.01	3.67E-01
regulation of macropinocytosis (GO:1905301)	2	0	.05	-	 < 0.01	9.54E-01
calcium-ion regulated exocytosis (GO:0017156)	43	0	1.00	-	 < 0.01	3.67E-01
polynucleotide 5' dephosphorylation (GO:0098507)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of lipoprotein lipase activity (GO:0051006)	10	0	.23	-	 < 0.01	7.92E-01
negative regulation of lipoprotein lipase activity (GO:0051005)	6	0	.14	-	 < 0.01	8.69E-01
regulation of lipoprotein lipase activity (GO:0051004)	16	0	.37	-	 < 0.01	6.89E-01
positive regulation of nitric-oxide synthase activity (GO:0051000)	19	0	.44	-	 < 0.01	6.42E-01
response to methotrexate (GO:0031427)	1	0	.02	-	 < 0.01	9.77E-01
keratinization (GO:0031424)	33	0	.77	-	 < 0.01	4.63E-01
stem cell division (GO:0017145)	30	0	.70	-	 < 0.01	4.97E-01
insecticide metabolic process (GO:0017143)	1	0	.02	-	 < 0.01	9.77E-01
establishment of protein localization to chromosome (GO:0070199)	9	0	.21	-	 < 0.01	8.11E-01
protein localization to chromosome, telomeric region (GO:0070198)	14	0	.33	-	 < 0.01	7.21E-01
meiotic attachment of telomere to nuclear envelope (GO:0070197)	2	0	.05	-	 < 0.01	9.54E-01
synaptonemal complex disassembly (GO:0070194)	2	0	.05	-	 < 0.01	9.54E-01
synaptonemal complex organization (GO:0070193)	24	0	.56	-	 < 0.01	5.71E-01
chromosome organization involved in meiotic cell cycle (GO:0070192)	66	0	1.54	-	 < 0.01	2.14E-01
kynurenine metabolic process (GO:0070189)	9	0	.21	-	 < 0.01	8.11E-01
nucleologenesis (GO:0017126)	2	0	.05	-	 < 0.01	9.54E-01
mitochondrial tyrosyl-tRNA aminoacylation (GO:0070184)	1	0	.02	-	 < 0.01	9.77E-01
mitochondrial tryptophanyl-tRNA aminoacylation (GO:0070183)	1	0	.02	-	 < 0.01	9.77E-01
regulation of Golgi to plasma membrane CFTR protein transport (GO:0042999)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of Golgi to plasma membrane protein transport (GO:0042998)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of isotype switching to IgA isotypes (GO:0048298)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of isotype switching to IgA isotypes (GO:0048297)	1	0	.02	-	 < 0.01	9.77E-01
regulation of isotype switching to IgA isotypes (GO:0048296)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of isotype switching to IgE isotypes (GO:0048295)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of isotype switching to IgE isotypes (GO:0048294)	3	0	.07	-	 < 0.01	9.32E-01
regulation of isotype switching to IgE isotypes (GO:0048293)	7	0	.16	-	 < 0.01	8.49E-01
isotype switching to IgG isotypes (GO:0048291)	1	0	.02	-	 < 0.01	9.77E-01
isotype switching to IgA isotypes (GO:0048290)	1	0	.02	-	 < 0.01	9.77E-01
D-serine biosynthetic process (GO:0070179)	1	0	.02	-	 < 0.01	9.77E-01
D-serine metabolic process (GO:0070178)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of hepatic stellate cell proliferation (GO:1904899)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of enamel mineralization (GO:0070175)	3	0	.07	-	 < 0.01	9.32E-01
regulation of hepatic stellate cell proliferation (GO:1904897)	1	0	.02	-	 < 0.01	9.77E-01
ESCRT complex disassembly (GO:1904896)	1	0	.02	-	 < 0.01	9.77E-01
regulation of enamel mineralization (GO:0070173)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of receptor signaling pathway via STAT (GO:1904894)	58	0	1.35	-	 < 0.01	2.58E-01
positive regulation of tooth mineralization (GO:0070172)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of receptor signaling pathway via STAT (GO:1904893)	26	0	.61	-	 < 0.01	5.45E-01
negative regulation of tooth mineralization (GO:0070171)	2	0	.05	-	 < 0.01	9.54E-01
regulation of receptor signaling pathway via STAT (GO:1904892)	94	0	2.19	-	 < 0.01	1.11E-01
regulation of tooth mineralization (GO:0070170)	9	0	.21	-	 < 0.01	8.11E-01
positive regulation of excitatory synapse assembly (GO:1904891)	3	0	.07	-	 < 0.01	9.32E-01
sequestering of actin monomers (GO:0042989)	10	0	.23	-	 < 0.01	7.92E-01
amyloid precursor protein catabolic process (GO:0042987)	16	0	.37	-	 < 0.01	6.89E-01
positive regulation of amyloid precursor protein biosynthetic process (GO:0042986)	4	0	.09	-	 < 0.01	9.11E-01
amyloid precursor protein biosynthetic process (GO:0042983)	1	0	.02	-	 < 0.01	9.77E-01
amyloid precursor protein metabolic process (GO:0042982)	21	0	.49	-	 < 0.01	6.13E-01
vesicle fusion with Golgi apparatus (GO:0048280)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of biomineral tissue development (GO:0070168)	26	0	.61	-	 < 0.01	5.45E-01
regulation of excitatory synapse assembly (GO:1904889)	17	0	.40	-	 < 0.01	6.73E-01
positive regulation of adiponectin secretion (GO:0070165)	2	0	.05	-	 < 0.01	9.54E-01
Wnt signalosome assembly (GO:1904887)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of adiponectin secretion (GO:0070164)	4	0	.09	-	 < 0.01	9.11E-01
regulation of adiponectin secretion (GO:0070163)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of telomerase catalytic core complex assembly (GO:1904884)	2	0	.05	-	 < 0.01	9.54E-01
regulation of telomerase catalytic core complex assembly (GO:1904882)	2	0	.05	-	 < 0.01	9.54E-01
cellular response to hydrogen sulfide (GO:1904881)	2	0	.05	-	 < 0.01	9.54E-01
response to hydrogen sulfide (GO:1904880)	2	0	.05	-	 < 0.01	9.54E-01
activation of Janus kinase activity (GO:0042976)	8	0	.19	-	 < 0.01	8.30E-01
vesicle docking (GO:0048278)	62	0	1.45	-	 < 0.01	2.35E-01
mitochondrial seryl-tRNA aminoacylation (GO:0070158)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1904879)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1904878)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of DNA ligase activity (GO:1904877)	1	0	.02	-	 < 0.01	9.77E-01
regulation of DNA ligase activity (GO:1904875)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of telomerase RNA localization to Cajal body (GO:1904874)	4	0	.09	-	 < 0.01	9.11E-01
regulation of telomerase RNA localization to Cajal body (GO:1904872)	7	0	.16	-	 < 0.01	8.49E-01
mitochondrial glycyl-tRNA aminoacylation (GO:0070150)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of protein localization to Cajal body (GO:1904871)	2	0	.05	-	 < 0.01	9.54E-01
determination of ventral identity (GO:0048264)	1	0	.02	-	 < 0.01	9.77E-01
determination of dorsal identity (GO:0048263)	6	0	.14	-	 < 0.01	8.69E-01
regulation of centriole-centriole cohesion (GO:0030997)	3	0	.07	-	 < 0.01	9.32E-01
determination of dorsal/ventral asymmetry (GO:0048262)	7	0	.16	-	 < 0.01	8.49E-01
recombinational interstrand cross-link repair (GO:0036298)	2	0	.05	-	 < 0.01	9.54E-01
interstrand cross-link repair (GO:0036297)	26	0	.61	-	 < 0.01	5.45E-01
response to increased oxygen levels (GO:0036296)	14	0	.33	-	 < 0.01	7.21E-01
cellular response to increased oxygen levels (GO:0036295)	12	0	.28	-	 < 0.01	7.56E-01
regulation of protein localization to Cajal body (GO:1904869)	2	0	.05	-	 < 0.01	9.54E-01
protein localization to Cajal body (GO:1904867)	1	0	.02	-	 < 0.01	9.77E-01
mitochondrial asparaginyl-tRNA aminoacylation (GO:0070145)	1	0	.02	-	 < 0.01	9.77E-01
DNA rewinding (GO:0036292)	1	0	.02	-	 < 0.01	9.77E-01
mitochondrial alanyl-tRNA aminoacylation (GO:0070143)	1	0	.02	-	 < 0.01	9.77E-01
protein trans-autophosphorylation (GO:0036290)	1	0	.02	-	 < 0.01	9.77E-01
inhibitory synapse assembly (GO:1904862)	11	0	.26	-	 < 0.01	7.74E-01
excitatory synapse assembly (GO:1904861)	14	0	.33	-	 < 0.01	7.21E-01
lipoprotein transport (GO:0042953)	13	0	.30	-	 < 0.01	7.38E-01
snoRNA localization (GO:0048254)	5	0	.12	-	 < 0.01	8.90E-01
elastic fiber assembly (GO:0048251)	11	0	.26	-	 < 0.01	7.74E-01
iron import into the mitochondrion (GO:0048250)	2	0	.05	-	 < 0.01	9.54E-01
peptidyl-serine autophosphorylation (GO:0036289)	9	0	.21	-	 < 0.01	8.11E-01
positive regulation of mitochondrial translation (GO:0070131)	16	0	.37	-	 < 0.01	6.89E-01
positive regulation of establishment of protein localization to telomere (GO:1904851)	10	0	.23	-	 < 0.01	7.92E-01
negative regulation of establishment of protein localization to telomere (GO:1904850)	1	0	.02	-	 < 0.01	9.77E-01
glucoside transport (GO:0042946)	2	0	.05	-	 < 0.01	9.54E-01
D-serine transport (GO:0042942)	3	0	.07	-	 < 0.01	9.32E-01
D-alanine transport (GO:0042941)	1	0	.02	-	 < 0.01	9.77E-01
epinephrine secretion (GO:0048242)	2	0	.05	-	 < 0.01	9.54E-01
epinephrine transport (GO:0048241)	5	0	.12	-	 < 0.01	8.90E-01
sperm capacitation (GO:0048240)	27	0	.63	-	 < 0.01	5.33E-01
thiamine pyrophosphate transmembrane transport (GO:0030974)	2	0	.05	-	 < 0.01	9.54E-01
regulation of mitochondrial translation (GO:0070129)	23	0	.54	-	 < 0.01	5.85E-01
response to 5-fluorouracil (GO:0036275)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of cell chemotaxis to fibroblast growth factor (GO:1904849)	4	0	.09	-	 < 0.01	9.11E-01
tRNA aminoacylation for mitochondrial protein translation (GO:0070127)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of cell chemotaxis to fibroblast growth factor (GO:1904848)	1	0	.02	-	 < 0.01	9.77E-01
mitochondrial translational termination (GO:0070126)	3	0	.07	-	 < 0.01	9.32E-01
regulation of cell chemotaxis to fibroblast growth factor (GO:1904847)	7	0	.16	-	 < 0.01	8.49E-01
mitochondrial translational elongation (GO:0070125)	4	0	.09	-	 < 0.01	9.11E-01
mitochondrial translational initiation (GO:0070124)	1	0	.02	-	 < 0.01	9.77E-01
response to L-glutamine (GO:1904844)	1	0	.02	-	 < 0.01	9.77E-01
ciliary neurotrophic factor-mediated signaling pathway (GO:0070120)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of male germ-line stem cell asymmetric division (GO:1904840)	1	0	.02	-	 < 0.01	9.77E-01
dipeptide transport (GO:0042938)	5	0	.12	-	 < 0.01	8.90E-01
regulation of protein targeting to vacuolar membrane (GO:1900483)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of DNA recombination at telomere (GO:0048239)	3	0	.07	-	 < 0.01	9.32E-01
regulation of diacylglycerol biosynthetic process (GO:1900480)	1	0	.02	-	 < 0.01	9.77E-01
swimming behavior (GO:0036269)	2	0	.05	-	 < 0.01	9.54E-01
swimming (GO:0036268)	1	0	.02	-	 < 0.01	9.77E-01
peptidyl-arginine hydroxylation (GO:0030961)	1	0	.02	-	 < 0.01	9.77E-01
RNA (guanine-N7)-methylation (GO:0036265)	5	0	.12	-	 < 0.01	8.90E-01
regulation of male germ-line stem cell asymmetric division (GO:1904838)	1	0	.02	-	 < 0.01	9.77E-01
7-methylguanosine cap hypermethylation (GO:0036261)	1	0	.02	-	 < 0.01	9.77E-01
RNA capping (GO:0036260)	6	0	.14	-	 < 0.01	8.69E-01
dorsal root ganglion morphogenesis (GO:1904835)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of aortic smooth muscle cell differentiation (GO:1904831)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter (GO:1900477)	2	0	.05	-	 < 0.01	9.54E-01
glucocorticoid receptor signaling pathway (GO:0042921)	4	0	.09	-	 < 0.01	9.11E-01
plasma membrane to endosome transport (GO:0048227)	7	0	.16	-	 < 0.01	8.49E-01
astral microtubule nucleation (GO:0030954)	1	0	.02	-	 < 0.01	9.77E-01
astral microtubule organization (GO:0030953)	13	0	.30	-	 < 0.01	7.38E-01
multivesicular body assembly (GO:0036258)	3	0	.07	-	 < 0.01	9.32E-01
establishment or maintenance of microtubule cytoskeleton polarity (GO:0030951)	4	0	.09	-	 < 0.01	9.11E-01
multivesicular body organization (GO:0036257)	4	0	.09	-	 < 0.01	9.11E-01
regulation of aortic smooth muscle cell differentiation (GO:1904829)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of hydrogen sulfide biosynthetic process (GO:1904828)	1	0	.02	-	 < 0.01	9.77E-01
interleukin-27-mediated signaling pathway (GO:0070106)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of interleukin-6-mediated signaling pathway (GO:0070105)	3	0	.07	-	 < 0.01	9.32E-01
regulation of hydrogen sulfide biosynthetic process (GO:1904826)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of interleukin-6-mediated signaling pathway (GO:0070104)	2	0	.05	-	 < 0.01	9.54E-01
regulation of interleukin-6-mediated signaling pathway (GO:0070103)	5	0	.12	-	 < 0.01	8.90E-01
peroxisome transport along microtubule (GO:0036250)	1	0	.02	-	 < 0.01	9.77E-01
interleukin-6-mediated signaling pathway (GO:0070102)	13	0	.30	-	 < 0.01	7.38E-01
positive regulation of chemokine-mediated signaling pathway (GO:0070101)	3	0	.07	-	 < 0.01	9.32E-01
purine nucleobase transmembrane transport (GO:1904823)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of chemokine-mediated signaling pathway (GO:0070100)	5	0	.12	-	 < 0.01	8.90E-01
alkanesulfonate transport (GO:0042918)	6	0	.14	-	 < 0.01	8.69E-01
inter-Golgi cisterna vesicle-mediated transport (GO:0048219)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949)	12	0	.28	-	 < 0.01	7.56E-01
negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948)	12	0	.28	-	 < 0.01	7.56E-01
Golgi vesicle prefusion complex stabilization (GO:0048213)	2	0	.05	-	 < 0.01	9.54E-01
regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947)	29	0	.68	-	 < 0.01	5.08E-01
Golgi vesicle docking (GO:0048211)	2	0	.05	-	 < 0.01	9.54E-01
Golgi vesicle fusion to target membrane (GO:0048210)	4	0	.09	-	 < 0.01	9.11E-01
cellular response to menadione (GO:0036245)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of protein localization to chromosome, telomeric region (GO:1904816)	13	0	.30	-	 < 0.01	7.38E-01
negative regulation of protein localization to chromosome, telomeric region (GO:1904815)	1	0	.02	-	 < 0.01	9.77E-01
regulation of protein localization to chromosome, telomeric region (GO:1904814)	14	0	.33	-	 < 0.01	7.21E-01
rRNA acetylation involved in maturation of SSU-rRNA (GO:1904812)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of dense core granule transport (GO:1904811)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of long-term synaptic depression (GO:1900454)	10	0	.23	-	 < 0.01	7.92E-01
9-cis-retinoic acid metabolic process (GO:0042905)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of long-term synaptic depression (GO:1900453)	3	0	.07	-	 < 0.01	9.32E-01
9-cis-retinoic acid biosynthetic process (GO:0042904)	7	0	.16	-	 < 0.01	8.49E-01
regulation of vesicle targeting, to, from or within Golgi (GO:0048209)	1	0	.02	-	 < 0.01	9.77E-01
COPII vesicle coating (GO:0048208)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of glutamate receptor signaling pathway (GO:1900451)	3	0	.07	-	 < 0.01	9.32E-01
vesicle targeting, rough ER to cis-Golgi (GO:0048207)	7	0	.16	-	 < 0.01	8.49E-01
COPI coating of Golgi vesicle (GO:0048205)	4	0	.09	-	 < 0.01	9.11E-01
vesicle targeting, trans-Golgi to endosome (GO:0048203)	2	0	.05	-	 < 0.01	9.54E-01
Golgi transport vesicle coating (GO:0048200)	4	0	.09	-	 < 0.01	9.11E-01
regulation of dense core granule transport (GO:1904809)	4	0	.09	-	 < 0.01	9.11E-01
granulocyte activation (GO:0036230)	26	0	.61	-	 < 0.01	5.45E-01
regulation of translation involved in cellular response to UV (GO:1904803)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of neuron remodeling (GO:1904800)	1	0	.02	-	 < 0.01	9.77E-01
protein localization to nuclear inner membrane (GO:0036228)	2	0	.05	-	 < 0.01	9.54E-01
peptidyl-serine acetylation (GO:0030920)	1	0	.02	-	 < 0.01	9.77E-01
midbrain-hindbrain boundary development (GO:0030917)	9	0	.21	-	 < 0.01	8.11E-01
paranodal junction assembly (GO:0030913)	7	0	.16	-	 < 0.01	8.49E-01
olfactory placode formation (GO:0030910)	4	0	.09	-	 < 0.01	9.11E-01
cellular response to stem cell factor stimulus (GO:0036216)	2	0	.05	-	 < 0.01	9.54E-01
response to stem cell factor (GO:0036215)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of defense response to bacterium (GO:1900425)	5	0	.12	-	 < 0.01	8.90E-01
protein splicing (GO:0030908)	3	0	.07	-	 < 0.01	9.32E-01
spermine transport (GO:0000296)	1	0	.02	-	 < 0.01	9.77E-01
nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay (GO:0000294)	2	0	.05	-	 < 0.01	9.54E-01
nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)	15	0	.35	-	 < 0.01	7.05E-01
deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290)	10	0	.23	-	 < 0.01	7.92E-01
negative regulation of cellular response to oxidative stress (GO:1900408)	3	0	.07	-	 < 0.01	9.32E-01
nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289)	14	0	.33	-	 < 0.01	7.21E-01
nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)	36	0	.84	-	 < 0.01	4.32E-01
Rac protein signal transduction (GO:0016601)	22	0	.51	-	 < 0.01	5.99E-01
M phase (GO:0000279)	13	0	.30	-	 < 0.01	7.38E-01
polysaccharide catabolic process (GO:0000272)	14	0	.33	-	 < 0.01	7.21E-01
ureter maturation (GO:0035799)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of mitochondrial membrane permeability (GO:0035795)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of mitochondrial membrane permeability (GO:0035794)	16	0	.37	-	 < 0.01	6.89E-01
positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway (GO:0035793)	3	0	.07	-	 < 0.01	9.32E-01
platelet-derived growth factor receptor-beta signaling pathway (GO:0035791)	7	0	.16	-	 < 0.01	8.49E-01
platelet-derived growth factor receptor-alpha signaling pathway (GO:0035790)	1	0	.02	-	 < 0.01	9.77E-01
allantoin catabolic process (GO:0000256)	1	0	.02	-	 < 0.01	9.77E-01
allantoin metabolic process (GO:0000255)	3	0	.07	-	 < 0.01	9.32E-01
metanephric mesenchymal cell migration (GO:0035789)	1	0	.02	-	 < 0.01	9.77E-01
regulation of corticotropin-releasing hormone secretion (GO:0043397)	4	0	.09	-	 < 0.01	9.11E-01
cell migration involved in metanephros development (GO:0035788)	2	0	.05	-	 < 0.01	9.54E-01
cell migration involved in kidney development (GO:0035787)	3	0	.07	-	 < 0.01	9.32E-01
CD4-positive, alpha-beta T cell costimulation (GO:0035783)	2	0	.05	-	 < 0.01	9.54E-01
mature natural killer cell chemotaxis (GO:0035782)	1	0	.02	-	 < 0.01	9.77E-01
CD86 biosynthetic process (GO:0035781)	2	0	.05	-	 < 0.01	9.54E-01
CD80 biosynthetic process (GO:0035780)	1	0	.02	-	 < 0.01	9.77E-01
spliceosomal tri-snRNP complex assembly (GO:0000244)	9	0	.21	-	 < 0.01	8.11E-01
positive regulation of CAMKK-AMPK signaling cascade (GO:1905291)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of CAMKK-AMPK signaling cascade (GO:1905290)	1	0	.02	-	 < 0.01	9.77E-01
mycotoxin catabolic process (GO:0043387)	2	0	.05	-	 < 0.01	9.54E-01
mycotoxin metabolic process (GO:0043385)	3	0	.07	-	 < 0.01	9.32E-01
negative T cell selection (GO:0043383)	15	0	.35	-	 < 0.01	7.05E-01
positive regulation of memory T cell differentiation (GO:0043382)	4	0	.09	-	 < 0.01	9.11E-01
insulin secretion involved in cellular response to glucose stimulus (GO:0035773)	7	0	.16	-	 < 0.01	8.49E-01
interleukin-13-mediated signaling pathway (GO:0035772)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of memory T cell differentiation (GO:0043381)	1	0	.02	-	 < 0.01	9.77E-01
regulation of memory T cell differentiation (GO:0043380)	6	0	.14	-	 < 0.01	8.69E-01
interleukin-4-mediated signaling pathway (GO:0035771)	2	0	.05	-	 < 0.01	9.54E-01
regulation of CAMKK-AMPK signaling cascade (GO:1905289)	4	0	.09	-	 < 0.01	9.11E-01
pachytene (GO:0000239)	3	0	.07	-	 < 0.01	9.32E-01
leptotene (GO:0000237)	6	0	.14	-	 < 0.01	8.69E-01
fibrous ring of heart morphogenesis (GO:1905285)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of retrograde transport, endosome to Golgi (GO:1905280)	1	0	.02	-	 < 0.01	9.77E-01
memory T cell differentiation (GO:0043379)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043378)	4	0	.09	-	 < 0.01	9.11E-01
B cell chemotaxis across high endothelial venule (GO:0035769)	1	0	.02	-	 < 0.01	9.77E-01
endothelial cell chemotaxis to fibroblast growth factor (GO:0035768)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043377)	2	0	.05	-	 < 0.01	9.54E-01
regulation of CD8-positive, alpha-beta T cell differentiation (GO:0043376)	6	0	.14	-	 < 0.01	8.69E-01
endothelial cell chemotaxis (GO:0035767)	9	0	.21	-	 < 0.01	8.11E-01
cell chemotaxis to fibroblast growth factor (GO:0035766)	1	0	.02	-	 < 0.01	9.77E-01
CD8-positive, alpha-beta T cell lineage commitment (GO:0043375)	2	0	.05	-	 < 0.01	9.54E-01
CD8-positive, alpha-beta T cell differentiation (GO:0043374)	11	0	.26	-	 < 0.01	7.74E-01
CD4-positive, alpha-beta T cell lineage commitment (GO:0043373)	16	0	.37	-	 < 0.01	6.89E-01
positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)	29	0	.68	-	 < 0.01	5.08E-01
negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371)	23	0	.54	-	 < 0.01	5.85E-01
regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)	48	0	1.12	-	 < 0.01	3.26E-01
regulation of retrograde transport, endosome to Golgi (GO:1905279)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of epithelial tube formation (GO:1905278)	8	0	.19	-	 < 0.01	8.30E-01
regulation of epithelial tube formation (GO:1905276)	8	0	.19	-	 < 0.01	8.30E-01
CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369)	20	0	.47	-	 < 0.01	6.27E-01
positive T cell selection (GO:0043368)	34	0	.79	-	 < 0.01	4.52E-01
CD4-positive, alpha-beta T cell differentiation (GO:0043367)	45	0	1.05	-	 < 0.01	3.50E-01
beta selection (GO:0043366)	3	0	.07	-	 < 0.01	9.32E-01
B cell chemotaxis (GO:0035754)	5	0	.12	-	 < 0.01	8.90E-01
lysosomal lumen pH elevation (GO:0035752)	1	0	.02	-	 < 0.01	9.77E-01
protein localization to myelin sheath abaxonal region (GO:0035750)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of prostaglandin biosynthetic process (GO:0031394)	9	0	.21	-	 < 0.01	8.11E-01
negative regulation of prostaglandin biosynthetic process (GO:0031393)	2	0	.05	-	 < 0.01	9.54E-01
regulation of prostaglandin biosynthetic process (GO:0031392)	12	0	.28	-	 < 0.01	7.56E-01
endonucleolytic cleavage involved in tRNA processing (GO:1905267)	2	0	.05	-	 < 0.01	9.54E-01
meiotic spindle organization (GO:0000212)	17	0	.40	-	 < 0.01	6.73E-01
natural killer cell chemotaxis (GO:0035747)	1	0	.02	-	 < 0.01	9.77E-01
T-helper 2 cell cytokine production (GO:0035745)	5	0	.12	-	 < 0.01	8.90E-01
T-helper 1 cell cytokine production (GO:0035744)	5	0	.12	-	 < 0.01	8.90E-01
CD4-positive, alpha-beta T cell cytokine production (GO:0035743)	10	0	.23	-	 < 0.01	7.92E-01
CD8-positive, alpha-beta T cell proliferation (GO:0035740)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway (GO:1905259)	2	0	.05	-	 < 0.01	9.54E-01
regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway (GO:1905258)	2	0	.05	-	 < 0.01	9.54E-01
CD4-positive, alpha-beta T cell proliferation (GO:0035739)	1	0	.02	-	 < 0.01	9.77E-01
intraciliary transport involved in cilium assembly (GO:0035735)	7	0	.16	-	 < 0.01	8.49E-01
hepatic stellate cell activation (GO:0035733)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of aspartic-type peptidase activity (GO:1905247)	9	0	.21	-	 < 0.01	8.11E-01
negative regulation of aspartic-type peptidase activity (GO:1905246)	3	0	.07	-	 < 0.01	9.32E-01
regulation of aspartic-type peptidase activity (GO:1905245)	12	0	.28	-	 < 0.01	7.56E-01
cellular response to 3,3',5-triiodo-L-thyronine (GO:1905243)	1	0	.02	-	 < 0.01	9.77E-01
response to 3,3',5-triiodo-L-thyronine (GO:1905242)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation (GO:1905240)	1	0	.02	-	 < 0.01	9.77E-01
protein unfolding (GO:0043335)	1	0	.02	-	 < 0.01	9.77E-01
interleukin-15-mediated signaling pathway (GO:0035723)	6	0	.14	-	 < 0.01	8.69E-01
interleukin-12-mediated signaling pathway (GO:0035722)	2	0	.05	-	 < 0.01	9.54E-01
intraciliary retrograde transport (GO:0035721)	15	0	.35	-	 < 0.01	7.05E-01
intraciliary anterograde transport (GO:0035720)	5	0	.12	-	 < 0.01	8.90E-01
regulation of canonical Wnt signaling pathway involved in osteoblast differentiation (GO:1905239)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to L-glutamate (GO:1905232)	4	0	.09	-	 < 0.01	9.11E-01
response to insecticide (GO:0017085)	5	0	.12	-	 < 0.01	8.90E-01
protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328)	4	0	.09	-	 < 0.01	9.11E-01
pigment metabolic process involved in developmental pigmentation (GO:0043324)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of natural killer cell degranulation (GO:0043323)	3	0	.07	-	 < 0.01	9.32E-01
cellular response to nitrogen dioxide (GO:0035714)	1	0	.02	-	 < 0.01	9.77E-01
response to nitrogen dioxide (GO:0035713)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of natural killer cell degranulation (GO:0043322)	1	0	.02	-	 < 0.01	9.77E-01
regulation of natural killer cell degranulation (GO:0043321)	4	0	.09	-	 < 0.01	9.11E-01
T-helper 2 cell activation (GO:0035712)	1	0	.02	-	 < 0.01	9.77E-01
natural killer cell degranulation (GO:0043320)	5	0	.12	-	 < 0.01	8.90E-01
T-helper 1 cell activation (GO:0035711)	3	0	.07	-	 < 0.01	9.32E-01
CD4-positive, alpha-beta T cell activation (GO:0035710)	52	0	1.21	-	 < 0.01	2.97E-01
cellular response to thyrotropin-releasing hormone (GO:1905229)	1	0	.02	-	 < 0.01	9.77E-01
regulation of adhesion of symbiont to host epithelial cell (GO:1905226)	1	0	.02	-	 < 0.01	9.77E-01
response to thyrotropin-releasing hormone (GO:1905225)	1	0	.02	-	 < 0.01	9.77E-01
clathrin-coated pit assembly (GO:1905224)	2	0	.05	-	 < 0.01	9.54E-01
epicardium morphogenesis (GO:1905223)	2	0	.05	-	 < 0.01	9.54E-01
atrioventricular canal morphogenesis (GO:1905222)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of platelet formation (GO:1905221)	2	0	.05	-	 < 0.01	9.54E-01
memory T cell activation (GO:0035709)	2	0	.05	-	 < 0.01	9.54E-01
cytotoxic T cell degranulation (GO:0043316)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of neutrophil degranulation (GO:0043315)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of neutrophil degranulation (GO:0043314)	2	0	.05	-	 < 0.01	9.54E-01
T-helper 17 cell chemotaxis (GO:0035705)	1	0	.02	-	 < 0.01	9.77E-01
regulation of neutrophil degranulation (GO:0043313)	9	0	.21	-	 < 0.01	8.11E-01
neutrophil degranulation (GO:0043312)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of eosinophil degranulation (GO:0043311)	2	0	.05	-	 < 0.01	9.54E-01
monocyte homeostasis (GO:0035702)	3	0	.07	-	 < 0.01	9.32E-01
hematopoietic stem cell migration (GO:0035701)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of eosinophil degranulation (GO:0043310)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of cell killing (GO:0031343)	77	0	1.79	-	 < 0.01	1.65E-01
positive regulation of vesicle fusion (GO:0031340)	12	0	.28	-	 < 0.01	7.56E-01
regulation of platelet formation (GO:1905219)	2	0	.05	-	 < 0.01	9.54E-01
response to astaxanthin (GO:1905217)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of RNA binding (GO:1905216)	9	0	.21	-	 < 0.01	8.11E-01
negative regulation of RNA binding (GO:1905215)	1	0	.02	-	 < 0.01	9.77E-01
regulation of RNA binding (GO:1905214)	12	0	.28	-	 < 0.01	7.56E-01
regulation of eosinophil degranulation (GO:0043309)	3	0	.07	-	 < 0.01	9.32E-01
eosinophil degranulation (GO:0043308)	2	0	.05	-	 < 0.01	9.54E-01
eosinophil activation (GO:0043307)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of mast cell degranulation (GO:0043306)	23	0	.54	-	 < 0.01	5.85E-01
respiratory chain complex III assembly (GO:0017062)	6	0	.14	-	 < 0.01	8.69E-01
7-methylguanosine RNA capping (GO:0009452)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of mast cell degranulation (GO:0043305)	6	0	.14	-	 < 0.01	8.69E-01
regulation of mast cell degranulation (GO:0043304)	37	0	.86	-	 < 0.01	4.22E-01
RNA modification (GO:0009451)	127	0	2.96	-	 < 0.01	5.13E-02
mast cell degranulation (GO:0043303)	19	0	.44	-	 < 0.01	6.42E-01
gamma-aminobutyric acid catabolic process (GO:0009450)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of leukocyte degranulation (GO:0043302)	33	0	.77	-	 < 0.01	4.63E-01
negative regulation of leukocyte degranulation (GO:0043301)	10	0	.23	-	 < 0.01	7.92E-01
regulation of leukocyte degranulation (GO:0043300)	52	0	1.21	-	 < 0.01	2.97E-01
negative regulation of vesicle fusion (GO:0031339)	5	0	.12	-	 < 0.01	8.90E-01
regulation of vesicle fusion (GO:0031338)	26	0	.61	-	 < 0.01	5.45E-01
positive regulation of sulfur amino acid metabolic process (GO:0031337)	1	0	.02	-	 < 0.01	9.77E-01
regulation of sulfur amino acid metabolic process (GO:0031335)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of cardiocyte differentiation (GO:1905209)	17	0	.40	-	 < 0.01	6.73E-01
negative regulation of cardiocyte differentiation (GO:1905208)	12	0	.28	-	 < 0.01	7.56E-01
regulation of cardiocyte differentiation (GO:1905207)	29	0	.68	-	 < 0.01	5.08E-01
positive regulation of hydrogen peroxide-induced cell death (GO:1905206)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of connective tissue replacement (GO:1905205)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of connective tissue replacement (GO:1905204)	2	0	.05	-	 < 0.01	9.54E-01
regulation of connective tissue replacement (GO:1905203)	6	0	.14	-	 < 0.01	8.69E-01
gamma-aminobutyric acid biosynthetic process (GO:0009449)	3	0	.07	-	 < 0.01	9.32E-01
gamma-aminobutyric acid metabolic process (GO:0009448)	5	0	.12	-	 < 0.01	8.90E-01
putrescine catabolic process (GO:0009447)	1	0	.02	-	 < 0.01	9.77E-01
putrescine biosynthetic process (GO:0009446)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0017055)	1	0	.02	-	 < 0.01	9.77E-01
putrescine metabolic process (GO:0009445)	7	0	.16	-	 < 0.01	8.49E-01
pyruvate oxidation (GO:0009444)	1	0	.02	-	 < 0.01	9.77E-01
pyridoxal 5'-phosphate salvage (GO:0009443)	1	0	.02	-	 < 0.01	9.77E-01
glycolate metabolic process (GO:0009441)	2	0	.05	-	 < 0.01	9.54E-01
methylglyoxal metabolic process (GO:0009438)	6	0	.14	-	 < 0.01	8.69E-01
carnitine metabolic process (GO:0009437)	13	0	.30	-	 < 0.01	7.38E-01
glyoxylate catabolic process (GO:0009436)	3	0	.07	-	 < 0.01	9.32E-01
NAD biosynthetic process (GO:0009435)	12	0	.28	-	 < 0.01	7.56E-01
regulation of chemokine-mediated signaling pathway (GO:0070099)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of glucagon secretion (GO:0070093)	5	0	.12	-	 < 0.01	8.90E-01
glucagon secretion (GO:0070091)	1	0	.02	-	 < 0.01	9.77E-01
ubiquitin-dependent endocytosis (GO:0070086)	3	0	.07	-	 < 0.01	9.32E-01
response to water deprivation (GO:0009414)	5	0	.12	-	 < 0.01	8.90E-01
vesicle targeting, to, from or within Golgi (GO:0048199)	15	0	.35	-	 < 0.01	7.05E-01
Golgi vesicle budding (GO:0048194)	8	0	.19	-	 < 0.01	8.30E-01
response to cold (GO:0009409)	38	0	.89	-	 < 0.01	4.12E-01
regulation of neuron remodeling (GO:1904799)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of core promoter binding (GO:1904798)	7	0	.16	-	 < 0.01	8.49E-01
toxin catabolic process (GO:0009407)	2	0	.05	-	 < 0.01	9.54E-01
tear secretion (GO:0070075)	1	0	.02	-	 < 0.01	9.77E-01
protein nitrosylation (GO:0017014)	7	0	.16	-	 < 0.01	8.49E-01
pathogenesis (GO:0009405)	1	0	.02	-	 < 0.01	9.77E-01
clustering of voltage-gated calcium channels (GO:0070073)	1	0	.02	-	 < 0.01	9.77E-01
vacuolar proton-transporting V-type ATPase complex assembly (GO:0070072)	5	0	.12	-	 < 0.01	8.90E-01
toxin biosynthetic process (GO:0009403)	1	0	.02	-	 < 0.01	9.77E-01
proton-transporting two-sector ATPase complex assembly (GO:0070071)	13	0	.30	-	 < 0.01	7.38E-01
regulation of euchromatin binding (GO:1904793)	1	0	.02	-	 < 0.01	9.77E-01
proton-transporting V-type ATPase complex assembly (GO:0070070)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of shelterin complex assembly (GO:1904792)	1	0	.02	-	 < 0.01	9.77E-01
regulation of shelterin complex assembly (GO:1904790)	1	0	.02	-	 < 0.01	9.77E-01
cysteine transport (GO:0042883)	2	0	.05	-	 < 0.01	9.54E-01
protein-tetrapyrrole linkage (GO:0017006)	1	0	.02	-	 < 0.01	9.77E-01
cytochrome complex assembly (GO:0017004)	23	0	.54	-	 < 0.01	5.85E-01
protein-heme linkage (GO:0017003)	1	0	.02	-	 < 0.01	9.77E-01
NLRP1 inflammasome complex assembly (GO:1904784)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of NMDA glutamate receptor activity (GO:1904783)	8	0	.19	-	 < 0.01	8.30E-01
'de novo' actin filament nucleation (GO:0070060)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of NMDA glutamate receptor activity (GO:1904782)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of protein localization to centrosome (GO:1904781)	7	0	.16	-	 < 0.01	8.49E-01
arachidonic acid secretion (GO:0050482)	24	0	.56	-	 < 0.01	5.71E-01
negative regulation of short-term neuronal synaptic plasticity (GO:0048174)	1	0	.02	-	 < 0.01	9.77E-01
regulation of short-term neuronal synaptic plasticity (GO:0048172)	19	0	.44	-	 < 0.01	6.42E-01
positive regulation of long-term neuronal synaptic plasticity (GO:0048170)	8	0	.19	-	 < 0.01	8.30E-01
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059)	38	0	.89	-	 < 0.01	4.12E-01
positive regulation of protein localization to cell cortex (GO:1904778)	5	0	.12	-	 < 0.01	8.90E-01
regulation of protein localization to cell cortex (GO:1904776)	6	0	.14	-	 < 0.01	8.69E-01
mRNA splicing, via endonucleolytic cleavage and ligation (GO:0070054)	1	0	.02	-	 < 0.01	9.77E-01
response to tetrachloromethane (GO:1904772)	2	0	.05	-	 < 0.01	9.54E-01
antisense RNA metabolic process (GO:0042868)	1	0	.02	-	 < 0.01	9.77E-01
pyruvate biosynthetic process (GO:0042866)	6	0	.14	-	 < 0.01	8.69E-01
fused antrum stage (GO:0048165)	3	0	.07	-	 < 0.01	9.32E-01
multi-layer follicle stage (GO:0048162)	2	0	.05	-	 < 0.01	9.54E-01
primary follicle stage (GO:0048160)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of B cell proliferation (GO:0030890)	43	0	1.00	-	 < 0.01	3.67E-01
negative regulation of macroautophagy by TORC1 signaling (GO:1904766)	1	0	.02	-	 < 0.01	9.77E-01
chaperone-mediated autophagy translocation complex disassembly (GO:1904764)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of myofibroblast differentiation (GO:1904762)	1	0	.02	-	 < 0.01	9.77E-01
L-alanine catabolic process (GO:0042853)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of B cell proliferation (GO:0030889)	20	0	.47	-	 < 0.01	6.27E-01
regulation of B cell proliferation (GO:0030888)	67	0	1.56	-	 < 0.01	2.09E-01
positive regulation of myeloid dendritic cell activation (GO:0030887)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of myeloid dendritic cell activation (GO:0030886)	4	0	.09	-	 < 0.01	9.11E-01
regulation of myeloid dendritic cell activation (GO:0030885)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of vascular associated smooth muscle cell migration (GO:1904753)	9	0	.21	-	 < 0.01	8.11E-01
positive regulation of protein localization to nucleolus (GO:1904751)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of protein localization to nucleolus (GO:1904750)	1	0	.02	-	 < 0.01	9.77E-01
behavioral response to ethanol (GO:0048149)	11	0	.26	-	 < 0.01	7.74E-01
D-xylose catabolic process (GO:0042843)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of fibroblast proliferation (GO:0048146)	68	0	1.59	-	 < 0.01	2.04E-01
D-glucuronate catabolic process (GO:0042840)	1	0	.02	-	 < 0.01	9.77E-01
astrocyte activation (GO:0048143)	15	0	.35	-	 < 0.01	7.05E-01
osteoclast maturation (GO:0036179)	1	0	.02	-	 < 0.01	9.77E-01
regulation of protein localization to nucleolus (GO:1904749)	9	0	.21	-	 < 0.01	8.11E-01
positive regulation of telomeric DNA binding (GO:1904744)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of telomeric DNA binding (GO:1904743)	2	0	.05	-	 < 0.01	9.54E-01
regulation of telomeric DNA binding (GO:1904742)	4	0	.09	-	 < 0.01	9.11E-01
protein arginylation (GO:0016598)	1	0	.02	-	 < 0.01	9.77E-01
D-glucuronate metabolic process (GO:0042839)	1	0	.02	-	 < 0.01	9.77E-01
defense response to protozoan (GO:0042832)	34	0	.79	-	 < 0.01	4.52E-01
male germ-line stem cell asymmetric division (GO:0048133)	4	0	.09	-	 < 0.01	9.11E-01
female germ-line stem cell asymmetric division (GO:0048132)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of polarized epithelial cell differentiation (GO:0030862)	2	0	.05	-	 < 0.01	9.54E-01
regulation of polarized epithelial cell differentiation (GO:0030860)	3	0	.07	-	 < 0.01	9.32E-01
phenotypic switching (GO:0036166)	1	0	.02	-	 < 0.01	9.77E-01
vascular associated smooth muscle cell migration (GO:1904738)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:1904736)	1	0	.02	-	 < 0.01	9.77E-01
regulation of fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:1904735)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of electron transfer activity (GO:1904734)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of electron transfer activity (GO:1904733)	1	0	.02	-	 < 0.01	9.77E-01
regulation of electron transfer activity (GO:1904732)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of intestinal lipid absorption (GO:1904731)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of intestinal lipid absorption (GO:1904730)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of secondary metabolite biosynthetic process (GO:1900377)	5	0	.12	-	 < 0.01	8.90E-01
nucleosome positioning (GO:0016584)	10	0	.23	-	 < 0.01	7.92E-01
amyloid-beta metabolic process (GO:0050435)	20	0	.47	-	 < 0.01	6.27E-01
positive regulation of viral transcription (GO:0050434)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of purine nucleotide biosynthetic process (GO:1900373)	17	0	.40	-	 < 0.01	6.73E-01
pyridoxal phosphate biosynthetic process (GO:0042823)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of purine nucleotide biosynthetic process (GO:1900372)	6	0	.14	-	 < 0.01	8.69E-01
catecholamine secretion (GO:0050432)	3	0	.07	-	 < 0.01	9.32E-01
pyridoxal phosphate metabolic process (GO:0042822)	3	0	.07	-	 < 0.01	9.32E-01
regulation of purine nucleotide biosynthetic process (GO:1900371)	31	0	.72	-	 < 0.01	4.85E-01
positive regulation of RNA interference (GO:1900370)	1	0	.02	-	 < 0.01	9.77E-01
vitamin B6 catabolic process (GO:0042820)	1	0	.02	-	 < 0.01	9.77E-01
polarized epithelial cell differentiation (GO:0030859)	21	0	.49	-	 < 0.01	6.13E-01
positive regulation of granulocyte differentiation (GO:0030854)	9	0	.21	-	 < 0.01	8.11E-01
inner dynein arm assembly (GO:0036159)	9	0	.21	-	 < 0.01	8.11E-01
negative regulation of granulocyte differentiation (GO:0030853)	10	0	.23	-	 < 0.01	7.92E-01
regulation of granulocyte differentiation (GO:0030852)	18	0	.42	-	 < 0.01	6.57E-01
granulocyte differentiation (GO:0030851)	21	0	.49	-	 < 0.01	6.13E-01
acylglycerol acyl-chain remodeling (GO:0036155)	1	0	.02	-	 < 0.01	9.77E-01
regulation of intestinal lipid absorption (GO:1904729)	12	0	.28	-	 < 0.01	7.56E-01
triglyceride acyl-chain remodeling (GO:0036153)	1	0	.02	-	 < 0.01	9.77E-01
phosphatidylethanolamine acyl-chain remodeling (GO:0036152)	7	0	.16	-	 < 0.01	8.49E-01
phosphatidylcholine acyl-chain remodeling (GO:0036151)	13	0	.30	-	 < 0.01	7.38E-01
phosphatidylserine acyl-chain remodeling (GO:0036150)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of Wnt-Frizzled-LRP5/6 complex assembly (GO:1904723)	1	0	.02	-	 < 0.01	9.77E-01
histone deubiquitination (GO:0016578)	20	0	.47	-	 < 0.01	6.27E-01
histone dephosphorylation (GO:0016576)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of RNA interference (GO:1900369)	2	0	.05	-	 < 0.01	9.54E-01
3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428)	2	0	.05	-	 < 0.01	9.54E-01
vitamin B6 biosynthetic process (GO:0042819)	2	0	.05	-	 < 0.01	9.54E-01
regulation of RNA interference (GO:1900368)	3	0	.07	-	 < 0.01	9.32E-01
3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427)	7	0	.16	-	 < 0.01	8.49E-01
vitamin B6 metabolic process (GO:0042816)	3	0	.07	-	 < 0.01	9.32E-01
histone phosphorylation (GO:0016572)	26	0	.61	-	 < 0.01	5.45E-01
negative regulation of mRNA polyadenylation (GO:1900364)	8	0	.19	-	 < 0.01	8.30E-01
phospholipase C-inhibiting G protein-coupled receptor signaling pathway (GO:0030845)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of intermediate filament depolymerization (GO:0030844)	1	0	.02	-	 < 0.01	9.77E-01
phosphatidylinositol acyl-chain remodeling (GO:0036149)	3	0	.07	-	 < 0.01	9.32E-01
phosphatidylglycerol acyl-chain remodeling (GO:0036148)	2	0	.05	-	 < 0.01	9.54E-01
regulation of intermediate filament depolymerization (GO:0030842)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of AMPA glutamate receptor clustering (GO:1904719)	5	0	.12	-	 < 0.01	8.90E-01
regulation of AMPA glutamate receptor clustering (GO:1904717)	9	0	.21	-	 < 0.01	8.11E-01
positive regulation of chaperone-mediated autophagy (GO:1904716)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of chaperone-mediated autophagy (GO:1904715)	2	0	.05	-	 < 0.01	9.54E-01
regulation of chaperone-mediated autophagy (GO:1904714)	4	0	.09	-	 < 0.01	9.11E-01
regulation of Wnt-Frizzled-LRP5/6 complex assembly (GO:1904711)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of granulosa cell apoptotic process (GO:1904710)	1	0	.02	-	 < 0.01	9.77E-01
protein import into peroxisome matrix, translocation (GO:0016561)	3	0	.07	-	 < 0.01	9.32E-01
protein import into peroxisome matrix, docking (GO:0016560)	4	0	.09	-	 < 0.01	9.11E-01
establishment of body hair planar orientation (GO:0048105)	4	0	.09	-	 < 0.01	9.11E-01
establishment of body hair or bristle planar orientation (GO:0048104)	4	0	.09	-	 < 0.01	9.11E-01
somatic stem cell division (GO:0048103)	13	0	.30	-	 < 0.01	7.38E-01
positive regulation of actin filament depolymerization (GO:0030836)	10	0	.23	-	 < 0.01	7.92E-01
peptidyl-histidine hydroxylation (GO:0036138)	1	0	.02	-	 < 0.01	9.77E-01
Schwann cell migration (GO:0036135)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of granulosa cell apoptotic process (GO:1904709)	1	0	.02	-	 < 0.01	9.77E-01
regulation of granulosa cell apoptotic process (GO:1904708)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706)	23	0	.54	-	 < 0.01	5.85E-01
peroxisome fission (GO:0016559)	9	0	.21	-	 < 0.01	8.11E-01
protein import into peroxisome matrix (GO:0016558)	12	0	.28	-	 < 0.01	7.56E-01
regulation of protein localization to adherens junction (GO:1904702)	1	0	.02	-	 < 0.01	9.77E-01
peroxisome membrane biogenesis (GO:0016557)	4	0	.09	-	 < 0.01	9.11E-01
mRNA modification (GO:0016556)	23	0	.54	-	 < 0.01	5.85E-01
cytidine to uridine editing (GO:0016554)	6	0	.14	-	 < 0.01	8.69E-01
base conversion or substitution editing (GO:0016553)	14	0	.33	-	 < 0.01	7.21E-01
histone H3-K9 trimethylation (GO:0036124)	6	0	.14	-	 < 0.01	8.69E-01
histone H3-K9 dimethylation (GO:0036123)	3	0	.07	-	 < 0.01	9.32E-01
cellular response to platelet-derived growth factor stimulus (GO:0036120)	16	0	.37	-	 < 0.01	6.89E-01
regulation of cardiac endothelial to mesenchymal transition (GO:0061999)	1	0	.02	-	 < 0.01	9.77E-01
protein autoprocessing (GO:0016540)	21	0	.49	-	 < 0.01	6.13E-01
response to platelet-derived growth factor (GO:0036119)	17	0	.40	-	 < 0.01	6.73E-01
long-chain fatty-acyl-CoA catabolic process (GO:0036116)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of nucleotide biosynthetic process (GO:0030810)	17	0	.40	-	 < 0.01	6.73E-01
fatty-acyl-CoA catabolic process (GO:0036115)	4	0	.09	-	 < 0.01	9.11E-01
medium-chain fatty-acyl-CoA catabolic process (GO:0036114)	2	0	.05	-	 < 0.01	9.54E-01
very long-chain fatty-acyl-CoA catabolic process (GO:0036113)	1	0	.02	-	 < 0.01	9.77E-01
intein-mediated protein splicing (GO:0016539)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of transcription from RNA polymerase II promoter by glucose (GO:0061987)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of transcription by glucose (GO:0061986)	1	0	.02	-	 < 0.01	9.77E-01
meiosis II cell cycle process (GO:0061983)	13	0	.30	-	 < 0.01	7.38E-01
meiosis I cell cycle process (GO:0061982)	104	0	2.42	-	 < 0.01	8.79E-02
negative regulation of nucleotide biosynthetic process (GO:0030809)	6	0	.14	-	 < 0.01	8.69E-01
regulation of nucleotide biosynthetic process (GO:0030808)	31	0	.72	-	 < 0.01	4.85E-01
leukotriene B4 metabolic process (GO:0036102)	3	0	.07	-	 < 0.01	9.32E-01
leukotriene B4 catabolic process (GO:0036101)	3	0	.07	-	 < 0.01	9.32E-01
leukotriene catabolic process (GO:0036100)	3	0	.07	-	 < 0.01	9.32E-01
mandibular condyle articular cartilage development (GO:0061978)	1	0	.02	-	 < 0.01	9.77E-01
temporomandibular joint articular cartilage development (GO:0061976)	1	0	.02	-	 < 0.01	9.77E-01
perichondral bone morphogenesis (GO:0061974)	1	0	.02	-	 < 0.01	9.77E-01
membrane bone morphogenesis (GO:0061973)	1	0	.02	-	 < 0.01	9.77E-01
establishment of left/right asymmetry (GO:0061966)	3	0	.07	-	 < 0.01	9.32E-01
activation of MAPKK activity (GO:0000186)	33	0	.77	-	 < 0.01	4.63E-01
activation of MAPKKK activity (GO:0000185)	10	0	.23	-	 < 0.01	7.92E-01
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)	33	0	.77	-	 < 0.01	4.63E-01
rDNA heterochromatin assembly (GO:0000183)	7	0	.16	-	 < 0.01	8.49E-01
penetration of cumulus oophorus (GO:0061956)	1	0	.02	-	 < 0.01	9.77E-01
midbody abscission (GO:0061952)	16	0	.37	-	 < 0.01	6.89E-01
regulation of protein K48-linked ubiquitination (GO:0061945)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of protein K48-linked ubiquitination (GO:0061944)	2	0	.05	-	 < 0.01	9.54E-01
CD8-positive, alpha-beta T cell extravasation (GO:0035697)	1	0	.02	-	 < 0.01	9.77E-01
monocyte extravasation (GO:0035696)	5	0	.12	-	 < 0.01	8.90E-01
mitophagy by induced vacuole formation (GO:0035695)	1	0	.02	-	 < 0.01	9.77E-01
protein localization to somatodendritic compartment (GO:0061938)	1	0	.02	-	 < 0.01	9.77E-01
mitochondrial protein catabolic process (GO:0035694)	4	0	.09	-	 < 0.01	9.11E-01
macrophage migration inhibitory factor signaling pathway (GO:0035691)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of erythrocyte enucleation (GO:0061931)	1	0	.02	-	 < 0.01	9.77E-01
regulation of erythrocyte enucleation (GO:0061930)	1	0	.02	-	 < 0.01	9.77E-01
rRNA modification (GO:0000154)	28	0	.65	-	 < 0.01	5.20E-01
leukocyte degranulation (GO:0043299)	28	0	.65	-	 < 0.01	5.20E-01
T-helper 1 cell diapedesis (GO:0035688)	1	0	.02	-	 < 0.01	9.77E-01
T-helper 1 cell extravasation (GO:0035687)	1	0	.02	-	 < 0.01	9.77E-01
helper T cell diapedesis (GO:0035685)	3	0	.07	-	 < 0.01	9.32E-01
helper T cell extravasation (GO:0035684)	4	0	.09	-	 < 0.01	9.11E-01
memory T cell extravasation (GO:0035683)	2	0	.05	-	 < 0.01	9.54E-01
peptidyl-lysine propionylation (GO:0061921)	1	0	.02	-	 < 0.01	9.77E-01
manchette disassembly (GO:1905199)	1	0	.02	-	 < 0.01	9.77E-01
manchette assembly (GO:1905198)	4	0	.09	-	 < 0.01	9.11E-01
posterior lateral line neuromast hair cell development (GO:0035677)	1	0	.02	-	 < 0.01	9.77E-01
neuromast hair cell development (GO:0035675)	1	0	.02	-	 < 0.01	9.77E-01
tricarboxylic acid transmembrane transport (GO:0035674)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of growth plate cartilage chondrocyte proliferation (GO:0061914)	1	0	.02	-	 < 0.01	9.77E-01
selective autophagy (GO:0061912)	30	0	.70	-	 < 0.01	4.97E-01
positive regulation of metaphase/anaphase transition of meiosis I (GO:1905188)	1	0	.02	-	 < 0.01	9.77E-01
regulation of metaphase/anaphase transition of meiosis I (GO:1905186)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of protein serine/threonine phosphatase activity (GO:1905184)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of protein serine/threonine phosphatase activity (GO:1905183)	1	0	.02	-	 < 0.01	9.77E-01
response to morphine (GO:0043278)	17	0	.40	-	 < 0.01	6.73E-01
TRAM-dependent toll-like receptor 4 signaling pathway (GO:0035669)	3	0	.07	-	 < 0.01	9.32E-01
TRAM-dependent toll-like receptor signaling pathway (GO:0035668)	3	0	.07	-	 < 0.01	9.32E-01
anoikis (GO:0043276)	9	0	.21	-	 < 0.01	8.11E-01
TRIF-dependent toll-like receptor signaling pathway (GO:0035666)	6	0	.14	-	 < 0.01	8.69E-01
autophagosome-lysosome fusion (GO:0061909)	4	0	.09	-	 < 0.01	9.11E-01
TIRAP-dependent toll-like receptor 4 signaling pathway (GO:0035665)	1	0	.02	-	 < 0.01	9.77E-01
TIRAP-dependent toll-like receptor signaling pathway (GO:0035664)	1	0	.02	-	 < 0.01	9.77E-01
MyD88-dependent toll-like receptor 4 signaling pathway (GO:0035660)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of 1-phosphatidylinositol-3-kinase activity (GO:0061903)	1	0	.02	-	 < 0.01	9.77E-01
regulation of 1-phosphatidylinositol-3-kinase activity (GO:0061901)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of cardiac muscle tissue regeneration (GO:1905179)	2	0	.05	-	 < 0.01	9.54E-01
regulation of cardiac muscle tissue regeneration (GO:1905178)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of vascular associated smooth muscle cell dedifferentiation (GO:1905176)	1	0	.02	-	 < 0.01	9.77E-01
regulation of vascular associated smooth muscle cell dedifferentiation (GO:1905174)	2	0	.05	-	 < 0.01	9.54E-01
interleukin-18-mediated signaling pathway (GO:0035655)	5	0	.12	-	 < 0.01	8.90E-01
replication fork processing (GO:0031297)	32	0	.75	-	 < 0.01	4.74E-01
B cell costimulation (GO:0031296)	4	0	.09	-	 < 0.01	9.11E-01
T cell costimulation (GO:0031295)	27	0	.63	-	 < 0.01	5.33E-01
lymphocyte costimulation (GO:0031294)	29	0	.68	-	 < 0.01	5.08E-01
Ran protein signal transduction (GO:0031291)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of double-strand break repair via homologous recombination (GO:1905168)	13	0	.30	-	 < 0.01	7.38E-01
positive regulation of lysosomal protein catabolic process (GO:1905167)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of lysosomal protein catabolic process (GO:1905166)	3	0	.07	-	 < 0.01	9.32E-01
regulation of transcription involved in G2/M transition of mitotic cell cycle (GO:0000117)	2	0	.05	-	 < 0.01	9.54E-01
regulation of lysosomal protein catabolic process (GO:1905165)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of phagosome maturation (GO:1905164)	1	0	.02	-	 < 0.01	9.77E-01
regulation of phagosome maturation (GO:1905162)	3	0	.07	-	 < 0.01	9.32E-01
endosome to melanosome transport (GO:0035646)	10	0	.23	-	 < 0.01	7.92E-01
enteric smooth muscle cell differentiation (GO:0035645)	1	0	.02	-	 < 0.01	9.77E-01
phosphoanandamide dephosphorylation (GO:0035644)	1	0	.02	-	 < 0.01	9.77E-01
sodium-dependent organic anion transport (GO:0043251)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of guanylate cyclase activity (GO:0031284)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of guanylate cyclase activity (GO:0031283)	2	0	.05	-	 < 0.01	9.54E-01
regulation of guanylate cyclase activity (GO:0031282)	8	0	.19	-	 < 0.01	8.30E-01
positive regulation of cyclase activity (GO:0031281)	18	0	.42	-	 < 0.01	6.57E-01
negative regulation of cyclase activity (GO:0031280)	15	0	.35	-	 < 0.01	7.05E-01
positive regulation of membrane invagination (GO:1905155)	16	0	.37	-	 < 0.01	6.89E-01
negative regulation of membrane invagination (GO:1905154)	3	0	.07	-	 < 0.01	9.32E-01
regulation of membrane invagination (GO:1905153)	20	0	.47	-	 < 0.01	6.27E-01
histidine biosynthetic process (GO:0000105)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of voltage-gated sodium channel activity (GO:1905152)	2	0	.05	-	 < 0.01	9.54E-01
sulfate assimilation (GO:0000103)	4	0	.09	-	 < 0.01	9.11E-01
FMN biosynthetic process (GO:0009398)	1	0	.02	-	 < 0.01	9.77E-01
regulation of voltage-gated sodium channel activity (GO:1905150)	8	0	.19	-	 < 0.01	8.30E-01
folic acid-containing compound catabolic process (GO:0009397)	2	0	.05	-	 < 0.01	9.54E-01
folic acid-containing compound biosynthetic process (GO:0009396)	8	0	.19	-	 < 0.01	8.30E-01
sulfur amino acid transport (GO:0000101)	6	0	.14	-	 < 0.01	8.69E-01
erythrocyte maturation (GO:0043249)	14	0	.33	-	 < 0.01	7.21E-01
phospholipid catabolic process (GO:0009395)	47	0	1.10	-	 < 0.01	3.34E-01
proteasome assembly (GO:0043248)	13	0	.30	-	 < 0.01	7.38E-01
telomere maintenance in response to DNA damage (GO:0043247)	9	0	.21	-	 < 0.01	8.11E-01
2'-deoxyribonucleotide metabolic process (GO:0009394)	39	0	.91	-	 < 0.01	4.02E-01
entry of bacterium into host cell (GO:0035635)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of protein-containing complex disassembly (GO:0043243)	32	0	.75	-	 < 0.01	4.74E-01
response to stilbenoid (GO:0035634)	20	0	.47	-	 < 0.01	6.27E-01
regulation of cyclase activity (GO:0031279)	37	0	.86	-	 < 0.01	4.22E-01
bone mineralization involved in bone maturation (GO:0035630)	8	0	.19	-	 < 0.01	8.30E-01
regulation of lateral pseudopodium assembly (GO:0031275)	1	0	.02	-	 < 0.01	9.77E-01
lysosomal protein catabolic process (GO:1905146)	10	0	.23	-	 < 0.01	7.92E-01
translational attenuation (GO:0009386)	1	0	.02	-	 < 0.01	9.77E-01
ceramide transport (GO:0035627)	11	0	.26	-	 < 0.01	7.74E-01
receptor transactivation (GO:0035624)	4	0	.09	-	 < 0.01	9.11E-01
renal glucose absorption (GO:0035623)	1	0	.02	-	 < 0.01	9.77E-01
intrahepatic bile duct development (GO:0035622)	3	0	.07	-	 < 0.01	9.32E-01
ER to Golgi ceramide transport (GO:0035621)	3	0	.07	-	 < 0.01	9.32E-01
pseudopodium assembly (GO:0031269)	2	0	.05	-	 < 0.01	9.54E-01
pseudopodium organization (GO:0031268)	3	0	.07	-	 < 0.01	9.32E-01
biotin import across plasma membrane (GO:1905135)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of meiotic chromosome separation (GO:1905134)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of meiotic chromosome separation (GO:1905133)	3	0	.07	-	 < 0.01	9.32E-01
regulation of meiotic chromosome separation (GO:1905132)	4	0	.09	-	 < 0.01	9.11E-01
stress granule disassembly (GO:0035617)	5	0	.12	-	 < 0.01	8.90E-01
histone H2B conserved C-terminal lysine deubiquitination (GO:0035616)	3	0	.07	-	 < 0.01	9.32E-01
protein branching point deglutamylation (GO:0035611)	1	0	.02	-	 < 0.01	9.77E-01
protein side chain deglutamylation (GO:0035610)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of axo-dendritic protein transport (GO:1905128)	1	0	.02	-	 < 0.01	9.77E-01
regulation of axo-dendritic protein transport (GO:1905126)	1	0	.02	-	 < 0.01	9.77E-01
regulation of glucosylceramidase activity (GO:1905123)	2	0	.05	-	 < 0.01	9.54E-01
C-terminal protein deglutamylation (GO:0035609)	3	0	.07	-	 < 0.01	9.32E-01
myelin maintenance (GO:0043217)	16	0	.37	-	 < 0.01	6.89E-01
protein deglutamylation (GO:0035608)	6	0	.14	-	 < 0.01	8.69E-01
peptidyl-cysteine S-trans-nitrosylation (GO:0035606)	2	0	.05	-	 < 0.01	9.54E-01
daunorubicin transport (GO:0043215)	1	0	.02	-	 < 0.01	9.77E-01
tRNA methylthiolation (GO:0035600)	1	0	.02	-	 < 0.01	9.77E-01
actin rod assembly (GO:0031247)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of lateral attachment of mitotic spindle microtubules to kinetochore (GO:1905116)	1	0	.02	-	 < 0.01	9.77E-01
regulation of lateral attachment of mitotic spindle microtubules to kinetochore (GO:1905115)	1	0	.02	-	 < 0.01	9.77E-01
auditory behavior (GO:0031223)	13	0	.30	-	 < 0.01	7.38E-01
posttranslational protein targeting to membrane, translocation (GO:0031204)	7	0	.16	-	 < 0.01	8.49E-01
oligosaccharide biosynthetic process (GO:0009312)	14	0	.33	-	 < 0.01	7.21E-01
amine catabolic process (GO:0009310)	20	0	.47	-	 < 0.01	6.27E-01
snRNA transcription by RNA polymerase III (GO:0042796)	7	0	.16	-	 < 0.01	8.49E-01
snRNA transcription by RNA polymerase II (GO:0042795)	9	0	.21	-	 < 0.01	8.11E-01
5S class rRNA transcription by RNA polymerase III (GO:0042791)	1	0	.02	-	 < 0.01	9.77E-01
chromatin-mediated maintenance of transcription (GO:0048096)	12	0	.28	-	 < 0.01	7.56E-01
nucleolar large rRNA transcription by RNA polymerase I (GO:0042790)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of acinar cell proliferation (GO:1904699)	1	0	.02	-	 < 0.01	9.77E-01
regulation of acinar cell proliferation (GO:1904697)	1	0	.02	-	 < 0.01	9.77E-01
protein biotinylation (GO:0009305)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of vascular associated smooth muscle contraction (GO:1904695)	1	0	.02	-	 < 0.01	9.77E-01
rRNA transcription (GO:0009303)	13	0	.30	-	 < 0.01	7.38E-01
midbrain morphogenesis (GO:1904693)	1	0	.02	-	 < 0.01	9.77E-01
snRNA transcription (GO:0009301)	11	0	.26	-	 < 0.01	7.74E-01
positive regulation of type B pancreatic cell proliferation (GO:1904692)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of type B pancreatic cell proliferation (GO:1904691)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of cytoplasmic translational initiation (GO:1904690)	3	0	.07	-	 < 0.01	9.32E-01
tRNA 3'-end processing (GO:0042780)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of developmental pigmentation (GO:0048086)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of cytoplasmic translational initiation (GO:1904689)	1	0	.02	-	 < 0.01	9.77E-01
regulation of cytoplasmic translational initiation (GO:1904688)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of metalloendopeptidase activity (GO:1904685)	2	0	.05	-	 < 0.01	9.54E-01
cellular response to 3-methylcholanthrene (GO:1904682)	1	0	.02	-	 < 0.01	9.77E-01
response to 3-methylcholanthrene (GO:1904681)	1	0	.02	-	 < 0.01	9.77E-01
tRNA 3'-trailer cleavage (GO:0042779)	3	0	.07	-	 < 0.01	9.32E-01
mitochondrial ATP synthesis coupled proton transport (GO:0042776)	10	0	.23	-	 < 0.01	7.92E-01
mitochondrial ATP synthesis coupled electron transport (GO:0042775)	44	0	1.03	-	 < 0.01	3.58E-01
ATP synthesis coupled electron transport (GO:0042773)	45	0	1.05	-	 < 0.01	3.50E-01
DNA damage response, signal transduction resulting in transcription (GO:0042772)	13	0	.30	-	 < 0.01	7.38E-01
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771)	30	0	.70	-	 < 0.01	4.97E-01
signal transduction in response to DNA damage (GO:0042770)	57	0	1.33	-	 < 0.01	2.64E-01
negative regulation of eye pigmentation (GO:0048074)	1	0	.02	-	 < 0.01	9.77E-01
regulation of eye pigmentation (GO:0048073)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of somatic stem cell division (GO:1904677)	1	0	.02	-	 < 0.01	9.77E-01
regulation of somatic stem cell division (GO:1904675)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of somatic stem cell population maintenance (GO:1904674)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of somatic stem cell population maintenance (GO:1904673)	4	0	.09	-	 < 0.01	9.11E-01
regulation of somatic stem cell population maintenance (GO:1904672)	9	0	.21	-	 < 0.01	8.11E-01
nucleosome mobilization (GO:0042766)	3	0	.07	-	 < 0.01	9.32E-01
eye pigmentation (GO:0048069)	4	0	.09	-	 < 0.01	9.11E-01
regulation of sulfur metabolic process (GO:0042762)	11	0	.26	-	 < 0.01	7.74E-01
very long-chain fatty acid catabolic process (GO:0042760)	7	0	.16	-	 < 0.01	8.49E-01
male germ-line stem cell population maintenance (GO:0036098)	1	0	.02	-	 < 0.01	9.77E-01
ATP export (GO:1904669)	2	0	.05	-	 < 0.01	9.54E-01
germ cell proliferation (GO:0036093)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of ubiquitin protein ligase activity (GO:1904668)	8	0	.19	-	 < 0.01	8.30E-01
phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of ubiquitin protein ligase activity (GO:1904667)	10	0	.23	-	 < 0.01	7.92E-01
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0036091)	4	0	.09	-	 < 0.01	9.11E-01
regulation of ubiquitin protein ligase activity (GO:1904666)	22	0	.51	-	 < 0.01	5.99E-01
cleavage furrow ingression (GO:0036090)	2	0	.05	-	 < 0.01	9.54E-01
long-chain fatty acid catabolic process (GO:0042758)	5	0	.12	-	 < 0.01	8.90E-01
post-embryonic eye morphogenesis (GO:0048050)	6	0	.14	-	 < 0.01	8.69E-01
D-serine catabolic process (GO:0036088)	1	0	.02	-	 < 0.01	9.77E-01
GDP-fucose import into Golgi lumen (GO:0036085)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of fat cell apoptotic process (GO:1904651)	1	0	.02	-	 < 0.01	9.77E-01
circadian sleep/wake cycle, non-REM sleep (GO:0042748)	2	0	.05	-	 < 0.01	9.54E-01
circadian sleep/wake cycle, REM sleep (GO:0042747)	1	0	.02	-	 < 0.01	9.77E-01
hydrogen peroxide catabolic process (GO:0042744)	21	0	.49	-	 < 0.01	6.13E-01
hydrogen peroxide metabolic process (GO:0042743)	37	0	.86	-	 < 0.01	4.22E-01
mating behavior, sex discrimination (GO:0048047)	1	0	.02	-	 < 0.01	9.77E-01
focal adhesion assembly (GO:0048041)	27	0	.63	-	 < 0.01	5.33E-01
regulation of fat cell apoptotic process (GO:1904649)	2	0	.05	-	 < 0.01	9.54E-01
cellular response to amyloid-beta (GO:1904646)	33	0	.77	-	 < 0.01	4.63E-01
N-glycan fucosylation (GO:0036071)	1	0	.02	-	 < 0.01	9.77E-01
exogenous drug catabolic process (GO:0042738)	47	0	1.10	-	 < 0.01	3.34E-01
drug catabolic process (GO:0042737)	48	0	1.12	-	 < 0.01	3.26E-01
D-xylose metabolic process (GO:0042732)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of CD4-positive, alpha-beta T cell costimulation (GO:1900281)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of CD4-positive, alpha-beta T cell costimulation (GO:1900280)	1	0	.02	-	 < 0.01	9.77E-01
fibrinolysis (GO:0042730)	13	0	.30	-	 < 0.01	7.38E-01
heme O biosynthetic process (GO:0048034)	1	0	.02	-	 < 0.01	9.77E-01
heme o metabolic process (GO:0048033)	1	0	.02	-	 < 0.01	9.77E-01
protein O-linked fucosylation (GO:0036066)	4	0	.09	-	 < 0.01	9.11E-01
fucosylation (GO:0036065)	14	0	.33	-	 < 0.01	7.21E-01
cellular response to ionomycin (GO:1904637)	5	0	.12	-	 < 0.01	8.90E-01
response to ionomycin (GO:1904636)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of glomerular visceral epithelial cell apoptotic process (GO:1904635)	3	0	.07	-	 < 0.01	9.32E-01
slit diaphragm assembly (GO:0036060)	1	0	.02	-	 < 0.01	9.77E-01
regulation of glomerular visceral epithelial cell apoptotic process (GO:1904633)	3	0	.07	-	 < 0.01	9.32E-01
farnesol catabolic process (GO:0016488)	2	0	.05	-	 < 0.01	9.54E-01
cellular response to glucoside (GO:1904632)	1	0	.02	-	 < 0.01	9.77E-01
farnesol metabolic process (GO:0016487)	2	0	.05	-	 < 0.01	9.54E-01
response to glucoside (GO:1904631)	1	0	.02	-	 < 0.01	9.77E-01
regulation of CD4-positive, alpha-beta T cell costimulation (GO:1900279)	2	0	.05	-	 < 0.01	9.54E-01
cellular response to diterpene (GO:1904630)	1	0	.02	-	 < 0.01	9.77E-01
flavin-containing compound catabolic process (GO:0042728)	1	0	.02	-	 < 0.01	9.77E-01
flavin-containing compound biosynthetic process (GO:0042727)	2	0	.05	-	 < 0.01	9.54E-01
regulation of proteinase activated receptor activity (GO:1900276)	1	0	.02	-	 < 0.01	9.77E-01
flavin-containing compound metabolic process (GO:0042726)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of phospholipase C activity (GO:1900275)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of transcription by RNA polymerase III (GO:0016480)	3	0	.07	-	 < 0.01	9.32E-01
thiamine-containing compound metabolic process (GO:0042723)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of melanin biosynthetic process (GO:0048022)	5	0	.12	-	 < 0.01	8.90E-01
filtration diaphragm assembly (GO:0036058)	1	0	.02	-	 < 0.01	9.77E-01
response to diterpene (GO:1904629)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to phorbol 13-acetate 12-myristate (GO:1904628)	4	0	.09	-	 < 0.01	9.11E-01
response to phorbol 13-acetate 12-myristate (GO:1904627)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of transcription by RNA polymerase I (GO:0016479)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of actin-dependent ATPase activity (GO:1904622)	1	0	.02	-	 < 0.01	9.77E-01
regulation of actin-dependent ATPase activity (GO:1904621)	1	0	.02	-	 < 0.01	9.77E-01
sperm ejaculation (GO:0042713)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of RNA-directed 5'-3' RNA polymerase activity (GO:1900260)	1	0	.02	-	 < 0.01	9.77E-01
Tie signaling pathway (GO:0048014)	5	0	.12	-	 < 0.01	8.90E-01
hepatocyte growth factor receptor signaling pathway (GO:0048012)	9	0	.21	-	 < 0.01	8.11E-01
neurotrophin TRK receptor signaling pathway (GO:0048011)	15	0	.35	-	 < 0.01	7.05E-01
vascular endothelial growth factor receptor signaling pathway (GO:0048010)	25	0	.58	-	 < 0.01	5.58E-01
peptidyl-lysine desuccinylation (GO:0036049)	2	0	.05	-	 < 0.01	9.54E-01
protein desuccinylation (GO:0036048)	2	0	.05	-	 < 0.01	9.54E-01
peptidyl-lysine demalonylation (GO:0036047)	1	0	.02	-	 < 0.01	9.77E-01
protein demalonylation (GO:0036046)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of actin binding (GO:1904618)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of actin binding (GO:1904617)	1	0	.02	-	 < 0.01	9.77E-01
regulation of actin binding (GO:1904616)	3	0	.07	-	 < 0.01	9.32E-01
cellular response to 2,3,7,8-tetrachlorodibenzodioxine (GO:1904613)	2	0	.05	-	 < 0.01	9.54E-01
response to 2,3,7,8-tetrachlorodibenzodioxine (GO:1904612)	2	0	.05	-	 < 0.01	9.54E-01
regulation of RNA-directed 5'-3' RNA polymerase activity (GO:1900259)	1	0	.02	-	 < 0.01	9.77E-01
eye photoreceptor cell fate commitment (GO:0042706)	3	0	.07	-	 < 0.01	9.32E-01
antigen processing and presentation, exogenous lipid antigen via MHC class Ib (GO:0048007)	4	0	.09	-	 < 0.01	9.11E-01
luteinizing hormone signaling pathway (GO:0042700)	3	0	.07	-	 < 0.01	9.32E-01
antigen processing and presentation, endogenous lipid antigen via MHC class Ib (GO:0048006)	2	0	.05	-	 < 0.01	9.54E-01
antigen processing and presentation of lipid antigen via MHC class Ib (GO:0048003)	4	0	.09	-	 < 0.01	9.11E-01
CD8-positive, alpha-beta T cell activation (GO:0036037)	15	0	.35	-	 < 0.01	7.05E-01
sequestering of triglyceride (GO:0030730)	4	0	.09	-	 < 0.01	9.11E-01
osteoclast development (GO:0036035)	6	0	.14	-	 < 0.01	8.69E-01
cellular response to monosodium L-glutamate (GO:1904609)	1	0	.02	-	 < 0.01	9.77E-01
response to monosodium L-glutamate (GO:1904608)	1	0	.02	-	 < 0.01	9.77E-01
neural crest cell delamination (GO:0036032)	1	0	.02	-	 < 0.01	9.77E-01
recruitment of mRNA capping enzyme to RNA polymerase II holoenzyme complex (GO:0036031)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of advanced glycation end-product receptor activity (GO:1904605)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of advanced glycation end-product receptor activity (GO:1904604)	1	0	.02	-	 < 0.01	9.77E-01
regulation of advanced glycation end-product receptor activity (GO:1904603)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of cytoplasmic translational elongation (GO:1900248)	1	0	.02	-	 < 0.01	9.77E-01
regulation of cytoplasmic translational elongation (GO:1900247)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of RIG-I signaling pathway (GO:1900246)	9	0	.21	-	 < 0.01	8.11E-01
positive regulation of MDA-5 signaling pathway (GO:1900245)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of synaptic vesicle endocytosis (GO:1900244)	12	0	.28	-	 < 0.01	7.56E-01
negative regulation of synaptic vesicle endocytosis (GO:1900243)	1	0	.02	-	 < 0.01	9.77E-01
regulation of synaptic vesicle endocytosis (GO:1900242)	22	0	.51	-	 < 0.01	5.99E-01
negative regulation of phenotypic switching (GO:1900240)	2	0	.05	-	 < 0.01	9.54E-01
ovulation (GO:0030728)	18	0	.42	-	 < 0.01	6.57E-01
embryonic skeletal limb joint morphogenesis (GO:0036023)	3	0	.07	-	 < 0.01	9.32E-01
limb joint morphogenesis (GO:0036022)	4	0	.09	-	 < 0.01	9.11E-01
somatic recombination of immunoglobulin gene segments (GO:0016447)	28	0	.65	-	 < 0.01	5.20E-01
somatic hypermutation of immunoglobulin genes (GO:0016446)	12	0	.28	-	 < 0.01	7.56E-01
regulation of phenotypic switching (GO:1900239)	3	0	.07	-	 < 0.01	9.32E-01
somatic diversification of immunoglobulins (GO:0016445)	33	0	.77	-	 < 0.01	4.63E-01
regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway (GO:1900238)	3	0	.07	-	 < 0.01	9.32E-01
somatic cell DNA recombination (GO:0016444)	37	0	.86	-	 < 0.01	4.22E-01
negative regulation of Kit signaling pathway (GO:1900235)	2	0	.05	-	 < 0.01	9.54E-01
regulation of Kit signaling pathway (GO:1900234)	2	0	.05	-	 < 0.01	9.54E-01
P granule organization (GO:0030719)	2	0	.05	-	 < 0.01	9.54E-01
cellular response to erythropoietin (GO:0036018)	2	0	.05	-	 < 0.01	9.54E-01
response to erythropoietin (GO:0036017)	2	0	.05	-	 < 0.01	9.54E-01
cellular response to interleukin-3 (GO:0036016)	5	0	.12	-	 < 0.01	8.90E-01
response to interleukin-3 (GO:0036015)	5	0	.12	-	 < 0.01	8.90E-01
protein localization to endosome (GO:0036010)	10	0	.23	-	 < 0.01	7.92E-01
negative regulation of single-species biofilm formation in or on host organism (GO:1900229)	3	0	.07	-	 < 0.01	9.32E-01
regulation of single-species biofilm formation in or on host organism (GO:1900228)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of mini excitatory postsynaptic potential (GO:0061885)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of NLRP3 inflammasome complex assembly (GO:1900226)	4	0	.09	-	 < 0.01	9.11E-01
regulation of mini excitatory postsynaptic potential (GO:0061884)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of amyloid-beta clearance (GO:1900223)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of anterograde axonal transport of mitochondrion (GO:0061881)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of amyloid-beta clearance (GO:1900222)	9	0	.21	-	 < 0.01	8.11E-01
regulation of anterograde axonal transport of mitochondrion (GO:0061880)	1	0	.02	-	 < 0.01	9.77E-01
regulation of amyloid-beta clearance (GO:1900221)	18	0	.42	-	 < 0.01	6.57E-01
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis (GO:1900220)	2	0	.05	-	 < 0.01	9.54E-01
vitelline membrane formation (GO:0030704)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to macrophage colony-stimulating factor stimulus (GO:0036006)	7	0	.16	-	 < 0.01	8.49E-01
response to macrophage colony-stimulating factor (GO:0036005)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of apoptotic process involved in metanephric nephron tubule development (GO:1900218)	2	0	.05	-	 < 0.01	9.54E-01
regulation of apoptotic process involved in metanephric nephron tubule development (GO:1900217)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of hepatic stellate cell contraction (GO:0061875)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of hepatic stellate cell contraction (GO:0061874)	1	0	.02	-	 < 0.01	9.77E-01
regulation of hepatic stellate cell contraction (GO:0061873)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of apoptotic process involved in metanephric collecting duct development (GO:1900215)	2	0	.05	-	 < 0.01	9.54E-01
regulation of apoptotic process involved in metanephric collecting duct development (GO:1900214)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of hepatic stellate cell migration (GO:0061871)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of hepatic stellate cell migration (GO:0061870)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of mesenchymal cell apoptotic process involved in metanephros development (GO:1900212)	4	0	.09	-	 < 0.01	9.11E-01
regulation of mesenchymal cell apoptotic process involved in metanephros development (GO:1900211)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of cardiolipin metabolic process (GO:1900210)	2	0	.05	-	 < 0.01	9.54E-01
sulfur amino acid catabolic process (GO:0000098)	6	0	.14	-	 < 0.01	8.69E-01
sulfur amino acid biosynthetic process (GO:0000097)	15	0	.35	-	 < 0.01	7.05E-01
sulfur amino acid metabolic process (GO:0000096)	28	0	.65	-	 < 0.01	5.20E-01
regulation of hepatic stellate cell migration (GO:0061869)	3	0	.07	-	 < 0.01	9.32E-01
regulation of cardiolipin metabolic process (GO:1900208)	4	0	.09	-	 < 0.01	9.11E-01
mitotic metaphase (GO:0000089)	2	0	.05	-	 < 0.01	9.54E-01
mitotic M phase (GO:0000087)	2	0	.05	-	 < 0.01	9.54E-01
mitotic G2 phase (GO:0000085)	1	0	.02	-	 < 0.01	9.77E-01
regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083)	18	0	.42	-	 < 0.01	6.57E-01
mitotic G1 phase (GO:0000080)	2	0	.05	-	 < 0.01	9.54E-01
endoplasmic reticulum stress-induced pre-emptive quality control (GO:0061857)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of neuroblast migration (GO:0061855)	1	0	.02	-	 < 0.01	9.77E-01
regulation of neuroblast migration (GO:0061853)	1	0	.02	-	 < 0.01	9.77E-01
DNA damage checkpoint (GO:0000077)	84	0	1.96	-	 < 0.01	1.40E-01
DNA replication checkpoint (GO:0000076)	15	0	.35	-	 < 0.01	7.05E-01
cell cycle checkpoint (GO:0000075)	140	0	3.26	-	 < 0.01	3.78E-02
response to cholecystokinin (GO:0061847)	3	0	.07	-	 < 0.01	9.32E-01
Sertoli cell barrier remodeling (GO:0061843)	1	0	.02	-	 < 0.01	9.77E-01
microtubule organizing center localization (GO:0061842)	32	0	.75	-	 < 0.01	4.74E-01
neuropeptide processing (GO:0061837)	1	0	.02	-	 < 0.01	9.77E-01
protein localization to tricellular tight junction (GO:0061833)	3	0	.07	-	 < 0.01	9.32E-01
ribosomal small subunit export from nucleus (GO:0000056)	6	0	.14	-	 < 0.01	8.69E-01
ribosomal large subunit export from nucleus (GO:0000055)	7	0	.16	-	 < 0.01	8.49E-01
ribosomal subunit export from nucleus (GO:0000054)	14	0	.33	-	 < 0.01	7.21E-01
argininosuccinate metabolic process (GO:0000053)	2	0	.05	-	 < 0.01	9.54E-01
citrulline metabolic process (GO:0000052)	7	0	.16	-	 < 0.01	8.49E-01
urea cycle (GO:0000050)	9	0	.21	-	 < 0.01	8.11E-01
calcium-mediated signaling using extracellular calcium source (GO:0035585)	1	0	.02	-	 < 0.01	9.77E-01
calcium-mediated signaling using intracellular calcium source (GO:0035584)	17	0	.40	-	 < 0.01	6.73E-01
sequestering of TGFbeta in extracellular matrix (GO:0035583)	3	0	.07	-	 < 0.01	9.32E-01
sequestering of BMP in extracellular matrix (GO:0035582)	4	0	.09	-	 < 0.01	9.11E-01
sequestering of extracellular ligand from receptor (GO:0035581)	9	0	.21	-	 < 0.01	8.11E-01
telomeric D-loop disassembly (GO:0061820)	8	0	.19	-	 < 0.01	8.30E-01
positive regulation of guanyl-nucleotide exchange factor activity (GO:1905099)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of guanyl-nucleotide exchange factor activity (GO:1905098)	7	0	.16	-	 < 0.01	8.49E-01
regulation of guanyl-nucleotide exchange factor activity (GO:1905097)	10	0	.23	-	 < 0.01	7.92E-01
negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization (GO:1905090)	1	0	.02	-	 < 0.01	9.77E-01
telomeric DNA-containing double minutes formation (GO:0061819)	4	0	.09	-	 < 0.01	9.11E-01
histone H4-K20 demethylation (GO:0035574)	2	0	.05	-	 < 0.01	9.54E-01
endoplasmic reticulum-plasma membrane tethering (GO:0061817)	6	0	.14	-	 < 0.01	8.69E-01
N-terminal peptidyl-serine trimethylation (GO:0035573)	1	0	.02	-	 < 0.01	9.77E-01
N-terminal peptidyl-serine dimethylation (GO:0035572)	1	0	.02	-	 < 0.01	9.77E-01
vacuolar sequestering (GO:0043181)	1	0	.02	-	 < 0.01	9.77E-01
N-terminal peptidyl-serine methylation (GO:0035570)	1	0	.02	-	 < 0.01	9.77E-01
regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization (GO:1905089)	1	0	.02	-	 < 0.01	9.77E-01
electron transport coupled proton transport (GO:0015990)	1	0	.02	-	 < 0.01	9.77E-01
cell wall mannoprotein biosynthetic process (GO:0000032)	1	0	.02	-	 < 0.01	9.77E-01
rhythmic excitation (GO:0043179)	2	0	.05	-	 < 0.01	9.54E-01
N-terminal peptidyl-proline methylation (GO:0035568)	1	0	.02	-	 < 0.01	9.77E-01
regulation of metanephros size (GO:0035566)	2	0	.05	-	 < 0.01	9.54E-01
nucleoside salvage (GO:0043174)	4	0	.09	-	 < 0.01	9.11E-01
regulation of pronephros size (GO:0035565)	1	0	.02	-	 < 0.01	9.77E-01
nucleotide salvage (GO:0043173)	8	0	.19	-	 < 0.01	8.30E-01
regulation of kidney size (GO:0035564)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of chromatin binding (GO:0035563)	13	0	.30	-	 < 0.01	7.38E-01
negative regulation of chromatin binding (GO:0035562)	9	0	.21	-	 < 0.01	8.11E-01
regulation of chromatin binding (GO:0035561)	23	0	.54	-	 < 0.01	5.85E-01
energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988)	1	0	.02	-	 < 0.01	9.77E-01
ATP synthesis coupled proton transport (GO:0015986)	15	0	.35	-	 < 0.01	7.05E-01
energy coupled proton transport, down electrochemical gradient (GO:0015985)	15	0	.35	-	 < 0.01	7.05E-01
ribosomal large subunit assembly (GO:0000027)	26	0	.61	-	 < 0.01	5.45E-01
positive regulation of tight junction disassembly (GO:1905075)	3	0	.07	-	 < 0.01	9.32E-01
regulation of tight junction disassembly (GO:1905073)	3	0	.07	-	 < 0.01	9.32E-01
cardiac jelly development (GO:1905072)	1	0	.02	-	 < 0.01	9.77E-01
mitotic spindle elongation (GO:0000022)	5	0	.12	-	 < 0.01	8.90E-01
D-alanine catabolic process (GO:0055130)	1	0	.02	-	 < 0.01	9.77E-01
cell envelope organization (GO:0043163)	1	0	.02	-	 < 0.01	9.77E-01
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162)	17	0	.40	-	 < 0.01	6.73E-01
oxidative single-stranded RNA demethylation (GO:0035553)	3	0	.07	-	 < 0.01	9.32E-01
oxidative single-stranded DNA demethylation (GO:0035552)	3	0	.07	-	 < 0.01	9.32E-01
allantois development (GO:1905069)	2	0	.05	-	 < 0.01	9.54E-01
L-proline biosynthetic process (GO:0055129)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of canonical Wnt signaling pathway involved in heart development (GO:1905068)	1	0	.02	-	 < 0.01	9.77E-01
regulation of mitotic recombination (GO:0000019)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of canonical Wnt signaling pathway involved in heart development (GO:1905067)	1	0	.02	-	 < 0.01	9.77E-01
regulation of canonical Wnt signaling pathway involved in heart development (GO:1905066)	2	0	.05	-	 < 0.01	9.54E-01
alpha-glucoside transport (GO:0000017)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064)	8	0	.19	-	 < 0.01	8.30E-01
regulation of vascular associated smooth muscle cell differentiation (GO:1905063)	15	0	.35	-	 < 0.01	7.05E-01
positive regulation of cardioblast proliferation (GO:1905062)	1	0	.02	-	 < 0.01	9.77E-01
single strand break repair (GO:0000012)	11	0	.26	-	 < 0.01	7.74E-01
determination of left/right asymmetry in nervous system (GO:0035545)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of SNARE complex assembly (GO:0035544)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of SNARE complex assembly (GO:0035543)	1	0	.02	-	 < 0.01	9.77E-01
induction of bacterial agglutination (GO:0043152)	5	0	.12	-	 < 0.01	8.90E-01
regulation of SNARE complex assembly (GO:0035542)	7	0	.16	-	 < 0.01	8.49E-01
diadenosine tetraphosphate biosynthetic process (GO:0015966)	3	0	.07	-	 < 0.01	9.32E-01
diadenosine tetraphosphate metabolic process (GO:0015965)	3	0	.07	-	 < 0.01	9.32E-01
diadenosine triphosphate catabolic process (GO:0015964)	1	0	.02	-	 < 0.01	9.77E-01
diadenosine triphosphate metabolic process (GO:0015962)	1	0	.02	-	 < 0.01	9.77E-01
diadenosine polyphosphate catabolic process (GO:0015961)	5	0	.12	-	 < 0.01	8.90E-01
relaxation of cardiac muscle (GO:0055119)	10	0	.23	-	 < 0.01	7.92E-01
diadenosine polyphosphate biosynthetic process (GO:0015960)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of cardiac muscle contraction (GO:0055118)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of base-excision repair (GO:1905053)	2	0	.05	-	 < 0.01	9.54E-01
epiboly involved in gastrulation with mouth forming second (GO:0055113)	1	0	.02	-	 < 0.01	9.77E-01
ingression involved in gastrulation with mouth forming second (GO:0055111)	1	0	.02	-	 < 0.01	9.77E-01
regulation of base-excision repair (GO:1905051)	2	0	.05	-	 < 0.01	9.54E-01
GDP-mannose biosynthetic process (GO:0009298)	3	0	.07	-	 < 0.01	9.32E-01
mitochondrial genome maintenance (GO:0000002)	21	0	.49	-	 < 0.01	6.13E-01
positive regulation of metallopeptidase activity (GO:1905050)	6	0	.14	-	 < 0.01	8.69E-01
sno(s)RNA processing (GO:0043144)	12	0	.28	-	 < 0.01	7.56E-01
regulation of translation by machinery localization (GO:0043143)	1	0	.02	-	 < 0.01	9.77E-01
peptide modification (GO:0031179)	2	0	.05	-	 < 0.01	9.54E-01
diadenosine polyphosphate metabolic process (GO:0015959)	8	0	.19	-	 < 0.01	8.30E-01
Golgi to transport vesicle transport (GO:0055108)	2	0	.05	-	 < 0.01	9.54E-01
Golgi to secretory granule transport (GO:0055107)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of epithelium regeneration (GO:1905043)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of epithelium regeneration (GO:1905042)	1	0	.02	-	 < 0.01	9.77E-01
regulation of epithelium regeneration (GO:1905041)	2	0	.05	-	 < 0.01	9.54E-01
otic placode development (GO:1905040)	1	0	.02	-	 < 0.01	9.77E-01
DNA replication, removal of RNA primer (GO:0043137)	4	0	.09	-	 < 0.01	9.11E-01
retrograde transport, plasma membrane to Golgi (GO:0035526)	2	0	.05	-	 < 0.01	9.54E-01
regulation of hindgut contraction (GO:0043134)	3	0	.07	-	 < 0.01	9.32E-01
protein K29-linked deubiquitination (GO:0035523)	5	0	.12	-	 < 0.01	8.90E-01
NAD transport (GO:0043132)	2	0	.05	-	 < 0.01	9.54E-01
monoubiquitinated histone H2A deubiquitination (GO:0035522)	4	0	.09	-	 < 0.01	9.11E-01
monoubiquitinated histone deubiquitination (GO:0035521)	4	0	.09	-	 < 0.01	9.11E-01
monoubiquitinated protein deubiquitination (GO:0035520)	9	0	.21	-	 < 0.01	8.11E-01
rRNA methylation (GO:0031167)	18	0	.42	-	 < 0.01	6.57E-01
metallo-sulfur cluster assembly (GO:0031163)	18	0	.42	-	 < 0.01	6.57E-01
phosphatidylinositol catabolic process (GO:0031161)	3	0	.07	-	 < 0.01	9.32E-01
formate metabolic process (GO:0015942)	1	0	.02	-	 < 0.01	9.77E-01
regulation of membrane lipid metabolic process (GO:1905038)	13	0	.30	-	 < 0.01	7.38E-01
positive regulation of antifungal innate immune response (GO:1905036)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of antifungal innate immune response (GO:1905035)	1	0	.02	-	 < 0.01	9.77E-01
regulation of antifungal innate immune response (GO:1905034)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of membrane repolarization during cardiac muscle cell action potential (GO:1905033)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of membrane repolarization during cardiac muscle cell action potential (GO:1905032)	1	0	.02	-	 < 0.01	9.77E-01
regulation of membrane repolarization during cardiac muscle cell action potential (GO:1905031)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of 1-phosphatidylinositol 4-kinase activity (GO:0043128)	1	0	.02	-	 < 0.01	9.77E-01
protein K29-linked ubiquitination (GO:0035519)	5	0	.12	-	 < 0.01	8.90E-01
regulation of 1-phosphatidylinositol 4-kinase activity (GO:0043126)	1	0	.02	-	 < 0.01	9.77E-01
oxidative RNA demethylation (GO:0035513)	5	0	.12	-	 < 0.01	8.90E-01
oxidative DNA demethylation (GO:0035511)	7	0	.16	-	 < 0.01	8.49E-01
DNA dealkylation (GO:0035510)	16	0	.37	-	 < 0.01	6.89E-01
pantothenate metabolic process (GO:0015939)	2	0	.05	-	 < 0.01	9.54E-01
coenzyme A catabolic process (GO:0015938)	1	0	.02	-	 < 0.01	9.77E-01
coenzyme A biosynthetic process (GO:0015937)	10	0	.23	-	 < 0.01	7.92E-01
coenzyme A metabolic process (GO:0015936)	14	0	.33	-	 < 0.01	7.21E-01
positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential (GO:1905026)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential (GO:1905025)	1	0	.02	-	 < 0.01	9.77E-01
regulation of membrane repolarization during ventricular cardiac muscle cell action potential (GO:1905024)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of threonine-tRNA ligase activity (GO:1905023)	1	0	.02	-	 < 0.01	9.77E-01
regulation of threonine-tRNA ligase activity (GO:1905021)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of methionine-tRNA ligase activity (GO:1905020)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of myosin-light-chain-phosphatase activity (GO:0035509)	6	0	.14	-	 < 0.01	8.69E-01
2'-deoxyribonucleotide biosynthetic process (GO:0009265)	10	0	.23	-	 < 0.01	7.92E-01
positive regulation of vascular permeability (GO:0043117)	21	0	.49	-	 < 0.01	6.13E-01
deoxyribonucleotide catabolic process (GO:0009264)	27	0	.63	-	 < 0.01	5.33E-01
positive regulation of myosin-light-chain-phosphatase activity (GO:0035508)	1	0	.02	-	 < 0.01	9.77E-01
regulation of myosin-light-chain-phosphatase activity (GO:0035507)	8	0	.19	-	 < 0.01	8.30E-01
deoxyribonucleotide biosynthetic process (GO:0009263)	13	0	.30	-	 < 0.01	7.38E-01
deoxyribonucleotide metabolic process (GO:0009262)	44	0	1.03	-	 < 0.01	3.58E-01
ribonucleotide catabolic process (GO:0009261)	44	0	1.03	-	 < 0.01	3.58E-01
positive regulation of myosin light chain kinase activity (GO:0035505)	2	0	.05	-	 < 0.01	9.54E-01
regulation of myosin light chain kinase activity (GO:0035504)	2	0	.05	-	 < 0.01	9.54E-01
replication fork arrest (GO:0043111)	3	0	.07	-	 < 0.01	9.32E-01
metanephric part of ureteric bud development (GO:0035502)	1	0	.02	-	 < 0.01	9.77E-01
SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146)	45	0	1.05	-	 < 0.01	3.50E-01
anaphase-promoting complex-dependent catabolic process (GO:0031145)	16	0	.37	-	 < 0.01	6.89E-01
lipopolysaccharide transport (GO:0015920)	2	0	.05	-	 < 0.01	9.54E-01
regulation of methionine-tRNA ligase activity (GO:1905018)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of isoleucine-tRNA ligase activity (GO:1905017)	1	0	.02	-	 < 0.01	9.77E-01
regulation of isoleucine-tRNA ligase activity (GO:1905015)	1	0	.02	-	 < 0.01	9.77E-01
10-formyltetrahydrofolate catabolic process (GO:0009258)	2	0	.05	-	 < 0.01	9.54E-01
10-formyltetrahydrofolate biosynthetic process (GO:0009257)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of L-lysine import across plasma membrane (GO:1905010)	1	0	.02	-	 < 0.01	9.77E-01
10-formyltetrahydrofolate metabolic process (GO:0009256)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of GTP cyclohydrolase I activity (GO:0043105)	1	0	.02	-	 < 0.01	9.77E-01
glucan catabolic process (GO:0009251)	10	0	.23	-	 < 0.01	7.92E-01
hypoxanthine salvage (GO:0043103)	2	0	.05	-	 < 0.01	9.54E-01
amino acid salvage (GO:0043102)	7	0	.16	-	 < 0.01	8.49E-01
purine-containing compound salvage (GO:0043101)	8	0	.19	-	 < 0.01	8.30E-01
peroxisomal membrane transport (GO:0015919)	19	0	.44	-	 < 0.01	6.42E-01
sister chromatid biorientation (GO:0031134)	3	0	.07	-	 < 0.01	9.32E-01
regulation of axon diameter (GO:0031133)	6	0	.14	-	 < 0.01	8.69E-01
short-chain fatty acid import (GO:0015913)	1	0	.02	-	 < 0.01	9.77E-01
short-chain fatty acid transport (GO:0015912)	2	0	.05	-	 < 0.01	9.54E-01
long-chain fatty acid import into peroxisome (GO:0015910)	4	0	.09	-	 < 0.01	9.11E-01
regulation of L-lysine import across plasma membrane (GO:1905008)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905006)	2	0	.05	-	 < 0.01	9.54E-01
regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005)	6	0	.14	-	 < 0.01	8.69E-01
protein lipoylation (GO:0009249)	4	0	.09	-	 < 0.01	9.11E-01
regulation of membrane repolarization during atrial cardiac muscle cell action potential (GO:1905000)	1	0	.02	-	 < 0.01	9.77E-01
inductive cell-cell signaling (GO:0031129)	1	0	.02	-	 < 0.01	9.77E-01
developmental induction (GO:0031128)	34	0	.79	-	 < 0.01	4.52E-01
sno(s)RNA 3'-end processing (GO:0031126)	11	0	.26	-	 < 0.01	7.74E-01
rRNA 3'-end processing (GO:0031125)	10	0	.23	-	 < 0.01	7.92E-01
mRNA 3'-end processing (GO:0031124)	44	0	1.03	-	 < 0.01	3.58E-01
RNA 3'-end processing (GO:0031123)	83	0	1.93	-	 < 0.01	1.44E-01
snRNA pseudouridine synthesis (GO:0031120)	3	0	.07	-	 < 0.01	9.32E-01
siderophore metabolic process (GO:0009237)	1	0	.02	-	 < 0.01	9.77E-01
cobalamin metabolic process (GO:0009235)	6	0	.14	-	 < 0.01	8.69E-01
menaquinone biosynthetic process (GO:0009234)	1	0	.02	-	 < 0.01	9.77E-01
menaquinone metabolic process (GO:0009233)	4	0	.09	-	 < 0.01	9.11E-01
riboflavin biosynthetic process (GO:0009231)	1	0	.02	-	 < 0.01	9.77E-01
tRNA pseudouridine synthesis (GO:0031119)	5	0	.12	-	 < 0.01	8.90E-01
rRNA pseudouridine synthesis (GO:0031118)	9	0	.21	-	 < 0.01	8.11E-01
positive regulation of microtubule depolymerization (GO:0031117)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of microtubule polymerization (GO:0031116)	29	0	.68	-	 < 0.01	5.08E-01
negative regulation of microtubule polymerization (GO:0031115)	15	0	.35	-	 < 0.01	7.05E-01
regulation of microtubule depolymerization (GO:0031114)	37	0	.86	-	 < 0.01	4.22E-01
positive regulation of microtubule polymerization or depolymerization (GO:0031112)	33	0	.77	-	 < 0.01	4.63E-01
negative regulation of microtubule polymerization or depolymerization (GO:0031111)	47	0	1.10	-	 < 0.01	3.34E-01
thiamine diphosphate biosynthetic process (GO:0009229)	1	0	.02	-	 < 0.01	9.77E-01
nucleotide-sugar catabolic process (GO:0009227)	2	0	.05	-	 < 0.01	9.54E-01
nucleotide-sugar biosynthetic process (GO:0009226)	13	0	.30	-	 < 0.01	7.38E-01
nucleotide-sugar metabolic process (GO:0009225)	30	0	.70	-	 < 0.01	4.97E-01
CMP biosynthetic process (GO:0009224)	1	0	.02	-	 < 0.01	9.77E-01
pyrimidine deoxyribonucleotide catabolic process (GO:0009223)	13	0	.30	-	 < 0.01	7.38E-01
pyrimidine ribonucleotide catabolic process (GO:0009222)	11	0	.26	-	 < 0.01	7.74E-01
pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221)	8	0	.19	-	 < 0.01	8.30E-01
pyrimidine ribonucleotide biosynthetic process (GO:0009220)	14	0	.33	-	 < 0.01	7.21E-01
septin ring organization (GO:0031106)	2	0	.05	-	 < 0.01	9.54E-01
dendrite regeneration (GO:0031104)	3	0	.07	-	 < 0.01	9.32E-01
pyrimidine deoxyribonucleotide metabolic process (GO:0009219)	20	0	.47	-	 < 0.01	6.27E-01
pyrimidine ribonucleotide metabolic process (GO:0009218)	26	0	.61	-	 < 0.01	5.45E-01
purine deoxyribonucleoside triphosphate catabolic process (GO:0009217)	5	0	.12	-	 < 0.01	8.90E-01
purine deoxyribonucleoside triphosphate biosynthetic process (GO:0009216)	1	0	.02	-	 < 0.01	9.77E-01
purine deoxyribonucleoside triphosphate metabolic process (GO:0009215)	12	0	.28	-	 < 0.01	7.56E-01
cyclic nucleotide catabolic process (GO:0009214)	6	0	.14	-	 < 0.01	8.69E-01
pyrimidine deoxyribonucleoside triphosphate catabolic process (GO:0009213)	2	0	.05	-	 < 0.01	9.54E-01
pyrimidine deoxyribonucleoside triphosphate biosynthetic process (GO:0009212)	3	0	.07	-	 < 0.01	9.32E-01
pyrimidine deoxyribonucleoside triphosphate metabolic process (GO:0009211)	5	0	.12	-	 < 0.01	8.90E-01
pyrimidine ribonucleoside triphosphate catabolic process (GO:0009210)	1	0	.02	-	 < 0.01	9.77E-01
follicle-stimulating hormone signaling pathway (GO:0042699)	6	0	.14	-	 < 0.01	8.69E-01
menopause (GO:0042697)	1	0	.02	-	 < 0.01	9.77E-01
menarche (GO:0042696)	1	0	.02	-	 < 0.01	9.77E-01
thelarche (GO:0042695)	6	0	.14	-	 < 0.01	8.69E-01
muscle cell fate specification (GO:0042694)	1	0	.02	-	 < 0.01	9.77E-01
muscle cell fate commitment (GO:0042693)	12	0	.28	-	 < 0.01	7.56E-01
pyrimidine ribonucleoside triphosphate biosynthetic process (GO:0009209)	9	0	.21	-	 < 0.01	8.11E-01
pyrimidine ribonucleoside triphosphate metabolic process (GO:0009208)	11	0	.26	-	 < 0.01	7.74E-01
purine ribonucleoside triphosphate catabolic process (GO:0009207)	1	0	.02	-	 < 0.01	9.77E-01
purine ribonucleoside triphosphate biosynthetic process (GO:0009206)	37	0	.86	-	 < 0.01	4.22E-01
negative regulation of connective tissue replacement involved in inflammatory response wound healing (GO:1904597)	1	0	.02	-	 < 0.01	9.77E-01
purine ribonucleoside triphosphate metabolic process (GO:0009205)	53	0	1.24	-	 < 0.01	2.90E-01
regulation of connective tissue replacement involved in inflammatory response wound healing (GO:1904596)	1	0	.02	-	 < 0.01	9.77E-01
deoxyribonucleoside triphosphate catabolic process (GO:0009204)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of termination of RNA polymerase II transcription (GO:1904595)	1	0	.02	-	 < 0.01	9.77E-01
ribonucleoside triphosphate catabolic process (GO:0009203)	2	0	.05	-	 < 0.01	9.54E-01
regulation of termination of RNA polymerase II transcription (GO:1904594)	3	0	.07	-	 < 0.01	9.32E-01
deoxyribonucleoside triphosphate biosynthetic process (GO:0009202)	4	0	.09	-	 < 0.01	9.11E-01
ribonucleoside triphosphate biosynthetic process (GO:0009201)	39	0	.91	-	 < 0.01	4.02E-01
positive regulation of protein refolding (GO:1904592)	1	0	.02	-	 < 0.01	9.77E-01
deoxyribonucleoside triphosphate metabolic process (GO:0009200)	18	0	.42	-	 < 0.01	6.57E-01
negative regulation of protein import (GO:1904590)	15	0	.35	-	 < 0.01	7.05E-01
regulation of cardioblast cell fate specification (GO:0042686)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to glycoprotein (GO:1904588)	1	0	.02	-	 < 0.01	9.77E-01
response to glycoprotein (GO:1904587)	7	0	.16	-	 < 0.01	8.49E-01
cellular response to putrescine (GO:1904586)	1	0	.02	-	 < 0.01	9.77E-01
response to putrescine (GO:1904585)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of intracellular mRNA localization (GO:1904582)	3	0	.07	-	 < 0.01	9.32E-01
regulation of intracellular mRNA localization (GO:1904580)	4	0	.09	-	 < 0.01	9.11E-01
retinal cone cell differentiation (GO:0042670)	13	0	.30	-	 < 0.01	7.38E-01
cellular response to thapsigargin (GO:1904579)	2	0	.05	-	 < 0.01	9.54E-01
response to thapsigargin (GO:1904578)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of selenocysteine insertion sequence binding (GO:1904574)	1	0	.02	-	 < 0.01	9.77E-01
regulation of selenocysteine insertion sequence binding (GO:1904573)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of mRNA binding (GO:1904572)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of selenocysteine incorporation (GO:1904571)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of selenocysteine incorporation (GO:1904570)	1	0	.02	-	 < 0.01	9.77E-01
regulation of inner ear auditory receptor cell fate specification (GO:0042669)	1	0	.02	-	 < 0.01	9.77E-01
auditory receptor cell fate determination (GO:0042668)	1	0	.02	-	 < 0.01	9.77E-01
auditory receptor cell fate specification (GO:0042667)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of ectodermal cell fate specification (GO:0042666)	1	0	.02	-	 < 0.01	9.77E-01
regulation of ectodermal cell fate specification (GO:0042665)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of endodermal cell fate specification (GO:0042664)	2	0	.05	-	 < 0.01	9.54E-01
regulation of endodermal cell fate specification (GO:0042663)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of mesodermal cell fate specification (GO:0042662)	3	0	.07	-	 < 0.01	9.32E-01
regulation of mesodermal cell fate specification (GO:0042661)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of cell fate specification (GO:0042660)	4	0	.09	-	 < 0.01	9.11E-01
regulation of selenocysteine incorporation (GO:1904569)	2	0	.05	-	 < 0.01	9.54E-01
cellular response to wortmannin (GO:1904568)	1	0	.02	-	 < 0.01	9.77E-01
response to wortmannin (GO:1904567)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to 1-oleoyl-sn-glycerol 3-phosphate (GO:1904566)	1	0	.02	-	 < 0.01	9.77E-01
response to 1-oleoyl-sn-glycerol 3-phosphate (GO:1904565)	1	0	.02	-	 < 0.01	9.77E-01
platelet activating factor catabolic process (GO:0062234)	2	0	.05	-	 < 0.01	9.54E-01
prostanoid catabolic process (GO:0062232)	3	0	.07	-	 < 0.01	9.32E-01
phosphatidylinositol 5-phosphate metabolic process (GO:1904562)	2	0	.05	-	 < 0.01	9.54E-01
regulation of cell fate specification (GO:0042659)	18	0	.42	-	 < 0.01	6.57E-01
mitigation of host defenses by symbiont (GO:0030682)	1	0	.02	-	 < 0.01	9.77E-01
L-alanine transmembrane transport (GO:1904557)	4	0	.09	-	 < 0.01	9.11E-01
L-tryptophan transmembrane transport (GO:1904556)	1	0	.02	-	 < 0.01	9.77E-01
response to arachidonic acid (GO:1904550)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of oocyte maturation (GO:1900195)	3	0	.07	-	 < 0.01	9.32E-01
membrane bending (GO:0097753)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of oocyte maturation (GO:1900194)	5	0	.12	-	 < 0.01	8.90E-01
regulation of oocyte maturation (GO:1900193)	8	0	.19	-	 < 0.01	8.30E-01
regulation of DNA stability (GO:0097752)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of single-species biofilm formation (GO:1900191)	3	0	.07	-	 < 0.01	9.32E-01
regulation of single-species biofilm formation (GO:1900190)	3	0	.07	-	 < 0.01	9.32E-01
anagen (GO:0042640)	12	0	.28	-	 < 0.01	7.56E-01
negative regulation of clathrin-dependent endocytosis (GO:1900186)	5	0	.12	-	 < 0.01	8.90E-01
catagen (GO:0042637)	4	0	.09	-	 < 0.01	9.11E-01
mitochondrial tRNA 5'-end processing (GO:0097745)	2	0	.05	-	 < 0.01	9.54E-01
urate salt excretion (GO:0097744)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of hair cycle (GO:0042636)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of hair cycle (GO:0042635)	2	0	.05	-	 < 0.01	9.54E-01
de novo centriole assembly (GO:0097742)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of protein localization to nucleus (GO:1900181)	32	0	.75	-	 < 0.01	4.74E-01
cellular response to water deprivation (GO:0042631)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of pattern recognition receptor signaling pathway (GO:0062208)	41	0	.96	-	 < 0.01	3.84E-01
negative regulation of glycolytic process through fructose-6-phosphate (GO:1904539)	1	0	.02	-	 < 0.01	9.77E-01
regulation of glycolytic process through fructose-6-phosphate (GO:1904538)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of telomeric loop disassembly (GO:1904535)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of telomeric loop disassembly (GO:1904534)	2	0	.05	-	 < 0.01	9.54E-01
regulation of telomeric loop disassembly (GO:1904533)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of actin filament binding (GO:1904531)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of actin filament binding (GO:1904530)	1	0	.02	-	 < 0.01	9.77E-01
mating plug formation (GO:0042628)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry (GO:1900176)	2	0	.05	-	 < 0.01	9.54E-01
extracellular exosome biogenesis (GO:0097734)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of glucocorticoid mediated signaling pathway (GO:1900170)	1	0	.02	-	 < 0.01	9.77E-01
regulation of vitamin metabolic process (GO:0030656)	13	0	.30	-	 < 0.01	7.38E-01
beta-lactam antibiotic metabolic process (GO:0030653)	1	0	.02	-	 < 0.01	9.77E-01
regulation of actin filament binding (GO:1904529)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of microtubule binding (GO:1904527)	2	0	.05	-	 < 0.01	9.54E-01
regulation of glucocorticoid mediated signaling pathway (GO:1900169)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of glial cell-derived neurotrophic factor production (GO:1900168)	3	0	.07	-	 < 0.01	9.32E-01
regulation of glial cell-derived neurotrophic factor production (GO:1900166)	3	0	.07	-	 < 0.01	9.32E-01
nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry (GO:1900164)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of phospholipid scramblase activity (GO:1900163)	1	0	.02	-	 < 0.01	9.77E-01
regulation of phospholipid scramblase activity (GO:1900161)	1	0	.02	-	 < 0.01	9.77E-01
aminoglycoside antibiotic metabolic process (GO:0030647)	10	0	.23	-	 < 0.01	7.92E-01
cellular chloride ion homeostasis (GO:0030644)	12	0	.28	-	 < 0.01	7.56E-01
cellular phosphate ion homeostasis (GO:0030643)	11	0	.26	-	 < 0.01	7.74E-01
positive regulation of TORC2 signaling (GO:1904515)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of bone mineralization involved in bone maturation (GO:1900159)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of protein localization to basolateral plasma membrane (GO:1904510)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of bone mineralization involved in bone maturation (GO:1900158)	4	0	.09	-	 < 0.01	9.11E-01
regulation of bone mineralization involved in bone maturation (GO:1900157)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of bone trabecula formation (GO:1900155)	2	0	.05	-	 < 0.01	9.54E-01
regulation of bone trabecula formation (GO:1900154)	2	0	.05	-	 < 0.01	9.54E-01
vesicle targeting, trans-Golgi to periciliary membrane compartment (GO:0097712)	1	0	.02	-	 < 0.01	9.77E-01
ciliary basal body-plasma membrane docking (GO:0097711)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900152)	3	0	.07	-	 < 0.01	9.32E-01
regulation of defense response to fungus (GO:1900150)	5	0	.12	-	 < 0.01	8.90E-01
polyketide metabolic process (GO:0030638)	10	0	.23	-	 < 0.01	7.92E-01
regulation of protein localization to basolateral plasma membrane (GO:1904508)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of telomere maintenance in response to DNA damage (GO:1904506)	5	0	.12	-	 < 0.01	8.90E-01
regulation of telomere maintenance in response to DNA damage (GO:1904505)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of lipophagy (GO:1904504)	5	0	.12	-	 < 0.01	8.90E-01
regulation of lipophagy (GO:1904502)	5	0	.12	-	 < 0.01	8.90E-01
connective tissue replacement (GO:0097709)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of chromatin-mediated maintenance of transcription (GO:1904501)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of Schwann cell migration (GO:1900149)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of Schwann cell migration (GO:1900148)	1	0	.02	-	 < 0.01	9.77E-01
regulation of Schwann cell migration (GO:1900147)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of nodal signaling pathway involved in determination of left/right asymmetry (GO:1900146)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of oligodendrocyte apoptotic process (GO:1900143)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of oligodendrocyte apoptotic process (GO:1900142)	2	0	.05	-	 < 0.01	9.54E-01
regulation of oligodendrocyte apoptotic process (GO:1900141)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of arachidonic acid secretion (GO:1900139)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of phospholipase A2 activity (GO:1900138)	3	0	.07	-	 < 0.01	9.32E-01
meiotic chromosome movement towards spindle pole (GO:0016344)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of renin secretion into blood stream (GO:1900135)	2	0	.05	-	 < 0.01	9.54E-01
secretory granule maturation (GO:0061792)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of renin secretion into blood stream (GO:1900134)	1	0	.02	-	 < 0.01	9.77E-01
regulation of renin secretion into blood stream (GO:1900133)	4	0	.09	-	 < 0.01	9.11E-01
calcium-dependent cell-matrix adhesion (GO:0016340)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of lipid binding (GO:1900131)	1	0	.02	-	 < 0.01	9.77E-01
regulation of lipid binding (GO:1900130)	1	0	.02	-	 < 0.01	9.77E-01
calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339)	32	0	.75	-	 < 0.01	4.74E-01
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338)	7	0	.16	-	 < 0.01	8.49E-01
dense core granule priming (GO:0061789)	4	0	.09	-	 < 0.01	9.11E-01
regulation of G-protein activated inward rectifier potassium channel activity (GO:1900128)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of hyaluronan biosynthetic process (GO:1900127)	5	0	.12	-	 < 0.01	8.90E-01
establishment or maintenance of polarity of follicular epithelium (GO:0016334)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of hyaluronan biosynthetic process (GO:1900126)	4	0	.09	-	 < 0.01	9.11E-01
morphogenesis of follicular epithelium (GO:0016333)	1	0	.02	-	 < 0.01	9.77E-01
establishment or maintenance of polarity of embryonic epithelium (GO:0016332)	2	0	.05	-	 < 0.01	9.54E-01
regulation of hyaluronan biosynthetic process (GO:1900125)	9	0	.21	-	 < 0.01	8.11E-01
negative regulation of nodal receptor complex assembly (GO:1900124)	1	0	.02	-	 < 0.01	9.77E-01
vesicle fusion with vesicle (GO:0061782)	1	0	.02	-	 < 0.01	9.77E-01
regulation of nodal receptor complex assembly (GO:1900123)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of receptor binding (GO:1900121)	16	0	.37	-	 < 0.01	6.89E-01
positive regulation of DNA repair by transcription from RNA polymerase II promoter (GO:0100026)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of execution phase of apoptosis (GO:1900119)	10	0	.23	-	 < 0.01	7.92E-01
negative regulation of execution phase of apoptosis (GO:1900118)	9	0	.21	-	 < 0.01	8.11E-01
regulation of execution phase of apoptosis (GO:1900117)	18	0	.42	-	 < 0.01	6.57E-01
extracellular negative regulation of signal transduction (GO:1900116)	10	0	.23	-	 < 0.01	7.92E-01
extracellular regulation of signal transduction (GO:1900115)	10	0	.23	-	 < 0.01	7.92E-01
female meiosis chromosome segregation (GO:0016321)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of histone H3-K9 trimethylation (GO:1900114)	4	0	.09	-	 < 0.01	9.11E-01
xenobiotic transport across blood-nerve barrier (GO:0061772)	1	0	.02	-	 < 0.01	9.77E-01
response to caloric restriction (GO:0061771)	3	0	.07	-	 < 0.01	9.32E-01
endoplasmic reticulum membrane fusion (GO:0016320)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of histone H3-K9 trimethylation (GO:1900113)	7	0	.16	-	 < 0.01	8.49E-01
regulation of histone H3-K9 trimethylation (GO:1900112)	12	0	.28	-	 < 0.01	7.56E-01
positive regulation of histone H3-K9 dimethylation (GO:1900111)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of histone H3-K9 dimethylation (GO:1900110)	2	0	.05	-	 < 0.01	9.54E-01
mitochondrion transport along microtubule (GO:0047497)	21	0	.49	-	 < 0.01	6.13E-01
regulation of histone H3-K9 dimethylation (GO:1900109)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of nodal signaling pathway (GO:1900108)	4	0	.09	-	 < 0.01	9.11E-01
regulation of heart induction by canonical Wnt signaling pathway (GO:0100012)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of hyaluranon cable assembly (GO:1900106)	3	0	.07	-	 < 0.01	9.32E-01
multivesicular body-lysosome fusion (GO:0061763)	2	0	.05	-	 < 0.01	9.54E-01
regulation of hyaluranon cable assembly (GO:1900104)	3	0	.07	-	 < 0.01	9.32E-01
CAMKK-AMPK signaling cascade (GO:0061762)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103)	10	0	.23	-	 < 0.01	7.92E-01
negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102)	11	0	.26	-	 < 0.01	7.74E-01
antifungal innate immune response (GO:0061760)	2	0	.05	-	 < 0.01	9.54E-01
regulation of endoplasmic reticulum unfolded protein response (GO:1900101)	22	0	.51	-	 < 0.01	5.99E-01
positive regulation of plasma cell differentiation (GO:1900100)	3	0	.07	-	 < 0.01	9.32E-01
low-density lipoprotein particle mediated signaling (GO:0055096)	3	0	.07	-	 < 0.01	9.32E-01
lipoprotein particle mediated signaling (GO:0055095)	3	0	.07	-	 < 0.01	9.32E-01
response to lipoprotein particle (GO:0055094)	24	0	.56	-	 < 0.01	5.71E-01
response to hyperoxia (GO:0055093)	7	0	.16	-	 < 0.01	8.49E-01
regulation of response to osmotic stress (GO:0047484)	15	0	.35	-	 < 0.01	7.05E-01
phospholipid homeostasis (GO:0055091)	16	0	.37	-	 < 0.01	6.89E-01
leukocyte adhesion to arterial endothelial cell (GO:0061757)	1	0	.02	-	 < 0.01	9.77E-01
regulation of skeletal muscle contraction by action potential (GO:0100001)	1	0	.02	-	 < 0.01	9.77E-01
substrate localization to autophagosome (GO:0061753)	1	0	.02	-	 < 0.01	9.77E-01
monovalent inorganic anion homeostasis (GO:0055083)	22	0	.51	-	 < 0.01	5.99E-01
anion homeostasis (GO:0055081)	43	0	1.00	-	 < 0.01	3.67E-01
motor learning (GO:0061743)	7	0	.16	-	 < 0.01	8.49E-01
chaperone-mediated protein transport involved in chaperone-mediated autophagy (GO:0061741)	1	0	.02	-	 < 0.01	9.77E-01
protein targeting to lysosome involved in chaperone-mediated autophagy (GO:0061740)	2	0	.05	-	 < 0.01	9.54E-01
sodium ion homeostasis (GO:0055078)	37	0	.86	-	 < 0.01	4.22E-01
potassium ion homeostasis (GO:0055075)	31	0	.72	-	 < 0.01	4.85E-01
cadmium ion homeostasis (GO:0055073)	3	0	.07	-	 < 0.01	9.32E-01
manganese ion homeostasis (GO:0055071)	3	0	.07	-	 < 0.01	9.32E-01
copper ion homeostasis (GO:0055070)	15	0	.35	-	 < 0.01	7.05E-01
carnosine biosynthetic process (GO:0035499)	1	0	.02	-	 < 0.01	9.77E-01
carnosine metabolic process (GO:0035498)	1	0	.02	-	 < 0.01	9.77E-01
protein lipidation involved in autophagosome assembly (GO:0061739)	4	0	.09	-	 < 0.01	9.11E-01
SNARE complex disassembly (GO:0035494)	3	0	.07	-	 < 0.01	9.32E-01
late endosomal microautophagy (GO:0061738)	3	0	.07	-	 < 0.01	9.32E-01
SNARE complex assembly (GO:0035493)	12	0	.28	-	 < 0.01	7.56E-01
leukotriene signaling pathway (GO:0061737)	1	0	.02	-	 < 0.01	9.77E-01
engulfment of target by autophagosome (GO:0061736)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of leukotriene production involved in inflammatory response (GO:0035491)	1	0	.02	-	 < 0.01	9.77E-01
regulation of leukotriene production involved in inflammatory response (GO:0035490)	1	0	.02	-	 < 0.01	9.77E-01
parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization (GO:0061734)	4	0	.09	-	 < 0.01	9.11E-01
mitochondrial acetyl-CoA biosynthetic process from pyruvate (GO:0061732)	8	0	.19	-	 < 0.01	8.30E-01
zinc ion homeostasis (GO:0055069)	27	0	.63	-	 < 0.01	5.33E-01
chloride ion homeostasis (GO:0055064)	21	0	.49	-	 < 0.01	6.13E-01
phosphate ion homeostasis (GO:0055062)	16	0	.37	-	 < 0.01	6.89E-01
purine nucleobase salvage (GO:0043096)	3	0	.07	-	 < 0.01	9.32E-01
regulation of GTP cyclohydrolase I activity (GO:0043095)	1	0	.02	-	 < 0.01	9.77E-01
cellular metabolic compound salvage (GO:0043094)	17	0	.40	-	 < 0.01	6.73E-01
gastric emptying (GO:0035483)	4	0	.09	-	 < 0.01	9.11E-01
methylglyoxal catabolic process to lactate (GO:0061727)	5	0	.12	-	 < 0.01	8.90E-01
mitochondrion disassembly (GO:0061726)	36	0	.84	-	 < 0.01	4.32E-01
gastric motility (GO:0035482)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of Notch signaling pathway involved in heart induction (GO:0035481)	5	0	.12	-	 < 0.01	8.90E-01
cytosolic lipolysis (GO:0061725)	1	0	.02	-	 < 0.01	9.77E-01
regulation of Notch signaling pathway involved in heart induction (GO:0035480)	5	0	.12	-	 < 0.01	8.90E-01
lipophagy (GO:0061724)	2	0	.05	-	 < 0.01	9.54E-01
glycophagy (GO:0061723)	2	0	.05	-	 < 0.01	9.54E-01
asymmetric neuroblast division (GO:0055059)	6	0	.14	-	 < 0.01	8.69E-01
angioblast cell migration (GO:0035476)	1	0	.02	-	 < 0.01	9.77E-01
penile erection (GO:0043084)	5	0	.12	-	 < 0.01	8.90E-01
miRNA 2'-O-methylation (GO:0061715)	1	0	.02	-	 < 0.01	9.77E-01
luteinizing hormone signaling pathway involved in ovarian follicle development (GO:0035471)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of vascular wound healing (GO:0035470)	5	0	.12	-	 < 0.01	8.90E-01
anterior neural tube closure (GO:0061713)	4	0	.09	-	 < 0.01	9.11E-01
amiloride transport (GO:0015898)	1	0	.02	-	 < 0.01	9.77E-01
drug transport (GO:0015893)	15	0	.35	-	 < 0.01	7.05E-01
siderophore transport (GO:0015891)	2	0	.05	-	 < 0.01	9.54E-01
anastral spindle assembly (GO:0055048)	1	0	.02	-	 < 0.01	9.77E-01
determination of pancreatic left/right asymmetry (GO:0035469)	5	0	.12	-	 < 0.01	8.90E-01
reticulophagy (GO:0061709)	10	0	.23	-	 < 0.01	7.92E-01
cobalamin transport (GO:0015889)	4	0	.09	-	 < 0.01	9.11E-01
thiamine transport (GO:0015888)	3	0	.07	-	 < 0.01	9.32E-01
pantothenate transmembrane transport (GO:0015887)	1	0	.02	-	 < 0.01	9.77E-01
heme transport (GO:0015886)	10	0	.23	-	 < 0.01	7.92E-01
folic acid transport (GO:0015884)	6	0	.14	-	 < 0.01	8.69E-01
FAD transport (GO:0015883)	1	0	.02	-	 < 0.01	9.77E-01
coenzyme A transport (GO:0015880)	1	0	.02	-	 < 0.01	9.77E-01
vesicle cargo loading (GO:0035459)	15	0	.35	-	 < 0.01	7.05E-01
cellular response to interferon-beta (GO:0035458)	35	0	.82	-	 < 0.01	4.42E-01
cellular response to interferon-alpha (GO:0035457)	11	0	.26	-	 < 0.01	7.74E-01
intercellular bridge organization (GO:0043063)	1	0	.02	-	 < 0.01	9.77E-01
meiotic metaphase I plate congression (GO:0043060)	2	0	.05	-	 < 0.01	9.54E-01
carnitine transport (GO:0015879)	6	0	.14	-	 < 0.01	8.69E-01
biotin transport (GO:0015878)	3	0	.07	-	 < 0.01	9.32E-01
norepinephrine transport (GO:0015874)	6	0	.14	-	 < 0.01	8.69E-01
dopamine transport (GO:0015872)	11	0	.26	-	 < 0.01	7.74E-01
choline transport (GO:0015871)	8	0	.19	-	 < 0.01	8.30E-01
acetylcholine transport (GO:0015870)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of cardiac muscle tissue development (GO:0055026)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of cardiac muscle fiber development (GO:0055020)	1	0	.02	-	 < 0.01	9.77E-01
forward locomotion (GO:0043056)	1	0	.02	-	 < 0.01	9.77E-01
thermotaxis (GO:0043052)	2	0	.05	-	 < 0.01	9.54E-01
dipeptide transmembrane transport (GO:0035442)	5	0	.12	-	 < 0.01	8.90E-01
cell migration involved in vasculogenesis (GO:0035441)	4	0	.09	-	 < 0.01	9.11E-01
deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087)	4	0	.09	-	 < 0.01	9.11E-01
purine ribonucleotide transport (GO:0015868)	13	0	.30	-	 < 0.01	7.38E-01
nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)	6	0	.14	-	 < 0.01	8.69E-01
ATP transport (GO:0015867)	9	0	.21	-	 < 0.01	8.11E-01
ADP transport (GO:0015866)	4	0	.09	-	 < 0.01	9.11E-01
purine nucleotide transport (GO:0015865)	16	0	.37	-	 < 0.01	6.89E-01
pyrimidine nucleoside transport (GO:0015864)	5	0	.12	-	 < 0.01	8.90E-01
uridine transport (GO:0015862)	5	0	.12	-	 < 0.01	8.90E-01
cytidine transport (GO:0015861)	1	0	.02	-	 < 0.01	9.77E-01
purine nucleoside transmembrane transport (GO:0015860)	4	0	.09	-	 < 0.01	9.11E-01
regulation of cardiac muscle fiber development (GO:0055018)	1	0	.02	-	 < 0.01	9.77E-01
ventricular cardiac muscle cell development (GO:0055015)	11	0	.26	-	 < 0.01	7.74E-01
atrial cardiac muscle cell development (GO:0055014)	3	0	.07	-	 < 0.01	9.32E-01
cardiac muscle cell development (GO:0055013)	68	0	1.59	-	 < 0.01	2.04E-01
ventricular cardiac muscle cell differentiation (GO:0055012)	17	0	.40	-	 < 0.01	6.73E-01
ribonucleoside triphosphate metabolic process (GO:0009199)	55	0	1.28	-	 < 0.01	2.77E-01
atrial cardiac muscle cell differentiation (GO:0055011)	3	0	.07	-	 < 0.01	9.32E-01
pyrimidine deoxyribonucleoside diphosphate biosynthetic process (GO:0009197)	3	0	.07	-	 < 0.01	9.32E-01
pyrimidine deoxyribonucleoside diphosphate metabolic process (GO:0009196)	3	0	.07	-	 < 0.01	9.32E-01
pyrimidine ribonucleoside diphosphate catabolic process (GO:0009195)	2	0	.05	-	 < 0.01	9.54E-01
dolichyl monophosphate biosynthetic process (GO:0043048)	1	0	.02	-	 < 0.01	9.77E-01
pyrimidine ribonucleoside diphosphate biosynthetic process (GO:0009194)	1	0	.02	-	 < 0.01	9.77E-01
pyrimidine ribonucleoside diphosphate metabolic process (GO:0009193)	3	0	.07	-	 < 0.01	9.32E-01
DNA methylation involved in gamete generation (GO:0043046)	19	0	.44	-	 < 0.01	6.42E-01
deoxyribonucleoside diphosphate catabolic process (GO:0009192)	1	0	.02	-	 < 0.01	9.77E-01
DNA methylation involved in embryo development (GO:0043045)	7	0	.16	-	 < 0.01	8.49E-01
ribonucleoside diphosphate catabolic process (GO:0009191)	11	0	.26	-	 < 0.01	7.74E-01
copper ion transmembrane transport (GO:0035434)	5	0	.12	-	 < 0.01	8.90E-01
amino acid activation for nonribosomal peptide biosynthetic process (GO:0043041)	1	0	.02	-	 < 0.01	9.77E-01
post-embryonic camera-type eye development (GO:0031077)	10	0	.23	-	 < 0.01	7.92E-01
nucleoside transport (GO:0015858)	7	0	.16	-	 < 0.01	8.49E-01
pyrimidine nucleobase transport (GO:0015855)	3	0	.07	-	 < 0.01	9.32E-01
guanine transport (GO:0015854)	1	0	.02	-	 < 0.01	9.77E-01
adenine transport (GO:0015853)	1	0	.02	-	 < 0.01	9.77E-01
nucleobase transport (GO:0015851)	4	0	.09	-	 < 0.01	9.11E-01
atrial cardiac muscle tissue morphogenesis (GO:0055009)	8	0	.19	-	 < 0.01	8.30E-01
cardiac muscle cell differentiation (GO:0055007)	101	0	2.35	-	 < 0.01	9.43E-02
ventricular cardiac myofibril assembly (GO:0055005)	3	0	.07	-	 < 0.01	9.32E-01
cardiac myofibril assembly (GO:0055003)	18	0	.42	-	 < 0.01	6.57E-01
deoxyribonucleoside diphosphate biosynthetic process (GO:0009189)	4	0	.09	-	 < 0.01	9.11E-01
ribonucleoside diphosphate biosynthetic process (GO:0009188)	5	0	.12	-	 < 0.01	8.90E-01
tRNA aminoacylation (GO:0043039)	39	0	.91	-	 < 0.01	4.02E-01
deoxyribonucleoside diphosphate metabolic process (GO:0009186)	5	0	.12	-	 < 0.01	8.90E-01
amino acid activation (GO:0043038)	40	0	.93	-	 < 0.01	3.93E-01
purine deoxyribonucleoside diphosphate catabolic process (GO:0009184)	1	0	.02	-	 < 0.01	9.77E-01
purine deoxyribonucleoside diphosphate biosynthetic process (GO:0009183)	1	0	.02	-	 < 0.01	9.77E-01
purine deoxyribonucleoside diphosphate metabolic process (GO:0009182)	2	0	.05	-	 < 0.01	9.54E-01
extracellular matrix-cell signaling (GO:0035426)	5	0	.12	-	 < 0.01	8.90E-01
purine ribonucleoside diphosphate catabolic process (GO:0009181)	7	0	.16	-	 < 0.01	8.49E-01
purine ribonucleoside diphosphate biosynthetic process (GO:0009180)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of histone deacetylation (GO:0031064)	4	0	.09	-	 < 0.01	9.11E-01
polyamine transport (GO:0015846)	1	0	.02	-	 < 0.01	9.77E-01
monoamine transport (GO:0015844)	25	0	.58	-	 < 0.01	5.58E-01
aminergic neurotransmitter loading into synaptic vesicle (GO:0015842)	4	0	.09	-	 < 0.01	9.11E-01
urea transport (GO:0015840)	6	0	.14	-	 < 0.01	8.69E-01
pyrimidine deoxyribonucleoside monophosphate catabolic process (GO:0009178)	11	0	.26	-	 < 0.01	7.74E-01
pyrimidine deoxyribonucleoside monophosphate biosynthetic process (GO:0009177)	4	0	.09	-	 < 0.01	9.11E-01
T cell homeostasis (GO:0043029)	38	0	.89	-	 < 0.01	4.12E-01
pyrimidine deoxyribonucleoside monophosphate metabolic process (GO:0009176)	15	0	.35	-	 < 0.01	7.05E-01
pyrimidine ribonucleoside monophosphate catabolic process (GO:0009175)	9	0	.21	-	 < 0.01	8.11E-01
pyrimidine ribonucleoside monophosphate biosynthetic process (GO:0009174)	3	0	.07	-	 < 0.01	9.32E-01
pyrimidine ribonucleoside monophosphate metabolic process (GO:0009173)	12	0	.28	-	 < 0.01	7.56E-01
purine deoxyribonucleoside monophosphate catabolic process (GO:0009172)	9	0	.21	-	 < 0.01	8.11E-01
purine deoxyribonucleoside monophosphate metabolic process (GO:0009170)	10	0	.23	-	 < 0.01	7.92E-01
chromatin remodeling at centromere (GO:0031055)	8	0	.19	-	 < 0.01	8.30E-01
amine transport (GO:0015837)	6	0	.14	-	 < 0.01	8.69E-01
peptidoglycan transport (GO:0015835)	3	0	.07	-	 < 0.01	9.32E-01
chromosome breakage (GO:0031052)	1	0	.02	-	 < 0.01	9.77E-01
purine ribonucleoside monophosphate catabolic process (GO:0009169)	13	0	.30	-	 < 0.01	7.38E-01
purine ribonucleoside monophosphate biosynthetic process (GO:0009168)	18	0	.42	-	 < 0.01	6.57E-01
purine ribonucleoside monophosphate metabolic process (GO:0009167)	33	0	.77	-	 < 0.01	4.63E-01
nucleotide catabolic process (GO:0009166)	65	0	1.52	-	 < 0.01	2.19E-01
histone H3-Y41 phosphorylation (GO:0035409)	1	0	.02	-	 < 0.01	9.77E-01
histone H3-T6 phosphorylation (GO:0035408)	2	0	.05	-	 < 0.01	9.54E-01
nucleoside catabolic process (GO:0009164)	22	0	.51	-	 < 0.01	5.99E-01
nucleoside biosynthetic process (GO:0009163)	20	0	.47	-	 < 0.01	6.27E-01
histone H3-T11 phosphorylation (GO:0035407)	1	0	.02	-	 < 0.01	9.77E-01
deoxyribonucleoside monophosphate metabolic process (GO:0009162)	25	0	.58	-	 < 0.01	5.58E-01
histone-tyrosine phosphorylation (GO:0035406)	1	0	.02	-	 < 0.01	9.77E-01
histone-threonine phosphorylation (GO:0035405)	6	0	.14	-	 < 0.01	8.69E-01
ribonucleoside monophosphate metabolic process (GO:0009161)	45	0	1.05	-	 < 0.01	3.50E-01
histone-serine phosphorylation (GO:0035404)	8	0	.19	-	 < 0.01	8.30E-01
myeloid dendritic cell differentiation (GO:0043011)	22	0	.51	-	 < 0.01	5.99E-01
programmed DNA elimination (GO:0031049)	1	0	.02	-	 < 0.01	9.77E-01
heterochromatin assembly by small RNA (GO:0031048)	3	0	.07	-	 < 0.01	9.32E-01
valine transport (GO:0015829)	1	0	.02	-	 < 0.01	9.77E-01
tryptophan transport (GO:0015827)	4	0	.09	-	 < 0.01	9.11E-01
threonine transport (GO:0015826)	1	0	.02	-	 < 0.01	9.77E-01
phenylalanine transport (GO:0015823)	2	0	.05	-	 < 0.01	9.54E-01
ornithine transport (GO:0015822)	8	0	.19	-	 < 0.01	8.30E-01
leucine transport (GO:0015820)	6	0	.14	-	 < 0.01	8.69E-01
deoxyribonucleoside monophosphate catabolic process (GO:0009159)	20	0	.47	-	 < 0.01	6.27E-01
ribonucleoside monophosphate catabolic process (GO:0009158)	21	0	.49	-	 < 0.01	6.13E-01
deoxyribonucleoside monophosphate biosynthetic process (GO:0009157)	4	0	.09	-	 < 0.01	9.11E-01
ribonucleoside monophosphate biosynthetic process (GO:0009156)	22	0	.51	-	 < 0.01	5.99E-01
purine deoxyribonucleotide catabolic process (GO:0009155)	14	0	.33	-	 < 0.01	7.21E-01
purine ribonucleotide catabolic process (GO:0009154)	34	0	.79	-	 < 0.01	4.52E-01
maintenance of rDNA (GO:0043007)	1	0	.02	-	 < 0.01	9.77E-01
purine deoxyribonucleotide biosynthetic process (GO:0009153)	2	0	.05	-	 < 0.01	9.54E-01
activation of phospholipase A2 activity by calcium-mediated signaling (GO:0043006)	1	0	.02	-	 < 0.01	9.77E-01
purine deoxyribonucleotide metabolic process (GO:0009151)	20	0	.47	-	 < 0.01	6.27E-01
cytoplasmic sequestering of CFTR protein (GO:0043004)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of Golgi to plasma membrane CFTR protein transport (GO:0043002)	1	0	.02	-	 < 0.01	9.77E-01
Golgi to plasma membrane CFTR protein transport (GO:0043000)	2	0	.05	-	 < 0.01	9.54E-01
lysine transport (GO:0015819)	2	0	.05	-	 < 0.01	9.54E-01
myosin filament assembly (GO:0031034)	4	0	.09	-	 < 0.01	9.11E-01
myosin filament organization (GO:0031033)	4	0	.09	-	 < 0.01	9.11E-01
gamma-aminobutyric acid transport (GO:0015812)	11	0	.26	-	 < 0.01	7.74E-01
L-cystine transport (GO:0015811)	4	0	.09	-	 < 0.01	9.11E-01
pyrimidine nucleoside triphosphate catabolic process (GO:0009149)	3	0	.07	-	 < 0.01	9.32E-01
pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148)	12	0	.28	-	 < 0.01	7.56E-01
pyrimidine nucleoside triphosphate metabolic process (GO:0009147)	16	0	.37	-	 < 0.01	6.89E-01
purine nucleoside triphosphate catabolic process (GO:0009146)	6	0	.14	-	 < 0.01	8.69E-01
purine nucleoside triphosphate biosynthetic process (GO:0009145)	38	0	.89	-	 < 0.01	4.12E-01
purine nucleoside triphosphate metabolic process (GO:0009144)	62	0	1.45	-	 < 0.01	2.35E-01
negative regulation of hemoglobin biosynthetic process (GO:0046986)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of hemoglobin biosynthetic process (GO:0046985)	4	0	.09	-	 < 0.01	9.11E-01
regulation of hemoglobin biosynthetic process (GO:0046984)	6	0	.14	-	 < 0.01	8.69E-01
pyrimidine nucleoside diphosphate catabolic process (GO:0009140)	2	0	.05	-	 < 0.01	9.54E-01
arginine transport (GO:0015809)	9	0	.21	-	 < 0.01	8.11E-01
S-adenosyl-L-methionine transport (GO:0015805)	1	0	.02	-	 < 0.01	9.77E-01
nuclear migration along microfilament (GO:0031022)	2	0	.05	-	 < 0.01	9.54E-01
branched-chain amino acid transport (GO:0015803)	4	0	.09	-	 < 0.01	9.11E-01
aromatic amino acid transport (GO:0015801)	8	0	.19	-	 < 0.01	8.30E-01
pyrimidine nucleoside diphosphate biosynthetic process (GO:0009139)	3	0	.07	-	 < 0.01	9.32E-01
pyrimidine nucleoside diphosphate metabolic process (GO:0009138)	5	0	.12	-	 < 0.01	8.90E-01
purine nucleoside diphosphate catabolic process (GO:0009137)	7	0	.16	-	 < 0.01	8.49E-01
purine nucleoside diphosphate biosynthetic process (GO:0009136)	4	0	.09	-	 < 0.01	9.11E-01
nucleoside diphosphate biosynthetic process (GO:0009133)	8	0	.19	-	 < 0.01	8.30E-01
pyrimidine nucleoside monophosphate catabolic process (GO:0009131)	11	0	.26	-	 < 0.01	7.74E-01
pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130)	7	0	.16	-	 < 0.01	8.49E-01
endocrine pancreas development (GO:0031018)	53	0	1.24	-	 < 0.01	2.90E-01
exocrine pancreas development (GO:0031017)	9	0	.21	-	 < 0.01	8.11E-01
pancreas development (GO:0031016)	84	0	1.96	-	 < 0.01	1.40E-01
pyrimidine nucleoside monophosphate metabolic process (GO:0009129)	18	0	.42	-	 < 0.01	6.57E-01
purine nucleoside monophosphate catabolic process (GO:0009128)	14	0	.33	-	 < 0.01	7.21E-01
purine nucleoside monophosphate biosynthetic process (GO:0009127)	18	0	.42	-	 < 0.01	6.57E-01
peptide antigen transport (GO:0046968)	1	0	.02	-	 < 0.01	9.77E-01
purine nucleoside monophosphate metabolic process (GO:0009126)	34	0	.79	-	 < 0.01	4.52E-01
cytosol to endoplasmic reticulum transport (GO:0046967)	4	0	.09	-	 < 0.01	9.11E-01
nucleoside monophosphate catabolic process (GO:0009125)	25	0	.58	-	 < 0.01	5.58E-01
nucleoside monophosphate biosynthetic process (GO:0009124)	27	0	.63	-	 < 0.01	5.33E-01
nucleoside monophosphate metabolic process (GO:0009123)	54	0	1.26	-	 < 0.01	2.83E-01
3'-phosphoadenosine 5'-phosphosulfate transport (GO:0046963)	1	0	.02	-	 < 0.01	9.77E-01
deoxyribonucleoside metabolic process (GO:0009120)	8	0	.19	-	 < 0.01	8.30E-01
ribonucleoside metabolic process (GO:0009119)	61	0	1.42	-	 < 0.01	2.41E-01
radial spoke assembly (GO:0062177)	2	0	.05	-	 < 0.01	9.54E-01
nucleoside metabolic process (GO:0009116)	79	0	1.84	-	 < 0.01	1.58E-01
R-loop disassembly (GO:0062176)	4	0	.09	-	 < 0.01	9.11E-01
brexanolone catabolic process (GO:0062175)	1	0	.02	-	 < 0.01	9.77E-01
xanthine catabolic process (GO:0009115)	7	0	.16	-	 < 0.01	8.49E-01
hypoxanthine catabolic process (GO:0009114)	1	0	.02	-	 < 0.01	9.77E-01
purine nucleobase biosynthetic process (GO:0009113)	7	0	.16	-	 < 0.01	8.49E-01
brexanolone metabolic process (GO:0062173)	2	0	.05	-	 < 0.01	9.54E-01
nucleobase metabolic process (GO:0009112)	33	0	.77	-	 < 0.01	4.63E-01
vitamin catabolic process (GO:0009111)	13	0	.30	-	 < 0.01	7.38E-01
vitamin biosynthetic process (GO:0009110)	12	0	.28	-	 < 0.01	7.56E-01
ketone body catabolic process (GO:0046952)	3	0	.07	-	 < 0.01	9.32E-01
behavioral response to starvation (GO:0042595)	2	0	.05	-	 < 0.01	9.54E-01
G protein-coupled receptor signaling pathway involved in heart process (GO:0086103)	6	0	.14	-	 < 0.01	8.69E-01
peptidyl-lysine deacetylation (GO:0034983)	8	0	.19	-	 < 0.01	8.30E-01
mitochondrial protein processing (GO:0034982)	12	0	.28	-	 < 0.01	7.56E-01
antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590)	9	0	.21	-	 < 0.01	8.11E-01
endothelin receptor signaling pathway (GO:0086100)	6	0	.14	-	 < 0.01	8.69E-01
regulation of chromatin-mediated maintenance of transcription (GO:1904499)	1	0	.02	-	 < 0.01	9.77E-01
fatty-acyl-CoA biosynthetic process (GO:0046949)	5	0	.12	-	 < 0.01	8.90E-01
lipoate biosynthetic process (GO:0009107)	1	0	.02	-	 < 0.01	9.77E-01
lipoate metabolic process (GO:0009106)	2	0	.05	-	 < 0.01	9.54E-01
hydroxylysine biosynthetic process (GO:0046947)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of substance P secretion, neurotransmission (GO:1904496)	1	0	.02	-	 < 0.01	9.77E-01
hydroxylysine metabolic process (GO:0046946)	2	0	.05	-	 < 0.01	9.54E-01
lipopolysaccharide catabolic process (GO:0009104)	1	0	.02	-	 < 0.01	9.77E-01
regulation of substance P secretion, neurotransmission (GO:1904494)	1	0	.02	-	 < 0.01	9.77E-01
vascular endothelial cell response to fluid shear stress (GO:0097699)	1	0	.02	-	 < 0.01	9.77E-01
protein localization to ciliary transition zone (GO:1904491)	7	0	.16	-	 < 0.01	8.49E-01
telomere maintenance via base-excision repair (GO:0097698)	1	0	.02	-	 < 0.01	9.77E-01
nucleoside monophosphate phosphorylation (GO:0046940)	1	0	.02	-	 < 0.01	9.77E-01
establishment of RNA localization to telomere (GO:0097694)	2	0	.05	-	 < 0.01	9.54E-01
protein folding in endoplasmic reticulum (GO:0034975)	5	0	.12	-	 < 0.01	8.90E-01
histone H3-K4 monomethylation (GO:0097692)	6	0	.14	-	 < 0.01	8.69E-01
histone H3-R26 methylation (GO:0034972)	1	0	.02	-	 < 0.01	9.77E-01
histone H3-R17 methylation (GO:0034971)	2	0	.05	-	 < 0.01	9.54E-01
histone H3-R2 methylation (GO:0034970)	2	0	.05	-	 < 0.01	9.54E-01
cellular response to tetrahydrofolate (GO:1904482)	1	0	.02	-	 < 0.01	9.77E-01
response to tetrahydrofolate (GO:1904481)	1	0	.02	-	 < 0.01	9.77E-01
glutamate receptor clustering (GO:0097688)	6	0	.14	-	 < 0.01	8.69E-01
pore complex assembly (GO:0046931)	23	0	.54	-	 < 0.01	5.85E-01
positive regulation of intestinal absorption (GO:1904480)	4	0	.09	-	 < 0.01	9.11E-01
histone arginine methylation (GO:0034969)	7	0	.16	-	 < 0.01	8.49E-01
histone lysine methylation (GO:0034968)	58	0	1.35	-	 < 0.01	2.58E-01
retinoic acid metabolic process (GO:0042573)	25	0	.58	-	 < 0.01	5.58E-01
box H/ACA RNA processing (GO:0034964)	2	0	.05	-	 < 0.01	9.54E-01
double-strand break repair via alternative nonhomologous end joining (GO:0097681)	2	0	.05	-	 < 0.01	9.54E-01
retinol metabolic process (GO:0042572)	23	0	.54	-	 < 0.01	5.85E-01
double-strand break repair via classical nonhomologous end joining (GO:0097680)	6	0	.14	-	 < 0.01	8.69E-01
box C/D RNA processing (GO:0034963)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of transport across blood-brain barrier (GO:0150202)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of transport across blood-brain barrier (GO:0150201)	1	0	.02	-	 < 0.01	9.77E-01
regulation of transport across blood-brain barrier (GO:0150200)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of intestinal absorption (GO:1904479)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of neurotransmitter secretion (GO:0046929)	11	0	.26	-	 < 0.01	7.74E-01
regulation of intestinal absorption (GO:1904478)	15	0	.35	-	 < 0.01	7.05E-01
positive regulation of endothelin production (GO:1904472)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of endothelin production (GO:1904471)	1	0	.02	-	 < 0.01	9.77E-01
regulation of endothelin production (GO:1904470)	3	0	.07	-	 < 0.01	9.32E-01
histone H3-K36 dimethylation (GO:0097676)	3	0	.07	-	 < 0.01	9.32E-01
pteridine-containing compound catabolic process (GO:0042560)	2	0	.05	-	 < 0.01	9.54E-01
DNA ADP-ribosylation (GO:0030592)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of matrix metallopeptidase secretion (GO:1904466)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of matrix metallopeptidase secretion (GO:1904465)	2	0	.05	-	 < 0.01	9.54E-01
regulation of matrix metallopeptidase secretion (GO:1904464)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of substance P secretion (GO:1904460)	1	0	.02	-	 < 0.01	9.77E-01
pteridine-containing compound biosynthetic process (GO:0042559)	13	0	.30	-	 < 0.01	7.38E-01
superoxide anion generation (GO:0042554)	15	0	.35	-	 < 0.01	7.05E-01
regulation of substance P secretion (GO:1904458)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of neuronal action potential (GO:1904457)	3	0	.07	-	 < 0.01	9.32E-01
fatty acid primary amide metabolic process (GO:0062126)	1	0	.02	-	 < 0.01	9.77E-01
regulation of mitochondrial gene expression (GO:0062125)	27	0	.63	-	 < 0.01	5.33E-01
negative regulation of neuronal action potential (GO:1904456)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of potassium:proton exchanging ATPase activity (GO:1904453)	1	0	.02	-	 < 0.01	9.77E-01
regulation of mitochondrial membrane permeability (GO:0046902)	51	0	1.19	-	 < 0.01	3.04E-01
regulation of potassium:proton exchanging ATPase activity (GO:1904451)	1	0	.02	-	 < 0.01	9.77E-01
tetrahydrofolylpolyglutamate biosynthetic process (GO:0046901)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of aspartate secretion (GO:1904450)	2	0	.05	-	 < 0.01	9.54E-01
tetrahydrofolylpolyglutamate metabolic process (GO:0046900)	2	0	.05	-	 < 0.01	9.54E-01
regulation of plasma cell differentiation (GO:1900098)	3	0	.07	-	 < 0.01	9.32E-01
regulation of dosage compensation by inactivation of X chromosome (GO:1900095)	1	0	.02	-	 < 0.01	9.77E-01
cell wall biogenesis (GO:0042546)	1	0	.02	-	 < 0.01	9.77E-01
regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry (GO:1900094)	4	0	.09	-	 < 0.01	9.11E-01
protein N-linked glycosylation via arginine (GO:0042543)	1	0	.02	-	 < 0.01	9.77E-01
ubiquitin-dependent SMAD protein catabolic process (GO:0030579)	6	0	.14	-	 < 0.01	8.69E-01
Cajal body organization (GO:0030576)	4	0	.09	-	 < 0.01	9.11E-01
bile acid catabolic process (GO:0030573)	2	0	.05	-	 < 0.01	9.54E-01
regulation of eIF2 alpha phosphorylation by heme (GO:0010999)	3	0	.07	-	 < 0.01	9.32E-01
regulation of aspartate secretion (GO:1904448)	2	0	.05	-	 < 0.01	9.54E-01
regulation of translational initiation by eIF2 alpha phosphorylation (GO:0010998)	2	0	.05	-	 < 0.01	9.54E-01
folate import across plasma membrane (GO:1904447)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of establishment of Sertoli cell barrier (GO:1904446)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of establishment of Sertoli cell barrier (GO:1904445)	1	0	.02	-	 < 0.01	9.77E-01
free ubiquitin chain polymerization (GO:0010994)	5	0	.12	-	 < 0.01	8.90E-01
regulation of establishment of Sertoli cell barrier (GO:1904444)	3	0	.07	-	 < 0.01	9.32E-01
fatty acid primary amide biosynthetic process (GO:0062112)	1	0	.02	-	 < 0.01	9.77E-01
zinc ion import into organelle (GO:0062111)	2	0	.05	-	 < 0.01	9.54E-01
ubiquitin recycling (GO:0010992)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of thyroid gland epithelial cell proliferation (GO:1904442)	1	0	.02	-	 < 0.01	9.77E-01
regulation of thyroid gland epithelial cell proliferation (GO:1904441)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of SMAD protein complex assembly (GO:0010991)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of iron ion import across plasma membrane (GO:1904440)	2	0	.05	-	 < 0.01	9.54E-01
regulation of SMAD protein complex assembly (GO:0010990)	6	0	.14	-	 < 0.01	8.69E-01
amylin receptor signaling pathway (GO:0097647)	6	0	.14	-	 < 0.01	8.69E-01
hypotonic salinity response (GO:0042539)	2	0	.05	-	 < 0.01	9.54E-01
calcitonin family receptor signaling pathway (GO:0097646)	7	0	.16	-	 < 0.01	8.49E-01
hyperosmotic salinity response (GO:0042538)	8	0	.19	-	 < 0.01	8.30E-01
benzene-containing compound metabolic process (GO:0042537)	22	0	.51	-	 < 0.01	5.99E-01
positive regulation of peptidyl-tyrosine autophosphorylation (GO:1900086)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of peptidyl-tyrosine autophosphorylation (GO:1900085)	1	0	.02	-	 < 0.01	9.77E-01
regulation of peptidyl-tyrosine autophosphorylation (GO:1900084)	7	0	.16	-	 < 0.01	8.49E-01
L-ornithine import across plasma membrane (GO:0097640)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532)	14	0	.33	-	 < 0.01	7.21E-01
negative regulation of low-density lipoprotein particle clearance (GO:0010989)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of iron ion import across plasma membrane (GO:1904439)	1	0	.02	-	 < 0.01	9.77E-01
regulation of low-density lipoprotein particle clearance (GO:0010988)	13	0	.30	-	 < 0.01	7.38E-01
regulation of iron ion import across plasma membrane (GO:1904438)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of transferrin receptor binding (GO:1904437)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of high-density lipoprotein particle clearance (GO:0010987)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of lipoprotein particle clearance (GO:0010986)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of lipoprotein particle clearance (GO:0010985)	10	0	.23	-	 < 0.01	7.92E-01
regulation of transferrin receptor binding (GO:1904435)	2	0	.05	-	 < 0.01	9.54E-01
double-stranded RNA biosynthetic process (GO:0062103)	1	0	.02	-	 < 0.01	9.77E-01
regulation of lipoprotein particle clearance (GO:0010984)	20	0	.47	-	 < 0.01	6.27E-01
positive regulation of ferrous iron binding (GO:1904434)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of high-density lipoprotein particle clearance (GO:0010983)	2	0	.05	-	 < 0.01	9.54E-01
regulation of high-density lipoprotein particle clearance (GO:0010982)	3	0	.07	-	 < 0.01	9.32E-01
regulation of ferrous iron binding (GO:1904432)	2	0	.05	-	 < 0.01	9.54E-01
L-lysine import across plasma membrane (GO:0097639)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of t-circle formation (GO:1904431)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of programmed necrotic cell death (GO:0062100)	4	0	.09	-	 < 0.01	9.11E-01
L-arginine import across plasma membrane (GO:0097638)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of t-circle formation (GO:1904430)	3	0	.07	-	 < 0.01	9.32E-01
regulation of arginine biosynthetic process (GO:1900079)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of neuromuscular synaptic transmission (GO:1900075)	1	0	.02	-	 < 0.01	9.77E-01
regulation of neuromuscular synaptic transmission (GO:1900073)	1	0	.02	-	 < 0.01	9.77E-01
regulation of t-circle formation (GO:1904429)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of tubulin deacetylation (GO:1904428)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of GTP binding (GO:1904426)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of GTP binding (GO:1904425)	2	0	.05	-	 < 0.01	9.54E-01
regulation of GTP binding (GO:1904424)	17	0	.40	-	 < 0.01	6.73E-01
negative regulation of G2/M transition of mitotic cell cycle (GO:0010972)	44	0	1.03	-	 < 0.01	3.58E-01
positive regulation of G2/M transition of mitotic cell cycle (GO:0010971)	27	0	.63	-	 < 0.01	5.33E-01
regulation of cellular hyperosmotic salinity response (GO:1900069)	4	0	.09	-	 < 0.01	9.11E-01
potassium ion export across plasma membrane (GO:0097623)	15	0	.35	-	 < 0.01	7.05E-01
regulation of peroxisome organization (GO:1900063)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of ceramide biosynthetic process (GO:1900060)	4	0	.09	-	 < 0.01	9.11E-01
female genitalia development (GO:0030540)	18	0	.42	-	 < 0.01	6.57E-01
regulation of microtubule nucleation (GO:0010968)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of xenophagy (GO:1904417)	8	0	.19	-	 < 0.01	8.30E-01
regulation of polyamine biosynthetic process (GO:0010967)	1	0	.02	-	 < 0.01	9.77E-01
regulation of phosphate transport (GO:0010966)	9	0	.21	-	 < 0.01	8.11E-01
regulation of xenophagy (GO:1904415)	8	0	.19	-	 < 0.01	8.30E-01
positive regulation of cardiac ventricle development (GO:1904414)	1	0	.02	-	 < 0.01	9.77E-01
regulation of L-arginine import (GO:0010963)	3	0	.07	-	 < 0.01	9.32E-01
regulation of cardiac ventricle development (GO:1904412)	1	0	.02	-	 < 0.01	9.77E-01
O-glycan processing, core 1 (GO:0016267)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of secretory granule organization (GO:1904411)	1	0	.02	-	 < 0.01	9.77E-01
O-glycan processing (GO:0016266)	7	0	.16	-	 < 0.01	8.49E-01
gap junction assembly (GO:0016264)	7	0	.16	-	 < 0.01	8.49E-01
pyrimidine-containing compound salvage (GO:0008655)	1	0	.02	-	 < 0.01	9.77E-01
lipopolysaccharide metabolic process (GO:0008653)	1	0	.02	-	 < 0.01	9.77E-01
selenocysteine catabolic process (GO:0016261)	1	0	.02	-	 < 0.01	9.77E-01
cellular amino acid biosynthetic process (GO:0008652)	52	0	1.21	-	 < 0.01	2.97E-01
positive regulation of retinoic acid biosynthetic process (GO:1900054)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of retinoic acid biosynthetic process (GO:1900053)	1	0	.02	-	 < 0.01	9.77E-01
selenocysteine biosynthetic process (GO:0016260)	2	0	.05	-	 < 0.01	9.54E-01
regulation of retinoic acid biosynthetic process (GO:1900052)	2	0	.05	-	 < 0.01	9.54E-01
serine phosphorylation of STAT protein (GO:0042501)	4	0	.09	-	 < 0.01	9.11E-01
male genitalia development (GO:0030539)	23	0	.54	-	 < 0.01	5.85E-01
embryonic genitalia morphogenesis (GO:0030538)	4	0	.09	-	 < 0.01	9.11E-01
regulation of secretory granule organization (GO:1904409)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of vitamin D biosynthetic process (GO:0010957)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of calcidiol 1-monooxygenase activity (GO:0010956)	3	0	.07	-	 < 0.01	9.32E-01
selenocysteine metabolic process (GO:0016259)	4	0	.09	-	 < 0.01	9.11E-01
N-glycan processing to lysosome (GO:0016256)	1	0	.02	-	 < 0.01	9.77E-01
attachment of GPI anchor to protein (GO:0016255)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of hemostasis (GO:1900047)	45	0	1.05	-	 < 0.01	3.50E-01
negative regulation of protein K63-linked ubiquitination (GO:1900045)	7	0	.16	-	 < 0.01	8.49E-01
androgen receptor signaling pathway (GO:0030521)	15	0	.35	-	 < 0.01	7.05E-01
intracellular estrogen receptor signaling pathway (GO:0030520)	15	0	.35	-	 < 0.01	7.05E-01
negative regulation of intestinal phytosterol absorption (GO:0010949)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of transcription by competitive promoter binding (GO:0010944)	9	0	.21	-	 < 0.01	8.11E-01
protein deglutarylation (GO:0061698)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of necrotic cell death (GO:0010940)	10	0	.23	-	 < 0.01	7.92E-01
apoptotic mitochondrial changes (GO:0008637)	61	0	1.42	-	 < 0.01	2.41E-01
positive regulation of cellular response to hypoxia (GO:1900039)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of cellular response to hypoxia (GO:1900038)	11	0	.26	-	 < 0.01	7.74E-01
activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635)	6	0	.14	-	 < 0.01	8.69E-01
regulation of cellular response to hypoxia (GO:1900037)	16	0	.37	-	 < 0.01	6.89E-01
regulation of autophagosome size (GO:0016243)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of cellular response to heat (GO:1900036)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of macroautophagy (GO:0016242)	29	0	.68	-	 < 0.01	5.08E-01
negative regulation of cellular response to heat (GO:1900035)	1	0	.02	-	 < 0.01	9.77E-01
autophagosome membrane docking (GO:0016240)	4	0	.09	-	 < 0.01	9.11E-01
intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630)	74	0	1.73	-	 < 0.01	1.78E-01
intracellular steroid hormone receptor signaling pathway (GO:0030518)	41	0	.96	-	 < 0.01	3.84E-01
negative regulation of BMP signaling pathway (GO:0030514)	54	0	1.26	-	 < 0.01	2.83E-01
regulation of necrotic cell death (GO:0010939)	34	0	.79	-	 < 0.01	4.52E-01
cytoplasmic microtubule depolymerization (GO:0010938)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of macrophage cytokine production (GO:0010936)	5	0	.12	-	 < 0.01	8.90E-01
regulation of macrophage cytokine production (GO:0010935)	16	0	.37	-	 < 0.01	6.89E-01
macrophage cytokine production (GO:0010934)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of macrophage tolerance induction (GO:0010933)	1	0	.02	-	 < 0.01	9.77E-01
regulation of macrophage tolerance induction (GO:0010932)	1	0	.02	-	 < 0.01	9.77E-01
hormone-mediated apoptotic signaling pathway (GO:0008628)	3	0	.07	-	 < 0.01	9.32E-01
lysosomal microautophagy (GO:0016237)	5	0	.12	-	 < 0.01	8.90E-01
detoxification of inorganic compound (GO:0061687)	8	0	.19	-	 < 0.01	8.30E-01
intrinsic apoptotic signaling pathway in response to osmotic stress (GO:0008627)	1	0	.02	-	 < 0.01	9.77E-01
granzyme-mediated apoptotic signaling pathway (GO:0008626)	1	0	.02	-	 < 0.01	9.77E-01
extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625)	29	0	.68	-	 < 0.01	5.08E-01
chaperone-mediated autophagy (GO:0061684)	6	0	.14	-	 < 0.01	8.69E-01
seminal vesicle morphogenesis (GO:0061682)	1	0	.02	-	 < 0.01	9.77E-01
regulation of D-erythro-sphingosine kinase activity (GO:1900022)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of protein kinase C activity (GO:1900020)	5	0	.12	-	 < 0.01	8.90E-01
inorganic diphosphate transport (GO:0030505)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of bone mineralization (GO:0030502)	19	0	.44	-	 < 0.01	6.42E-01
positive regulation of inositol-polyphosphate 5-phosphatase activity (GO:0010925)	1	0	.02	-	 < 0.01	9.77E-01
regulation of inositol-polyphosphate 5-phosphatase activity (GO:0010924)	1	0	.02	-	 < 0.01	9.77E-01
iron-sulfur cluster assembly (GO:0016226)	18	0	.42	-	 < 0.01	6.57E-01
regulation of protein kinase C activity (GO:1900019)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of inositol phosphate biosynthetic process (GO:0010920)	2	0	.05	-	 < 0.01	9.54E-01
guanosine metabolic process (GO:0008617)	1	0	.02	-	 < 0.01	9.77E-01
pyridoxine biosynthetic process (GO:0008615)	1	0	.02	-	 < 0.01	9.77E-01
pyridoxine metabolic process (GO:0008614)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of cytokine production involved in inflammatory response (GO:1900016)	17	0	.40	-	 < 0.01	6.73E-01
peptidyl-lysine modification to peptidyl-hypusine (GO:0008612)	2	0	.05	-	 < 0.01	9.54E-01
ether lipid biosynthetic process (GO:0008611)	11	0	.26	-	 < 0.01	7.74E-01
evoked neurotransmitter secretion (GO:0061670)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of corticotropin-releasing hormone receptor activity (GO:1900011)	1	0	.02	-	 < 0.01	9.77E-01
regulation of corticotropin-releasing hormone receptor activity (GO:1900010)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of mitochondrial membrane potential (GO:0010918)	13	0	.30	-	 < 0.01	7.38E-01
negative regulation of mitochondrial membrane potential (GO:0010917)	15	0	.35	-	 < 0.01	7.05E-01
negative regulation of very-low-density lipoprotein particle clearance (GO:0010916)	4	0	.09	-	 < 0.01	9.11E-01
regulation of very-low-density lipoprotein particle clearance (GO:0010915)	4	0	.09	-	 < 0.01	9.11E-01
spontaneous neurotransmitter secretion (GO:0061669)	8	0	.19	-	 < 0.01	8.30E-01
positive regulation of isomerase activity (GO:0010912)	5	0	.12	-	 < 0.01	8.90E-01
attachment of spindle microtubules to kinetochore (GO:0008608)	20	0	.47	-	 < 0.01	6.27E-01
negative regulation of eating behavior (GO:1903999)	6	0	.14	-	 < 0.01	8.69E-01
mitochondrial ribosome assembly (GO:0061668)	6	0	.14	-	 < 0.01	8.69E-01
regulation of isomerase activity (GO:0010911)	5	0	.12	-	 < 0.01	8.90E-01
regulation of eating behavior (GO:1903998)	12	0	.28	-	 < 0.01	7.56E-01
positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903996)	1	0	.02	-	 < 0.01	9.77E-01
regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of serine-type endopeptidase activity (GO:1900004)	4	0	.09	-	 < 0.01	9.11E-01
regulation of serine-type endopeptidase activity (GO:1900003)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of heparan sulfate proteoglycan biosynthetic process (GO:0010909)	3	0	.07	-	 < 0.01	9.32E-01
regulation of heparan sulfate proteoglycan biosynthetic process (GO:0010908)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of very-low-density lipoprotein particle remodeling (GO:0010903)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of very-low-density lipoprotein particle remodeling (GO:0010902)	1	0	.02	-	 < 0.01	9.77E-01
regulation of very-low-density lipoprotein particle remodeling (GO:0010901)	4	0	.09	-	 < 0.01	9.11E-01
iron ion export across plasma membrane (GO:1903988)	1	0	.02	-	 < 0.01	9.77E-01
muscle attachment (GO:0016203)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of microglial cell activation (GO:1903980)	7	0	.16	-	 < 0.01	8.49E-01
histone H3-K9 modification (GO:0061647)	15	0	.35	-	 < 0.01	7.05E-01
positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization (GO:0061646)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of glial cell migration (GO:1903976)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of cellular response to macrophage colony-stimulating factor stimulus (GO:1903974)	2	0	.05	-	 < 0.01	9.54E-01
chemoattraction of axon (GO:0061642)	5	0	.12	-	 < 0.01	8.90E-01
CENP-A containing chromatin organization (GO:0061641)	5	0	.12	-	 < 0.01	8.90E-01
regulation of cellular response to macrophage colony-stimulating factor stimulus (GO:1903972)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of response to macrophage colony-stimulating factor (GO:1903971)	2	0	.05	-	 < 0.01	9.54E-01
helper T cell enhancement of adaptive immune response (GO:0035397)	1	0	.02	-	 < 0.01	9.77E-01
regulation of response to macrophage colony-stimulating factor (GO:1903969)	5	0	.12	-	 < 0.01	8.90E-01
regulation of protein complex stability (GO:0061635)	9	0	.21	-	 < 0.01	8.11E-01
monounsaturated fatty acid biosynthetic process (GO:1903966)	4	0	.09	-	 < 0.01	9.11E-01
monounsaturated fatty acid metabolic process (GO:1903964)	4	0	.09	-	 < 0.01	9.11E-01
arachidonate transport (GO:1903963)	24	0	.56	-	 < 0.01	5.71E-01
Roundabout signaling pathway (GO:0035385)	6	0	.14	-	 < 0.01	8.69E-01
thioester biosynthetic process (GO:0035384)	21	0	.49	-	 < 0.01	6.13E-01
sterol transmembrane transport (GO:0035382)	1	0	.02	-	 < 0.01	9.77E-01
glycolytic process through fructose-1-phosphate (GO:0061625)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of protein targeting to mitochondrion (GO:1903955)	7	0	.16	-	 < 0.01	8.49E-01
fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate (GO:0061624)	2	0	.05	-	 < 0.01	9.54E-01
glycolytic process from galactose (GO:0061623)	3	0	.07	-	 < 0.01	9.32E-01
glycolytic process through glucose-1-phosphate (GO:0061622)	4	0	.09	-	 < 0.01	9.11E-01
carbon dioxide transmembrane transport (GO:0035378)	1	0	.02	-	 < 0.01	9.77E-01
transepithelial water transport (GO:0035377)	3	0	.07	-	 < 0.01	9.32E-01
sterol import (GO:0035376)	6	0	.14	-	 < 0.01	8.69E-01
glycolytic process from mannose through fructose-6-phosphate (GO:0061619)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of atrial cardiac muscle cell action potential (GO:1903949)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of ventricular cardiac muscle cell action potential (GO:1903946)	1	0	.02	-	 < 0.01	9.77E-01
pri-miRNA transcription by RNA polymerase II (GO:0061614)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of hepatocyte apoptotic process (GO:1903944)	4	0	.09	-	 < 0.01	9.11E-01
regulation of hepatocyte apoptotic process (GO:1903943)	4	0	.09	-	 < 0.01	9.11E-01
mannose to fructose-6-phosphate metabolic process (GO:0061611)	1	0	.02	-	 < 0.01	9.77E-01
mannitol transport (GO:0015797)	1	0	.02	-	 < 0.01	9.77E-01
glycerol-3-phosphate transmembrane transport (GO:0015794)	1	0	.02	-	 < 0.01	9.77E-01
glycerol transport (GO:0015793)	5	0	.12	-	 < 0.01	8.90E-01
UDP-xylose transmembrane transport (GO:0015790)	1	0	.02	-	 < 0.01	9.77E-01
regulation of TORC2 signaling (GO:1903939)	2	0	.05	-	 < 0.01	9.54E-01
thymine transport (GO:0035364)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360)	8	0	.19	-	 < 0.01	8.30E-01
UDP-glucose transmembrane transport (GO:0015786)	1	0	.02	-	 < 0.01	9.77E-01
GDP-fucose transmembrane transport (GO:0015783)	1	0	.02	-	 < 0.01	9.77E-01
CMP-N-acetylneuraminate transmembrane transport (GO:0015782)	1	0	.02	-	 < 0.01	9.77E-01
nucleotide-sugar transmembrane transport (GO:0015780)	10	0	.23	-	 < 0.01	7.92E-01
negative regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035359)	4	0	.09	-	 < 0.01	9.11E-01
regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358)	14	0	.33	-	 < 0.01	7.21E-01
peroxisome proliferator activated receptor signaling pathway (GO:0035357)	7	0	.16	-	 < 0.01	8.49E-01
primary palate development (GO:1903929)	3	0	.07	-	 < 0.01	9.32E-01
NAD transmembrane transport (GO:0035352)	1	0	.02	-	 < 0.01	9.77E-01
FAD transmembrane transport (GO:0035350)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of protein processing in phagocytic vesicle (GO:1903923)	2	0	.05	-	 < 0.01	9.54E-01
regulation of protein processing in phagocytic vesicle (GO:1903921)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of actin filament severing (GO:1903920)	1	0	.02	-	 < 0.01	9.77E-01
polysaccharide transport (GO:0015774)	1	0	.02	-	 < 0.01	9.77E-01
oligosaccharide transport (GO:0015772)	3	0	.07	-	 < 0.01	9.32E-01
sucrose transport (GO:0015770)	3	0	.07	-	 < 0.01	9.32E-01
viral budding via host ESCRT complex (GO:0039702)	8	0	.19	-	 < 0.01	8.30E-01
coenzyme A transmembrane transport (GO:0035349)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of actin filament severing (GO:1903919)	2	0	.05	-	 < 0.01	9.54E-01
hypoxanthine transport (GO:0035344)	1	0	.02	-	 < 0.01	9.77E-01
regulation of actin filament severing (GO:1903918)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation (GO:1903917)	1	0	.02	-	 < 0.01	9.77E-01
angiotensin-activated signaling pathway involved in heart process (GO:0086098)	2	0	.05	-	 < 0.01	9.54E-01
regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation (GO:1903916)	1	0	.02	-	 < 0.01	9.77E-01
phospholipase C-activating angiotensin-activated signaling pathway (GO:0086097)	2	0	.05	-	 < 0.01	9.54E-01
inosine transport (GO:0035340)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation (GO:1903912)	6	0	.14	-	 < 0.01	8.69E-01
disaccharide transport (GO:0015766)	3	0	.07	-	 < 0.01	9.32E-01
regulation of the force of heart contraction by cardiac conduction (GO:0086092)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of receptor clustering (GO:1903910)	1	0	.02	-	 < 0.01	9.77E-01
glucose-6-phosphate transport (GO:0015760)	5	0	.12	-	 < 0.01	8.90E-01
valine biosynthetic process (GO:0009099)	3	0	.07	-	 < 0.01	9.32E-01
leucine biosynthetic process (GO:0009098)	2	0	.05	-	 < 0.01	9.54E-01
isoleucine biosynthetic process (GO:0009097)	3	0	.07	-	 < 0.01	9.32E-01
aromatic amino acid family biosynthetic process, prephenate pathway (GO:0009095)	1	0	.02	-	 < 0.01	9.77E-01
long-chain fatty-acyl-CoA biosynthetic process (GO:0035338)	4	0	.09	-	 < 0.01	9.11E-01
cysteine catabolic process (GO:0009093)	3	0	.07	-	 < 0.01	9.32E-01
homoserine metabolic process (GO:0009092)	5	0	.12	-	 < 0.01	8.90E-01
peptidyl-tyrosine dephosphorylation (GO:0035335)	38	0	.89	-	 < 0.01	4.12E-01
positive regulation of hippo signaling (GO:0035332)	3	0	.07	-	 < 0.01	9.32E-01
regulation of plasma membrane raft polarization (GO:1903906)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of establishment of T cell polarity (GO:1903905)	2	0	.05	-	 < 0.01	9.54E-01
regulation of establishment of T cell polarity (GO:1903903)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of viral life cycle (GO:1903902)	33	0	.77	-	 < 0.01	4.63E-01
galactose transmembrane transport (GO:0015757)	1	0	.02	-	 < 0.01	9.77E-01
fructose transmembrane transport (GO:0015755)	4	0	.09	-	 < 0.01	9.11E-01
methionine catabolic process (GO:0009087)	1	0	.02	-	 < 0.01	9.77E-01
methionine biosynthetic process (GO:0009086)	12	0	.28	-	 < 0.01	7.56E-01
lysine biosynthetic process (GO:0009085)	2	0	.05	-	 < 0.01	9.54E-01
glutamine family amino acid biosynthetic process (GO:0009084)	13	0	.30	-	 < 0.01	7.38E-01
branched-chain amino acid catabolic process (GO:0009083)	14	0	.33	-	 < 0.01	7.21E-01
branched-chain amino acid biosynthetic process (GO:0009082)	5	0	.12	-	 < 0.01	8.90E-01
branched-chain amino acid metabolic process (GO:0009081)	17	0	.40	-	 < 0.01	6.73E-01
pyruvate family amino acid catabolic process (GO:0009080)	3	0	.07	-	 < 0.01	9.32E-01
bundle of His cell-Purkinje myocyte adhesion involved in cell communication (GO:0086073)	6	0	.14	-	 < 0.01	8.69E-01
urate transport (GO:0015747)	6	0	.14	-	 < 0.01	8.69E-01
AV node cell-bundle of His cell adhesion involved in cell communication (GO:0086072)	1	0	.02	-	 < 0.01	9.77E-01
alpha-ketoglutarate transport (GO:0015742)	2	0	.05	-	 < 0.01	9.54E-01
non-replicative transposition, DNA-mediated (GO:0098038)	1	0	.02	-	 < 0.01	9.77E-01
aromatic amino acid family catabolic process (GO:0009074)	14	0	.33	-	 < 0.01	7.21E-01
aromatic amino acid family biosynthetic process (GO:0009073)	1	0	.02	-	 < 0.01	9.77E-01
aromatic amino acid family metabolic process (GO:0009072)	28	0	.65	-	 < 0.01	5.20E-01
hair cell differentiation (GO:0035315)	51	0	1.19	-	 < 0.01	3.04E-01
serine family amino acid catabolic process (GO:0009071)	12	0	.28	-	 < 0.01	7.56E-01
serine family amino acid biosynthetic process (GO:0009070)	15	0	.35	-	 < 0.01	7.05E-01
bundle of His cell to Purkinje myocyte communication (GO:0086069)	13	0	.30	-	 < 0.01	7.38E-01
Purkinje myocyte to ventricular cardiac muscle cell communication (GO:0086068)	4	0	.09	-	 < 0.01	9.11E-01
AV node cell to bundle of His cell communication (GO:0086067)	11	0	.26	-	 < 0.01	7.74E-01
sialic acid transport (GO:0015739)	5	0	.12	-	 < 0.01	8.90E-01
cell communication by electrical coupling involved in cardiac conduction (GO:0086064)	4	0	.09	-	 < 0.01	9.11E-01
taurine transport (GO:0015734)	6	0	.14	-	 < 0.01	8.69E-01
propanoate transport (GO:0015730)	1	0	.02	-	 < 0.01	9.77E-01
aspartate family amino acid catabolic process (GO:0009068)	12	0	.28	-	 < 0.01	7.56E-01
aspartate family amino acid biosynthetic process (GO:0009067)	20	0	.47	-	 < 0.01	6.27E-01
aspartate family amino acid metabolic process (GO:0009066)	35	0	.82	-	 < 0.01	4.42E-01
glutamine family amino acid catabolic process (GO:0009065)	22	0	.51	-	 < 0.01	5.99E-01
glutamine family amino acid metabolic process (GO:0009064)	54	0	1.26	-	 < 0.01	2.83E-01
cellular amino acid catabolic process (GO:0009063)	78	0	1.82	-	 < 0.01	1.62E-01
bundle of His cell to Purkinje myocyte communication by electrical coupling (GO:0086054)	1	0	.02	-	 < 0.01	9.77E-01
AV node cell to bundle of His cell communication by electrical coupling (GO:0086053)	3	0	.07	-	 < 0.01	9.32E-01
membrane repolarization during SA node cell action potential (GO:0086052)	1	0	.02	-	 < 0.01	9.77E-01
membrane repolarization during bundle of His cell action potential (GO:0086050)	1	0	.02	-	 < 0.01	9.77E-01
formate transport (GO:0015724)	1	0	.02	-	 < 0.01	9.77E-01
canalicular bile acid transport (GO:0015722)	6	0	.14	-	 < 0.01	8.69E-01
bile acid and bile salt transport (GO:0015721)	24	0	.56	-	 < 0.01	5.71E-01
negative regulation of phosphatidylcholine metabolic process (GO:0150174)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of phosphatidylcholine metabolic process (GO:0150173)	3	0	.07	-	 < 0.01	9.32E-01
response to cycloheximide (GO:0046898)	1	0	.02	-	 < 0.01	9.77E-01
pentose-phosphate shunt, non-oxidative branch (GO:0009052)	5	0	.12	-	 < 0.01	8.90E-01
pentose-phosphate shunt, oxidative branch (GO:0009051)	4	0	.09	-	 < 0.01	9.11E-01
membrane depolarization during bundle of His cell action potential (GO:0086048)	3	0	.07	-	 < 0.01	9.32E-01
membrane depolarization during Purkinje myocyte cell action potential (GO:0086047)	3	0	.07	-	 < 0.01	9.32E-01
membrane depolarization during SA node cell action potential (GO:0086046)	4	0	.09	-	 < 0.01	9.11E-01
membrane depolarization during AV node cell action potential (GO:0086045)	5	0	.12	-	 < 0.01	8.90E-01
atrial cardiac muscle cell to AV node cell communication by electrical coupling (GO:0086044)	1	0	.02	-	 < 0.01	9.77E-01
bundle of His cell action potential (GO:0086043)	5	0	.12	-	 < 0.01	8.90E-01
cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042)	7	0	.16	-	 < 0.01	8.49E-01
hexose phosphate transport (GO:0015712)	5	0	.12	-	 < 0.01	8.90E-01
dosage compensation by inactivation of X chromosome (GO:0009048)	19	0	.44	-	 < 0.01	6.42E-01
positive regulation of hormone biosynthetic process (GO:0046886)	14	0	.33	-	 < 0.01	7.21E-01
regulation of hormone biosynthetic process (GO:0046885)	30	0	.70	-	 < 0.01	4.97E-01
follicle-stimulating hormone secretion (GO:0046884)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of follicle-stimulating hormone secretion (GO:0046882)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of follicle-stimulating hormone secretion (GO:0046881)	4	0	.09	-	 < 0.01	9.11E-01
nitrite transport (GO:0015707)	1	0	.02	-	 < 0.01	9.77E-01
nitrate transport (GO:0015706)	1	0	.02	-	 < 0.01	9.77E-01
iodide transport (GO:0015705)	4	0	.09	-	 < 0.01	9.11E-01
adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation (GO:0086030)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of programmed necrotic cell death (GO:0062099)	16	0	.37	-	 < 0.01	6.89E-01
regulation of programmed necrotic cell death (GO:0062098)	22	0	.51	-	 < 0.01	5.99E-01
positive regulation of saliva secretion (GO:0046878)	5	0	.12	-	 < 0.01	8.90E-01
regulation of saliva secretion (GO:0046877)	9	0	.21	-	 < 0.01	8.11E-01
stomach development (GO:0062094)	3	0	.07	-	 < 0.01	9.32E-01
quinolinate metabolic process (GO:0046874)	6	0	.14	-	 < 0.01	8.69E-01
Purkinje myocyte to ventricular cardiac muscle cell signaling (GO:0086029)	4	0	.09	-	 < 0.01	9.11E-01
bundle of His cell to Purkinje myocyte signaling (GO:0086028)	5	0	.12	-	 < 0.01	8.90E-01
AV node cell to bundle of His cell signaling (GO:0086027)	7	0	.16	-	 < 0.01	8.49E-01
adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process (GO:0086023)	3	0	.07	-	 < 0.01	9.32E-01
cell-cell junction disassembly (GO:0150147)	1	0	.02	-	 < 0.01	9.77E-01
cell junction disassembly (GO:0150146)	11	0	.26	-	 < 0.01	7.74E-01
regulation of vein smooth muscle contraction (GO:0062086)	1	0	.02	-	 < 0.01	9.77E-01
terpenoid transport (GO:0046865)	3	0	.07	-	 < 0.01	9.32E-01
isoprenoid transport (GO:0046864)	3	0	.07	-	 < 0.01	9.32E-01
Purkinje myocyte action potential (GO:0086017)	3	0	.07	-	 < 0.01	9.32E-01
AV node cell action potential (GO:0086016)	7	0	.16	-	 < 0.01	8.49E-01
membrane depolarization during cardiac muscle cell action potential (GO:0086012)	12	0	.28	-	 < 0.01	7.56E-01
membrane depolarization during action potential (GO:0086010)	24	0	.56	-	 < 0.01	5.71E-01
phosphatidylinositol dephosphorylation (GO:0046856)	27	0	.63	-	 < 0.01	5.33E-01
inositol phosphate dephosphorylation (GO:0046855)	15	0	.35	-	 < 0.01	7.05E-01
negative regulation of bone remodeling (GO:0046851)	20	0	.47	-	 < 0.01	6.27E-01
detection of diacyl bacterial lipopeptide (GO:0042496)	2	0	.05	-	 < 0.01	9.54E-01
detection of triacyl bacterial lipopeptide (GO:0042495)	2	0	.05	-	 < 0.01	9.54E-01
detection of bacterial lipoprotein (GO:0042494)	5	0	.12	-	 < 0.01	8.90E-01
gamma-delta T cell differentiation (GO:0042492)	7	0	.16	-	 < 0.01	8.49E-01
inner ear auditory receptor cell differentiation (GO:0042491)	44	0	1.03	-	 < 0.01	3.58E-01
positive regulation of interleukin-33 production (GO:0150129)	1	0	.02	-	 < 0.01	9.77E-01
regulation of interleukin-33 production (GO:0150127)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of neuromuscular junction development (GO:1904398)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of neuromuscular junction development (GO:1904397)	2	0	.05	-	 < 0.01	9.54E-01
filopodium assembly (GO:0046847)	21	0	.49	-	 < 0.01	6.13E-01
regulation of neuromuscular junction development (GO:1904396)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of skeletal muscle acetylcholine-gated channel clustering (GO:1904394)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of odontogenesis of dentin-containing tooth (GO:0042489)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of odontogenesis of dentin-containing tooth (GO:0042488)	2	0	.05	-	 < 0.01	9.54E-01
regulation of odontogenesis of dentin-containing tooth (GO:0042487)	13	0	.30	-	 < 0.01	7.38E-01
negative regulation of odontogenesis (GO:0042483)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of odontogenesis (GO:0042482)	7	0	.16	-	 < 0.01	8.49E-01
regulation of odontogenesis (GO:0042481)	22	0	.51	-	 < 0.01	5.99E-01
cell-substrate junction organization (GO:0150115)	38	0	.89	-	 < 0.01	4.12E-01
regulation of transepithelial transport (GO:0150111)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of cholesterol esterification (GO:0150110)	1	0	.02	-	 < 0.01	9.77E-01
phospholipid dephosphorylation (GO:0046839)	35	0	.82	-	 < 0.01	4.42E-01
phosphorylated carbohydrate dephosphorylation (GO:0046838)	17	0	.40	-	 < 0.01	6.73E-01
response to L-phenylalanine derivative (GO:1904386)	1	0	.02	-	 < 0.01	9.77E-01
glycolipid transport (GO:0046836)	4	0	.09	-	 < 0.01	9.11E-01
carbohydrate phosphorylation (GO:0046835)	12	0	.28	-	 < 0.01	7.56E-01
response to sodium phosphate (GO:1904383)	1	0	.02	-	 < 0.01	9.77E-01
mannose trimming involved in glycoprotein ERAD pathway (GO:1904382)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of RNA export from nucleus (GO:0046833)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of RNA export from nucleus (GO:0046832)	2	0	.05	-	 < 0.01	9.54E-01
endoplasmic reticulum mannose trimming (GO:1904380)	3	0	.07	-	 < 0.01	9.32E-01
middle ear morphogenesis (GO:0042474)	24	0	.56	-	 < 0.01	5.71E-01
lamellipodium organization (GO:0097581)	45	0	1.05	-	 < 0.01	3.50E-01
outer ear morphogenesis (GO:0042473)	8	0	.19	-	 < 0.01	8.30E-01
positive regulation of protein localization to cell-cell junction (GO:0150107)	1	0	.02	-	 < 0.01	9.77E-01
regulation of protein localization to cell-cell junction (GO:0150106)	3	0	.07	-	 < 0.01	9.32E-01
protein localization to cell-cell junction (GO:0150105)	21	0	.49	-	 < 0.01	6.13E-01
reactive gliosis (GO:0150103)	1	0	.02	-	 < 0.01	9.77E-01
regulation of microtubule anchoring at centrosome (GO:0150101)	1	0	.02	-	 < 0.01	9.77E-01
protein localization to cytosolic proteasome complex involved in ERAD pathway (GO:1904379)	1	0	.02	-	 < 0.01	9.77E-01
maintenance of unfolded protein involved in ERAD pathway (GO:1904378)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of protein export from nucleus (GO:0046827)	17	0	.40	-	 < 0.01	6.73E-01
negative regulation of protein export from nucleus (GO:0046826)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of cardiac epithelial to mesenchymal transition (GO:0062044)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043)	8	0	.19	-	 < 0.01	8.30E-01
regulation of protein export from nucleus (GO:0046825)	31	0	.72	-	 < 0.01	4.85E-01
regulation of cardiac epithelial to mesenchymal transition (GO:0062042)	9	0	.21	-	 < 0.01	8.11E-01
negative regulation of nucleocytoplasmic transport (GO:0046823)	23	0	.54	-	 < 0.01	5.85E-01
positive regulation of protein localization to actin cortical patch (GO:1904372)	1	0	.02	-	 < 0.01	9.77E-01
regulation of protein localization to actin cortical patch (GO:1904370)	1	0	.02	-	 < 0.01	9.77E-01
sequestering of iron ion (GO:0097577)	5	0	.12	-	 < 0.01	8.90E-01
chemokinesis (GO:0042466)	1	0	.02	-	 < 0.01	9.77E-01
kinesis (GO:0042465)	1	0	.02	-	 < 0.01	9.77E-01
eye photoreceptor cell development (GO:0042462)	39	0	.91	-	 < 0.01	4.02E-01
positive regulation of chemokinesis (GO:1904367)	1	0	.02	-	 < 0.01	9.77E-01
sensory perception of cold stimulus (GO:0062035)	1	0	.02	-	 < 0.01	9.77E-01
regulation of chemokinesis (GO:1904365)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of mitotic sister chromatid segregation (GO:0062033)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of calcitonin secretion (GO:1904364)	1	0	.02	-	 < 0.01	9.77E-01
coreceptor-mediated virion attachment to host cell (GO:0046814)	1	0	.02	-	 < 0.01	9.77E-01
receptor-mediated virion attachment to host cell (GO:0046813)	4	0	.09	-	 < 0.01	9.11E-01
regulation of calcitonin secretion (GO:1904362)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of stress granule assembly (GO:0062030)	1	0	.02	-	 < 0.01	9.77E-01
ribonucleoside biosynthetic process (GO:0042455)	20	0	.47	-	 < 0.01	6.27E-01
ribonucleoside catabolic process (GO:0042454)	19	0	.44	-	 < 0.01	6.42E-01
deoxyguanosine metabolic process (GO:0042453)	1	0	.02	-	 < 0.01	9.77E-01
purine nucleoside biosynthetic process (GO:0042451)	20	0	.47	-	 < 0.01	6.27E-01
arginine biosynthetic process via ornithine (GO:0042450)	2	0	.05	-	 < 0.01	9.54E-01
tRNA methylation (GO:0030488)	27	0	.63	-	 < 0.01	5.33E-01
positive regulation of stress granule assembly (GO:0062029)	2	0	.05	-	 < 0.01	9.54E-01
regulation of stress granule assembly (GO:0062028)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of SCF-dependent proteasomal ubiquitin-dependent catabolic process (GO:0062026)	1	0	.02	-	 < 0.01	9.77E-01
regulation of SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0062025)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of telomere capping (GO:1904354)	9	0	.21	-	 < 0.01	8.11E-01
positive regulation of protein catabolic process in the vacuole (GO:1904352)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of protein catabolic process in the vacuole (GO:1904351)	3	0	.07	-	 < 0.01	9.32E-01
regulation of protein catabolic process in the vacuole (GO:1904350)	8	0	.19	-	 < 0.01	8.30E-01
anterior/posterior axis specification, embryo (GO:0008595)	15	0	.35	-	 < 0.01	7.05E-01
regulation of Toll signaling pathway (GO:0008592)	3	0	.07	-	 < 0.01	9.32E-01
mitochondrial double-strand break repair via homologous recombination (GO:0097552)	1	0	.02	-	 < 0.01	9.77E-01
mitochondrial double-strand break repair (GO:0097551)	1	0	.02	-	 < 0.01	9.77E-01
phenylethylamine metabolic process (GO:0042443)	1	0	.02	-	 < 0.01	9.77E-01
eye pigment metabolic process (GO:0042441)	1	0	.02	-	 < 0.01	9.77E-01
pigment metabolic process (GO:0042440)	56	0	1.31	-	 < 0.01	2.71E-01
nuclear migration along microtubule (GO:0030473)	4	0	.09	-	 < 0.01	9.11E-01
regulation of phosphatidylcholine catabolic process (GO:0010899)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of small intestine smooth muscle contraction (GO:1904349)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of triglyceride catabolic process (GO:0010898)	11	0	.26	-	 < 0.01	7.74E-01
negative regulation of small intestine smooth muscle contraction (GO:1904348)	2	0	.05	-	 < 0.01	9.54E-01
regulation of small intestine smooth muscle contraction (GO:1904347)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of triglyceride catabolic process (GO:0010897)	5	0	.12	-	 < 0.01	8.90E-01
regulation of triglyceride catabolic process (GO:0010896)	16	0	.37	-	 < 0.01	6.89E-01
positive regulation of gastric mucosal blood circulation (GO:1904346)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of steroid biosynthetic process (GO:0010894)	24	0	.56	-	 < 0.01	5.71E-01
regulation of gastric mucosal blood circulation (GO:1904344)	3	0	.07	-	 < 0.01	9.32E-01
axon midline choice point recognition (GO:0016199)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of colon smooth muscle contraction (GO:1904343)	2	0	.05	-	 < 0.01	9.54E-01
axon choice point recognition (GO:0016198)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of sequestering of triglyceride (GO:0010891)	5	0	.12	-	 < 0.01	8.90E-01
regulation of colon smooth muscle contraction (GO:1904341)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of dopaminergic neuron differentiation (GO:1904340)	3	0	.07	-	 < 0.01	9.32E-01
ethanolamine-containing compound metabolic process (GO:0042439)	10	0	.23	-	 < 0.01	7.92E-01
melanin biosynthetic process (GO:0042438)	13	0	.30	-	 < 0.01	7.38E-01
indole-containing compound catabolic process (GO:0042436)	7	0	.16	-	 < 0.01	8.49E-01
synaptic vesicle uncoating (GO:0016191)	5	0	.12	-	 < 0.01	8.90E-01
regulation of synaptic growth at neuromuscular junction (GO:0008582)	6	0	.14	-	 < 0.01	8.69E-01
indole-containing compound biosynthetic process (GO:0042435)	5	0	.12	-	 < 0.01	8.90E-01
indole-containing compound metabolic process (GO:0042430)	22	0	.51	-	 < 0.01	5.99E-01
negative regulation of dopaminergic neuron differentiation (GO:1904339)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of lipid storage (GO:0010888)	20	0	.47	-	 < 0.01	6.27E-01
regulation of dopaminergic neuron differentiation (GO:1904338)	9	0	.21	-	 < 0.01	8.11E-01
negative regulation of cholesterol storage (GO:0010887)	8	0	.19	-	 < 0.01	8.30E-01
positive regulation of cholesterol storage (GO:0010886)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of ductus arteriosus closure (GO:1904336)	1	0	.02	-	 < 0.01	9.77E-01
regulation of cholesterol storage (GO:0010885)	15	0	.35	-	 < 0.01	7.05E-01
regulation of ductus arteriosus closure (GO:1904335)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity (GO:0062003)	1	0	.02	-	 < 0.01	9.77E-01
synaptic vesicle to endosome fusion (GO:0016189)	4	0	.09	-	 < 0.01	9.11E-01
regulation of all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity (GO:0062002)	1	0	.02	-	 < 0.01	9.77E-01
synaptic vesicle maturation (GO:0016188)	12	0	.28	-	 < 0.01	7.56E-01
positive regulation of cardiac endothelial to mesenchymal transition (GO:0062000)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of myofibroblast contraction (GO:1904330)	1	0	.02	-	 < 0.01	9.77E-01
thymus epithelium morphogenesis (GO:0097536)	2	0	.05	-	 < 0.01	9.54E-01
serotonin metabolic process (GO:0042428)	13	0	.30	-	 < 0.01	7.38E-01
lymphoid lineage cell migration into thymus (GO:0097535)	2	0	.05	-	 < 0.01	9.54E-01
serotonin biosynthetic process (GO:0042427)	4	0	.09	-	 < 0.01	9.11E-01
lymphoid lineage cell migration (GO:0097534)	2	0	.05	-	 < 0.01	9.54E-01
synaptic vesicle budding from endosome (GO:0016182)	4	0	.09	-	 < 0.01	9.11E-01
choline catabolic process (GO:0042426)	1	0	.02	-	 < 0.01	9.77E-01
cellular stress response to acid chemical (GO:0097533)	2	0	.05	-	 < 0.01	9.54E-01
catecholamine catabolic process (GO:0042424)	7	0	.16	-	 < 0.01	8.49E-01
snRNA processing (GO:0016180)	22	0	.51	-	 < 0.01	5.99E-01
stress response to acid chemical (GO:0097532)	2	0	.05	-	 < 0.01	9.54E-01
mast cell migration (GO:0097531)	6	0	.14	-	 < 0.01	8.69E-01
dopamine catabolic process (GO:0042420)	6	0	.14	-	 < 0.01	8.69E-01
regulation of complement activation, alternative pathway (GO:0030451)	2	0	.05	-	 < 0.01	9.54E-01
regulation of complement activation, classical pathway (GO:0030450)	2	0	.05	-	 < 0.01	9.54E-01
cholesterol transport involved in cholesterol storage (GO:0010879)	1	0	.02	-	 < 0.01	9.77E-01
regulation of myofibroblast contraction (GO:1904328)	2	0	.05	-	 < 0.01	9.54E-01
cholesterol storage (GO:0010878)	2	0	.05	-	 < 0.01	9.54E-01
lipid transport involved in lipid storage (GO:0010877)	2	0	.05	-	 < 0.01	9.54E-01
protein localization to cytosolic proteasome complex (GO:1904327)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of circadian sleep/wake cycle, wakefulness (GO:1904326)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of inhibitory G protein-coupled receptor phosphorylation (GO:1904325)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of cholesterol esterification (GO:0010873)	9	0	.21	-	 < 0.01	8.11E-01
regulation of inhibitory G protein-coupled receptor phosphorylation (GO:1904323)	2	0	.05	-	 < 0.01	9.54E-01
regulation of cholesterol esterification (GO:0010872)	12	0	.28	-	 < 0.01	7.56E-01
positive regulation of smooth muscle contraction involved in micturition (GO:1904320)	1	0	.02	-	 < 0.01	9.77E-01
execution phase of necroptosis (GO:0097528)	2	0	.05	-	 < 0.01	9.54E-01
necroptotic signaling pathway (GO:0097527)	9	0	.21	-	 < 0.01	8.11E-01
epinephrine biosynthetic process (GO:0042418)	2	0	.05	-	 < 0.01	9.54E-01
epinephrine metabolic process (GO:0042414)	3	0	.07	-	 < 0.01	9.32E-01
carnitine catabolic process (GO:0042413)	1	0	.02	-	 < 0.01	9.77E-01
taurine biosynthetic process (GO:0042412)	1	0	.02	-	 < 0.01	9.77E-01
regulation of complement activation (GO:0030449)	15	0	.35	-	 < 0.01	7.05E-01
regulation of smooth muscle contraction involved in micturition (GO:1904318)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of triglyceride biosynthetic process (GO:0010868)	2	0	.05	-	 < 0.01	9.54E-01
cristae formation (GO:0042407)	13	0	.30	-	 < 0.01	7.38E-01
thyroid hormone catabolic process (GO:0042404)	2	0	.05	-	 < 0.01	9.54E-01
thyroid hormone metabolic process (GO:0042403)	23	0	.54	-	 < 0.01	5.85E-01
cellular biogenic amine catabolic process (GO:0042402)	20	0	.47	-	 < 0.01	6.27E-01
base-excision repair, AP site formation via deaminated base removal (GO:0097510)	1	0	.02	-	 < 0.01	9.77E-01
peristalsis (GO:0030432)	14	0	.33	-	 < 0.01	7.21E-01
positive regulation of gastro-intestinal system smooth muscle contraction (GO:1904306)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of gastro-intestinal system smooth muscle contraction (GO:1904305)	2	0	.05	-	 < 0.01	9.54E-01
regulation of gastro-intestinal system smooth muscle contraction (GO:1904304)	8	0	.19	-	 < 0.01	8.30E-01
positive regulation of maternal process involved in parturition (GO:1904303)	1	0	.02	-	 < 0.01	9.77E-01
regulation of maternal process involved in parturition (GO:1904301)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of transcytosis (GO:1904300)	2	0	.05	-	 < 0.01	9.54E-01
sialylation (GO:0097503)	6	0	.14	-	 < 0.01	8.69E-01
stress response to metal ion (GO:0097501)	8	0	.19	-	 < 0.01	8.30E-01
receptor localization to non-motile cilium (GO:0097500)	4	0	.09	-	 < 0.01	9.11E-01
chromosome localization (GO:0050000)	71	0	1.66	-	 < 0.01	1.90E-01
targeting of mRNA for destruction involved in RNA interference (GO:0030423)	4	0	.09	-	 < 0.01	9.11E-01
production of siRNA involved in RNA interference (GO:0030422)	6	0	.14	-	 < 0.01	8.69E-01
defecation (GO:0030421)	1	0	.02	-	 < 0.01	9.77E-01
regulation of proton-transporting ATPase activity, rotational mechanism (GO:0010849)	1	0	.02	-	 < 0.01	9.77E-01
regulation of chromatin disassembly (GO:0010848)	2	0	.05	-	 < 0.01	9.54E-01
regulation of chromatin assembly (GO:0010847)	18	0	.42	-	 < 0.01	6.57E-01
positive regulation of reciprocal meiotic recombination (GO:0010845)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of circadian sleep/wake cycle, wakefulness (GO:0010841)	4	0	.09	-	 < 0.01	9.11E-01
regulation of circadian sleep/wake cycle, wakefulness (GO:0010840)	6	0	.14	-	 < 0.01	8.69E-01
respiratory chain complex IV assembly (GO:0008535)	16	0	.37	-	 < 0.01	6.89E-01
calcium activated galactosylceramide scrambling (GO:0061591)	5	0	.12	-	 < 0.01	8.90E-01
calcium activated phosphatidylcholine scrambling (GO:0061590)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of keratinocyte proliferation (GO:0010838)	14	0	.33	-	 < 0.01	7.21E-01
glycoside catabolic process (GO:0016139)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of myotube differentiation (GO:0010832)	14	0	.33	-	 < 0.01	7.21E-01
calcium activated phosphatidylserine scrambling (GO:0061589)	4	0	.09	-	 < 0.01	9.11E-01
glycoside metabolic process (GO:0016137)	19	0	.44	-	 < 0.01	6.42E-01
calcium activated phospholipid scrambling (GO:0061588)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of transcription by transcription factor localization (GO:0061586)	1	0	.02	-	 < 0.01	9.77E-01
brassinosteroid biosynthetic process (GO:0016132)	1	0	.02	-	 < 0.01	9.77E-01
intestinal epithelial cell migration (GO:0061582)	2	0	.05	-	 < 0.01	9.54E-01
brassinosteroid metabolic process (GO:0016131)	1	0	.02	-	 < 0.01	9.77E-01
colon epithelial cell migration (GO:0061580)	1	0	.02	-	 < 0.01	9.77E-01
DNA-templated viral transcription (GO:0039695)	1	0	.02	-	 < 0.01	9.77E-01
viral RNA genome replication (GO:0039694)	13	0	.30	-	 < 0.01	7.38E-01
negative regulation of glucose transmembrane transport (GO:0010829)	26	0	.61	-	 < 0.01	5.45E-01
single stranded viral RNA replication via double stranded DNA intermediate (GO:0039692)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of centrosome duplication (GO:0010826)	11	0	.26	-	 < 0.01	7.74E-01
positive regulation of centrosome duplication (GO:0010825)	5	0	.12	-	 < 0.01	8.90E-01
regulation of centrosome duplication (GO:0010824)	44	0	1.03	-	 < 0.01	3.58E-01
negative regulation of mitochondrion organization (GO:0010823)	44	0	1.03	-	 < 0.01	3.58E-01
phytosteroid biosynthetic process (GO:0016129)	2	0	.05	-	 < 0.01	9.54E-01
phytosteroid metabolic process (GO:0016128)	2	0	.05	-	 < 0.01	9.54E-01
sterol catabolic process (GO:0016127)	10	0	.23	-	 < 0.01	7.92E-01
positive regulation of T cell chemotaxis (GO:0010820)	14	0	.33	-	 < 0.01	7.21E-01
calcium ion transmembrane transport via high voltage-gated calcium channel (GO:0061577)	3	0	.07	-	 < 0.01	9.32E-01
xanthophyll biosynthetic process (GO:0016123)	1	0	.02	-	 < 0.01	9.77E-01
xanthophyll metabolic process (GO:0016122)	2	0	.05	-	 < 0.01	9.54E-01
carotene catabolic process (GO:0016121)	1	0	.02	-	 < 0.01	9.77E-01
negative stranded viral RNA replication (GO:0039689)	4	0	.09	-	 < 0.01	9.11E-01
regulation of T cell chemotaxis (GO:0010819)	15	0	.35	-	 < 0.01	7.05E-01
carotene metabolic process (GO:0016119)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of PERK-mediated unfolded protein response (GO:1903899)	4	0	.09	-	 < 0.01	9.11E-01
carotenoid biosynthetic process (GO:0016117)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of PERK-mediated unfolded protein response (GO:1903898)	4	0	.09	-	 < 0.01	9.11E-01
carotenoid metabolic process (GO:0016116)	2	0	.05	-	 < 0.01	9.54E-01
terpenoid catabolic process (GO:0016115)	7	0	.16	-	 < 0.01	8.49E-01
regulation of PERK-mediated unfolded protein response (GO:1903897)	8	0	.19	-	 < 0.01	8.30E-01
positive regulation of IRE1-mediated unfolded protein response (GO:1903896)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of IRE1-mediated unfolded protein response (GO:1903895)	4	0	.09	-	 < 0.01	9.11E-01
regulation of IRE1-mediated unfolded protein response (GO:1903894)	8	0	.19	-	 < 0.01	8.30E-01
positive regulation of ATF6-mediated unfolded protein response (GO:1903893)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of ATF6-mediated unfolded protein response (GO:1903892)	2	0	.05	-	 < 0.01	9.54E-01
regulation of ATF6-mediated unfolded protein response (GO:1903891)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of synaptic vesicle priming (GO:0010808)	2	0	.05	-	 < 0.01	9.54E-01
regulation of synaptic vesicle priming (GO:0010807)	11	0	.26	-	 < 0.01	7.74E-01
negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804)	13	0	.30	-	 < 0.01	7.38E-01
regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803)	29	0	.68	-	 < 0.01	5.08E-01
tetraterpenoid biosynthetic process (GO:0016109)	1	0	.02	-	 < 0.01	9.77E-01
tetraterpenoid metabolic process (GO:0016108)	2	0	.05	-	 < 0.01	9.54E-01
sesquiterpenoid catabolic process (GO:0016107)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of chemokine (C-C motif) ligand 20 production (GO:1903886)	1	0	.02	-	 < 0.01	9.77E-01
diterpenoid catabolic process (GO:0016103)	5	0	.12	-	 < 0.01	8.90E-01
diterpenoid biosynthetic process (GO:0016102)	10	0	.23	-	 < 0.01	7.92E-01
regulation of chemokine (C-C motif) ligand 20 production (GO:1903884)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of interleukin-17-mediated signaling pathway (GO:1903883)	1	0	.02	-	 < 0.01	9.77E-01
ganglion morphogenesis (GO:0061552)	2	0	.05	-	 < 0.01	9.54E-01
trigeminal ganglion development (GO:0061551)	5	0	.12	-	 < 0.01	8.90E-01
cranial ganglion development (GO:0061550)	6	0	.14	-	 < 0.01	8.69E-01
regulation of interleukin-17-mediated signaling pathway (GO:1903881)	1	0	.02	-	 < 0.01	9.77E-01
membrane fusion involved in viral entry into host cell (GO:0039663)	3	0	.07	-	 < 0.01	9.32E-01
sympathetic ganglion development (GO:0061549)	9	0	.21	-	 < 0.01	8.11E-01
ganglion development (GO:0061548)	16	0	.37	-	 < 0.01	6.89E-01
glycine secretion, neurotransmission (GO:0061537)	1	0	.02	-	 < 0.01	9.77E-01
extraembryonic membrane development (GO:1903867)	10	0	.23	-	 < 0.01	7.92E-01
glycine secretion (GO:0061536)	1	0	.02	-	 < 0.01	9.77E-01
glutamate secretion, neurotransmission (GO:0061535)	2	0	.05	-	 < 0.01	9.54E-01
gamma-aminobutyric acid secretion, neurotransmission (GO:0061534)	2	0	.05	-	 < 0.01	9.54E-01
trunk segmentation (GO:0035290)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of oxidative phosphorylation (GO:1903862)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of dendrite extension (GO:1903860)	5	0	.12	-	 < 0.01	8.90E-01
brain segmentation (GO:0035284)	3	0	.07	-	 < 0.01	9.32E-01
central nervous system segmentation (GO:0035283)	3	0	.07	-	 < 0.01	9.32E-01
acetylcholine secretion (GO:0061526)	1	0	.02	-	 < 0.01	9.77E-01
pre-miRNA export from nucleus (GO:0035281)	1	0	.02	-	 < 0.01	9.77E-01
cilium disassembly (GO:0061523)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of cristae formation (GO:1903852)	3	0	.07	-	 < 0.01	9.32E-01
Langerhans cell differentiation (GO:0061520)	2	0	.05	-	 < 0.01	9.54E-01
regulation of cristae formation (GO:1903850)	4	0	.09	-	 < 0.01	9.11E-01
macrophage homeostasis (GO:0061519)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of aorta morphogenesis (GO:1903849)	4	0	.09	-	 < 0.01	9.11E-01
regulation of aorta morphogenesis (GO:1903847)	4	0	.09	-	 < 0.01	9.11E-01
myeloid cell development (GO:0061515)	64	0	1.49	-	 < 0.01	2.24E-01
negative regulation of cellular response to transforming growth factor beta stimulus (GO:1903845)	3	0	.07	-	 < 0.01	9.32E-01
interleukin-34-mediated signaling pathway (GO:0061514)	1	0	.02	-	 < 0.01	9.77E-01
protein localization to cilium (GO:0061512)	54	0	1.26	-	 < 0.01	2.83E-01
centriole elongation (GO:0061511)	2	0	.05	-	 < 0.01	9.54E-01
ammonium transport (GO:0015696)	9	0	.21	-	 < 0.01	8.11E-01
mercury ion transport (GO:0015694)	1	0	.02	-	 < 0.01	9.77E-01
lead ion transport (GO:0015692)	1	0	.02	-	 < 0.01	9.77E-01
cadmium ion transport (GO:0015691)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of mRNA 3'-UTR binding (GO:1903839)	1	0	.02	-	 < 0.01	9.77E-01
gonad morphogenesis (GO:0035262)	3	0	.07	-	 < 0.01	9.32E-01
regulation of mRNA 3'-UTR binding (GO:1903837)	1	0	.02	-	 < 0.01	9.77E-01
external genitalia morphogenesis (GO:0035261)	2	0	.05	-	 < 0.01	9.54E-01
internal genitalia morphogenesis (GO:0035260)	1	0	.02	-	 < 0.01	9.77E-01
early endosome to recycling endosome transport (GO:0061502)	1	0	.02	-	 < 0.01	9.77E-01
molybdate ion transport (GO:0015689)	1	0	.02	-	 < 0.01	9.77E-01
magnesium ion transmembrane transport (GO:1903830)	2	0	.05	-	 < 0.01	9.54E-01
protein maturation by copper ion transfer (GO:0015680)	1	0	.02	-	 < 0.01	9.77E-01
arginine transmembrane transport (GO:1903826)	7	0	.16	-	 < 0.01	8.49E-01
plasma membrane copper ion transport (GO:0015679)	2	0	.05	-	 < 0.01	9.54E-01
copper ion import (GO:0015677)	7	0	.16	-	 < 0.01	8.49E-01
vanadium ion transport (GO:0015676)	1	0	.02	-	 < 0.01	9.77E-01
nickel cation transport (GO:0015675)	2	0	.05	-	 < 0.01	9.54E-01
oxygen transport (GO:0015671)	6	0	.14	-	 < 0.01	8.69E-01
carbon dioxide transport (GO:0015670)	9	0	.21	-	 < 0.01	8.11E-01
synaptic transmission, glutamatergic (GO:0035249)	39	0	.91	-	 < 0.01	4.02E-01
peptidyl-arginine omega-N-methylation (GO:0035247)	4	0	.09	-	 < 0.01	9.11E-01
peptidyl-arginine N-methylation (GO:0035246)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of voltage-gated potassium channel activity (GO:1903818)	15	0	.35	-	 < 0.01	7.05E-01
negative regulation of voltage-gated potassium channel activity (GO:1903817)	12	0	.28	-	 < 0.01	7.56E-01
positive regulation of collecting lymphatic vessel constriction (GO:1903816)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of collecting lymphatic vessel constriction (GO:1903815)	1	0	.02	-	 < 0.01	9.77E-01
regulation of collecting lymphatic vessel constriction (GO:1903814)	2	0	.05	-	 < 0.01	9.54E-01
gas transport (GO:0015669)	15	0	.35	-	 < 0.01	7.05E-01
L-serine import across plasma membrane (GO:1903812)	1	0	.02	-	 < 0.01	9.77E-01
L-histidine import across plasma membrane (GO:1903810)	1	0	.02	-	 < 0.01	9.77E-01
ectopic germ cell programmed cell death (GO:0035234)	9	0	.21	-	 < 0.01	8.11E-01
glycine import across plasma membrane (GO:1903804)	2	0	.05	-	 < 0.01	9.54E-01
L-glutamine import across plasma membrane (GO:1903803)	1	0	.02	-	 < 0.01	9.77E-01
L-leucine import across plasma membrane (GO:1903801)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800)	12	0	.28	-	 < 0.01	7.56E-01
positive regulation of glutamate-cysteine ligase activity (GO:0035229)	1	0	.02	-	 < 0.01	9.77E-01
regulation of glutamate-cysteine ligase activity (GO:0035227)	1	0	.02	-	 < 0.01	9.77E-01
neuron-glial cell signaling (GO:0150099)	5	0	.12	-	 < 0.01	8.90E-01
glial cell-neuron signaling (GO:0150098)	4	0	.09	-	 < 0.01	9.11E-01
amyloid-beta clearance by transcytosis (GO:0150093)	7	0	.16	-	 < 0.01	8.49E-01
cell competition in a multicellular organism (GO:0035212)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of neuroinflammatory response (GO:0150078)	8	0	.19	-	 < 0.01	8.30E-01
neuroinflammatory response (GO:0150076)	8	0	.19	-	 < 0.01	8.30E-01
positive regulation of protein-glutamine gamma-glutamyltransferase activity (GO:0150074)	1	0	.02	-	 < 0.01	9.77E-01
regulation of protein-glutamine gamma-glutamyltransferase activity (GO:0150073)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of arginase activity (GO:0150072)	1	0	.02	-	 < 0.01	9.77E-01
regulation of arginase activity (GO:0150070)	1	0	.02	-	 < 0.01	9.77E-01
transport of virus (GO:0046794)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of deacetylase activity (GO:0150066)	2	0	.05	-	 < 0.01	9.54E-01
regulation of deacetylase activity (GO:0150065)	11	0	.26	-	 < 0.01	7.74E-01
vertebrate eye-specific patterning (GO:0150064)	3	0	.07	-	 < 0.01	9.32E-01
complement-mediated synapse pruning (GO:0150062)	4	0	.09	-	 < 0.01	9.11E-01
viral replication complex formation and maintenance (GO:0046786)	1	0	.02	-	 < 0.01	9.77E-01
microtubule polymerization (GO:0046785)	33	0	.77	-	 < 0.01	4.63E-01
viral mRNA export from host cell nucleus (GO:0046784)	7	0	.16	-	 < 0.01	8.49E-01
regulation of viral transcription (GO:0046782)	21	0	.49	-	 < 0.01	6.13E-01
negative regulation of protein localization to lysosome (GO:0150033)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of protein localization to lysosome (GO:0150032)	1	0	.02	-	 < 0.01	9.77E-01
regulation of protein localization to lysosome (GO:0150031)	2	0	.05	-	 < 0.01	9.54E-01
viral budding (GO:0046755)	14	0	.33	-	 < 0.01	7.21E-01
phosphagen biosynthetic process (GO:0042396)	4	0	.09	-	 < 0.01	9.11E-01
oxidised low-density lipoprotein particle clearance (GO:0150024)	1	0	.02	-	 < 0.01	9.77E-01
basal dendrite arborization (GO:0150020)	3	0	.07	-	 < 0.01	9.32E-01
regulation of transcytosis (GO:1904298)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of ERAD pathway (GO:1904294)	13	0	.30	-	 < 0.01	7.38E-01
viral capsid secondary envelopment (GO:0046745)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of ERAD pathway (GO:1904293)	6	0	.14	-	 < 0.01	8.69E-01
regulation of ERAD pathway (GO:1904292)	19	0	.44	-	 < 0.01	6.42E-01
protein localization to non-motile cilium (GO:0097499)	12	0	.28	-	 < 0.01	7.56E-01
endothelial tube lumen extension (GO:0097498)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of mitotic DNA damage checkpoint (GO:1904290)	1	0	.02	-	 < 0.01	9.77E-01
blood vessel endothelial cell delamination (GO:0097497)	1	0	.02	-	 < 0.01	9.77E-01
regulation of vesicle size (GO:0097494)	10	0	.23	-	 < 0.01	7.92E-01
response to histamine (GO:0034776)	12	0	.28	-	 < 0.01	7.56E-01
sympathetic neuron projection guidance (GO:0097491)	4	0	.09	-	 < 0.01	9.11E-01
histone H4-K20 trimethylation (GO:0034773)	5	0	.12	-	 < 0.01	8.90E-01
sympathetic neuron projection extension (GO:0097490)	4	0	.09	-	 < 0.01	9.11E-01
histone H4-K20 methylation (GO:0034770)	7	0	.16	-	 < 0.01	8.49E-01
basal dendrite morphogenesis (GO:0150019)	3	0	.07	-	 < 0.01	9.32E-01
basal dendrite development (GO:0150018)	3	0	.07	-	 < 0.01	9.32E-01
regulation of mitotic DNA damage checkpoint (GO:1904289)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:1904283)	1	0	.02	-	 < 0.01	9.77E-01
regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:1904282)	1	0	.02	-	 < 0.01	9.77E-01
basement membrane disassembly (GO:0034769)	3	0	.07	-	 < 0.01	9.32E-01
vitamin K catabolic process (GO:0042377)	3	0	.07	-	 < 0.01	9.32E-01
phylloquinone catabolic process (GO:0042376)	4	0	.09	-	 < 0.01	9.11E-01
phylloquinone metabolic process (GO:0042374)	4	0	.09	-	 < 0.01	9.11E-01
vitamin K metabolic process (GO:0042373)	6	0	.14	-	 < 0.01	8.69E-01
vitamin K biosynthetic process (GO:0042371)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of iron ion transmembrane transport (GO:0034761)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of iron ion transmembrane transport (GO:0034760)	5	0	.12	-	 < 0.01	8.90E-01
clathrin-dependent synaptic vesicle endocytosis (GO:0150007)	3	0	.07	-	 < 0.01	9.32E-01
regulation of spontaneous synaptic transmission (GO:0150003)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation by virus of viral protein levels in host cell (GO:0046726)	3	0	.07	-	 < 0.01	9.32E-01
tricellular tight junction assembly (GO:1904274)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation by virus of viral protein levels in host cell (GO:0046725)	2	0	.05	-	 < 0.01	9.54E-01
oxalic acid secretion (GO:0046724)	2	0	.05	-	 < 0.01	9.54E-01
L-alanine import across plasma membrane (GO:1904273)	3	0	.07	-	 < 0.01	9.32E-01
lactic acid secretion (GO:0046722)	1	0	.02	-	 < 0.01	9.77E-01
pyroptosome complex assembly (GO:1904270)	1	0	.02	-	 < 0.01	9.77E-01
lateral motor column neuron migration (GO:0097477)	3	0	.07	-	 < 0.01	9.32E-01
citric acid secretion (GO:0046720)	1	0	.02	-	 < 0.01	9.77E-01
vitamin D catabolic process (GO:0042369)	3	0	.07	-	 < 0.01	9.32E-01
spinal cord motor neuron migration (GO:0097476)	4	0	.09	-	 < 0.01	9.11E-01
regulation of iron ion transmembrane transport (GO:0034759)	7	0	.16	-	 < 0.01	8.49E-01
vitamin D biosynthetic process (GO:0042368)	3	0	.07	-	 < 0.01	9.32E-01
motor neuron migration (GO:0097475)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of iron ion transport (GO:0034758)	2	0	.05	-	 < 0.01	9.54E-01
retinal cone cell apoptotic process (GO:0097474)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of iron ion transport (GO:0034757)	5	0	.12	-	 < 0.01	8.90E-01
cobalamin catabolic process (GO:0042366)	1	0	.02	-	 < 0.01	9.77E-01
regulation of iron ion transport (GO:0034756)	9	0	.21	-	 < 0.01	8.11E-01
retinal rod cell apoptotic process (GO:0097473)	1	0	.02	-	 < 0.01	9.77E-01
water-soluble vitamin catabolic process (GO:0042365)	2	0	.05	-	 < 0.01	9.54E-01
water-soluble vitamin biosynthetic process (GO:0042364)	7	0	.16	-	 < 0.01	8.49E-01
iron ion transmembrane transport (GO:0034755)	11	0	.26	-	 < 0.01	7.74E-01
fat-soluble vitamin catabolic process (GO:0042363)	11	0	.26	-	 < 0.01	7.74E-01
fat-soluble vitamin biosynthetic process (GO:0042362)	5	0	.12	-	 < 0.01	8.90E-01
menaquinone catabolic process (GO:0042361)	3	0	.07	-	 < 0.01	9.32E-01
vitamin E metabolic process (GO:0042360)	2	0	.05	-	 < 0.01	9.54E-01
regulation by virus of viral protein levels in host cell (GO:0046719)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of Schwann cell chemotaxis (GO:1904268)	1	0	.02	-	 < 0.01	9.77E-01
regulation of Schwann cell chemotaxis (GO:1904266)	1	0	.02	-	 < 0.01	9.77E-01
muscle cell cellular homeostasis (GO:0046716)	21	0	.49	-	 < 0.01	6.13E-01
positive regulation of TORC1 signaling (GO:1904263)	17	0	.40	-	 < 0.01	6.73E-01
borate transport (GO:0046713)	1	0	.02	-	 < 0.01	9.77E-01
GDP catabolic process (GO:0046712)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261)	5	0	.12	-	 < 0.01	8.90E-01
GDP biosynthetic process (GO:0046711)	1	0	.02	-	 < 0.01	9.77E-01
GDP metabolic process (GO:0046710)	2	0	.05	-	 < 0.01	9.54E-01
ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466)	6	0	.14	-	 < 0.01	8.69E-01
thiamine diphosphate metabolic process (GO:0042357)	2	0	.05	-	 < 0.01	9.54E-01
'de novo' GDP-L-fucose biosynthetic process (GO:0042351)	2	0	.05	-	 < 0.01	9.54E-01
GDP-L-fucose biosynthetic process (GO:0042350)	2	0	.05	-	 < 0.01	9.54E-01
fructosamine metabolic process (GO:0030389)	2	0	.05	-	 < 0.01	9.54E-01
sperm mitochondrion organization (GO:0030382)	4	0	.09	-	 < 0.01	9.11E-01
regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259)	5	0	.12	-	 < 0.01	8.90E-01
IDP catabolic process (GO:0046709)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of iron ion transmembrane transporter activity (GO:1904256)	1	0	.02	-	 < 0.01	9.77E-01
IDP metabolic process (GO:0046707)	2	0	.05	-	 < 0.01	9.54E-01
CDP biosynthetic process (GO:0046705)	1	0	.02	-	 < 0.01	9.77E-01
regulation of iron ion transmembrane transporter activity (GO:1904254)	1	0	.02	-	 < 0.01	9.77E-01
CDP metabolic process (GO:0046704)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of bile acid metabolic process (GO:1904252)	2	0	.05	-	 < 0.01	9.54E-01
regulation of multivesicular body size involved in endosome transport (GO:0010797)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of polynucleotide adenylyltransferase activity (GO:1904247)	1	0	.02	-	 < 0.01	9.77E-01
regulation of multivesicular body size (GO:0010796)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of polynucleotide adenylyltransferase activity (GO:1904246)	1	0	.02	-	 < 0.01	9.77E-01
regulation of ubiquinone biosynthetic process (GO:0010795)	2	0	.05	-	 < 0.01	9.54E-01
regulation of polynucleotide adenylyltransferase activity (GO:1904245)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of pancreatic trypsinogen secretion (GO:1904244)	1	0	.02	-	 < 0.01	9.77E-01
DNA double-strand break processing involved in repair via single-strand annealing (GO:0010792)	4	0	.09	-	 < 0.01	9.11E-01
monoterpenoid metabolic process (GO:0016098)	2	0	.05	-	 < 0.01	9.54E-01
regulation of pancreatic trypsinogen secretion (GO:1904242)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly (GO:1904240)	1	0	.02	-	 < 0.01	9.77E-01
polyprenol catabolic process (GO:0016095)	3	0	.07	-	 < 0.01	9.32E-01
keratan sulfate metabolic process (GO:0042339)	2	0	.05	-	 < 0.01	9.54E-01
polyprenol biosynthetic process (GO:0016094)	3	0	.07	-	 < 0.01	9.32E-01
histone H3-K79 methylation (GO:0034729)	1	0	.02	-	 < 0.01	9.77E-01
polyprenol metabolic process (GO:0016093)	8	0	.19	-	 < 0.01	8.30E-01
piecemeal microautophagy of the nucleus (GO:0034727)	5	0	.12	-	 < 0.01	8.90E-01
cuticle development (GO:0042335)	2	0	.05	-	 < 0.01	9.54E-01
DNA replication-independent nucleosome organization (GO:0034724)	15	0	.35	-	 < 0.01	7.05E-01
DNA replication-dependent nucleosome organization (GO:0034723)	8	0	.19	-	 < 0.01	8.30E-01
meiotic sister chromatid cohesion involved in meiosis I (GO:0010789)	1	0	.02	-	 < 0.01	9.77E-01
regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly (GO:1904239)	1	0	.02	-	 < 0.01	9.77E-01
pericyte cell differentiation (GO:1904238)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of substrate-dependent cell migration, cell attachment to substrate (GO:1904237)	3	0	.07	-	 < 0.01	9.32E-01
regulation of substrate-dependent cell migration, cell attachment to substrate (GO:1904235)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of aconitate hydratase activity (GO:1904234)	3	0	.07	-	 < 0.01	9.32E-01
regulation of aconitate hydratase activity (GO:1904232)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of succinate dehydrogenase activity (GO:1904231)	2	0	.05	-	 < 0.01	9.54E-01
synaptic vesicle priming (GO:0016082)	20	0	.47	-	 < 0.01	6.27E-01
synaptic vesicle docking (GO:0016081)	12	0	.28	-	 < 0.01	7.56E-01
synaptic vesicle targeting (GO:0016080)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of circadian sleep/wake cycle, non-REM sleep (GO:0042323)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of circadian sleep/wake cycle, REM sleep (GO:0042322)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of circadian sleep/wake cycle, sleep (GO:0042321)	7	0	.16	-	 < 0.01	8.49E-01
regulation of circadian sleep/wake cycle, REM sleep (GO:0042320)	7	0	.16	-	 < 0.01	8.49E-01
regulation of succinate dehydrogenase activity (GO:1904229)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of glycogen synthase activity, transferring glucose-1-phosphate (GO:1904227)	1	0	.02	-	 < 0.01	9.77E-01
regulation of glycogen synthase activity, transferring glucose-1-phosphate (GO:1904226)	1	0	.02	-	 < 0.01	9.77E-01
synaptic vesicle exocytosis (GO:0016079)	55	0	1.28	-	 < 0.01	2.77E-01
tRNA catabolic process (GO:0016078)	8	0	.19	-	 < 0.01	8.30E-01
sno(s)RNA catabolic process (GO:0016077)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of serine C-palmitoyltransferase activity (GO:1904221)	1	0	.02	-	 < 0.01	9.77E-01
protein maturation by iron-sulfur cluster transfer (GO:0097428)	9	0	.21	-	 < 0.01	8.11E-01
snRNA catabolic process (GO:0016076)	2	0	.05	-	 < 0.01	9.54E-01
rRNA catabolic process (GO:0016075)	16	0	.37	-	 < 0.01	6.89E-01
sno(s)RNA metabolic process (GO:0016074)	13	0	.30	-	 < 0.01	7.38E-01
snRNA metabolic process (GO:0016073)	31	0	.72	-	 < 0.01	4.85E-01
penicillin metabolic process (GO:0042316)	1	0	.02	-	 < 0.01	9.77E-01
liver regeneration (GO:0097421)	13	0	.30	-	 < 0.01	7.38E-01
protein kinase C deactivation (GO:0042313)	1	0	.02	-	 < 0.01	9.77E-01
regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage (GO:0010767)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of sodium ion transport (GO:0010766)	18	0	.42	-	 < 0.01	6.57E-01
negative regulation of fibroblast migration (GO:0010764)	9	0	.21	-	 < 0.01	8.11E-01
negative regulation of iodide transmembrane transport (GO:1904213)	1	0	.02	-	 < 0.01	9.77E-01
regulation of iodide transmembrane transport (GO:1904212)	1	0	.02	-	 < 0.01	9.77E-01
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol (GO:1904211)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of macrophage chemotaxis (GO:0010760)	7	0	.16	-	 < 0.01	8.49E-01
homoiothermy (GO:0042309)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of protein import into nucleus (GO:0042308)	15	0	.35	-	 < 0.01	7.05E-01
immunoglobulin mediated immune response (GO:0016064)	78	0	1.82	-	 < 0.01	1.62E-01
adaptation of rhodopsin mediated signaling (GO:0016062)	2	0	.05	-	 < 0.01	9.54E-01
hypoxia-inducible factor-1alpha signaling pathway (GO:0097411)	4	0	.09	-	 < 0.01	9.11E-01
DNA damage response, signal transduction by p53 class mediator (GO:0030330)	31	0	.72	-	 < 0.01	4.85E-01
positive regulation of plasminogen activation (GO:0010756)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of skeletal muscle hypertrophy (GO:1904206)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of skeletal muscle hypertrophy (GO:1904205)	1	0	.02	-	 < 0.01	9.77E-01
regulation of skeletal muscle hypertrophy (GO:1904204)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of cGMP-mediated signaling (GO:0010753)	9	0	.21	-	 < 0.01	8.11E-01
negative regulation of iodide transport (GO:1904202)	1	0	.02	-	 < 0.01	9.77E-01
regulation of iodide transport (GO:1904201)	1	0	.02	-	 < 0.01	9.77E-01
rhodopsin mediated signaling pathway (GO:0016056)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of nitric oxide mediated signal transduction (GO:0010750)	4	0	.09	-	 < 0.01	9.11E-01
iodide transmembrane transport (GO:1904200)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to raffinose (GO:0097403)	1	0	.02	-	 < 0.01	9.77E-01
neuroblast migration (GO:0097402)	3	0	.07	-	 < 0.01	9.32E-01
synaptic vesicle lumen acidification (GO:0097401)	2	0	.05	-	 < 0.01	9.54E-01
interleukin-17-mediated signaling pathway (GO:0097400)	4	0	.09	-	 < 0.01	9.11E-01
prenylcysteine metabolic process (GO:0030329)	2	0	.05	-	 < 0.01	9.54E-01
prenylcysteine catabolic process (GO:0030328)	2	0	.05	-	 < 0.01	9.54E-01
prenylated protein catabolic process (GO:0030327)	3	0	.07	-	 < 0.01	9.32E-01
transepithelial chloride transport (GO:0030321)	6	0	.14	-	 < 0.01	8.69E-01
cellular monovalent inorganic anion homeostasis (GO:0030320)	13	0	.30	-	 < 0.01	7.38E-01
positive regulation of long-chain fatty acid import across plasma membrane (GO:0010747)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of macrophage derived foam cell differentiation (GO:0010745)	10	0	.23	-	 < 0.01	7.92E-01
positive regulation of macrophage derived foam cell differentiation (GO:0010744)	13	0	.30	-	 < 0.01	7.38E-01
regulation of macrophage derived foam cell differentiation (GO:0010743)	23	0	.54	-	 < 0.01	5.85E-01
macrophage derived foam cell differentiation (GO:0010742)	5	0	.12	-	 < 0.01	8.90E-01
detection of fungus (GO:0016046)	1	0	.02	-	 < 0.01	9.77E-01
osteoclast differentiation (GO:0030316)	45	0	1.05	-	 < 0.01	3.50E-01
positive regulation of protein kinase A signaling (GO:0010739)	10	0	.23	-	 < 0.01	7.92E-01
protein kinase A signaling (GO:0010737)	12	0	.28	-	 < 0.01	7.56E-01
positive regulation of transcription via serum response element binding (GO:0010735)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of protein glutathionylation (GO:0010734)	1	0	.02	-	 < 0.01	9.77E-01
regulation of protein glutathionylation (GO:0010732)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to phosphate starvation (GO:0016036)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of hydrogen peroxide biosynthetic process (GO:0010730)	4	0	.09	-	 < 0.01	9.11E-01
memory T cell proliferation (GO:0061485)	1	0	.02	-	 < 0.01	9.77E-01
tRNA import into mitochondrion (GO:0016031)	2	0	.05	-	 < 0.01	9.54E-01
response to TNF agonist (GO:0061481)	1	0	.02	-	 < 0.01	9.77E-01
regulation of intestinal cholesterol absorption (GO:0030300)	11	0	.26	-	 < 0.01	7.74E-01
positive regulation of hydrogen peroxide biosynthetic process (GO:0010729)	4	0	.09	-	 < 0.01	9.11E-01
regulation of hydrogen peroxide biosynthetic process (GO:0010728)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of hydrogen peroxide metabolic process (GO:0010727)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of hydrogen peroxide metabolic process (GO:0010726)	5	0	.12	-	 < 0.01	8.90E-01
regulation of primitive erythrocyte differentiation (GO:0010725)	3	0	.07	-	 < 0.01	9.32E-01
regulation of definitive erythrocyte differentiation (GO:0010724)	4	0	.09	-	 < 0.01	9.11E-01
regulation of ferrochelatase activity (GO:0010722)	1	0	.02	-	 < 0.01	9.77E-01
response to anticoagulant (GO:0061476)	1	0	.02	-	 < 0.01	9.77E-01
CDP-diacylglycerol biosynthetic process (GO:0016024)	2	0	.05	-	 < 0.01	9.54E-01
T follicular helper cell differentiation (GO:0061470)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of extracellular matrix disassembly (GO:0010716)	2	0	.05	-	 < 0.01	9.54E-01
regulation of extracellular matrix disassembly (GO:0010715)	14	0	.33	-	 < 0.01	7.21E-01
positive regulation of collagen metabolic process (GO:0010714)	32	0	.75	-	 < 0.01	4.74E-01
negative regulation of collagen metabolic process (GO:0010713)	17	0	.40	-	 < 0.01	6.73E-01
negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799)	15	0	.35	-	 < 0.01	7.05E-01
regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798)	25	0	.58	-	 < 0.01	5.58E-01
regulation of collagen catabolic process (GO:0010710)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of inorganic anion transmembrane transport (GO:1903797)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of inorganic anion transmembrane transport (GO:1903796)	2	0	.05	-	 < 0.01	9.54E-01
regulation of inorganic anion transmembrane transport (GO:1903795)	8	0	.19	-	 < 0.01	8.30E-01
guanine nucleotide transmembrane transport (GO:1903790)	1	0	.02	-	 < 0.01	9.77E-01
glycolysis from storage polysaccharide through glucose-1-phosphate (GO:0093001)	1	0	.02	-	 < 0.01	9.77E-01
globoside biosynthetic process via lactosylceramide (GO:0010707)	1	0	.02	-	 < 0.01	9.77E-01
ganglioside biosynthetic process via lactosylceramide (GO:0010706)	5	0	.12	-	 < 0.01	8.90E-01
meiotic DNA double-strand break processing involved in reciprocal meiotic recombination (GO:0010705)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of norepinephrine secretion (GO:0010701)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of glutathione biosynthetic process (GO:1903788)	2	0	.05	-	 < 0.01	9.54E-01
regulation of glutathione biosynthetic process (GO:1903786)	3	0	.07	-	 < 0.01	9.32E-01
retrotrapezoid nucleus neuron differentiation (GO:0061452)	1	0	.02	-	 < 0.01	9.77E-01
retrotrapezoid nucleus development (GO:0061451)	1	0	.02	-	 < 0.01	9.77E-01
trophoblast cell migration (GO:0061450)	1	0	.02	-	 < 0.01	9.77E-01
charged-tRNA amino acid modification (GO:0019988)	1	0	.02	-	 < 0.01	9.77E-01
translesion synthesis (GO:0019985)	14	0	.33	-	 < 0.01	7.21E-01
protein localization to vacuolar membrane (GO:1903778)	1	0	.02	-	 < 0.01	9.77E-01
endocardial cushion cell fate commitment (GO:0061445)	1	0	.02	-	 < 0.01	9.77E-01
regulation of DNA double-strand break processing (GO:1903775)	2	0	.05	-	 < 0.01	9.54E-01
endocardial cushion cell development (GO:0061444)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of viral budding via host ESCRT complex (GO:1903774)	3	0	.07	-	 < 0.01	9.32E-01
endocardial cushion cell differentiation (GO:0061443)	2	0	.05	-	 < 0.01	9.54E-01
regulation of viral budding via host ESCRT complex (GO:1903772)	4	0	.09	-	 < 0.01	9.11E-01
renal artery morphogenesis (GO:0061441)	1	0	.02	-	 < 0.01	9.77E-01
kidney vasculature development (GO:0061440)	18	0	.42	-	 < 0.01	6.57E-01
negative regulation of beta-galactosidase activity (GO:1903770)	1	0	.02	-	 < 0.01	9.77E-01
kidney vasculature morphogenesis (GO:0061439)	7	0	.16	-	 < 0.01	8.49E-01
renal system vasculature morphogenesis (GO:0061438)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of cell proliferation in bone marrow (GO:1903769)	1	0	.02	-	 < 0.01	9.77E-01
renal system vasculature development (GO:0061437)	18	0	.42	-	 < 0.01	6.57E-01
establishment of skin barrier (GO:0061436)	26	0	.61	-	 < 0.01	5.45E-01
positive regulation of potassium ion export across plasma membrane (GO:1903766)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of potassium ion export across plasma membrane (GO:1903765)	2	0	.05	-	 < 0.01	9.54E-01
regulation of potassium ion export across plasma membrane (GO:1903764)	6	0	.14	-	 < 0.01	8.69E-01
cellular response to caloric restriction (GO:0061433)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1903762)	1	0	.02	-	 < 0.01	9.77E-01
regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1903760)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061428)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of SUMO transferase activity (GO:1903755)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of RIG-I signaling pathway (GO:0039536)	7	0	.16	-	 < 0.01	8.49E-01
regulation of RIG-I signaling pathway (GO:0039535)	15	0	.35	-	 < 0.01	7.05E-01
negative regulation of MDA-5 signaling pathway (GO:0039534)	3	0	.07	-	 < 0.01	9.32E-01
regulation of MDA-5 signaling pathway (GO:0039533)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532)	9	0	.21	-	 < 0.01	8.11E-01
regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531)	17	0	.40	-	 < 0.01	6.73E-01
MDA-5 signaling pathway (GO:0039530)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419)	6	0	.14	-	 < 0.01	8.69E-01
regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418)	13	0	.30	-	 < 0.01	7.38E-01
positive regulation of establishment of protein localization to mitochondrion (GO:1903749)	10	0	.23	-	 < 0.01	7.92E-01
positive regulation of anterograde synaptic vesicle transport (GO:1903744)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of anterograde synaptic vesicle transport (GO:1903743)	1	0	.02	-	 < 0.01	9.77E-01
regulation of anterograde synaptic vesicle transport (GO:1903742)	2	0	.05	-	 < 0.01	9.54E-01
modulation by virus of host apoptotic process (GO:0039526)	4	0	.09	-	 < 0.01	9.11E-01
suppression by virus of host autophagy (GO:0039521)	1	0	.02	-	 < 0.01	9.77E-01
induction by virus of host autophagy (GO:0039520)	2	0	.05	-	 < 0.01	9.54E-01
post-embryonic hemopoiesis (GO:0035166)	6	0	.14	-	 < 0.01	8.69E-01
embryonic hemopoiesis (GO:0035162)	28	0	.65	-	 < 0.01	5.20E-01
positive regulation of transcription from RNA polymerase II promoter in response to calcium ion (GO:0061400)	1	0	.02	-	 < 0.01	9.77E-01
modulation by virus of host autophagy (GO:0039519)	3	0	.07	-	 < 0.01	9.32E-01
cGMP-mediated signaling (GO:0019934)	23	0	.54	-	 < 0.01	5.85E-01
negative regulation of phospholipid metabolic process (GO:1903726)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of centriole elongation (GO:1903724)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of centriole elongation (GO:1903723)	2	0	.05	-	 < 0.01	9.54E-01
regulation of centriole elongation (GO:1903722)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of I-kappaB phosphorylation (GO:1903720)	1	0	.02	-	 < 0.01	9.77E-01
regulation of aerobic respiration (GO:1903715)	9	0	.21	-	 < 0.01	8.11E-01
asparagine transmembrane transport (GO:1903713)	1	0	.02	-	 < 0.01	9.77E-01
cysteine transmembrane transport (GO:1903712)	1	0	.02	-	 < 0.01	9.77E-01
spermine transmembrane transport (GO:1903710)	1	0	.02	-	 < 0.01	9.77E-01
peptidyl-arginine methylation, to asymmetrical-dimethyl arginine (GO:0019919)	4	0	.09	-	 < 0.01	9.11E-01
forelimb morphogenesis (GO:0035136)	45	0	1.05	-	 < 0.01	3.50E-01
uterine gland development (GO:1903709)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of production of siRNA involved in RNA interference (GO:1903704)	1	0	.02	-	 < 0.01	9.77E-01
substantia propria of cornea development (GO:1903701)	1	0	.02	-	 < 0.01	9.77E-01
post-embryonic forelimb morphogenesis (GO:0035128)	1	0	.02	-	 < 0.01	9.77E-01
post-embryonic limb morphogenesis (GO:0035127)	1	0	.02	-	 < 0.01	9.77E-01
post-embryonic appendage morphogenesis (GO:0035120)	1	0	.02	-	 < 0.01	9.77E-01
cell-cell signaling involved in kidney development (GO:0060995)	2	0	.05	-	 < 0.01	9.54E-01
regulation of transcription from RNA polymerase II promoter involved in kidney development (GO:0060994)	1	0	.02	-	 < 0.01	9.77E-01
response to fungicide (GO:0060992)	1	0	.02	-	 < 0.01	9.77E-01
embryonic forelimb morphogenesis (GO:0035115)	36	0	.84	-	 < 0.01	4.32E-01
genitalia morphogenesis (GO:0035112)	16	0	.37	-	 < 0.01	6.89E-01
lipid tube assembly (GO:0060988)	3	0	.07	-	 < 0.01	9.32E-01
epicardium-derived cardiac vascular smooth muscle cell differentiation (GO:0060983)	2	0	.05	-	 < 0.01	9.54E-01
coronary artery morphogenesis (GO:0060982)	10	0	.23	-	 < 0.01	7.92E-01
cell migration involved in coronary angiogenesis (GO:0060981)	1	0	.02	-	 < 0.01	9.77E-01
cell migration involved in coronary vasculogenesis (GO:0060980)	1	0	.02	-	 < 0.01	9.77E-01
operant conditioning (GO:0035106)	5	0	.12	-	 < 0.01	8.90E-01
angiogenesis involved in coronary vascular morphogenesis (GO:0060978)	7	0	.16	-	 < 0.01	8.49E-01
cardioblast migration to the midline involved in heart field formation (GO:0060975)	1	0	.02	-	 < 0.01	9.77E-01
cell migration involved in heart formation (GO:0060974)	2	0	.05	-	 < 0.01	9.54E-01
cell migration involved in heart development (GO:0060973)	14	0	.33	-	 < 0.01	7.21E-01
embryonic heart tube left/right pattern formation (GO:0060971)	6	0	.14	-	 < 0.01	8.69E-01
decidualization (GO:0046697)	21	0	.49	-	 < 0.01	6.13E-01
sperm competition (GO:0046692)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of gene silencing (GO:0060969)	28	0	.65	-	 < 0.01	5.20E-01
negative regulation of gene silencing by RNA (GO:0060967)	21	0	.49	-	 < 0.01	6.13E-01
negative regulation of gene silencing by miRNA (GO:0060965)	19	0	.44	-	 < 0.01	6.42E-01
response to mercury ion (GO:0046689)	11	0	.26	-	 < 0.01	7.74E-01
response to chromate (GO:0046687)	1	0	.02	-	 < 0.01	9.77E-01
response to pyrethroid (GO:0046684)	3	0	.07	-	 < 0.01	9.32E-01
response to organophosphorus (GO:0046683)	87	0	2.03	-	 < 0.01	1.31E-01
endocardial cell fate commitment (GO:0060957)	1	0	.02	-	 < 0.01	9.77E-01
response to antibiotic (GO:0046677)	32	0	.75	-	 < 0.01	4.74E-01
negative regulation of retinal cell programmed cell death (GO:0046671)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of retinal cell programmed cell death (GO:0046670)	1	0	.02	-	 < 0.01	9.77E-01
cardiac vascular smooth muscle cell development (GO:0060948)	5	0	.12	-	 < 0.01	8.90E-01
cardiac vascular smooth muscle cell differentiation (GO:0060947)	13	0	.30	-	 < 0.01	7.38E-01
cardiac neuron differentiation (GO:0060945)	1	0	.02	-	 < 0.01	9.77E-01
epithelial to mesenchymal transition involved in cardiac fibroblast development (GO:0060940)	1	0	.02	-	 < 0.01	9.77E-01
regulation of retinal cell programmed cell death (GO:0046668)	5	0	.12	-	 < 0.01	8.90E-01
retinal cell programmed cell death (GO:0046666)	3	0	.07	-	 < 0.01	9.32E-01
His-Purkinje system cell differentiation (GO:0060932)	2	0	.05	-	 < 0.01	9.54E-01
sinoatrial node cell development (GO:0060931)	6	0	.14	-	 < 0.01	8.69E-01
sinoatrial node cell fate commitment (GO:0060930)	1	0	.02	-	 < 0.01	9.77E-01
folic acid metabolic process (GO:0046655)	5	0	.12	-	 < 0.01	8.90E-01
tetrahydrofolate biosynthetic process (GO:0046654)	6	0	.14	-	 < 0.01	8.69E-01
tetrahydrofolate metabolic process (GO:0046653)	19	0	.44	-	 < 0.01	6.42E-01
vocal learning (GO:0042297)	7	0	.16	-	 < 0.01	8.49E-01
atrioventricular node cell fate commitment (GO:0060929)	1	0	.02	-	 < 0.01	9.77E-01
atrioventricular node cell development (GO:0060928)	2	0	.05	-	 < 0.01	9.54E-01
cardiac pacemaker cell fate commitment (GO:0060927)	2	0	.05	-	 < 0.01	9.54E-01
cardiac pacemaker cell development (GO:0060926)	8	0	.19	-	 < 0.01	8.30E-01
cardiac muscle cell fate commitment (GO:0060923)	7	0	.16	-	 < 0.01	8.49E-01
atrioventricular node cell differentiation (GO:0060922)	2	0	.05	-	 < 0.01	9.54E-01
sinoatrial node cell differentiation (GO:0060921)	7	0	.16	-	 < 0.01	8.49E-01
cardiac pacemaker cell differentiation (GO:0060920)	9	0	.21	-	 < 0.01	8.11E-01
positive regulation of regulation of vascular associated smooth muscle cell membrane depolarization (GO:1904199)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of granulosa cell proliferation (GO:1904197)	1	0	.02	-	 < 0.01	9.77E-01
regulation of granulosa cell proliferation (GO:1904195)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of gamma-delta T cell activation (GO:0046645)	9	0	.21	-	 < 0.01	8.11E-01
negative regulation of cholangiocyte apoptotic process (GO:1904193)	3	0	.07	-	 < 0.01	9.32E-01
regulation of gamma-delta T cell activation (GO:0046643)	12	0	.28	-	 < 0.01	7.56E-01
regulation of cholangiocyte apoptotic process (GO:1904192)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of alpha-beta T cell proliferation (GO:0046642)	13	0	.30	-	 < 0.01	7.38E-01
cellular response to interleukin-17 (GO:0097398)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of alpha-beta T cell proliferation (GO:0046641)	22	0	.51	-	 < 0.01	5.99E-01
regulation of alpha-beta T cell proliferation (GO:0046640)	37	0	.86	-	 < 0.01	4.22E-01
response to interleukin-17 (GO:0097396)	4	0	.09	-	 < 0.01	9.11E-01
heart formation (GO:0060914)	16	0	.37	-	 < 0.01	6.89E-01
chemotaxis to arachidonic acid (GO:0034670)	1	0	.02	-	 < 0.01	9.77E-01
cardiac cell fate determination (GO:0060913)	4	0	.09	-	 < 0.01	9.11E-01
cardiac cell fate specification (GO:0060912)	1	0	.02	-	 < 0.01	9.77E-01
cardiac cell fate commitment (GO:0060911)	12	0	.28	-	 < 0.01	7.56E-01
negative regulation of alpha-beta T cell differentiation (GO:0046639)	27	0	.63	-	 < 0.01	5.33E-01
negative regulation of transformation of host cell by virus (GO:1904188)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of alpha-beta T cell differentiation (GO:0046638)	48	0	1.12	-	 < 0.01	3.26E-01
regulation of transformation of host cell by virus (GO:1904187)	1	0	.02	-	 < 0.01	9.77E-01
regulation of alpha-beta T cell differentiation (GO:0046637)	65	0	1.52	-	 < 0.01	2.19E-01
negative regulation of alpha-beta T cell activation (GO:0046636)	42	0	.98	-	 < 0.01	3.75E-01
positive regulation of pyruvate dehydrogenase activity (GO:1904184)	2	0	.05	-	 < 0.01	9.54E-01
alpha-beta T cell proliferation (GO:0046633)	4	0	.09	-	 < 0.01	9.11E-01
regulation of pyruvate dehydrogenase activity (GO:1904182)	3	0	.07	-	 < 0.01	9.32E-01
alpha-beta T cell differentiation (GO:0046632)	68	0	1.59	-	 < 0.01	2.04E-01
positive regulation of membrane depolarization (GO:1904181)	12	0	.28	-	 < 0.01	7.56E-01
alpha-beta T cell activation (GO:0046631)	84	0	1.96	-	 < 0.01	1.40E-01
negative regulation of membrane depolarization (GO:1904180)	6	0	.14	-	 < 0.01	8.69E-01
purine nucleoside metabolic process (GO:0042278)	58	0	1.35	-	 < 0.01	2.58E-01
cellular lipid biosynthetic process (GO:0097384)	12	0	.28	-	 < 0.01	7.56E-01
error-prone translesion synthesis (GO:0042276)	5	0	.12	-	 < 0.01	8.90E-01
error-free postreplication DNA repair (GO:0042275)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of macrophage cytokine production (GO:0060907)	11	0	.26	-	 < 0.01	7.74E-01
susceptibility to natural killer cell mediated cytotoxicity (GO:0042271)	2	0	.05	-	 < 0.01	9.54E-01
protection from natural killer cell mediated cytotoxicity (GO:0042270)	7	0	.16	-	 < 0.01	8.49E-01
ncRNA catabolic process (GO:0034661)	25	0	.58	-	 < 0.01	5.58E-01
positive regulation of meiosis I (GO:0060903)	5	0	.12	-	 < 0.01	8.90E-01
regulation of hair cycle by canonical Wnt signaling pathway (GO:0060901)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of adipose tissue development (GO:1904179)	6	0	.14	-	 < 0.01	8.69E-01
gamma-delta T cell activation (GO:0046629)	11	0	.26	-	 < 0.01	7.74E-01
negative regulation of adipose tissue development (GO:1904178)	3	0	.07	-	 < 0.01	9.32E-01
regulation of adipose tissue development (GO:1904177)	9	0	.21	-	 < 0.01	8.11E-01
regulation of histone demethylase activity (H3-K4 specific) (GO:1904173)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of bleb assembly (GO:1904172)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of bleb assembly (GO:1904171)	1	0	.02	-	 < 0.01	9.77E-01
regulation of bleb assembly (GO:1904170)	3	0	.07	-	 < 0.01	9.32E-01
regulation of natural killer cell mediated cytotoxicity (GO:0042269)	43	0	1.00	-	 < 0.01	3.67E-01
regulation of cytolysis (GO:0042268)	3	0	.07	-	 < 0.01	9.32E-01
interneuron axon guidance (GO:0097376)	1	0	.02	-	 < 0.01	9.77E-01
natural killer cell mediated cytotoxicity (GO:0042267)	13	0	.30	-	 < 0.01	7.38E-01
sensory neuron axon guidance (GO:0097374)	3	0	.07	-	 < 0.01	9.32E-01
nucleobase-containing small molecule catabolic process (GO:0034656)	25	0	.58	-	 < 0.01	5.58E-01
peptidyl-asparagine hydroxylation (GO:0042265)	1	0	.02	-	 < 0.01	9.77E-01
peptidyl-aspartic acid hydroxylation (GO:0042264)	2	0	.05	-	 < 0.01	9.54E-01
retinoic acid catabolic process (GO:0034653)	5	0	.12	-	 < 0.01	8.90E-01
DNA protection (GO:0042262)	2	0	.05	-	 < 0.01	9.54E-01
protein O-GlcNAcylation via threonine (GO:0097370)	1	0	.02	-	 < 0.01	9.77E-01
cortisol biosynthetic process (GO:0034651)	2	0	.05	-	 < 0.01	9.54E-01
cortisol metabolic process (GO:0034650)	4	0	.09	-	 < 0.01	9.11E-01
intestinal cholesterol absorption (GO:0030299)	7	0	.16	-	 < 0.01	8.49E-01
optic placode formation involved in camera-type eye formation (GO:0046619)	2	0	.05	-	 < 0.01	9.54E-01
drug export (GO:0046618)	3	0	.07	-	 < 0.01	9.32E-01
DNA synthesis involved in UV-damage excision repair (GO:1904161)	2	0	.05	-	 < 0.01	9.54E-01
establishment of Sertoli cell barrier (GO:0097368)	5	0	.12	-	 < 0.01	8.90E-01
mature ribosome assembly (GO:0042256)	6	0	.14	-	 < 0.01	8.69E-01
establishment of mitochondrion localization, microtubule-mediated (GO:0034643)	21	0	.49	-	 < 0.01	6.13E-01
mitochondrion migration along actin filament (GO:0034642)	1	0	.02	-	 < 0.01	9.77E-01
establishment of mitochondrion localization by microtubule attachment (GO:0034640)	1	0	.02	-	 < 0.01	9.77E-01
DN3 thymocyte differentiation (GO:1904156)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of centrosome cycle (GO:0046606)	11	0	.26	-	 < 0.01	7.74E-01
DN2 thymocyte differentiation (GO:1904155)	1	0	.02	-	 < 0.01	9.77E-01
regulation of centrosome cycle (GO:0046605)	49	0	1.14	-	 < 0.01	3.19E-01
positive regulation of retrograde protein transport, ER to cytosol (GO:1904154)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of microglial cell mediated cytotoxicity (GO:1904151)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of centriole replication (GO:0046601)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of centriole replication (GO:0046600)	6	0	.14	-	 < 0.01	8.69E-01
establishment of planar polarity of embryonic epithelium (GO:0042249)	5	0	.12	-	 < 0.01	8.90E-01
phosphatidylcholine catabolic process (GO:0034638)	12	0	.28	-	 < 0.01	7.56E-01
protein localization to heterochromatin (GO:0097355)	2	0	.05	-	 < 0.01	9.54E-01
establishment of planar polarity of follicular epithelium (GO:0042247)	1	0	.02	-	 < 0.01	9.77E-01
prenylation (GO:0097354)	11	0	.26	-	 < 0.01	7.74E-01
RNA repair (GO:0042245)	2	0	.05	-	 < 0.01	9.54E-01
autophagosome maturation (GO:0097352)	21	0	.49	-	 < 0.01	6.13E-01
neutrophil clearance (GO:0097350)	4	0	.09	-	 < 0.01	9.11E-01
retinol transport (GO:0034633)	2	0	.05	-	 < 0.01	9.54E-01
maintenance of gastrointestinal epithelium (GO:0030277)	13	0	.30	-	 < 0.01	7.38E-01
regulation of microglial cell mediated cytotoxicity (GO:1904149)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of meiotic cell cycle process involved in oocyte maturation (GO:1904145)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of alkaline phosphatase activity (GO:0010693)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of microglial cell migration (GO:1904140)	1	0	.02	-	 < 0.01	9.77E-01
cellular protein-containing complex localization (GO:0034629)	25	0	.58	-	 < 0.01	5.58E-01
mitochondrial outer membrane permeabilization (GO:0097345)	8	0	.19	-	 < 0.01	8.30E-01
'de novo' NAD biosynthetic process (GO:0034627)	4	0	.09	-	 < 0.01	9.11E-01
ripoptosome assembly (GO:0097343)	2	0	.05	-	 < 0.01	9.54E-01
zymogen inhibition (GO:0097341)	7	0	.16	-	 < 0.01	8.49E-01
inhibition of cysteine-type endopeptidase activity (GO:0097340)	6	0	.14	-	 < 0.01	8.69E-01
nuclear fragmentation involved in apoptotic nuclear change (GO:0030264)	1	0	.02	-	 < 0.01	9.77E-01
response to laminar fluid shear stress (GO:0034616)	7	0	.16	-	 < 0.01	8.49E-01
growth hormone secretion (GO:0030252)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of otic vesicle morphogenesis (GO:1904120)	1	0	.02	-	 < 0.01	9.77E-01
cellular modified amino acid catabolic process (GO:0042219)	21	0	.49	-	 < 0.01	6.13E-01
response to antineoplastic agent (GO:0097327)	1	0	.02	-	 < 0.01	9.77E-01
melanocyte adhesion (GO:0097326)	1	0	.02	-	 < 0.01	9.77E-01
melanocyte proliferation (GO:0097325)	2	0	.05	-	 < 0.01	9.54E-01
B cell adhesion (GO:0097323)	1	0	.02	-	 < 0.01	9.77E-01
terpene metabolic process (GO:0042214)	1	0	.02	-	 < 0.01	9.77E-01
autophagy of peroxisome (GO:0030242)	6	0	.14	-	 < 0.01	8.69E-01
skeletal muscle myosin thick filament assembly (GO:0030241)	2	0	.05	-	 < 0.01	9.54E-01
skeletal muscle thin filament assembly (GO:0030240)	6	0	.14	-	 < 0.01	8.69E-01
epithelial structure maintenance (GO:0010669)	21	0	.49	-	 < 0.01	6.13E-01
ectodermal cell differentiation (GO:0010668)	5	0	.12	-	 < 0.01	8.90E-01
regulation of otic vesicle morphogenesis (GO:1904118)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to vasopressin (GO:1904117)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of cardiac muscle cell apoptotic process (GO:0010666)	21	0	.49	-	 < 0.01	6.13E-01
response to vasopressin (GO:1904116)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of striated muscle cell apoptotic process (GO:0010663)	22	0	.51	-	 < 0.01	5.99E-01
negative regulation of muscle filament sliding (GO:1904113)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of muscle cell apoptotic process (GO:0010661)	37	0	.86	-	 < 0.01	4.22E-01
maternal determination of anterior/posterior axis, embryo (GO:0008358)	3	0	.07	-	 < 0.01	9.32E-01
L-histidine transmembrane transport (GO:0089709)	4	0	.09	-	 < 0.01	9.11E-01
asymmetric cell division (GO:0008356)	17	0	.40	-	 < 0.01	6.73E-01
L-histidine transmembrane export from vacuole (GO:0089708)	1	0	.02	-	 < 0.01	9.77E-01
cap2 mRNA methylation (GO:0097310)	1	0	.02	-	 < 0.01	9.77E-01
protein kinase D signaling (GO:0089700)	3	0	.07	-	 < 0.01	9.32E-01
male sex determination (GO:0030238)	16	0	.37	-	 < 0.01	6.89E-01
female sex determination (GO:0030237)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of cholesterol import (GO:1904109)	4	0	.09	-	 < 0.01	9.11E-01
cardiac muscle cell apoptotic process (GO:0010659)	6	0	.14	-	 < 0.01	8.69E-01
striated muscle cell apoptotic process (GO:0010658)	6	0	.14	-	 < 0.01	8.69E-01
protein localization to ciliary inversin compartment (GO:1904108)	1	0	.02	-	 < 0.01	9.77E-01
muscle cell apoptotic process (GO:0010657)	7	0	.16	-	 < 0.01	8.49E-01
protein localization to microvillus (GO:1904106)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of cell communication by chemical coupling (GO:0010652)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of antimicrobial humoral response (GO:0008348)	1	0	.02	-	 < 0.01	9.77E-01
cap1 mRNA methylation (GO:0097309)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of protein O-linked glycosylation (GO:1904100)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of cell communication by electrical coupling (GO:0010650)	1	0	.02	-	 < 0.01	9.77E-01
adult feeding behavior (GO:0008343)	9	0	.21	-	 < 0.01	8.11E-01
programmed necrotic cell death (GO:0097300)	29	0	.68	-	 < 0.01	5.08E-01
extracellular matrix disassembly (GO:0022617)	18	0	.42	-	 < 0.01	6.57E-01
macrophage differentiation (GO:0030225)	23	0	.54	-	 < 0.01	5.85E-01
DNA strand elongation (GO:0022616)	18	0	.42	-	 < 0.01	6.57E-01
monocyte differentiation (GO:0030224)	14	0	.33	-	 < 0.01	7.21E-01
protein to membrane docking (GO:0022615)	4	0	.09	-	 < 0.01	9.11E-01
neutrophil differentiation (GO:0030223)	6	0	.14	-	 < 0.01	8.69E-01
membrane to membrane docking (GO:0022614)	1	0	.02	-	 < 0.01	9.77E-01
eosinophil differentiation (GO:0030222)	3	0	.07	-	 < 0.01	9.32E-01
basophil differentiation (GO:0030221)	1	0	.02	-	 < 0.01	9.77E-01
platelet formation (GO:0030220)	18	0	.42	-	 < 0.01	6.57E-01
regulation of cell communication by electrical coupling (GO:0010649)	8	0	.19	-	 < 0.01	8.30E-01
regulation of cell communication by chemical coupling (GO:0010645)	2	0	.05	-	 < 0.01	9.54E-01
cell communication by electrical coupling (GO:0010644)	8	0	.19	-	 < 0.01	8.30E-01
cell communication by chemical coupling (GO:0010643)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642)	14	0	.33	-	 < 0.01	7.21E-01
histone mRNA metabolic process (GO:0008334)	15	0	.35	-	 < 0.01	7.05E-01
megakaryocyte differentiation (GO:0030219)	24	0	.56	-	 < 0.01	5.71E-01
hyaluronan catabolic process (GO:0030214)	10	0	.23	-	 < 0.01	7.92E-01
mammalian oogenesis stage (GO:0022605)	7	0	.16	-	 < 0.01	8.49E-01
hyaluronan biosynthetic process (GO:0030213)	6	0	.14	-	 < 0.01	8.69E-01
heparin catabolic process (GO:0030211)	1	0	.02	-	 < 0.01	9.77E-01
menstrual cycle phase (GO:0022601)	2	0	.05	-	 < 0.01	9.54E-01
heparin biosynthetic process (GO:0030210)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of mitochondrial fusion (GO:0010637)	8	0	.19	-	 < 0.01	8.30E-01
positive regulation of mitochondrial fusion (GO:0010636)	4	0	.09	-	 < 0.01	9.11E-01
regulation of mitochondrial fusion (GO:0010635)	12	0	.28	-	 < 0.01	7.56E-01
cell migration in diencephalon (GO:0061381)	1	0	.02	-	 < 0.01	9.77E-01
dermatan sulfate catabolic process (GO:0030209)	1	0	.02	-	 < 0.01	9.77E-01
dermatan sulfate biosynthetic process (GO:0030208)	3	0	.07	-	 < 0.01	9.32E-01
chondroitin sulfate catabolic process (GO:0030207)	1	0	.02	-	 < 0.01	9.77E-01
chondroitin sulfate biosynthetic process (GO:0030206)	14	0	.33	-	 < 0.01	7.21E-01
dermatan sulfate metabolic process (GO:0030205)	5	0	.12	-	 < 0.01	8.90E-01
heparin metabolic process (GO:0030202)	8	0	.19	-	 < 0.01	8.30E-01
heparan sulfate proteoglycan metabolic process (GO:0030201)	24	0	.56	-	 < 0.01	5.71E-01
heparan sulfate proteoglycan catabolic process (GO:0030200)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of Schwann cell proliferation (GO:0010626)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of Schwann cell proliferation (GO:0010625)	1	0	.02	-	 < 0.01	9.77E-01
regulation of Schwann cell proliferation (GO:0010624)	8	0	.19	-	 < 0.01	8.30E-01
programmed cell death involved in cell development (GO:0010623)	13	0	.30	-	 < 0.01	7.38E-01
inferior colliculus development (GO:0061379)	2	0	.05	-	 < 0.01	9.54E-01
corpora quadrigemina development (GO:0061378)	2	0	.05	-	 < 0.01	9.54E-01
G2/MI transition of meiotic cell cycle (GO:0008315)	2	0	.05	-	 < 0.01	9.54E-01
mammillothalamic axonal tract development (GO:0061374)	1	0	.02	-	 < 0.01	9.77E-01
testosterone biosynthetic process (GO:0061370)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of cardiac muscle adaptation (GO:0010615)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of testicular blood vessel morphogenesis (GO:0061369)	1	0	.02	-	 < 0.01	9.77E-01
tarsal gland development (GO:1903699)	2	0	.05	-	 < 0.01	9.54E-01
regulation of mRNA stability involved in response to stress (GO:0010610)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of microvillus assembly (GO:1903697)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of triglyceride lipase activity (GO:0061365)	11	0	.26	-	 < 0.01	7.74E-01
isoprenoid catabolic process (GO:0008300)	10	0	.23	-	 < 0.01	7.92E-01
optic chiasma development (GO:0061360)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of wound healing, spreading of epidermal cells (GO:1903691)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of wound healing, spreading of epidermal cells (GO:1903690)	4	0	.09	-	 < 0.01	9.11E-01
mRNA localization resulting in posttranscriptional regulation of gene expression (GO:0010609)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of cytoplasmic mRNA processing body assembly (GO:0010607)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of cytoplasmic mRNA processing body assembly (GO:0010606)	5	0	.12	-	 < 0.01	8.90E-01
axonal transport of mitochondrion (GO:0019896)	14	0	.33	-	 < 0.01	7.21E-01
regulation of wound healing, spreading of epidermal cells (GO:1903689)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of Wnt protein secretion (GO:0061358)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of Wnt protein secretion (GO:0061357)	3	0	.07	-	 < 0.01	9.32E-01
regulation of Wnt protein secretion (GO:0061356)	4	0	.09	-	 < 0.01	9.11E-01
Wnt protein secretion (GO:0061355)	2	0	.05	-	 < 0.01	9.54E-01
planar cell polarity pathway involved in pericardium morphogenesis (GO:0061354)	1	0	.02	-	 < 0.01	9.77E-01
planar cell polarity pathway involved in cardiac muscle tissue morphogenesis (GO:0061350)	1	0	.02	-	 < 0.01	9.77E-01
pteridine metabolic process (GO:0019889)	1	0	.02	-	 < 0.01	9.77E-01
planar cell polarity pathway involved in cardiac right atrium morphogenesis (GO:0061349)	1	0	.02	-	 < 0.01	9.77E-01
planar cell polarity pathway involved in ventricular septum morphogenesis (GO:0061348)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of cap-independent translational initiation (GO:1903679)	3	0	.07	-	 < 0.01	9.32E-01
planar cell polarity pathway involved in outflow tract morphogenesis (GO:0061347)	1	0	.02	-	 < 0.01	9.77E-01
antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885)	27	0	.63	-	 < 0.01	5.33E-01
planar cell polarity pathway involved in heart morphogenesis (GO:0061346)	2	0	.05	-	 < 0.01	9.54E-01
regulation of cap-independent translational initiation (GO:1903677)	3	0	.07	-	 < 0.01	9.32E-01
antigen processing and presentation of endogenous antigen (GO:0019883)	30	0	.70	-	 < 0.01	4.97E-01
positive regulation of cap-dependent translational initiation (GO:1903676)	1	0	.02	-	 < 0.01	9.77E-01
regulation of cell adhesion involved in heart morphogenesis (GO:0061344)	3	0	.07	-	 < 0.01	9.32E-01
regulation of cap-dependent translational initiation (GO:1903674)	1	0	.02	-	 < 0.01	9.77E-01
mitotic cleavage furrow formation (GO:1903673)	1	0	.02	-	 < 0.01	9.77E-01
non-canonical Wnt signaling pathway involved in heart development (GO:0061341)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of sprouting angiogenesis (GO:1903672)	21	0	.49	-	 < 0.01	6.13E-01
lysine biosynthetic process via aminoadipic acid (GO:0019878)	2	0	.05	-	 < 0.01	9.54E-01
establishment or maintenance of monopolar cell polarity (GO:0061339)	23	0	.54	-	 < 0.01	5.85E-01
spermatogenesis, exchange of chromosomal proteins (GO:0035093)	8	0	.19	-	 < 0.01	8.30E-01
sperm chromatin condensation (GO:0035092)	11	0	.26	-	 < 0.01	7.74E-01
positive regulation of complement-dependent cytotoxicity (GO:1903661)	1	0	.02	-	 < 0.01	9.77E-01
establishment of apical/basal cell polarity (GO:0035089)	21	0	.49	-	 < 0.01	6.13E-01
cell proliferation involved in outflow tract morphogenesis (GO:0061325)	2	0	.05	-	 < 0.01	9.54E-01
canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation (GO:0061324)	2	0	.05	-	 < 0.01	9.54E-01
cell proliferation involved in heart morphogenesis (GO:0061323)	2	0	.05	-	 < 0.01	9.54E-01
uracil metabolic process (GO:0019860)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of cytoplasmic transport (GO:1903651)	12	0	.28	-	 < 0.01	7.56E-01
negative regulation of cytoplasmic transport (GO:1903650)	3	0	.07	-	 < 0.01	9.32E-01
thymine metabolic process (GO:0019859)	3	0	.07	-	 < 0.01	9.32E-01
cytosine metabolic process (GO:0019858)	2	0	.05	-	 < 0.01	9.54E-01
5-methylcytosine metabolic process (GO:0019857)	3	0	.07	-	 < 0.01	9.32E-01
renal filtration cell differentiation (GO:0061318)	14	0	.33	-	 < 0.01	7.21E-01
pyrimidine nucleobase biosynthetic process (GO:0019856)	7	0	.16	-	 < 0.01	8.49E-01
regulation of cytoplasmic transport (GO:1903649)	27	0	.63	-	 < 0.01	5.33E-01
canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment (GO:0061317)	1	0	.02	-	 < 0.01	9.77E-01
canonical Wnt signaling pathway involved in heart development (GO:0061316)	3	0	.07	-	 < 0.01	9.32E-01
L-ascorbic acid biosynthetic process (GO:0019853)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of chaperone-mediated protein folding (GO:1903646)	2	0	.05	-	 < 0.01	9.54E-01
Notch signaling involved in heart development (GO:0061314)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of chaperone-mediated protein folding (GO:1903645)	2	0	.05	-	 < 0.01	9.54E-01
regulation of chaperone-mediated protein folding (GO:1903644)	5	0	.12	-	 < 0.01	8.90E-01
BMP signaling pathway involved in heart development (GO:0061312)	7	0	.16	-	 < 0.01	8.49E-01
cell surface receptor signaling pathway involved in heart development (GO:0061311)	21	0	.49	-	 < 0.01	6.13E-01
canonical Wnt signaling pathway involved in cardiac neural crest cell differentiation involved in heart development (GO:0061310)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of gastrin-induced gastric acid secretion (GO:1903640)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of histone acetylation (GO:0035067)	18	0	.42	-	 < 0.01	6.57E-01
positive regulation of histone acetylation (GO:0035066)	31	0	.72	-	 < 0.01	4.85E-01
cardiac neural crest cell development involved in outflow tract morphogenesis (GO:0061309)	7	0	.16	-	 < 0.01	8.49E-01
regulation of histone acetylation (GO:0035065)	57	0	1.33	-	 < 0.01	2.64E-01
cardiac neural crest cell development involved in heart development (GO:0061308)	10	0	.23	-	 < 0.01	7.92E-01
regulation of gastrin-induced gastric acid secretion (GO:1903639)	2	0	.05	-	 < 0.01	9.54E-01
cardiac neural crest cell differentiation involved in heart development (GO:0061307)	11	0	.26	-	 < 0.01	7.74E-01
positive regulation of protein insertion into mitochondrial outer membrane (GO:1903638)	1	0	.02	-	 < 0.01	9.77E-01
nuclear speck organization (GO:0035063)	4	0	.09	-	 < 0.01	9.11E-01
regulation of protein insertion into mitochondrial outer membrane (GO:1903636)	1	0	.02	-	 < 0.01	9.77E-01
retinal blood vessel morphogenesis (GO:0061304)	5	0	.12	-	 < 0.01	8.90E-01
cornea development in camera-type eye (GO:0061303)	10	0	.23	-	 < 0.01	7.92E-01
negative regulation of leucine-tRNA ligase activity (GO:1903634)	1	0	.02	-	 < 0.01	9.77E-01
smooth muscle cell-matrix adhesion (GO:0061302)	2	0	.05	-	 < 0.01	9.54E-01
regulation of leucine-tRNA ligase activity (GO:1903633)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of aminoacyl-tRNA ligase activity (GO:1903632)	2	0	.05	-	 < 0.01	9.54E-01
cerebellum vasculature morphogenesis (GO:0061301)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of aminoacyl-tRNA ligase activity (GO:1903631)	1	0	.02	-	 < 0.01	9.77E-01
cerebellum vasculature development (GO:0061300)	2	0	.05	-	 < 0.01	9.54E-01
regulation of aminoacyl-tRNA ligase activity (GO:1903630)	3	0	.07	-	 < 0.01	9.32E-01
embryonic heart tube anterior/posterior pattern specification (GO:0035054)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of dUTP diphosphatase activity (GO:1903629)	1	0	.02	-	 < 0.01	9.77E-01
cytolysis (GO:0019835)	24	0	.56	-	 < 0.01	5.71E-01
regulation of dUTP diphosphatase activity (GO:1903627)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of DNA catabolic process (GO:1903625)	4	0	.09	-	 < 0.01	9.11E-01
protein localization to photoreceptor connecting cilium (GO:1903621)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of transdifferentiation (GO:1903620)	1	0	.02	-	 < 0.01	9.77E-01
regulation of transdifferentiation (GO:1903618)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of protein tyrosine phosphatase activity (GO:1903615)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of protein tyrosine phosphatase activity (GO:1903614)	2	0	.05	-	 < 0.01	9.54E-01
regulation of protein tyrosine phosphatase activity (GO:1903613)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of calcium-dependent ATPase activity (GO:1903612)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of calcium-dependent ATPase activity (GO:1903611)	1	0	.02	-	 < 0.01	9.77E-01
regulation of calcium-dependent ATPase activity (GO:1903610)	2	0	.05	-	 < 0.01	9.54E-01
male pronucleus assembly (GO:0035039)	1	0	.02	-	 < 0.01	9.77E-01
female pronucleus assembly (GO:0035038)	2	0	.05	-	 < 0.01	9.54E-01
sperm entry (GO:0035037)	1	0	.02	-	 < 0.01	9.77E-01
sperm-egg recognition (GO:0035036)	49	0	1.14	-	 < 0.01	3.19E-01
negative regulation of inward rectifier potassium channel activity (GO:1903609)	2	0	.05	-	 < 0.01	9.54E-01
protein localization to cytoplasmic stress granule (GO:1903608)	7	0	.16	-	 < 0.01	8.49E-01
leading edge cell differentiation (GO:0035026)	2	0	.05	-	 < 0.01	9.54E-01
quinolinate biosynthetic process (GO:0019805)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of Rac protein signal transduction (GO:0035022)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of Rac protein signal transduction (GO:0035021)	4	0	.09	-	 < 0.01	9.11E-01
neural plate regionalization (GO:0060897)	4	0	.09	-	 < 0.01	9.11E-01
neuronal signal transduction (GO:0023041)	3	0	.07	-	 < 0.01	9.32E-01
semicircular canal fusion (GO:0060879)	1	0	.02	-	 < 0.01	9.77E-01
semicircular canal formation (GO:0060876)	2	0	.05	-	 < 0.01	9.54E-01
lateral semicircular canal development (GO:0060875)	1	0	.02	-	 < 0.01	9.77E-01
anterior semicircular canal development (GO:0060873)	1	0	.02	-	 < 0.01	9.77E-01
semicircular canal development (GO:0060872)	10	0	.23	-	 < 0.01	7.92E-01
regulation of centriole replication (GO:0046599)	20	0	.47	-	 < 0.01	6.27E-01
positive regulation of viral entry into host cell (GO:0046598)	11	0	.26	-	 < 0.01	7.74E-01
termination of signal transduction (GO:0023021)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of calcium-dependent cell-cell adhesion (GO:0046587)	1	0	.02	-	 < 0.01	9.77E-01
regulation of calcium-dependent cell-cell adhesion (GO:0046586)	1	0	.02	-	 < 0.01	9.77E-01
establishment of glial blood-brain barrier (GO:0060857)	2	0	.05	-	 < 0.01	9.54E-01
Notch signaling pathway involved in arterial endothelial cell fate commitment (GO:0060853)	2	0	.05	-	 < 0.01	9.54E-01
chondrocyte development involved in endochondral bone morphogenesis (GO:0003433)	8	0	.19	-	 < 0.01	8.30E-01
growth plate cartilage chondrocyte development (GO:0003431)	5	0	.12	-	 < 0.01	8.90E-01
growth plate cartilage chondrocyte growth (GO:0003430)	3	0	.07	-	 < 0.01	9.32E-01
endothelial cell fate specification (GO:0060847)	3	0	.07	-	 < 0.01	9.32E-01
blood vessel endothelial cell fate commitment (GO:0060846)	2	0	.05	-	 < 0.01	9.54E-01
arterial endothelial cell fate commitment (GO:0060844)	2	0	.05	-	 < 0.01	9.54E-01
venous endothelial cell differentiation (GO:0060843)	1	0	.02	-	 < 0.01	9.77E-01
arterial endothelial cell differentiation (GO:0060842)	6	0	.14	-	 < 0.01	8.69E-01
venous blood vessel development (GO:0060841)	18	0	.42	-	 < 0.01	6.57E-01
growth plate cartilage chondrocyte morphogenesis (GO:0003429)	1	0	.02	-	 < 0.01	9.77E-01
growth plate cartilage morphogenesis (GO:0003422)	2	0	.05	-	 < 0.01	9.54E-01
growth plate cartilage axis specification (GO:0003421)	1	0	.02	-	 < 0.01	9.77E-01
regulation of growth plate cartilage chondrocyte proliferation (GO:0003420)	3	0	.07	-	 < 0.01	9.32E-01
endothelial cell fate commitment (GO:0060839)	7	0	.16	-	 < 0.01	8.49E-01
lymphatic endothelial cell fate commitment (GO:0060838)	3	0	.07	-	 < 0.01	9.32E-01
blood vessel endothelial cell differentiation (GO:0060837)	8	0	.19	-	 < 0.01	8.30E-01
ciliary receptor clustering involved in smoothened signaling pathway (GO:0060830)	4	0	.09	-	 < 0.01	9.11E-01
growth plate cartilage chondrocyte proliferation (GO:0003419)	2	0	.05	-	 < 0.01	9.54E-01
growth plate cartilage chondrocyte differentiation (GO:0003418)	9	0	.21	-	 < 0.01	8.11E-01
chondrocyte hypertrophy (GO:0003415)	4	0	.09	-	 < 0.01	9.11E-01
chondrocyte morphogenesis involved in endochondral bone morphogenesis (GO:0003414)	1	0	.02	-	 < 0.01	9.77E-01
chondrocyte differentiation involved in endochondral bone morphogenesis (GO:0003413)	15	0	.35	-	 < 0.01	7.05E-01
establishment of epithelial cell apical/basal polarity involved in camera-type eye morphogenesis (GO:0003412)	1	0	.02	-	 < 0.01	9.77E-01
photoreceptor cell fate commitment (GO:0046552)	3	0	.07	-	 < 0.01	9.32E-01
hydroxyproline transport (GO:0034589)	1	0	.02	-	 < 0.01	9.77E-01
halogenated hydrocarbon metabolic process (GO:0042197)	1	0	.02	-	 < 0.01	9.77E-01
piRNA metabolic process (GO:0034587)	16	0	.37	-	 < 0.01	6.89E-01
chlorinated hydrocarbon metabolic process (GO:0042196)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation (GO:0060829)	1	0	.02	-	 < 0.01	9.77E-01
regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation (GO:0060827)	1	0	.02	-	 < 0.01	9.77E-01
fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation (GO:0060825)	1	0	.02	-	 < 0.01	9.77E-01
inactivation of X chromosome by DNA methylation (GO:0060821)	2	0	.05	-	 < 0.01	9.54E-01
optic cup structural organization (GO:0003409)	1	0	.02	-	 < 0.01	9.77E-01
inactivation of X chromosome by heterochromatin assembly (GO:0060820)	1	0	.02	-	 < 0.01	9.77E-01
optic cup formation involved in camera-type eye development (GO:0003408)	1	0	.02	-	 < 0.01	9.77E-01
optic vesicle morphogenesis (GO:0003404)	2	0	.05	-	 < 0.01	9.54E-01
planar cell polarity pathway involved in axis elongation (GO:0003402)	3	0	.07	-	 < 0.01	9.32E-01
retinal cone cell development (GO:0046549)	13	0	.30	-	 < 0.01	7.38E-01
regulation of protein O-linked glycosylation (GO:1904098)	3	0	.07	-	 < 0.01	9.32E-01
retinal rod cell development (GO:0046548)	14	0	.33	-	 < 0.01	7.21E-01
regulation of COPII vesicle coating (GO:0003400)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of autophagic cell death (GO:1904093)	4	0	.09	-	 < 0.01	9.11E-01
development of secondary male sexual characteristics (GO:0046544)	3	0	.07	-	 < 0.01	9.32E-01
development of secondary female sexual characteristics (GO:0046543)	10	0	.23	-	 < 0.01	7.92E-01
regulation of autophagic cell death (GO:1904092)	7	0	.16	-	 < 0.01	8.49E-01
saliva secretion (GO:0046541)	5	0	.12	-	 < 0.01	8.90E-01
regulation of nucleus size (GO:0097298)	1	0	.02	-	 < 0.01	9.77E-01
inactivation of X chromosome by genetic imprinting (GO:0060819)	2	0	.05	-	 < 0.01	9.54E-01
renal phosphate ion absorption (GO:0097291)	1	0	.02	-	 < 0.01	9.77E-01
ketone catabolic process (GO:0042182)	12	0	.28	-	 < 0.01	7.56E-01
inactivation of paternal X chromosome (GO:0060817)	1	0	.02	-	 < 0.01	9.77E-01
random inactivation of X chromosome (GO:0060816)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of photoreceptor cell differentiation (GO:0046534)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of photoreceptor cell differentiation (GO:0046533)	6	0	.14	-	 < 0.01	8.69E-01
regulation of photoreceptor cell differentiation (GO:0046532)	7	0	.16	-	 < 0.01	8.49E-01
xenobiotic catabolic process (GO:0042178)	14	0	.33	-	 < 0.01	7.21E-01
hepatocyte apoptotic process (GO:0097284)	14	0	.33	-	 < 0.01	7.21E-01
mesodermal to mesenchymal transition involved in gastrulation (GO:0060809)	3	0	.07	-	 < 0.01	9.32E-01
immune complex formation (GO:0097281)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of cell differentiation involved in embryonic placenta development (GO:0060806)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of Wnt signaling pathway by BMP signaling pathway (GO:0060804)	1	0	.02	-	 < 0.01	9.77E-01
BMP signaling pathway involved in mesodermal cell fate specification (GO:0060803)	1	0	.02	-	 < 0.01	9.77E-01
epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification (GO:0060802)	1	0	.02	-	 < 0.01	9.77E-01
regulation of cell differentiation involved in embryonic placenta development (GO:0060800)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of trophectodermal cell proliferation (GO:1904075)	1	0	.02	-	 < 0.01	9.77E-01
regulation of trophectodermal cell proliferation (GO:1904073)	1	0	.02	-	 < 0.01	9.77E-01
presynaptic active zone assembly (GO:1904071)	3	0	.07	-	 < 0.01	9.32E-01
complement-dependent cytotoxicity (GO:0097278)	2	0	.05	-	 < 0.01	9.54E-01
sphingoid biosynthetic process (GO:0046520)	13	0	.30	-	 < 0.01	7.38E-01
cellular urea homeostasis (GO:0097277)	1	0	.02	-	 < 0.01	9.77E-01
heme metabolic process (GO:0042168)	31	0	.72	-	 < 0.01	4.85E-01
cellular creatinine homeostasis (GO:0097276)	1	0	.02	-	 < 0.01	9.77E-01
heme catabolic process (GO:0042167)	4	0	.09	-	 < 0.01	9.11E-01
cellular ammonium homeostasis (GO:0097275)	1	0	.02	-	 < 0.01	9.77E-01
urea homeostasis (GO:0097274)	3	0	.07	-	 < 0.01	9.32E-01
creatinine homeostasis (GO:0097273)	4	0	.09	-	 < 0.01	9.11E-01
ammonium homeostasis (GO:0097272)	2	0	.05	-	 < 0.01	9.54E-01
mitochondrial respiratory chain complex II assembly (GO:0034553)	2	0	.05	-	 < 0.01	9.54E-01
respiratory chain complex II assembly (GO:0034552)	2	0	.05	-	 < 0.01	9.54E-01
mitochondrial respiratory chain complex III assembly (GO:0034551)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of blood coagulation (GO:0030195)	44	0	1.03	-	 < 0.01	3.58E-01
sphingoid metabolic process (GO:0046519)	21	0	.49	-	 < 0.01	6.13E-01
negative regulation of cation transmembrane transport (GO:1904063)	89	0	2.07	-	 < 0.01	1.25E-01
sphingosine biosynthetic process (GO:0046512)	13	0	.30	-	 < 0.01	7.38E-01
negative regulation of locomotor rhythm (GO:1904060)	1	0	.02	-	 < 0.01	9.77E-01
sphinganine biosynthetic process (GO:0046511)	2	0	.05	-	 < 0.01	9.54E-01
omega-hydroxylase P450 pathway (GO:0097267)	5	0	.12	-	 < 0.01	8.90E-01
self proteolysis (GO:0097264)	11	0	.26	-	 < 0.01	7.74E-01
melatonin biosynthetic process (GO:0030187)	1	0	.02	-	 < 0.01	9.77E-01
melatonin metabolic process (GO:0030186)	1	0	.02	-	 < 0.01	9.77E-01
nitric oxide transport (GO:0030185)	2	0	.05	-	 < 0.01	9.54E-01
regulation of locomotor rhythm (GO:1904059)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of sensory perception of pain (GO:1904058)	10	0	.23	-	 < 0.01	7.92E-01
negative regulation of sensory perception of pain (GO:1904057)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of cholangiocyte proliferation (GO:1904056)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of cholangiocyte proliferation (GO:1904055)	1	0	.02	-	 < 0.01	9.77E-01
regulation of cholangiocyte proliferation (GO:1904054)	5	0	.12	-	 < 0.01	8.90E-01
glycerol ether biosynthetic process (GO:0046504)	11	0	.26	-	 < 0.01	7.74E-01
glycerolipid catabolic process (GO:0046503)	50	0	1.17	-	 < 0.01	3.11E-01
intracellular mRNA localization (GO:0008298)	10	0	.23	-	 < 0.01	7.92E-01
uroporphyrinogen III metabolic process (GO:0046502)	2	0	.05	-	 < 0.01	9.54E-01
protoporphyrinogen IX metabolic process (GO:0046501)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of spontaneous neurotransmitter secretion (GO:1904050)	1	0	.02	-	 < 0.01	9.77E-01
S-adenosylmethionine metabolic process (GO:0046500)	14	0	.33	-	 < 0.01	7.21E-01
strand invasion (GO:0042148)	4	0	.09	-	 < 0.01	9.11E-01
spermidine biosynthetic process (GO:0008295)	3	0	.07	-	 < 0.01	9.32E-01
renal tubular secretion (GO:0097254)	2	0	.05	-	 < 0.01	9.54E-01
acetylcholine biosynthetic process (GO:0008292)	3	0	.07	-	 < 0.01	9.32E-01
acetylcholine metabolic process (GO:0008291)	4	0	.09	-	 < 0.01	9.11E-01
oligodendrocyte apoptotic process (GO:0097252)	2	0	.05	-	 < 0.01	9.54E-01
mitochondrial respirasome assembly (GO:0097250)	7	0	.16	-	 < 0.01	8.49E-01
regulation of DNA-dependent DNA replication initiation (GO:0030174)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of spontaneous neurotransmitter secretion (GO:1904049)	1	0	.02	-	 < 0.01	9.77E-01
regulation of spontaneous neurotransmitter secretion (GO:1904048)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of vascular endothelial growth factor production (GO:1904046)	2	0	.05	-	 < 0.01	9.54E-01
cellular response to aldosterone (GO:1904045)	4	0	.09	-	 < 0.01	9.11E-01
response to aldosterone (GO:1904044)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of cystathionine beta-synthase activity (GO:1904042)	1	0	.02	-	 < 0.01	9.77E-01
regulation of cystathionine beta-synthase activity (GO:1904041)	1	0	.02	-	 < 0.01	9.77E-01
meiotic DNA double-strand break formation (GO:0042138)	4	0	.09	-	 < 0.01	9.11E-01
sequestering of neurotransmitter (GO:0042137)	1	0	.02	-	 < 0.01	9.77E-01
neurotransmitter biosynthetic process (GO:0042136)	12	0	.28	-	 < 0.01	7.56E-01
neurotransmitter catabolic process (GO:0042135)	11	0	.26	-	 < 0.01	7.74E-01
hematopoietic stem cell migration to bone marrow (GO:0097241)	4	0	.09	-	 < 0.01	9.11E-01
neurotransmitter metabolic process (GO:0042133)	25	0	.58	-	 < 0.01	5.58E-01
chromosome attachment to the nuclear envelope (GO:0097240)	4	0	.09	-	 < 0.01	9.11E-01
proteoglycan catabolic process (GO:0030167)	4	0	.09	-	 < 0.01	9.11E-01
proteoglycan biosynthetic process (GO:0030166)	46	0	1.07	-	 < 0.01	3.42E-01
miRNA catabolic process (GO:0010587)	6	0	.14	-	 < 0.01	8.69E-01
glutamine secretion (GO:0010585)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of t-SNARE clustering (GO:1904034)	1	0	.02	-	 < 0.01	9.77E-01
regulation of t-SNARE clustering (GO:1904032)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to methylglyoxal (GO:0097238)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of cyclin-dependent protein kinase activity (GO:1904030)	28	0	.65	-	 < 0.01	5.20E-01
cellular response to toxic substance (GO:0097237)	34	0	.79	-	 < 0.01	4.52E-01
nitrate assimilation (GO:0042128)	1	0	.02	-	 < 0.01	9.77E-01
nitrate metabolic process (GO:0042126)	5	0	.12	-	 < 0.01	8.90E-01
response to vitamin B6 (GO:0034516)	1	0	.02	-	 < 0.01	9.77E-01
protein galactosylation (GO:0042125)	1	0	.02	-	 < 0.01	9.77E-01
mitochondrial unfolded protein response (GO:0034514)	1	0	.02	-	 < 0.01	9.77E-01
cell motility in response to calcium ion (GO:0097231)	1	0	.02	-	 < 0.01	9.77E-01
pancreatic juice secretion (GO:0030157)	5	0	.12	-	 < 0.01	8.90E-01
protein import into mitochondrial matrix (GO:0030150)	17	0	.40	-	 < 0.01	6.73E-01
positive regulation of collagen fibril organization (GO:1904028)	3	0	.07	-	 < 0.01	9.32E-01
regulation of adenylate cyclase activity involved in G protein-coupled receptor signaling pathway (GO:0010578)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of collagen fibril organization (GO:1904027)	2	0	.05	-	 < 0.01	9.54E-01
regulation of collagen fibril organization (GO:1904026)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of vascular endothelial growth factor production (GO:0010575)	26	0	.61	-	 < 0.01	5.45E-01
positive regulation of glucose catabolic process to lactate via pyruvate (GO:1904025)	1	0	.02	-	 < 0.01	9.77E-01
regulation of vascular endothelial growth factor production (GO:0010574)	32	0	.75	-	 < 0.01	4.74E-01
negative regulation of glucose catabolic process to lactate via pyruvate (GO:1904024)	1	0	.02	-	 < 0.01	9.77E-01
regulation of glucose catabolic process to lactate via pyruvate (GO:1904023)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of platelet activation (GO:0010572)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of G protein-coupled receptor internalization (GO:1904022)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of nuclear cell cycle DNA replication (GO:0010571)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of G protein-coupled receptor internalization (GO:1904021)	2	0	.05	-	 < 0.01	9.54E-01
regulation of G protein-coupled receptor internalization (GO:1904020)	4	0	.09	-	 < 0.01	9.11E-01
neutrophil activation (GO:0042119)	22	0	.51	-	 < 0.01	5.99E-01
endothelial cell activation (GO:0042118)	8	0	.19	-	 < 0.01	8.30E-01
centromere complex assembly (GO:0034508)	23	0	.54	-	 < 0.01	5.85E-01
monocyte activation (GO:0042117)	4	0	.09	-	 < 0.01	9.11E-01
mitochondrial mRNA polyadenylation (GO:0097222)	1	0	.02	-	 < 0.01	9.77E-01
protein localization to chromosome (GO:0034502)	65	0	1.52	-	 < 0.01	2.19E-01
protein localization to kinetochore (GO:0034501)	15	0	.35	-	 < 0.01	7.05E-01
epithelial cell apoptotic process (GO:1904019)	29	0	.68	-	 < 0.01	5.08E-01
cellular response to Thyroglobulin triiodothyronine (GO:1904017)	3	0	.07	-	 < 0.01	9.32E-01
regulation of ketone biosynthetic process (GO:0010566)	18	0	.42	-	 < 0.01	6.57E-01
response to Thyroglobulin triiodothyronine (GO:1904016)	3	0	.07	-	 < 0.01	9.32E-01
cellular response to serotonin (GO:1904015)	1	0	.02	-	 < 0.01	9.77E-01
response to serotonin (GO:1904014)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of lysosomal membrane permeability (GO:0097214)	3	0	.07	-	 < 0.01	9.32E-01
regulation of lysosomal membrane permeability (GO:0097213)	4	0	.09	-	 < 0.01	9.11E-01
lysosomal membrane organization (GO:0097212)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of activated T cell proliferation (GO:0042104)	26	0	.61	-	 < 0.01	5.45E-01
cellular response to gonadotropin-releasing hormone (GO:0097211)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of T cell homeostatic proliferation (GO:0042103)	1	0	.02	-	 < 0.01	9.77E-01
response to gonadotropin-releasing hormone (GO:0097210)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of T cell proliferation (GO:0042102)	99	0	2.31	-	 < 0.01	9.88E-02
negative regulation of smooth muscle cell migration (GO:0014912)	26	0	.61	-	 < 0.01	5.45E-01
cellular response to monosodium glutamate (GO:1904009)	2	0	.05	-	 < 0.01	9.54E-01
response to monosodium glutamate (GO:1904008)	2	0	.05	-	 < 0.01	9.54E-01
tRNA threonylcarbamoyladenosine modification (GO:0002949)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of phospholipase D activity (GO:1904006)	1	0	.02	-	 < 0.01	9.77E-01
tRNA C5-cytosine methylation (GO:0002946)	2	0	.05	-	 < 0.01	9.54E-01
regulation of phospholipase D activity (GO:1904005)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of sebum secreting cell proliferation (GO:1904003)	1	0	.02	-	 < 0.01	9.77E-01
tRNA dihydrouridine synthesis (GO:0002943)	1	0	.02	-	 < 0.01	9.77E-01
regulation of sebum secreting cell proliferation (GO:1904002)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of eating behavior (GO:1904000)	5	0	.12	-	 < 0.01	8.90E-01
tRNA N2-guanine methylation (GO:0002940)	1	0	.02	-	 < 0.01	9.77E-01
renal filtration (GO:0097205)	13	0	.30	-	 < 0.01	7.38E-01
negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201)	13	0	.30	-	 < 0.01	7.38E-01
myotube differentiation involved in skeletal muscle regeneration (GO:0014908)	7	0	.16	-	 < 0.01	8.49E-01
myoblast fusion involved in skeletal muscle regeneration (GO:0014905)	4	0	.09	-	 < 0.01	9.11E-01
myotube cell development (GO:0014904)	28	0	.65	-	 < 0.01	5.20E-01
satellite cell activation involved in skeletal muscle regeneration (GO:0014901)	2	0	.05	-	 < 0.01	9.54E-01
muscle hyperplasia (GO:0014900)	1	0	.02	-	 < 0.01	9.77E-01
tRNA N1-guanine methylation (GO:0002939)	2	0	.05	-	 < 0.01	9.54E-01
bradykinin biosynthetic process (GO:0002936)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of platelet activation (GO:0010544)	19	0	.44	-	 < 0.01	6.42E-01
regulation of platelet activation (GO:0010543)	37	0	.86	-	 < 0.01	4.22E-01
retina vasculature morphogenesis in camera-type eye (GO:0061299)	11	0	.26	-	 < 0.01	7.74E-01
lipid hydroxylation (GO:0002933)	3	0	.07	-	 < 0.01	9.32E-01
retina vasculature development in camera-type eye (GO:0061298)	19	0	.44	-	 < 0.01	6.42E-01
tendon sheath development (GO:0002932)	1	0	.02	-	 < 0.01	9.77E-01
trabecular meshwork development (GO:0002930)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis (GO:0061296)	1	0	.02	-	 < 0.01	9.77E-01
regulation of mesenchymal cell apoptotic process involved in mesonephric nephron morphogenesis (GO:0061295)	1	0	.02	-	 < 0.01	9.77E-01
canonical Wnt signaling pathway involved in metanephric kidney development (GO:0061290)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of activation of Janus kinase activity (GO:0010536)	4	0	.09	-	 < 0.01	9.11E-01
tRNA wobble base 5-methoxycarbonylmethyl-2-thiouridinylation (GO:0002926)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002925)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924)	4	0	.09	-	 < 0.01	9.11E-01
regulation of activation of Janus kinase activity (GO:0010533)	7	0	.16	-	 < 0.01	8.49E-01
regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923)	11	0	.26	-	 < 0.01	7.74E-01
Wnt signaling pathway involved in kidney development (GO:0061289)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of humoral immune response (GO:0002922)	19	0	.44	-	 < 0.01	6.42E-01
opsonization (GO:0008228)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of humoral immune response (GO:0002921)	11	0	.26	-	 < 0.01	7.74E-01
regulation of humoral immune response (GO:0002920)	38	0	.89	-	 < 0.01	4.12E-01
water homeostasis (GO:0030104)	62	0	1.45	-	 < 0.01	2.35E-01
vasopressin secretion (GO:0030103)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of transposition (GO:0010529)	19	0	.44	-	 < 0.01	6.42E-01
regulation of transposition (GO:0010528)	19	0	.44	-	 < 0.01	6.42E-01
negative regulation of transposition, RNA-mediated (GO:0010526)	2	0	.05	-	 < 0.01	9.54E-01
regulation of transposition, RNA-mediated (GO:0010525)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of calcium ion transport into cytosol (GO:0010523)	15	0	.35	-	 < 0.01	7.05E-01
positive regulation of lymphocyte anergy (GO:0002913)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of lymphocyte anergy (GO:0002912)	1	0	.02	-	 < 0.01	9.77E-01
regulation of reciprocal meiotic recombination (GO:0010520)	3	0	.07	-	 < 0.01	9.32E-01
regulation of lymphocyte anergy (GO:0002911)	7	0	.16	-	 < 0.01	8.49E-01
spermidine metabolic process (GO:0008216)	8	0	.19	-	 < 0.01	8.30E-01
spermine metabolic process (GO:0008215)	6	0	.14	-	 < 0.01	8.69E-01
mineralocorticoid metabolic process (GO:0008212)	5	0	.12	-	 < 0.01	8.90E-01
glucocorticoid metabolic process (GO:0008211)	15	0	.35	-	 < 0.01	7.05E-01
negative regulation of phospholipase activity (GO:0010519)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of mature B cell apoptotic process (GO:0002906)	5	0	.12	-	 < 0.01	8.90E-01
regulation of mature B cell apoptotic process (GO:0002905)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of B cell apoptotic process (GO:0002904)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of B cell apoptotic process (GO:0002903)	13	0	.30	-	 < 0.01	7.38E-01
negative regulation of phosphatidylinositol biosynthetic process (GO:0010512)	2	0	.05	-	 < 0.01	9.54E-01
regulation of B cell apoptotic process (GO:0002902)	21	0	.49	-	 < 0.01	6.13E-01
positive regulation of autophagy of mitochondrion (GO:1903599)	6	0	.14	-	 < 0.01	8.69E-01
C21-steroid hormone catabolic process (GO:0008208)	1	0	.02	-	 < 0.01	9.77E-01
regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of gap junction assembly (GO:1903598)	3	0	.07	-	 < 0.01	9.32E-01
bile acid metabolic process (GO:0008206)	25	0	.58	-	 < 0.01	5.58E-01
negative regulation of gap junction assembly (GO:1903597)	2	0	.05	-	 < 0.01	9.54E-01
regulation of gap junction assembly (GO:1903596)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of histamine secretion by mast cell (GO:1903595)	5	0	.12	-	 < 0.01	8.90E-01
ergosterol metabolic process (GO:0008204)	1	0	.02	-	 < 0.01	9.77E-01
regulation of histamine secretion by mast cell (GO:1903593)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of autophagy (GO:0010507)	71	0	1.66	-	 < 0.01	1.90E-01
positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903589)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of histone deubiquitination (GO:1903586)	1	0	.02	-	 < 0.01	9.77E-01
regulation of histone deubiquitination (GO:1903584)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of ATP metabolic process (GO:1903579)	31	0	.72	-	 < 0.01	4.85E-01
cornified envelope assembly (GO:1903575)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of response to endoplasmic reticulum stress (GO:1903573)	40	0	.93	-	 < 0.01	3.93E-01
positive regulation of protein kinase D signaling (GO:1903572)	1	0	.02	-	 < 0.01	9.77E-01
regulation of protein kinase D signaling (GO:1903570)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of protein localization to ciliary membrane (GO:1903569)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of protein localization to ciliary membrane (GO:1903568)	1	0	.02	-	 < 0.01	9.77E-01
regulation of protein localization to ciliary membrane (GO:1903567)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of protein localization to cilium (GO:1903565)	2	0	.05	-	 < 0.01	9.54E-01
pattern specification involved in mesonephros development (GO:0061227)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of mesonephros development (GO:0061218)	1	0	.02	-	 < 0.01	9.77E-01
regulation of mesonephros development (GO:0061217)	5	0	.12	-	 < 0.01	8.90E-01
one-carbon compound transport (GO:0019755)	15	0	.35	-	 < 0.01	7.05E-01
regulation of growth hormone activity (GO:1903547)	2	0	.05	-	 < 0.01	9.54E-01
protein localization to photoreceptor outer segment (GO:1903546)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of exosomal secretion (GO:1903542)	2	0	.05	-	 < 0.01	9.54E-01
establishment of protein localization to postsynaptic membrane (GO:1903540)	19	0	.44	-	 < 0.01	6.42E-01
cell proliferation involved in mesonephros development (GO:0061209)	3	0	.07	-	 < 0.01	9.32E-01
regulation of isoprenoid metabolic process (GO:0019747)	4	0	.09	-	 < 0.01	9.11E-01
regulation of meiotic cell cycle process involved in oocyte maturation (GO:1903538)	3	0	.07	-	 < 0.01	9.32E-01
paramesonephric duct development (GO:0061205)	5	0	.12	-	 < 0.01	8.90E-01
regulation of protein targeting (GO:1903533)	50	0	1.17	-	 < 0.01	3.11E-01
nitrogen utilization (GO:0019740)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of membrane tubulation (GO:1903527)	5	0	.12	-	 < 0.01	8.90E-01
antifungal humoral response (GO:0019732)	9	0	.21	-	 < 0.01	8.11E-01
antibacterial humoral response (GO:0019731)	56	0	1.31	-	 < 0.01	2.71E-01
negative regulation of blood circulation (GO:1903523)	28	0	.65	-	 < 0.01	5.20E-01
positive regulation of single strand break repair (GO:1903518)	2	0	.05	-	 < 0.01	9.54E-01
B cell mediated immunity (GO:0019724)	82	0	1.91	-	 < 0.01	1.47E-01
regulation of single strand break repair (GO:1903516)	2	0	.05	-	 < 0.01	9.54E-01
calcium ion transport from cytosol to endoplasmic reticulum (GO:1903515)	2	0	.05	-	 < 0.01	9.54E-01
release of sequestered calcium ion into cytosol by endoplasmic reticulum (GO:1903514)	7	0	.16	-	 < 0.01	8.49E-01
Mo-molybdopterin cofactor metabolic process (GO:0019720)	6	0	.14	-	 < 0.01	8.69E-01
phytanic acid metabolic process (GO:1903512)	1	0	.02	-	 < 0.01	9.77E-01
regulation of mitotic spindle checkpoint (GO:1903504)	13	0	.30	-	 < 0.01	7.38E-01
apical constriction (GO:0003383)	5	0	.12	-	 < 0.01	8.90E-01
cell fate commitment involved in formation of primary germ layer (GO:0060795)	25	0	.58	-	 < 0.01	5.58E-01
sphingosine-1-phosphate receptor signaling pathway (GO:0003376)	8	0	.19	-	 < 0.01	8.30E-01
cellular response to camptothecin (GO:0072757)	4	0	.09	-	 < 0.01	9.11E-01
cellular response to benomyl (GO:0072755)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to rapamycin (GO:0072752)	3	0	.07	-	 < 0.01	9.32E-01
cellular response to leptomycin B (GO:0072750)	2	0	.05	-	 < 0.01	9.54E-01
hair follicle placode formation (GO:0060789)	5	0	.12	-	 < 0.01	8.90E-01
ectodermal placode formation (GO:0060788)	15	0	.35	-	 < 0.01	7.05E-01
regulation of apoptosis involved in tissue homeostasis (GO:0060785)	1	0	.02	-	 < 0.01	9.77E-01
regulation of cell proliferation involved in tissue homeostasis (GO:0060784)	1	0	.02	-	 < 0.01	9.77E-01
mesenchymal smoothened signaling pathway involved in prostate gland development (GO:0060783)	1	0	.02	-	 < 0.01	9.77E-01
regulation of mesenchymal cell proliferation involved in prostate gland development (GO:0060782)	1	0	.02	-	 < 0.01	9.77E-01
cell-matrix adhesion involved in ameboidal cell migration (GO:0003366)	2	0	.05	-	 < 0.01	9.54E-01
lamellipodium assembly involved in ameboidal cell migration (GO:0003363)	1	0	.02	-	 < 0.01	9.77E-01
brainstem development (GO:0003360)	2	0	.05	-	 < 0.01	9.54E-01
cellular response to cytochalasin B (GO:0072749)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to anisomycin (GO:0072740)	1	0	.02	-	 < 0.01	9.77E-01
planar cell polarity pathway involved in gastrula mediolateral intercalation (GO:0060775)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of epithelial cell proliferation involved in prostate gland development (GO:0060770)	7	0	.16	-	 < 0.01	8.49E-01
noradrenergic neuron fate commitment (GO:0003359)	1	0	.02	-	 < 0.01	9.77E-01
noradrenergic neuron development (GO:0003358)	3	0	.07	-	 < 0.01	9.32E-01
noradrenergic neuron differentiation (GO:0003357)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of cilium movement (GO:0003354)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of cilium movement (GO:0003353)	12	0	.28	-	 < 0.01	7.56E-01
S-adenosylmethioninamine metabolic process (GO:0046499)	1	0	.02	-	 < 0.01	9.77E-01
S-adenosylhomocysteine metabolic process (GO:0046498)	6	0	.14	-	 < 0.01	8.69E-01
pulmonary myocardium development (GO:0003350)	3	0	.07	-	 < 0.01	9.32E-01
nicotinate nucleotide metabolic process (GO:0046497)	1	0	.02	-	 < 0.01	9.77E-01
nicotinamide nucleotide metabolic process (GO:0046496)	24	0	.56	-	 < 0.01	5.71E-01
response to anisomycin (GO:0072739)	2	0	.05	-	 < 0.01	9.54E-01
L-methylmalonyl-CoA metabolic process (GO:0046491)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to staurosporine (GO:0072734)	3	0	.07	-	 < 0.01	9.32E-01
response to staurosporine (GO:0072733)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of epithelial cell proliferation involved in prostate gland development (GO:0060769)	3	0	.07	-	 < 0.01	9.32E-01
regulation of epithelial cell proliferation involved in prostate gland development (GO:0060768)	11	0	.26	-	 < 0.01	7.74E-01
epithelial cell proliferation involved in prostate gland development (GO:0060767)	1	0	.02	-	 < 0.01	9.77E-01
cell-cell signaling involved in mammary gland development (GO:0060764)	2	0	.05	-	 < 0.01	9.54E-01
mammary duct terminal end bud growth (GO:0060763)	7	0	.16	-	 < 0.01	8.49E-01
regulation of branching involved in mammary gland duct morphogenesis (GO:0060762)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of response to cytokine stimulus (GO:0060761)	53	0	1.24	-	 < 0.01	2.90E-01
positive regulation of response to cytokine stimulus (GO:0060760)	51	0	1.19	-	 < 0.01	3.04E-01
epicardium-derived cardiac endothelial cell differentiation (GO:0003349)	2	0	.05	-	 < 0.01	9.54E-01
proepicardium cell migration involved in pericardium morphogenesis (GO:0003345)	1	0	.02	-	 < 0.01	9.77E-01
pericardium morphogenesis (GO:0003344)	9	0	.21	-	 < 0.01	8.11E-01
septum transversum development (GO:0003343)	2	0	.05	-	 < 0.01	9.54E-01
proepicardium development (GO:0003342)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003340)	3	0	.07	-	 < 0.01	9.32E-01
glyoxylate metabolic process (GO:0046487)	6	0	.14	-	 < 0.01	8.69E-01
ether lipid metabolic process (GO:0046485)	17	0	.40	-	 < 0.01	6.73E-01
response to dithiothreitol (GO:0072720)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of mast cell chemotaxis (GO:0060755)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of mast cell chemotaxis (GO:0060754)	7	0	.16	-	 < 0.01	8.49E-01
regulation of mast cell chemotaxis (GO:0060753)	9	0	.21	-	 < 0.01	8.11E-01
branch elongation involved in mammary gland duct branching (GO:0060751)	6	0	.14	-	 < 0.01	8.69E-01
epithelial cell proliferation involved in mammary gland duct elongation (GO:0060750)	5	0	.12	-	 < 0.01	8.90E-01
regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339)	8	0	.19	-	 < 0.01	8.30E-01
metanephros morphogenesis (GO:0003338)	24	0	.56	-	 < 0.01	5.71E-01
mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337)	7	0	.16	-	 < 0.01	8.49E-01
corneocyte development (GO:0003335)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of extracellular matrix constituent secretion (GO:0003332)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of extracellular matrix constituent secretion (GO:0003331)	3	0	.07	-	 < 0.01	9.32E-01
regulation of extracellular matrix constituent secretion (GO:0003330)	7	0	.16	-	 < 0.01	8.49E-01
lactosylceramide metabolic process (GO:0046478)	1	0	.02	-	 < 0.01	9.77E-01
glycosylceramide catabolic process (GO:0046477)	6	0	.14	-	 < 0.01	8.69E-01
glycosylceramide biosynthetic process (GO:0046476)	7	0	.16	-	 < 0.01	8.49E-01
glycerophospholipid catabolic process (GO:0046475)	29	0	.68	-	 < 0.01	5.08E-01
cellular response to cisplatin (GO:0072719)	4	0	.09	-	 < 0.01	9.11E-01
response to cisplatin (GO:0072718)	5	0	.12	-	 < 0.01	8.90E-01
cellular response to actinomycin D (GO:0072717)	3	0	.07	-	 < 0.01	9.32E-01
response to actinomycin D (GO:0072716)	4	0	.09	-	 < 0.01	9.11E-01
phosphatidylglycerol metabolic process (GO:0046471)	25	0	.58	-	 < 0.01	5.58E-01
cellular response to hydroxyurea (GO:0072711)	10	0	.23	-	 < 0.01	7.92E-01
response to hydroxyurea (GO:0072710)	11	0	.26	-	 < 0.01	7.74E-01
tertiary branching involved in mammary gland duct morphogenesis (GO:0060748)	3	0	.07	-	 < 0.01	9.32E-01
mammary gland branching involved in thelarche (GO:0060744)	6	0	.14	-	 < 0.01	8.69E-01
epithelial cell maturation involved in prostate gland development (GO:0060743)	4	0	.09	-	 < 0.01	9.11E-01
prostate gland stromal morphogenesis (GO:0060741)	3	0	.07	-	 < 0.01	9.32E-01
pancreatic PP cell fate commitment (GO:0003329)	2	0	.05	-	 < 0.01	9.54E-01
type B pancreatic cell fate commitment (GO:0003327)	1	0	.02	-	 < 0.01	9.77E-01
pancreatic A cell fate commitment (GO:0003326)	2	0	.05	-	 < 0.01	9.54E-01
type B pancreatic cell development (GO:0003323)	14	0	.33	-	 < 0.01	7.21E-01
pancreatic A cell development (GO:0003322)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of blood pressure by epinephrine-norepinephrine (GO:0003321)	7	0	.16	-	 < 0.01	8.49E-01
platelet activating factor metabolic process (GO:0046469)	7	0	.16	-	 < 0.01	8.49E-01
dolichyl diphosphate metabolic process (GO:0046465)	3	0	.07	-	 < 0.01	9.32E-01
cellular response to sorbitol (GO:0072709)	1	0	.02	-	 < 0.01	9.77E-01
acylglycerol catabolic process (GO:0046464)	28	0	.65	-	 < 0.01	5.20E-01
response to sorbitol (GO:0072708)	3	0	.07	-	 < 0.01	9.32E-01
neutral lipid catabolic process (GO:0046461)	28	0	.65	-	 < 0.01	5.20E-01
cellular response to mercaptoethanol (GO:0072705)	1	0	.02	-	 < 0.01	9.77E-01
response to mercaptoethanol (GO:0072704)	1	0	.02	-	 < 0.01	9.77E-01
protein localization to phagophore assembly site (GO:0034497)	13	0	.30	-	 < 0.01	7.38E-01
mesenchymal-epithelial cell signaling involved in prostate gland development (GO:0060739)	1	0	.02	-	 < 0.01	9.77E-01
epithelial-mesenchymal signaling involved in prostate gland development (GO:0060738)	2	0	.05	-	 < 0.01	9.54E-01
regulation of eIF2 alpha phosphorylation by dsRNA (GO:0060735)	1	0	.02	-	 < 0.01	9.77E-01
regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation (GO:0060734)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of intestinal epithelial structure maintenance (GO:0060731)	1	0	.02	-	 < 0.01	9.77E-01
regulation of intestinal epithelial structure maintenance (GO:0060730)	2	0	.05	-	 < 0.01	9.54E-01
cell migration to the midline involved in heart development (GO:0003318)	1	0	.02	-	 < 0.01	9.77E-01
pancreatic PP cell differentiation (GO:0003312)	2	0	.05	-	 < 0.01	9.54E-01
short-chain fatty acid metabolic process (GO:0046459)	13	0	.30	-	 < 0.01	7.38E-01
pancreatic D cell differentiation (GO:0003311)	1	0	.02	-	 < 0.01	9.77E-01
hexadecanal metabolic process (GO:0046458)	1	0	.02	-	 < 0.01	9.77E-01
pancreatic A cell differentiation (GO:0003310)	7	0	.16	-	 < 0.01	8.49E-01
prostanoid biosynthetic process (GO:0046457)	19	0	.44	-	 < 0.01	6.42E-01
dihydrofolate metabolic process (GO:0046452)	2	0	.05	-	 < 0.01	9.54E-01
vacuolar transmembrane transport (GO:0034486)	2	0	.05	-	 < 0.01	9.54E-01
intestinal epithelial structure maintenance (GO:0060729)	3	0	.07	-	 < 0.01	9.32E-01
T-helper cell differentiation (GO:0042093)	33	0	.77	-	 < 0.01	4.63E-01
type 2 immune response (GO:0042092)	11	0	.26	-	 < 0.01	7.74E-01
regulation of cell proliferation involved in embryonic placenta development (GO:0060723)	2	0	.05	-	 < 0.01	9.54E-01
cell proliferation involved in embryonic placenta development (GO:0060722)	2	0	.05	-	 < 0.01	9.54E-01
regulation of spongiotrophoblast cell proliferation (GO:0060721)	2	0	.05	-	 < 0.01	9.54E-01
type B pancreatic cell differentiation (GO:0003309)	21	0	.49	-	 < 0.01	6.13E-01
spongiotrophoblast cell proliferation (GO:0060720)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of Wnt signaling pathway involved in heart development (GO:0003308)	8	0	.19	-	 < 0.01	8.30E-01
regulation of Wnt signaling pathway involved in heart development (GO:0003307)	10	0	.23	-	 < 0.01	7.92E-01
Wnt signaling pathway involved in heart development (GO:0003306)	5	0	.12	-	 < 0.01	8.90E-01
physiological cardiac muscle hypertrophy (GO:0003301)	14	0	.33	-	 < 0.01	7.21E-01
creatinine metabolic process (GO:0046449)	1	0	.02	-	 < 0.01	9.77E-01
cardiac muscle hypertrophy (GO:0003300)	37	0	.86	-	 < 0.01	4.22E-01
FMN metabolic process (GO:0046444)	1	0	.02	-	 < 0.01	9.77E-01
FAD metabolic process (GO:0046443)	1	0	.02	-	 < 0.01	9.77E-01
histone H3-K36 trimethylation (GO:0097198)	3	0	.07	-	 < 0.01	9.32E-01
L-lysine metabolic process (GO:0046440)	2	0	.05	-	 < 0.01	9.54E-01
T-helper 1 type immune response (GO:0042088)	22	0	.51	-	 < 0.01	5.99E-01
phosphatidylglycerol catabolic process (GO:0034478)	2	0	.05	-	 < 0.01	9.54E-01
pilomotor reflex (GO:0097195)	3	0	.07	-	 < 0.01	9.32E-01
U6 snRNA 3'-end processing (GO:0034477)	1	0	.02	-	 < 0.01	9.77E-01
U5 snRNA 3'-end processing (GO:0034476)	3	0	.07	-	 < 0.01	9.32E-01
U4 snRNA 3'-end processing (GO:0034475)	7	0	.16	-	 < 0.01	8.49E-01
chorionic trophoblast cell differentiation (GO:0060718)	6	0	.14	-	 < 0.01	8.69E-01
U2 snRNA 3'-end processing (GO:0034474)	1	0	.02	-	 < 0.01	9.77E-01
chorion development (GO:0060717)	8	0	.19	-	 < 0.01	8.30E-01
U1 snRNA 3'-end processing (GO:0034473)	3	0	.07	-	 < 0.01	9.32E-01
labyrinthine layer blood vessel development (GO:0060716)	26	0	.61	-	 < 0.01	5.45E-01
snRNA 3'-end processing (GO:0034472)	17	0	.40	-	 < 0.01	6.73E-01
syncytiotrophoblast cell differentiation involved in labyrinthine layer development (GO:0060715)	2	0	.05	-	 < 0.01	9.54E-01
spongiotrophoblast layer development (GO:0060712)	16	0	.37	-	 < 0.01	6.89E-01
cardiac muscle hypertrophy in response to stress (GO:0014898)	17	0	.40	-	 < 0.01	6.73E-01
chorio-allantoic fusion (GO:0060710)	9	0	.21	-	 < 0.01	8.11E-01
striated muscle hypertrophy (GO:0014897)	39	0	.91	-	 < 0.01	4.02E-01
muscle hypertrophy (GO:0014896)	41	0	.96	-	 < 0.01	3.84E-01
smooth muscle hypertrophy (GO:0014895)	1	0	.02	-	 < 0.01	9.77E-01
response to denervation involved in regulation of muscle adaptation (GO:0014894)	6	0	.14	-	 < 0.01	8.69E-01
striated muscle atrophy (GO:0014891)	4	0	.09	-	 < 0.01	9.11E-01
L-cysteine metabolic process (GO:0046439)	3	0	.07	-	 < 0.01	9.32E-01
D-amino acid biosynthetic process (GO:0046437)	1	0	.02	-	 < 0.01	9.77E-01
D-alanine metabolic process (GO:0046436)	1	0	.02	-	 < 0.01	9.77E-01
dentin mineralization (GO:0097188)	1	0	.02	-	 < 0.01	9.77E-01
dentinogenesis (GO:0097187)	5	0	.12	-	 < 0.01	8.90E-01
germ-line stem cell division (GO:0042078)	5	0	.12	-	 < 0.01	8.90E-01
cellular response to azide (GO:0097185)	1	0	.02	-	 < 0.01	9.77E-01
response to azide (GO:0097184)	1	0	.02	-	 < 0.01	9.77E-01
cell migration involved in gastrulation (GO:0042074)	16	0	.37	-	 < 0.01	6.89E-01
response to carbon monoxide (GO:0034465)	1	0	.02	-	 < 0.01	9.77E-01
glycogen cell differentiation involved in embryonic placenta development (GO:0060709)	1	0	.02	-	 < 0.01	9.77E-01
spongiotrophoblast differentiation (GO:0060708)	5	0	.12	-	 < 0.01	8.90E-01
trophoblast giant cell differentiation (GO:0060707)	19	0	.44	-	 < 0.01	6.42E-01
90S preribosome assembly (GO:0034463)	1	0	.02	-	 < 0.01	9.77E-01
cell differentiation involved in embryonic placenta development (GO:0060706)	32	0	.75	-	 < 0.01	4.74E-01
small-subunit processome assembly (GO:0034462)	3	0	.07	-	 < 0.01	9.32E-01
muscle atrophy (GO:0014889)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of endoribonuclease activity (GO:0060702)	2	0	.05	-	 < 0.01	9.54E-01
striated muscle adaptation (GO:0014888)	27	0	.63	-	 < 0.01	5.33E-01
negative regulation of ribonuclease activity (GO:0060701)	2	0	.05	-	 < 0.01	9.54E-01
cardiac muscle adaptation (GO:0014887)	17	0	.40	-	 < 0.01	6.73E-01
regulation of ribonuclease activity (GO:0060700)	14	0	.33	-	 < 0.01	7.21E-01
transition between fast and slow fiber (GO:0014883)	10	0	.23	-	 < 0.01	7.92E-01
positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427)	53	0	1.24	-	 < 0.01	2.90E-01
negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426)	25	0	.58	-	 < 0.01	5.58E-01
regulation of receptor signaling pathway via JAK-STAT (GO:0046425)	88	0	2.05	-	 < 0.01	1.28E-01
epoxide metabolic process (GO:0097176)	4	0	.09	-	 < 0.01	9.11E-01
microtubule anchoring at centrosome (GO:0034454)	10	0	.23	-	 < 0.01	7.92E-01
microtubule anchoring (GO:0034453)	22	0	.51	-	 < 0.01	5.99E-01
response to electrical stimulus involved in regulation of muscle adaptation (GO:0014878)	3	0	.07	-	 < 0.01	9.32E-01
response to muscle inactivity involved in regulation of muscle adaptation (GO:0014877)	6	0	.14	-	 < 0.01	8.69E-01
response to injury involved in regulation of muscle adaptation (GO:0014876)	2	0	.05	-	 < 0.01	9.54E-01
response to stimulus involved in regulation of muscle adaptation (GO:0014874)	11	0	.26	-	 < 0.01	7.74E-01
response to muscle activity involved in regulation of muscle adaptation (GO:0014873)	4	0	.09	-	 < 0.01	9.11E-01
protein repair (GO:0030091)	5	0	.12	-	 < 0.01	8.90E-01
response to muscle inactivity (GO:0014870)	6	0	.14	-	 < 0.01	8.69E-01
D-amino acid metabolic process (GO:0046416)	3	0	.07	-	 < 0.01	9.32E-01
urate metabolic process (GO:0046415)	14	0	.33	-	 < 0.01	7.21E-01
mesenchymal stem cell proliferation (GO:0097168)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059)	26	0	.61	-	 < 0.01	5.45E-01
very-low-density lipoprotein particle clearance (GO:0034447)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of plasma lipoprotein oxidation (GO:0034445)	2	0	.05	-	 < 0.01	9.54E-01
regulation of plasma lipoprotein oxidation (GO:0034444)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of lipoprotein oxidation (GO:0034443)	1	0	.02	-	 < 0.01	9.77E-01
regulation of lipoprotein oxidation (GO:0034442)	2	0	.05	-	 < 0.01	9.54E-01
plasma lipoprotein particle oxidation (GO:0034441)	1	0	.02	-	 < 0.01	9.77E-01
skeletal myofibril assembly (GO:0014866)	7	0	.16	-	 < 0.01	8.49E-01
regulation of skeletal muscle contraction by chemo-mechanical energy conversion (GO:0014862)	3	0	.07	-	 < 0.01	9.32E-01
regulation of skeletal muscle contraction via regulation of action potential (GO:0014861)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of central B cell tolerance induction (GO:0002897)	1	0	.02	-	 < 0.01	9.77E-01
regulation of central B cell tolerance induction (GO:0002895)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of type II hypersensitivity (GO:0002894)	5	0	.12	-	 < 0.01	8.90E-01
regulation of type II hypersensitivity (GO:0002892)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of immunoglobulin mediated immune response (GO:0002891)	37	0	.86	-	 < 0.01	4.22E-01
negative regulation of immunoglobulin mediated immune response (GO:0002890)	9	0	.21	-	 < 0.01	8.11E-01
fasciculation of motor neuron axon (GO:0097156)	2	0	.05	-	 < 0.01	9.54E-01
fasciculation of sensory neuron axon (GO:0097155)	3	0	.07	-	 < 0.01	9.32E-01
epithelial fluid transport (GO:0042045)	10	0	.23	-	 < 0.01	7.92E-01
glycoprotein transport (GO:0034436)	4	0	.09	-	 < 0.01	9.11E-01
mesenchymal cell apoptotic process (GO:0097152)	2	0	.05	-	 < 0.01	9.54E-01
fluid transport (GO:0042044)	27	0	.63	-	 < 0.01	5.33E-01
cholesterol esterification (GO:0034435)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of inhibitory postsynaptic potential (GO:0097151)	8	0	.19	-	 < 0.01	8.30E-01
sterol esterification (GO:0034434)	5	0	.12	-	 < 0.01	8.90E-01
steroid esterification (GO:0034433)	5	0	.12	-	 < 0.01	8.90E-01
metal incorporation into metallo-molybdopterin complex (GO:0042040)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of skeletal muscle cell proliferation (GO:0014858)	4	0	.09	-	 < 0.01	9.11E-01
skeletal muscle cell proliferation (GO:0014856)	2	0	.05	-	 < 0.01	9.54E-01
insulin secretion (GO:0030073)	43	0	1.00	-	 < 0.01	3.67E-01
response to inactivity (GO:0014854)	6	0	.14	-	 < 0.01	8.69E-01
regulation of mitotic metaphase/anaphase transition (GO:0030071)	53	0	1.24	-	 < 0.01	2.90E-01
regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction (GO:0014853)	2	0	.05	-	 < 0.01	9.54E-01
insulin processing (GO:0030070)	3	0	.07	-	 < 0.01	9.32E-01
regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction (GO:0014852)	2	0	.05	-	 < 0.01	9.54E-01
proteasomal ubiquitin-independent protein catabolic process (GO:0010499)	22	0	.51	-	 < 0.01	5.99E-01
response to muscle activity (GO:0014850)	12	0	.28	-	 < 0.01	7.56E-01
regulation of immunoglobulin mediated immune response (GO:0002889)	51	0	1.19	-	 < 0.01	3.04E-01
positive regulation of myeloid leukocyte mediated immunity (GO:0002888)	24	0	.56	-	 < 0.01	5.71E-01
intercellular transport (GO:0010496)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of myeloid leukocyte mediated immunity (GO:0002887)	9	0	.21	-	 < 0.01	8.11E-01
regulation of myeloid leukocyte mediated immunity (GO:0002886)	67	0	1.56	-	 < 0.01	2.09E-01
positive regulation of hypersensitivity (GO:0002885)	9	0	.21	-	 < 0.01	8.11E-01
negative regulation of hypersensitivity (GO:0002884)	3	0	.07	-	 < 0.01	9.32E-01
regulation of hypersensitivity (GO:0002883)	13	0	.30	-	 < 0.01	7.38E-01
positive regulation of chronic inflammatory response to non-antigenic stimulus (GO:0002882)	1	0	.02	-	 < 0.01	9.77E-01
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)	10	0	.23	-	 < 0.01	7.92E-01
post-translational protein acetylation (GO:0034421)	3	0	.07	-	 < 0.01	9.32E-01
ureter smooth muscle contraction (GO:0014849)	3	0	.07	-	 < 0.01	9.32E-01
esophagus smooth muscle contraction (GO:0014846)	2	0	.05	-	 < 0.01	9.54E-01
growth factor dependent regulation of skeletal muscle satellite cell proliferation (GO:0014843)	1	0	.02	-	 < 0.01	9.77E-01
skeletal muscle satellite cell proliferation (GO:0014841)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of acute inflammatory response to non-antigenic stimulus (GO:0002879)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of acute inflammatory response to non-antigenic stimulus (GO:0002878)	1	0	.02	-	 < 0.01	9.77E-01
regulation of acute inflammatory response to non-antigenic stimulus (GO:0002877)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of chronic inflammatory response to antigenic stimulus (GO:0002876)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of chronic inflammatory response to antigenic stimulus (GO:0002875)	1	0	.02	-	 < 0.01	9.77E-01
regulation of chronic inflammatory response to antigenic stimulus (GO:0002874)	3	0	.07	-	 < 0.01	9.32E-01
regulation of epidermal cell division (GO:0010482)	2	0	.05	-	 < 0.01	9.54E-01
epidermal cell division (GO:0010481)	1	0	.02	-	 < 0.01	9.77E-01
urate biosynthetic process (GO:0034418)	3	0	.07	-	 < 0.01	9.32E-01
protein refolding (GO:0042026)	15	0	.35	-	 < 0.01	7.05E-01
DNA endoreduplication (GO:0042023)	1	0	.02	-	 < 0.01	9.77E-01
tRNA 3'-trailer cleavage, endonucleolytic (GO:0034414)	1	0	.02	-	 < 0.01	9.77E-01
myoblast migration involved in skeletal muscle regeneration (GO:0014839)	4	0	.09	-	 < 0.01	9.11E-01
myoblast differentiation involved in skeletal muscle regeneration (GO:0014835)	3	0	.07	-	 < 0.01	9.32E-01
skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration (GO:0014834)	4	0	.09	-	 < 0.01	9.11E-01
vesicle transport along actin filament (GO:0030050)	19	0	.44	-	 < 0.01	6.42E-01
gastro-intestinal system smooth muscle contraction (GO:0014831)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of acute inflammatory response to antigenic stimulus (GO:0002866)	11	0	.26	-	 < 0.01	7.74E-01
negative regulation of acute inflammatory response to antigenic stimulus (GO:0002865)	5	0	.12	-	 < 0.01	8.90E-01
regulation of acute inflammatory response to antigenic stimulus (GO:0002864)	18	0	.42	-	 < 0.01	6.57E-01
positive regulation of inflammatory response to antigenic stimulus (GO:0002863)	17	0	.40	-	 < 0.01	6.73E-01
regulation of gastrulation (GO:0010470)	18	0	.42	-	 < 0.01	6.57E-01
positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002860)	6	0	.14	-	 < 0.01	8.69E-01
recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex (GO:0034402)	2	0	.05	-	 < 0.01	9.54E-01
muscle filament sliding (GO:0030049)	7	0	.16	-	 < 0.01	8.49E-01
actin modification (GO:0030047)	2	0	.05	-	 < 0.01	9.54E-01
intestine smooth muscle contraction (GO:0014827)	4	0	.09	-	 < 0.01	9.11E-01
actin filament fragmentation (GO:0030043)	4	0	.09	-	 < 0.01	9.11E-01
actin filament depolymerization (GO:0030042)	12	0	.28	-	 < 0.01	7.56E-01
response to activity (GO:0014823)	26	0	.61	-	 < 0.01	5.45E-01
detection of wounding (GO:0014822)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002859)	3	0	.07	-	 < 0.01	9.32E-01
regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858)	9	0	.21	-	 < 0.01	8.11E-01
positive regulation of natural killer cell mediated immune response to tumor cell (GO:0002857)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of natural killer cell mediated immune response to tumor cell (GO:0002856)	3	0	.07	-	 < 0.01	9.32E-01
regulation of natural killer cell mediated immune response to tumor cell (GO:0002855)	10	0	.23	-	 < 0.01	7.92E-01
positive regulation of T cell mediated cytotoxicity directed against tumor cell target (GO:0002854)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of T cell mediated cytotoxicity directed against tumor cell target (GO:0002853)	1	0	.02	-	 < 0.01	9.77E-01
postsynaptic density protein 95 clustering (GO:0097119)	6	0	.14	-	 < 0.01	8.69E-01
regulation of T cell mediated cytotoxicity directed against tumor cell target (GO:0002852)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of peripheral T cell tolerance induction (GO:0002851)	1	0	.02	-	 < 0.01	9.77E-01
neuroligin clustering involved in postsynaptic membrane assembly (GO:0097118)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of DNA replication (GO:0008156)	28	0	.65	-	 < 0.01	5.20E-01
guanylate kinase-associated protein clustering (GO:0097117)	2	0	.05	-	 < 0.01	9.54E-01
gephyrin clustering involved in postsynaptic density assembly (GO:0097116)	4	0	.09	-	 < 0.01	9.11E-01
neurexin clustering involved in presynaptic membrane assembly (GO:0097115)	1	0	.02	-	 < 0.01	9.77E-01
regulation of embryonic development (GO:0045995)	61	0	1.42	-	 < 0.01	2.41E-01
NMDA glutamate receptor clustering (GO:0097114)	6	0	.14	-	 < 0.01	8.69E-01
AMPA glutamate receptor clustering (GO:0097113)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of translational initiation by iron (GO:0045994)	2	0	.05	-	 < 0.01	9.54E-01
gamma-aminobutyric acid receptor clustering (GO:0097112)	5	0	.12	-	 < 0.01	8.90E-01
endoplasmic reticulum-Golgi intermediate compartment organization (GO:0097111)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of embryonic development (GO:0045992)	2	0	.05	-	 < 0.01	9.54E-01
carbon catabolite activation of transcription (GO:0045991)	5	0	.12	-	 < 0.01	8.90E-01
carbon catabolite regulation of transcription (GO:0045990)	5	0	.12	-	 < 0.01	8.90E-01
translocation of peptides or proteins into host (GO:0042000)	1	0	.02	-	 < 0.01	9.77E-01
regulation of skeletal muscle contraction (GO:0014819)	14	0	.33	-	 < 0.01	7.21E-01
microspike assembly (GO:0030035)	4	0	.09	-	 < 0.01	9.11E-01
skeletal muscle satellite cell differentiation (GO:0014816)	5	0	.12	-	 < 0.01	8.90E-01
microvillar actin bundle assembly (GO:0030034)	1	0	.02	-	 < 0.01	9.77E-01
microvillus assembly (GO:0030033)	10	0	.23	-	 < 0.01	7.92E-01
lamellipodium assembly (GO:0030032)	37	0	.86	-	 < 0.01	4.22E-01
skeletal muscle satellite cell commitment (GO:0014813)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of heart rate (GO:0010459)	10	0	.23	-	 < 0.01	7.92E-01
exit from mitosis (GO:0010458)	12	0	.28	-	 < 0.01	7.56E-01
regulation of peripheral T cell tolerance induction (GO:0002849)	1	0	.02	-	 < 0.01	9.77E-01
centriole-centriole cohesion (GO:0010457)	12	0	.28	-	 < 0.01	7.56E-01
positive regulation of cell fate commitment (GO:0010455)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of cell fate commitment (GO:0010454)	16	0	.37	-	 < 0.01	6.89E-01
positive regulation of tolerance induction to tumor cell (GO:0002845)	1	0	.02	-	 < 0.01	9.77E-01
regulation of cell fate commitment (GO:0010453)	34	0	.79	-	 < 0.01	4.52E-01
histone H3-K36 methylation (GO:0010452)	6	0	.14	-	 < 0.01	8.69E-01
regulation of tolerance induction to tumor cell (GO:0002843)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of T cell mediated immune response to tumor cell (GO:0002842)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of striated muscle contraction (GO:0045989)	14	0	.33	-	 < 0.01	7.21E-01
negative regulation of T cell mediated immune response to tumor cell (GO:0002841)	1	0	.02	-	 < 0.01	9.77E-01
postsynaptic density assembly (GO:0097107)	9	0	.21	-	 < 0.01	8.11E-01
negative regulation of striated muscle contraction (GO:0045988)	8	0	.19	-	 < 0.01	8.30E-01
regulation of T cell mediated immune response to tumor cell (GO:0002840)	6	0	.14	-	 < 0.01	8.69E-01
postsynaptic density organization (GO:0097106)	18	0	.42	-	 < 0.01	6.57E-01
positive regulation of smooth muscle contraction (GO:0045987)	33	0	.77	-	 < 0.01	4.63E-01
endothelial tip cell fate specification (GO:0097102)	1	0	.02	-	 < 0.01	9.77E-01
blood vessel endothelial cell fate specification (GO:0097101)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of nucleotide metabolic process (GO:0045980)	23	0	.54	-	 < 0.01	5.85E-01
regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion (GO:0014809)	2	0	.05	-	 < 0.01	9.54E-01
protein maturation by protein folding (GO:0022417)	6	0	.14	-	 < 0.01	8.69E-01
release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0014808)	6	0	.14	-	 < 0.01	8.69E-01
cellular manganese ion homeostasis (GO:0030026)	2	0	.05	-	 < 0.01	9.54E-01
regulation of somitogenesis (GO:0014807)	7	0	.16	-	 < 0.01	8.49E-01
smooth muscle hyperplasia (GO:0014806)	1	0	.02	-	 < 0.01	9.77E-01
smooth muscle adaptation (GO:0014805)	2	0	.05	-	 < 0.01	9.54E-01
circadian sleep/wake cycle process (GO:0022410)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of immune response to tumor cell (GO:0002839)	16	0	.37	-	 < 0.01	6.89E-01
negative regulation of immune response to tumor cell (GO:0002838)	4	0	.09	-	 < 0.01	9.11E-01
regulation of immune response to tumor cell (GO:0002837)	21	0	.49	-	 < 0.01	6.13E-01
response to alkaline pH (GO:0010446)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of response to tumor cell (GO:0002836)	16	0	.37	-	 < 0.01	6.89E-01
negative regulation of response to tumor cell (GO:0002835)	4	0	.09	-	 < 0.01	9.11E-01
regulation of response to tumor cell (GO:0002834)	21	0	.49	-	 < 0.01	6.13E-01
negative regulation of response to biotic stimulus (GO:0002832)	94	0	2.19	-	 < 0.01	1.11E-01
fungiform papilla formation (GO:0061198)	4	0	.09	-	 < 0.01	9.11E-01
fungiform papilla morphogenesis (GO:0061197)	6	0	.14	-	 < 0.01	8.69E-01
fungiform papilla development (GO:0061196)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of mitotic cell cycle, embryonic (GO:0045977)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of mitotic cell cycle, embryonic (GO:0045976)	2	0	.05	-	 < 0.01	9.54E-01
taste bud development (GO:0061193)	2	0	.05	-	 < 0.01	9.54E-01
regulation of sclerotome development (GO:0061190)	1	0	.02	-	 < 0.01	9.77E-01
membrane docking (GO:0022406)	80	0	1.86	-	 < 0.01	1.54E-01
cell cycle phase (GO:0022403)	22	0	.51	-	 < 0.01	5.99E-01
regulation of rhodopsin mediated signaling pathway (GO:0022400)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of type 2 immune response (GO:0002829)	14	0	.33	-	 < 0.01	7.21E-01
positive regulation of T-helper 1 type immune response (GO:0002827)	17	0	.40	-	 < 0.01	6.73E-01
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824)	110	0	2.56	-	 < 0.01	7.64E-02
positive regulation of sclerotome development (GO:0061189)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of ribosomal DNA heterochromatin assembly (GO:0061188)	2	0	.05	-	 < 0.01	9.54E-01
regulation of ribosomal DNA heterochromatin assembly (GO:0061187)	2	0	.05	-	 < 0.01	9.54E-01
fatty acid omega-oxidation (GO:0010430)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of adaptive immune response (GO:0002821)	117	0	2.73	-	 < 0.01	6.48E-02
negative regulation of growth rate (GO:0045967)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of dermatome development (GO:0061185)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of dermatome development (GO:0061184)	3	0	.07	-	 < 0.01	9.32E-01
regulation of dermatome development (GO:0061183)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of chondrocyte development (GO:0061182)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of dopamine metabolic process (GO:0045963)	4	0	.09	-	 < 0.01	9.11E-01
regulation of chondrocyte development (GO:0061181)	5	0	.12	-	 < 0.01	8.90E-01
cellular potassium ion homeostasis (GO:0030007)	15	0	.35	-	 < 0.01	7.05E-01
cellular anion homeostasis (GO:0030002)	22	0	.51	-	 < 0.01	5.99E-01
regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria (GO:0002816)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061179)	17	0	.40	-	 < 0.01	6.73E-01
biosynthetic process of antibacterial peptides active against Gram-negative bacteria (GO:0002812)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of complement activation, classical pathway (GO:0045959)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of complement activation, alternative pathway (GO:0045957)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of calcium ion-dependent exocytosis (GO:0045956)	18	0	.42	-	 < 0.01	6.57E-01
negative regulation of calcium ion-dependent exocytosis (GO:0045955)	9	0	.21	-	 < 0.01	8.11E-01
positive regulation of natural killer cell mediated cytotoxicity (GO:0045954)	26	0	.61	-	 < 0.01	5.45E-01
negative regulation of natural killer cell mediated cytotoxicity (GO:0045953)	21	0	.49	-	 < 0.01	6.13E-01
establishment of bipolar cell polarity (GO:0061171)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of hair follicle placode formation (GO:0061170)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of mitotic recombination (GO:0045951)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of mitotic recombination (GO:0045950)	5	0	.12	-	 < 0.01	8.90E-01
regulation of antibacterial peptide biosynthetic process (GO:0002808)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of antimicrobial peptide biosynthetic process (GO:0002807)	1	0	.02	-	 < 0.01	9.77E-01
regulation of antimicrobial peptide biosynthetic process (GO:0002805)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of antibacterial peptide production (GO:0002803)	4	0	.09	-	 < 0.01	9.11E-01
regulation of hair follicle placode formation (GO:0061168)	1	0	.02	-	 < 0.01	9.77E-01
response to 11-deoxycorticosterone (GO:1903496)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of transcription by RNA polymerase III (GO:0045945)	10	0	.23	-	 < 0.01	7.92E-01
response to dehydroepiandrosterone (GO:1903494)	1	0	.02	-	 < 0.01	9.77E-01
establishment of monopolar cell polarity (GO:0061162)	23	0	.54	-	 < 0.01	5.85E-01
positive regulation of mitotic cytokinesis (GO:1903490)	2	0	.05	-	 < 0.01	9.54E-01
box H/ACA RNA metabolic process (GO:0033979)	2	0	.05	-	 < 0.01	9.54E-01
establishment of bipolar cell polarity involved in cell morphogenesis (GO:0061159)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of lactation (GO:1903489)	25	0	.58	-	 < 0.01	5.58E-01
3'-UTR-mediated mRNA destabilization (GO:0061158)	17	0	.40	-	 < 0.01	6.73E-01
mRNA destabilization (GO:0061157)	32	0	.75	-	 < 0.01	4.74E-01
negative regulation of steroid metabolic process (GO:0045939)	25	0	.58	-	 < 0.01	5.58E-01
regulation of lactation (GO:1903487)	26	0	.61	-	 < 0.01	5.45E-01
positive regulation of circadian sleep/wake cycle, sleep (GO:0045938)	14	0	.33	-	 < 0.01	7.21E-01
pulmonary artery morphogenesis (GO:0061156)	7	0	.16	-	 < 0.01	8.49E-01
alkanesulfonate metabolic process (GO:0019694)	7	0	.16	-	 < 0.01	8.49E-01
pulmonary artery endothelial tube morphogenesis (GO:0061155)	1	0	.02	-	 < 0.01	9.77E-01
deoxyribose phosphate metabolic process (GO:0019692)	39	0	.91	-	 < 0.01	4.02E-01
endothelial tube morphogenesis (GO:0061154)	12	0	.28	-	 < 0.01	7.56E-01
trachea gland development (GO:0061153)	3	0	.07	-	 < 0.01	9.32E-01
trachea submucosa development (GO:0061152)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of muscle contraction (GO:0045933)	47	0	1.10	-	 < 0.01	3.34E-01
BMP signaling pathway involved in renal system segmentation (GO:0061151)	1	0	.02	-	 < 0.01	9.77E-01
renal system segmentation (GO:0061150)	1	0	.02	-	 < 0.01	9.77E-01
box C/D RNA metabolic process (GO:0033967)	3	0	.07	-	 < 0.01	9.32E-01
neural plate anterior/posterior regionalization (GO:0021999)	3	0	.07	-	 < 0.01	9.32E-01
neural plate mediolateral regionalization (GO:0021998)	1	0	.02	-	 < 0.01	9.77E-01
neuropore closure (GO:0021995)	2	0	.05	-	 < 0.01	9.54E-01
initiation of neural tube closure (GO:0021993)	1	0	.02	-	 < 0.01	9.77E-01
neural plate formation (GO:0021990)	1	0	.02	-	 < 0.01	9.77E-01
BMP signaling pathway involved in ureter morphogenesis (GO:0061149)	1	0	.02	-	 < 0.01	9.77E-01
Peyer's patch morphogenesis (GO:0061146)	2	0	.05	-	 < 0.01	9.54E-01
lung smooth muscle development (GO:0061145)	2	0	.05	-	 < 0.01	9.54E-01
glyceraldehyde-3-phosphate metabolic process (GO:0019682)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of female receptivity (GO:0045925)	4	0	.09	-	 < 0.01	9.11E-01
alveolar primary septum development (GO:0061143)	1	0	.02	-	 < 0.01	9.77E-01
regulation of female receptivity (GO:0045924)	9	0	.21	-	 < 0.01	8.11E-01
lung ciliated cell differentiation (GO:0061141)	1	0	.02	-	 < 0.01	9.77E-01
lung secretory cell differentiation (GO:0061140)	13	0	.30	-	 < 0.01	7.38E-01
negative regulation of exocytosis (GO:0045920)	29	0	.68	-	 < 0.01	5.08E-01
mitochondrial DNA inheritance (GO:0033955)	1	0	.02	-	 < 0.01	9.77E-01
olfactory cortex development (GO:0021989)	1	0	.02	-	 < 0.01	9.77E-01
habenula development (GO:0021986)	3	0	.07	-	 < 0.01	9.32E-01
neurohypophysis development (GO:0021985)	2	0	.05	-	 < 0.01	9.54E-01
adenohypophysis development (GO:0021984)	14	0	.33	-	 < 0.01	7.21E-01
pituitary gland development (GO:0021983)	39	0	.91	-	 < 0.01	4.02E-01
NAD catabolic process (GO:0019677)	4	0	.09	-	 < 0.01	9.11E-01
ammonia assimilation cycle (GO:0019676)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of cytolysis (GO:0045919)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of cytolysis (GO:0045918)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of complement activation (GO:0045917)	4	0	.09	-	 < 0.01	9.11E-01
GDP-mannose metabolic process (GO:0019673)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of mitotic cell cycle DNA replication (GO:1903465)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of complement activation (GO:0045916)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of mitotic cell cycle DNA replication (GO:1903464)	1	0	.02	-	 < 0.01	9.77E-01
regulation of mitotic cell cycle DNA replication (GO:1903463)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of catecholamine metabolic process (GO:0045914)	5	0	.12	-	 < 0.01	8.90E-01
Okazaki fragment processing involved in mitotic DNA replication (GO:1903461)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of DNA recombination (GO:0045911)	39	0	.91	-	 < 0.01	4.02E-01
hypothalamus cell differentiation (GO:0021979)	9	0	.21	-	 < 0.01	8.11E-01
corticospinal neuron axon guidance through spinal cord (GO:0021972)	1	0	.02	-	 < 0.01	9.77E-01
lactate catabolic process (GO:1903457)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of translational termination (GO:0045905)	3	0	.07	-	 < 0.01	9.32E-01
glucose catabolic process to lactate via pyruvate (GO:0019661)	1	0	.02	-	 < 0.01	9.77E-01
glycolytic fermentation (GO:0019660)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of translational fidelity (GO:0045903)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of G1 to G0 transition (GO:1903452)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of translational elongation (GO:0045901)	4	0	.09	-	 < 0.01	9.11E-01
regulation of G1 to G0 transition (GO:1903450)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of translational elongation (GO:0045900)	4	0	.09	-	 < 0.01	9.11E-01
corticospinal neuron axon guidance (GO:0021966)	2	0	.05	-	 < 0.01	9.54E-01
spinal cord ventral commissure morphogenesis (GO:0021965)	3	0	.07	-	 < 0.01	9.32E-01
glucose catabolic process to lactate (GO:0019659)	1	0	.02	-	 < 0.01	9.77E-01
anterior commissure morphogenesis (GO:0021960)	7	0	.16	-	 < 0.01	8.49E-01
lung proximal/distal axis specification (GO:0061115)	1	0	.02	-	 < 0.01	9.77E-01
protein transport from ciliary membrane to plasma membrane (GO:1903445)	3	0	.07	-	 < 0.01	9.32E-01
branching involved in pancreas morphogenesis (GO:0061114)	1	0	.02	-	 < 0.01	9.77E-01
pancreas morphogenesis (GO:0061113)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of brown fat cell differentiation (GO:1903444)	2	0	.05	-	 < 0.01	9.54E-01
protein localization to ciliary membrane (GO:1903441)	11	0	.26	-	 < 0.01	7.74E-01
dense core granule biogenesis (GO:0061110)	1	0	.02	-	 < 0.01	9.77E-01
central nervous system interneuron axonogenesis (GO:0021956)	1	0	.02	-	 < 0.01	9.77E-01
aerobic electron transport chain (GO:0019646)	9	0	.21	-	 < 0.01	8.11E-01
seminal vesicle epithelium development (GO:0061108)	1	0	.02	-	 < 0.01	9.77E-01
seminal vesicle development (GO:0061107)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of mitotic cytokinetic process (GO:1903438)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of stomach neuroendocrine cell differentiation (GO:0061106)	1	0	.02	-	 < 0.01	9.77E-01
regulation of mitotic cytokinetic process (GO:1903436)	2	0	.05	-	 < 0.01	9.54E-01
regulation of stomach neuroendocrine cell differentiation (GO:0061105)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of constitutive secretory pathway (GO:1903435)	1	0	.02	-	 < 0.01	9.77E-01
adrenal chromaffin cell differentiation (GO:0061104)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of constitutive secretory pathway (GO:1903434)	1	0	.02	-	 < 0.01	9.77E-01
carotid body glomus cell differentiation (GO:0061103)	1	0	.02	-	 < 0.01	9.77E-01
regulation of constitutive secretory pathway (GO:1903433)	2	0	.05	-	 < 0.01	9.54E-01
stomach neuroendocrine cell differentiation (GO:0061102)	1	0	.02	-	 < 0.01	9.77E-01
neuroendocrine cell differentiation (GO:0061101)	8	0	.19	-	 < 0.01	8.30E-01
positive regulation of cell maturation (GO:1903431)	11	0	.26	-	 < 0.01	7.74E-01
lung neuroendocrine cell differentiation (GO:0061100)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of cell maturation (GO:1903430)	10	0	.23	-	 < 0.01	7.92E-01
neuronal-glial interaction involved in hindbrain glial-mediated radial cell migration (GO:0021944)	1	0	.02	-	 < 0.01	9.77E-01
formation of radial glial scaffolds (GO:0021943)	5	0	.12	-	 < 0.01	8.90E-01
radial glia guided migration of Purkinje cell (GO:0021942)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of cerebellar granule cell precursor proliferation (GO:0021941)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of cerebellar granule cell precursor proliferation (GO:0021940)	11	0	.26	-	 < 0.01	7.74E-01
protein localization to cell cortex (GO:0072697)	3	0	.07	-	 < 0.01	9.32E-01
regulation of cell maturation (GO:1903429)	27	0	.63	-	 < 0.01	5.33E-01
regulation of DNA recombination at telomere (GO:0072695)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of synaptic vesicle recycling (GO:1903423)	15	0	.35	-	 < 0.01	7.05E-01
negative regulation of synaptic vesicle recycling (GO:1903422)	3	0	.07	-	 < 0.01	9.32E-01
regulation of synaptic vesicle recycling (GO:1903421)	30	0	.70	-	 < 0.01	4.97E-01
protein localization to endoplasmic reticulum tubular network (GO:1903420)	1	0	.02	-	 < 0.01	9.77E-01
smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation (GO:0021938)	5	0	.12	-	 < 0.01	8.90E-01
cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation (GO:0021937)	7	0	.16	-	 < 0.01	8.49E-01
regulation of cerebellar granule cell precursor proliferation (GO:0021936)	14	0	.33	-	 < 0.01	7.21E-01
cerebellar granule cell precursor tangential migration (GO:0021935)	2	0	.05	-	 < 0.01	9.54E-01
hindbrain tangential cell migration (GO:0021934)	3	0	.07	-	 < 0.01	9.32E-01
radial glia guided migration of cerebellar granule cell (GO:0021933)	2	0	.05	-	 < 0.01	9.54E-01
hindbrain radial glia guided cell migration (GO:0021932)	15	0	.35	-	 < 0.01	7.05E-01
urate catabolic process (GO:0019628)	3	0	.07	-	 < 0.01	9.32E-01
cerebellar granule cell precursor proliferation (GO:0021930)	7	0	.16	-	 < 0.01	8.49E-01
urea metabolic process (GO:0019627)	9	0	.21	-	 < 0.01	8.11E-01
short-chain fatty acid catabolic process (GO:0019626)	6	0	.14	-	 < 0.01	8.69E-01
mitochondrial tRNA 3'-trailer cleavage, endonucleolytic (GO:0072684)	1	0	.02	-	 < 0.01	9.77E-01
T cell extravasation (GO:0072683)	7	0	.16	-	 < 0.01	8.49E-01
response to glycoside (GO:1903416)	2	0	.05	-	 < 0.01	9.54E-01
cellular response to bile acid (GO:1903413)	4	0	.09	-	 < 0.01	9.11E-01
response to bile acid (GO:1903412)	4	0	.09	-	 < 0.01	9.11E-01
muscle hypertrophy in response to stress (GO:0003299)	17	0	.40	-	 < 0.01	6.73E-01
physiological muscle hypertrophy (GO:0003298)	14	0	.33	-	 < 0.01	7.21E-01
atrial ventricular junction remodeling (GO:0003294)	2	0	.05	-	 < 0.01	9.54E-01
cardiac septum cell differentiation (GO:0003292)	2	0	.05	-	 < 0.01	9.54E-01
atrial septum secundum morphogenesis (GO:0003290)	2	0	.05	-	 < 0.01	9.54E-01
cell proliferation in external granule layer (GO:0021924)	7	0	.16	-	 < 0.01	8.49E-01
thymocyte migration (GO:0072679)	2	0	.05	-	 < 0.01	9.54E-01
reactive oxygen species biosynthetic process (GO:1903409)	25	0	.58	-	 < 0.01	5.58E-01
osteoclast fusion (GO:0072675)	7	0	.16	-	 < 0.01	8.49E-01
multinuclear osteoclast differentiation (GO:0072674)	10	0	.23	-	 < 0.01	7.92E-01
catechol-containing compound catabolic process (GO:0019614)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of sodium:potassium-exchanging ATPase activity (GO:1903407)	1	0	.02	-	 < 0.01	9.77E-01
lamellipodium morphogenesis (GO:0072673)	7	0	.16	-	 < 0.01	8.49E-01
neutrophil extravasation (GO:0072672)	6	0	.14	-	 < 0.01	8.69E-01
protein localization to nuclear body (GO:1903405)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of renal phosphate excretion (GO:1903403)	1	0	.02	-	 < 0.01	9.77E-01
regulation of renal phosphate excretion (GO:1903402)	1	0	.02	-	 < 0.01	9.77E-01
L-lysine transmembrane transport (GO:1903401)	3	0	.07	-	 < 0.01	9.32E-01
L-arginine transmembrane transport (GO:1903400)	7	0	.16	-	 < 0.01	8.49E-01
atrial septum primum morphogenesis (GO:0003289)	5	0	.12	-	 < 0.01	8.90E-01
septum secundum development (GO:0003285)	3	0	.07	-	 < 0.01	9.32E-01
septum primum development (GO:0003284)	6	0	.14	-	 < 0.01	8.69E-01
BMP signaling pathway involved in spinal cord dorsal/ventral patterning (GO:0021919)	1	0	.02	-	 < 0.01	9.77E-01
atrial septum development (GO:0003283)	22	0	.51	-	 < 0.01	5.99E-01
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning (GO:0021914)	3	0	.07	-	 < 0.01	9.32E-01
smoothened signaling pathway involved in ventral spinal cord patterning (GO:0021910)	4	0	.09	-	 < 0.01	9.11E-01
2-oxobutyrate catabolic process (GO:0019606)	1	0	.02	-	 < 0.01	9.77E-01
butyrate metabolic process (GO:0019605)	1	0	.02	-	 < 0.01	9.77E-01
establishment of protein localization to peroxisome (GO:0072663)	18	0	.42	-	 < 0.01	6.57E-01
protein localization to peroxisome (GO:0072662)	18	0	.42	-	 < 0.01	6.57E-01
maintenance of protein location in plasma membrane (GO:0072660)	3	0	.07	-	 < 0.01	9.32E-01
regulation of endoribonuclease activity (GO:0060699)	3	0	.07	-	 < 0.01	9.32E-01
mechanosensory behavior (GO:0007638)	16	0	.37	-	 < 0.01	6.89E-01
positive regulation of phospholipid catabolic process (GO:0060697)	3	0	.07	-	 < 0.01	9.32E-01
regulation of phospholipid catabolic process (GO:0060696)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of cholesterol transporter activity (GO:0060695)	1	0	.02	-	 < 0.01	9.77E-01
optokinetic behavior (GO:0007634)	2	0	.05	-	 < 0.01	9.54E-01
regulation of cholesterol transporter activity (GO:0060694)	1	0	.02	-	 < 0.01	9.77E-01
regulation of branching involved in salivary gland morphogenesis (GO:0060693)	11	0	.26	-	 < 0.01	7.74E-01
epithelial cell maturation involved in salivary gland development (GO:0060691)	1	0	.02	-	 < 0.01	9.77E-01
jump response (GO:0007630)	1	0	.02	-	 < 0.01	9.77E-01
epithelial cell differentiation involved in salivary gland development (GO:0060690)	2	0	.05	-	 < 0.01	9.54E-01
apoptotic process involved in heart morphogenesis (GO:0003278)	2	0	.05	-	 < 0.01	9.54E-01
endocardial cushion fusion (GO:0003274)	4	0	.09	-	 < 0.01	9.11E-01
cell migration involved in endocardial cushion formation (GO:0003273)	4	0	.09	-	 < 0.01	9.11E-01
endocardial cushion formation (GO:0003272)	20	0	.47	-	 < 0.01	6.27E-01
smoothened signaling pathway involved in regulation of secondary heart field cardioblast proliferation (GO:0003271)	1	0	.02	-	 < 0.01	9.77E-01
Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation (GO:0003270)	1	0	.02	-	 < 0.01	9.77E-01
forebrain-midbrain boundary formation (GO:0021905)	1	0	.02	-	 < 0.01	9.77E-01
rostrocaudal neural tube patterning (GO:0021903)	14	0	.33	-	 < 0.01	7.21E-01
commitment of neuronal cell to specific neuron type in forebrain (GO:0021902)	7	0	.16	-	 < 0.01	8.49E-01
maintenance of protein location in membrane (GO:0072658)	3	0	.07	-	 < 0.01	9.32E-01
maintenance of protein location in mitochondrion (GO:0072656)	5	0	.12	-	 < 0.01	8.90E-01
establishment of protein localization to mitochondrion (GO:0072655)	65	0	1.52	-	 < 0.01	2.19E-01
cell differentiation involved in salivary gland development (GO:0060689)	5	0	.12	-	 < 0.01	8.90E-01
regulation of branching involved in prostate gland morphogenesis (GO:0060687)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of prostatic bud formation (GO:0060686)	4	0	.09	-	 < 0.01	9.11E-01
regulation of prostatic bud formation (GO:0060685)	6	0	.14	-	 < 0.01	8.69E-01
grooming behavior (GO:0007625)	15	0	.35	-	 < 0.01	7.05E-01
ultradian rhythm (GO:0007624)	2	0	.05	-	 < 0.01	9.54E-01
epithelial-mesenchymal cell signaling (GO:0060684)	6	0	.14	-	 < 0.01	8.69E-01
regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling (GO:0060683)	1	0	.02	-	 < 0.01	9.77E-01
primary ureteric bud growth (GO:0060682)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of female receptivity (GO:0007621)	4	0	.09	-	 < 0.01	9.11E-01
branch elongation involved in ureteric bud branching (GO:0060681)	1	0	.02	-	 < 0.01	9.77E-01
copulation (GO:0007620)	18	0	.42	-	 < 0.01	6.57E-01
regulation of secondary heart field cardioblast proliferation (GO:0003266)	11	0	.26	-	 < 0.01	7.74E-01
regulation of cardioblast proliferation (GO:0003264)	12	0	.28	-	 < 0.01	7.56E-01
cardioblast migration (GO:0003260)	1	0	.02	-	 < 0.01	9.77E-01
courtship behavior (GO:0007619)	5	0	.12	-	 < 0.01	8.90E-01
dichotomous subdivision of terminal units involved in ureteric bud branching (GO:0060678)	1	0	.02	-	 < 0.01	9.77E-01
mating (GO:0007618)	42	0	.98	-	 < 0.01	3.75E-01
ureteric bud elongation (GO:0060677)	6	0	.14	-	 < 0.01	8.69E-01
mating behavior (GO:0007617)	27	0	.63	-	 < 0.01	5.33E-01
long-term memory (GO:0007616)	40	0	.93	-	 < 0.01	3.93E-01
ureteric bud formation (GO:0060676)	5	0	.12	-	 < 0.01	8.90E-01
epithelial cell morphogenesis involved in placental branching (GO:0060672)	3	0	.07	-	 < 0.01	9.32E-01
epithelial cell differentiation involved in embryonic placenta development (GO:0060671)	3	0	.07	-	 < 0.01	9.32E-01
cardioblast anterior-lateral migration (GO:0003259)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003257)	3	0	.07	-	 < 0.01	9.32E-01
regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256)	6	0	.14	-	 < 0.01	8.69E-01
regulation of membrane depolarization (GO:0003254)	45	0	1.05	-	 < 0.01	3.50E-01
cardiac neural crest cell migration involved in outflow tract morphogenesis (GO:0003253)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of cell proliferation involved in heart valve morphogenesis (GO:0003252)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of cell proliferation involved in heart valve morphogenesis (GO:0003251)	1	0	.02	-	 < 0.01	9.77E-01
regulation of cell proliferation involved in heart valve morphogenesis (GO:0003250)	3	0	.07	-	 < 0.01	9.32E-01
UDP-glucuronate metabolic process (GO:0046398)	2	0	.05	-	 < 0.01	9.54E-01
5-phosphoribose 1-diphosphate metabolic process (GO:0046391)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of phospholipid efflux (GO:1902999)	1	0	.02	-	 < 0.01	9.77E-01
regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling (GO:0060668)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of neurofibrillary tangle assembly (GO:1902998)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of neurofibrillary tangle assembly (GO:1902997)	1	0	.02	-	 < 0.01	9.77E-01
regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling (GO:0060665)	5	0	.12	-	 < 0.01	8.90E-01
regulation of neurofibrillary tangle assembly (GO:1902996)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of phospholipid efflux (GO:1902995)	4	0	.09	-	 < 0.01	9.11E-01
phototransduction, UV (GO:0007604)	1	0	.02	-	 < 0.01	9.77E-01
phototransduction, visible light (GO:0007603)	9	0	.21	-	 < 0.01	8.11E-01
regulation of phospholipid efflux (GO:1902994)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of amyloid precursor protein catabolic process (GO:1902993)	26	0	.61	-	 < 0.01	5.45E-01
phototransduction (GO:0007602)	27	0	.63	-	 < 0.01	5.33E-01
salivary gland cavitation (GO:0060662)	6	0	.14	-	 < 0.01	8.69E-01
submandibular salivary gland formation (GO:0060661)	1	0	.02	-	 < 0.01	9.77E-01
mitotic telomere maintenance via semi-conservative replication (GO:1902990)	3	0	.07	-	 < 0.01	9.32E-01
post-embryonic cardiac muscle cell growth involved in heart morphogenesis (GO:0003247)	1	0	.02	-	 < 0.01	9.77E-01
cardiac muscle tissue growth involved in heart morphogenesis (GO:0003245)	2	0	.05	-	 < 0.01	9.54E-01
circumferential growth involved in left ventricle morphogenesis (GO:0003243)	1	0	.02	-	 < 0.01	9.77E-01
growth involved in heart morphogenesis (GO:0003241)	5	0	.12	-	 < 0.01	8.90E-01
deoxyribose phosphate catabolic process (GO:0046386)	26	0	.61	-	 < 0.01	5.45E-01
deoxyribose phosphate biosynthetic process (GO:0046385)	10	0	.23	-	 < 0.01	7.92E-01
CMP-N-acetylneuraminate metabolic process (GO:0046381)	2	0	.05	-	 < 0.01	9.54E-01
N-acetylneuraminate biosynthetic process (GO:0046380)	1	0	.02	-	 < 0.01	9.77E-01
nipple sheath formation (GO:0060659)	1	0	.02	-	 < 0.01	9.77E-01
nipple morphogenesis (GO:0060658)	2	0	.05	-	 < 0.01	9.54E-01
DNA strand elongation involved in mitotic DNA replication (GO:1902983)	1	0	.02	-	 < 0.01	9.77E-01
sinus venosus morphogenesis (GO:0003236)	1	0	.02	-	 < 0.01	9.77E-01
sinus venosus development (GO:0003235)	1	0	.02	-	 < 0.01	9.77E-01
extracellular polysaccharide metabolic process (GO:0046379)	3	0	.07	-	 < 0.01	9.32E-01
cardiac atrium development (GO:0003230)	38	0	.89	-	 < 0.01	4.12E-01
L-arabinose metabolic process (GO:0046373)	2	0	.05	-	 < 0.01	9.54E-01
fructose biosynthetic process (GO:0046370)	2	0	.05	-	 < 0.01	9.54E-01
mammary gland bud elongation (GO:0060649)	1	0	.02	-	 < 0.01	9.77E-01
mitotic DNA replication preinitiation complex assembly (GO:1902977)	1	0	.02	-	 < 0.01	9.77E-01
mitotic DNA replication initiation (GO:1902975)	5	0	.12	-	 < 0.01	8.90E-01
atrial cardiac muscle tissue development (GO:0003228)	10	0	.23	-	 < 0.01	7.92E-01
right ventricular compact myocardium morphogenesis (GO:0003226)	1	0	.02	-	 < 0.01	9.77E-01
ventricular trabecula myocardium morphogenesis (GO:0003222)	16	0	.37	-	 < 0.01	6.89E-01
right ventricular cardiac muscle tissue morphogenesis (GO:0003221)	3	0	.07	-	 < 0.01	9.32E-01
left ventricular cardiac muscle tissue morphogenesis (GO:0003220)	3	0	.07	-	 < 0.01	9.32E-01
GDP-L-fucose metabolic process (GO:0046368)	3	0	.07	-	 < 0.01	9.32E-01
2-oxobutyrate metabolic process (GO:0046361)	2	0	.05	-	 < 0.01	9.54E-01
2-oxobutyrate biosynthetic process (GO:0046360)	1	0	.02	-	 < 0.01	9.77E-01
telomere tethering at nuclear periphery (GO:0034398)	2	0	.05	-	 < 0.01	9.54E-01
telomere localization (GO:0034397)	9	0	.21	-	 < 0.01	8.11E-01
regulation of transcription from RNA polymerase II promoter in response to iron (GO:0034395)	3	0	.07	-	 < 0.01	9.32E-01
mitotic DNA replication (GO:1902969)	11	0	.26	-	 < 0.01	7.74E-01
mesenchymal-epithelial cell signaling (GO:0060638)	9	0	.21	-	 < 0.01	8.11E-01
positive regulation of smooth muscle cell apoptotic process (GO:0034393)	14	0	.33	-	 < 0.01	7.21E-01
negative regulation of smooth muscle cell apoptotic process (GO:0034392)	11	0	.26	-	 < 0.01	7.74E-01
regulation of smooth muscle cell apoptotic process (GO:0034391)	27	0	.63	-	 < 0.01	5.33E-01
positive regulation of protein localization to early endosome (GO:1902966)	8	0	.19	-	 < 0.01	8.30E-01
regulation of protein localization to early endosome (GO:1902965)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of transcription initiation from RNA polymerase II promoter (GO:0060633)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902963)	2	0	.05	-	 < 0.01	9.54E-01
regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902962)	2	0	.05	-	 < 0.01	9.54E-01
regulation of meiosis I (GO:0060631)	8	0	.19	-	 < 0.01	8.30E-01
positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961)	8	0	.19	-	 < 0.01	8.30E-01
cardiac right ventricle formation (GO:0003219)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902960)	3	0	.07	-	 < 0.01	9.32E-01
cardiac left ventricle formation (GO:0003218)	2	0	.05	-	 < 0.01	9.54E-01
cardiac right ventricle morphogenesis (GO:0003215)	19	0	.44	-	 < 0.01	6.42E-01
cardiac left ventricle morphogenesis (GO:0003214)	18	0	.42	-	 < 0.01	6.57E-01
cardiac right atrium morphogenesis (GO:0003213)	2	0	.05	-	 < 0.01	9.54E-01
butyrate catabolic process (GO:0046359)	1	0	.02	-	 < 0.01	9.77E-01
cardiac ventricle formation (GO:0003211)	10	0	.23	-	 < 0.01	7.92E-01
cardiac atrium formation (GO:0003210)	2	0	.05	-	 < 0.01	9.54E-01
acetyl-CoA catabolic process (GO:0046356)	2	0	.05	-	 < 0.01	9.54E-01
disaccharide catabolic process (GO:0046352)	1	0	.02	-	 < 0.01	9.77E-01
disaccharide biosynthetic process (GO:0046351)	4	0	.09	-	 < 0.01	9.11E-01
lipid droplet organization (GO:0034389)	23	0	.54	-	 < 0.01	5.85E-01
regulation of homologous chromosome segregation (GO:0060629)	1	0	.02	-	 < 0.01	9.77E-01
regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959)	11	0	.26	-	 < 0.01	7.74E-01
regulation of ER to Golgi vesicle-mediated transport (GO:0060628)	16	0	.37	-	 < 0.01	6.89E-01
high-density lipoprotein particle clearance (GO:0034384)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of mitochondrial electron transport, NADH to ubiquinone (GO:1902958)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of mitochondrial electron transport, NADH to ubiquinone (GO:1902957)	1	0	.02	-	 < 0.01	9.77E-01
chylomicron remnant clearance (GO:0034382)	4	0	.09	-	 < 0.01	9.11E-01
regulation of mitochondrial electron transport, NADH to ubiquinone (GO:1902956)	4	0	.09	-	 < 0.01	9.11E-01
high-density lipoprotein particle assembly (GO:0034380)	8	0	.19	-	 < 0.01	8.30E-01
positive regulation of early endosome to recycling endosome transport (GO:1902955)	1	0	.02	-	 < 0.01	9.77E-01
regulation of early endosome to recycling endosome transport (GO:1902954)	2	0	.05	-	 < 0.01	9.54E-01
regulation of chromosome condensation (GO:0060623)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of ER to Golgi vesicle-mediated transport (GO:1902953)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of dendritic spine maintenance (GO:1902952)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of cholesterol import (GO:0060621)	1	0	.02	-	 < 0.01	9.77E-01
cardiac atrium morphogenesis (GO:0003209)	33	0	.77	-	 < 0.01	4.63E-01
regulation of cholesterol import (GO:0060620)	6	0	.14	-	 < 0.01	8.69E-01
cardiac chamber formation (GO:0003207)	12	0	.28	-	 < 0.01	7.56E-01
endocardial cushion morphogenesis (GO:0003203)	33	0	.77	-	 < 0.01	4.63E-01
amino sugar biosynthetic process (GO:0046349)	8	0	.19	-	 < 0.01	8.30E-01
CDP-diacylglycerol metabolic process (GO:0046341)	3	0	.07	-	 < 0.01	9.32E-01
diacylglycerol catabolic process (GO:0046340)	4	0	.09	-	 < 0.01	9.11E-01
chylomicron assembly (GO:0034378)	3	0	.07	-	 < 0.01	9.32E-01
high-density lipoprotein particle remodeling (GO:0034375)	12	0	.28	-	 < 0.01	7.56E-01
positive regulation of tau-protein kinase activity (GO:1902949)	6	0	.14	-	 < 0.01	8.69E-01
synaptic vesicle clustering (GO:0097091)	9	0	.21	-	 < 0.01	8.11E-01
low-density lipoprotein particle remodeling (GO:0034374)	13	0	.30	-	 < 0.01	7.38E-01
nipple development (GO:0060618)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of tau-protein kinase activity (GO:1902948)	3	0	.07	-	 < 0.01	9.32E-01
regulation of tau-protein kinase activity (GO:1902947)	12	0	.28	-	 < 0.01	7.56E-01
very-low-density lipoprotein particle remodeling (GO:0034372)	7	0	.16	-	 < 0.01	8.49E-01
protein localization to early endosome (GO:1902946)	2	0	.05	-	 < 0.01	9.54E-01
chylomicron remodeling (GO:0034371)	2	0	.05	-	 < 0.01	9.54E-01
triglyceride-rich lipoprotein particle remodeling (GO:0034370)	8	0	.19	-	 < 0.01	8.30E-01
positive regulation of voltage-gated chloride channel activity (GO:1902943)	2	0	.05	-	 < 0.01	9.54E-01
mammary gland fat development (GO:0060611)	1	0	.02	-	 < 0.01	9.77E-01
regulation of voltage-gated chloride channel activity (GO:1902941)	2	0	.05	-	 < 0.01	9.54E-01
phosphatidylethanolamine catabolic process (GO:0046338)	3	0	.07	-	 < 0.01	9.32E-01
phosphatidylethanolamine metabolic process (GO:0046337)	21	0	.49	-	 < 0.01	6.13E-01
octopamine metabolic process (GO:0046333)	3	0	.07	-	 < 0.01	9.32E-01
methyl-branched fatty acid metabolic process (GO:0097089)	3	0	.07	-	 < 0.01	9.32E-01
lateral inhibition (GO:0046331)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of JNK cascade (GO:0046330)	86	0	2.00	-	 < 0.01	1.34E-01
plasma lipoprotein particle remodeling (GO:0034369)	23	0	.54	-	 < 0.01	5.85E-01
protein-lipid complex remodeling (GO:0034368)	23	0	.54	-	 < 0.01	5.85E-01
vascular associated smooth muscle cell development (GO:0097084)	12	0	.28	-	 < 0.01	7.56E-01
protein-containing complex remodeling (GO:0034367)	25	0	.58	-	 < 0.01	5.58E-01
negative regulation of intracellular calcium activated chloride channel activity (GO:1902939)	1	0	.02	-	 < 0.01	9.77E-01
regulation of intracellular calcium activated chloride channel activity (GO:1902938)	3	0	.07	-	 < 0.01	9.32E-01
plasma membrane selenite transport (GO:0097080)	1	0	.02	-	 < 0.01	9.77E-01
tube lumen cavitation (GO:0060605)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of alcohol biosynthetic process (GO:1902931)	14	0	.33	-	 < 0.01	7.21E-01
glycerol biosynthetic process from pyruvate (GO:0046327)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of glucose import (GO:0046325)	21	0	.49	-	 < 0.01	6.13E-01
NAD salvage (GO:0034355)	1	0	.02	-	 < 0.01	9.77E-01
'de novo' NAD biosynthetic process from tryptophan (GO:0034354)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of glial cell apoptotic process (GO:0034352)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of glial cell apoptotic process (GO:0034351)	9	0	.21	-	 < 0.01	8.11E-01
regulation of glial cell apoptotic process (GO:0034350)	13	0	.30	-	 < 0.01	7.38E-01
phosphocreatine biosynthetic process (GO:0046314)	4	0	.09	-	 < 0.01	9.11E-01
response to thyroxine (GO:0097068)	1	0	.02	-	 < 0.01	9.77E-01
cellular response to thyroid hormone stimulus (GO:0097067)	10	0	.23	-	 < 0.01	7.92E-01
response to thyroid hormone (GO:0097066)	14	0	.33	-	 < 0.01	7.21E-01
glial cell apoptotic process (GO:0034349)	4	0	.09	-	 < 0.01	9.11E-01
anterior head development (GO:0097065)	6	0	.14	-	 < 0.01	8.69E-01
ncRNA export from nucleus (GO:0097064)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of type III interferon production (GO:0034346)	1	0	.02	-	 < 0.01	9.77E-01
regulation of type III interferon production (GO:0034344)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of protein polyubiquitination (GO:1902916)	12	0	.28	-	 < 0.01	7.56E-01
negative regulation of protein polyubiquitination (GO:1902915)	10	0	.23	-	 < 0.01	7.92E-01
positive regulation of neuroepithelial cell differentiation (GO:1902913)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of melanosome transport (GO:1902910)	1	0	.02	-	 < 0.01	9.77E-01
alkanesulfonate biosynthetic process (GO:0046305)	1	0	.02	-	 < 0.01	9.77E-01
selenocysteinyl-tRNA(Sec) biosynthetic process (GO:0097056)	1	0	.02	-	 < 0.01	9.77E-01
RNA folding (GO:0034337)	1	0	.02	-	 < 0.01	9.77E-01
L-kynurenine metabolic process (GO:0097052)	2	0	.05	-	 < 0.01	9.54E-01
establishment of protein localization to endoplasmic reticulum membrane (GO:0097051)	3	0	.07	-	 < 0.01	9.32E-01
type B pancreatic cell apoptotic process (GO:0097050)	4	0	.09	-	 < 0.01	9.11E-01
adherens junction assembly (GO:0034333)	12	0	.28	-	 < 0.01	7.56E-01
regulation of melanosome transport (GO:1902908)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of autophagosome assembly (GO:1902902)	14	0	.33	-	 < 0.01	7.21E-01
negative regulation of antibacterial peptide production (GO:0002787)	1	0	.02	-	 < 0.01	9.77E-01
regulation of antibacterial peptide production (GO:0002786)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of antimicrobial peptide production (GO:0002785)	1	0	.02	-	 < 0.01	9.77E-01
regulation of antimicrobial peptide production (GO:0002784)	7	0	.16	-	 < 0.01	8.49E-01
motor neuron apoptotic process (GO:0097049)	5	0	.12	-	 < 0.01	8.90E-01
antibacterial peptide biosynthetic process (GO:0002780)	2	0	.05	-	 < 0.01	9.54E-01
phosphatidylserine exposure on blood platelet (GO:0097045)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of muscle adaptation (GO:0014744)	7	0	.16	-	 < 0.01	8.49E-01
regulation of G2/M transition of mitotic cell cycle (GO:0010389)	82	0	1.91	-	 < 0.01	1.47E-01
negative regulation of muscle hyperplasia (GO:0014740)	2	0	.05	-	 < 0.01	9.54E-01
antibacterial peptide secretion (GO:0002779)	1	0	.02	-	 < 0.01	9.77E-01
COP9 signalosome assembly (GO:0010387)	5	0	.12	-	 < 0.01	8.90E-01
antibacterial peptide production (GO:0002778)	2	0	.05	-	 < 0.01	9.54E-01
antimicrobial peptide biosynthetic process (GO:0002777)	2	0	.05	-	 < 0.01	9.54E-01
antimicrobial peptide secretion (GO:0002776)	1	0	.02	-	 < 0.01	9.77E-01
antimicrobial peptide production (GO:0002775)	2	0	.05	-	 < 0.01	9.54E-01
Fc receptor mediated inhibitory signaling pathway (GO:0002774)	1	0	.02	-	 < 0.01	9.77E-01
mesodermal cell migration (GO:0008078)	5	0	.12	-	 < 0.01	8.90E-01
protein linear polyubiquitination (GO:0097039)	3	0	.07	-	 < 0.01	9.32E-01
heme export (GO:0097037)	3	0	.07	-	 < 0.01	9.32E-01
regulation of plasma membrane sterol distribution (GO:0097036)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316)	7	0	.16	-	 < 0.01	8.49E-01
regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315)	22	0	.51	-	 < 0.01	5.99E-01
Arp2/3 complex-mediated actin nucleation (GO:0034314)	16	0	.37	-	 < 0.01	6.89E-01
diol biosynthetic process (GO:0034312)	21	0	.49	-	 < 0.01	6.13E-01
diol metabolic process (GO:0034311)	28	0	.65	-	 < 0.01	5.20E-01
primary alcohol catabolic process (GO:0034310)	8	0	.19	-	 < 0.01	8.30E-01
positive regulation of muscle hyperplasia (GO:0014739)	1	0	.02	-	 < 0.01	9.77E-01
regulation of muscle hyperplasia (GO:0014738)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of muscle atrophy (GO:0014737)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of muscle atrophy (GO:0014736)	2	0	.05	-	 < 0.01	9.54E-01
regulation of muscle atrophy (GO:0014735)	5	0	.12	-	 < 0.01	8.90E-01
skeletal muscle hypertrophy (GO:0014734)	2	0	.05	-	 < 0.01	9.54E-01
skeletal muscle atrophy (GO:0014732)	2	0	.05	-	 < 0.01	9.54E-01
natural killer cell inhibitory signaling pathway (GO:0002769)	3	0	.07	-	 < 0.01	9.32E-01
immune response-inhibiting cell surface receptor signaling pathway (GO:0002767)	5	0	.12	-	 < 0.01	8.90E-01
immune response-inhibiting signal transduction (GO:0002765)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of myeloid leukocyte differentiation (GO:0002762)	50	0	1.17	-	 < 0.01	3.11E-01
mature conventional dendritic cell differentiation (GO:0097029)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of antimicrobial humoral response (GO:0002760)	7	0	.16	-	 < 0.01	8.49E-01
primary alcohol biosynthetic process (GO:0034309)	4	0	.09	-	 < 0.01	9.11E-01
establishment of blood-nerve barrier (GO:0008065)	4	0	.09	-	 < 0.01	9.11E-01
dendritic cell dendrite assembly (GO:0097026)	2	0	.05	-	 < 0.01	9.54E-01
primary alcohol metabolic process (GO:0034308)	54	0	1.26	-	 < 0.01	2.83E-01
Toll signaling pathway (GO:0008063)	6	0	.14	-	 < 0.01	8.69E-01
lymphocyte migration into lymph node (GO:0097022)	2	0	.05	-	 < 0.01	9.54E-01
lymphocyte migration into lymphoid organs (GO:0097021)	7	0	.16	-	 < 0.01	8.49E-01
regulation of the force of skeletal muscle contraction (GO:0014728)	3	0	.07	-	 < 0.01	9.32E-01
regulation of twitch skeletal muscle contraction (GO:0014724)	4	0	.09	-	 < 0.01	9.11E-01
regulation of skeletal muscle contraction by calcium ion signaling (GO:0014722)	3	0	.07	-	 < 0.01	9.32E-01
twitch skeletal muscle contraction (GO:0014721)	2	0	.05	-	 < 0.01	9.54E-01
regulation of antimicrobial humoral response (GO:0002759)	10	0	.23	-	 < 0.01	7.92E-01
innate immune response-activating signal transduction (GO:0002758)	8	0	.19	-	 < 0.01	8.30E-01
MyD88-independent toll-like receptor signaling pathway (GO:0002756)	12	0	.28	-	 < 0.01	7.56E-01
cell surface pattern recognition receptor signaling pathway (GO:0002752)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899)	12	0	.28	-	 < 0.01	7.56E-01
negative regulation of anion channel activity (GO:0010360)	6	0	.14	-	 < 0.01	8.69E-01
eye pigment granule organization (GO:0008057)	1	0	.02	-	 < 0.01	9.77E-01
regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898)	14	0	.33	-	 < 0.01	7.21E-01
renal protein absorption (GO:0097017)	1	0	.02	-	 < 0.01	9.77E-01
mitochondrial fusion (GO:0008053)	15	0	.35	-	 < 0.01	7.05E-01
sensory organ boundary specification (GO:0008052)	1	0	.02	-	 < 0.01	9.77E-01
response to granulocyte macrophage colony-stimulating factor (GO:0097012)	12	0	.28	-	 < 0.01	7.56E-01
cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011)	11	0	.26	-	 < 0.01	7.74E-01
female courtship behavior (GO:0008050)	3	0	.07	-	 < 0.01	9.32E-01
eukaryotic translation initiation factor 4F complex assembly (GO:0097010)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of satellite cell activation involved in skeletal muscle regeneration (GO:0014718)	2	0	.05	-	 < 0.01	9.54E-01
regulation of satellite cell activation involved in skeletal muscle regeneration (GO:0014717)	3	0	.07	-	 < 0.01	9.32E-01
regulation of anion channel activity (GO:0010359)	12	0	.28	-	 < 0.01	7.56E-01
male courtship behavior (GO:0008049)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of synaptic growth at neuromuscular junction (GO:0045887)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of synaptic growth at neuromuscular junction (GO:0045886)	1	0	.02	-	 < 0.01	9.77E-01
branchiomeric skeletal muscle development (GO:0014707)	3	0	.07	-	 < 0.01	9.32E-01
modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade (GO:0085032)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of myeloid dendritic cell cytokine production (GO:0002735)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of protein tyrosine kinase activity (GO:0061099)	26	0	.61	-	 < 0.01	5.45E-01
regulation of myeloid dendritic cell cytokine production (GO:0002733)	6	0	.14	-	 < 0.01	8.69E-01
synaptic target recognition (GO:0008039)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of dendritic cell cytokine production (GO:0002732)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of dendritic cell cytokine production (GO:0002731)	1	0	.02	-	 < 0.01	9.77E-01
regulation of dendritic cell cytokine production (GO:0002730)	13	0	.30	-	 < 0.01	7.38E-01
negative regulation of sister chromatid cohesion (GO:0045875)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of sequestering of zinc ion (GO:0061090)	1	0	.02	-	 < 0.01	9.77E-01
extracellular matrix assembly (GO:0085029)	30	0	.70	-	 < 0.01	4.97E-01
positive regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045870)	2	0	.05	-	 < 0.01	9.54E-01
protein K6-linked ubiquitination (GO:0085020)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of natural killer cell cytokine production (GO:0002729)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of natural killer cell cytokine production (GO:0002728)	1	0	.02	-	 < 0.01	9.77E-01
regulation of natural killer cell cytokine production (GO:0002727)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of T cell cytokine production (GO:0002726)	19	0	.44	-	 < 0.01	6.42E-01
response to non-ionic osmotic stress (GO:0010335)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of T cell cytokine production (GO:0002725)	8	0	.19	-	 < 0.01	8.30E-01
regulation of T cell cytokine production (GO:0002724)	29	0	.68	-	 < 0.01	5.08E-01
regulation of sequestering of zinc ion (GO:0061088)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of histone H3-K27 methylation (GO:0061087)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of histone H3-K27 methylation (GO:0061086)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of cytokine production involved in immune response (GO:0002720)	53	0	1.24	-	 < 0.01	2.90E-01
regulation of histone H3-K27 methylation (GO:0061085)	10	0	.23	-	 < 0.01	7.92E-01
negative regulation of protein refolding (GO:0061084)	3	0	.07	-	 < 0.01	9.32E-01
regulation of protein refolding (GO:0061083)	4	0	.09	-	 < 0.01	9.11E-01
myeloid leukocyte cytokine production (GO:0061082)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081)	20	0	.47	-	 < 0.01	6.27E-01
maintenance of symbiont-containing vacuole by host (GO:0085018)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of cytokine production involved in immune response (GO:0002719)	22	0	.51	-	 < 0.01	5.99E-01
regulation of cytokine production involved in immune response (GO:0002718)	81	0	1.89	-	 < 0.01	1.51E-01
positive regulation of natural killer cell mediated immunity (GO:0002717)	27	0	.63	-	 < 0.01	5.33E-01
negative regulation of natural killer cell mediated immunity (GO:0002716)	22	0	.51	-	 < 0.01	5.99E-01
regulation of natural killer cell mediated immunity (GO:0002715)	45	0	1.05	-	 < 0.01	3.50E-01
positive regulation of B cell mediated immunity (GO:0002714)	37	0	.86	-	 < 0.01	4.22E-01
negative regulation of B cell mediated immunity (GO:0002713)	9	0	.21	-	 < 0.01	8.11E-01
regulation of B cell mediated immunity (GO:0002712)	51	0	1.19	-	 < 0.01	3.04E-01
positive regulation of prostaglandin secretion involved in immune response (GO:0061078)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of T cell mediated immunity (GO:0002711)	60	0	1.40	-	 < 0.01	2.46E-01
negative regulation of T cell mediated immunity (GO:0002710)	20	0	.47	-	 < 0.01	6.27E-01
regulation of neural retina development (GO:0061074)	3	0	.07	-	 < 0.01	9.32E-01
ciliary body morphogenesis (GO:0061073)	5	0	.12	-	 < 0.01	8.90E-01
iris morphogenesis (GO:0061072)	7	0	.16	-	 < 0.01	8.49E-01
pH elevation (GO:0045852)	7	0	.16	-	 < 0.01	8.49E-01
pH reduction (GO:0045851)	38	0	.89	-	 < 0.01	4.12E-01
regulation of T cell mediated immunity (GO:0002709)	85	0	1.98	-	 < 0.01	1.37E-01
positive regulation of lymphocyte mediated immunity (GO:0002708)	113	0	2.63	-	 < 0.01	7.12E-02
negative regulation of lymphocyte mediated immunity (GO:0002707)	47	0	1.10	-	 < 0.01	3.34E-01
regulation of lymphocyte mediated immunity (GO:0002706)	164	0	3.82	-	 < 0.01	2.15E-02
positive regulation of leukocyte mediated immunity (GO:0002705)	133	0	3.10	-	 < 0.01	4.45E-02
negative regulation of leukocyte mediated immunity (GO:0002704)	57	0	1.33	-	 < 0.01	2.64E-01
regulation of leukocyte mediated immunity (GO:0002703)	228	0	5.31	-	 < 0.01	4.75E-03
detoxification of zinc ion (GO:0010312)	1	0	.02	-	 < 0.01	9.77E-01
regulation of hydrogen peroxide metabolic process (GO:0010310)	16	0	.37	-	 < 0.01	6.89E-01
positive regulation of nitrogen utilization (GO:0045848)	1	0	.02	-	 < 0.01	9.77E-01
protein localization to kinetochore involved in kinetochore assembly (GO:1903394)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of adherens junction organization (GO:1903393)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of adherens junction organization (GO:1903392)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of mitotic metaphase/anaphase transition (GO:0045842)	13	0	.30	-	 < 0.01	7.38E-01
regulation of adherens junction organization (GO:1903391)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of mitotic metaphase/anaphase transition (GO:0045841)	27	0	.63	-	 < 0.01	5.33E-01
sclerotome development (GO:0061056)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of membrane potential (GO:0045838)	20	0	.47	-	 < 0.01	6.27E-01
positive regulation of homophilic cell adhesion (GO:1903387)	1	0	.02	-	 < 0.01	9.77E-01
myotome development (GO:0061055)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of membrane potential (GO:0045837)	19	0	.44	-	 < 0.01	6.42E-01
regulation of homophilic cell adhesion (GO:1903385)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of meiotic nuclear division (GO:0045836)	17	0	.40	-	 < 0.01	6.73E-01
negative regulation of meiotic nuclear division (GO:0045835)	11	0	.26	-	 < 0.01	7.74E-01
negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway (GO:1903384)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of cell growth involved in cardiac muscle cell development (GO:0061052)	13	0	.30	-	 < 0.01	7.38E-01
regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway (GO:1903383)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of cell growth involved in cardiac muscle cell development (GO:0061051)	15	0	.35	-	 < 0.01	7.05E-01
negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903382)	1	0	.02	-	 < 0.01	9.77E-01
regulation of cell growth involved in cardiac muscle cell development (GO:0061050)	29	0	.68	-	 < 0.01	5.08E-01
regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903381)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of isotype switching (GO:0045830)	22	0	.51	-	 < 0.01	5.99E-01
nucleoside bisphosphate catabolic process (GO:0033869)	6	0	.14	-	 < 0.01	8.69E-01
nucleoside bisphosphate biosynthetic process (GO:0033866)	31	0	.72	-	 < 0.01	4.85E-01
positive regulation of NAD(P)H oxidase activity (GO:0033864)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of NAD(P)H oxidase activity (GO:0033861)	3	0	.07	-	 < 0.01	9.32E-01
regulation of NAD(P)H oxidase activity (GO:0033860)	9	0	.21	-	 < 0.01	8.11E-01
forebrain astrocyte development (GO:0021897)	2	0	.05	-	 < 0.01	9.54E-01
forebrain astrocyte differentiation (GO:0021896)	2	0	.05	-	 < 0.01	9.54E-01
cerebral cortex neuron differentiation (GO:0021895)	27	0	.63	-	 < 0.01	5.33E-01
cerebral cortex GABAergic interneuron development (GO:0021894)	8	0	.19	-	 < 0.01	8.30E-01
cerebral cortex GABAergic interneuron fate commitment (GO:0021893)	2	0	.05	-	 < 0.01	9.54E-01
cerebral cortex GABAergic interneuron differentiation (GO:0021892)	11	0	.26	-	 < 0.01	7.74E-01
olfactory bulb interneuron development (GO:0021891)	9	0	.21	-	 < 0.01	8.11E-01
cell growth involved in cardiac muscle cell development (GO:0061049)	14	0	.33	-	 < 0.01	7.21E-01
negative regulation of branching involved in lung morphogenesis (GO:0061048)	1	0	.02	-	 < 0.01	9.77E-01
glucuronate metabolic process (GO:0019585)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of isotype switching (GO:0045829)	5	0	.12	-	 < 0.01	8.90E-01
positive regulation of branching involved in lung morphogenesis (GO:0061047)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903378)	3	0	.07	-	 < 0.01	9.32E-01
regulation of branching involved in lung morphogenesis (GO:0061046)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of isoprenoid metabolic process (GO:0045828)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of isoprenoid metabolic process (GO:0045827)	1	0	.02	-	 < 0.01	9.77E-01
regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of vascular wound healing (GO:0061044)	4	0	.09	-	 < 0.01	9.11E-01
facioacoustic ganglion development (GO:1903375)	3	0	.07	-	 < 0.01	9.32E-01
regulation of vascular wound healing (GO:0061043)	9	0	.21	-	 < 0.01	8.11E-01
negative regulation of innate immune response (GO:0045824)	64	0	1.49	-	 < 0.01	2.24E-01
vascular wound healing (GO:0061042)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of endoplasmic reticulum tubular network organization (GO:1903373)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of heart contraction (GO:0045822)	26	0	.61	-	 < 0.01	5.45E-01
regulation of endoplasmic reticulum tubular network organization (GO:1903371)	6	0	.14	-	 < 0.01	8.69E-01
female gonad morphogenesis (GO:0061040)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of glycolytic process (GO:0045820)	16	0	.37	-	 < 0.01	6.89E-01
olfactory bulb interneuron differentiation (GO:0021889)	15	0	.35	-	 < 0.01	7.05E-01
hypothalamus gonadotrophin-releasing hormone neuron development (GO:0021888)	5	0	.12	-	 < 0.01	8.90E-01
hypothalamus gonadotrophin-releasing hormone neuron differentiation (GO:0021886)	5	0	.12	-	 < 0.01	8.90E-01
uterus morphogenesis (GO:0061038)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of glycogen catabolic process (GO:0045819)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of glycogen catabolic process (GO:0045818)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of fear response (GO:1903366)	1	0	.02	-	 < 0.01	9.77E-01
olfactory bulb mitral cell layer development (GO:0061034)	3	0	.07	-	 < 0.01	9.32E-01
secretion by lung epithelial cell involved in lung growth (GO:0061033)	3	0	.07	-	 < 0.01	9.32E-01
positive regulation of gene expression, epigenetic (GO:0045815)	22	0	.51	-	 < 0.01	5.99E-01
negative regulation of gene expression, epigenetic (GO:0045814)	43	0	1.00	-	 < 0.01	3.67E-01
protein localization to basolateral plasma membrane (GO:1903361)	4	0	.09	-	 < 0.01	9.11E-01
forebrain neuron fate commitment (GO:0021877)	10	0	.23	-	 < 0.01	7.92E-01
Wnt signaling pathway involved in forebrain neuroblast division (GO:0021874)	2	0	.05	-	 < 0.01	9.54E-01
Cajal-Retzius cell differentiation (GO:0021870)	1	0	.02	-	 < 0.01	9.77E-01
arabinose metabolic process (GO:0019566)	2	0	.05	-	 < 0.01	9.54E-01
umbilical cord development (GO:0061027)	2	0	.05	-	 < 0.01	9.54E-01
cardiac muscle tissue regeneration (GO:0061026)	3	0	.07	-	 < 0.01	9.32E-01
glycerol catabolic process (GO:0019563)	1	0	.02	-	 < 0.01	9.77E-01
regulation of nucleus organization (GO:1903353)	1	0	.02	-	 < 0.01	9.77E-01
L-ornithine transmembrane transport (GO:1903352)	7	0	.16	-	 < 0.01	8.49E-01
blood coagulation, intrinsic pathway (GO:0007597)	2	0	.05	-	 < 0.01	9.54E-01
forebrain radial glial cell differentiation (GO:0021861)	8	0	.19	-	 < 0.01	8.30E-01
histidine catabolic process to glutamate and formamide (GO:0019556)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of bicellular tight junction assembly (GO:1903348)	7	0	.16	-	 < 0.01	8.49E-01
hepatoblast differentiation (GO:0061017)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of bicellular tight junction assembly (GO:1903347)	4	0	.09	-	 < 0.01	9.11E-01
snRNA import into nucleus (GO:0061015)	2	0	.05	-	 < 0.01	9.54E-01
glutamate catabolic process to 2-oxoglutarate (GO:0019551)	2	0	.05	-	 < 0.01	9.54E-01
glutamate catabolic process to aspartate (GO:0019550)	2	0	.05	-	 < 0.01	9.54E-01
hepatic duct development (GO:0061011)	1	0	.02	-	 < 0.01	9.77E-01
gall bladder development (GO:0061010)	3	0	.07	-	 < 0.01	9.32E-01
GABAergic neuron differentiation in basal ganglia (GO:0021858)	1	0	.02	-	 < 0.01	9.77E-01
hypothalamic tangential migration using cell-axon interactions (GO:0021856)	4	0	.09	-	 < 0.01	9.11E-01
hypothalamus cell migration (GO:0021855)	6	0	.14	-	 < 0.01	8.69E-01
hypothalamus development (GO:0021854)	18	0	.42	-	 < 0.01	6.57E-01
cerebral cortex GABAergic interneuron migration (GO:0021853)	6	0	.14	-	 < 0.01	8.69E-01
pyramidal neuron migration (GO:0021852)	3	0	.07	-	 < 0.01	9.32E-01
common bile duct development (GO:0061009)	8	0	.19	-	 < 0.01	8.30E-01
arginine catabolic process to ornithine (GO:0019547)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of vacuolar transport (GO:1903337)	1	0	.02	-	 < 0.01	9.77E-01
arginine catabolic process to glutamate (GO:0019544)	1	0	.02	-	 < 0.01	9.77E-01
propionate catabolic process (GO:0019543)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of vacuolar transport (GO:1903336)	1	0	.02	-	 < 0.01	9.77E-01
regulation of vacuolar transport (GO:1903335)	3	0	.07	-	 < 0.01	9.32E-01
pattern specification involved in kidney development (GO:0061004)	9	0	.21	-	 < 0.01	8.11E-01
propionate biosynthetic process (GO:0019542)	2	0	.05	-	 < 0.01	9.54E-01
propionate metabolic process (GO:0019541)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of protein folding (GO:1903334)	7	0	.16	-	 < 0.01	8.49E-01
negative regulation of protein folding (GO:1903333)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of dendritic spine morphogenesis (GO:0061002)	8	0	.19	-	 < 0.01	8.30E-01
regulation of protein folding (GO:1903332)	13	0	.30	-	 < 0.01	7.38E-01
negative regulation of dendritic spine development (GO:0061000)	16	0	.37	-	 < 0.01	6.89E-01
nucleolar fragmentation (GO:0007576)	1	0	.02	-	 < 0.01	9.77E-01
age-dependent general metabolic decline (GO:0007571)	3	0	.07	-	 < 0.01	9.32E-01
neuroblast division in subventricular zone (GO:0021849)	3	0	.07	-	 < 0.01	9.32E-01
substrate-independent telencephalic tangential interneuron migration (GO:0021843)	9	0	.21	-	 < 0.01	8.11E-01
establishment of protein localization to endoplasmic reticulum (GO:0072599)	37	0	.86	-	 < 0.01	4.22E-01
chemorepulsion involved in interneuron migration from the subpallium to the cortex (GO:0021842)	1	0	.02	-	 < 0.01	9.77E-01
directional guidance of interneurons involved in migration from the subpallium to the cortex (GO:0021840)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of tRNA metabolic process (GO:1903327)	2	0	.05	-	 < 0.01	9.54E-01
regulation of tRNA metabolic process (GO:1903326)	2	0	.05	-	 < 0.01	9.54E-01
taurine metabolic process (GO:0019530)	7	0	.16	-	 < 0.01	8.49E-01
motogenic signaling involved in postnatal olfactory bulb interneuron migration (GO:0021837)	1	0	.02	-	 < 0.01	9.77E-01
chemorepulsion involved in postnatal olfactory bulb interneuron migration (GO:0021836)	2	0	.05	-	 < 0.01	9.54E-01
embryonic olfactory bulb interneuron precursor migration (GO:0021831)	2	0	.05	-	 < 0.01	9.54E-01
pentitol catabolic process (GO:0019527)	1	0	.02	-	 < 0.01	9.77E-01
interneuron migration from the subpallium to the cortex (GO:0021830)	8	0	.19	-	 < 0.01	8.30E-01
caveolin-mediated endocytosis (GO:0072584)	5	0	.12	-	 < 0.01	8.90E-01
D-gluconate metabolic process (GO:0019521)	2	0	.05	-	 < 0.01	9.54E-01
regulation of nitrogen cycle metabolic process (GO:1903314)	1	0	.02	-	 < 0.01	9.77E-01
aldonic acid metabolic process (GO:0019520)	2	0	.05	-	 < 0.01	9.54E-01
endocardial cushion to mesenchymal transition involved in heart valve formation (GO:0003199)	4	0	.09	-	 < 0.01	9.11E-01
epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198)	12	0	.28	-	 < 0.01	7.56E-01
tricuspid valve formation (GO:0003195)	4	0	.09	-	 < 0.01	9.11E-01
pulmonary valve formation (GO:0003193)	2	0	.05	-	 < 0.01	9.54E-01
gonadotrophin-releasing hormone neuronal migration to the hypothalamus (GO:0021828)	4	0	.09	-	 < 0.01	9.11E-01
postnatal olfactory bulb interneuron migration (GO:0021827)	3	0	.07	-	 < 0.01	9.32E-01
mitral valve formation (GO:0003192)	5	0	.12	-	 < 0.01	8.90E-01
substrate-independent telencephalic tangential migration (GO:0021826)	9	0	.21	-	 < 0.01	8.11E-01
substrate-dependent cerebral cortex tangential migration (GO:0021825)	3	0	.07	-	 < 0.01	9.32E-01
atrioventricular valve formation (GO:0003190)	8	0	.19	-	 < 0.01	8.30E-01
cerebral cortex tangential migration using cell-cell interactions (GO:0021823)	3	0	.07	-	 < 0.01	9.32E-01
pentitol metabolic process (GO:0019519)	1	0	.02	-	 < 0.01	9.77E-01
glycine receptor clustering (GO:0072579)	1	0	.02	-	 < 0.01	9.77E-01
neurotransmitter-gated ion channel clustering (GO:0072578)	13	0	.30	-	 < 0.01	7.38E-01
endothelial cell apoptotic process (GO:0072577)	4	0	.09	-	 < 0.01	9.11E-01
liver morphogenesis (GO:0072576)	10	0	.23	-	 < 0.01	7.92E-01
lactate oxidation (GO:0019516)	1	0	.02	-	 < 0.01	9.77E-01
epithelial cell proliferation involved in liver morphogenesis (GO:0072575)	8	0	.19	-	 < 0.01	8.30E-01
response to phenylpropanoid (GO:0080184)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of regulated secretory pathway (GO:1903307)	59	0	1.38	-	 < 0.01	2.52E-01
hepatocyte proliferation (GO:0072574)	8	0	.19	-	 < 0.01	8.30E-01
negative regulation of regulated secretory pathway (GO:1903306)	22	0	.51	-	 < 0.01	5.99E-01
histone H3-K4 trimethylation (GO:0080182)	16	0	.37	-	 < 0.01	6.89E-01
tolerance induction to lipopolysaccharide (GO:0072573)	2	0	.05	-	 < 0.01	9.54E-01
S-adenosylhomocysteine catabolic process (GO:0019510)	1	0	.02	-	 < 0.01	9.77E-01
dosage compensation (GO:0007549)	19	0	.44	-	 < 0.01	6.42E-01
regulation of pyruvate kinase activity (GO:1903302)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of hexokinase activity (GO:1903301)	6	0	.14	-	 < 0.01	8.69E-01
negative regulation of hexokinase activity (GO:1903300)	4	0	.09	-	 < 0.01	9.11E-01
primary sex determination, germ-line (GO:0007542)	2	0	.05	-	 < 0.01	9.54E-01
heart valve formation (GO:0003188)	14	0	.33	-	 < 0.01	7.21E-01
tricuspid valve morphogenesis (GO:0003186)	7	0	.16	-	 < 0.01	8.49E-01
sinoatrial valve morphogenesis (GO:0003185)	1	0	.02	-	 < 0.01	9.77E-01
pulmonary valve morphogenesis (GO:0003184)	17	0	.40	-	 < 0.01	6.73E-01
mitral valve morphogenesis (GO:0003183)	12	0	.28	-	 < 0.01	7.56E-01
coronary sinus valve morphogenesis (GO:0003182)	1	0	.02	-	 < 0.01	9.77E-01
nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration (GO:0021817)	3	0	.07	-	 < 0.01	9.32E-01
atrioventricular valve morphogenesis (GO:0003181)	23	0	.54	-	 < 0.01	5.85E-01
extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration (GO:0021816)	1	0	.02	-	 < 0.01	9.77E-01
aortic valve morphogenesis (GO:0003180)	20	0	.47	-	 < 0.01	6.27E-01
modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration (GO:0021815)	4	0	.09	-	 < 0.01	9.11E-01
cell motility involved in cerebral cortex radial glia guided migration (GO:0021814)	6	0	.14	-	 < 0.01	8.69E-01
cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration (GO:0021813)	1	0	.02	-	 < 0.01	9.77E-01
neuronal-glial interaction involved in cerebral cortex radial glia guided migration (GO:0021812)	2	0	.05	-	 < 0.01	9.54E-01
L-methionine salvage from methylthioadenosine (GO:0019509)	5	0	.12	-	 < 0.01	8.90E-01
hydrogen peroxide transmembrane transport (GO:0080170)	1	0	.02	-	 < 0.01	9.77E-01
type B pancreatic cell maturation (GO:0072560)	1	0	.02	-	 < 0.01	9.77E-01
lateral sprouting involved in mammary gland duct morphogenesis (GO:0060599)	2	0	.05	-	 < 0.01	9.54E-01
dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis (GO:0060598)	2	0	.05	-	 < 0.01	9.54E-01
primary sex determination (GO:0007538)	2	0	.05	-	 < 0.01	9.54E-01
mammary placode formation (GO:0060596)	4	0	.09	-	 < 0.01	9.11E-01
chondroblast differentiation (GO:0060591)	4	0	.09	-	 < 0.01	9.11E-01
sex determination (GO:0007530)	26	0	.61	-	 < 0.01	5.45E-01
coronary sinus valve development (GO:0003178)	1	0	.02	-	 < 0.01	9.77E-01
pulmonary valve development (GO:0003177)	21	0	.49	-	 < 0.01	6.13E-01
aortic valve development (GO:0003176)	25	0	.58	-	 < 0.01	5.58E-01
tricuspid valve development (GO:0003175)	8	0	.19	-	 < 0.01	8.30E-01
mitral valve development (GO:0003174)	13	0	.30	-	 < 0.01	7.38E-01
cytosolic calcium signaling involved in initiation of cell movement in glial-mediated radial cell migration (GO:0021808)	1	0	.02	-	 < 0.01	9.77E-01
sinoatrial valve development (GO:0003172)	1	0	.02	-	 < 0.01	9.77E-01
atrioventricular valve development (GO:0003171)	26	0	.61	-	 < 0.01	5.45E-01
initiation of movement involved in cerebral cortex radial glia guided migration (GO:0021806)	1	0	.02	-	 < 0.01	9.77E-01
cerebral cortex tangential migration (GO:0021800)	7	0	.16	-	 < 0.01	8.49E-01
blood vessel lumenization (GO:0072554)	2	0	.05	-	 < 0.01	9.54E-01
regulation of protein serine/threonine phosphatase activity (GO:0080163)	1	0	.02	-	 < 0.01	9.77E-01
terminal button organization (GO:0072553)	4	0	.09	-	 < 0.01	9.11E-01
establishment of synaptic specificity at neuromuscular junction (GO:0007529)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of lipoprotein lipid oxidation (GO:0060588)	1	0	.02	-	 < 0.01	9.77E-01
regulation of lipoprotein lipid oxidation (GO:0060587)	2	0	.05	-	 < 0.01	9.54E-01
multicellular organismal iron ion homeostasis (GO:0060586)	9	0	.21	-	 < 0.01	8.11E-01
cell fate determination involved in pattern specification (GO:0060582)	1	0	.02	-	 < 0.01	9.77E-01
visceral muscle development (GO:0007522)	1	0	.02	-	 < 0.01	9.77E-01
cell fate commitment involved in pattern specification (GO:0060581)	12	0	.28	-	 < 0.01	7.56E-01
muscle cell fate determination (GO:0007521)	2	0	.05	-	 < 0.01	9.54E-01
coronary vein morphogenesis (GO:0003169)	2	0	.05	-	 < 0.01	9.54E-01
ventral spinal cord interneuron fate determination (GO:0060580)	1	0	.02	-	 < 0.01	9.77E-01
Purkinje myocyte differentiation (GO:0003168)	1	0	.02	-	 < 0.01	9.77E-01
atrioventricular bundle cell differentiation (GO:0003167)	1	0	.02	-	 < 0.01	9.77E-01
Purkinje myocyte development (GO:0003165)	2	0	.05	-	 < 0.01	9.54E-01
sinoatrial node development (GO:0003163)	7	0	.16	-	 < 0.01	8.49E-01
atrioventricular node development (GO:0003162)	3	0	.07	-	 < 0.01	9.32E-01
regulation of fertilization (GO:0080154)	13	0	.30	-	 < 0.01	7.38E-01
T-helper 17 cell lineage commitment (GO:0072540)	9	0	.21	-	 < 0.01	8.11E-01
ventral spinal cord interneuron fate commitment (GO:0060579)	12	0	.28	-	 < 0.01	7.56E-01
myoblast fate determination (GO:0007518)	1	0	.02	-	 < 0.01	9.77E-01
superior vena cava morphogenesis (GO:0060578)	1	0	.02	-	 < 0.01	9.77E-01
pulmonary vein morphogenesis (GO:0060577)	2	0	.05	-	 < 0.01	9.54E-01
intestinal epithelial cell development (GO:0060576)	14	0	.33	-	 < 0.01	7.21E-01
intestinal epithelial cell differentiation (GO:0060575)	21	0	.49	-	 < 0.01	6.13E-01
intestinal epithelial cell maturation (GO:0060574)	2	0	.05	-	 < 0.01	9.54E-01
cell fate specification involved in pattern specification (GO:0060573)	8	0	.19	-	 < 0.01	8.30E-01
adult heart development (GO:0007512)	16	0	.37	-	 < 0.01	6.89E-01
morphogenesis of an endothelium (GO:0003159)	12	0	.28	-	 < 0.01	7.56E-01
regulation of animal organ formation (GO:0003156)	31	0	.72	-	 < 0.01	4.85E-01
glycolate catabolic process (GO:0046296)	1	0	.02	-	 < 0.01	9.77E-01
T-helper 17 cell differentiation (GO:0072539)	12	0	.28	-	 < 0.01	7.56E-01
glycolate biosynthetic process (GO:0046295)	1	0	.02	-	 < 0.01	9.77E-01
T-helper 17 type immune response (GO:0072538)	13	0	.30	-	 < 0.01	7.38E-01
formaldehyde catabolic process (GO:0046294)	3	0	.07	-	 < 0.01	9.32E-01
fibroblast activation (GO:0072537)	5	0	.12	-	 < 0.01	8.90E-01
formaldehyde biosynthetic process (GO:0046293)	1	0	.02	-	 < 0.01	9.77E-01
formaldehyde metabolic process (GO:0046292)	5	0	.12	-	 < 0.01	8.90E-01
amino acid homeostasis (GO:0080144)	6	0	.14	-	 < 0.01	8.69E-01
pyrimidine-containing compound transmembrane transport (GO:0072531)	11	0	.26	-	 < 0.01	7.74E-01
purine-containing compound transmembrane transport (GO:0072530)	7	0	.16	-	 < 0.01	8.49E-01
mesoderm migration involved in gastrulation (GO:0007509)	1	0	.02	-	 < 0.01	9.77E-01
regulation of postsynaptic density protein 95 clustering (GO:1902897)	4	0	.09	-	 < 0.01	9.11E-01
positive regulation of DNA-templated transcription, termination (GO:0060566)	1	0	.02	-	 < 0.01	9.77E-01
terminal web assembly (GO:1902896)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894)	17	0	.40	-	 < 0.01	6.73E-01
neuroepithelial cell differentiation (GO:0060563)	22	0	.51	-	 < 0.01	5.99E-01
digestive tract mesoderm development (GO:0007502)	1	0	.02	-	 < 0.01	9.77E-01
apoptotic process involved in morphogenesis (GO:0060561)	17	0	.40	-	 < 0.01	6.73E-01
mesodermal cell fate specification (GO:0007501)	6	0	.14	-	 < 0.01	8.69E-01
mesodermal cell fate determination (GO:0007500)	1	0	.02	-	 < 0.01	9.77E-01
neural crest cell migration involved in heart formation (GO:0003147)	1	0	.02	-	 < 0.01	9.77E-01
embryonic heart tube formation (GO:0003144)	1	0	.02	-	 < 0.01	9.77E-01
cardiogenic plate morphogenesis (GO:0003142)	1	0	.02	-	 < 0.01	9.77E-01
determination of left/right asymmetry in lateral mesoderm (GO:0003140)	6	0	.14	-	 < 0.01	8.69E-01
pyrimidine-containing compound catabolic process (GO:0072529)	22	0	.51	-	 < 0.01	5.99E-01
pyrimidine-containing compound biosynthetic process (GO:0072528)	24	0	.56	-	 < 0.01	5.71E-01
pyrimidine-containing compound metabolic process (GO:0072527)	53	0	1.24	-	 < 0.01	2.90E-01
pyridine-containing compound catabolic process (GO:0072526)	10	0	.23	-	 < 0.01	7.92E-01
pyridine-containing compound biosynthetic process (GO:0072525)	22	0	.51	-	 < 0.01	5.99E-01
pyridine-containing compound metabolic process (GO:0072524)	32	0	.75	-	 < 0.01	4.74E-01
purine-containing compound catabolic process (GO:0072523)	46	0	1.07	-	 < 0.01	3.42E-01
positive regulation of calcidiol 1-monooxygenase activity (GO:0060559)	3	0	.07	-	 < 0.01	9.32E-01
protein localization to spindle microtubule (GO:1902889)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of vitamin D biosynthetic process (GO:0060557)	2	0	.05	-	 < 0.01	9.54E-01
regulation of vitamin D biosynthetic process (GO:0060556)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of response to oxidative stress (GO:1902884)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of fructose 1,6-bisphosphate metabolic process (GO:0060552)	1	0	.02	-	 < 0.01	9.77E-01
regulation of fructose 1,6-bisphosphate metabolic process (GO:0060551)	1	0	.02	-	 < 0.01	9.77E-01
secondary heart field specification (GO:0003139)	11	0	.26	-	 < 0.01	7.74E-01
positive regulation of fructose 1,6-bisphosphate 1-phosphatase activity (GO:0060550)	1	0	.02	-	 < 0.01	9.77E-01
primary heart field specification (GO:0003138)	3	0	.07	-	 < 0.01	9.32E-01
negative regulation of heart induction by canonical Wnt signaling pathway (GO:0003136)	1	0	.02	-	 < 0.01	9.77E-01
endodermal-mesodermal cell signaling involved in heart induction (GO:0003134)	3	0	.07	-	 < 0.01	9.32E-01
endodermal-mesodermal cell signaling (GO:0003133)	3	0	.07	-	 < 0.01	9.32E-01
BMP signaling pathway involved in heart induction (GO:0003130)	3	0	.07	-	 < 0.01	9.32E-01
proteasome core complex assembly (GO:0080129)	1	0	.02	-	 < 0.01	9.77E-01
stilbene catabolic process (GO:0046272)	1	0	.02	-	 < 0.01	9.77E-01
phenylpropanoid catabolic process (GO:0046271)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of secondary heart field cardioblast proliferation (GO:0072513)	5	0	.12	-	 < 0.01	8.90E-01
AMP transport (GO:0080121)	1	0	.02	-	 < 0.01	9.77E-01
CAAX-box protein maturation (GO:0080120)	2	0	.05	-	 < 0.01	9.54E-01
regulation of fructose 1,6-bisphosphate 1-phosphatase activity (GO:0060549)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of necrotic cell death (GO:0060547)	21	0	.49	-	 < 0.01	6.13E-01
negative regulation of necroptotic process (GO:0060546)	15	0	.35	-	 < 0.01	7.05E-01
positive regulation of necroptotic process (GO:0060545)	3	0	.07	-	 < 0.01	9.32E-01
regulation of necroptotic process (GO:0060544)	19	0	.44	-	 < 0.01	6.42E-01
regulation of strand invasion (GO:0060542)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of amacrine cell differentiation (GO:1902871)	2	0	.05	-	 < 0.01	9.54E-01
heart induction (GO:0003129)	3	0	.07	-	 < 0.01	9.32E-01
diaphragm morphogenesis (GO:0060540)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of amacrine cell differentiation (GO:1902870)	2	0	.05	-	 < 0.01	9.54E-01
heart field specification (GO:0003128)	12	0	.28	-	 < 0.01	7.56E-01
detection of nodal flow (GO:0003127)	3	0	.07	-	 < 0.01	9.32E-01
trivalent inorganic anion homeostasis (GO:0072506)	16	0	.37	-	 < 0.01	6.89E-01
DNA demethylation (GO:0080111)	14	0	.33	-	 < 0.01	7.21E-01
cellular trivalent inorganic anion homeostasis (GO:0072502)	11	0	.26	-	 < 0.01	7.74E-01
regulation of amacrine cell differentiation (GO:1902869)	4	0	.09	-	 < 0.01	9.11E-01
cartilage morphogenesis (GO:0060536)	12	0	.28	-	 < 0.01	7.56E-01
trachea cartilage morphogenesis (GO:0060535)	4	0	.09	-	 < 0.01	9.11E-01
trachea cartilage development (GO:0060534)	8	0	.19	-	 < 0.01	8.30E-01
bronchus cartilage development (GO:0060532)	2	0	.05	-	 < 0.01	9.54E-01
propionyl-CoA biosynthetic process (GO:1902860)	1	0	.02	-	 < 0.01	9.77E-01
detection of monosaccharide stimulus (GO:0034287)	2	0	.05	-	 < 0.01	9.54E-01
response to disaccharide (GO:0034285)	2	0	.05	-	 < 0.01	9.54E-01
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development (GO:0060528)	4	0	.09	-	 < 0.01	9.11E-01
propionyl-CoA catabolic process (GO:1902859)	1	0	.02	-	 < 0.01	9.77E-01
propionyl-CoA metabolic process (GO:1902858)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of non-motile cilium assembly (GO:1902857)	11	0	.26	-	 < 0.01	7.74E-01
activation of prostate induction by androgen receptor signaling pathway (GO:0060520)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of the force of heart contraction by chemical signal (GO:0003108)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of glomerular filtration by angiotensin (GO:0003106)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of glomerular filtration (GO:0003105)	6	0	.14	-	 < 0.01	8.69E-01
positive regulation of glomerular filtration (GO:0003104)	4	0	.09	-	 < 0.01	9.11E-01
terpene catabolic process (GO:0046247)	1	0	.02	-	 < 0.01	9.77E-01
kynurenic acid biosynthetic process (GO:0034276)	2	0	.05	-	 < 0.01	9.54E-01
kynurenic acid metabolic process (GO:0034275)	2	0	.05	-	 < 0.01	9.54E-01
epithelial cell proliferation involved in prostatic bud elongation (GO:0060517)	1	0	.02	-	 < 0.01	9.77E-01
primary prostatic bud elongation (GO:0060516)	2	0	.05	-	 < 0.01	9.54E-01
regulation of neuronal signal transduction (GO:1902847)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of mitotic spindle elongation (GO:1902846)	1	0	.02	-	 < 0.01	9.77E-01
prostatic bud formation (GO:0060513)	4	0	.09	-	 < 0.01	9.11E-01
type II pneumocyte differentiation (GO:0060510)	7	0	.16	-	 < 0.01	8.49E-01
type I pneumocyte differentiation (GO:0060509)	7	0	.16	-	 < 0.01	8.49E-01
positive regulation of autophagy in response to ER overload (GO:0034263)	3	0	.07	-	 < 0.01	9.32E-01
regulation of nuclear migration along microtubule (GO:1902838)	1	0	.02	-	 < 0.01	9.77E-01
smoothened signaling pathway involved in lung development (GO:0060506)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of proline import across plasma membrane (GO:1902836)	1	0	.02	-	 < 0.01	9.77E-01
regulation of proline import across plasma membrane (GO:1902834)	1	0	.02	-	 < 0.01	9.77E-01
bud dilation involved in lung branching (GO:0060503)	1	0	.02	-	 < 0.01	9.77E-01
epithelial cell proliferation involved in lung morphogenesis (GO:0060502)	3	0	.07	-	 < 0.01	9.32E-01
coumarin catabolic process (GO:0046226)	1	0	.02	-	 < 0.01	9.77E-01
aflatoxin catabolic process (GO:0046223)	2	0	.05	-	 < 0.01	9.54E-01
aflatoxin metabolic process (GO:0046222)	3	0	.07	-	 < 0.01	9.32E-01
regulation of urea metabolic process (GO:0034255)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of late endosome to lysosome transport (GO:1902824)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of late endosome to lysosome transport (GO:1902823)	1	0	.02	-	 < 0.01	9.77E-01
regulation of late endosome to lysosome transport (GO:1902822)	2	0	.05	-	 < 0.01	9.54E-01
indolalkylamine catabolic process (GO:0046218)	7	0	.16	-	 < 0.01	8.49E-01
nitric oxide catabolic process (GO:0046210)	1	0	.02	-	 < 0.01	9.77E-01
snoRNA splicing (GO:0034247)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244)	11	0	.26	-	 < 0.01	7.74E-01
regulation of transcription elongation from RNA polymerase II promoter (GO:0034243)	31	0	.72	-	 < 0.01	4.85E-01
negative regulation of protein localization to microtubule (GO:1902817)	2	0	.05	-	 < 0.01	9.54E-01
negative regulation of syncytium formation by plasma membrane fusion (GO:0034242)	6	0	.14	-	 < 0.01	8.69E-01
regulation of protein localization to microtubule (GO:1902816)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of macrophage fusion (GO:0034241)	5	0	.12	-	 < 0.01	8.90E-01
negative regulation of macrophage fusion (GO:0034240)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of skeletal muscle fiber differentiation (GO:1902811)	3	0	.07	-	 < 0.01	9.32E-01
nitric oxide metabolic process (GO:0046209)	17	0	.40	-	 < 0.01	6.73E-01
spermine catabolic process (GO:0046208)	3	0	.07	-	 < 0.01	9.32E-01
nor-spermidine metabolic process (GO:0046204)	1	0	.02	-	 < 0.01	9.77E-01
positive regulation of cellular extravasation (GO:0002693)	20	0	.47	-	 < 0.01	6.27E-01
spermidine catabolic process (GO:0046203)	2	0	.05	-	 < 0.01	9.54E-01
regulation of macrophage fusion (GO:0034239)	6	0	.14	-	 < 0.01	8.69E-01
macrophage fusion (GO:0034238)	2	0	.05	-	 < 0.01	9.54E-01
regulation of skeletal muscle fiber differentiation (GO:1902809)	4	0	.09	-	 < 0.01	9.11E-01
islet amyloid polypeptide processing (GO:0034231)	1	0	.02	-	 < 0.01	9.77E-01
enkephalin processing (GO:0034230)	2	0	.05	-	 < 0.01	9.54E-01
positive regulation of synaptic vesicle transport (GO:1902805)	1	0	.02	-	 < 0.01	9.77E-01
negative regulation of synaptic vesicle transport (GO:1902804)	1	0	.02	-	 < 0.01	9.77E-01
regulation of synaptic vesicle transport (GO:1902803)	4	0	.09	-	 < 0.01	9.11E-01
negative regulation of leukocyte chemotaxis (GO:0002689)	17	0	.40	-	 < 0.01	6.73E-01
somatic recombination of T cell receptor gene segments (GO:0002681)	5	0	.12	-	 < 0.01	8.90E-01
tRNA thio-modification (GO:0034227)	5	0	.12	-	 < 0.01	8.90E-01
cellular response to zinc ion starvation (GO:0034224)	2	0	.05	-	 < 0.01	9.54E-01
